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Lung cancer most often presents as a pulmonary nodule or mass, less commonly 
as a hilar mass or endobronchial lesion. Most small tumours radiologically present 
as pulmonary nodules. Chest radiography (CXR) is limited in demonstration of small 
nodules and even lesions as large as 3 cm may be missed. Digital tomosynthesis 
has been shown to markedly improve sensitivity for pulmonary nodules as com-
pared to CXR but is not yet widely available. Magnetic resonance imaging (MRI), 
too, is more sensitive than CXR, but is not routinely performed due to cost and 
limited availability. The gold standard for detection of pulmonary nodules as small 
as 1-2 mm is multidetector computed tomography (MDCT). Technically, MDCT 
can demonstrate pulmonary nodules with a sensitivity close to 100%, however, 
sensitivity of individual radiologists is much lower. Computer-assisted detection 
(CAD) software may improve sensitivity but may be limited by false positive find-
ings. Positron emission tomography (PET)-CT using 18 F-Deoxyglucose (18 FDG) 
has a high sensitivity for lung cancer, however, false negative findings may be due 
to well-differentiated adenocarcinoma, carcinoid and nodules < 10 mm whereas 
false positive findings may be due to inflammatory lesions. This interactive ses-
sion will include examples of manifestations of lung cancer as well as data on the 
accuracy of different imaging methods for lung cancer detection. Endobronchial 
and hilar tumours are more difficult to detect radiologically. Flat mucosal lesions 
may go undetected altogether with bronchoscopy representing the gold standard 
for these lesions.
Learning Objectives:
1.  To learn which imaging techniques are appropriate for detecting lung cancer.
2.  To learn about the most relevant imaging findings in lung cancer.
3.  To understand the behaviour of lung cancer related to imaging.
A-004 14:45
B. Follow-up 
F. Gleeson; Oxford/UK (fergus.gleeson@orh.nhs.uk) 
Although the initial staging of lung cancer is well worked up and agreed, the method 
of follow-up, and the frequency of follow-up investigations is less well investigated 
or agreed. There are now second line treatments available for patients with lung 
cancer initially treated with intention to cure. The second line treatments are in part 
dependent upon the volume of disease at relapse. It is important to understand 
which patients should be carefully followed up for potential second line treatment. 
Second line treatments include surgery, radiotherapy, percutaneous ablation and 
chemotherapy. All have evidence to demonstrate an increase in survival follow-
ing relapse or disease progression. This presentation will summarise the current 
evidence and suggest algorithms that may be implemented to reduce cost and 
maximise patient benefit.
Learning Objectives:
1.  To know the common features of lung cancer recurrence.
2.  To learn how to establish follow-up protocols after treatment of lung cancer.
12:30 - 13:30  Room N/O 
The Beauty of Basic Knowledge: Head and Neck 
MC 24 A 
A taste of the oral cavity and salivary glands 
A-001 12:30
A taste of the oral cavity and salivary glands 
A. Borges; Lisbon/PT (borgalexandra@gmail.com) 
The oral cavity is a large mucosal space open anteriorly, bordered superiorly by 
the nasal cavity and posteriorly by the oropharynx, containing a central muscular 
piece- the oral tongue. Inferiorly, the floor of the mouth, composed by the milohyoid 
muscles, separates the mucosal space from the sublingual and submandibular 
spaces which contain the homonym salivary glands. The parotid gland, the larg-
est of the salivary glands, lays in the parotid space with its major duct traveling 
through the buccal space and opening in the oral mucosa opposed to the second 
upper molars. It surrounds the ascending ramus of the mandible and is traversed 
by the main trunk of the facial nerve which divides the gland into superficial and 
deep lobes; the later insinuating itself into the parapharyngeal space through the 
stylomandibular tunnel. Although the mucosal space is widely accessible to clinical 
inspection, imaging is crucial to depict pathology spreading to or originating from 
the submucosa as well as to adequately depict areas of difficult clinical access 
such as the retromolar space- a small triangular area of mucosa posterior to the last 
molars. Superficial structures in the submandibular and parotid-bucco-masseteric 
region can be adequately depicted by ultrasound whereas deep seated structures 
are best evaluated using CT and/or MRI. Here, we will review the basic anatomy, 
imaging technique and main pathological processes affecting these head and 
neck structures.
Learning Objecties:
1.  To become familiar with the anatomy of the oral cavity and salivary glands.
2.  To learn how to tailor imaging approaches to the patient’s clinical presentation.
3.  To appreciate the main pathologic processes of the oral cavity and salivary 
glands.
12:30 - 13:30 Room P 
The Beauty of Basic Knowledge: Musculoskeletal Imaging 




A. Kassarjian; Majadahonda/ES (akassarjian@gmail.com) 
A basic understanding of anatomy and biomechanics is crucial for the understanding 
of musculoskeletal injuries. Such thorough knowledge allows one to look beyond 
the obvious/primary injury and search for commonly associated injuries that may 
be quite subtle, are often overlooked, and may have significant clinical implications. 
This session will cover upper and lower extremity injuries and explore the biome-
chanics, pathophysiology and constellation of injury patterns as seen on imaging.
Learning Objectives:
1.  To learn about the basic mechanisms of musculoskeletal trauma.
2.  To become familiar with typical musculoskeletal injuries and injury patterns.




SB C D E F GA
Thursday
16:00 - 17:30 Room C 
GI Tract 
RC 301 
Staging and restaging of rectal and anal cancer 
A-007 16:00
Chairman’s introduction 
R.G.H. Beets-Tan; Maastricht/NL (r.beets.tan@mumc.nl) 
The increasing role of radiologists in the multidisciplinary management team of 
patients with rectal and anal cancer is well recognised and MR imaging has become 
the imaging method of choice for staging these tumours. Although organ saving 
treatment has been adopted in patients with anal cancer, it is still debatable in pa-
tients with rectal cancer. Partly, this is because in rectal cancer, in contrast to anal 
cancer - where clinical examination is accurate for selection of patients for organ 
preservation -, it is not reliable to solely base decision-making on the endoscopic 
inspection of the luminal aspect of the rectal wall. The shift in rectal cancer treatment 
however is eminent and the role of imaging pushing forward this shift is obvious. 
Hence, the relevant questions that will be asked to radiologists in the coming years 
are: “how accurate can we assess response to treatment and how accurate can we 
monitor sustained response during the long term surveillance?” The objective of this 
session is to understand the value of modern planar imaging method for primary 
staging of rectal and anal cancer patients (MRI, PET/CT). A second objective is to 
know the performance of these imaging techniques for assessment of response, for 
selection of patients for organ preserving treatment and for monitoring of sustained 
response at long term follow-up. The session will elaborate on the similarities and 
differences of diagnostic questions for anal and rectal cancer.
A-008 16:05
A. Local staging of anal and rectal cancer and impact on initial 
therapeutic strategy 
S. Gourtsoyianni; London/UK (sgty76@gmail.com) 
New generation MRI scanners with optimal phased array body coils, resulting in 
improved contrast and spatial resolution images due to better signal to noise ratio, 
have contributed to production of high-resolution images in which visualisation of 
anatomical details such as the mesorectal fascia, mesorectal lymph nodes with a 
diameter down to 2 mm and the bowel wall layers are feasible. Pre-operative MRI 
of the rectum using mainly high-resolution T2 weighted sequences has gained 
significant accreditation, especially after the introduction of total mesorectal excision 
(TME) surgery and neoadjuvant therapy in the treatment regimen of rectal cancer. 
MR Imaging is so far the only method that can preoperatively identify patients 
most likely to benefit from neoadjuvant therapy as well as demonstrate high-risk 
patients for local recurrence. Anal cancers are more rare, account for < 1% of large 
bowel tumours, are predominantly squamous cell carcinomas and are treated with 
definitive chemoradiation. Imaging and especially MRI with multiple advanced 
contrast mechanisms may play a significant role in radiotherapy planning as it may 
accurately delineate the extent of the primary tumour and allow for more precise 
gross tumour volume and potentially target volume definition.
Learning Objectives:
1.  To learn about optimised MR techniques for rectal and anal cancer staging.
2.  To become familiar with the role of endorectal ultrasound in anorectal cancer 
staging.
3.  To understand basic TNM staging and assessment of the CRM on imaging.
4.  To understand how imaging findings influence the initial therapeutic approach.
A-009 16:35
B. Assessment of rectal cancer response 
L. Curvo-Semedo; Coimbra/PT (curvosemedo@gmail.com) 
The objective of neoadjuvant therapy is to downstage and downsize the tumour 
in order to improve resectability and achieve better local control. Preoperative 
chemoradiation therapy (CRT) has become standard of care for locally advanced 
rectal cancer and led to a decline in local recurrence rates. Post-CRT MRI for 
assessing invasion of mesorectal fascia (MRF) based on morphologic criteria 
alone shows both high sensitivity and NPV. Its main challenge is the assessment 
of hypointense “fibrotic” tissue in the initial tumour area that may contain small 
residual tumour nests. DWI can help differentiate neoplastic from radiation-induced 
fibrosis and inflammation within the MRF, potentially improving the overall diag-
nostic accuracy. The reported overall accuracy of MRI in assessing the T stage 
16:00 - 17:30 Room B 
Interactive Teaching Session 
E³ 320 
Malignant pancreatic tumours 
A-005 16:00
A. Solid tumours 
W. Schima; Vienna/AT (wolfgang.schima@khgh.at) 
The most common pancreatic malignancy is ductal adenocarcinoma, with neu-
roendocrine tumours (NET), lymphoma and metastases being important differential 
diagnoses. Non-neoplastic pitfalls include focal pancreatitis and lipoma. Multi-phasic 
hydro-MDCT is very effective in detection of hypoattenuating adenocarcinoma (sen-
sitivity up to 90%). In 5-11% of patients, isoattenuatting cancers will show only indi-
rect tumour signs (duct dilatation, contour deformity, loss of lobulation, mass effect). 
MRI is a problem-solving tool in equivocal CT to depict small cancers. Best pulse 
sequences for detection are unenhanced T1w GRE fatsat, dynamic enhanced 3D-
GRE fatsat and DWI. Important issues in cancer staging are presence of vascular 
involvement (celiac taxis, SMA, SMV, portal vein), lymph nodes, or liver metastases. 
3D reformations (MIP, VRT, CPR) of MDCT datasets are helpful to demonstrate 
vascular invasion, although minimal invasion may elapse CT or MR imaging. NET 
tend to be hypervascular, which is best seen in the arterial phase. RCC metastases 
to the pancreas are not uncommon. They are typically hypervascular, mimicking 
NET at imaging. Most important non-neoplastic solid mass is focal pancreatitis. 
The duct penetrating sign at MRCP helps to differentiate focal inflammation from 
cancer, although multimodality imaging including biopsy is often required to make 
a definitive diagnosis. Focal steatosis or lipoma is easily diagnosed by chemical 
shift MRI (T1w GRE in- and opposed-phase). In conclusion, multi-phasic hydro-
MDCT is excellent for cancer detection, with 3D reformations for demonstration of 
vascular involvement. For differentiation between cancer and tumour-simulating 
disease (focal pancreatitis, steatosis), MRI is complementary to MDCT. 
Learning Objectives:
1.  To learn how to differentiate tumours from other non-tumoural pathology.
2.  To understand how to choose the proper imaging technology.
3.  To appreciate how to determine resectability and extension of the tumour.
Author Disclosure:
W. Schima: Advisory Board; GE Healthcare. Speaker; Siemens. 
A-006 16:45
B. Cystic tumours 
G. Morana; Treviso/IT (gmorana@ulss.tv.it) 
Cystic lesions of the pancreas can be recognised in up to 8%-10% of abdominal 
studies, although most of them are benign. Real cystic tumours of the pancreas 
are more rare and less frequent than solid lesions; quite often they are occasionally 
recognised, as many of these lesions are small and asymptomatic, but they may 
be associated with pancreatitis. An accurate differentiation between different cystic 
lesions is important because they require a different treatment according to their 
hystological type and differentiation, but due to the frequent lack of specific clinical 
and laboratoristic signs, the overlap of imaging findings between different cystic 
tumours and between non-neoplastic and neoplastic cistic lesions of the pancreas, 
the management of these patients is complex, and knowledge of symptoms of 
the patients, natural history and predictors of malignancy are important. When 
dealing with pancreatic cysts, aim of the imaging is to differentiate cystic tumour 
from tumour-like lesions and to characterise cystic tumour, distinguishing benign 
tumour, which usually do not require surgical excission, from border-line or malig-
nant ones, which must be resected whenever possible. On the basis of imaging 
criteria alone, it can be very difficult to differentiate non-tumoural cystic lesions from 
neoplastic ones; in order to achieve a correct diagnosis, it is important to correlate 
the imaging findings with the clinical history of the patient, the presence or absence 
of symptoms, and their type. US, CT and MRI are excellent tools which permit to 
accurately evaluate these lesions, making thus possible their correct management.
Learning Objectives:
1.  To learn how to choose the proper imaging modality.
2.  To understand the criteria of malignancy and benignity.
3.  To learn how to follow-up the lesions.
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substantially benefit from the B0 increase. The work horse of cardiac MRI, cine 
SSFP is affected by off-resonance artifacts at higher B0, with proper adjustments 
(shimming, frequency scouting) though diagnostic image quality can be maintained. 
Most importantly, in daily routine also the safety aspect of the patient with potential 
devices has to be taken into account.
Learning Objectives:
1.  To learn about the differences between 1.5 T and 3 T cardiac MRI.
2.  To understand the clinical applications of high-field cardiac MRI.
3.  To become familiar with the problems of using high-field cardiac MRI in daily 
routine.
Author Disclosure:
B. J. Wintersperger: Speaker; Siemens Healthcare, Bayer Healthcare. 
A-012 16:30
B. Cardiac CT: technique in 2020; where to next? 
K. Nikolaou; Munich/DE (konstantin.nikolaou@med.uni‑muenchen.de) 
In recent years, technical advances and improvements in cardiac computed 
tomography (CT) have provoked increasing interest in the potential clinical role 
of this technique in the non-invasive work-up of patients with various cardiac 
diseases - most importantly in patients with suspected coronary artery disease 
(CAD). Within the next years, several trends are foreseeable: from a research 
standpoint, the strengthening of clinical evidence by larger, randomised, clinical 
multicentre trials for cardiac-CT indications can be expected. From a technical 
standpoint, there are two main fields of interest and technical developments to be 
expected: further optimising radiation dose and image quality, by techniques such 
as high-pitch scanning, iterative reconstruction algorithms, wide detectors with 
single heart beat acquisitions and digital detector technology. On the other hand, 
introduction of new applications and protocols, such as the combined assessment 
of cardiac morphology, function, and viability/perfusion, will broaden the clinical 
applicability of cardiac-CT.
Learning Objectives:
1.  To learn about the latest technical developments in state-of-the-art cardiac 
CT.
2.  To explore what new developments will influence cardiac CT over the next 
few years.
3.  To understand if what you need is a lot of rows, tubes or both for optimal 
cardiac CT.
A-013 17:00




1.  To understand the principles of cardiac hybrid imaging.
2.  To learn about the diagnostic value of hybrid imaging.
3.  To know about possible indications for performing hybrid imaging.
16:00 - 17:30 Room E1 
Molecular Imaging 
RC 306 




A. New PET-tracers for oncology 
P.L. Choyke; Bethesda, MD/US (pchoyke@nih.gov) 
PET tracers represent an exciting development in the imaging of cancers. Because 
of the sensitivity of PET (nano-pico molar sensitivity vs. micromolar for MRI), it is 
possible to image cell membrane-based receptors responsible for the abnormal 
growth associated with cancers and detect subtle changes in the integrity of cancer 
cells. FDG-PET /CT has been the trailblazer agent, demonstrating unique sensitiv-
ity for cancers, however, while FDG uptake does reflect glycolysis, it is relatively 
non-specific and, to date, has not dictated the choice of therapies. The promise 
of new PET agents is that they will aid clinicians in adding or deleting therapies 
depending on the pharmacodynamics of the imaging biomarker. For instance, 
classes of agents have been developed to investigate angiogenesis, proliferation, 
of irradiated rectal cancer is 47%-54%. The major cause of overstaging is diffuse 
hypointense tissue infiltration into the mesorectal fat, related to marked fibrosis of 
the bowel wall and desmoplastic reaction. Replacement by fibrotic scar tissue with 
an island of residual adenocarcinoma can make it difficult to identify viable tumour 
on MR images, causing understaging. Imaging after CRT is not sufficiently accurate 
for identifying complete responders, with PPVs ranging from 17 to 50%. In most 
cases, a hypointense scar replaces the site of disease, and the major component 
of error on MRI is overstaging due to its limited capability to differentiate between 
viable tumour, residual fibrotic tissue, and desmoplastic reaction. DWI in addition 
to standard MRI significantly improves the performance of radiologists to select 
complete responders.
Learning Objectives:
1.  To learn the rationale for following-up on patients after neoadjuvant chemo-
radiation.
2.  To understand conventional imaging criteria for assessing tumour response.
3.  To learn about new techniques for assessing response, including diffusion 
MRI and PET/CT.
A-010 16:55
C. Assessment of anal cancer response 
V.J. Goh; London/UK (vicky.goh@kcl.ac.uk) 
Anal cancer is an uncommon cancer, accounting for 1.5% of all gastrointestinal 
cancers, but is increasing in incidence. Anal cancer is predominantly a loco-regional 
disease; less than 5% of patients have disease outside the pelvis at presentation. 
Definitive chemoradiation, combining radiotherapy with concomitant 5-fluorouracil 
and mitomycin C, is recognised to be the optimal treatment modality for squamous 
cell cancers of the anal canal and margin, offering good loco-regional control and 
survival rates similar to surgery. Traditionally clinical examination and proctoscopy 
have been the main tools for locoregional tumour assessment, however, in recent 
years, imaging has become the method of choice for assessing tumour regression 
following chemoradiation. The advantage and limitations of the different imaging 
techniques in assessing response will be described. The complications of treatment 
and imaging appearances will also be discussed.
Learning Objectives:
1.  To learn the rationale for restaging after therapy.
2.  To know how to assess the tumour response with conventional imaging criteria.
3.  To learn about new techniques for assessing response in anal cancer, including 
diffusion MRI and PET/CT.
Panel discussion:
What clinicians expect from us in rectal and anal cancer staging and 
restaging? How should we image patients? 17:15 
16:00 - 17:30 Room D2 
Cardiac 
RC 303 




A. Cardiac MRI: do we need more than 1.5 T? 
B.J. Wintersperger; Toronto, ON/CA (Bernd.Wintersperger@uhn.ca) 
1.5 T cardiac MR imaging is a main stay of cross-sectional imaging of various cardiac 
diseases and has proven high accuracies and new insights into diseases. Based 
on its success, diagnostic approaches have changed and also risk assessment 
for some cardiac diseases has become possible. Based on continuous techni-
cal developments though higher field strength have become available in recent 
years with clinical use of 3 T and research use of 7 T. However, specific changes 
that come along with the increase in B0 have to be incorporated in most aspects 
of a cardiovascular MR imaging procedures; from patient screening to imaging 
technique details. Basic changes at higher B0 are: B0 proportional increase of 
SNR, substantial increase in RF deposition, changes in magnetic tissue proper-
ties and B0/B1 inhomogeneities. While most of these changes affect all aspects 
of cardiac imaging at 3 T, some may only affect certain applications (e.g. assess-
ment of myocardial iron). CE MRA benefit from SNR increase at higher B0 (e.g. 
3 T) and improved background suppression based on short TR and prolonged T1 
values. While some applications at higher B0 have not yet been proven to impact 
diagnosis signal starving applications at 1.5 T (e.g. myocardial perfusion), also 
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and to monitor cancer therapy. First molecular ultrasound microbubbles are currently 
under clinical evaluation. Since microbubbles can also be used to permeate the 
vasculature locally and to transport drugs, its theranostic potential will be outlined. 
Learning Objectives:
1.  To become familiar with optical imaging techniques and probes.
2.  To learn about the potential of targeted US contrast agents.
3.  To appreciate emerging hybrid imaging techniques.
Author Disclosure:
F. M. A. Kiessling: Board Member; ESR Research Board, Council ESMI. 
Founder; invivoContrast GmbH. Grant Recipient; DFG, BMBF, EU. Research/
Grant Support; Financial support by Bracco, Bayer, Philips, Roche, Astra 
Zeneca. 
16:00 - 17:30 Room E2 
Multidisciplinary Session: Managing Patients with Cancer 
MS 3 
Colorectal liver metastases 
A-017 16:00
Chairman’s introduction 
V. Vilgrain; Clichy/FR (valerie.vilgrain@bjn.aphp.fr) 
Patients with colorectal liver metastases require a multidisciplinary approach includ-
ing hepatobiliary surgeons, oncologists, diagnostic and interventional radiologists. 
This session will cover the most important issues in these patients. The role of 
imaging in assessing intra- and extrahepatic staging will be discussed. Cases will 
illustrate the most recent improvements in imaging such as diffusion-weighted and 
liver specific contrast-enhanced MR imaging. Curative hepatic surgery is standard 
of care for resectable patients, but most patients are not initially resectable. The re-
sectability depends on the size, location, and extent of disease. Resectable and non-
resectable cases will be shown as well as two-step procedures such as portal vein 
embolisation which allow surgical resection in patients who cannot initially meet the 
surgical criteria. The role of systemic chemotherapy with or without targeted therapy 
is crucial in patients with resectable or non-resectable colorectal liver metastases. 
Notably, chemotherapy can render resectable patients who are unresectable. Yet, 
these treatments can induce hepatotoxicities. Last, interventional radiology plays an 
important role in these patients allowing local ablation or endovascular treatments 
such as hepatic arterial chemoembolisation and selective internal radiation therapy. 
Session Objectives:
1.  To learn about the prognostic factors of colorectal liver metastases.
2.  To become familiar with the most common therapeutic strategies.
3.  To understand the role of the multidisciplinary team in patients with colorectal 
liver metastases.
A-018 16:05
Role of imaging in the pretreatment assessment 
V. Vilgrain; Clichy/FR (valerie.vilgrain@bjn.aphp.fr) 
There are various treatments for liver metastases from primary colorectal cancer 
including surgical resection, non-surgical ablative treatments, and chemotherapy. 
Yet, surgical resection with perioperative chemotherapy has been shown to be the 
best treatment option for cure in these patients. Therefore, the role of imaging in the 
pretherapeutic assessment is key and can be splitted into four topics: 1) diagnosis of 
liver lesions as liver metastases, 2) extrahepatic staging including nodal metastases, 
peritoneal implants, regional or local recurrent or residual disease, and pulmonary 
metastases, 3) intrahepatic staging which aims to define number and extent of liver 
metastases in the segmental and lobar distribution in order to evaluate surgical 
resectability or feasibility of non-surgical ablative treatments, 4) and eventually 
response to chemotherapy with or without targeted therapy. Multimodal imaging is 
needed to answer all these questions. The most important imaging modalities are 
CT, MR imaging and PET. Multidetector CT is particularly helpful for whole body 
investigation and anatomic information for surgical planning. MR imaging is better 
than CT for lesion detection and lesion characterisation in the liver in particular with 
diffusion-weighted images and sequences using liver-specific agents. PET imaging 
is highly sensitive in detecting extrahepatic metastatic lesions, particularly when 
CT and PET interpretation can be combined. Pretherapeutic and intraoperative 
contrast-enhanced ultrasound may complete the work-up.
Learning Objectives:
1.  To become familiar with imaging findings indicating surgical resectability.
2.  To understand the role of CT and MR imaging in staging liver metastases.
3.  To learn about the role of new imaging techniques in staging liver metastases.
hypoxia, apoptosis, hormone sensitivity and amino acid transport. Each of these 
provides a unique window on the biology of each cancer and will hopefully guide 
therapies in the near future. In the specific example of metastatic prostate cancers, 
Sodium Fluoride PET is proving far more sensitive than conventional bone scans. 
Agents such as F-ACBC (amino acid transport), F-DCFBC (Prostate Membrane 
Specific Antigen PSMA), F-DHT (androgen receptor) and F-Choline (cell membrane 
turnover) are proving efficacious in the detection of metastastic disease and reflect 
actual tumour burden in contrast to existing methods that only indirectly image 
tumour (bone uptake). Thus, there is a rich future in new PET tracers for oncology 
that is only in its infancy.
Learning Objectives:
1.  To learn about the new specific tracers that can be used in oncologic patients.
2.  To become familiar with their possible impact on patient management.
3.  To understand their potential and limitations for practice.
Author Disclosure:
P. L. Choyke: Other; Research Agreements with GE, Siemens and Philips. 
A-015 16:30
B. Potential of MRI for molecular imaging in oncology 
F.A. Gallagher; Cambridge/UK (fag1000@cam.ac.uk) 
Imaging targets in cancer range from simple size measurements to more specific 
biomarkers on functional, cellular, metabolic and molecular levels. As our under-
standing of basic tumour biology has advanced, techniques have been developed 
to exploit this information to produce increasingly specific molecular imaging tools. 
The biodistribution of these molecular imaging probes should be more specific in 
diagnosing and assessing cancer than the morphological information acquired 
using anatomical imaging alone. This lecture will discuss current and emerging 
functional and molecular imaging techniques using MRI and their applications in 
oncology. Functional measures of tumour blood flow and vascular permeability can 
be made using dynamic contrast-enhanced MRI. Diffusion-weighted imaging is a 
surrogate for the cellular content of the tumour and emerging methods can be used 
to probe features of the extracellular space such as tumour pH and stromal content. 
On the molecular level, cell surface expression of specific proteins and enzyme 
activity within the cell can be imaged; labelled probes have been developed which 
bind to these proteins and a new MR technique is being developed for assessing 
tumour glucose in a similar way to PET. Hyperpolarisation methods are emerging 
to overcome the major limitation of MR: its low sensitivity. One such approach is 
dynamic nuclear polarisation, which can probe carbon metabolism non-invasively 
in patients with cancer. Functional and molecular imaging techniques with MRI will 
increasingly be used in radiology in conjunction with anatomical imaging methods 
to improve diagnosis and prognosis, target biopsies, as well as predict and detect 
response to treatment.
Learning Objectives:
1.  To become familiar with the different approaches to molecular imaging with 
MRI.
2.  To understand the role of molecular imaging in oncology.
3.  To learn about emerging MRI techniques for molecular imaging.
Author Disclosure:
F. A. Gallagher: Grant Recipient; GE Healthcare. 
A-016 17:00
C. Emerging molecular imaging techniques 
F.M.A. Kiessling; Aachen/DE (fkiessling@ukaachen.de) 
Optical in vivo imaging derives from microscopy techniques and is establishing 
as a valuable and cheap tool in preclinical research. Some optical methods have 
recently been translated to the patient and show promising results. However, the 
ability to gain quantitative or spatially high resolved data differs between optical 
imaging methods. Therefore, principles, strengths and limitations of optical reflect-
ance imaging, mesoscopic epi-fluorescence tomography (MEFT), and fluorescence 
molecular tomography (FMT) will be discussed. Optical imaging benefits from being 
combined with CT or MRI and it will be show how µCT not only improves the locali-
sation of fluorescent spots within animals but also improves the reconstruction of 
fluorescent raw data. Also in PET-CT, CT data is not only used as a morphological 
correlate but also to perform the attenuation correction. This is much more difficult, 
when using PET in combination with MRI. A possible solution is the use of UTE-
Dixon MR sequences that can reliably distinguish fat, soft tissue and bone, which 
are the tissue components with most different photon absorption. The last part of 
the talk is dedicated to molecular ultrasound imaging. Here stabilised gas bubbles 
linked to targeting moieties are used as intravascular contrast materials. Markers 
of vascular inflammation and of angiogenesis can be addressed. Many preclinical 
studies successfully applied molecular ultrasound imaging to characterise cancer 
7
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tases approaches 35-50%. However, approximately half of the patients will have 
a recurrence within 5 years. In spite of the significant progress made in systemic 
treatment of metastatic disease, the development of image-guided percutaneous 
techniques for local tumour ablation has been one of the major advances in the 
treatment of non-resectable liver and pulmonary metastases. If tumour load is still 
limited, local ablative therapy such as Radiofrequency ablation, Microwave or more 
recently Irreversible Electroporation are relevant treatment options. Particularly in 
patients who previously underwent surgery, minimal invasive percutaneous ablative 
procedures are preferred not only because of lower morbidity and mortality but 
also because the procedure is easy to repeat in case of residual/recurrent tumour. 
Trans-arterial techniques are a feasible salvage treatment for chemorefractory meta-
static colorectal cancer that remains a leading cause of cancer-related death with 
promising results of DC Beads loaded with doxorubicin and Irinotecan drug-eluting 
beads. Although chemoembolisation represents the mainstay, 90Y microsphere 
therapy has recently gained increasing awareness. Last, recent studies have shown 
the safety and efficacy of intra-arterial hepatic chemotherapy and percutaneous 
isolated hepatic perfusion in the treatment of liver metastases of colorectal cancer.
Learning Objectives:
1.  To learn about the most common image-guided treatments.
2.  To understand advantages and drawbacks of each treatment.
3.  To become familiar with the role of image-guided treatments.
Case presentation and discussion 17:05 
16:00 - 17:30 Room F1 
Professional Challenges Session 
PC 3 
Bringing radiology to medical undergraduates 
A-022 16:00
Chairman’s introduction: why does it matter? 
S.J. Golding; Oxford/UK (stephen.golding@nds.ox.ac.uk) 
Today all radiologists face competing demands for their time and skills. Prioritisa-
tion has become an essential tool of the efficient radiologist. In this scenario, it 
is inevitable that the greatest demand is clinical service, with the risk that other 
activity will be displaced or excluded. This Professional Challenges session 
arises from work of the ESR Working Group on Undergraduate Education. It 
addresses the need for radiologists to ensure that their involvement with medi-
cal undergraduates is not lost due to pressure of clinical demand. The work is 
important because it ensures that: (1) medical undergraduates are equipped to 
practise appropriately, (2) their use of radiological resources is efficient and ef-
fective, (3) Radiology achieves a greater profile in undergraduate career choice, 
and (4) the opportunities that Radiology offers to support learning elsewhere in 
the curriculum are realised. To achieve effective involvement, radiologists require 
understanding of the needs of the undergraduate, the skills necessary to use 
their time efficiently, knowledge of which of the available educational options 
are appropriate to the speciality, and the skill and ability to maintain Radiology’s 
voice in curricular planning and medical school direction. These presentations, 
from leaders in radiological education, are intended to assist the teaching ra-
diologist in their efforts to make such an impact on the medical undergraduate. 
Session Objectives:
1.  To understand why radiologists need to make undergraduate teaching a priority.
2.  To become familiar with the effect of teaching undergraduates on the student 
and the institution.
3.  To appreciate the objectives with which the undergraduate should be taught.
A-023 16:05
Establishing a radiological presence in the undergraduate curriculum 
R.N. Gibson; Melbourne/AU (r.gibson@unimelb.edu.au) 
Establishing a radiological presence in the undergraduate medical curriculum em-
beds the perception of a specialty which is pivotal in medical education, health care 
delivery and research. It also attracts students into radiology. Educational outcomes 
relate to: (a) imaging as a learning tool for anatomy, pathology, and clinical medicine 
(b) the principles and practice of radiology (image generation and interpretation, 
procedural radiology, interpretation skills for common or life-threatening conditions, 
diagnostic accuracy, referral guidelines, and the consultative process, safety and 
risk, cost and resource management, and the patient experience of diagnostic 
and procedural imaging). Gaining a curricular presence requires: (a) proactive 
engagement with university and clinical campus leaders in developing explicit 
A-019 16:20
Surgical resection of liver metastases: when and how 
J. Belghiti; Clichy/FR (jacques.belghiti@bjn.aphp.fr) 
Liver resection (LR) remains the only curative option for patients with colorectal 
liver metastases (CLM). Chemotherapy increases the possibility and the efficiency 
of LR. The indication of LR is increasing to patients with multiple and bilobar liver 
metastases whatever their size and location if a sufficient remnant liver volume is 
preserved and even to selected cases with localised carcinomatosis and/or pulmo-
nary metastasis. There is an ongoing debate regarding: (a) the optimal timing for 
LR in patients with synchronous liver metastases which can be performed before, 
during or after resection of the primary lesion; (b) the exact benefits of neoadjuvant 
chemotherapy in patients with solitary metachronous metastases; (c) the trend in 
extending the indications for surgery for patients with initially unresectable CLM. 
Increased efficiency of chemotherapy regimen using targeted therapies or intra-
arterial chemotherapy currently provides response rates up to 70%. Refinements 
in surgical technique such as liver volume modulation using portal vein occlusion 
and two-step strategies allow overcoming technical issues formerly considered as 
limitations to surgery. Altogether, secondary resectability can be achieved in ap-
proximately 25-30% of initially unresectable patients. However, both existence of 
chemotherapy liver injury following numerous cycles and complex resection in order 
to achieve adequate surgical margins can impair the post-operative course and 
jeopardise post-operative chemotherapy. It therefore appears that these patients 
would get benefit from both repeated morphological evaluation of the response to 
chemotherapy and more limited resection conservative strategies. 
Learning Objectives:
1.  To become familiar with surgical indications of liver metastases.
2.  To understand treatment planning strategies.
3.  To learn about prognostic factors for surgical candidates.
A-020 16:35
Chemotherapy and novel therapy in colorectal liver metastases: 
rationale, indications and results 
S. Faivre; Clichy/FR (sandrine.faivre@bjn.aphp.fr) 
During several decades, the only agent for the treatment of metastatic colorectal 
cancer was 5-fluoro-uracile (5 FU), yielding < 25% response rates and median 
overall survivals (OS) of 8-12 months. In the 1990s, oxaliplatin and irinotecan, 
2 major active compounds have been made available in combination with 5 FU 
(FOLFOX and FOLFIRI regimens), reaching #50% response rate and median 
OS > 16 months. From 2005 to 2006, the introduction of targeted therapies 
(cetuximab-ERBITUX; bevacizumab-AVASTIN) was shown useful to optimise 
the effects of FOLFOX/FOLFIRI by blocking proliferation (EGFR for cetuximab in 
KRas non-mutated tumours) and angiogenesis (VEGF for bevacizumab), further 
improving OS > 20 months. Doublet and triplet chemotherapies (CT) were usually 
well tolerated. Importantly, systemic CT increases the proportion of patients who 
become candidate for liver surgery from #12% to #22%, several cases of patients 
with liver metastasis being finally cured following multimodality treatments includ-
ing CT and surgery. This highlights the importance of multidisciplinary manage-
ment for liver metastasis to offer patients the best strategy. Baseline radiological 
assessment is crucial to address surgical resectability and urge deciding for the 
most efficient CT regimen. Optimally, the first radiological evaluation, along with 
blood tumour markers, must be performed between 8 and 12 weeks. An objective 
response by RECIST criteria warrants continuing on the same CT if the patient 
remains not operable, or start planning liver resection if the patient is recognised 
operable by the multidisciplinary tumour board. In addition to tumour shrinkage, 
a decrease in tumour density may indicate antitumour effects for patients treated 
with antiangiogenic agents.
Learning Objectives:
1.  To appreciate the rationale behind chemotherapy and novel therapy.
2.  To learn about the most common protocols of chemotherapy and novel therapy.
3.  To consolidate knowledge in treatment efficacy.
A-021 16:50
Role of image-guided treatment in colorectal liver metastases 
M. Abdel Rehim, A. Sibert, V. Barrau, Z. Ben Lakhdar, V. Vilgrain; Clichy/FR 
(m_solouma@hotmail.com) 
There are more than 200,000 cases of colorectal cancer (CRC) each year in 
Europe. More than half of patients with newly diagnosed (CRC) will develop 
metastatic disease (25% synchronous, 30% metachronous). Hepatic resection is 
the standard local treatment of hepatic metastases. Yet, only onethird of patients 
are eligible for curative resection. Survival following hepatic resection of all metas-
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A-026 16:50
How to ensure teachers are suitably trained 
E. Szabó, Z. Morvay, E. Nagy, I. Mátéka; Szeged/HU (endrebacsi@gmail.com) 
The presentation will give a result-oriented overview of the history of research on 
learning methods from Skinner to Wenger-Trayner, tries to highlight the most ap-
propriate ones necessary for teaching the undergraduates and hopes to fertilise 
further discussions and future ECR involvement in this area. Some aspects of 
course composition and examinations will also be discussed. 
Learning Objectives:
1.  To learn that teaching is a psychomotor skill with its own training requirements.
2.  To understand the importance of course design and methods of assessment 
to learning.
3.  To understand the ways in which radiological teachers may obtain training 
appropriate to their needs.
Panel discussion:  
What needs to be done to overcome the constraints on radiologists? 17:05 
16:00 - 17:30 Room F2 
Breast 
RC 302 




A. Contrast-enhanced mammography 
C.S. Balleyguier1, E. Fallenberg2, S. Canale1, C. Dromain1; 1Villejuif/FR, 
2Berlin/DE (balleyguier@igr.fr) 
Contrast-Enhanced Spectral Mammography (CESM) is a new imaging technique 
combining Digital Mammography and injection of iodinated contrast agent. Mam-
mography images are acquired at two (high and low) energy levels. Based on 
different attenuation characteristics between iodine and soft tissue, parametric im-
ages showing enhancement are reconstructed. There is some mandatory hardware 
adaptation, for instance adding a copper filter and a dedicated software is required. 
However, interpretation of images is based on morphological criteria. Two sets of 
images are acquired (CC and MLO). Obtained images compete with subtraction 
images obtained after dynamic contrast-enhanced MRI. Radiation dose is 1.2 
more that of a normal Digital Mammogram. Indications for CESM are quite similar 
to that of MRI. CESM significantly improves characterisation of breast lesions as 
compared with mammography. For breast cancer staging, as compared with MRI, 
CME carries a slightly lower sensitivity, but conversely a better specificity, cutting 
down the number of false positives. Some false negatives were observed in case 
of Infiltrative Lobular carcinoma and DCIS. CESM might become a very practical, 
cost-saving, alternative to Breast MRI in specific clinical situations.
Learning Objectives:
1.  To understand the underlying physical principles of contrast-enhanced mam-
mography (CEM).
2.  To become familiar with different protocols.
3.  To appreciate the potential impact of CEM on every day clinical practice.
A-028 16:30
B. Ultrasound elastography 
A. Athanasiou; Paris/FR (alex_athanasiou@hotmail.com) 
Breast ultrasound elastography provides information about tissue elasticity Young 
modulus E = s / e, where s is the compression (stress) and e is the deformation 
(strain) of the tissue. It is a complementary tool to breast ultrasonography, easily 
performed in clinical practice. Two elasticity modes are currently available: strain 
imaging, where manual compression is applied to the ultrasound probe and tis-
sue displacement is registered; tissue deformation is then calculated by means 
of dedicated software providing real-time elasticity images (color- or grey-coded) 
superimposed on B-mode imaging. This is a qualitative or semi-quantitative mode. 
Shear wave imaging, where US probe is used to induce mechanical vibrations using 
acoustic radiation force generating local tissue displacement. This mode provides 
quantitative information about either tissue displacement velocity or tissue stiffness 
itself in kPa. Functional information provided by elasticity imaging can be particularly 
useful for BIRADS 3 or 4a lesions. Various studies indicate that elasticity combined 
to B-mode imaging can improve breast ultrasound specificity up to 75-88%. False 
core curriculum and (b) identification of key radiologists as leaders. Preclinical 
involvement is most appropriate via anatomy learning and can introduce principles 
of image generation and interpretation. Engagement in clinical years should be 
strong and integration with the clinical curriculum is desirable. Small versus larger 
group teaching depends on overall curriculum and human resources. Resources 
include print texts, CDs or on-line resources, and PACS teaching files and must be 
pitched at medical student level. Development of local resources raises the local 
status of radiology and its place in the curriculum. Direct interface with the radiology 
department can include structured departmental visits, clinicoradiological working 
meetings, electives or clerkships. Opportunities should be provided for research if 
part of the overall curriculum. Involvement in assessment throughout the course 
is critical and linked to the curriculum.
Learning Objectives:
1.  To understand the importance of radiology’s undergraduate profile.
2.  To understand the effect of a presence throughout the curriculum on education.
3.  To become familiar with the ways in which radiology’s curricular presence may 
be achieved at individual stages.
A-024 16:20
Finding the time and resources in the radiology department 
J. del Cura; Bilbao/ES (joseluis.delcurarodriguez@osakidetza.net) 
One of the problems of undergraduate teaching of Radiology is the lack of time 
for teaching, due to competition for resources with other academic disciplines. 
Available classroom time and hours of practice are often insufficient to teach the 
increasingly complex modern Radiology. Also, the availability of financial resources 
to hire staff or access to educational facilities is competitive and limited, especially 
in a context of economic crisis. A good solution is to shift the paradigm of education, 
changing theoretical teaching into self-learning by students. This change allows to 
free class time to effectively teach Radiology. Classes are converted in workshops, 
doubt-solving sessions and problem-based learning, all of which matches better 
with a visual discipline like Radiology. Both on-line classes and e-learning can be 
useful for this purpose. This kind of teaching also makes Radiology a very attractive 
discipline for Medicine students. Also, Radiology practices can be carried out using 
custom computer applications. The lack of professors (and time) for practices can 
be solved with the help of residents, who are willing to participate as they are more 
prone to understand the learning needs of the students. Finally, the lack of economic 
resources makes it is necessary to seek alliances: with the industry, professional 
associations or with professors from other universities, sharing resources. Internet 
also provides free materials that can be used to teach.
Learning Objectives:
1.  To be aware of the competing demands on departmental resources.
2.  To understand the available methods for creating time for teaching.
3.  To understand the physical resources that aid effective and efficient teaching.
A-025 16:35
Involving the undergraduate with the radiology department 
K.L.A. Verstraete; Gent/BE (koenraad.verstraete@ugent.be) 
There are many opportunities to involve students in a radiology department. A 
basic investment of the radiology staff is required, but the return from the students 
is certainly worthwhile for the whole department. In basic years: bring students 
into contact with the radiological techniques (x-ray, US, CT, MRI), and use this 
opportunity to let them discover „normal anatomy“ (usually in guided visits to the 
department or short clerckships). After basic years: 1. allow free clerckships to 
let students discover „radiology“ as discipline (workload, workflow, techniques, 
research) and as potential future career, 2. involve students in the creation of 
teaching cases for students (practical methods will be explained in the lecture), 3. 
involve students in routine radiological practice (take history of patients, perform 
physical exam, follow radiological investigation, preview imaging studies, make 
differential diagnosis, discuss their findings with radiologist); in some departments: 
students can perform the exams (ultrasound, take radiography), 4. involve students 
in ongoing research in the department (as volunteers; for gathering „data“, for 
processing „data“, for statistical analysis, as co-author or author of abstracts and 
publications); this student involvement can be integrated into the undergraduate 
curriculum (e.g. via Master thesis), 5. allow longer clerckships for scientific work 
(e.g. 5 months during last year) for larger projects - studies and 6. other (literature 
studies). In the lecture, practical examples of student involvement in the radiology 
department will be provided.
Learning Objectives:
1.  To understand the effect of involvement in radiology on learning.
2.  To become familiar with the potential methods of undergraduate involvement.
3.  To understand the value and management of short-term and long-term attach-
ments to the radiology department.
9
Postgraduate Educational Programme
S1 CB D E F GA
Learning Objectives:
1.  To become familiar with the different imaging appearances of adrenal masses 
including pathological relation.
2.  To learn the different imaging techniques to improve evaluation of benign 
versus malignant adrenal masses.
3.  To understand the impact of imaging given the information that the patient 
has/has not a known malignancy.
A-031 16:30
B. Staging renal cancer 
R. Pozzi-Mucelli; Verona/IT 
The diagnosis of renal cell carcinoma (RCC) by means of imaging modalities 
include the identification of the lesion, its characterisation, the staging and the 
follow-up. Staging is an important part of the diagnostic process since it has direct 
effect on the therapeutical decision. In the case of renal tumour, staging is based 
on the TNM (AJCC Cancer Staging system) which has replaced other staging 
classifications such as the Robson classification. Based on the TNM classifica-
tion, two main types of renal tumours can be defined, the localised RCC (T1-T2) 
and the locally advanced RCC (T3-T4). In the case of T1 and T2 RCC, the most 
important parameter is tumour size: the cut point is 7 cm which separates T1 from 
T2 tumours. T1 tumours are further divided into T1a and T1b if less than 4 cm or 
between 4 and 7 cm, respectively. This further division has impact on type of surgery, 
i.e. partial versus radical nephrectomy. In the case of T3 and T4 RCC, different 
features should be carefully evaluated: these include the perirenal fat invasion, the 
direct infiltration of the ipsilateral adrenal gland, the infiltration of renal sinus fat, the 
vena cava and renal vein thrombosis, the urinary collecting system invasion and 
metastatic disease to local lymphonodes and other organs. CT still represents the 
method of choice for the staging of renal tumours since, also by using MPR and 
VR images, it gives all the information for the local and distant evaluation. MRI can 
support CT in complex cases. 
Learning Objectives:
1.  To recognise the CT/MRI/US findings for staging.
2.  To learn about the optimal imaging protocol for the diagnosis and staging of 
renal cancer.
3.  To understand treatment options and implications.
A-032 17:00
C. How to deal with small indeterminate renal masses 
O. Hélénon; Paris/FR (olivier.helenon@nck.aphp.fr) 
Renal masses include three categories with respect to the size and the gross 
architecture of the lesion: indeterminate very small masses, cystic and solid renal 
masses. Very small lesions (< 10 mm) usually remain unclassified because of 
partial volume effect that prevents accurate CT attenuation measurement. With the 
exception of patients at risk of renal neoplasms such as familial-hereditary renal 
tumour disease and patients with history of removed carcinoma, such lesions are 
likely to be microcysts and do not require further workup. If better characterisation 
is needed, MRI using T2 and Diffusion-Weighted imaging or contrast-enhanced 
US may help differentiate very small cysts from solid neoplasms. Characterisation 
of small cystic masses relies on the Bosniak's classification which consists of 5 
categories: benign (I) and minimally complicated (II) cysts, indeterminate cystic 
lesions (IIF and III) and malignant cystic masses (IV). Certain cases of cystic 
masses remain not categorisable at CT because of their proper atypical attenuation 
characteristics or enhancement properties. US and MRI play a major role by provid-
ing useful additional diagnostic information that help distinguish between atypical 
fluid fill masses and atypical solid neoplasms especially solid papillary RCC with 
poor vascularity. The goal of imaging in characterising small solid renal tumours is 
to differentiate typical angiomyolipoma containing macroscopic fat from non-fatty 
indeterminate renal neoploasms that should be removed. Percutaneous-guided 
biopsy is performed when accurate characterisation is needed before surgery or 
when renal metastases or lymphoma are suspected.
Learning Objectives:
1.  To become familiar with the various appearances of small indeterminate renal 
masses.
2.  To learn about the respective roles of US, CT and MR imaging in investigating 
small renal masses.
3.  To learn the main pitfalls in assessing small renal masses.
negative findings may be encountered in case of “soft” lesions (mucinous, medullary 
or cystic carcinomas) or inflammatory cancers. Differentiation between echogenic 
cysts and homogeneous solid lesions (such as fibroadenomas) can be improved 
as cystic features are usually specific in elasticity imaging. Iso-echoic lesions such 
as infiltrating lobular carcinomas may be better delimitated. Lymph-node charac-
terisation and microcalcification assessment can be improved, although few data 
are available and need further validation. 3D elastography is actually in progress 
and would be useful in monitoring response to neoadjuvant treatment.
Learning Objectives:
1.  To understand the basic principles of US elastography.
2.  To learn about the difference between strain and shear wave elastography 
and their respective results.
3.  To appreciate the additional value of US elastography to B-mode US.
A-029 17:00
C. MRI diffusion, perfusion and spectroscopy 
P.A.T. Baltzer; Vienna/AT 
Dynamic contrast-enhanced MR-mammography is the most sensitive method for 
detection of breast cancer. Diagnostic results using this technique may vary due 
to reader experience as image interpretation is to some degree a subjective task. 
In the last years, further, more or less quantitative MRI techniques have been in-
vestigated. While pharmacokinetic modelling of high-temporal resolution dynamic 
contrast-enhanced imaging (perfusion imaging) promises further, quantitative 
insights into the pathological characteristics of neoplastic vasculature, diffusion-
weighted imaging (DWI) and MR-spectroscopy (MRS) are based on entirely different 
concepts. While MRS is a molecular imaging technique able to quantify biochemical 
tissue properties, DWI is influenced by microstructural tissue changes. This talk 
aims to outline the concepts of perfusion, DWI and MRS, provide knowledge to 
implement these techniques into clinical practice and critically discusses the pos-
sible diagnostic benefit of doing so.
Learning Objectives:
1.  To understand the diagnostic value of diffusion weighted imaging (DWI) in its 
present clinical applications.
2.  To learn about the technical basics and potential use of MRI perfusion in the 
breast.
3.  To understand promises and challenges of MR spectroscopy in clinical practice.
16:00 - 17:30 Room G/H 
Genitourinary 
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A. Adrenal masses, a practical approach 
G. Heinz-Peer; St. Pölten/AT (Gertraud.Heinz@stpoelten.lknoe.at) 
The increased use of imaging modalities has demonstrated the presence of varying 
sized mass lesions in up to 5% of individuals subjected to CT studies for reasons 
unrelated to adrenal dysfunction. When confronting an adrenal incidentaloma for 
which the diagnosis is not certain, one must address the adverse outcomes by 
which the patient can potentially be harmed: morbidity or mortality from hormonal 
excess or cancer and the anxiety that comes from knowing about a tumour which 
might cause problems in the future. Most of these incidentally discovered lesions 
are non-functioning benign lesions of cortical origin. However, incidentalomas may 
also represent functioning (clinical or subclinical) lesions arising from either the 
cortex or the medulla and malignant masses. Clinical diagnostic and biochemical 
evaluation is used to further subdivide functional and non-functional adrenal le-
sions. CT and MR imaging are first choice in characterisation of adrenal lesions. 
Recently developed techniques of dual energy CT and histogram analysis may offer 
additional information. The value of PET and PET/CT has already been proven. 
Other new functional imaging techniques, such as perfusion, diffusion-weighted 
imaging and MR-spectroscopy may play an important role in lesion characterisation. 
Most of adrenal masses can be characterised with accuracy of > 90% by using 
these techniques. Differentiating benign from malignant adrenal masses using 
non-invasive imaging methods can reduce the need both for percutaneous adrenal 
biopsy in patients with underlying malignant disease and the follow-up imaging of 
incidentally detected adrenal adenomas. 
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C. Keyzer; Brussels/BE (caroline.keyzer@erasme.ulb.ac.be) 
FDG-PET/CT has proven diagnostic value for evaluating primary malignancy and 
metastatic disease. Integrated PET/CT systems provide PET and CT images that 
are acquired nearly simultaneously and are capable of producing superimposed, 
coregistered images, giving anatomic and molecular informations together suscep-
tible to facilitate interpretation. Many interpretation pitfalls are however encountered 
particularly in relation with biological factors, such as normal variants of FDG 
uptake. Knowledge of these pitfalls is thus important for preventing misinterpre-
tation. Interpretation of PET/CT may be complicated by the presence of benign 
conditions that can display high metabolic activity simulating malignancy. These 
conditions include brown fat, granulomatous disease, post-therapeutic changes, 
infection and inflammatory disease. Conversely, some malignant disease may 
exhibit only modest FDG uptake due to their histology, partial volume averaging 
effects, or respiratory motions. Hence, factors other than intensity of FDG uptake 
are often essential to discriminate benign and malignant diseases. Additional 
helpful information includes patient history, lesion distribution and symmetry and 
CT characteristics of the lesions. The approach to interpretation and strategies for 
discriminating malignant from benign diseases will be highlighted with a special 
attention to the evaluation of thoracic neoplasia and their usual metastatic sites, 
as well as non-oncologic chest disorders.
Learning Objectives:
1.  To understand the basic principles of PET/CT using FDG.
2.  To become familiar with physiologic FDG uptake and frequent pitfalls.
3.  To learn about FDG PET/CT in non-oncologic and oncologic disorders and 
how to report.
16:00 - 17:30 Room L/M 
Organs from A to Z: Heart 
MC 322 





A. Anatomy: too many details in cardiac imaging? 
A.J.B.S. Madureira; Porto/PT (ajbmadureira@gmail.com) 
There has been a marked increase in the utilisation of cardiac CT and MR in the 
evaluation of cardiac and pericardial diseases. All those involved in these exami-
nations must possess a solid knowledge of the anatomy of the heart and great 
vessels, in order to be able to identify normal structures and variants and not to 
misdiagnose them as disease or pathological lesions. Each cardiac chamber has 
specific and unique characteristics that allow its precise identification. The aortic 
arch can be located on the left or on the right and can have different branching 
patterns. These must be recognised and diagnosed as such. Incidental findings are 
relatively frequent when imaging the heart. When present they have to be divided 
into non- or clinically significant.
Learning Objectives:
1.  To learn about the detailed anatomy of the heart.
2.  To learn about the anatomy of the thoracic vasculature and great vessels.
3.  To get an overview of important incidental findings in cardiac imaging.
A-037 16:20
B. Examination protocols for imaging the heart: CT 
H. Alkadhi; Zurich/CH 
This presentation is aimed at a demonstration of the many steps that were under-
taken in the last decade for lowering the radiation exposure of patients undergoing 
cardiac CT examinations. Employing these various techniques, the effective radia-
tion dose of a CT coronary angiography study can be reduced from around 15 to 
as low as 1 mSv in selected patients. In parallel to these options for lowering the 
radiation dose, it is important that radiologists adhere to the appropriate, defined 
indications for CT of the heart.
Learning Objectives:
1.  To get an overview of different examination protocols.
2.  To learn about various strategies in radiation dose optimisation.
3.  To identify suitable clinical indications for cardiac CT.
16:00 - 17:30 Room I/K 
Chest 
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A. Bedside chest radiography 
R. Eibel; Schwerin/DE (roger.eibel@helios‑kliniken.de) 
Film-based imaging has been the workhorse of radiology ever since the x-rays had 
been discovered nearly 120 years ago. Despite well-known problems (projection 
of a volume onto a two-dimensional screen, over- or underexposure of the film, 
positioning of the patient, post-processing, and reproducible technical quality from 
one day to another), e.g. the portable chest x-ray is still one of the most important 
parts of the work up and treatment of the patient in the ICU. The first part of this 
lecture is focussed on technical features, necessary to gain the best quality from 
this medium. The second part deals with the interpretation principles and careful 
film analysis. Of course, a CT is in some instances much easier to interpret with 
regard to anatomy and pathology. It offers more tools for post-processing. On the 
other hand, the radiation exposure, the time and efforts and last not least the risk 
for the patient to perform a CT in the radiology department is much higher than 
investigating the patient in the ICU with portable chest x-ray. From this point of 
view, it makes sense, to interpret plain film as comprehensive as possible including 
most probable differentials. But it is also necessary to be familiar with its limitations. 
And of course, it is a condition sine qua non to have clinical information. In the last 
part and intrinsically tied to the second part a side-by-side comparison between 
standard radiography and CT follows to better understand the imaging findings 
and discover the main pitfalls.
Learning Objectives:
1.  To learn a structured reporting approach.
2.  To understand key imaging findings in different clinical settings.
3.  To improve confidence by linking pattern recognition, interpretation and diag-
nosis.
A-034 16:30
B. CTA and MRA of the pulmonary arteries 
J.E. Wildberger; Maastricht/NL (j.wildberger@mumc.nl) 
The clinical impact of CTA and MRA of the pulmonary arteries will be outlined. 
Multislice spiral CT allows for a robust examination of the entire chest with sub-
millimeter collimated protocols within a single breath-hold. This acquisition is the 
basis for dedicated analysis of the thoracic vasculature, especially in an interactive 
setting. CTA is mainly used for clinically suspicion of acute pulmonary embolism 
(PE) and may be regarded as the current clinical gold standard in this respect.
CTA can also be included in the work-up of patients with acute chest pain. Iodine 
mapping, depicting the (sub)segmental defects in iodine distribution in locations 
corresponding to embolic vessel occlusions, has become technically feasible, e.g. 
using quantitative dual-energy acquisition protocols. This might further improve 
detection of emboli and give insights into the effects on perfusion deficits in the 
adjacent lung parenchyma. MRA has made substantial improvements in the last 
years which are not always reflected in the current literature (e.g. PIOPEDIII). At 
this moment, there is no dedicated „official“ role for MRA in the assessment of acute 
PE. However, substantial efforts are made to provide MRA protocols on a 24/7 
basis, also under emergency conditions. Time-resolved angiography, steady-state 
free precession sequences and utilisation of other new techniques, such as parallel 
imaging, will be discussed. MR is becoming increasingly popular in the follow-up 
setting and for the evaluation of chronic disease. MRA and MR-derived pulmonary 
perfusion imaging are the current gold standard for non-invasive and quantitative 
assessment for chronic PE and pulmonary hypertension.
Learning Objectives:
1.  To learn more about recent improvements in CT and MR angiography.
2.  To learn a structured approach to reporting CTA or MRA.
3.  To become familiar with the role of CT angiography in comparison to MR 
angiography.
Author Disclosure:
J. E. Wildberger: Research/Grant Support; Institutional: Siemens, Philips, GE, 
Bracco, Bayer. Speaker; Siemens, GE, Bayer, Boston Scientific. 
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before surgery. It is in the interest of the patient and of the imaging community 
that these medical acts are being performed by trained interventional radiologists!
Author Disclosure:
A. D. Kelekis: Consultant; Benvenue Medical. 
A-041 16:05
A. Sacroiliac joint syndrome 
D.J. Wilson; Oxford/UK (david.wilson@ndorms.ox.ac.uk) 
Sacroiliac joint pain may arise from a number of conditions including inflammatory 
arthritis, degeneration, fractures and tumours. Studies suggest a prevalence of 10% 
to 60% pain arising from the joint in patients with positive clinical signs. Temporary 
effect is provided by a mixture of local anesthetics with steroids with a response 
varying between 50% and 80% in reported series. Dual blocks using agents of 
differing duration are considered more precise but as less often used in practice. 
Imaging including MR and Scintigraphy are of limited predictive value. Injections 
may be into the synovial joint, around the joint or adjacent to the nerve innervation 
of the joint. There is evidence that para-articular sources of pain are common and 
injection outside the joint may be more effective. Sl-joint-injections are performed 
through a dorsal approach guided by ultrasound, fluoroscopy or by low-dose CT. 
Short acting agents may have lasting benefit but radio-frequency ablation has 
been employed in an attempt to obtain long term response. The evidence for last-
ing therapeutic response to intra-articular or periarticular injection of steroids and 
conventional radiofrequency neurotomy is weak. There is fair evidence of long 
term response to cooled radiofrequency neurotomy. 
Learning Objectives:
1.  To learn about relevant anatomy and clinical presentations of the syndrome.
2.  To know more about the available treatments.
3.  To learn about clinical results and possible further developments.
Author Disclosure:
D.J. Wilson: Advisory Board; Chair ESSR research committee. Author; Editor 
of a multiauthor text on MSK Imaging (Springer). Owner; St Luke’s Radiology 
Oxford.
A-042 16:28
B. Facet syndrome 
M. Gallucci; L’Aquila/IT (massimo.gallucci@cc.univaq.it) 
The most constant symptom of lumbar facet arthropathy is pain lateralized which 
can radiate below the knee. Other symptoms are local paraspinal tenderness over a 
facet joint, posterior pain aggravated by extension and rotation toward the involved 
side, hip and buttock pain in a non-radicular distribution, morning pain and stiffness. 
Differential diagnoses include fibromialgia, lumbar compression fracture, lumbar 
degenerative disk disease, lumbar spondylolysis and spondylolysthesis, sacroiliac 
joint syndrome, overuse injury, piriformis syndrome. Radiological images may dem-
onstrate abnormalities like osteophytes, articular fluid or a synovial cyst. However, 
up to 45% of false positive had been registered on the base of clinical exam only, and 
there is a poor correlation between pain and imaging. The diagnosis is, therefore, 
made on both clinical and radiological grounds, and is confirmed by anthalgic facet 
joint block with elimination of pain. Anesthetic block include intra-articular or peri-
articular injections and medial branch blocks. Some reports suggests that medial 
branch block is more accurate than direct joint injection for prediction of outcome. 
It offers both diagnostic information and therapeutic goals. However, since in 50% 
of cases, a recurrence of pain is registered after a period variable between 3 and 
6 months, cryoablation or radiofrequency are often proposed offering longer term 
pain relief. Potential risks include allergic reaction, transient post-procedural pain, 
flare-up, bleeding, and infection. If steroids are administered, side effects and risks 
should be discussed mostly in case of diabetic subjects.
Learning Objectives:
1.  To understand the difference between facet joint and disc disease.
2.  To learn about different treatment options for facet disease.
3.  To learn how to manage patients.
A-043 16:51
C. Intervertebral disc syndromes 
A. Gangi, J. Garnon, G. Tsoumakidou, I. Enescu; Strasbourg/FR 
(gangi@rad6.u‑strasbg.fr) 
Pain management in disc herniation relies mainly on conservative care combin-
ing rest, physiotherapy and oral medication (analgesics and anti-inflammatory 
drugs). If early conservative treatment fails, treatment options turn to percutaneous 
techniques. Periradicular or epidural steroid injection (PSI) are the first minimally 
A-038 16:40
C. Examination protocols for imaging the heart: MRI 
N.L. Kelekis; Athens/GR (kelnik@med.uoa.gr) 
Cardiac MRI is among the most demanding MR applications, due to the complex 
3D  movement of the heart during contraction and relaxation. The goal of the wide 
arsenal of fast/ultrafast/real time sequences, motion compensation techniques 
triggering/gating/navigator gating), acceleration techniques (such as parallel 
imaging, k-t BLAST), flow sensitive and MR angiography sequences is to 
provide information on:
Cardiac anatomy: all kinds of dark-blood SE or TSE single-phase sequences 
(diastolic or systolic), single-slice or multislice multi-phase GE sequences (bFFE, 
FIESTA, TrueFISP).
Anatomy of thoracic vessels: non-gated white-blood GE sequences, single-slice 
or multi-slice multi-phase gradient echo sequences, MR angiographic sequences 
(static or time-resolved MRA with ultrafast techniques). Myocardial tissue: single-
phase STIR sequences mainly for oedema, T1- and T2-weighted SE or TSE for 
tissue characterisation. Contrast-enhanced 2D or 3D IR sequences for ischaemic 
scar, myocardial necrosis, presence of fibrosis (of diverse etiology), presence of 
thrombi. Myocardial blood flow: ultrafast GE sequences (SR, bFFE) during first 
pass of contrast medium. Myocardial contraction and relaxation: multislice multi-
phase GE sequences covering the whole extent of ventricles, myocardial tagging 
sequences, phase-contrast flow sequences to assess myocardial velocity patterns. 
Flow quantification: phase-contrast sequences (through-plane in all 4 valves and 
thoracic vessels, in-plane for jet and stenosis quantification), combination with 
volumetric measurements for complete quantification of normal/abnormal flows 
and volumes in both circulations. White-blood, dark-blood or contrast-enhanced 
coronary angiography sequences. Regarding imaging planes, a multislice acqui-
sition should cover both ventricles in the short-axis plane, as well as at least in 
4-chamber plane when addressing RV or congenital heart disease.
Learning Objectives:
1.  To get an overview of different examination protocols.
2.  To learn about typical cardiac MR artefacts and pitfalls.
3.  To identify suitable clinical indications for cardiac MRI.
A-039 17:00
Interactive case discussion 
A. de Roos; Leiden/NL (A.de_Roos@lumc.nl) 
Case material using CT and MRI will be presented for cardiovascular disease 
evaluation. A number of common and uncommon cases will presented, starting 
with the clinical presentation, imaging findings and summary of teaching points. 
The session is aimed to include incidental findings on routine chest imaging as 
well as more specific cardiac applications.
16:00 - 17:30 Room N/O 
Interventional Radiology 
RC 309 




A.D. Kelekis; Athens/GR (akelekis@med.uoa.gr) 
It is a fact that 80% of the human population will have at least one crisis of back 
pain and/or sciatica. It is also a fact that amid a population of volunteers that had 
no incidence of back pain and/or sciatica, 60% will have at least one finding associ-
ated with disc/spine degeneration. Until now, most treatments associated with back 
pain/sciatica were addressed by other medical communities either by medication 
or surgery. This has created a lot of inconsistencies. The interventional radiologist 
or neuroradiologist, who is trained in back pain interventional techniques has many 
advantages. First, he is professionally trained to read and evaluate adequately the 
imaging information. Second, he has the skill to guide, through imaging, specific 
tools and medication in selective spine regions, being thus more efficient than other 
specialties. The interventional spine and back pain treatments is the Eldorado of 
Interventional Radiology and can be compared to the 1970s of the percutaneous 
vascular Interventional world. As a new subspecialty, it is a fact that it lacks the 
necessary structure of formal clinical training, but in modern back pain centers, 
imaging-guided interventions have a key role in treatment, after medication and 
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A-045 16:30
B. Vertebrobasilar atherosclerotic disease 
L. Valvassori, M. Piano; Milan/IT (Luca.Valvassori@ospedaleniguarda.it) 
Intracranial atherosclerosis is a systemic and multifactorial disease, associated with 
atherosclerosis of carotids, coronaries, aorta, renal and iliofemoral arteries. Over 
one-third of ischaemic strokes occur in the posterior circulation, a leading cause 
of which is atherosclerotic vertebrobasilar (VB) disease. Symptomatic VB disease 
carries a high annual risk of recurrent stroke, averaging 10-15% per year, despite 
medical therapy. VB stroke is particularly prone to devastating consequences due 
to the eloquence of the regional brain tissue and is associated with high rates of 
death and disability. More common in older age and in Western countries, without 
differences of gender. CTA and/or MRA are excellent screening tool, but DSA is the 
gold standard to show focal stenosis, luminal irregularities, thrombosis, occlusion, 
arteries ectasia and elongation, serpentine aneurysms. Transient ischaemic attack, 
along with severe stenosis and progressive occlusion, are most common symptoms. 
An important stroke mechanism in VB atherostenosis is regional hypoperfusion. 
Furthermore, both embolic and flow processes can synergize to increase stroke 
risk, reducing the wash-out of emboli from the distal circulation in hypoperfused 
regions. Posterior circulation collateral channels may maintain adequate distal flow. 
The existence and extent of these compensatory blood flow pathways, evaluated 
by DSA, may influence the risk of stroke. Percutaneous angioplasty and stenting 
for symptomatic atherosclerotic VB stenosis is a feasible and effective therapeutic 
method, but good experience and full understanding of neurology and haemody-
namics are required, as well as for diagnostic purposes.
Learning Objectives:
1.  To learn about the appropriate imaging protocol and the imaging signs of 
extracranial and intracranial atherosclerosis.
2.  To learn about the epidemiology, symptomatology and natural history.
3.  To learn about the classification of lesions and indications for treatment.
A-046 17:00
C. Dissection and vasculitis of intracranial and extracranial arteries 
H.R. Jäger; London/UK (r.jager@ion.ucl.ac.uk) 
Dissection of the cervical arteries is a major cause of stroke in young adults and 
may also present with headache, neckpain, cranial nerve palsies. Intradural dis-
sections can cause subarachnoid haemorhage. 80% of carotid artery dissections 
are extracranial and 20% are intracranial; vertebral artery dissections occur most 
often in the atlas loop or at the junction of the V2/V3 segments. Dissections are 
casued by a tear in the intima leading to an intramural haematoma which results 
in an expansion of the external vessel diameter with a variable degree of luminal 
narrowing. Compromise of the arterial lumen and complications, such apseudo-
aneurym formation, are visualised with angiographic techniques (CTA and MRA 
now mostly replacing DSA). The intramuralhaematoma can be directly visualised 
with cross-sectional CT and MR. The MR signal intensity of the heamatoma is time-
dependent: it is T2- and T1- hypo- or isointense in the acute stage before becoming 
T2- and T1-hyperintense in the subacute stage. Cerebral vasculitis of the large 
and medium-sized intracranial vessel causes segmental narrowing or “beading” of 
the intracranial vessels which is readily demontrated on CTA and high-resolution 
intracranial MRA. Reversible Cerebral Vasoconstriction Syndrome (RCVS) is an 
important differential diagnosis for these appearances. Cerebral vasculitis affecting 
the small vessels (< 300 µm) is often difficult to diagnose, even on high-resolution 
DSA, and frequently requires confirmation with brain biopsy. Haemodynamic com-
promise caused by arterial dissections or by cerebral vasculitis can be assessed 
with CT perfusion and MR perfusion imaging.
Learning Objectives:
1.  To learn the imaging signs of dissection and different types of large/medium 
vessel vasculitis.
2.  To learn about lesion morphology and haemodynamic consequences of dis-
section and vasculitis.
3.  To learn about imaging protocols for detection of dissection and large/medium 
vessel vasculitis.
invasive technique which should be considered early in the treatment regime. It 
aims to stop the biochemical inflammatory reaction around the nerve root. It is ide-
ally performed under image guidance to ensure proper deposition of steroid and 
to avoid complications. Although periradicular steroid injection has been used for 
decades, its efficacy is still controversial. Non-controlled studies report success 
in 33% to 72% of patients. Short-term benefit of percutaneous nerve root block is 
quite high with good pain relief especially in irritative radiculopathy. Failure of 4 to 6 
weeks of conservative therapy and a minimum of one selective image-guided steroid 
injection, the treatment is directed to the disc. The minimally invasive percutane-
ous techniques in use today, aim at removing a small amount of central nucleus 
pulposus, so as to reduce intradiscal pressure and thus obviate disco-radicular 
compression. several alternative techniques of percutaneous nucleotomy have been 
developed, relying either on pure mechanical (automated percutaneous lumbar 
discectomy), chemical (alcohol, oxygen-ozone) or thermal (Laser, radiofrequency) 
decompression. Many non-controlled studies with large series report a high success 
rate of percutaneous thermal nucleotomy with 70 to 89% good results on radicular 
pain. The three most critical elements for successful nucleotomy are: proper patient 
selection, correct needle placement and effective cavitation.
Learning Objectives:
1.  To understand possible treatment techniques for disc disease.
2.  To know more about clinical and imaging findings in treatment.
3.  To learn about published results on percutaneous disc treatment.
Panel discussion:  
How can imaging methods separate candidates for percutaneous 
therapy and surgery? 17:14 
16:00 - 17:30 Room P 
Vascular 
RC 315 




A. Intracranial atherosclerotic disease of carotid arteries 
T. Jargiello; Lublin/PL (tojarg@interia.pl) 
Intracranial atherosclerotic lesions of carotid arteries are relatively seldom, espe-
cially when compared with extracranial atherosclerosis. According to statistics, 
intracranial lesions do not exceed 2-3% of all carotid occlusive disease, and in 
a whole group, less than 1% needs invasive treatment. This means that the role 
of intracranial stenotic disease is not big, but still important, especially when not 
properly diagnosed. In practice, intracranial carotid lesions are the most frequently 
revealed during the imaging process for evaluation of extracranial atherosclerotic 
disease in patients qualified for carotid stenting or endarterectomy. In patients 
qualified for stenting, arteriography (DSA) is the main imaging modality, done right 
before intervention to look for possible tandem extracranial / intracranial stenosis. In 
patients qualified for open surgery, CT-angio and MR-angio are usually performed to 
assess intracranial circulation. CT-angio is more popular today (available and less 
expensive) but contrast-enhanced MR-angio (CE-MRA) seems to be superior - be-
ing free of radiation, iodine contrast medium and has less possible artefacts (skull 
bas bones). Except stated above, there is a group of patients who are clinically 
suspected with intracranial stenosis with negative extracranial findings. For them, 
transcranial Doppler examination is a good solution as a screening test. When 
positive or even not evidently negative, CTA or CE-MRA are adviced. Indications 
for invasive (endovascular) treatment depend strictly on the degree of stenosis, its 
location and coexistent other stenoses (tandem lesions). These factors are always 
evaluated together with visible and potential collateral circulation - individally for 
each patient.
Learning Objectives:
1.  To become familiar with appropriate imaging protocols for all imaging modali-
ties and the pros and cons of each modality.
2.  To learn about imaging signs of atherosclerotic disease in the carotid artery 
territory.
3.  To learn about the classification of lesions and indications for treatment.
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A-049 16:28
B. Intraoperative imaging for surgeons 
A. Pietrabissa1, L. Pugliese1, A. Peri1, F.P. Tinozzi1, V. Ferrari2; 1Pavia/IT, 2Pisa/IT 
(andrea.pietrabissa@gmail.com) 
Modern radiological scanners allow the acquisition of volumetric datasets describing 
human anatomy, functionality and pathology, with high level of detail. On the other 
hand minimally invasive surgery offers excellent views of surface anatomy but is 
unable to provide details on deeper or hidden structures and bears the limit of a 
low grade tactile feedback. The highly detailed information contained in radiological 
images, which are partially lost when passing to the surgical room, can be expressly 
used to overcome these limitations. In this setting, computer-assisted technolo-
gies allow to augment real views of the patient, taken by means of cameras and 
optical tracking systems, with virtual information obtained from pre-operative or 
intra-operative radiological images, coherently mixing them in order to obtain an 
accurate superimposition of both. This augmented-reality, or in general mixed-reality 
technique, introduces many advantages for some tasks where the surgeon has to 
interact with the patient (localisation of target lesion, sharp definition of nodule’s 
margins, identification of vascular or other relevant adjacent anatomic structures, 
introduction of biopsy needle etc). improving the physician’s perception of deep 
or unexposed tissues and consequently the precision level of the procedure. The 
surgical robotic platforms available, as computer-assisted systems provided with 
3D stereoscopic vision, may support the application of these techniques in many 
fields of surgery. Further technological development should be claimed since the 
relevant implications involved with the clinical use of this promising new approach 
to enhance intra-operative visualisation during minimally invasive surgery. 
Learning Objectives:
1.  To understand why surgeons need more intraoperative guidance.
2.  To learn about the role of robotics and augmented reality in general surgery.
3.  To become familiar with patient-specific simulation.
4.  To appreciate the place of surgical training and accreditation.
A-050 16:51
C. Dismantling PACS: separating image viewing from the data 
storage and sharing 
B. Gibaud; Rennes/FR (bernard.gibaud@univ‑rennes1.fr) 
The evolution of a domain such as Picture Archiving and Communication Systems 
results from four main factors: (1) the emergence of new functional needs; (2) the 
evolution of basic technology (i.e. communication, storage, computing); (3) the 
existence and the maturity of standards; and (4) the evolution of general economic 
conditions. If we consider recent PACS evolution from these four viewpoints, we 
can notice: (1) the growing importance of image processing and the emergence 
besides radiology, cardiology and oncology of new sectors of medical imaging (e.g. 
surgery, pathologic anatomy); (2) the supremacy of internet technologies and the 
emergence of cloud storage and cloud computing technologies; (3) the maturity 
of interoperability standards such as DICOM, HL7 and IHE, and finally (4) a very 
stringent economical context in public hospitals, leading to the absolute necessity 
of mutualising resources as much as possible. In this context, separating storage/
archiving resources and image viewing/processing resources appears as an ap-
pealing approach. It is not a new idea, since PACS operation based on Application 
Service Providers (ASP) appeared more than ten years ago, but they had limited 
impact, yet. In this context, the course aims at: (1) clarifying the advantages - from 
both functional and economical viewpoints - of PACS solutions based on a clear 
separation of components implementing storage/archiving and image viewing/
processing; (2) reviewing and discussing the difficulties of a such evolution, espe-
cially with regards to security and confidentiality of information, on the one hand, 
and with compliance with existing interoperability standards, on the other hand.
Learning Objectives:
1.  To learn about strategic issues of generic image archiving and distribution.
2.  To understand new concepts of independent ‘front ends’ of PACS.
3.  To become familiar with new examples of PACS implementation based on 
component architecture.
4.  To appreciate new strategies of PACS architecture and migration.
Panel discussion:  
How should we manage our images today? 17:14 
1.  New challenges for large-scale image sharing and image distribution.
2.  Use of imaging outside radiology.
3.  Regulatory issues in image sharing.
4.  Practical and workflow issues of image distribution and management. 
16:00 - 17:30 Room Q 
Computer Applications 
RC 305 
New PACS architecture: decoupling image 




Image-based diagnostic and therapeutic workflows, particularly in interventional 
suites, are essential for the health care of patients but they are also a very cost-
intensive component in clinical settings. The understanding of workflows and ICT 
tools for image management beyond radiology, and in particular, for image-based in-
terventional suites has become not only of concern to radiologists and surgeons but 
also to other healthcare providers, managers, and administrators. Communication, 
simulation, visualisation and navigation with images and associated patient-specific 
models are becoming essential features in the planning and implementation of 
complex digital PACS like infrastructures in support of diagnostic and interventional 
procedures (e.g. interventional radiology, minimally invasive surgery, computer 
assisted surgical procedures and image guided therapy). While the full potentiali-
ties of multidisciplinary image sharing within health care settings are being further 
explored, it is now increasingly common to see intense cooperation between radiolo-
gists and other clinicians for planning and guiding interventions. Surgical planning 
units are a typical example of such a multidisciplinary setting. During the session 
on “New PACS architecture: decoupling image management from image naviga-
tion”, the lecturers - exceptional experts in their respective fields - will give insights 
into image sharing: from hospital-based applications to remote consultation, with 
specific reference to the support of surgeons (training and intraoperative guidance). 
Session Objectives:
1.  To introduce models of image management and workflow.
2.  To present the evolution of image management outside of radiology (surgery, 
interventions etc).
3.  To discuss the technical requirements for better image sharing and distribution.
A-048 16:05
A. Image navigation and new PACS architecture 
J. Reponen; Raahe/FI (jarmo.reponen@oulu.fi) 
Picture archiving and communication systems (PACS) have become an instrumental 
tool for storing and distributing medical images, not only within radiology but also 
in other medical domains. Typically, a PACS consists of imaging modalities like 
computed tomography (CT) and magnetic resonance imaging (MRI), image stor-
age device and reading workstations all connected with a secure data network. 
New challenges are introduced when more and more images are distributed over 
wide area networks, even utilising mobile and web technologies. Thin clients are 
becoming more widely used especially in clinical setting. When PACS is used 
outside radiology (e.g. in surgical operating theatre or in clinical wards) and for 
other modalities than radiology (e.g. for ECG or photographs) different types of 
user interfaces are needed. A radiology information system (RIS) is mandatory 
in order to manage the information stored into the archive. As more and more 
hospitals utilise comprehensive electronic patient record, a seamless integration 
is necessary. Standardisation of the modules and pre-defined workflows through 
Integrated Healthcare Enterprise (IHE) profiles will make interoperability easier. 
Regional image archives and shared access to images make it possible to distribute 
workload remotely and also decrease repetitive examinations for moving patients. 
Teleradiology offers a means to share medical expertise and workload. Legal as-
pects have to be discussed if PACS storage is outsourced to a cloud-based PACS. 
Stored information should be backed up, so that a full disaster recovery without 
unwanted breaks in service is possible. 
Learning Objectives:
1.  To learn about recent changes in PACS design and infrastructure.
2.  To understand the role of data management in PACS architecture.
3.  To become acquainted with different PACS architectures.
4.  To understand technical, workflow and legal aspects of innovative technologies.
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wavelengths to resolve small concealed objects. The talk will describe properties 
of materials and contrast mechanisms, principles of operation of both active and 
passive imagers at millimetre-wave, submillimetre-wave and terahertz frequen-
cies. Benefits, limitations, technology trends and a range of current and potential 
applications including aviation security, loss-prevention and stand-off detection 
will be discussed. Non-ionising radiation standards, ethical and privacy issues will 
also be discussed, together with the techniques and concepts-of-operation which 
are used to mitigate privacy concerns.
Learning Objectives:
1.  To understand the current status of non-ionising radiation technology for the 
detection of explosives and other threats.
2.  To learn about trends for development of millimetre-wave and terahertz tech-
nology.
3.  To learn about the challenges and limitations of these technologies.






Promises and facts of liver-directed gene therapy 
J.M. Prieto; Pamplona/ES (jprieto@unav.es) 
Gene therapy is based on the introduction of genetic material into the cells to 
promote local expression of a therapeutic protein. The transgene is incorporated 
into vectors, frequently of viral origin, to facilitate cell transduction. Due to the 
development of neutralising antibodies, gene therapy is frequently one-time treat-
ment and therefore the duration and control of transgene expression is a key issue. 
Hepatotropic long-term expression vectors such as adeno-associated virus (AAV) 
and third generation adenovirus (gutless Ad) are preferred vectors for many ap-
plications. Recently, treatment of patients with haemophilia B with AAV encoding 
Factor IX resulted in cessation of spontaneous bleeding in most patients. Acute 
Intermitent Porphiria (AIP) is a hereditary metabolic disorder due to mutations of 
porphobilinogen deaminase (PBGD). Genetic supplementation of liver cells with 
AAV-PBGD normalises biochemistry in AIP mice and corrects the associated neu-
rological alterations. A clinical trial involving 8 AIP patients is currently underway 
in our institution. In liver cirrhosis, hepatocellular insufficiency causes a sharp 
decline in IGF1 synthesis. In experimental hepatic cirrhosis, liver transduction with 
AAV-IGF1 leads to fibrosis reversal and improved liver function holding promise for 
clinical application. Primary and metastatic liver cancer can be treated by forcing 
the expression of molecules that stimulate antitumour immunity or block tumour 
progression by reducing vessel formation or altering tumour microenvironment. In 
experimental models of colorectal cancer metastatic to the liver, IL-12 immunogene 
therapy was found to synergise with oxaliplatin chemotherapy to control tumour 
growth. Summarising, gene therapy constitutes today a realistic option to treat 
previously intractable liver disorders. 
Learning Objectives:
1.  To learn about novel therapeutic approaches in hepatology.
2.  To understand principles and applications of liver-directed gene therapy.
3.  To appreciate flexibility, potential and limitations of the procedure.
4.  To become familiar with gene therapy vectors and their clinical use.
5.  To consolidate knowledge of novel approaches to treat liver diseases.
Author Disclosure:
J. M. Prieto: Advisory Board; Digna Biotech. Consultant; uniQure, Digna 
Biotech. 
16:00 - 17:30 Room Z 
ESR Radiation Protection Session 





X-ray backscatter security scanners: principles, performance and 
potential health risks 
J. Damilakis; Iraklion/GR (damilaki@med.uoc.gr) 
The operation of x-ray backscatter security scanners is based on backscattering 
of photons. The equipment consists of two x-ray tubes, collimators and detectors 
on both sides of the exposed passenger. Radiation detectors detect photons scat-
tered back from the body and the scanner builds up front and back images of the 
individual. Studies show that the effective dose to an adult passenger from scanners 
used in aviation security screening is lower than 0.25 μSv per screening, which is the 
dose limit defined by the American National Standards Institute. However, children 
receive higher doses per screening than adults. This is a point of concern since 
children are more vulnerable to radiation than adults. Superficial organs receive 
higher doses than deeper organs. Pregnant passengers may also be exposed to 
radiation from security scanners. A screening that delivers 0.25 μSv effective dose 
to the mother would deliver approximately 0.12 μGy to the uterus. Little information 
exists on the detection performance of x-ray backscatter systems. A study (Kaufman 
and Carlson, J Transp Secur, 4:73-94, 2011) shows that contraband can remain 
undetected by x-ray backscatter security scanners under certain conditions. In 
conclusion, doses and associated radiogenic risks from exposing individuals to 
radiation for backscatter x-ray screening are negligible. The possible effects on 
public health, however, from very low-level exposure to ionising radiation remain 
unknown. For this reason, non-ionising technology should be considered before 
x-ray scanners become a primary screening tool in aviation security.
Learning Objectives:
1.  To become familiar with the technological principles of security scanners.
2.  To learn about the detection performance of x-ray security scanners.
3.  To understand the radiation doses and risks from x-ray backscatter security 
scanners.
A-052 16:30
Cumulative low-level x-ray radiation exposure: is it harmful? 
P. Vock; Berne/CH (peter.vock@med.unibe.ch) 
While acute exposures of around 100 mGy and more of individuals and populations 
to ionising radiation have been studied quite well over the last 60 years, the evidence 
base of the impact of lower level and cumulative exposure is much weaker. This 
type of exposure tends to have similarities to the continuous natural exposure to 
cosmic radiation and - in certain geographical locations - to terrestrial radiation. 
The limits of the linear-no threshold (LNT) model of stochastic radiation effects and 
reasons for a different biological impact at low levels will be discussed; potential 
consequences to the individual person and to the population are important but can 
only be estimated. The age at exposure and the sex are key factors determining 
the impact, with a generally higher sensitivity of young and female individuals. 
Currently, in medicine repeated low-level exposures tend to increase due to 
follow-up imaging for disease and to new screening procedures; consequences 
of this development will be evaluated.
Learning Objectives:
1.  To learn about risks of x-ray exposure in relation to age.
2.  To appreciate the difference between individual and collective radiogenic risks.
3.  To understand issues related to cumulative radiation doses and possible risks 
from medical x-ray screening procedures.
A-053 17:00
Security scanners using non-ionising radiation: current status and 
trends for development 
M. Kemp; Cambridge/UK (mike.kemp@iconal.com) 
Security scanners are used in aviation security and in other applications to detect 
metallic and non-metal explosives, weapons and other contraband concealed 
on the body. Whilst some types of scanner use low-dose x-rays, others avoid 
the use of ionising radiation by employing radio waves at millimetre wavelengths 
(1 cm - 0.5 mm; 30 - 600 GHz), which penetrate clothing and have short enough 
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of imaging for other reasons. Although small cysts are more likely to be benign, 
size alone cannot be an independent decision making variable. Radiologists 
must attempt to exclude the presence of morphologic abnormalities that raise the 
suspicion of a complex cyst (mural nodules, dilatation of the common bile duct, 
dilatation of the main pancreatic duct larger than 6 mm, duct wall enhancement, 
lymphadenopathy, and peripheral calcifications). Microsyctic adenoma is the only 
type of cystic neoplasm that can be diagnosed with almost complete certainty, while 
diagnosis of mucinous cystic tumours is often hypothetical. Determination of CEA 
and amylase levels in cyst fluid aspirated by EUS-FNA is helpful in making the dif-
ferential diagnosis. Concerning correct management of unclassified cystic lesions at 
imaging one should keep in mind that even small morphologically benign-appearing 
cysts present moderate frequency of malignancy. Several professional societies 
have developed guidelines for the management of pancreatic cysts. According to 
the white paper of the ACR incidental findings committee any cyst > 3 cm should 
be resected unless it is serous cystadenoma or proven to be pseudocyst through 
aspiration. For cysts < 2 cm, a single follow-up in 1 year is needed, while for the 
cysts measuring 2-3 cm, a follow-up of every 6 months for 2 years and then yearly 
is proposed. Any decision should be based on a balance between the risk of ma-
lignancy and the benefit of pancreatic resection.
Learning Objectives:
1.  To learn how to differentiate between benign and malignant cystic lesions.
2.  To know the correct management of unclassified cystic lesions through imag-
ing.
3.  To become familiar with the reference imaging criteria suggesting treatment.
08:30 - 10:00 Room C 
Oncologic Imaging 
RC 416 
MR imaging for prostate cancer management: the 




Prostate cancer has become the most frequent cancer in men of the industrialised 
countries over the last 30 years, and the incidence is still increasing. The disease 
is associated with high morbidity and accordingly high socio-economic impact. 
Although radical prostatectomy has been proven to prolong survival, avoidable 
morbidity and costs are feared in a selective but unpredictable patient group due 
to overdiagnosis and overtreatment. The conventional way of establishing the 
diagnosis and making individual treatment decisions relies on the individual PSA 
serum level and pathologic Gleason score from systematic TRUS biopsy samples, 
which has well-known limitations. Patient stratification for choosing the best indi-
vidual treatment becomes increasingly challenging as various less invasive treat-
ment alternatives and active surveillance has been established. Multiparametric 
MR imaging has been proven to be remarkably advantageous in this context for 
detecting cancer, characterising its heterogeneity and aggressiveness, targeting the 
most aggressive part (the dominant intraprostatic lesion, DIL), guiding the biopsy 
needle to that area and evaluation of local tumour spreading. The gained information 
supports individualised decision making concerning treatment selection, planning, 
guidance, monitoring and follow-up. In case of active surveillance, functional MR 
parameters additionally yield objective and reproducible biomarkers for monitoring 
temporal changes of individual tumour aggressiveness during follow-up. This course 
will give an insight into the current diagnostic strategies and treatment options in 
prostate cancer and will discuss the role of MR imaging for patient management. 
A-059 08:35
A. Clinical challenges: how to treat prostate cancer 
B.A. Hadaschik; Heidelberg/DE (Boris.Hadaschik@med.uni‑heidelberg.de) 
Prostate cancer (PC) is the third leading cause of male cancer deaths in developed 
countries. PSA-based screening results in a modest reduction of PC mortality, but 
is associated with considerable overdiagnosis of PC, which, in turn, results in a 
significant burden of overtreatment. PC diagnosis is currently made by systematic 
TRUS-guided random biopsies. Indication for biopsy is preferably an individual 
risk assessment based on various parameters, predominantly PSA, age, prostate 
volume, digital rectal examination, family history, and co-morbidity. However, the 
majority of biopsies taken are negative. Moreover, random biopsies may miss 
important tumours and they also result in cancer detection in men who are unlikely 
to benefit from the diagnosis. Precise information of grade, stage and location of 
08:30 - 10:00 Room A 
Abdominal Viscera 
RC 401 




A. Pancreatic cancer or pancreatitis? 
B.J. Op de Beeck, A. Snoeckx, M. Spinhoven, R. Salgado, P.M. Parizel; 
Antwerp/BE (bart.op.de.beeck@uza.be) 
A common diagnostic problem is how to differentiate malignant solid pancreatic 
lesions from benign entities like pancreatitis. Especially, if you are dealing with 
focal forms like paraduodenal pancreatitis (cystic dystrophy of the duodenum 
or groove pancreatitis) or autoimmune pancreatitis (IgG4 related pancreatitis). 
Paraduodenal pancreatitis is a distinct form of chronic pancreatitis characterised 
by inflammation and fibrous tissue formation, affecting the groove area near 
the minor papilla between the head of the pancreas, the duodenal wall and the 
common bile duct. Paraduodenal pancreatitis has been divided into pure (the 
head of the pancreas is spared), segmental (the pancreatic head and the ducts 
are affected) and non-segmental (secondary to established chronic pancreatitis) 
forms. Autoimmune pancreatitis is distinct from calcifying and obstructive forms 
of chronic pancreatitis. Destructive changes of the pancreatic ducts characterised 
by multiple or single strictures without marked upstream dilatation are important 
features. Pancreatic calcifications and pseudocysts are usually absent. We radiolo-
gists have the important role to differentiate these benign entities from pancreatic 
adenocarcinoma, neuroendocrine tumours, lymphoma and pancreatic metastases. 
The typical CT-findings and limitations will be demonstrated as well as the additional 
and complementary role of MRI. We will focus on morphological signs (pancreatic, 
peripancreatic and ductal), dynamic contrast behaviour and value/limitations of 
diffusion weighted imaging and ADC. Clues to a correct diagnosis will be given 
and pitfalls in imaging interpretation will be discussed.
Learning Objectives:
1.  To become familiar with the common benign mimickers of pancreatic malig-
nancy.
2.  To learn how to differentiate between benign and malignant lesions.
3.  To know the limitations and complementary roles of CT and MR.
A-056 09:00
B. How can we differentiate cystic neoplasms from pseudocysts? 
T. Denecke; Berlin/DE (timm.denecke@charite.de) 
The differential diagnosis of cystic lesions of the pancreas includes primary neo-
plasms and pseudocysts. The clinical relevance of cystic pancreatic lesions is given 
because cystic neoplasms can be malignant or premalignant. The differentiation 
of pseudocysts and cystic lesions can be demanding. Ultrasound, endoscopic 
ultrasound, computed tomography and magnetic resonance imaging are the imag-
ing tools employed for differentiation of cystic lesions, supplemented by image-
guided biopsies. The initial findings determine the sequence of further diagnostic 
steps and, if necessary, therapy. The initial non-invasive diagnostic work-up of 
incidential cystic lesions usually contents CT and/or MRI. Here, typical patterns of 
benign cystic neoplasms, sings of malignancy, and imaging features in favour of 
pseudocyst formations can be recognised. Prerequisites for differential diagnosis 
by radiologic imaging are a comprehensive examination protocol, exact knowledge 
of the entities possibly presenting as cystic lesion including their imaging features 
and clinical relevance, as well as important clinical and paraclinical cofactors which 
aid in the discrimination of cystic neoplasms and pseudocysts. These issues will 
be demonstrated and discussed in this presentation.
Learning Objectives:
1.  To learn the most common cystic lesions of the pancreas.
2.  To know typical imaging findings of pseudocysts and cystic tumours.
3.  To become familiar with imaging elements that help differentiate between 
cystic lesions.
A-057 09:30
C. How to manage incidental findings 
C. Triantopoulou; Athens/GR (ctriantopoulou@gmail.com) 
The diagnosis and management of pancreatic cystic lesions is a common problem. 
Half of these lesions are asymptomatic and incidentally discovered at the time 
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Learning Objectives:
1.  To learn how advanced MR techniques improve staging.
2.  To learn how imaging impacts on clinical management (treatment selection 
and response monitoring).
3.  To understand the need for the implementation of MRI in clinical practice and 
clinical trials.
4.  To understand the need for specialised training of radiologists in prostate 
cancer imaging.
Panel discussion:  
Is MRI an integral part of the clinical routine? 09:44 
08:30 - 10:00 Room D1 
Controversies in Breast Imaging 
MC 423 
Overdiagnosis from screening mammography: 






A. The risk of overdiagnosis from screening mammography 
E. Paci, D. Puliti; Florence/IT (paci.eugenio@gmail.com) 
Overdiagnosis is the detection of a breast cancer through screening that would 
never have been identified in the lifetime of the woman, and is thus an adverse 
outcome of screening. EUROSCREEN WG reviewed the observational studies 
evaluating overdiagnosis in Europe and published a balance sheet of the outcomes 
of service screening in Europe. From a literature search, studies were classified 
according to the presence and the type of adjustment for breast cancer risk, and for 
lead time (statistical adjustment or compensatory drop). Estimates of overdiagnosis 
are percentage of the expected incidence in the absence of screening. There were 
13 primary studies in seven European countries (The NL, I, N, Sw, DK, UK and S). 
Unadjusted estimates ranged from 0 to 54%. Estimates adjusted for breast cancer 
risk and lead time ranged from 2.8% in The Netherlands, to 4.6% and 1.0% in Italy, 
7.0% in Denmark and 10% and 3.3% in England and Wales. A summary measure 
of 6.5% was considered the most likely estimate of overdiagnosis. Higher estimates 
in the literature are due to the lack of adjustment for breast cancer risk and/or lead 
time. A balance sheet of mortality reduction and overdiagnosis was estimated for a 
screened womn starting at 50 years of age a 20 years screening regimen and fol-
lowed up till 79 years of age. Out of 1000 women, 30 deaths for breast cancer were 
expected and 7/9 lifes saved. 4 breast cancer were estimated as overdiagnosed.
A-063 08:55
B. How breast radiologists should control the risk of overdiagnosis 
U. Bick; Berlin/DE (Ulrich.Bick@charite.de) 
Overdiagnosis, defined as the detection of malignant disease, which without 
screening would not have lead to significant morbidity for the patient, cannot be 
avoided completely in mammography screening. Aggressive pursuit of subtle mam-
mographic findings - both masses as well as microcalcifications - is a prerequisite 
for the successful early detection of breast cancer, which in turn is the basis for 
the desired reduction in breast cancer mortality. However, mammography, as a 
modality primarily based on morphology, is inherently unable to reliably predict 
prognosis and outcome for lesions detected in screening. In addition, the so-called 
length-time bias in screening will lead to preferential detection of slow-growing, 
less aggressive tumours. A possible strategy to lower the risk of overdiagnosis in 
mammography screening is the additional use of breast MRI as an assessment 
tool, since MRI may be better able to predict the biological behavior of breast le-
sions, in combination with a short-term follow-up approach, e.g. for older patients, 
in whom based on imaging the likelihood of clinically relevant breast cancer is low. 
Ideally, the decision by the breast radiologist, whether to biopsy or not to biopsy 
a suspicious lesion detected in screening, should not be based on imaging alone, 
but should also incorporate clinical factors such as the individual breast cancer risk 
and the biological age of the patient as well as possible comorbidities.
Author Disclosure:
U. Bick: Equipment Support Recipient; Hologic, Inc, Toshiba Corporation. 
Patent Holder; Hologic, Inc. Speaker; General Electric Company, Carestream 
Health, Inc. 
tumours is mandatory in order to counsel men with prostate cancer and to indi-
vidualise therapy. To prevent overtreatment of low-risk disease and to decrease 
treatment-related morbidity, active surveillance is the treatment modality of choice 
for men with indolent tumours. Unfortunately, in most places, it is not used frequently 
and men who are unlikely to die of their cancer undergo unnecessary treatment, 
including radical prostatectomy and radiation therapy, which significantly impairs 
quality of life. At the same time, still up to 40% of men shift to active therapy dur-
ing their active surveillance due to tumour progression or reclassification towards 
higher risk disease. To safely increase widespread use of active surveillance and 
to pave the way for focal therapy, PC diagnostics need to be refined to correctly 
identify biologically significant disease.
Learning Objectives:
1.  To understand how diagnosis is established through PSA evaluation and 
biopsy.
2.  To learn about different treatment options.
A-060 08:58
B. The radiologist’s contribution: how to detect and characterise a tumour 
A.R. Padhani; Northwood/UK (anwar.padhani@stricklandscanner.org.uk) 
The importance of detecting and accurately localizing significant intra-prostatic 
focal disease lies in two clinical areas. First, in men with persistently raised serum 
PSA levels and in whom there have been multiple negative biopsies or positive 
but low-grade/volume tumour with discordant PSA kinetics. These un- or under-
diagnosed cancers need to be located and histologic evaluated before appropri-
ate can be instituted. Second, the usage and future success of local ablative 
treatments such as high-intensity focused ultrasound (HIFU) is dependent on the 
accurate identification of the dominant intra-prostatic lesion, also known as the 
index lesion. Multiparametric MRI components including T2-weighted, diffusion, 
dynamic contrast enhancement and MR spectroscopy can all enable the accurate 
detection, localisation and characterisation of prostate cancer to be undertaken 
with high accuracy particularly when all components are combined into a single 
comprehensive assessment. This is because each technique interrogates the 
unique biology of cancers which differs from normal tissues. In order for MRI data 
to inform on patient management, multiparametric data need to be communicated 
to oncologists/urologists in a simple but meaningful way. This is best done using 
structured reporting systems, incorporating simple scoring systems via graphical 
interface that matches prostate anatomy. These aspects will be discussed in detail.
Learning Objectives:
1.  To understand how multiparametric MRI detects prostate cancer.
2.  To learn how to perform, interpret and communicate multi parametric MRIs.
3.  To learn how to support image guided biopsy.
4.  To understand the need for the standardisation of MRI protocols and reports.
Author Disclosure:
A. R. Padhani: Advisory Board; Siemens HeathCare. Speaker; Siemens 
HeathCare. 
A-061 09:21
C. The radiologist’s influence on management. Staging prostate 
cancer: how it impacts on treatment selection 
H. Hricak; New York, NY/US 
Treatment recommendations for prostate cancer continue to evolve and are 
affected by technological advances (e.g., robotics, image-guided radiotherapy 
[IGRT)]), new discoveries regarding tumour biology, and the development of 
predictive and prognostic biomarkers. With the increased complexity of treatment 
decision-making, the role of MRI is evolving as well. While the value of MRI in 
staging prostate cancer, particularly for evaluating extracapsular extension and 
seminal vesicle invasion, has been documented, unresolved needs for uniform 
interpretation and standardised reporting still pose obstacles to its widespread use. 
MRI findings affecting treatment decision-making extend beyond those of staging. 
Tumour grade (aggressiveness), size/volume and location are all relevant to treat-
ment selection. When added to T2-weighted MRI, newer MR techniques, such as 
diffusion-weighted MRI, dynamic-contrast-enhanced MRI, and MR spectroscopy 
improve tumour detection while providing an indication of tumour aggressiveness. 
However, MRI performance on all sequences is dependent on lesion size/volume 
and grade, and this should be considered when applying MRI results to treatment 
selection and planning. Today, most patients are diagnosed with low-grade, clinically 
non-palpable disease (stage T1c), and the role of MRI is expanding from staging 
advanced disease to evaluating intraprostatic disease. The more individualized and 
targeted the treatment approach, the greater the role of imaging in treatment plan-
ning. MRI is especially critical for planning technologically sophisticated treatment 
approaches such as robotic surgery, IGRT, or focal therapy and can help assess 
patients’ eligibility for active surveillance. 
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The principles of ATLS® and discrepancies between the radiological literature, 
ATLS® and day-to-day practice will be addressed.
Learning Objectives:
1.  To understand the relationship between ATLS and emergency radiology.
2.  To know more about the rational use of CR, US and CT according to patient 
priorities in the emergency setting.
3.  To become familiar with priority-oriented reporting of findings.
A-067 09:30
C. Mechanism of injury and MDCT protocols: choosing the right 
protocol for the right patient 
S. Voelckel1, M. Rieger2; 1Innsbruck/AT, 2Hall in Tirol/AT 
(sandra.voelckel@i‑med.ac.at) 
Polytrauma is the leading cause of death in younger people. Because of the broad 
consensus on the time sensitivity of the very first emergency procedures, namely 
“time is life”, radiologists constantly attempt to devise new ways to reduce the 
amount of time needed to adequately image trauma victims while simultaneously 
improving image quality. Multidetector-row computed tomography (MDCT) is consid-
ered an accurate and reliable imaging modality for initial evaluation of patients with 
multiple injuries and is widely used in modern emergency radiology. In patients with 
haemodynamic and respiratory instability that is not appropriate for CT examination, 
the delay in the first emergency room phase is used for conventional radiographs 
and a comprehensive sonogram. Knowledge of trauma mechanism is essential 
to adapt the ideal diagnostic protocol. Choosing a surgical treatment strategy for 
patients with traumatic extremity injuries requires rapid detection, localisation, and 
characterisation of a possibly accompanying vascular injury. In these patients, a 
MDCT-angiography is included in the standard whole body protocol. Blunt cervical 
vascular injuries (BCVI) represent serious conditions with an increased risk of being 
initially underdiagnosed during the first patient management. If present, BCVI, e.g., 
arterial dissections, potentially can cause severe or even fatal cerebral damage. 
Therefore, a MDCA-angiography of the cervical arteries should be included in the 
standard work-up. 
Learning Objectives:
1.  To understand mechanisms of traumatic injuries.
2.  To become familiar with established whole body MDCT protocols and their 
possible relation to injuries.
3.  To know the impact of MDCT findings on patient management.
08:30 - 10:00 Room E1 
State of the Art Symposium 
SA 4 
Diffusion-weighted imaging (DWI) of the abdomen 
A-068 08:30
Chairman’s introduction 
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr) 
Diffusion-weighted imaging (DWI) is a very hot topic, because it comes with 
structural and physiological information, added to morphology. As the technique 
becomes mature, and as most of MRI machines are able to acquire DWI, it is in-
creasingly popular and the number of indications extends continuously. However, 
there are still unanswered or partially answered questions: should we integrate 
DWI sequences in every single abdominal examination? How standard are the 
acquisition technique and ADC measurements? Does it improve the lesion detection 
and/or characterisation? Is there any benefit in predicting or evaluating disease 
response to treatment, whether inflammation or tumour? Can it compete with PET 
for detection and/or characterisation? In this session, the basic principles and tools 
for interpretation of DWI will be addressed, with a focus on abdominal organs. At 
the end of the session, the speakers will comment on clinical cases provided by the 
Moderator:, in order to provide the attendees with clear and practical messages. 
Session Objectives:
1.  To understand DWI principles.
2.  To learn about appropriate protocols for DWI of the abdomen.
3.  To learn how to analyse and report DWI images.




T.H. Helbich1, H.J. de Koning2; 1Vienna/AT, 2Rotterdam/NL 
The discussion will address the following issues:
1.  Why do estimates of overdiagnosis differ?
2.  Should we begin to think about stopping mammographic screening?
3.  How to reduce overdiagnosis?
4.  DCIS as major part of overdiagnosis.
5.  How should we inform women about overdiagnosis?
08:30 - 10:00 Room D2 
Emergency Radiology 
RC 417 




A. Logistics and organisation of an emergency radiology department 
M. Körner; Landshut/DE (markus@dr‑koerner.net) 
The interest in emergency radiology has been growing over the last years. The 
European Society for Emergency Radiology is still young, and their first summer 
meeting in Munich in 2012 was a huge success, which is a strong indicator for the 
interest in this subspeciality. Besides optimising technical equipment and proto-
cols for imaging, different logistic concepts have to be considered in planning and 
organizing emergency radiology departments. First of all, logistic concepts have 
to be considered for having an optimal workflow: the radiology department has 
to be in close proximity to the emergency department and the admitting area, in 
particular. The whole workflow must be optimised for speed and accuracy. This also 
mandates to have dedicated and standardised examination and viewing protocols 
for CT. In contrast to the USA, where dedicated emergency radiology departments 
are well established, the reading of emergency radiology cases is still frequently 
done by non-specialized radiologists in European countries. The radiologic staff 
involved has to be trained for interpretation of trauma and other emergent cases. 
This does not only account for residents but also for consultants and attending 
radiologists as well. Since a large number of such cases will arrive during after 
hours and on weekends, staffing has to be adjusted to this fact, which includes 
attending radiologists to be available during these hours on call or, preferably, 
on-site. This lecture will give an overview of logistic concepts, organization of an 
emergency department and will also discuss critical issues in polytrauma imaging.
Learning Objectives:
1.  To understand how an emergency radiology department should be organised.
2.  To become familiar with the logistics, staffing and technical equipment of an 
ER department operating 24/7.
A-066 09:00
B. Advanced trauma life support: basic knowledge for radiologists 
D.R. Kool; Nijmegen/NL (dignakool@gmail.com) 
Advanced trauma life support® (ATLS®) is an established systematic approach 
assessing trauma patients prioritizing the most life-threatening injuries. The term 
‚golden hour‘ is used to emphasize a sense of urgency, not to define a set time 
frame. The assessment is divided in a primary and a secondary survey. In the 
primary survey, the mnemonic ABCDE (Airway, Breathing, Circulation, Disability, 
Exposure and Environment) is used to guide the order of assessment. For efficient 
communication, it is helpful to report imaging in a comparable order. Although imag-
ing should not postpone treatment, chest and pelvis radiographs and abdominal US 
can influence treatment decisions and should be performed in the primary survey. 
In the secondary survey, the patient is examined from head to toe and appropriate 
additional radiographs are performed. According to ATLS® and contrary to literature 
evidence, CT plays a minor role in the evaluation of trauma victims and indicated 
CT scans should be done in the secondary survey. Although improved in the most 
recent edition, the ATLS® is neither evidence-based nor up-to -date concerning 
imaging in trauma settings. However, surgeons use the ATLS® recommendations 
routinely to support indications for diagnostic imaging. In addition, surgeons refer 
to ATLS® in error with indications for imaging that are not supported by the present 
ATLS® guideline or radiological literature. In this refresher course, the rationale and 
indications of imaging will be assessed where it pertains to the ATLS® protocol. 
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care. Abdominal lymph node evaluation alone is not an absolute indication for 
MRI. These are depicted on MR images acquired for local staging of primary 
tumours in the pelvis and abdomen and for whole body staging in case of extra 
abdominal primaries and systemic disease such as malignant melanoma, breast 
and lymphoma. Cross-sectional imaging relying on nodal size and morphology 
and PET on metabolic activity for lymph node characterisation have not yet pro-
duced sufficiently effective staging results due to considerable overlap in imaging 
features of benign and malignant lymph nodes. Diffusion weighted whole body 
imaging with background body signal suppression (DWIBS) with inversion of grey 
scale producing images similar to PET and axial single shot EPI DWI with fat sup-
pression depict normal lymph nodes with a relative impeded diffusion, while both 
techniques increase conspicuity of small lymph nodes irrespective of histological 
composition. ADC map produced from the latter sequence using a wider range of b 
values is rendered necessary for quantification and thus characterisation of lymph 
nodes. ADC is relatively independent of lesion size and various criteria have been 
proposed to increase sensitivity of DWI in differentiation of metastatic from benign 
lymph nodes with a diagnostic accuracy comparable to PET/CT.
Learning Objectives:
1.  To understand the signal of lymph nodes on DWI sequences, and to identify 
the correlation between histological changes and DWI signal in benign and 
malignant lymph nodes involvement.
2.  To learn whether or not ADC value is helpful for characterisation.
3.  To compare DWI and PET and understand their respective roles.
4.  To open the door to the future combination of PET and MRI.
Clinical cases 09:35 
08:30 - 10:00 Room E2 
Foundation Course: Neuroimaging 
E³ 420 




A. Imaging of the orbit: the globe and conal lesions 
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se) 
There is a broad spectrum of diagnoses to orbital lesions including congenital 
malformation, traumatic, neoplastic, iatrogenic, inflammatory and infectious eti-
ologies. The purpose of this lecture is to briefly revise the pertinent anatomical 
and physiological properties of the globe and to familiarize the audience with the 
imaging findings of different lesions with the focus on the role of conventional and 
advanced magnetic resonance imaging (MRI) sequences in the work-up of orbital 
lesions and the imaging findings in the most common orbital abnormalities and 
their differential diagnosis.
Learning Objectives:
1.  To understand the embryology and imaging findings of the most common 
malformations of the orbit.
2.  To learn about space occupying lesions and the differential diagnosis of tumours 
and inflammatory conditions.
3.  To become familiar with the role of conventional and advanced MR sequences 
in the diagnostic approach of lesions in the orbit.
Author Disclosure:
P. C. Maly Sundgren: Board Member; ISMRM, ASNR. Consultant; ICON 
Medical Imaging. 
A-073 09:00
B. The petrous bone 
F. Veillon; Strasbourg/FR (Francis.Veillon@chru‑strasbourg.fr) 
CT (CB CT) and MRI provide very precise information about the pathology of the 
petrous bone. Minor malformations of the inner ear are extremely frequent and 
constitute a labyrinthine weakness which must be known by the otologist and pa-
tient. Chronic otitis media is very well documented by CT considering the ossicles 
particularly the stapes (with the footplate). MR is useful when the diagnostic is 
doubtful with CT before the surgery and in the follow-up of the postoperative middle 
ear knowing than diffusion is not totally specific. The evaluation of T1 is essential to 
avoid the false-positive diagnosis of cholesteatoma. CT allows a new classification 
of petrous traumatisms (we separate the fractures of the middle ear, the inner ear 
A-069 08:35
DWI of the abdomen: a tutorial for beginners 
H.C. Thoeny; Berne/CH (harriet.thoeny@insel.ch) 
DWI is a non-invasive imaging technique providing information on the Brownian 
motion of water molecules in the underlying tissue. The ADC is a quantitative DWI 
parameter and provides information on diffusion and perfusion depending on the 
choice of the applied b-values. Extracranial applications of DWI mainly in the 
abdomen-gained increasing acceptance in recent years, thanks to newer techni-
cal developments. It can easily be added to conventional MRI in daily routine and 
its interpretation is relatively easy - provided that accurate imaging protocols are 
used and correlation with morphological sequences is performed. In patients with 
renal insufficiency, DWI can also be applied as an alternative for contrast medium 
administration in various circumstances. DWI is helpful in lesion detection, lesion 
characterisation, functional evaluation of various organs, and treatment monitoring. 
Image interpretation can be performed qualitatively based on visual assessment 
of the high b-value images and the corresponding ADC map. In general, a cystic/
necrotic lesion is dark on the high b-value images and bright on the corresponding 
ADC map, whereas a solid or hypercellular lesion as observed in most malignant 
tumours is usually bright on the high b-value images and dark on the ADC map. 
Abscess and haematoma can present with the same features, therefore, compari-
son with morphological images is a prerequisite for correct image interpretation. 
Quantitative analysis is performed by ADC measurement, however, caution must 
be used when comparing results to those published in the literature because the 
ADC depends on the choice of underlying b-values.
Learning Objectives:
1.  To understand the principles of DWI.
2.  To learn the different acquisition protocols (optimal b values, optimal se-
quences) and their advantages and disadvantages.
3.  To learn how DWI can be integrated into acquisition protocols, and whether it 
precludes the need for other sequences.
4.  To learn how to interpret ADC maps and values.
A-070 08:55
Liver and pancreas: answering burning questions 
F. Caseiro-Alves; Coimbra/PT (caseiroalves@gmail.com) 
Diffusion-weighted MR imaging is gaining wide acceptance for liver and pancreatic 
imaging, due to its superior contrast resolution, overtly cooperating in lesion detec-
tion and/or characterisation. Focal liver lesion detection can be enhanced using DWI 
in a combined reading strategy of liver MR studies. The use of low b values are of 
utmost importance due to the black blood effect and higher b values assists further 
on to depict the type of restriction within the lesions. The ADC measurement helps 
on characterisation avoiding T2 shine-through effects. Pancreatic DWI may also 
assist on tumour detection increasing diagnostic confidence. The role of DWI for 
lesion characterisation is not clearly established since there is an overlap between 
benignancy and malignancy. Other strategies such as intravoxel incoherent motion 
(IVIM) may be foreseen in order to calculate the perfusion component. DWI, both 
in liver and pancreas, may play a role in tumour response evaluation but clinical 
validation still lacks behind. Intra and inter-vendor variations in the calculated ADC 
values of tumours may be the most important drawback to be solved in the near 
future. Major shortcomings of DWI are currently technique-related due to the use 
of EPI causing low resolution imaging and strong artifacts of various kinds. This, 
togheter with the lack of standardisation, are important problems that will be surely 
adressed and solved in order to increase the role of this technique for the daily 
practice in imaging the liver and pancreas.
Learning Objectives:
1.  To understand the images observed in the main focal liver and pancreatic 
diseases.
2.  To learn if DWI can provide useful information concerning tissue characterisa-
tion.
3.  To understand the clinical circumstances in which DWI is most helpful.
4.  To learn if DWI helps in the evaluation of diffuse liver diseases and how iron 
and fat could be misleading issues.
A-071 09:15
DWI of abdominal lymph nodes: PET competitive or just pseudo? 
S. Gourtsoyianni; London/UK (sgty76@gmail.com) 
Prognosis and appropriate treatment planning of patients with malignant disease 
depends on accurate tumour staging at presentation. Accurate identification 
of abdominal metastatic lymph nodes is of paramount importance as a single 
metastatic lymph node may change treatment from curative surgery to palliative 
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Author Disclosure:
B. Sangro: Advisory Board; Bayer Healthcare and Sirtex Medical. Speaker; 
Bayer Healthcare and Sirtex Medical. 
A-076 08:35
Abdominal radiology 
A. Benito; Pamplona/ES (albenitob@unav.es) 
Worldwide accepted staging procedures for hepatocellular carcinoma include dy-
namic CT or MRI, both based on typical tumoural behaviour after contrast in arterial 
(hypervascular) and in portal-venous phases (“washout” appearance). However, 
some tumours may show ambiguous features that precludes staging. Recent 
advances such as perfusion for CT or diffusion and liver-specific contrast agents 
for MRI have demonstrated a potential role to solve disagreements in diagnosis, 
staging, or distinguishing the grade of malignancy. Imaging tumoural response 
after non-surgical treatments (ablation, chemoembolisation, radioembolisation or 
sorafenib), based on tumoural viability as estimated by the degree of hypervascu-
larization in the arterial phase (modified-RECIST) seems to be more appropriate 
than conventional systems (WHO/RECIST). However, uncommon radiological 
patterns can be seen after sorafenib (gradual decrease in tumour hypervascularity 
before shrinkage) or after radioembolisation (heterogenous patchy hypervascular 
areas and/or fibrosis) leading to misinterpretation or late recognised responses if 
only morphologic changes are considered. Ethanol injection and RFA have been 
the two most employed local ablative techniques for the local control of HCC. 
However, other procedures could offer potential benefits. The use of microwave 
ablation is growing recently due to some presumed advantages such as larger 
ablations, shorter duration, less susceptibility to heat sink effect, or no requirement 
of grounding pads. Irrevesible electroporation is also a new non-chemical, non-
thermal technique (still under clinical investigation) that is based in the application 
of multiple direct pulses that result in an irreversible disruption of the cell membrane 
leading to cellular death. 
Learning Objectives:
1.  To learn which imaging procedures should be considered standard of care for 
staging HCC and which are potential improvements that await confirmation.
2.  To understand the limitations of imaging in the diagnosis and evaluation of 
response to locoregional and antiangiogenic therapies.
3.  To learn about the scientific evidence supporting the use of percutaneous 
ablation procedures other than radiofrequency.
A-077 08:50
Interventional radiology 
J.I. Bilbao; Pamplona/ES (jibilbao@unav.es) 
The rationale to perform endovascular procedures for the treatment of patients 
with Hepatocellular Carcinoma (HCC) is based on the anatomical fact that liver 
neovascular networks are nourished exclusively by arteries. Thus, HCC may be 
selectively treated by delivering therapeutic agents through the afferent arteries. 
Ischaemia, provoked by the selective endovascular deployment of particles, may 
induce tumoural necrosis with high local control. The drawback is that ischaemia 
will also actively induce neoangiogenesis which may facilitate tumoural recurrence. 
Targeting of tumoural vessels is higher if smaller particles (or fluids like Lipiodol) 
are used and, for this reason, they could be loaded with anticancer agents. It 
has been widely reported the high local control rates obtained with the mixed 
effect given by ischaemia (macroembolisation) and the delivery of drugs (chem-
oembolisation, drug-eluted-embolisation). Since macroembolisation will provoke 
ischaemia in the embolized volume the procedure must be performed, as selective 
as possible trying to avoid any damage to the surrounding, usually cirrhotic, liver 
parenchyma. If not achievable the treatment should not be performed in patients 
with liver insufficiency or in the presence of thrombosis of the main portal branches. 
Endovascular treatments may, even, pursue the superselective deployment of an 
anticancer agent (drug, radionucleide, antibodies) avoiding any ischaemic effect 
(microembolisation). Taking into account these considerations, their indications 
are increasing in patients with HCC. Several reports demonstrated its usefulness 
as a palliative method improving both local control and patients´ survival. But also 
tumours can be downstaged and then patients can receive curative treatments 
(surgery or ablation).
Learning Objectives:
1.  To learn about locoregional intraarterial therapies currently being used for 
HCC and the rationale behind their use.
2.  To become familiar with patient selection for embolising procedures prior to 
and after angiographic evaluation.
3.  To learn some tips that may help reduce side effects and prevent complications 
of transarterial therapies.
and both middle and inner ear) and of otosclerosis (a particular emphasis is put 
on the footplate which requires an excellent technic). MR opens a new way in the 
diagnostic of Meniere disease (the dilation of the saccule is nicely demonstrated 
with a 3 T MR unit) and in the analysis of the membranous labyrinth particularly in 
labyrinthitis. A new way of reading the inner ear is also provided by the 3 T machines. 
The foundation of the performance in imaging remains the knowledge of anatomy.
Learning Objectives:
1.  To understand the normal imaging anatomy.
2.  To learn about the role of CT and MRI in the evaluation of congenital malfor-
mations.
3.  To become familiar with the most common acquired lesions of the middle and 
inner ear.
A-074 09:30
C. Sella and parasellar pathology 
R. Gasparotti; Brescia/IT (gasparo@med.unibs.it) 
The sellar region can be subdivided into three anatomical compartments, intrasellar, 
suprasellar and parasellar, each of which is characterised by different diseases. 
Although pituitary adenomas represent 90% of all sellar masses, a large spectrum 
of diseases can be encountered in such a small area, including congenital lesions, 
tumours, infectious and inflammatory conditions and vascular pathologies. The aim 
of neuroimaging is to characterise and to precisely define the anatomical relation-
ships of the lesions, since a thorough understanding of the radiological anatomy 
is essential for the differential diagnosis and treatment planning. MRI has almost 
completely replaced CT in the study of the central skull base, because of its superior 
capability of tissue characterisation, although some tumours arising in this area 
may still take advantage from CT, which better identifies the extensive calcified 
components typical of craniopharingiomas or giant partially thrombosed aneurysms. 
A reliable diagnosis of sellar or parasellar mass lesion can usually be obtained 
with conventional MRI based on T2W and pre/post-gadolinium T1W sequences, 
however, advanced MR techniques may be relevant for further characterising 
the lesions. DWI sequences may represent a useful adjunct for the preoperative 
assessment of macroadenomas; 3D SPACE sequences may be used to identify 
either microcystic or tiny solid components respectively into large solid or cystic 
lesions, whereas 3D T1W fatsat post-gadolinium sequences can better display 
dural enhancement and cavernous sinus invasion by intrasellar mass lesions. We 
present an overview of the relevant neuroimaging features of sellar and parasellar 
pathology, including the differential diagnoses with less common lesions.
Learning Objectives:
1.  To consolidate knowledge about the normal anatomy and the age related 
patterns of the normal pituitary gland.
2.  To learn how to evaluate congenital and acquired lesions of the sella and 
parasellar region.
3.  To become familiar with imaging protocols.
08:30 - 10:00 Room F1 





B. Sangro; Pamplona/ES (bsangro@unav.es) 
A variety of options are available for the treatment of hepatocellular carcinoma (HCC) 
from liver transplantation or resection to percutaneous ablation by chemical or physi-
cal procedures, intraarterial injection of embolizing particles that may also serve 
as carriers of chemotherapeutic agents or radiation-emitting isotopes, or systemic 
delivery of molecularly targeted agents. Although large scale studies have identified 
groups of patients that may certainly benefit from some of these therapeutic tools, 
many areas of uncertainty still exist. Only by the coordinated action of HPB Oncology 
multidisciplinary teams may patients with HCC receive the best possible treatment. 
Session Objectives:
1.  To learn the current management of HCC as laid out in scientific guidelines.
2.  To identify those areas of uncertainty, where multidisciplinary teams are needed 
most.
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Author Disclosure:
B. Sangro: Advisory Board; Bayer Healthcare and Sirtex Medical. Speaker; 
Bayer Healthcare and Sitex Medical. 
Case presentation and discussion 09:35 
08:30 - 10:00 Room F2 
Special Focus Session 
SF 4a 
“MRI of the lung: to go?” 
A-080 08:30
Chairman’s introduction: “Apéritif 
H.-U. Kauczor; Heidelberg/DE (Hans‑Ulrich.Kauczor@med.uni‑heidelberg.de) 
MRI of the lung has experienced a series of groundbreaking technological de-
velopments in recent years. Most of them are related to imaging speed, gating 
and signal enhancement. It is now ready “to go” and to be used in clinical routine. 
Prerequisite is an easy-to-use standardised protocol off the shelf, which can be 
customized to clinical needs. Certainly, MRI rivals CT in many areas, however, 
the unique combination of structural and functional aspects in a single examina-
tion without using ionising radiation is an extraordinary asset. Patients suffering 
from vascular lung disease, e.g. pulmonary arterial hypertension and embolism, 
as well as neoplasms of the lung and mediastinum or inflammatory lung dis-
ease, especially, cystic fibrosis, pneumonia and pneumonitis will greatly benefit 
from the advantages of MRI. In patient population, such as children, younger 
subjects and pregnant women, MRI should clearly be preferred to CT for these 
indications. Therefore, when you return to your clinical environment consider and 
apply MRI of the lung more and more often: it is straightforward to do. Cheers! 
Session Objectives:
1.  To learn how to do MRI of the lung in clinical routine.
2.  To understand the rationales and potential clinical applications of MRI of the 
lung.
3.  To understand the prerequisites for acceptance of MRI of the lung by our 
clinical colleagues.
Author Disclosure:
H. -U. Kauczor: Advisory Board; Siemens. Investigator; Boehringer Ingelheim. 
Speaker; Siemens, Boehringer Ingelheim, Bayer, Bracco. 
A-081 08:33
The sequence buffet 
J.M. Wild; Sheffield/UK (j.m.wild@sheffield.ac.uk) 
MRI of the lungs has evolved radically in the last ten years to the point that it is now 
becoming used routinely in clinical practice. This talk will focus on the technical chal-
lenges and solutions for imaging lung structure and function with MRI methods using 
both the endogeneous protons in the lungs and inhaled magnetic contrast agents. 
The low proton density in the lungs (~ 0.1 g/cm3) and the magnetic inhomogoneity 
between tissue and air (susceptibility difference ~ 8 ppm) make structural proton MRI 
of the lung micro-structure challenging, particularly at higher B0 fields. Short echo 
time pulse sequences, parallel imaging and respiratory gating can all help improve 
proton anatomical MRI. Signal from the major pulmonary vessels can be enhanced 
using paramagnetic contrast agents and T1-weighted ultrafast pulse sequences for 
volume coverage providing 3D pulmonary angiograms. Pulse sequence methods 
for pulmonary angiography and time resolved pulmonary perfusion mapping will 
be covered. The role of under sampled and view shared sequences with parallel 
imaging will be discussed within the constraints of tradeoffs between spatial and 
temporal resolution. Again the focus will be on technical challenges with a “how to 
do it” theme. Clinical images will be used as a means of highlighting the applica-
tions of the respective methodologies.
Learning Objectives:
1.  To learn about the basic physics of MR imaging of protons in the lung.
2.  To understand the role of different magnetic field strengths and parallel receiver 
coils.
3.  To appreciate the potential of fast imaging sequences for imaging the lung.
4.  To understand how IRs can help patients with unresectable tumours being 
evaluated for resection.
Author Disclosure:
J. Bilbao: Consultant; Sirtex, Terumo. 
A-078 09:05
Surgery 
F. Pardo; Pamplona/ES (fpardo@unav.es) 
The goals of hepatocarcinoma (HCC) surgery are to achieve an R0 resection, 
to protect the liver remnant parenchyma and to prevent morbidity and mortality. 
Multiple factors have been associated with morbidity and mortality as remnant liver 
volume, age, comorbidities (cardiovascular disease, diabetes, renal function), liver 
functions tests, transfusion or the degree of portal hypertension. The requirements 
for safe resection are a sufficient remnant liver parenchyma and an adequate liver 
function. Contraindications for resection would be given by tumour size, preoperative 
staging and the degree of portal hypertension. Tumour size and location determines 
the type of surgery needed to perform oncological resection. Recent studies have 
shown that it is feasible to perform a major hepatectomy even in cirrhotic livers 
without increasing the risk considerably. Preoperative portal vein embolisation is a 
good strategy to increase the future liver remnant and reduce the morbi-mortality 
even in cirrhotic patients. Liver transplantation is the best option for patients with 
HCC and poor liver function. In 1996, Mazzaferro published excellent long term 
results of HCC transplantation when patients had a single nodule less than 5 cm 
in diameter or up to three nodules, none larger than 3 cm. These “Milan criteria” 
were adopted by most transplant teams in the world and confirmed by numerous 
series. Other groups also published good results with broader criteria (UCSF, 
Kyoto, Pamplona). Locoregional treatments such as TACE or SIRT are very useful 
for assessing the biological behaviour of HCC and also for achieve down staging, 
allowing the rescue of initially inoperable patients. 
Learning Objectives:
1.  To learn about the main factors behind the resectability of HCC.
2.  To learn about the evolving criteria for liver transplantation.
3.  To understand the potential role of radiologists in the intraoperative or post-
operative management of HCC.
4.  To learn about complications of locoregional therapies (percutaneous ablation 
or intraarterial therapies) that could complicate resection or transplantation.
A-079 09:20
Hepatology/oncology 
B. Sangro; Pamplona/ES (bsangro@unav.es) 
The scientific basis supporting the current treatment paradigm of hepatocellular 
carcinoma (HCC) is relatively week due to the scarcity of large-scale randomised 
clinical trials. Several staging systems have been developed and most of them take 
into account not-only tumour burden but also liver function, since the frequently 
underlying cirrhosis may determine prognosis as much as tumour growth does. In 
Europe, the Barcelona Clinic Liver Cancer (BCLC) system has been endorsed by 
EASL and EORTC. Generally speaking, patients with small tumours are ablated 
surgically (resection or liver transplantation depending on the presence of cirrhosis) 
or percutaneously (radiofrequency or ethanol injection). Intraarterial procedures 
(bland embolisation, chemoembolisation or radioembolisation) are used for larger 
or multiple tumourus not extended beyond the liver, while systemic therapy is used 
for patients with extrahepatic disease or a contraindication to transarterial therapy 
(mainly because of portal vein thrombosis). However, guidelines issued by different 
scientific societies worldwide diverge in the definition of patients that benefit the most 
from each treatment. Sorafenib (an oral agent with antiangiogenic properties) has 
been shown to prolong the survival of patients with unresectable, advanced disease 
and preserved liver function. After this proof of concept, a great number of clinical 
trials exploring agents with different molecular targets have been launched but so 
far none of this trial has yielded positive results. Sorafenib has failed to show any 
advantage in survival when given in combination with chemoembolisation and its 
role as an adjuvant therapy after resection or ablation is is currently being studied. 
Learning Objectives:
1.  To learn the basis of tumour staging in HCC and the general treatment para-
digm.
2.  To learn about the discrepancies between different treatment guidelines and 
clinical practice.
3.  To become familiar with systemic anticancer agents and their impact on 
locoregional and surgical treatment of HCC.
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A-084 09:23
Bon appétit! Main course”: pulmonary and mediastinal neoplasms 
E.J.R. van Beek; Edinburgh/UK (edwin‑vanbeek@ed.ac.uk) 
CT remains one of the main tools for the diagnosis of pulmonary and mediastinal 
neoplasms. In addition, PET imaging (with or without CT) plays an integral role 
in planning therapy due to its ability to enhance the staging requirements prior to 
treatment planning. However, MRI has made significant inroads into aiding treatment 
decisions and planning. MRI is the mainstay in the management of superior sulcus 
tumours, tumours where chest wall invasion is suspected and for characterisation 
of mediastinal tumours. It is now increasingly able to detect, assess and give 
additional (functional and often more detailed anatomical) information. The use 
of standard high-spatial resolution imaging in combination with the application of 
standard and dynamic contrast-enhanced imaging and the utility of ultrafast imaging 
demonstrating motion of organs and structures of the chest wall and diaphragm 
further enhance the capability of MRI. Thus, although still mainly reserved as a 
tool for “difficult cases”, it is very likely that MRI will play an increasingly important 
role in the diagnosis and staging of chest tumours, ranging from lung cancer to 
mediastinal and pleural processes. This presentation will give examples of benign 
and malignant processes, linking this with the previously demonstrated menu of 
sequences now available.
Learning Objectives:
1.  To understand the application of MRI sequences to the staging of lung cancer.
2.  To become familiar with the role of MRI in lung cancer work-ups.
3.  To learn about the limitations of MRI in chest tumours.
Author Disclosure:
E. J. R. van Beek: Advisory Board; Siemens Lung MRI. CEO; Quantitative 
Clinical Trials Imaging Services, Inc. Speaker; Toshiba Medical Systems, Vital 
Images. 
Panel discussion: 
“Bon appétit! Dessert”: what are the benefits of MRI of the lung in 
clinical workflow and decision-making? 09:43 
08:30 - 10:00 Room G/H 
Neuro 
RC 411 




A. Neurocutaneous syndromes: more than neurofibromatosis 
B. Ertl-Wagner; Munich/DE (Birgit.Ertl‑Wagner@med.uni‑muenchen.de) 
Neurofibromatosis type 1 is the most common, but certainly not the only neurocuta-
neous syndrome. In children, white matter signal alterations (“myelin vacuoles”) are 
a common neuroimaging finding. The incidences of optic gliomas and other gliomas 
are increased. Neurofibromas can occur in almost any body region. Plexiform neu-
rofibromas show a diffuse and often locally destructive growth. Neurofibrosarcomas 
are malignant nerve sheath tumours. Neurofibromatosis type 2 is characterised 
by acoustic neuromas (vestibular schwannomas), which can be uni- or bilateral. 
Schwannomas can also affect other cranial nerves and spinal nerves. The inci-
dences of meningiomas and to a lesser extent of gliomas are also increased. The 
hallmark feature of tuberous sclerosis is the combination of cortical or subcortical 
tubers and subependymal nodules. Tubers are hyperintense on T2w and FLAIR 
sequences. Other than heterotopia, subependymal nodules are NOT isointense 
to gray matter. Giant cell astrocytomas are located at the foramina of Monroi, in-
crease in size over time and show a contrast enhancement. Sturge-Weber disease 
(encephalotrigeminal angiomatosis) is characterised by a leptomeningeal angioma 
and facial naevus flammeus. There is increased leptomeningeal enhancement 
and hypertrophy of the ipsilateral choroid plexus. Atrophy of the affected region 
and tramtrack calcifications typically ensue. Von Hippel-Lindau disease is not a 
neurocutaneous syndrome per se, but was classically considered a phakomatosis. 
Typical features include haemangioblastomas of the brain, spinal cord or retina, and 
papillary cystadenomas of the endolymphatic sac. Most neurocutaneous syndromes 
have manifestations outside the central and peripheral nervous systems as well. 
Moreover, there are multiple rare neurocutanteous syndromes.
Learning Objectives:
1.  To become familiar with the typical clinical presentations of neurocutaneous 
syndromes.
A-082 08:48
Preparing your menu 
J. Biederer; Heidelberg/DE (Juergen.Biederer@med.uni‑heidelberg.de) 
Compared to other lung imaging modalities, magnetic resonance imaging might 
be considered complex and difficult to use in clinical routine at first sight. However, 
in practice, the application is facilitated by dedicated, pre-set protocol trees cus-
tomized for typical clinical questions. The procedures are simplified by avoiding 
ECG triggering or other time-consuming preparations for the examination. A basic 
protocol to be acquired within less than 15 min without administration of contrast 
material covers most clinical problems including infiltrates and lung nodules almost 
equally to CT. Excellent soft tissue contrast facilitates tumour staging, e.g. the 
differentiation of tumour and atelectasis or the diagnosis of mediastinal and chest 
wall masses. Visualisation of respiratory motion contributes functional information. 
Additional, contrast-enhanced series to be acquired within 5 more minutes increase 
the sensitivity of the examination for the detection of tumour necrosis and pleural 
reaction/carcinosis. A dedicated protocol for the diagnosis of pulmonary embolism 
can be acquired within 15 min. This comprises an initial, free breathing and non-
contrast-enhanced examination for quick detection of severe embolism combined 
with dynamic contrast-enhanced perfusion imaging, a high-resolution angiogram 
and a final 3D breath-hold acquisition. These pre-set protocols offer solutions for 
tricky problems of daily routine, in the lungs and the chest wall as well as for imag-
ing the mediastinum, or for cases in which radiation exposure or administration 
of CT contrast material should be strictly avoided, e. g. in paediatrics, pregnant 
women or for scientific studies.
Learning Objectives:
1.  To learn how to combine MR sequences with a comprehensive imaging pro-
tocol.
2.  To become familiar with the different diagnostic scopes of the protocol com-
ponents.
3.  To learn how to apply protocol variations for specific clinical questions.
4.  To learn when to use IV contrast-enhanced series.
Author Disclosure:
J. Biederer: Speaker; Siemens. 
A-083 09:03
Bon appétit! Starters”: cystic fibrosis, pneumonia and pulmonary 
embolism 
M.U. Puderbach; Heidelberg/DE (m.puderbach@dkfz.de) 
CF: MRI is comparable to CT with regard to the detection of relevant morphological 
changes in the CF lung. Compared to CT, the strength of MRI is the additional as-
sessment of „function“, i.e. perfusion, pulmonary haemodynamics and ventilation. 
In CF, regional ventilatory defects cause changes in regional lung perfusion due 
to the hypoxic vasoconstriction response or tissue destruction. Using dynamic 
contrast-enhanced MRI, these perfusion changes can be assessed. Pulmonary 
embolism: The current imaging reference technique in evaluation of acute pul-
monary embolism is helical computed tomography. To be competitive with CT, an 
abbreviated MR protocol focusing on lung vessel imaging and lung perfusion may 
be accomplished within 15 min in-room time. As a first step, a steady-state GRE 
sequence acquired in two or three planes during free breathing enables a non-
contrast-enhanced detection of large central emboli. As a second step, the protocol 
continues with the contrast-enhanced steps including first pass perfusion imaging, 
high spatial resolution contrast-enhanced (CE) MRA and a final acquisition with 
a volumetric interpolated 3D FLASH sequence in transverse orientation. Pneu-
monia: The potential of MRI to replace chest radiography, particularly in children, 
was already investigated several years ago. The experience from this work may 
be considered valid for the suggested protocols for 1.5-T scanners since image 
quality has significantly improved. Therefore, T2-weighted fat-suppressed as well 
as dynamic contrast-enhanced T1-GRE sequences are applied with a slice thick-
ness between 5 and 6 mm. Disease entities encompassing community-acquired 
pneumonia, empyema, fungal infections and chronic bronchitis are detectable. 
Learning Objectives:
1.  To understand the application of MRI to morphological and functional imaging 
of airway diseases.
2.  To appreciate the potential of MRI for imaging pulmonary embolisms using 
different morphological and functional MR-techniques.
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aware of the details of the staging system and pattern of spread for a given tumour; 
the strengths and limitations of available imaging modalities in specific oncologic 
applications, especially in assessing tumour response to different conventional and 
newer therapies and various pitfalls in the overall approach to interpretation and 
reporting of oncologic imaging examinations. Because a radiologic study is only a 
“snapshot” taken during a brief moment of a patient’s medical timeline, meaning-
ful interpretation (the radiologist’s “added value”) requires integration of current 
imaging findings with results from various prior radiologic studies and pertinent 
clinical information. The frequently numerous findings visible on an imaging study 
need to be distilled into a focused, clinically relevant report; otherwise, the radiolo-
gist functions simply as a “film reader” (rather than as a true consultant), and the 
resultant radiology report may be technically accurate but clinically unhelpful -- or 
even misleading. Better reports can be produced by using standardised report 
templates, integrated imaging summaries, and consistent lexicons.
Learning Objectives:
1.  To review general principles of oncologic imaging.
2.  To understand the critical importance of clinical context during interpretation 
of oncologic exams.
3.  To evaluate ways to ensure that our reports provide added value and reflect 
the radiologist’s role as consultant.
A-089 08:55
B. Lung cancers (primary, metastases) 
C.J. Herold; Vienna/AT (Christian.Herold@meduniwien.ac.at) 
Lung cancer is among the most common malignancies worldwide, and accounts for 
up to 30% of all lung cancer death annually. In the US, approximately 220.000 new 
cases are diagnosed every year. Accurate staging of non-small cell lung cancers 
(NSCLC) and small cell lung cancers (SCLC) is of utmost importance for selecting 
those patients, who benefit from attempted curative surgery versus those who may 
undergo palliative treatment. Recently, a new TNM staging system (7th edition) 
for lung cancer was introduced by the International Union against cancer and the 
American Joint Committee on Cancer and should now be uniformly used for lung 
cancer staging worldwide. This staging classification was based on the analysis 
of a large data base of approximately 70.000 cases of NSCLC and 13.000 cases 
of SCLC sampled in a multi-institutional effort containing detailed information from 
46 institutions in 19 countries. The most important parameter for the developing of 
the subgroups was overall survival based on disease stage. The major changes 
involve the T and M categories, resulting in subgroups that would more accurately 
be associated with prognosis of a patient with defined descriptors. In this course, 
the new TNM-staging classification will be demonstrated, and case examples will 
be used to interactively enhance the learning experience of attendees. In addition, 
the role of imaging methods in evaluating standard and innovative therapy regimen 
will be discussed, and typical findings and pitfalls will be presented. 
Learning Objectives:
1.  To review the strengths and limitations of radiologic techniques suitable for 
detecting and characterising primary and metastatic lesions in the lungs.
2.  To understand the imaging findings relevant for lung cancer T, N and M staging, 
and appraise the implications of the new IASLC lung cancer staging system.
3.  To evaluate the imaging findings used to assess response to conventional and 
new therapies for lung cancers.
A-090 09:25
C. Colon cancer 
R.M. Gore, R. Silvers; Evanston, IL/US (rgore@uchicago.edu) 
The treatment of colorectal cancer has significantly changed over the last decade. 
Neoadjuvant chemotherapy and radiation therapy have become the standard of 
care for rectal cancer. New biologic agents are being used with increasing frequency 
leading to personalized colorectal cancer therapy. In this presentation, the staging 
of colorectal cancer is reviewed, the relative role of MDCT, PET-CT, MRI, TRUS in 
staging these neoplasms, and the applications of molecular imaging in the monitor-
ing of tumour response to therapy is presented.
Learning Objectives:
1.  To get an overview of current recommendations for the diagnosis of colorectal 
cancer.
2.  To understand the specific role of MDCT, MR imaging, endoscopic ultrasound, 
and PET/CT in the staging of colorectal cancer in optimising patient manage-
ment.
3.  To learn the utility of imaging in assessing tumour response to therapy and in 
the general follow-up of patients with colorectal cancer.
Questions 09:50 
2.  To consolidate knowledge of the typical imaging patterns of the major neuro-
cutaneous syndromes.
3.  To become familiar with some less common features of neurocutaneous 
syndromes.
A-086 09:00
B. Patterns of white matter disease in children 
A. Rossi; Genoa/IT (andrearossi@ospedale‑gaslini.ge.it) 
Paediatric inherited white matter disorders can be distinguished into well-defined 
leukoencephalopathies and undefined leukoencephalopathies. The first category 
may be subdivided into: (a) hypomyelinating disorders; (b) dysmyelinating disorders; 
(c) leukodystrophies; (d) disorders related to cystic degeneration of myelin; and (e) 
disorders secondary to axonal damage. The second category, representing up to 
50% of leukoencephalopathies in childhood, requires a multidisciplinary approach 
in order to define novel homogeneous subgroups of patients, possibly representing 
“new genetic disorders’’. An integrated description of the clinical, neuroimaging, 
and pathophysiological features is crucial for categorizing myelin disorders and 
better understanding their genetic basis. A review of the MR imaging findings in the 
main genetic disorders affecting white matter in the paediatric age, including some 
novel entities, will be provided with a highlight on the concept of pattern recognition. 
Learning Objectives:
1.  To become familiar with the most common white matter diseases in children.
2.  To learn how to differentiate between white matter diseases in children.
3.  To consolidate knowledge of appropriate imaging protocols for MRI of children 
with white matter disease.
A-087 09:30
C. Paediatric brain tumours 
C. Hoffmann; Tel Hashomer/IL (chen.hoffmann@sheba.health.gov.il) 
In this short lecture, we will discuss the indications for imaging in the paediatric age 
group, the technique for imaging and the imaging characteristics of brain tumours in 
general, with examples of common and uncommon brain tumours. An emphasis will 
be given to new MR sequences, such as MR spectroscopy, perfusion sequences 
and diffusion tensor imaging. Brain tumourus are the second most common type 
of paediatric cancer. The incidence of supretentorial and infra tentorial tumours 
is equal, in the first two years of life, supra tentorial tumours are more frequent, 
and infra tentorial tumours are more frequent at the 4-10 years age group. Over 
the 10th year of life there is equal incidence. The location of brain tumours is help-
ing to predict the type of tumour. For example: tumourus in the 4th ventricles are 
mainly medulloblastoma and ependymoma, in the cerebellar hemisphere pilocytic 
astrocytoma. Tumours of the 3rd ventricles can also be differentiated by the loca-
tion in the ventricle. DWI sequences help in the diagnosis of the posterior fossa 
tumours. Tumours with high cellularity will present with low-ADC value (medullob-
lastoma), whereas tumours with lower cellularity will present with high ADC value 
(astrocytoma). MRS can also help: lactate and lipids are markers of malignant 
tumours. The combination of the characteristic location with the DWI and MRS 
appearance can lead to the accurate diagnosis in most of the cases before the 
pathology report is ready.
Learning Objectives:
1.  To learn about the difference between paediatric and adult brain tumours.
2.  To understand the imaging strategy for the paediatric population.
3.  To recognise the most common paediatric brain tumours.
08:30 - 10:00 Room I/K 
Joint Course of ESR and RSNA (Radiological Society of North 
America) 
MC 428 
Essentials in oncologic imaging: what radiologists 




A. Principles of oncologic imaging and reporting 
D.M. Panicek; New York, NY/US (panicekd@mskcc.org) 
Oncologic imaging examinations are often complex and specialized knowledge is 
required to interpret them in a clinically relevant manner. The radiologist needs to be 
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A-093 09:10
C. Cardiomyopathies 
P. Sipola; Kuopio/FI (petri.sipola@kuh.fi) 
Cardiac magnetic resonance imaging (CMRI) is highly valuable in the differential 
diagnosis of cardiomyopathies. MRI diagnosis is based on cine imaging of cardiac 
function, T2-weighted imaging of oedema and late gadolinium-enhanced (LGE) 
patterns of scar tissue. Hypertrophic cardiomyopathy (HCM). Left ventricular hyper-
trophy (LVH) is typically located in basal septum and anterior wall but has variable 
expression (diffuse, localised). Associated abnormalities include left ventricular (LV) 
high-ejection fraction (EF), mitral valve abnormalities, apical aneurysm, and right 
ventricular (RV) hypertrophy. Scattered intramyocardial LGE may occur in various 
patterns. The differential diagnoses in patient with hypertrophic phenotype include 
pressure overload hypertrophy, amyloidosis, sarcoidosis, and Fabry’s disease. 
LGE patterns is useful in differentiation. Dilated cardiomyopathy (DCM): Dilated LV 
end-systolic volume and impaired EF% are characteristics. Non-ischaemic DCM 
typically shows no LGE (in contrast to ischaemic cardiomyopthy). Sometimes faint 
midwall enhancement can be observed, which has prognostic value. Presence of 
extensive non-compacted myocardium indicates non-compaction cardiomyopa-
thy. Arrhythmogenic right ventricular cardiomyopathy (ARVC): The RV volume is 
enlargened and akinetic RV segments can be seen. Local bulging or dyskinesia 
in conjunction with fatty infiltration and LGE is typical. Restricted cardiomyopathy 
(RCM): Enlargened atrias and normal sized ventricles with preserved EF% and no 
LGE are characteristics. Myocarditis: LV systolic function is typically lowered but may 
be normal. T2 images may show increased signal. LGE limited to the subepicardial 
myocardium is highly suggestive of myocarditis. Iron overload cardiomyopathy: 
Cine imaging is used to assess LV global function and T2*-weighted imaging to 
quantitate ventricular iron deposition. 
Learning Objectives:
1.  To get an overview of different types of cardiomyopathies.
2.  To differentiate typical imaging findings in various cardiomyopathies.
A-094 09:30
Interactive case discussion 
V.E. Sinitsyn; Moscow/RU (vsini@mail.ru) 
Clinical cases of congenital heart disease, valvular disease and cardiomyopathy 
have been presented. Combined use of cardiac MRI and CT give both morphologi-
cal and functional information about heart structure, function, myocardial perfusion 
and myocardial viability. Cardiac CTA is superior in depiction general cardiac and 
extracardiac congenital abnormalities, such as anomalies of coronary vessels, 
systemic and pulmonary veins, bronchi, pulmonary collaterals, etc. cardiac CT 
can be used of diagnosis of valve abnormalities, especially in cases of aortic valve 
diseases. Cardiac MRI provides quantitative and qualitative information about 
intracardiac blood flow (shunts), cardiac valve function, structure of myocardium. 
Late enhancement pattern in patients with cardiomypathies have both diagnostic 
and prognostic value. Rationales for selection of different protocols for cardiac CT 
and MRI in patients with non-ischaemic heart diseases are discussed. 
08:30 - 10:00 Room N/O 
EIBIR/EORTC Joint Workshop 
A radiologist with a ruler in his hand is a dangerous 






Introduction: imaging and the future of cancer therapy 
P. Brader1, Y. Liu2; 1Vienna/AT, 2Brussels/BE (peter@brader.md) 
The use of imaging biomarkers will become more important in clinical trials in the 
future. Non-invasive imaging enables associations between therapy and effect, 
providing morphlogic but also functional information. Assessment of tumour burden 
and time to the development of disease progression is of importance in clinical evalu-
ation of cancer therapy, however, with increasing use of cytostatic over cytotoxic 
targeted agents, response evaluation using conventional morphologic assessment 
is limited and usually takes longer to detect response compared to functional and 
molecular imaging techniques. Therefore, the question is raised whether it is time 
to move from anatomic assessment of tumour burden to functional and molecular 
08:30 - 10:00 Room L/M 
Organs from A to Z: Heart 
MC 422 




A. Congenital heart disease 
M. Gutberlet; Leipzig/DE (matthias.gutberlet@herzzentrum‑leipzig.de) 
The numbers of newborns with congenital heart disease (CHD) is not rising but the 
number of infants with congenital heart disease who achieve adulthood is constantly 
increasing due to improved medical treatment especially in cardiac surgery and 
paediatric cardiology. The imaging modality of choice during infancy in patients 
with congenital heart disease is echocardiography. But in older patients, especially 
after cardiac surgery, it becomes very often more and more difficult to achieve an 
adequate acoustic window to assess important anatomical structures. In particular 
the visualisation of the right ventricle, which is involved in many CHD, becomes 
difficult. Therefore, all cross-sectional imaging modalities, especially magnetic 
resonance imaging but also computed tomography, and also the radiologist comes 
into play. The pros and cons of the different imaging modalities will be discussed 
as well as the possibilities in common diseases like coarctation, tetralogy of Fallot 
and Transposition of the Great Arteries. 
Learning Objectives:
1.  To understand the value of available imaging modalities in congenital heart 
disease.
2.  To get an overview of common cases of congenital heart failure.
3.  To learn how to read post-surgical cases in patients with congenital heart 
disease.
Author Disclosure:
M. Gutberlet: Research/Grant Support; BmBF (German Federal Ministry of 
Education and Research), Competence Network of Congenital Heart Defects. 
Speaker; Bayer, Bracco, Siemens, Philips and GE. 
A-092 08:50
B. Valvular disease 
J. Bogaert; Leuven/BE (Jan.Bogaert@uz.kuleuven.ac.be) 
In recent years there, has been an increased use of cardiac MRI and to a lesser 
extent also cardiac computed tomography (CT) to assess valvular heart disease. 
Both techniques have shown to provide complementary often unique information 
compared with conventional techniques such as echocardiography and cardiac 
catheterization (x-ray angiography). When investigating cardiac valves, the infor-
mation is required on 1. clarification of the affected valve after auscultation of the 
heart; 2. definition of the valvular anatomy; 3. assessment of valvular function and 
4. definition of the effect of the valvular dysfunction on other cardiac structures 
and function. These questions can be addressed by combining echocardiography 
with x-ray angiography. However, MRI can provide the required information in 
a single investigation that is safe, non-invasive and without exposure to x-rays. 
Moreover, both MRI and CT are increasingly used as pre-procedural imaging in 
patients scheduled for transcatheter, percutaneous treatment, ensuring optimal 
patient selection and safe implantation. Furthermore, with the increasing accept-
ance of cardiac MRI for the assessment of valvular heart disease, there has been 
an increase in the amount of follow-up and outcome data that enables MRI to be 
used to define when patients should undergo treatment of their valve disease. In 
this presentation, an overview of the MRI and CT techniques that are currently 
used in the assessment of valvular heart disease, discussing the advantages 
and limitations of these techniques with reference to more conventional imaging 
modalities for investigating valvular heart disease.
Learning Objectives:
1.  To learn about various imaging modalities available for imaging the cardiac 
valves.
2.  To get an overview of various types of valvular diseases.
3.  To understand myocardial changes caused by valvular pathologies.
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has only modest diagnostic value for the assessment of such tumours. Numerous 
studies on perfusion MR imaging (pMRI) have indicated potential added prognostic 
and diagnostic value of this advanced MR neuroimaging technique for the work-up 
and follow-up of brain tumour patients. These studies are, however, limited by the 
fact that they were monocentric and commonly retrospective, and did not include 
a systematic histological or imaging review. To evaluate pMRI as its suggested 
potential as a neuro-oncological biomarker, the EORTC Brain Tumour Group initi-
ated a three-phase feasibility study on the implementation of pMRI in prospective, 
multicentre, multinational trials of (anaplastic) gliomas. A standardised MR imag-
ing protocol, including pMRI, was developed and subsequently implemented in 
4 core sites. Available post-processing tools were assessed with respect to their 
applicability to multicentre data, and a protocol to standardise relative Cerebral 
Blood Volume (rCBV) measurement was established. Datasets from all core sites 
were independently analysed by 4 experienced raters, assessing inter-rater vari-
ability for each of the post-processing tools. In this presentation, a brief overview 
of rCBV measurement and its potential value for brain tumour assessment is given. 
Furthermore, the EORTC Brain Tumour Group’s experience with and findings of 
the feasibility study will be presented, highlighting the difficulties of consistently 
measuring rCBV in general, as well as those specifically arising in multicentre trials. 
A-099 09:40
Presentation of LUNG study: from the beginning until today 
U. Nestle; Freiburg/DE (ursula.nestle@uniklinik‑freiburg.de)
The LungTech trial will be a European multicenter study adressing the challenge 
of stereotacic radiotherapy for small centrally located lung tumours. High precision 
radiotherapy poses special needs on pre-treatment assessment and target volume 
definition. Post treatment, radiation induced normal tissue alterations may lead to 
diagnostic problems and misinterpretations. Therefore, imaging research will play a 
major role in the study concept. Beyond pre-treatment staging, 3D and 4D imaging 
will be used for target volume delineation, positioning and follow-up concerning 
tumour control and toxicity. Several translational imaging research projects will or 
may be attached to this study. These involve 4D FDG PET/CT for target volume 
delineation, serial FDG PET/CT for evaluation of local control, DCE CT, and chest 
MRI. Besides insights in high precision radiotherapy for lung tumours, the concepts 
and methods of the related imaging studies will be discussed, obstacles and chal-
lenges will be discussed. 
08:30 - 10:00 Room P 
Professional Challenges Session 
PC 4 
The visibility of the radiologist 
A-100 08:30
Chairman’s introduction 
J.A. Reekers; Amsterdam/NL (jimreekers@xs4all.nl) 
For decades, radiology practise was located in the basement of the hospital, no day-
light and no natural relation to the rest of the hospital. This was more or less the natu-
ral habitat. The radiologist was “the person” taking the pictures, he was not perceived 
as a doctor whose opinion would value the patient directly. During the last decade, 
the radiologist has come to the light, changing from light box to computer screen, 
and has started to become more involved in clinical decision taking. However, there 
is still a lot, which can be improved before the radiologist is a fulltime member of the 
clinical multidisciplinary treatment team. Reporting and at the same time, combining 
this with knowledge about treatment will contribute to this role and increase the 
visibility of the radiologist. The guidance of radiology in cancer treatment is a good 
example of this. Clinical involvement in combination with delivering care and treat-
ment, like in interventional radiology, will also improve the visibility of the radiologist 
within the hospital. The radiologist should learn how to make alliances with other 
medical specialists. To achieve these goals, it is also crucial to understand the 
importance of having a prominent place for radiology in the medical curriculum. In 
modern medicine, radiology needs to play a central role in diagnosis and treatment. 
The visible radiologist should be a clinical doctor, a conductor and a Webmaster in 
one. This special session will give suggestions and information how to achieve this. 
Session Objectives:
1.  To learn how the visibility of the radiologist can be increased.
2.  To understand that radiology needs to play a central role in diagnosis and 
treatment.
3.  To learn from the experts and increase understanding through Q & A.
assessment. Imaging biomarkers like apparent diffusion coefficient (ADC) reflect cell 
density/death/apoptosis, contrast enhanced magnetic resonance imaging (CE-MRI) 
or computer tomography (CE-CT) detect early changes of micro-vascularisation 
and perfusion in tumours, and magnetic resonance (MR) spectroscopy shows 
biochemical changes in the tumour tissue. Undoubtedly, these advanced functional 
techniques hold great promise, but qualifying these imaging biomarkers requires 
robust methodology. One needs proper study design following standardised pro-
cedures, correlation with pathology/outcome, reproducibility testing and optimal 
timing of observation, and sufficient statistical power. In this session, a road map for 
future collaboration between EORTC and EIBIR will emerge with the aim of seeking 
standardisation of advanced MR technology in multicenter cancer clinical trials. 
Learning Objectives:
1.  To seek standardisation of imaging biomarkers in multicenter cancer clinical 
trials.
2.  To demonstrate examples of imaging implementation in optimised study design.
3.  To explore future collaboration between EORTC and EIBIR.
A-096 08:40
Setting up clinical trials with functional imaging end-points: trials 
and tribulations 
N.M. deSouza; Sutton/UK (Nandita.Desouza@icr.ac.uk) 
The standard imaging assessment of tumour response relies on size measure-
ments, which, with predominantly cytostatic targeted agents, may not reflect the 
drug effect. Functional imaging biomarkers have the potential to quantify biological 
characteristics of tumours and measure on-target and off-target effects that indicate 
early likelihood of response to a specific therapy, which can then be used to guide 
the optimal biological dose and drug schedule. Serial, non-invasive assessments 
of whole tumour are possible. This is particularly important in the context of inter 
and intra-patient tumour heterogeneity as different parts of the tumour and primary 
vs metastatic lesions may be biologically different and these characteristics may 
change with treatment. However, functional imaging end-points suffer from variabil-
ity, which can be very significant in a multicentre setting. Strict Quality Assuarance 
and Quality Control measures need to be implemented at the start of a trial and 
the variability across centres documented. Data acquisition protocols need to take 
account of equipment variations. Data analysis methodology needs standardisation 
of software, central review and preferably double reading of scans. Automation may 
not always prove the most robust and reliable option. This presentation will focus 
on the factors that are crucial in determining the compatibility of data in multicentre 
trials with functional imaging end-points. 
Learning Objective:
1.  To understand the processes involved in incorporating functional imaging end 
points into clinical trials and appreciate the limitations.
Author Disclosure:
N. M. deSouza: Research/Grant Support; Cancer Research UK, Medical 
Research Council UK, Engineering and Physical Sciences Research Council 
UK, National Institute for Health Research (NIHR) UK. 
A-097 09:00
Challenges, problems on key imaging techniques 
B. Van Beers; Clichy/FR (bernard.van‑beers@bjn.aphp.fr) 
Imaging methods used in clinical trials of new drugs should be able to objectively 
assess the early response to treatment. Therefore, the imaging biomarkers should 
be validated and standardised and quality control should be performed. The amount 
of validation depends on the type of clinical trials. In phase 1 and 2 clinical trials, 
pharmacokinetic/dynamic biomarkers may be sufficient for taking “go/no go” deci-
sions. In phase 3 trials, surrogate imaging markers of hard endpoints, such as 
survival or time to progression, are required. The reproducibility of the imaging 
biomarker is an important factor that should be taken into account. Standardisation 
should concern both the image acquisition and analysis methods. Quality control 
may require repeated phantom measurements and central reading. Finally, the 
cost benefit of the imaging biomarkers should be considered relative to that of 
non-imaging biomarkers. 
A-098 09:20
Advanced MR neuroimaging in multicentre trials: experience from 
the EORTC Brain Tumour Group 
M. Smits; Rotterdam/NL (marion.smits@erasmusmc.nl) 
Anaplastic gliomas constitute a group of brain tumours with heterogeneous clinical 
behaviour, and the optimal treatment strategy is still a matter of debate. Conven-
tional MR imaging, including T2w/T2-FLAIR and contrast enhanced T1w sequences, 
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physicians in the appropriate use of diagnostic imaging studies. The radiologist’s 
participation in clinical meetings is also mandatory, but this takes time and neces-
sitates speaking the same language as clinicians, reading the same journals. As 
an example, clinicians rely more than ever on imaging studies to assess tumour 
response to various treatments. This hidden and time-consuming work is often 
not well recognised and rewarded. Lastly, answering clinicians’ questions needs 
adequate reporting, avoiding disorganized and imprecise document that can rarely 
be taken seriously by colleagues. 
Learning Objectives:
1.  To learn how to become more clinically involved.
2.  To learn about the requirements of clinical radiology.
3.  To learn how to manage the clinical problems of others.
A-104 09:25
Radiology in the 2 1st century: time to come out of the dark? 
A. Adam; London/UK (andy.adam@kcl.ac.uk) 
In a few years, we are likely to see 3D images generated instantly, and with com-
parable resolution to today’s 2D views. The detail on these images will make them 
increasingly relevant as detailed diagnostic and presurgical planning tools. Inclusion 
of functional information, possibly at the molecular level, could also assist in clinical 
decision-making. Specialist surgeons and physicians with intimate knowledge of 
their field of interest are likely to have a better understanding of the anatomy and 
physiology of an organ system than a general radiologist. So given that the images 
will be presented in a more familiar format, why should clinicians and surgeons wait 
for a general radiologist to read them? If radiologists wish to retain their role as the 
experts in image interpretation, they will not only need a thorough understanding of 
imaging, but also a detailed understanding of anatomy and pathophysiology and 
they will need to subspecialize. In addition to subspecialization, radiologists will 
need to play an important role in the determination of patient pathways. The way 
radiology is used at present is inefficient, as it is driven by requests for investigations 
by physicians who are not equipped to use imaging efficiently. Radiologists should 
be proactive, and should communicate with referring physicians and with patients 
when significant abnormalities are detected, planning further investigations rather 
than simply responding to requests. This will help to arrive at a diagnosis at an 
earlier stage, will save money and will improve clinical outcomes.
Learning Objectives:
1.  To learn about the role of the radiologist as quality controller.
2.  To learn how to become proactive and drive patient pathways rather than 
simply responding to requests.
3.  To learn about improved visibility through improved service.
Panel discussion: 
Should we improve the visibility of the radiologist? And if yes, how? 09:45 
08:30 - 10:00 Room Q 
Special Focus Session 
SF 4b 
Justifying CT in paediatric radiology 
A-105 08:30
Chairman’s introduction 
C. Owens; London/UK (owensc@gosh.nhs.uk) 
This session will provide a vitally important opportunity to listen to experts dis-
cussing the core issues which we face in a world with increasing expectations 
and demands on the imaging world. That is to provide the best quality images in 
the most challenging group of patients, i.e. children. The sensitivity of organs to 
radiation and the expectations of longer survival with state of the art treatment (for 
diseases which were previously lethal) dictates that we must act with prudence 
when choosing the best and most apropriate imaging modality to answer the 
relevant diagnostic question. The attendee will have an opportinity to indulge in 
the opinions and expertise of the speakers from various relevant subspecialites. 
Session Objectives:
1.  To become familiar with the importance of CT justification and optimisation.
2.  To understand the evidence base for concern.
3.  To become familiar with realistic alternatives to CT.
A-101 08:33
How to optimise the visibility of the radiology department 
J.A. Reekers; Amsterdam/NL (jimreekers@xs4all.nl) 
For decades, the radiology department was located in the basement of a hospital. 
Radiation was the main reason for this stuffy and airless environment. A clinician 
did not go to a radiology department, the pictures were sent to him, sometimes with 
a note describing what could be seen on the pictures. Imaging was easy and most 
medical specialists could read the film related to their own specialty. This has now 
changed dramatically, reading diagnostic images has become very complicated with 
the new imaging modalities and consultation on which imaging technique fits best 
with a clinical question is now the domain of the radiologist. With this new position 
also a new department has to be structured as a service-centre. First of all, out of 
the basement and centrally located in the hospital. All medical conferences where 
imaging plays an important role should take place at the radiology department. This 
means that smaller and larger conference rooms with state-of-the-art projection and 
access to a PACS should be build. As all reading is done from a computer screen, 
workspaces should be able to facilitate interactive medical specialist discussions. 
Radiology departments should be organised around medical subspecialties with 
fixed stations to make it easy for specialist to find there diagnostic partner. Natural 
light is important but if this is not possible daylight systems will improve the well 
being and ambiance at a department. In this session some important details will 
be discussed about how to increase the radiologist’s visibility by building an open 
department.
Learning Objectives:
1.  To learn how to organise a radiology department within a hospital.
2.  To learn how to optimise contact with clinical partners.
3.  To learn how to create an open radiology department.
A-102 08:45
Start early with radiological visibility 
M. Maas; Amsterdam/NL (m.maas@amc.nl) 
The future of radiology depends on what current medical students think of radiology 
and how they are attracted into the field. There is a high responsibility for academic 
radiologists to increase awareness amongst medical students considering the 
pivotal role of radiology as clinical speciality and of the opportunities in the field of 
radiological research. Radiology has got very powerful selling points: Radiology 
has got images (one image is more than 1000 words), Radiologists are used to 
perform (in clinical meetings), Radiology is the most Computer Integrated Spe-
cialty, Students nowadays are computer centered learners (digital natives, Homo 
Zappiens). Possible strategies to reach the goals are: 1. Teaching (Radiological 
Anatomy, in combination with department of Anatomy, Computer-based learning 
programs, Moderating small group learning); 2. Faculty development (Clinical 
rotations, Mentoring medical students); 3. Curriculum development (Board Medical 
school, National Advisory Boards). Some steps need to be taken, to be successful 
in this track. Head of the Department strategically needs to reserve time and money 
for some staff to pursue this goal. The individual Radiologist needs training in the 
field of education, attends courses on curriculum building and faculty development, 
as well as on preparation of exams and on class room performing. CME credits in 
the field of Medical Education need to be obtained. Furthermore, the person needs 
to be willing, creative and flexible, while skills in mentoring and providing feedback 
on students also are important to develop. IT IS GREAT FUN!
Learning Objectives:
1.  To learn how to set up an undergraduate teaching programme for radiology.
2.  To learn how to overcome the barriers of a traditional curriculum.
3.  To learn about the results of an undergraduate teaching programme for radiol-
ogy.
A-103 09:05
Clinical radiology puts you in the spotlight: taking over the clinical 
responsibility 
E. de Kerviler; Paris/FR (eric.de‑kerviler@sls.aphp.fr) 
Clinical radiology is the use of imaging to diagnose, treat and monitor various 
disease processes. Radiology is somewhat different from most other clinical 
practices because there is in theory a relatively weak connection to the individual 
patient. However, there are subspecialties of Radiology, which include a lot of 
patient interaction. Unfortunately, the volume and complexity of imaging work has 
driven many radiologists underground. There are many other factors that influence 
a radiologist’s clinical implication such as administrative, managerial, teaching 
or research duties. The radiologist must however recover his place in patients’ 
management, from imaging workup to therapeutic decision. This begins in guiding 
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and chest imaging, in comparison with CT. Moreover, functional applications of 
MRI represent a promising field, challenging for example scintigraphy, an ionising 
modality, in measurement of renal function.
Learning Objectives:
1.  To become familiar with alternative imaging methods to replace CT.
2.  To appreciate the advantages and disadvantages of these alternative methods 
of imaging.
3.  To become familiar with a practical model for CEUS and MRI in body imaging.
Panel discussion:  
Do we have guidelines for paediatric CT? Do we have alternatives? 09:40 
10:30 - 12:00 Room A 
Interactive Teaching Session 
E³ 520a 
Pitfalls in abdominal imaging 
A-109 10:30
A. Liver 
V. Vilgrain, M. Ronot, A. Kerbaol, O. Bruno; Clichy/FR 
(valerie.vilgrain@bjn.aphp.fr) 
The purpose of this lecture is to emphasize some pitfalls in liver imaging. Morpho-
logic changes in the liver are usually attributed to chronic liver disease where liver 
cirrhosis represents the most important cause. However, non-cirrhotic diseases 
may also induce atropho-hypertrophic changes of the liver. The most common 
mechanisms are related to venous obstruction (either portal or hepatic venous) and 
biliary obstruction. Multidetector CT and MR imaging are essential to highlight these 
abnormalities. When dealing with liver tumours, the most important question that 
has to be solved is tumour characterisation. Yet, it is often difficult to assess whether 
a large tumour is intra- or extrahepatic. Imaging findings that might be helpful will 
be shown. Last, some liver lesions can mimic liver tumours. Vascular disorders 
and focal fatty changes or focal fatty sparing are the most common causes. Some 
other conditions can be also mimickers and such cases will be shown.
Learning Objectives:
1.  To learn about morphologic changes in the liver observed in non-cirrhotic 
diseases.
2.  To understand imaging features enabling distinction between intra and extra-
hepatic tumours.
3.  To become familiar with liver lesions mimicking liver tumours.
A-110 11:15
B. Pancreas and bile ducts 
R. Manfredi; Verona/IT (riccardo.manfredi@univr.it) 
The technique and the anatomy of the bile duct and pancreatic duct will be de-
scribed. Anatomical variants of the biliary duct and the pancreatic duct system will 
be analyzed and their possible role in generating diagnostic imaging pitfalls, will 
be described. Strategies to avoid pitfalls in diagnostic imaging of the bile duct and 
the pancreatic duct system will be illustrated, considering the possible source of 
pitfalls. Diagnostic imaging findings of different diseases involving the biliary ducts 
and pancreatic duct system will be illustrated, as well as the diagnostic imaging 
criteria useful for the differential diagnosis.
Learning Objectives:
1.  To understand the MRI technique for evaluating the pancreatic parenchyma, 
the pancreatic duct system and the biliary tree, the functional assessment 
following secretin stimulation.
2.  To appreciate the signs in MR imaging of the pancreas and bile ducts.
3.  To understand the diagnostic imaging criteria useful for differential diagnosis.
A-106 08:34
How should CT be optimised? 
W.A. Kalender; Erlangen/DE (willi.kalender@imp.uni‑erlangen.de) 
In general, optimisation aims at maximising the benefit of a procedure while at the 
same time minimising potential risks or side effects. In paediatric radiology, this 
means that dose should be kept to the minimum necessary for adequate image 
quality. The aim of this lecture is to focus on dose issues and at options for reducing 
patient‘s dose without impairing image quality. Dose levels today are typically quoted 
at 1 to 15 mSv as effective dose per CT scan and will depend on the examination 
and on the anatomic range examined. The underlying dosimetry issues will be 
discussed briefly. Modern CT scanners offer a variety of means for reducing dose 
without a detriment in image quality. The availability of voltage values below the 
standard 120 kV setting is one of the most important steps. Model-based iterative 
image reconstruction, dedicated filtration, tube current modulation and automated 
exposure control are further examples which will be discussed. These measures 
have to be complemented by proper assessment of dose and by providing the re-
spective information to the user on the console. Respective tools will be presented. 
The current trend is to bring doses in paediatric CT down to the sub-mSv range 
and thereby to increase the benefit-to-risk ratio further. „As high as reasonably 
achievable“ or AHARA is the goal regarding this ratio.
Learning Objectives:
1.  To become familiar with the dose levels currently encountered in paediatric 
CT.
2.  To become familiar with new developments towards dose reduction in CT.
3.  To learn about tools for assessing organ dose and effective dose values.
Author Disclosure:
W. A. Kalender: CEO; CT Imaging GmbH, Erlangen, DE. Consultant; Siemens 
Healthcare, Erlangen, DE. Founder; CT Imaging GmbH, Erlangen, DE. 
Owner; CT Imaging GmbH, Erlangen, DE. Research/Grant Support; Siemens 
Healthcare, Erlangen, DE; CT Imaging GmbH, Erlangen, DE. 
A-107 08:56
When, how, and why I perform CT 
C. Owens; London/UK (owensc@gosh.nhs.uk) 
This presentation will help the atendee to understand how CT must be used with 
caution in children, and appropriate justification will be discussed in detail. We will 
give recommendations for appropriate use of in children, with examples of weight-
based protocols, used in house, for paediatric body imaging. Various tips and tricks 
for enhancing images with different acquistion tecniques and post-processing will 
be shown using cardiothoracic models, Relative strengths and weaknesses of the 
various modes of CT acquisition which can be prescribed by the attending radiolo-
gist will be discussed, and analysed.
Learning Objectives:
1.  To become familiar with the concept of CT ‘fit for purpose’.
2.  To appreciate the role of CT in paediatric body imaging.
3.  To become familiar with suggested parameters for use of CT in cardiothoracic 
imaging, describing risks and benefits.
A-108 09:18
Why and when CT does not need to be performed 
M. Claudon; Vandoeuvre‑les‑Nancy/FR (m.claudon@chu‑nancy.fr) 
While CT examination provides major clinical information in many cases, two other 
modalities which do not entail ionising radiation exposure have to be considered 
as appropriate methods and/or substitutes to CT in children and adolescents, in 
respect to an ALARA approach. Ultrasound (US) is a well assessed, low-cost and 
non-invasive modality, widely used for a large spectrum of diseases. It has to be 
considered as the first imaging modality in the emergency room and intensive care 
unit (ICU). New applications also include chest US, musculoskeletal US and flow 
imaging. Recent advances allow encompassing previous technical limitations, 
including high-frequency probes, fast imaging, elastography and volume imag-
ing. Contrast-enhanced sonography is still waiting for approval in the paediatric 
population. Paediatric US requires appropriate experience and sufficient alloca-
tion of technical and human resources to ensure high-quality performance. MRI 
offers another interesting alternative to CT. High-resolution images with various 
spontaneous contrast patterns are useful for morphological evaluation, and in 
some cases for characterisation of lesions. However, long exam times, sedation, 
motion artefacts, and cost are barriers to expand the use of MRI. This may be 
partly reduced by technical improvements, such as high-field systems, accelera-
tion and navigation processes. The place of US and MRI in diagnostic strategies 
will be discussed in abdominal imaging, including in emergency and ICU, renal 
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Author Disclosure:
J. Macho: Consultant; STRYKER, eV3. 
A-113 10:55
Interlude: Spanish radiologists: open to the world 
E. Fraile Moreno; Madrid/ES (eduardo.fraile@salud.madrid.org) 
Founded on February 11, 1917, SERAM, “Sociedad Española de Radiología 
Médica” is the Scientific Society that groups more than 4,700 members among 
Spanish radiologist. It is a professional scientific organization dedicated to promot-
ing education, research and development of all diagnostic and therapeutic aspects 
in relation to diagnostic images. As a society, the main challenges for us are to 
promote the education of radiologists and courses sponsored and run by SERAM 
are available for radiologists throughout all of their training. We also hold courses 
for senior radiologists in specific areas of interest such as oncology, molecular 
imaging or vascular diseases. SERAM also provides grants to attend different 
meetings like the ECR in Vienna or RSNA in Chicago and grants in research in 
collaboration with different companies involved in radiology. Another of SERAM’s 
contributions include promoting the sharing of knowledge creating and releasing 
different types of publication. Our official journal is called “Radiologia.” it is the only 
Spanish radiological publication in PubMed, and is also included in the GORAD 
portal of radiology magazines. The english version is also available online on our 
website www.seram.es. Other contribution that SERAM makes are available on 
our website is the virtual library. In 2009, with the support of SERAM, the book 
“Radiologia Esencial” was published. Establishing standards and references is 
another of SERAM’s contributions, since the year 2000, we have published the 
reference book of current procedural terminology.
A-114 11:00
Aortic aneurisms 
J.J. Martínez Rodrigo; Valencia/ES (martinez.jjo@gmail.com) 
Aortic aneurisms are a potentially devasting condition if misdiagnosed or not 
early detected and corrected. Aortic aneurism rupture prevention with a proper 
imaging follow-up and treatment indication are essential to provide a standard of 
care to these patients. Screening programs among elderly and risk patients have 
been addressed to detect patients with aortic aneurysms amenable to follow-up 
or treatment. Multidisciplinary teams focused on early detection and treatments of 
these pathologies have improved the outcomes of this disease. We will describe 
strategies to develop a multidisciplinary approach to early detection and diagnosis 
of aortic aneurisms and will describe our experience. Stent graft devices allowed 
interventional radiologists and other specialists a less-invasive approach to treat 
aortic patients but new challenges derived from this new treatment related to en-
dovascular treatment complications. The simple bifurcated technique has evolved 
to treat complex abdominal and thoracic aneurisms by means of fenestrated grafts 
and branched devices. The totally percutaneous approach with the new low-profile 
devices and percutaneous suture techniques is a fact. Imaging again is the leading 
tool allowing us to improve outcomes. We will discuss imaging role in increasing 
security in performing and guiding these interventions especially in 3D guiding 
imaging. Radiologists play also a major role in the follow-up of stent grafts to de-
tect endoleaks and other complications. Finding the right approach to solve these 
problems is mainly dependant on imaging techniques that provide interventional 
radiologists the tools to plan the adequate treatment strategies.
Learning Objectives:
1.  To understand the role of imaging modalities in diagnosis and endovascular 
treatment of aortic aneurisms.
2.  To learn about the role of 3D  imaging techniques to assist the endovascular 
treatment of aortic aneurisms.
3.  To appreciate the role of imaging modalities in evaluating the complications 
of endovascular aortic repair.
A-115 11:20
Interlude: Radiologists and Spanish wines 
L. Martí-Bonmatí; Valencia/ES (marti_lui@gva.es) 
Why are wines different? Which is the influence of the country, the climate and 
the situation. Why is the soil (and by extension terroir) so important? A wine from 
a particular patch of ground expresses characteristics related to the physical en-
vironment in which the grapes are grown. A combination of certain vineyard sites 
and grape varieties creates unique wines that faithfully express their geographical 
origins. But, how do soils affect wine quality? Is it a direct or indirect relationship? 
What are the scientific explanations for terroir effects? How many soils are present 
in wine-producing regions? The miracle of the plant kingdom is that these complex 
10:30 - 12:00 Room B 
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C. Ayuso; Barcelona/ES (cayuso@clinic.ub.es) 
Radiology had been continuously improving since x-rays were discovered by C. 
Roentgen in 1895, until nowadays. The technological developments had been 
dramatically followed and new tools and complex procedures guided by means 
of imaging techniques had been developed. These facts had been crucial for 
the clinical approach of Radiology in the recent decades. The organ-system 
organization of Radiology conducted us to focus in more specific scenarios, al-
lowing us to acquire deep knowledge on specific fields. Knowledge on Radiology 
is based on evidence nowadays. This has been the basis of the tremendous 
impact of including Radiology in the task of multidisciplinary teams where radi-
ologists have an interesting role in the decision making process. The session 
will include three particular scenarios where radiologists have a crucial role from 
the diagnosis of the disease, to the treatment and the follow-up of the patients. 
Session Objectives:
1.  To discuss the role of imaging techniques in different clinical scenarios where 
radiologists are key, from diagnosis to treatment.
2.  To present technical imaging innovations that assist the diagnosis, treatment 
and follow-up in three different clinical scenarios: ischaemic stroke, aortic 
aneurism and hepatocellular carcinoma.




J. Macho; Barcelona/ES (jmmacho@clinic.ub.es) 
Interventional neuroradiology (INR) has become an essential tool during the last 
decades in the management of hemorrhagic stroke as well as in the diagnosis and 
treatment of the different vascular lesions that may lead to them (aneurysms, AVM’s, 
Dural Fistulas, etc). However, the role of INR in the treatment and prevention of 
ischemic stroke has been controversial, with carotid stenting, intracranial stenting 
and intraarterial techniques in acute stroke, being frequently under debate. Lately, 
new devices and technology specifically designed for intracranial thrombectomy in 
acute stroke have shown their effectiveness in revascularization with better reper-
fusion rates than those achieved with intravenous lytics or previous thrombectomy 
devices. However, these good revascularization rates were not always correlated 
with good clinical outcomes. Advanced multimodal imaging techniques have been 
advocated as essential in the decision-making algorithm in order to achieve better 
long-term clinical outcomes. Morphological (angioMR - angioCT) and especially 
perfusion imaging techniques (perfusion computed tomography and diffusion and 
perfusion weighted magnetic resonance) have proved to be effective in the identi-
fication of cerebral penumbra in acute stroke and thus in the selection of patients 
for thrombolytic therapy, being both techniques equivalent in this task. Multidis-
ciplinar stroke teams in which diagnostic and therapeutic neuroradiology plays a 
significant role are achieving excellent rates of clinical recovery in this otherwise 
devastating disease. We will show algorithm protocols and stroke unit designs 
specifically addressed to improve clinical outcomes in those patients selected for 
Intraarterial treatment and with the aim to increase the number of patients eligible 
for revascularization. 
Learning Objectives:
1.  To discuss the clinical and neuroradiologic implications of an early diagnosis. 
Evaluation of CT and MR diffusion/perfusion in patient selection for endoarterial 
treatment.
2.  To understand the rationale behind mechanical endoarterial reperfusion of 
acute vascular occlusion.
3.  To analyse the short and medium term results of a regional programme for 
acute stroke treatment after three years.
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or Dynamic Contrast Enhanced Magnetic Resonance Imaging (DCE-MRI) can be 
helpful in this setting. The presentation aims to familiarize general radiologists, who 
have an interest in head and neck imaging, with common pitfalls encountered on 
CT and MR studies focussing on the neck. Both the pre-therapeutic, as well as 
the post-treatment setting, will be discussed using examples from daily practice.
Learning Objectives:
1.  To understand the variations of normal anatomy in the neck that should not 
be interpreted as abnormal.
2.  To become familiar with the incidental findings that are frequently encountered 
when searching for neck disease.
3.  To recognise suboptimal neck studies, or technique related problems and 
understand how these may influence interpretation.
A-118 11:15
B. Pitfalls in maxillofacial and skull base imaging 
R. Hermans; Leuven/BE (Robert.Hermans@uzleuven.be) 
Imaging of the skull base and maxillofacial skeleton requires a meticulous imag-
ing technique and a good knowledge of normal anatomy and possible anatomical 
variants. Asymmetry in the pneumatisation of the paranasal sinuses, skull base or 
temporal bone is a common reason for misinterpretation. For example, hypoplasia 
of the maxillary sinus may be misinterpreted on conventional radiography as maxil-
lary sinusitis or an orbital blow out fracture, depending on the context; asymmetric 
pneumatisation of the petrous apex or mastoid bone may mimick, respectively, 
a cholesterol granuloma and fluid effusion in the non-pneumatised side on MRI. 
Vascular variants may also cause interpretation problems. For example, turbulent 
flow in a large jugular bulb may mimick a jugular foramen tumour on MRI. Variants in 
the vascular plexus surrounding the facial nerve or branches of the trigeminal nerve 
may occur, and cause asymmetric findings on MRI, possibly mimicking neuritis or 
perineural tumour spread. Incomplete maturation or arrested development of skull 
base structures may also cause confusion. Examples are the cochlear cleft, not be 
confused with otosclerosis, or arrested pneumatisation of the sphenoid sinus, pos-
sibly mimicking a tumoural lesion in the central skull base. To avoid problems, one 
should keep in mind the existence of such variants, while correlating the imaging 
findings with the clinical problem; in some cases, an additional imaging study may 
be needed to exclude a pathological process more confidently. 
Learning Objectives:
1.  To understand the basic requirements for an optimal imaging study of the skull 
base and maxillofacial region.
2.  To become familiar with anatomical variants, potentially mimicking disease.
3.  To learn to appreciate incidental findings, avoiding unnecessary concern while 
recognising relevant pathology.
10:30 - 12:00 Room E2 






A. Neonatal hypoxic-ischaemic brain injury 
M.I. Argyropoulou; Ioannina/GR (margyrop@cc.uoi.gr) 
The pattern of neonatal brain lesions associated with hypoxia-ischaemia depends on 
the severity of the event and gestational age at birth. The immature brain of preterm 
babies reacts to hypoxia-ischaemia differently than the brain of full-term babies. 
Imaging plays an important role in the diagnostic work up of these patients, with 
brain ultrasound being the first line examination performed at bedside, followed by 
brain Magnetic Resonance Imaging. Germinal Matrix Haemorrhage appearing as 
an ovoid lesion anterior to the caudothalamic groove, Intraventricular Haemorrhage, 
Parenchymal Venous Haemorrhagic Infarction appearing as a paraventricular fron-
toparietal triangular lesion pointing towards the lateral ventricle, Post-haemorrhagic 
Hydrocephalus, Periventricular Leukomalacia with a focal necrotic form (fPVL) 
appearing with multiple coalescent periventricular cysts, irregular outlines of the 
lateral ventricles and white matter loss and a diffuse form (dPVL) appearing with 
regular outlines of the lateral ventricles and white matter loss represent the spec-
trum of lesions responsible for the encephalopathy of prematurity. Parasagittal 
Watershed Infarcts affecting the cortex and the subcortical white matter, Diffuse 
lesions of Macrocystic Encephalomalacia, due to partial prolonged asphyxia (1-3 
organisms build themselves from virtually nothing: all a plant needs to grow is some 
water, sunlight, air and a mix of trace elements and nutrients. Many viticultural 
interventions aim at encouraging the vine to partition nutrients to the grapes so that 
they ripen properly, rather than concentrating on growing more leaves and stems. 
Spain is a peninsula with so many different rivers, mountains, seas and climates. 
Even more, the soil composition of vineyards, one of the most important viticultural 
considerations when planting grape vines, is so different that a clear explanation 
has to be done. This will be the focus of this interlude.
Learning Objectives:
1.  To understand the influence of the country, the climate and the situation in the 
quality of wines.
2.  To learn about Spain’s characteristics that influence the wine quality.
3.  To appreciate why the soil (and by extension the terroir) is so important.
A-116 11:25
Hepatocellular carcinoma: the BCLC approach 
M. Burrel; Barcelona/ES (marta_burrel@yahoo.com) 
Hepatocellular carcinoma is recognised as one of the major cancer causes of death, 
its incidence has increased in several Western countries, and it is the leading cause 
of death in patients with cirrhosis. Screening allows detection at an early stage 
and there is a large range of therapeutic options to be considered while taking into 
consideration tumour burden and liver function. Imaging techniques are a key tool 
for clinical decision making in the evaluation of patients with liver tumours. The de-
velopment of ultrasound, computed tomography and magnetic resonance imaging 
has allowed the detection and diagnosis of liver tumours at an asymptomatic stage, 
which has modified their diagnostic approach and treatment. Moreover, assessment 
of treatment efficacy and follow-up is done through imaging. Imaging techniques 
and radiologists executing them have also a major impact in a variety of image-
guided therapeutic interventions. The capacity to identify the tumour site in real 
time allows percutaneous tumour ablation; several cohort studies and randomised 
trials have shown the value of ablation in patients with HCC at an early stage; cur-
rently, radiofrequency ablation and ethanol injection are established therapies in 
conventional clinical practice. Transarterial chemoembolisation has also shown to 
be effective in terms of burden reduction and has proved to positively affect patient 
survival in patients with multinodular HCC confined to the liver.
Learning Objectives:
1.  To understand the clinical implications of an early diagnosis, when the lesion 
is small and asymptomatic.
2.  To learn about the rationale behind the current guidelines for model treatment 
options.
3.  To appreciate the spectrum of locoregional therapies for HCC from percutane-
ous to intravascular approaches.
Panel discussion: 
Is the multidisciplinary environment the natural way to develop 
excellence and leadership in clinical imaging? 11:45 
10:30 - 12:00 Room C 
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Pitfalls in head and neck imaging 
A-117 10:30
A. Pitfalls in neck imaging 
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl) 
Pitfall: „a hidden or unexpected danger or difficulty“. Imaging methods can provide 
an extraordinary amount of useful data to specialists treating head and neck (can-
cer) patients. It is crucial that these data are used to full advantage of individual 
patients. The most important factor in this process is mutual cooperation between 
the physicians in charge of patient care and the diagnostic imaging specialist. Pitfalls 
in the head and neck may present in various ways: normal variants may look like 
disease, incidental findings are frequently encountered, suboptimal technique may 
obscure important findings. Moreover, many pitfalls are directly related to techni-
cal errors. In this potential ‚minefield‘, the post-treatment patient presents a major 
challenge to the imaging specialist. Ablative surgery usually results in distortion of 
the anatomy, especially when combined with flap reconstruction. When adequate 
preoperative and/or baseline postoperative imaging is lacking, determination of 
recurrence on a single postoperative examination may well be impossible. PET 
CT (MR) and advanced MR-techniques; e.g. Diffusion Weighted Imaging (DWI) 
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A. Pancreatic cancer 
F. Caseiro-Alves; Coimbra/PT (caseiroalves@gmail.com) 
Despite advances in cross-sectional techniques, imaging has still difficulties on as-
sessing pancreatic tumours and in particular adenocarcinoma. The main problems 
remain the early detection of small tumours and the clearcut definition of patients 
that are amenable to curative surgery. After reviewing current concepts in the 
classification of pancreatic tumours including the role of molecular biomarkers, the 
lecture will address the strategies that may be used to maximize tumour conspicuity 
in a multi-modality perspective that also encompasses uprising techniques, such 
as dual energy CT, perfusion CT/MR and diffusion-weighted MRI. The concept of 
borderline resectable pancreatic cancer will be explained as well as the key points 
for image interpretation in the setting of clinical decisions for patient management. 
In addition, the current role of adjuvant or neoadjuvant therapy will be shortly ad-
dressed especially concerning its imaging implications, as well as the new concepts 
on pancreatic adenocarcinoma oncogenesis and possible imaging strategies that 
may be used for earlier detection.
Learning Objectives:
1.  To understand current pathologic concepts for the classification of pancreatic 
tumours.
2.  To learn about imaging findings used for tumour detection, staging, and restag-
ing after adjuvant therapy.
3.  To understand the role of functional and molecular information provided by 
PET/CT, DWI and perfusion imaging when assessing pancreatic tumours.
A-123 10:55
B. Kidney cancer 
E.K. Fishman; Baltimore, MD/US (efishman@jhmi.edu) 
Carcinoma of the kidney is responsible for over 100,000 deaths worldwide each 
year. With advances in radiologic imaging up to two-thirds of renal cancers are 
picked up as serendipitous findings. Despite multiple advances in imaging chal-
lenges in lesion classification remain and may result in up to one fourth of lesions 
under 3 cm being resected being benign lesions. In this presentation we will focus 
on the role of CT in the detection, staging and management of the patient with 
renal cell carcinoma discussing both renal cell carcinoma (clear cell and papillary) 
and transitional cell carcinoma. The importance of proper protocol design, the use 
of multiphase acquisition and the value of 3D mapping will be discussed. The role 
of CT in staging tumours and its role in surgical planning will also be addressed. 
New understanding of how CT findings on arterial phase imaging closely correlate 
with the genetic findings is also addressed. The pitfalls in lesion detection and 
classification are also addressed and case examples of some of the pitfalls are 
provided. Protocols for the use of imaging as well as the use of dose reduction 
techniques including iterative reconstruction are addressed. 
Learning Objectives:
1.  To understand the diagnostic implications of minimally invasive treatments of 
renal cancer.
2.  To review the genetic causes of renal cancer and the radiologic appearances 
of specific histologic subtypes.
3.  To review the potential role of molecular imaging in the management of ad-
vanced renal cancer.
Author Disclosure:
E. K. Fishman: Advisory Board; GE, Siemens. Board Member; HipGraphics Inc. 
Founder; HipGraphics Inc. Research/Grant Support; GE, Siemens. 
h) and Lesions of the basal ganglia, the perirolandic cortex and the brain stem 
due to acute total asphyxia (10-15 min) comprise the spectrum of lesions following 
hypoxia ischaemia in the full-term baby. Stroke is an important cause of mortality 
and morbidity in the neonatal period. Neonatal stroke is less common than adult 
stroke but more common than that in childhood and the carotid artery territory is 
most commonly affected.
Learning Objectives:
1.  To understand gestational age-related patterns of brain injury.
2.  To understand the role of ultrasound and MRI for the initial diagnosis and 
follow-up of these patients.
3.  To understand when and how to use advanced MRI techniques for delineation 
of lesions and for prognosis.
A-120 11:00
B. Spine and spinal cord malformations 
A. Rossi; Genoa/IT (andrearossi@ospedale‑gaslini.ge.it) 
Spinal and spinal cord malformations are collectively named spinal dysraphisms. 
They arise from defects occurring in the early embryological stages of gastrulation 
(weeks 2-3), primary neurulation (weeks 3-4), and secondary neurulation (weeks 
5-6). They are categorized into open spinal dysraphisms, in which there is exposure 
of abnormal nervous tissues through a skin defect, and closed spinal dysraphisms, 
in which there is a continuous skin coverage to the underlying malformation. Open 
spinal dysraphisms basically include myelomeningocele and other rare abnormali-
ties such as myelocele and hemimyelo (meningo)cele. Closed spinal dysraphisms 
are further categorized based on the association with low-back subcutaneous 
masses. Closed spinal dysraphisms with mass are represented by lipomyelocele, 
lipomyelomeningocele, meningocele, and myelocystocele. Closed spinal dys-
raphisms without mass comprise simple dysraphic states (tight filum terminale, 
filar and intradural lipomas, persistent terminal ventricle, and dermal sinuses) and 
complex dysraphic states. The latter category further comprises defects of midline 
notochordal integration (basically represented by diastematomyelia) and defects 
of segmental notochordal formation (represented by caudal agenesis and spinal 
segmental dysgenesis). Magnetic resonance imaging is the preferred modality for 
imaging these complex abnormalities. The use of the aforementioned classification 
scheme is greatly helpful to make the diagnosis. 
Learning Objectives:
1.  To understand the embryology underlying the different categories of malforma-
tions.
2.  To learn the key morphological features.
3.  To learn how to use a simplified diagnostic imaging approach.
A-121 11:30
C. Imaging of the foetal brain 
C. Garel; Paris/FR (catherine.garel@trs.aphp.fr) 
The foetal brain undergoes changes throughout pregnancy according to a specific 
timing. Hence, the changing appearance of the cerebral parenchyma over time, 
the development of the different sulci and the structures of the posterior fossa 
must be well known in order to provide an accurate analysis of the fetal brain. 
Ultrasonography (US) is the imaging modality of choice for routine evaluation of 
the fetal brain. In favourable conditions, it enables detection of most cerebral abnor-
malities. The acquisition of images in the three planes of the space is mandatory. 
When available, the use of high-frequency probes enhances spatial resolution and 
may provide important details regarding brain anatomy. The different structures of 
the brain must be systematically analysed. Magnetic Resonance Imaging (MRI) 
provides excellent images whatever the foetal position and the thickness of the 
maternal wall but may be hampered by foetal motion. It is important to be aware of 
the contribution of the different sequences. The contrast resolution is better with MRI 
than with US. Imaging findings of the most common cerebral abnormalities will be 
displayed with emphasis on respective contribution, limitations and indications for 
both imaging modalities. For instance, certain lesions, such as focal parenchymal 
calicifications, may be overlooked by MRI. Conversely, other lesions such as focal 
haemorrhage or subependymal tubers may be missed by US. Awareness of these 
limitations is of utmost importance.
Learning Objectives:
1.  To become familiar with the normal appearance of the developing brain.
2.  To learn about the protocols and the limitations of foetal imaging.
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Learning Objectives:
1.  To understand the basic pathophysiology of degenerative processes in pe-
ripheral joints and in the spine.
2.  To become familiar with typical imaging findings of osteoarthritis and degenera-
tive changes in the spine.
3.  To learn about the differential diagnosis of degenerative disorders.
12:30 - 13:30 Room Q 
The Beauty of Basic Knowledge: Head and Neck 
MC 24B 
The infrahyoid neck and lymph nodes 
A-126 12:30
The infrahyoid neck and lymph nodes 
M.G. Mack; Munich/DE (m.mack@radiologie‑muenchen.de) 
The CT and MRI analysis of the anatomic compartments of the infrahyoid neck, and 
the signal intensity or the density of the different lesions correlated to the clinical 
history enable a precise assessment of the neck masses with a high degree of 
accuracy. The infrahyoid neck can be divided into a posterior or nuchal region and 
an anterior or cervical region. The nuchal region is composed primarily of muscular 
structures, but also of fat tissue and bone. The anterior region is almost entirely 
occupied by glands, nerves, muscles and vessels (arterial, venous and lymphatic) 
and can be further divided in one median and two lateral areas. The infrahyoid 
compartment is containing trachea, larynx, oesophagus, thyroid and parathyroid 
glands. Nodal classification is essential to accurately discuss the location of cervical 
nodes. About 300 of the 800 lymph nodes in the body are located in the head and 
neck. A simplified level nomenclature is used since 1984 cervical lymph nodes in 
seven levels. Lymphnode size is one of the most frequently used criteria for dis-
crimination of metastatic lymph nodes from benign reactive nodes. Furthermore, 
the shape of the node, abnormality of internal architecture, including necrosis, and 
extracapsular tumour spread have been demonstrated as additional morphologi-
cal criteria which lead to a diagnostic In the childhood, tumours and tumour-like 
lesions of the neck are rare and they tend to be benign. However, most of the soft 
tissue neck masses in the adult over the age of 40 are metastatic nodal lesions.
Learning Objectives:
1.  To become familiar with the different anatomic compartments of the infrahyoid 
neck.
2.  To understand lymph node classification and level system.
3.  To learn about the best imaging approach to an IHN mass.
4.  To be able to localise and provide a useful differential diagnosis.
12:45 - 13:15 Room A 
Plenary Session 
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MR guided focused ultrasound: a new string to the radiologist’s bow 
C. Catalano; Rome/IT (Carlo.Catalano@uniroma1.it) 
In the recent past, minimally invasive therapies have greatly benefited of the continu-
ous developments of imaging modalities. In fact, it has become feasible to perform 
minimally invasive therapies with high precision in the routine clinical practice under 
imaging guidance. MR-guided Focused Ultrasound is a new non-invasive method 
of treatment that allows, under continuous MR guidance, precise thermal ablation. 
MRI is used for target definition, planning of treatment and continuous control of 
thermal effect at the target and in the surrounding tissues. High-intensity focused 
ultrasound is an efficacious means of extracorporeal thermal ablation. For guid-
ance and monitoring, MRI provides several advantages over any other imaging 
modality; in fact, it allows to identify the target, it defines excellent three-dimensional 
planning, and with MR thermometry, it provides continuous thermal mapping at 
the target and the surrounding tissues. MR-guided Focused Ultrasound has been 
approved for uterine fibroids treatment and bone metastasis palliation; several are 
the ongoing clinical trials in breast, liver, pancreas, prostate, brain tumours and in 
A-124 11:20
C. Ovarian cancer 
H. Hricak; New York, NY/US 
In the developed world, ovarian cancer continues to have the highest mortality 
rate among gynaecologic cancers. At diagnosis, more than 62% of patients have 
advanced disease. The mainstay of treatment is comprehensive staging laparotomy 
(including transabdominal hysterectomy, bilateral salpingo-oophorectomy, omentec-
tomy, retroperitoneal lymph node sampling, peritoneal and diaphragmatic biopsies 
and cytology of peritoneal washings), usually followed by adjuvant chemotherapy. 
Patients with advanced non-resectable disease benefit from neoadjuvant (preop-
erative) chemotherapy. This lecture will review the key imaging findings in the 
management of ovarian cancer and will briefly consider how advances in molecular 
imaging may improve outcomes in the future. In ovarian cancer management, 
cross-sectional imaging is essential in (1) tumour characterisation; (2) treatment 
selection and planning (identifying difficult-to-reach tumour deposits or inoperable 
disease for which neoadjuvant chemotherapy is indicated); (3) monitoring treat-
ment response; (4) detecting recurrent disease. Ultrasound is the primary modality 
for detecting and characterising adnexal masses. MRI is used for characterising 
sonographically indeterminate lesions. CT is the modality of choice for preopera-
tive staging. FDG-PET-CT is valuable for detecting recurrent disease, particularly 
in the mesentery, bowel serosa and normal-sized lymph nodes. In recurrent dis-
ease, tumour size and standardised uptake values are also powerful prognostic 
biomarkers. The development of sensitive molecular imaging (MI) biomarkers could 
improve ovarian cancer management by allowing detection of the disease before 
symptoms arise and, in high risk patients, enabling repeat MI to substitute for 
preventative oophorectomy. In treatment selection and response assessment, MI 
may provide more powerful predictive biomarkers. Intraoperative MI may facilitate 
more complete tumour resection. 
Learning Objectives:
1.  To get an overview of the essential imaging findings in characterisation and 
staging of ovarian cancer.
2.  To learn the key imaging findings that affect management of ovarian cancer.
3.  To understand the changes in imaging armamentarium in ovarian cancer, and 
learn the best practice in proper image utilisation.
Questions 11:50 
12:30 - 13:30 Room P 





T.M. Link; San Francisco, CA/US (tmlink@radiology.ucsf.edu) 
Degenerative disease is related to abnormal loading and/or tissue-related deficien-
cies. Chronic and acute trauma, excessive physical activity and obesity are among 
the conditions that promote degenerative disease. In addition, dysplastic morphol-
ogy, inflammatory and metabolic disorders may eventually lead to degeneration. 
While cartilage and intervertebral disc are the target tissues, it should be noted 
that multiple structures are involved in the degenerative process. This includes the 
adjacent bone and bone marrow, ligaments, menisci and labrum. While standard 
radiographs have been the standard technique to diagnose and score osteoarthritis 
for many years, MR imaging has an increasing role in identifying early degenerative 
changes and determining the disease burden. Using molecular imaging techniques 
such as T1rho and T2 relaxation time measurements, the biochemical abnormalities 
of the cartilage and disc can be detected before macro-morphological damage. 
Subsequently, focal and diffuse defects of cartilage are shown with adjacent bone 
marrow abnormalities, such as subchondral cysts and bone marrow edema pattern. 
Mucoid degeneration with swelling and tears of ligaments are typical findings, so 
are degenerative meniscal and labral tissue transformation with signal abnormali-
ties and tears. The typical radiographic findings include joint space narrowing and 
osteophytes. Frequently, secondary degenerative disease is observed related to 
conditions such as previous infection, inflammatory arthropathies, trauma and 
metabolic disorders, which lead to deformity of the joint with altered biomechani-
cal loading. Underlying conditions and differential diagnoses of degenerative joint 
disease were need to be correctly identified. Sometimes differentiation between 
degenerative and inflammatory joint disorders can be challenging. 
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Discussion 
F. Sardanelli1, N. Houssami2; 1Milan/IT, 2Sydney/AU 
The discussion will address the following issues:
1.  How come there are divergent views on the evidence from randomised con-
trolled trials?
2.  Is the device for MR-guided procedures absolutely necessary?
3.  How to manage additional findings?
4.  How to reduce false positives?
5.  How to reduce overtreatment?
6.  How to translate MRI information from radiology to the operating theatre? 
14:00 - 15:30 Room E2 
Foundation Course: Neuroimaging 
E³ 620 




A. CNS trauma 
P.M. Parizel, C. Venstermans, F. De Belder, T. Van der Zijden, 
L. van den Hauwe, M. Voormolen, J. Van Goethem; Antwerp/BE 
(paul.parizel@ua.ac.be) 
Neuroimaging techniques constitute an essential part of the diagnostic work-up 
of patients with traumatic brain injury (TBI). In the acute setting, imaging findings 
determine patient management and influence clinical course. CT remains the first 
choice technique to determine the presence and extent of injury, and to guide 
surgical planning. Multi-detector CT allows simultaneous assessment of head and 
cervical spine, obviating the need for plain radiographs. From a clinical point of 
view, it is important to understand the difference between primary and secondary 
TBI. Primary injuries occur as a direct result of the impact with damage to brain 
tissue. Examples include fractures, different types of traumatic haemorrhage (epi-
dural, subdural, intracerebral, subarachnoid), cerebral contusion, diffuse axonal 
injury (DAI). CT-angiography is useful to document traumatic blood vessel injury. 
Whenever there is a discrepancy between the patient‘s clinical status and imag-
ing findings, MRI is indicated. Secondary injuries are caused by systemic factors 
such as increased intracranial pressure, oedema, brain herniation, decreased 
cerebral blood flow, excitotoxic damage. These lesions can be documented with 
multiparametric MRI including diffusion, perfusion, and susceptibility weighted 
imaging. Diffusion tensor imaging with fractional anisotropy mapping may show 
microstructural abnormalities in patients with mild TBI, even when traditional MRI 
sequences appear normal. Neuroimaging also plays a role in the chronic stage 
of TBI, identifying sequelae, determining prognosis, and guiding rehabilitation. In 
conclusion, advances in neuroimaging improve our understanding of the patho-
physiology of craniocerebral trauma and allow us to detect abnormalities, even in 
patients with mild TBI, when routine imaging studies appear normal.
Learning Objectives:
1.  To become familiar with the different types of intracranial injury and the ap-
propriate imaging patterns.
2.  To learn about the imaging characteristics of intracranial haemorrhage by CT 
and MR.
3.  To be able to recognise imaging findings that are critical for the patient’s 
prognosis.
A-132 14:30
B. Cerebral ischaemia and infarction 
L. Pierot; Reims/FR (lpierot@gmail.com) 
Ischaemic stroke is a diagnostic and therapeutic emergency. The diagnostic has 
to be established as rapidly as possible in order to be able to offer to the patient 
the best therapeutic approach. At the acute phase of stroke, the diagnostic is 
usually based on CT or MRI. CT will eliminate any haemorrhagic stroke, but will 
be normal in approximately 50% of cases. Precocious signs of ischaemia are 
sometimes visible including decreased density of lentiform nuclei, loss of gray-white 
matter interfaces, sulcal effacement, and hyperattenuating artery (indicating acute 
thrombus). CTA will show the occluded artery. MRI has an increased sensitivity 
compared with CT. At the hyperacute stage, diffusion will show hyperintensity in the 
other benign tumours and neurologic functional disorders. Furthermore, it appears 
to be an exceptional research tool, as it may temporarily modify cell membrane 
permeability and release or activate compounds for targeted drug delivery or gene 
therapy. There is no doubt that MR-guided Focused Ultrasound represents a new 
extremely powerful tool with already well defined clinical fields of applications and 
enormous potentials of research.
Learning Objectives:
1.  To learn about the technical and physical principles of MR guided focused 
ultrasound.
2.  To understand the advantages of MR guidance.
3.  To become familiar with the approved clinical applications and the ongoing 
clinical trials.
4.  To learn the research activities and the possible future applications in the fields 
of drug delivery and gene therapy.
14:00 - 15:30 Room D1 
Controversies in Breast Imaging
MC 623 
Preoperative MRI in newly diagnosed breast cancer: 






A. Why we should do preoperative MRI 
W.A. Kaiser; Jena/DE (Werner.Kaiser@med.uni‑jena.de) 
MR-Mammography (MRM) has been used in clinical research and in routine 
since 30 years now. It is now accepted that the sensitivity is extremely high for 
invasive cancers in a size of more than 3 mm (between 95 and 100%) and - using 
important morphological and kinetic signs in combination - the specificity is also 
much higher than previously published (above 90%). The positive arguments to 
use MR-Mammography preoperatively are the following: it is always important to 
know the truth (multifocality, multicentricity, bilaterality of breast cancers); both 
lumpectomy+radiation as well as mastectomy are equally effective, but not able to 
stop the continuous drop in long-term survival curves. The aim should be perma-
nent healing; knowing the precise staging is helpful for an exact surgical planning; 
knowing the precise staging is helpful for the inclusion or avoidance of radiation; 
knowing the precise staging is helpful for the avoidance of legal problems; the 
previous publications about the use of preoperative MRI are controversial and 
partially misleading. 
A-129 14:25
B. Reasons not to do preoperative MRI 
M.G. Wallis; Cambridge/UK (matthew.wallis@addenbrookes.nhs.uk) 
Pre-operative MRI staging undoubtedly finds additional disease with retrospec-
tive and prospective studies showing that this changes surgical practice. To date, 
there is no good prospective evidence that this change in surgery affects patient 
outcome in terms of reduction in re operation rates or improved disease free or 
overall survival. In fact, the 2 prospective studies show no or detrimental effects on 
care and there is evidence of increasing mastectomy rates. Conservation surgery 
plus radiotherapy was shown to be equivalent to mastectomy many years ago and 
surgery plus modern adjuvant treatment is associated with increasing survival and 
very low local surgical failure. Therefore, there are good reasons to suggest that 
the majority of the additional disease picked up by MRI is biologically and clinically 
irrelevant and only serves to increase the surgical burden on our patients. I will con-
tend that by merely demonstrating that our bigger/better (more expensive) kit finds 
more disease in not enough. We the radiological research community and those 
that fund our research have failed the profession, our patients and the community 
as a whole. We should be obliged to take the next step and demonstrate we can 
improve our patient’s outcomes, both survival and well being, before introducing 
new technology. Pre-operative MR staging is a classical example, after all if we had 
done a proper trial 10 years ago we would be standing here demonstrating 5-year 
disease free survival rather than entertaining you with an unanswerable debate.
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experience. The differential between cancer progression and complications of the 
treatment might be very difficult and requires an adequate communication with the 
referring clinician. Overall, most of the decisions taken by the clinician will be related 
to imaging results, stressing the importance of adequate protocols and reports.
Learning Objectives:
1.  To get an overview and precise explanation of current cancer-related terminol-
ogy, definitions and “buzz” words used in everyday practice.
2.  To understand why and how this terminology should ensure and simplify 
communication with all specialists involved in cancer management, including 
clinicians, researchers as well as other radiologists.
3.  To learn common tricks and traps in providing a radiology report, illustrated 
with clinical cases.
A-135 14:20
B. Liver cancers (primary, metastases) 
R.L. Baron; Chicago, IL/US (rbaron@uchicago.edu) 
Hepatocellular carcinoma (HCC) is the most common primary tumour with cholan-
giocarcinoma comprising 5-10% and only rare other primary tumours. HCC is 
commonly associated with chronic liver with hepatitis or cirrhosis. Nodular and 
fibrotic changes inherent in cirrhosis both simulate and obscure tumours and 
particular emphasis will be placed on characterising small nodular changes in cir-
rhosis that are often diagnostic dilemmas. Contrast enhancement characteristics 
and MR signal intensity changes play a critical role in these evaluations resulting 
in nonbiopsy imaging criteria for HCC diagnosis as the standard of care for man-
agement. Staging and treatment for HCC are based on lesion size and number 
(TNM staging system). False positive diagnoses in cirrhosis will be discussed. 
Cholangiocarcinoma has a varied imaging appearance based on the underlying 
histologic stroma (from glandular mucin producing to dense fibrous). The contrast 
enhancement characteristics that vary with the stroma is a key to detect and to 
characterise these lesions. There is no effective chemotherapy or interventional 
cure, and treatment options are limited to aggressive surgical approaches and the 
imaging assessment of extent of disease is critical in planning. Metastatic liver 
disease most often has very nonspecific imaging features that preclude diagnosis 
on imaging characteristics alone. Certain contrast enhancement characteristics, 
however, allow for characterisation and more importantly, assessment of response 
to treatment, particularly in vascular metastatic lesions such as GIST tumours. 
Detection of small lesions that can be critical for detection, characterisation and 
staging can be optimised with MR liver-specific imaging agents and with diffusion-
weighted imaging.
Learning Objectives:
1.  To get an overview of the AASLD/EASL imaging criteria for noninvasive diag-
nosis of hepatocellular carcinoma.
2.  To learn about best practice CT/MR/US imaging techniques that optimise 
characterisation, detection and staging of primary and metastatic liver tumours.
3.  To understand the key role specific findings reported by radiologists have in 
determining patient treatment options for hepatocellular carcinoma.
A-136 14:55
C. Prostate cancer 
J.O. Barentsz; Nijmegen/NL (J.Barentsz@rad.umcn.nl) 
This presentation provides guidelines for how to be successful in prostate MRI and 
convince urologists to use MRI. It is important that radiologists performing prostate 
MRI speak the same language as their referring physicians. They should know as 
to what is important for the patient. Therefore, this presentation provides guidelines 
for prostate MRI, assessed by prostate MRI experts from the European Society of 
Urogenital Radiology (ESUR). The proposed MRI protocols for “detection”, “stag-
ing” and “node and bone” will be shown. The use of endorectal coil versus pelvic 
phased array coil and 1.5 versus 3 T will be discussed. And most importantly, 
clinical indications are provided. Finally, the ESUR PiRADS classification and a 
reporting system will be presented.
Learning Objectives:
1.  To learn the key clinical indications for MR imaging in prostate cancer.
2.  To get an overview of essential MR imaging techniques in detection, charac-
terisation, localisation and staging of prostate cancer.
3.  To understand how MR imaging influences therapeutic decisions and how 
best to provide a value added MR report.
Questions 15:20
ischaemic area with reduced apparent diffusion coefficient. At this stage, T2 and 
FLAIR images are usually normal and hyperintensity will appear after few hours. 
Occluded vessels are easily detected by MRA. Perfusion imaging will permit an 
evaluation of the mismatch (penumbra). At the acute phase of stroke, treatment is 
based on IV administration of thrombolytics (rtPA), or mechanical thrombectomy. 
Only IV administration of rtPA has been validated in large randomised studies. It 
can be performed in the first 4.5 h of ischaemia. Mechanical thrombectomy can be 
performed after failure of the IV treatment or as a first line treatment.
Precocious follow-up imaging (CT or MRI) is performed to detect any haemorrhagic 
transformation of the ischaemic zone.
Learning Objectives:
1.  To consolidate knowledge of CT findings and conventional MRI findings.
2.  To become familiar with the imaging findings and diagnostic role of diffusion 
and perfusion MRI.
3.  To be informed of the indications and techniques for endovascular stroke 
treatment.
Author Disclosure:
L. Pierot: Consultant; EV3, Codman. 
A-133 15:00
C. Vascular malformations of the spinal cord 
D.A. Rüfenacht, I. Wanke; Zurich/CH (danielrufenacht@gmail.com) 
Vascular malformations of the spinal cord are rare, present with variable clinical 
symptoms and exhibit a variety of distinct oedema pattern in the spinal cord and 
distinct vascular pattern in- and outside the spinal cord. Accordingly, vascular le-
sions of the spinal cord are best evaluated by a combination of MRI and catheter-
based angiography. In addition, current treatment options relay for the majority 
of conditions on endovascular, image-guided methods. The lecture will include 
explanation and illustration of the criteria used to assess and classify lesions 
based on imaging. Imaging elements interesting to consider for lesion assessment, 
disease evolution, and success and risk prediction will be provided in form of a 
query. Spinal cord oedema being the most frequent form of changes that become 
visible along evolution of vascular malformations of the spinal cord is the reason 
to provide pathophysiological explanations and imaging examples to the variable 
oedema pattern. Examples of each type of vascular malformation will be given. 
Knowledge of such information may be useful to radiologist performing spinal MRI 
in the interest of avoiding to ignore subclinical lesions that may be readily detected 
with current MR imaging methods, and should not be missed. Early and correct 
identification of vascular spinal lesions may avoid progression into clinical potentially 
non-reversible damage of the spinal cord. Knowledge about current methods of 
diagnostic imaging and about endovascular treatment options allows for providing 
expert advice to referring physicians, something that should be in part possible 
after this medical education. 
Learning Objectives:
1.  To understand the pathophysiology of vascular anomalies.
2.  To become familiar with imaging protocols.
3.  To be informed of the indications of interventional therapeutic procedures.
14:00 - 15:30 Room I/K 
Joint Course of ESR and RSNA (Radiological Society of North 
America) 
MC 628 
Essentials in oncologic imaging: what radiologists 




A. Oncologic imaging: terminology, definitions and buzzwords 
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr) 
The routine practice of oncologic imaging requires standardisation, which means 
that we need to harmonise technical protocols and agree on the meaning of selected 
words for the radiological report. The words “Response, “Progression” and “Stable 
disease” are precisely defined according to internationally accepted thresholds and 
criteria. Although the rules are quite simple and rather easy to apply, they are very 
efficient in the classification of the response to treatment, and therefore for the medi-
cal decisions. However, the role of the radiologist is not limited to measurements 
and calculation. The detection of new lesions may be challenging and requires 
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ESR meets E-AHPBA 
EM 2 








P.-A. Clavien1, K. Conlon2; 1Zurich/CH, 2Dublin/IE (clavien@access.uzh.ch) 
Primary pancreatic cysts are being seen more commonly in clinical 
practice in part to increased awareness and improved diagnostic mo-
dalities. This timely symposium that the European-Africian Hepato-Pancreatico-
Biliary Association is pleased to co-sponsor with the European Society of 
Radiology will explore our understanding of the current pathological classifica-
tion, illustrate and define the “state-of-the-art” imaging modalities available, 
describe the role of Endoscopic Ultrasonography in contemporary diagnostic 
algorithms and establish the role for surgical resection for these conditions. 
Session Objectives:
1.  To understand the importance of the recent WHO classification and its rel-
evance to therapy.
2.  To become familiar with the radiological work-up for patients with pancreatic 
cystic tumours.
3.  To appreciate the current role of endoscopic ultrasonography in diagnosis and 
management.




C. Verbeke; Stockholm/SE (caroline.verbeke@ki.se) 
The increasing use of imaging has led to a more frequent detection of cystic le-
sions in the pancreas. Such lesions can be of a various nature, i.e. they may be 
neoplastic or non-neoplastic, benign, potentially or overtly malignant, epithelial or 
mesenchymal, congenital or degenerative. As these cystic entities obviously differ 
in terms of treatment, prognosis and need for follow-up, it is important that they 
are correctly diagnosed. The current morphological classification of pancreatic 
cystic lesions is based on the distinction between neoplastic/non-neoplastic and 
epithelial/non-epithelial cysts. In view of this significant histogenetic diversity, it is 
not surprising that pancreatic cystic lesions also differ in their gross appearance. 
Because the latter is the pathology correlate of findings on imaging, it is important 
to become familiar with the key distinctive macroscopic features of the various 
cyst entities and to understand the basic microscopic diagnostic features. It should 
be appreciated, however, that significant variation in macroscopic appearances 
can occur within single entities, whilst there can also be a considerable overlap in 
features between various entities. Therefore, in the individual case, the morphologi-
cal diagnosis of pancreatic cystic lesions can be problematic. The identification 
of malignant transformation within primarily benign cystic lesions represents a 
further diagnostic challenge. While this important diagnosis is ultimately based 
on unequivocal microscopic findings, there are certain macroscopic features that 
may suggest invasive malignancy and find their correlate in radiological imaging. 
Learning Objectives:
1.  To understand the morphological classification of pancreatic cystic lesions 
based on the distinction between neoplastic/non-neoplastic and epithelial/
non-epithelial cysts.
2.  To become familiar with the key distinctive macroscopic features of the various 
cyst entities and to understand the basic microscopic diagnostic features.
3.  To appreciate the considerable variation in macroscopic appearances and the 
potential overlap between certain entities.
4.  To become familiar with the macroscopic features of malignant transformation 
within primarily benign cystic lesions.
16:00 - 17:30 Room A 





C. Ozdoba; Berne/CH (christoph.ozdoba@insel.ch) 
Neurological emergencies, i.e. the sudden loss of motor, sensory, or cognitive 
functions up to coma, have numerous causes. The probably most important 
neurological emergency in absolute number of patients and in socio-economic 
impact is stroke. With recent advances in devices and techniques for interventional 
neuroradiology, neuroendovascular surgery is playing an increasing role in the 
treatment of acute stroke. Early diagnosis with a complete imaging work-up by CT 
or MRI is mandatory before these therapies can be applied, and although the time 
span for a successful therapy has increased to 4.5 h for i.v.-thrombolysis and up to 
8 h for intraarterial therapy, an efficient time-saving algorithm in the management 
of stroke patients remains crucial. Other causes besides stroke, however, must 
not be forgotten. This talk focuses on CNS pathology; conditions like coma due 
to metabolic causes or intoxication will not be covered. A wide range of possible 
aetiologies remains, ranging from vascular pathology (e.g. cervical artery dissection 
or venous sinus thrombosis) to epilepsy, metastatic disease, and inflammation. As 
in stroke, imaging studies today are an essential component of early diagnosis. MRI 
is the method of choice for nearly all of the above-mentioned conditions; at least 
in tertiary care centers, indications for MR in a neurological emergency should be 
seen generously - around the clock (24/7). In an emergency situation, structural 
imaging should routinely be complemented by special techniques like diffusion- and 
susceptibility-weighted imaging and perfusion studies. Examples will be shown and 
recommendations for optimised emergency study protocols are given.
Learning Objectives:
1.  To learn which imaging modality to use.
2.  To understand how to identify early ischaemia.
3.  To be able to select patients for treatment.
Author Disclosure:




M. Stajgis; Poznan/PL (stajgis@gmail.com) 
Traumatic brain injury (TBI) is a significant cause of mortality and morbidity in Eu-
rope. TBI encompasses a wide, heterogeneous group of intracranial injuries that 
include acute primary insults occurred at the time of impact and secondary ones 
such as cerebral swelling or herniation. Non-contrast CT is still the “gold standard” 
imaging modality in acute setting. Epidural, subdural and subarachnoid haemor-
rhage (extra-axial) as well as cortical contusion, intraparenchymal hematoma, 
diffuse axonal injury (intra-axial haemorrhage) will be discussed. Conventional 
MRI sequences are less-sensitive than CT in detection of hyperacute intracranial 
bleeding. However, FLAIR technique are capable to detect even small amount 
of extravasated blood. Susceptibility-weighted imaging (SWI) is mandatory in 
evaluation of microhemorrhages, together with DWI they play an important role in 
diagnosis of axonal injury. Traumatic injury of spinal cord (SCI) in majority of cases 
results with devastatingconsequences. MR examination is the imaging modality 
of choice in such patients. It enables the clear assessment of lesion morphology, 
extent and severity of trauma. For optimal characterisation of SCI, one has to start 
with estimation of canal compromise and the degree of spinal cord compression. 
Then qualitative intramedullary changes like cord swelling, oedema, contusive 
haemorrhage, haematomyelia, partial or complete laceration should be evaluated. 
Protocols for routine MRI of the patients SCI are proposed and discussed. 
Learning Objectives:
1.  To understand the proper imaging protocols for trauma patients.
2.  To become familiar with imaging findings in acute head trauma.
3.  To learn about the imaging findings in spinal cord trauma.
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approach. In general, symptomatic patients with low surgical risk should undergo 
resection unless the lesion is considered to be a serous cystadenoma on imaging. 
Patients with moderate surgical risk are more challenging and risk of resection 
versus risk of malignancy should be carefully taken into account. These patients 
require careful investigation tailored at grading the true malignant potential of their 
lesion. Of patients with a high operative risk, resection should be confined only to 
patients with confirmed malignant disease. Specific conditions require a tailored ap-
proach. Decisions regarding resection should be based on assessment of malignant 
potential of a lesion, size of lesion (³3 cm) and the patient's surgical risk factors. 
Learning Objectives:
1.  To understand the clinical indications for surgical intervention.
2.  To appreciate the rationale for deciding on a particular procedure.
3.  To discuss the outcomes of observation versus surgery.
Panel discussion: 
The multidisciplinary assessment and management of pancreatic 
cystic neoplasia 17:15 
16:00 - 17:30 Room C 





V.N. Cassar-Pullicino; Oswestry/UK (Victor.Pullicino@rjah.nhs.uk) 
In this New Horizon session dedicated to cartilage imaging, the audience will 
learn of new advances in imaging the normal and abnormal cartilage matrix and 
understand the basic techniques used in this assessment. It is hoped that these 
new techniques which are currently in the research field would very soon be 
translated into clinical application. Early detection of cartilage disease may lead 
to novel therapies which can help reverse and repair the degenerative process. 
Session Objectives:
1.  To review the basics of articular cartilage physiology.
2.  To introduce the quantitative MR tools used to assess collagen and proteo-
glycan depletion.




S. Trattnig; Vienna/AT (siegfried.trattnig@meduniwien.ac.at) 
The major advantage of sodium MRI in musculo-skeletal applications is that it 
is highly specific to glycosaminoglycan content. The recent proliferation of 7 T 
whole-body MRI offers a significant impact on sodium MRI and its potential for 
clinical use. Since SNR scales linearly with increasing field strength and the lack 
of B1 penetration and B0 susceptibility problems sodium MRI can be particularly 
advantageous at higher fields. The low-gyromagnetic ratio of sodium also means 
lower power deposition, thus reducing SAR problems at 7 T. Although sodium 
MRI has high specificity and does not require any exogenous contrast agent, it 
does require special hardware capabilities (multinuclear) and specialized RF coils. 
With the application of a 7T whole body system and a modified 3D GRE optimised 
for sodium imaging and dedicated multi-element sodium coils, we performed a 
series of clinical studies: in a small group of 12 patients after matrix-associated 
autologous chondrocyte transplantation (MACT) sodium imaging allowed to dif-
ferentiate between sodium content and hence GAG in the transplants compared 
to native, healthy cartilage. In all patients, the sodium SNR was lower in the repair 
tissue compared to healthy cartilage. In another study, 18 patients after different 
cartilage repair surgery sodium SNR was significantly lower in BMS and MACT 
repair tissue, compared to reference cartilage, but sodium SNR was significantly 
higher in MACT repair tissue. In addition to cartilage sodium imaging, preliminary 
clinical studies have shown the potential of sodium imaging in the quantification of 
glycosaminoglycans in the intervertebral disc and Achilles tendon.
Learning Objectives:
1.  To get familiar with the basic principles of sodium imaging.
2.  To understand technical challenges of sodium imaging and how to handle 
them.
3.  To learn about clinical applications of sodium imaging in cartilage, cartilage 
repair and other MSK structures.
A-146 16:21
Radiological diagnosis 
S. Skehan; Dublin/IE (s.skehan@st‑vincents.ie) 
Pancreatic cysts are recognised increasingly commonly in symptomatic and asymp-
tomatic individuals. The challenge of imaging is to differentiate cysts that need to be 
resected from those that can be safely left alone or kept under observation. While 
CT and ultrasound are often the initial modality that identifies a pancreatic cyst, 
MRI and endoscopic US typically provide the most useful diagnostic information. 
MR can accurately demonstrate the size of any cystic components of a lesion in 
addition to showing septations, mural nodules and areas of enhancement. MRI is 
also the optimal technique for imaging surveillance of pancreatic cysts. Pancreatic 
cystic lesions include pseudocyst, serous cystadenoma, mucinous cystadenoma 
and cystadenocarcinoma, intraductal papillary mucinous neoplasm, solid and 
papillary epithelial neoplasm and cystic neuroendocrine tumour. In classical cases, 
imaging features combined with knowledge of patient demographics can allow a 
confident non-invasive diagnosis. However, imaging features often overlap and in 
these cases the results of fine needle aspiration at the time of endoscopic ultrasound 
are critical in arriving at a diagnosis. 
Learning Objectives:
1.  To become familiar with the optimal imaging modalities for cystic pancreatic 
lesions.
2.  To learn about the characteristic imaging features of cystic pancreatic lesions 
and to describe how imaging can contribute to preoperative diagnosis.
3.  To discuss the appropriate imaging surveillance of selected cystic pancreatic 
lesions.
A-147 16:39
Current role of endoscopic ultrasonography 
P. Bauerfeind; Zurich/CH (peter.bauerfeind@usz.ch) 
With the increasing use of abdominal imaging (CT-scan and MRI) more and more 
pancreatic cystic lesions are incidentally detected. Pancreatic cystic neoplasms 
(PCN) represent 2/3 of all pancreatic cystic lesions. After initial detection it is cru-
cial to distinguish between benign, malignant or potentially malignant pancreatic 
cystic lesions. EUS allows morphologic analysis, guides fine-needle aspiration, 
and provides fluid for cytology, CEA, Amylase and DNA analysis. In future, 
EUS may play a role in the treatment of some PCN, e.g. intracystic injection of 
ethanol or ethanol/paclitaxel for intraductal papillary mucinous neoplasm (IPNM). 
Cross-sectional imaging and medical history allow in a large portion of patients to 
differentiate PCN from pseudocyst and to determine the type of PCN. In unclear 
cases, endoscopic ultrasonography (EUS) with CEA measurement in aspirated 
fluid can be used to discriminate between mucinous and benign serous cysts. A 
cut-off CEA level of 192 ng/mL has the sensitivity of 73%, specificity of 84%, and 
accuracy of 79% for differentiating mucinous from non-mucinous pancreatic cystic 
lesions (Brugge Gastroenterology 2004;126:1330). In case of mucinous lesions 
larger than 2 cm the primary question is whether the cyst is malignant or benign. 
Fluid cytology allows with 80% sensitivity and specificity to identify malignant IPMN. 
Amylase in aspirated fluid may allow to distinguish between IPMN and mucinous 
cystic neoplasms, the latter is usually without communication with the pancreatic 
duct. In summary, EUS with cyst fluid analysis increase the diagnostic certainty in 
patients with pancreatic cystic lesions. 
Learning Objectives:
1.  To appreciate the technical aspects, performance characteristics and limitations 
of EUS and EUS-FNA in PCNs.
2.  To understand how EUS and EUS-guided FNA help to establish a diagnosis 
in PCNs.
3.  To appreciate the added information that EUS brings in staging pre-malignant 
and malignant PCNs and in orientating surgical decision-making.
A-148 16:57
How aggressive should the surgeon be? 
K. Conlon; Dublin/IE (Kevin.Conlon1@amnch.ie) 
Primary pancreatic cysts are more prevalent in surgical practice due to improve-
ments and availability of sophisticated cross-sectional imaging techniques. They are 
identified in approximately 1% of patients undergoing abdominal CT scanning. His-
torically, surgical resection was recommended for all pancreatic cystic neoplasms. 
This philosophy resulted partly from limited understanding of the natural history, 
poor sensitivity and specificity of investigations and improved safety of pancreatic 
surgical resections. An aggressive surgical algorithm results in resection of numer-
ous benign lesions; frequently in asymptomatic patients with incidentally detected 
lesions. A consensus has now emerged towards a more conservative and tailored 
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clinical equipment and protocols can easily be implemented in a routine clinical 
workflow, the signal analysis in gagCEST imaging and the reading of gagCEST 
images are technically complex. For example, effects, which alter the T2 relaxation 
time of tissue such as high relative water concentration, can affect the magnitude 
of gagCEST effects although the absolute concentration of GAG is unchanged. 
Unless confounding effects are automatically corrected, careful analysis of images 
is necessary for proper interpretation of results. 
Learning Objectives:
1.  To understand basic principles of CEST imaging.
2.  To learn about the current status of gagCEST imaging.
3.  To become aware of technical pitfalls and future approaches.
Author Disclosure:
B. Schmitt: Research/Grant Support; Siemens Healthcare. 
Panel discussion: 
What are the envisaged future advances in these cartilage imaging 
techniques and can we expect to introduce them into clinical 
practice? 17:15 
16:00 - 17:30 Room D1 
Controversies in Breast Imaging 
MC 723 
Should we add ultrasound to mammographic 






A. We can reduce the interval cancer rate 
W.A. Berg; Pittsburgh, PA/US (wendieberg@gmail.com) 
Greater rates of interval cancers (detected clinically in the interval between screen-
ings), and even greater mortality, have been observed in women with dense breast 
tissue (heterogeneously dense or extremely dense mammographically) compared 
to those in women whose breasts are fatty or show minimal scattered fibroglandular 
density. Importantly, breast density itself is a strong risk factor for the development 
of non-hereditary breast cancer, with relative risk from extremely dense breast 
tissue 4- to 5-fold higher than for women with fatty breast tissue. Ultrasound (US) 
has been considered for supplemental screening of women with dense breasts. 
Across 8 single-center studies, and three prospective multicenter trials, encom-
passing over 64,000 examinations, supplemental cancer detection rate of US has 
consistently been 3 to 4 per 1000. Over 90% of cancers seen only on ultrasound 
are invasive, with median size of 10 mm. Over 85% of invasive cancers seen only 
on ultrasound are node negative. Interval cancer rate (ICR) after three years of 
programmatic screening with mammography plus ultrasound was only 8% after 
three years of screening mammography and ultrasound in the ACRIN 6666 study 
(which evaluated women with dense breasts and at least one other risk factor). 
In the Italian multicenter trial, after adding US to mammography in women with 
dense breasts, the ICR was not different than for women with nondense breasts. 
US carries a substantial risk of false positives, with from 2 to 7% of women biopsied 
because of screening US, and only 10% of additional biopsies prompted only by 
US showing cancer.
Author Disclosure:
W. A. Berg: Advisory Board; Philips Healthcare. Consultant; Naviscan, Inc. 
Equipment Support Recipient; Gamma Medica, Inc. Grant Recipient; Hologic, 
Inc. Research/Grant Support; Gamma Medica, Inc. Speaker; SuperSonic, 
Imagine. 
A-155 16:25
B. Do we have enough radiologists to do it? Alternatives to 
ultrasound to reduce interval cancers 
A. Frigerio; Turin/IT (alfonso.frigerio@gmail.com) 
Mammography screening (MS), i.e. screening with mammography only, is an 
effective and efficient means of significantly reducing breast cancer mortality. 
However, many European countries fail short of complete population coverage. 
This is largely due to the costs involved and mainly to a shortage in dedicated 
radiologists. Moreover, some countries already started, and others are considering, 
A-151 16:21
dGEMRIC (delayed gadolinium-enhanced MR imaging of cartilage) 
G. Welsch1, S. Trattnig2; 1Erlangen/DE, 2Vienna/AT (welsch@bwh.harvard.edu) 
Acute and chronic articular cartilage lesions are a common pathology and many 
patients could benefit from cartilage treatment which needs high sophisticated 
follow-up. Whereas standard morphological approaches can demonstrate the 
constitution of cartilage, quantitative/biochemical MR approaches are able to 
provide a specific measure of the composition of cartilage. One of the biochemical 
MRI techniques most often reported to visualise cartilage ultra-structure is delayed 
Gadolinium-Enhanced MRI of Cartilage (dGEMRIC). Using dGEMRIC, biochemical 
MRI has the ability to quantify functionally relevant macromolecules within articular 
cartilage such as glycosamnioglycans (GAG). GAG are the main source of fixed 
charge density in cartilage, which are often decreased in the early stages of cartilage 
degeneration and are considered as a key factor in the progression of cartilage 
damage. The role of GAG is comparably important in the follow-up after cartilage 
repair procedures where hyaline-like repair tissue with a normal or nearly normal 
amount of proteoglycans has been described to have a positive predictive value. 
The technical requirements and possible applications of dGEMRIC are presented 
in this „New Horizon session (NH 7) Cartilage imaging“. 
Learning Objectives:
1.  To learn the basic principles of dGEMRIC and the current used techniques for 
clinical imaging.
2.  To learn about the current clinical applications of dGEMRIC.
3.  To get an overview of future uses of dGEMRIC in therapeutic studies.
A-152 16:39
Diffusion tensor imaging 
C. Glaser; Munich/DE (glaser@rzm.de) 
DTI aims to monitor water proton diffusion as modified by a tissue’s macromolecular 
structure. This implies to apply (and register) at least 6 diffusion sensitizing gradi-
ent directions in order to obtain an adequate diffusion tensor data matrix. From 
the data metrics, commonly the apparent diffusion coefficient (ADC), fractional 
anisotropy (FA) and the principal eigenvector (EV1), are derived to characterise 
architectural tissue properties. This approach has been demonstrated to be feasible 
and applicable to articular cartilage in an experimental setting, and promising first 
in vivo data of human cartilage have been published. ADC appears to correlate 
to proteoglycan (PG) and water content and an increase of ADC (both bulk and 
depth dependent) has been shown to correlate to (local / bulk) PG depletion. FA 
reflects depth dependent anisotropy in the collagenous fibre architecture and is 
independent of PG content. EV1 has the potential to define cartilage zonal height 
but is the most SNR-demanding parameter of the three. A first in vivo study has 
shown very good accuracy for bulk ADC and FA to differentiate healthy volunteers 
from early OA patients and reproducibility data are comparable to dGEMRIC and 
T2. Most recently, an ex vivo study has obtained an excellent predictive value of DTI 
for the diagnosis of early cartilage degeneration and a good ability to grade early 
stages of cartilage degeneration - confirming the potential of DTI as a non-invasive 
non-CM-dependent biomarker for (early) OA. Current challenges are to implement 
and standardize robust acquisition protocols for in vivo human and animal imaging.
Learning Objectives:
1.  To discuss basic principles of diffusion imaging in MSK.
2.  To review technical challenges and current achievements.
3.  To look into potential future directions.
A-153 16:57
CEST (chemical exchange saturation transfer) 
B. Schmitt; Vienna/AT (benjamin.schmitt@meduniwien.ac.at) 
CEST imaging in principle relies on the chemical exchange of protons bound to 
solute molecules and surrounding bulk water molecules. The effect can be used 
for MRI because the magnetization of each solute proton, is also transferred to 
bulk water, and can thus be visualized via the MR signal. CEST effects can be 
evaluated for specific molecular groups due to their characteristic proton resonance 
frequencies, which provides the technique with a high intrinsic sensitivity to these 
groups. In healthy cartilage tissue, strong CEST effects from exchangeable protons 
of glycosaminoglycan (GAG) molecules can be observed. The magnitude of these 
effects decreases when concentration ratio between bulk water protons and GAG 
protons decreases, e.g. in the early stages of osteoarthritis (OA). Initial studies 
on patients after cartilage repair surgery with GAG-dependent CEST (gagCEST) 
imaging have demonstrated that it is feasible to visualize GAG loss in vivo at 7.0 
Tesla. Initial reports also claim that the technique might be transitioned to the clini-
cal field strength of 3 T. Although CEST imaging can be performed with standard 
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A-158 16:30
B. PERCIST: evolving considerations for PET response criteria in 
solid tumours 
T.F. Hany; Zurich/CH (thomas.hany@gmail.com) 
In solid as well as non-solid tumours, PET/CT imaging using 18-Fluoro-Deox-
yglucose (FDG) has demonstrated the ability to a) correctly stage disease, b) 
demonstrate therapy response and c) predict therapy outcome. FDG-uptake can 
be measured objectively, however several factors in the standardization proc-
esses of tracer application, image acquisition and post-processing are needed for 
reproducibility. The term standard uptake value (SUV) measurement is used for 
compensating the influence of injected dose, decay time, body mass and repre-
sents FDG-uptake in any selected pixel of the image. For therapy assessment, 
drop in FDG-uptake represents tumour cell kill, notably a negative PET scan does 
not exclude viable tumour cells but overall has a better outcome. PET response 
criteria in solid tumours (PERCIST 1.0) have been introduced to refine previously 
established PET response criteria by EORTC. Major changes concern the use of 
lean-body-mass based SUV (SUL), SULpeak measurement in a fixed ROI, use of 
only a single target lesion and normalisation to liver uptake. Metric measurements 
in CT component of the PET/CT as an intrinsic asset like in RECIST 1.1 have not 
yet been introduced but might be crucial in the future. The proposed PERCIST 1.0 
criteria are not yet standard since several limitations hamper its general use but 
may improve metabolic tumour response assessment.
Learning Objectives:
1.  To learn about the evaluation of solid tumours through metabolic imaging.
2.  To understand the benefits of metabolic imaging.
A-159 17:00
C. Evaluation of brain tumours 
C. Majós; L‘Hospitalet de Llobregat/ES (cmajos@bellvitgehospital.cat) 
Malignant gliomas (WHO grade III and IV) are the most common primary tumours 
in the brain. Consensus guidelines consider that the standard of care for malignant 
gliomas include maximal surgical resection followed by combined treatment with 
chemoradiotherapy including temozolomide. Radiological assessment is critical in 
the follow-up and should be done by MRI at three different times: (1) in the early 
postsurgical period, (2) 2 to 6 weeks after completing treatment with radiotherapy, 
and then (3) every 2 to 4 months. (1) Early postsurgical MR must be done within 
72 h after surgery to evaluate residual tumour and to be used as baseline for 
follow-up. (2) A new MR exam is recommended 2 to 6 weeks after completing 
RT to evaluate response to treatment. According to the Macdonald criteria, the 
response can be classified as Complete Response, Partial Response, Stability or 
Progressive Disease. The evaluation of this first exam after RT is challenging, and 
the pseudoprogression phenomenon can appear. Advanced MR imaging techniques 
can be of help. Recently, the Macdonald criteria of response have been updated 
by the Response Assessment in Neuro-Oncology Working Group, being the RANO 
criteria those to be preferentially used. (3) Additional follow-up with MR should 
be done every 2 to 4 months. When Progressive Disease is detected, several 
options can be offered, including antiangiogenic drugs. Evaluation of response to 
antiangiogenic drugs is challenging too, and the pseudoresponse phenomenon 
can appear. Management of these tumours in the context of multidisciplinary teams 
including neuroradiologists is recommended due to its complexity.
Learning Objectives:
1.  To learn about evaluation criteria for brain tumours.
2.  To become familiar with the evaluation of brain tumours after treatment with 
various therapies.
16:00 - 17:30 Room E1 
Musculoskeletal 
RC 710 
Peripheral nerve imaging: MRI and US 
A-160 16:00
Chairman’s introduction 
J. Renoux; Paris/FR (jeromerenoux@hotmail.com) 
Thanks to their excellent tissue contrast, ultrasonography and MRI can perfectly 
visualize peripheral nerves. Nevertheless, knowledge of their anatomic relationship 
remains necessary. The pathologic state can affect the nerve surrounding area or 
the nerve itself; therefore, good comprehension of these conditions is necessary to 
to extend the age target of MS to 45-75. This expanded target would obviously 
enhance the relevance of any staffing problems. It has been estimated that add-
ing traditional, hand-held ultrasound to MS - aiming to decrease interval cancers 
(IC) - might increase the need for radiologists by 40-100% depending on different 
estimates and especially on the criteria for the selection of women to be studied 
by ultrasound (age, breast density, different thresholds). This is simply not feasible, 
even not considering other relevant drawbacks of such a policy, as the increase in 
percutaneous biopsies and surgical procedures with a benign outcome. Alternative 
to ultrasound to reduce IC might include: 1. to employ only well trained, dedicated 
radiologists: this alone has been shown to reduce false negative IC rates from 
40% to below 10%. 2. consider new technologies, the most promising being at this 
moment (2a) digital breast tomosynthesis, while a complementary option could be 
(2b) automated whole breast ultrasound. These two options require proper valida-
tion in a screening setting. Indeed, both would also imply an increased demand in 
radiological personnel, mostly related to reading times. These could be tackled by 
the development of dedicated CAD systems.
A-156 16:50
Discussion 
F.J. Gilbert1, A. Tardivon2; 1Cambridge/UK, 2Paris/FR 
The discussion will address the following issues:
1.  How to define breast density?
2.  Additional cancer detection rate using ultrasound.
3.  The level of evidence for routine use of ultrasound as an adjunct to mam-
mography.
4.  How many more breast radiologists do we need to carry out ultrasound screen-
ing in Europe?
16:00 - 17:30 Room D2 
Oncologic Imaging: Follow-up of Systemic and Local Therapies 
CC 719 




A. RECIST criteria 
Y. Menu; Paris/FR (yves.menu@sat.aphp.fr) 
RECIST is a universal standard in tumour response evaluation. Therefore, it is of 
utmost importance that imaging technique and radiological reports are compliant 
with the recommendation. Advantages of standardization comprise the comparabil-
ity of different examinations in the same patient, and responses in a cohort. Precise 
definition of response or progression makes possible to evaluate the accuracy of 
a specific treatment. Another advantage is that structured reporting is easier to 
perform, improving efficiency and communication. Technical requirements are 
important though easily achievable: slice thickness of 5 mm or less reconstructed 
in the axial plane, contiguous slices (on CT, minimal gap on MRI), robust and re-
producible contrast injection with similar delay and injection rate, similar coverage 
ensure proper comparison of images and clear basis for decision making. Thinner 
slices, alternative planes, specific contrast media and/or customized MRI sequences 
are optional, and should not replace basic techniques. Interpretation of baseline 
images requires a perfect knowledge of the method for measurement of the larg-
est diameter, identification of targets and non targets. Interpretation of evaluation 
examinations needs iterative comparison with Baseline and Nadir examinations, 
and identification of unequivocal new lesions. Obviously, a universal standard does 
not fit all oncology cases. It appears that some tumours like GIST or HCC may 
need adapted criteria in addition to RECIST. PET is only mildly included among 
the criteria, although it proves to be an important method for evaluation. Finally, 
morphology does not summarize tumour biology. Besides RECIST, the addition of 
structural, metabolic and/or functional information would be desirable.
Learning Objectives:
1.  To consolidate knowledge of evaluation of solid tumour response.
2.  To learn about tips and tricks to help bring RECIST to everyday practice.
3.  To understand advantages and limitations of RECIST.
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MR imaging have followed parallel paths for nerve imaging with little comparison of 
the two modalities, US seems to have some advantages over MR imaging, including 
higher spatial resolution, time effectiveness, the ability to explore long nerve seg-
ments in a single study and to examine tissues in both static and dynamic states.
Learning Objectives:
1.  To become familiar with the strengths and weaknesses of US and MRI for 
assessing lower limb nerves.
2.  To appreciate the imaging findings of lower limb nerve entrapment.
Panel discussion: 
Which on-going technological advances in MRI and US could 
influence the way we image peripheral nerves in the future? 17:14 
16:00 - 17:30 Room E2 
Foundation Course: Neuroimaging 
E³ 720b 





E.T. Tali; Ankara/TR (turgut.tali@gmail.com) 
Cerebral infections can be caused by bacteria, fungi, parasites, viruses and pri-
ons. Radiological evaluation plays an important role in the diagnosis, subsequent 
treatment and treatment monitoring. Cerebritis is characterised by poorly local-
ised perivascular inflammatory infiltrations with scattered necrosis, oedema, and 
petechial haemorrhage. Radiological findings vary according to the stage of the 
infection from oedema, mass effect, mild/patchy/heterogeneous enhancement of 
cerebritis to ring-like lesions, with the capsule hypointense on T2WI, hyperintense 
on T1WI, heterogeneous enhancement, central necrotic area, surrounding oedema 
of abscesses. DWI shows high-signal intensity while ADC map shows low-signal 
intensity of the central necrotic area of the abscesses. MRS shows elevated lactate 
and amino acid peaks. Cystic lesions isointense to CSF are also seen with the 
parasitic infestations. Treatment can also be monitored mainly by MRI; decrease 
in oedema, in mass effect, and in the degree of enhancement, decreasing signal 
on DWI, increasing signal on ADC maps, gliosis, occasionally focal calcifications, 
turning of lactate and amino acid peaks to normal at MRS are the indicators of 
successful treatment. Imaging findings vary according to the causative fungus; 
from granuloma with hypointense signal on T2, abscess with rim enhancement, 
diffuse cerebritis with signal change and haemorrhages, haemorrhage, infarcts, 
enlarged perivascular space to gelatinous pseudocyst. Acute encephalitides are 
diffuse brain parenchymal inflammatory diseases mainly caused by viruses. They 
can also involve meninges. Pathologically the primary features of viral encepha-
litis include neuronal degeneration and inflammation with or without mass effect. 
Learning Objectives:
1.  To understand the concept of ‘leaky vessels’ in the infectious meningeal, 
parenchymal and ventricular involvement.
2.  To learn how to proceed with imaging when ‘time is of the essence’.
3.  To become familiar with the specific imaging patterns of bacterial, viral, fungal, 
parasitic and prion infections.
A-165 16:30
B. Multiple sclerosis 
F. Barkhof; Amsterdam/NL (f.barkhof@vumc.nl) 
MRI is often being used to demonstrate dissemination of lesions in the CNS in 
patients with multiple sclerosis (MS). In the McDonald diagnostic criteria for MS 
that rely more heavily on MRI than previously, a high specificity is warranted in 
demonstrating dissemination in space (DIS) and dissemination in time (DIT). In 
the 2010 updated criteria, DIS can be demonstrated by the presence of one or 
more asymptomatic T2 lesions in minimally 2 of 4 crucial anatomical locations: 
juxtacortical, periventricular, infratentorial or in the spinal cord. Simultaneous pres-
ence of asymptomatic gadolinium-enhancing and non-enhancing lesions at any 
time is sufficient for demonstration of DIT, or any new lesion at follow-up. MRI is 
also used to initiate and monitor treatment efficacy and its side-effects (like PML). 
In addition, neurodegenerative features such as atrophy and black holes can be 
determined. The most common differential diagnosis of WM lesions in patients 
suspected of MS are hypoxic-ischaemic white matter changes due to small vessel 
disease (SVD). They are usually asymptomatic but can also present with migraine, 
perform diagnostic imaging. Most of the time, clinical examination or electrophysi-
ological study come before imaging and help to orientate the exploration. The first 
part of this course will address brachial plexus anatomy and pathology. The two 
following parts will give an understanding on nerve anatomy and pathology of the 
upper and the lower limbs. Strengths and weaknesses of the two techniques will 
be discussed. 
A-161 16:05
A. Applied radiological anatomy and pathology of the brachial plexus 
S. Gerevini; Milan/IT (gerevini.simonetta@hsr.it) 
The Brachial Plexus (BP) originates from the ventral branches of the cervical nerve 
roots from C5 to T1.It comprises roots, trunks, divisions, cords, and branches, 
topographically divided into supraclavicular (roots and trunks), retroclavicular (divi-
sions), and infraclavicular sections (cords and branches).The various divisions of the 
brachial plexus appear as linear structures with low signal intensity on MR images 
obtained with all sequences and in all planes (especially sagittal and coronal). The 
T1-weighted images optimally delineate normal nerve tracts from the musculature 
and blood vessels, and show the size of the nerve. The nerves appear as elongated 
fibers that are isointense to the scalene muscle in T1 weighted images, posteriorly 
and superiorly to the curvilinear flow void of the subclavian artery. The general 
abnormal findings include: loss of fat planes around BP components, diffuse or 
focal enlargement of the nerves, hyperintensity of nerve signal on T2-weighted 
images, focal or extensive Gadolinium uptake of the nerves on T1 fat-saturated 
images. Pathology of brachial plexus can be divided into non-traumatic and trau-
matic brachial plexopathies. Post-actinic fibrosis is the most commonly reported 
non-traumatic cause of brachial plexopaties, accounting for about 30% of cases, 
followed by metastatic breast cancer (20%) and primary or metastatic lung cancer 
(20%). Together, these three processes represent almost 70% of the explainable 
causes of brachial plexopathies. The remaining cases are caused by a variety of 
situations ranging from benign and malignant tumours to inflammatory disease 
and Thoracic Outlet Disease.
Learning Objectives:
1.  To understand the anatomy of the brachial plexus as demonstrated with MRI.
2.  To appreciate the range of pathology seen at the brachial plexus.
3.  To become familiar with the MRI findings of brachial plexus pathology.
A-162 16:28
B. Upper limb nerve entrapment 
D. Weishaupt; Zurich/CH (dominik.weishaupt@triemli.zuerich.ch) 
The peripheral nerves of the upper limb are affected by a number of entrapment 
and compression neuropathies. These syndromes involve the brachial plexus as 
well as the musculocutaneous, axillary, suprascapular, ulnar, radial and median 
nerves. Clinical examination and electrophysiological studies are traditionally the 
mainstay of diagnostic work-up. However, ultrasonography and magentic resonon-
ance imaging (MRI) may provide key information about the exact anatomic location 
of the lesion or may help to narrow the differential diagnosis. In certain patients with 
the diagnosis of a peripheral neuropathy, imaging using either ultrasononography 
of MRI may help establish the cause of the condition and provide information 
crucial for conservative management or surgical planning. In addition, imaging is 
particularly valuable in compex cases with discrepant nerve functions test results.
Learning Objectives:
1.  To become familiar with the strengths and weaknesses of US and MRI for 
assessing upper limb nerves.
2.  To appreciate the imaging findings of upper limb nerve entrapment.
A-163 16:51
C. Lower limb nerve entrapment 
C. Martinoli, A. Tagliafico; Genoa/IT (carlo.martinoli@libero.it) 
A variety of peripheral neuropathies can be encountered in the lower limb. Most are 
entrapment syndromes affecting many nerves, such as the sciatic, gluteal, femoral, 
lateral femoral cutaneous, obturator and pudendal around the hip, the peroneal 
and its branches and the saphenous at the knee, the superficial peroneal at the 
lateral leg, the tibial with its plantar and calcanear branches at the ankle, the deep 
peroneal and the interdigital nerves in the foot. Although clinical examination and 
nerve conduction studies are the mainstays of the diagnostic work-up of peripheral 
neuropathies, ultrasound (US) and magnetic resonance (MR) imaging may provide 
key information about the exact anatomic location of a lesion and the nature of the 
constricting finding or may help narrow the differential diagnosis. In patients with 
peripheral neuropathies of the lower extremity, US and MR imaging may provide 
critical information for planning an adequate treatment strategy. Although US and 
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A-168 16:05
Levels of training and competencies across Europe 
M.T. Stanton; Dublin/IE (marie.stanton@ucd.ie) 
The aim of this presentation is to add to the knowledge we have of education and 
clinical practice of ultrasound by radiographers in Europe. Data collected via a 
survey of professional bodies and centres offering ultrasound education in Europe 
form the basis of the discussion. The aims of European ultrasound programmes 
are compared, and regulations guiding training and clinical practice are reviewed. 
Teaching and learning activities employed in the development of competent ultra-
sonographers are deliberated. Formative and summative assessment strategies 
are debated. The session finishes with some proposals for the development of 
ultrasound education for European Radiographers. 
Learning Objectives:
1.  To appreciate the similarities between radiographer competencies across 
Europe.
2.  To become familiar with the regulations for radiographers to train and practice 
in Europe.
3.  To understand an expert-derived consensus of educational standards for 
radiographer in Europe.
A-169 16:28
The role and impact of the radiographer conducted US in Portugal 
R.T. Ribeiro; Lisbon/PT (ricardo.ribeiro@estesl.ipl.pt) 
Radiographers have a role in ultrasound (US) within their professional boundaries. 
With the proper strategy, US have an unconditional value towards professional 
development. Abstract knowledge controlled by a group is the characteristic that 
best defines a profession, since abstraction gives survivability in a competitive 
system of professions. Radiographers exist integrated in the portuguese health 
system, so their professional development should consider the interdependence 
system that characterises the relationship between the professional groups. The 
focus of this professional framework should not only be on the cognitive knowledge, 
but also in the translation of it to the clinical practice. Radiographers can play an 
important role in the response time for diagnosis and therapeutic monitoring. The 
role of radiographers in US should be organized in an organ-oriented workflow 
division, profoundly related with the clinical problems that emerge from each 
medical specialty. The basic principle is that the incorporation of US as a routine 
extension of the clinical examination will lead to a considerable contribution to 
the understanding of the natural history of disease and to improve/optimise the 
follow-up. In this framework, the radiographer assumes the complex coordination 
probe-eye and special navigation while the clinician is focused on the clinical 
analysis of the normal/abnormal findings of the exam. In conclusion, the inclusion 
of a radiographer in clinical routines leads to a less patient waiting time, a more 
dynamic workflow and improved clinical services. 
Learning Objectives:
1.  To become familiar with the radiographers’ role in the context of a professional 
progression framework.
2.  To understand the synergies at play in interprofessional relationships and 
team-work.
3.  To learn the benefits of having radiographers in the management and optimisa-
tion of health systems.
A-170 16:51
Evolution of radiography education for US in the Netherlands since 
1990, and its influence on their role 
G. Plug; Haarlem/NL (Geert.plug@inholland.nl) 
This presentation will provide an overview of the past, present and future role of 
radiographers working in the field of ultrasound in the Netherlands. At the imple-
mentation of ultrasound in radiography practice in the 1970s, examinations were 
solely done by radiologists. The workload for the radiologists expanded quickly and 
already in 1980, a vocational one year course in ultrasound started in Haarlem 
to meet with the growing need for trained radiographers to work in ultrasound. 
Because the number of radiographers working in ultrasound was rising, ultrasound 
education became part of a four-year bachelor programme including radiography, 
radiotherapy and nuclear medicine (MIRT) from 1989. The initial one year course 
became a post-graduate course for diploma holders and later part of the Master 
course medical imaging and radiation oncology. The ultrasound education in the 
bachelor programme focuses on basis ultrasound physics and examination skills 
in abdominal ultrasound, as were the post-graduate course focuses on advanced 
practice. In present day, ultrasound is performed by radiographers in almost 75% 
of the hospitals in the Netherlands. Because of a growing availability of MIRT 
transient ischaemic attacks, stroke or subcortical arteriosclerotic encephalopathy. 
Several MRI features help distinguish between MS and SVD such as the presence 
of micro-bleeds in the basal ganglia and deep white matter regions, borderzone 
or watershed lesions and lacunes. The vascular distribution of lesions may differ 
between MS and SVD; perivenular versus arterial respectively. Spinal cord imaging 
may aid in the differentiation between MS and SVD, since cord lesion are never 
found in the latter. 
Learning Objectives:
1.  To learn about the role of MRI in detecting focal and diffuse multiple sclerosis 
pathology.
2.  To consolidate knowledge of lesion distribution, signal intensity characteristics 
and patterns of contrast enhancement.
3.  To be able to apply the 2010  McDonald criteria to the diagnosis of MS.
A-166 17:00
C. Mimics of multiple sclerosis 
V. Dousset; Bordeaux/FR (vincent.dousset@chu‑bordeaux.fr) 
Although the misdiagnosis of MS is very low due to the constant improvement 
of MS diagnostic criteria, there is no single biomarker to establish a definite MS 
diagnosis, and MRI lacks of specificity despite the use of new sequences or tedious 
post-processing methods! In addition, MS diagnostic criteria have a high-positive 
predictive value but they lack of sensitivity making numerous patient in suspense 
for the definite diagnosis. Since there are many diseases, very frequent or very 
rare which manifest symptoms similar to MS, an attentive inspection of clinical 
presentation, biological (both blood serum and CSF) and imaging markers may 
help in tracking mimics of MS and other differential diagnoses: immune-related 
disorders (ADEM, SLE, Sjögren’s Sd, Clippers Sd, thyroiditis, sarcoidosis, im-
mune reconstitution inflammatory Sd, etc)., microvessels diseases (diffuse small 
vessel occlusions, primary CNS angitis, etc)., infections (Lyme disease, HTLV1, 
etc)., primary CNS tumours, metabolic disorders (Biermer’s disease) and inherited 
myelinopathies. During the presentation we will review MRI and MRS signs that 
help in targeting diseases that may mix-up with MS : white matter lesions number, 
location, shape, signal intensity, enhancement and duration of enhancement, 
associated signs such as grey matter abnormalities, meninges involvement, T2* 
sensitive findings, changes in MRS biomarkers, etc.
Learning Objectives:
1.  To be aware of the top ten mimics of multiple sclerosis.
2.  To become familiar with the imaging findings suggestive of other disorders.
3.  To be informed of the importance of imaging the spinal cord for the differential 
diagnosis of MS/MS mimics.
16:00 - 17:30 Room F1 
Special Focus Session 
SF 7a 
Radiographers and ultrasonography in Europe 
A-167 16:00
Chairmen’s introduction 
D. Pekarovic1, V. Vilgrain2; 1Ljubljana/SI, 2Clichy/FR (dean.pekarovic@kclj.si) 
In the recent years, US became a new field for radiographers in some countries 
across Europe. Radiographers are now performing and reporting US examinations. 
Accordingly, a new role for radiographers in US performance and reporting has to be 
established. New emphasis on clinical knowledge and pathological correlation has to 
be implemented during radiographers educational curricula. In addition, regulations 
in some countries has to be adjusted accordingly. This session will also include 
Portuguese model with additional facts about the role of radiographers in the context 
of a professional framework and about the benefits and duties of radiographers in US 
management team. Dutch model of education will focus on US module curriculum 
in the first level of education. Guidelines and models will be available framework 
for those embracing the idea of US radiographer. The question: What are the chal-
lenges and barriers for role extension for radiographers role in US will be discussed 
during the debate including an overview of educational models across the Europe. 
Session Objectives:
1.  To understand why ultrasound continues to be a growth area in diagnostic 
imaging.
2.  To identify the challenges posed by the growth of this field.
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A-173 16:23
PET/CT for radiotherapy planning: how does it assist IMRT? 
A. Loft; Copenhagen/DK (annika.loft@rh.regionh.dk) 
In Radiotherapy, the use of PET/CT scans for dose planning is increasing. On the 
PET images, the viable tumour can be delineated as a support for the delineation 
performed on the corresponding CT. Small malignant foci are detected and can 
increase the Gross Tumour Volume- oppositely, non-malignant but on CT patho-
logical structures can be left out- of course at the discretion of the oncologist! 
Especially for IMRT, the tumour delineation must be very precise. This demands 
that the patient is prepared for therapy planning with use of fixation equipment 
for correct positioning and that the staff is well trained and collaborate with the 
staff from Radiotherapy when PET/CT scanning these patients. The collaboration 
across specialities, the technical issues, the tumour delineation process and the 
clinical impact are discussed.
Learning Objectives:
1.  To learn about anatomical imaging risk compartments that define gross tumour 
volume (GTV).
2.  To understand how PET/CT assists in delineating the GTV.
3.  To understand the role of PET/CT guided IMRT and how it can lead to treat-
ment adaptation.
A-174 16:41
Response evaluation and treatment adaptation 
K. Haustermans; Leuven/BE (karin.haustermans@uzleuven.be) 
Multimodal imaging is becoming more important in radiotherapy planning and 
delivery especially in the curative setting. Typically, before the start of a radiation 
treatment, a CT scan in the treatment position is taken. On this CT scan, the clini-
cal target volume, the gross target volume and the organs at risk are delineated. 
However, soft tissue contrast on CT scan is low, that is why MRI is often used as 
well. MR images are then registered to the CT scan as the HU are needed to cal-
culate the dose distribution. Also PET with different tracers and DW MR are under 
evaluation in the radiation treatment preparation process. These functional imaging 
modalities allow to depict more radioresistant areas within the tumour. Theoreti-
cally, a dose escalation to radioresistant subregions within the tumour becomes 
possible also thanks to the evolution in the technology to deliver the radiation. 
Several Phase II studies are ongoing to evaluate the benefits of an inhomogene-
ous dose distribution. Reimaging during a course of treatment allows to adapt the 
dose distribution, and this is called adaptive radiotherapy. Moreover, the changes 
measured on functional imaging performed during treatment, for example, changes 
in ADC values and/or SUV max are often predictive for treatment outcome. Overall, 
there is a rapid evolution in the integration of multimodal imaging in the radiation 
treatment process which will lead to a more personalized radiation treatment and 
to better patient outcome with higher chances of local control and less side effects. 
Learning Objectives:
1.  To understand the molecular tumour microenvironment (tumour hypoxia, 
-apoptosis and -proliferation) that may impact response to radiation treatment.
2.  To learn how tumour heterogeneity, reflecting tumour microenvironment, influ-
ences dose distribution in IMRT.
3.  To learn how response assessment during IMRT leads to adaptation and 
tailoring of radiation treatment.
A-175 16:59
MR imaging biomarkers for response evaluation 
R.G.H. Beets-Tan; Maastricht/NL (r.beets.tan@mumc.nl) 
Imaging plays a pivotal role in cancer diagnostics and therapy monitoring. Magnetic 
resonance imaging (MRI) stands out from other imaging modalities as a high-spatial 
resolution technique with superior soft-tissue contrast, which enables anatomic, 
functional as well as metabolic characterisation of the lesions. Anatomical informa-
tion on itself is invaluable but not sufficient to understand the biological profile of 
the tumour. With nowadays cancer specific treatment, non-invasive assessment of 
tumour biomarkers is highly desired to predict outcome of anti-cancer treatment. 
The most widespread method of non-invasive assessment of imaging biomarkers 
is functional imaging: perfusion dynamic contrast-enhanced MRI and diffusion 
weighted MRI. This lecture will elaborate on the value of perfusion and diffusion MR 
imaging for assessment of response after radiation treatment and for predicting of 
response during radiation treatment. The audience will learn whether the imaging 
biomarkers derived from such MR techniques enable a reliable stratification of 
treatment and patient specific adjustment of radiation treatment.
bachelors, it is to be expected that related work fields, such as echocardiography, 
gynaecology and obstetrics, vascular ultrasound, musculoskeletal ultrasound and 
ultrasound in private practice will be performed by radiographers in the near future. 
A continuous adjustment of ultrasound education is therefore essential. 
Learning Objectives:
1.  To learn about US education over an entire four year bachelor programme.
2.  To understand the role of the radiographers as a result of this bachelor pro-
gramme.
3.  To appreciate changes in the education programme following changes in the 
role of the radiographers.
Panel discussion: 
What are the challenges and barriers facing role extension? 17:14 
16:00 - 17:30 Room F2 
Special Focus Session 
SF 7b 
Imaging and radiotherapy: all you need to know 
A-171 16:00
Chairman’s introduction 
V.J. Goh; London/UK (vicky.goh@kcl.ac.uk) 
In this session, “Imaging and radiotherapy: all you need to know” the audi-
ence will have a comprehensive overview of the rationale for radiotherapy 
in cancer, current state-of-the-art planning and delivery of radiotherapy in 
cancer patients, and evaluation of the treatment response and radiotherapy 
effects. Following this session, the audience have insight into how develop-
ments in imaging may have contributed to improved outcomes in radiotherapy. 
Session Objectives:
1.  To understand the principles of modern radiotherapy.
2.  To learn how functional and metabolic imaging have been integrated into 
radiotherapy planning, adaptation and response evaluation.
3.  To become familiar with imaging findings after radiotherapy.
4.  To understand how imaging affects radiotherapy outcomes.
Author Disclosure:
V. J. Goh: Research/Grant Support; Siemens. 
A-172 16:05
Modern radiotherapy: what are the new technologies? 
V. Valentini; Rome/IT (vvalentini@rm.unicatt.it) 
Modern radiation oncology offers to cancer patients a safe, organ sparing, cost-
effective, well-validated treatment. Nowadays, radiation can be modulated in the 
four dimensions of space and time, and the dose can be precisely defined to 
produce a specified local effect of a given magnitude. The administration of non-
uniform intensity-modulated radiotherapy (IMRT) to patients as a way to create a 
specified, non-uniform absorbed dose distribution that provides better conformality 
around the tumours and increasing the amount of spared surrounding organs. 
The optimal implementation of IMRT requires effective control of the tumour’s 
location as well as of the changes in tumour volume during the daily treatment. 
Image-guided radiation therapy (IGRT) aims at in-room imaging guiding the radia-
tion delivery based on instant knowledge of the target location. The combination 
of diagnostic tools and radiation intensity modulated technology is providing new 
generation of hybrid machine, suitable to offer this new service. The effectiveness 
and convenience for the patient to practice high dose delivery in few fractions 
through stereotactic body radiotherapy (SBRT) implies optimal reduction of treat-
ment margins, practical implementation of sharp dose gradients and interactive 
adaptation of the treatment based on IGRT modalities. Its efficacy and feasibility 
enlarged the offer of SBRT to different clinical conditions, where small volumes 
have to be treated in primary or also in oligometastatic setting. The conformality 
and reliability of dose delivery provided by new technology and imaging integration 
promoted new onset of clinical benefit and more affordability of cure to address 
the aging of cancer patient population.
Learning Objectives:
1.  To become familiar with 3D  conformal radiotherapy and intensity modulated 
radiation therapy (IMRT) and intensity modulated radiosurgery (IMRS).
2.  To learn about brachytherapy and intraoperative radiotherapy (IORT) and its 
indications.
3.  To understand how IMRT contributes to better treatment outcomes as com-
pared with conventional radiotherapy.
2
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remain useful both in the initial evaluation and in the follow-up of trauma to the 
urinary bladder and urethra.
Learning Objectives:
1.  To be able to identify patients requiring urgent cysto-urethrography.
2.  To learn to identify bladder and urethral injury.
3.  To learn the imaging techniques necessary for accurate initial evaluation of 
the urethra in cases of complicated pelvic trauma.
A-178 17:00
C. Interventional radiology for GU trauma 
B. Peynircioglu; Ankara/TR (borapeynir@gmail.com) 
GU trauma can easily being missed when associated with other abdominal/pelvic 
injuries.The type/mechanism of the trauma is the key for both imaging and treat-
ment. Iatrogenic injuries of the GU tract are getting more and more common as a 
result of increasing numbers of percutaneous procedures (e.g. nephrolithotomies, 
biopsies). In general, renals are the most common injured part of the tract, however, 
by increasing numbers of renal transplantation, ureteral injuries are now common as 
well. Timing of the intervention is as important as taking the decision of percutaneous 
approach for optimal management of injury. Multiphasic CT imaging with contrast 
injection via both IV line and trans-urethral catheter (if possible) can demonstrate 
most of the injured sites with high sensitivity. CT is also useful in predicting which 
hemodynamically stable patients may benefit from percutaneous (non-operative) 
management. Vascular injury of the GU tract almost always involves renals, and 
bleeding and/or ischaemia is the problem. Unless the patient is at unresponsive 
haemodynamic shock, or has complete vascular avulsion, endovascular treatment 
may always be the choice.The American Association for the Surgery of Trauma‘s 
system for grading injury to the kidney is also helpful in making a decision whether 
surgical or endovascular intervention. Embolisation of a bleeding artery/pseudoan-
eurysm or stenting of an intimal dissection are the most common cases. Although the 
vascular injuries of the GU results with retroperitoneal hemorrhages, non-vascular 
injuries leading urine leaks may present with intra or extra-peritoneal urinomas. 
Non-vascular percutaneous intervention may be applied to urinoma, urine leak, 
ureteral laceration and transection injuries. These interventions include percutane-
ous nephrostomy for urine diversion, ureteral stent placement for ureteral injuries, 
and drainage tube placement for urinoma formation.
Learning Objectives:
1.  To be able to determine which cases deserve management by interventional 
radiology.
2.  To understand the techniques to manage fistulas and ruptures of the ureter 
and urethra.
3.  To appreciate the vascular and non-vascular interventional techniques in kidney 
trauma.
16:00 - 17:30 Room I/K 
Joint Course of ESR and RSNA (Radiological Society of North 
America) 
MC 728 
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This presentation will emphasize the important contributions of FDG PET imaging 
in staging and management of lymphoma, with particular emphasis on response 
assessment and response adapted therapy. The role of surveillance imaging, imag-
ing in the setting of stem cell transplant, as well as the potential utility of alternate 
radiotracers and DWI will also be discussed briefly. 
Learning Objectives:
1.  To get a practical, clinically relevant summary of key imaging issues in Hodgkin 
and non-Hodgkin lymphoma.
2.  To learn how imaging, especially PET and PET-CT can optimally assess and 
measure tumour treatment response, providing a value-added radiology report.
Learning Objectives:
1.  To learn about the range of MR imaging biomarkers that can be used for 
markers of tumour microenvironment and heterogeneity.
2.  To understand the role and accuracy of diffusion and perfusion (MR) imaging 
for evaluation of response during and after radiotherapy.
3.  To become familiar with the MR imaging findings after radiotherapy and un-
derstand the pitfalls and interpretation difficulties.
Panel discussion: 
How can imaging improve outcomes in radiotherapy? 17:17 
16:00 - 17:30 Room G/H 
Genitourinary 
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A. Imaging the kidney and ureter 
M.-F. Bellin; Le Kremlin‑Bicêtre/FR (marie‑france.bellin@bct.aphp.fr) 
Urinary tract injuries occur in approximately 10% of all abdominal trauma patients, 
the kidney being the most commonly injured organ. The spectrum of renal injuries 
ranges from minor trauma requiring no treatment to major life-threatening renal inju-
ries that require surgical intervention. There is a growing trend toward conservative 
management of renal trauma. To help predict the outcome and to guide manage-
ment of renal trauma, the American Association for Surgery of Trauma has created 
a renal injury grading system, which is based on the appearance of the kidney at 
surgery. Indications for renal imaging include: penetrating trauma and haematuria; 
blunt trauma, shock, and haematuria; and gross haematuria. Contrast-enhanced 
MDCT is currently the test of choice for assessing renal injury, since it provides, 
with short examination times, both anatomic and functional data. It is helpful to 
assess the type and extent of parenchymal injuries. It can help in detecting active 
extravasation of contrast and is of great help in guiding transcatheter embolisation. 
It may demonstrate vascular injuries including dissection, thrombosis, laceration, 
pseudoaneurysm, or arteriovenous fistula. It may also show urine leakage, pre-
existing abnormalities with increased risk of injury from blunt trauma, and associ-
ated abdominal and retroperitoneal injuries. The volumetric data acquired can be 
used to obtain high-resolution MPR, MIP, and 3D images that help display complex 
injuries. The wide availability of MDCT in major trauma patients has reduced the 
use of other imaging modalities: IVU in unstable patients already in the operative 
room, and ultrasonography. 
Learning Objectives:
1.  To learn the indications, advantages and disadvantages of imaging modalities 
after trauma.
2.  To learn the appropriate diagnostic imaging studies and imaging findings of 
different types of trauma.
3.  To be able to identify a kidney that is in danger after trauma.
A-177 16:30
B. Imaging the bladder and urethra 
U.G. Mueller-Lisse; Munich/DE 
Trauma to the bladder and urethra may be caused by blunt force or by penetrat-
ing objects in the course of accidents, or by invasive surgical measures, such as 
catheterization, prostatectomy, sling operations for urinary obstruction or urinary 
continence or by foreign bodies introduced into the urethra. Diagnostic clarification 
of the exact location and nature of urethral injury requires high-quality imaging 
studies. In patients who have suffered either blunt or penetrating abdominal or 
pelvic trauma, or polytrauma, multiorgan injury is common and frequently involves 
the genitourinary tract. Contrast-enhanced CT is currently considered to be the 
primary imaging technique to evaluate trauma patients. In trauma affecting the 
pelvis, urethral injury is a common complication which may lead to significant long-
term morbidity if remaining undiagnosed. The posterior urethra, which is close to 
the pubic rami and the puboprostatic ligaments, is particularly vulnerable in pelvic 
trauma. Certain types of pelvic fractures are associated with an increased risk of 
urethral injury, such that timely radiologic recognition facilitates the early diagnosis 
of urethral injury and ensures that serious long-term sequelae are minimized. Ure-
thral injury may be better assessed and classified by means of urethrography than 
by CT. Thus, the traditional imaging modalities of RUG, VCUG, and cystography 
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A. Imaging of the coronary arteries: the Holy Grail 
G. Roditi; Glasgow/UK (Giles.Roditi@ggc.scot.nhs.uk) 
Small critical structures in the human body require high spatial resolution imag-
ing. Coronary artery disease carries a high disease burden regarding morbidity 
and mortality. The coronary arteries are not only small but also move rapidly and 
in a complex manner predicated on movements of the beating heart with super-
imposed asynchronous respiratory motion. Conventional angiography has high 
temporal fidelity and spatial resolution, however, this lumenogram does not fully 
evaluate coronary disease, a process affecting the vessel wall. The non-invasive 
acquisition of three-dimensional data combining high spatial and temporal resolu-
tion for coronary visualisation has proven challenging, hence the description as 
the ‘Holy Grail’. The Holy Grail was sought not as an object but for what it could 
do. In similar fashion not only are the heart and related great vessels now reliably 
imaged in unprecedented detail but the heart can be reincorporated into a holistic 
evaluation of the whole patient and the advances in technology allowing coronary 
CT to enter clinical routine have benefited many other CT techniques. Advances 
in temporal resolution, broad detector arrays and dual energy imaging spurred by 
cardiac CT have expanded the opportunities in other areas such as whole organ 
CT perfusion. Perhaps more importantly the high radiation doses delivered by the 
initial schema for cardiac CT have led to development of dose reduction techniques 
with profound benefits in all CT applications as the risk:benefit changes compared 
to plain film radiography become compelling to allow CT as a first line modality 
in many situations.
Learning Objectives:
1.  To learn about the meaning of CT coronary calcium screening for risk assess-
ment.
2.  To identify suitable modalities and challenges for non-invasive coronary an-
giography.
3.  To understand the potential of coronary plaque imaging beyond calcium.
Author Disclosure:
G. Roditi: Advisory Board; Bayer Advisory Board member 2012. Consultant; 
past consulting for Toshiba Medical Visualisation Systems Europe. Speaker; 
In the past 5 years I have undertaken speaking engagements for the following: 
Bayer, Bracco, Guerbet, GE Healthcare & Toshiba Medical Systems. 
A-183 16:20
B. The ischaemic myocardium: what to do? 
C. Loewe; Vienna/AT (christian.loewe@meduniwien.ac.at) 
In case of ischaemic heart disease, the assessment of myocardial viability is crucial 
for treatment decision making. Simply, patients with viable tissue left will improve 
by revascularization therapy, whereas treatment of non-viable tissue by revascu-
larization could be fatal. Assessment of myocardial viability by imaging is dedicated 
to and follows different distinct pathophysiological mechanisms. It includes the 
assessment of regional wall motion abnormalities, regional perfusion deficits, 
abnormal metabolism or the direct demonstration of myocardial scars. Different 
methods have been established so far for demonstration of the different abnormali-
ties including SPECT (perfusion), PET (metabolism), PET/CT (metabolism) and 
cardiac MR (perfusion, function, scar). Recently, even cardiac CT was introduced 
as comparative method for the assessment of myocardial viability and function of 
ischaemic myocardium combined with the possibility of direct demonstration of the 
coronary pathologies. Given the number of different modalities and their different 
approaches, knowledge about the specific strengths of each method is crucial for 
adequate management of patients with ischaemic heart disease. In this presen-
tation, the importance of careful assessment of myocardium in ischaemic heart 
disease for adequate treatment decision making and planning will be underlined. 
The different methods with their different approaches to myocardial assessment 
should be presented together with possible advantages and disadvantages. Based 
on this, potential imaging algorithm will be proposed. In addition, possibilities of 
careful assessment of contractile reserve will be presented. Finally, therapeutic 
consequences of different imaging results will be demonstrated based on clinical 
cases, and the most important differentials should be shown.
A-180 16:30
B. Musculoskeletal neoplasms 
M.F. Reiser; Munich/DE 
Diagnosis, staging and follow-up of musculoskeletal tumours are most important 
for selection of adequate therapeutic measures and prognosis of patients. Modern 
imaging technologies have greatly contributed to improvement. With modern MRI 
systems high contrast of neoplastic tissue versus normal uninvolved structures is 
achieved. This allows for adequate delineation of intraosseous and soft tissue ex-
tension and thereby facilitating high precision in staging. Compartmental infiltration 
is readily detected. Dynamic, contrast-enhanced studies allow for assessment of 
vascularity and perfusion, which provides valuable information concerning malig-
nancy and benign character of a particular tumour. With diffusion-weighted imaging 
and diffusion-tensor imaging, microstructural information can be obtained, which 
correlates with response to chemotherapy and viability of the tissue. Malignant 
bone tumours may spread within the bone or to distant organs. Therefore, whole 
body imaging modalities hold great potential for comprehensive assessment. In 
computer tomography, major advances have been achieved recently. The combina-
tion of CT and PET in hybrid systems allows to assess function and morphology 
within one session. With FDG-PET, the metabolic activity of a particular lesion can 
be analyzed. The standard uptake value (SUV) can be utilised for differentiation 
of benign malignant lesions. However, there are various benign lesions, such as 
NOF, fibrous dysplasia, eosinophilic granuloma and aneuysmal bone cysts as well 
as inflammation and infection. False-negative results in FDG-PET may be found in 
low-grade chondrosarcoma, multiple myeloma, low-grade osteosarcoma, Ewing’s 
sarcoma and low-grade soft tissue sarcomas. 
Learning Objectives:
1.  To become familiar with the imaging modalities which enable to detect and 
differentiate benign and malignant bone neoplasms.
2.  To consolidate knowledge of radiographic, CT and MRI findings which enable 
to classify and stage bone tumours.
3.  To understand the potential role of PET-CT and whole body MRI.
4.  To learn the signs indicative of favourable and poor response to preoperative 
chemotherapy and for recurrence of malignant bone tumours.
A-181 16:55
C. Chemo- and radiation therapy-induced toxicity 
H.-U. Kauczor; Heidelberg/DE (Hans‑Ulrich.Kauczor@med.uni‑heidelberg.de) 
Multimodal cancer therapy, including chemotherapy, biologicals and radiotherapy, is 
frequently associated with adverse toxic effects. Depending on the specific agent, 
different organs, such as brain, lung, liver, bowel, bone, heart might be affected. 
„Inflammatory“ reactions will occur. These will be detected on imaging as white 
matter lesions in the brain, reticular changes and consolidations in the lung (fibrosis, 
cryptogenic organizing pneumonia), diffuse liver disease, colitis, bone necrosis, or 
cardiomyopathy. These direct toxic effects have to be differentiated from infectious 
complications due to chemotherapy-induced neutropenia. These infections mainly 
affect the lung and are caused by fungi or viruses. Angioinvasive aspergillosis of 
the lung is the most frequent, but sinusitis, abscesses in brain and liver as well as 
sepsis with haematogeneous foci are also encountered. Toxic effects of radiotherapy 
will mainly occur within the planned target volume and result from application of 
high doses to radiosensitive normal tissue leading to inflammation, fibrosis and 
necrosis. As imaging is routinely performed for therapy response monitoring or 
surveillance in patients suffering from cancer, toxic effects have to be differentiated 
from infectious complications, postsurgical or postradiation scar tissue or tumour 
recurrence. Specific patterns of toxic effects of cancer therapy in brain, lung, liver, 
pelvis and their differential diagnoses will be reviewed.
Learning Objectives:
1.  To get an overview of organ-specific toxicity and other adverse effects of 
chemo- and radiotherapy.
2.  To review the key imaging findings of therapy-induced organ toxicity and 
adverse effects.
3.  To understand how to differentiate inflammatory, infectious, fibrotic, and necrotic 
changes from tumour recurrence.
Author Disclosure:
H. -U. Kauczor: Advisory Board; Siemens. Investigator; Boehringer Ingelheim. 
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B, solitary HCC or up to 3 nodules < 3 cm in size) HCC. The best outcomes have 
been reported in Child-Pugh a patients with small single tumour, commonly less 
than 2 cm in diameter. When the patient is considered inoperable, RFA can be 
indicated also in huge tumours, even in combination with other procedures. After 
correctly indicated and performed RFA, we can expect a 5-year survival in 40 - 
70% and curative treatments in 30% patients. RFA also plays an important role in 
the multidisciplinary treatment of HCC. Substantial number of HCC patients has 
undergone TACE as the first-line treatment for tumour control and survival prolon-
gation. TACE (transcatheter arterial chemoembolisation) is recommended as first 
line non-curative therapy for non-surgical patients with large-multifocal HCC who 
do not have vascular invasion or extrahepatic spread. The choice of the treatment 
modality depends on the size and the number of tumours, the stage and the cause 
of cirrhosis and finally on the availability of various modalities in each centre.
A-187 16:05
A. RF ablation 
J. del Cura; Bilbao/ES (joseluis.delcurarodriguez@osakidetza.net) 
RF ablation is currently indicated in HCC as curative treatment in Child-Pugh A-B 
patients with: single < 2 cm nodule and not candidates for transplation, 1-3 nod-
ules < 3 cm and not candidates for resection or transplantation. RF can be also 
performed in patients waiting for liver transplantation. Some studies suggest that 
survival does not differ between RF ablation and resection in 5 cm because of the 
high possibility of recurrence. Different types of electrodes can be used: internally 
cooled, cluster, expandable, with saline instillation. Although results can be good 
with any of them, every type of device requires a different technique of ablation. 
Obtaining a margin of at least 0.5 cm of ablated tissue around the tumour is key 
to avoid recurrences. Combined treatments like combining chemoembolisation 
or PEI with RFA can be useful to increase the ablation volume. Published data 
show a pooled 5-year survival of 48-55%, with better outcomes in Child-Pugh A 
patients. In candidates for surgery, 5-year survival is similar to resection: 76%. 
RFA is safe: major complications appear in 10% and reported mortality is 0.15%. 
Tumours located subcapsular or near major vessels, biliary tree or bowel are more 
prone to complications. Laparoscopic ablation can be an alternative in these cases. 
Imaging follow-up with CT, MRI or CEUS is performed to assess the outcome and 
detect recurrences, new lesions or complications. Although not well established, 
most protocols include an immediate post-procedure imaging, 1-month follow-up 
and explorations every 3 or 6 months for 2-3 years.
Learning Objectives:
1.  To understand the indications for RF ablation.
2.  To learn about the technique and devices for RF ablation.
3.  To learn about results, complications and follow-up strategies.
A-188 16:28
B. Intra-arterial procedures 
F. Orsi; Milan/IT (franco.orsi@ieo.it) 
Liver resection and ablation are the standard of care for early stage HCC, but 
majority of patients are not candidate because of a more advanced stage. Several 
intra-arterial procedures are now available for treating advanced HCC.There is no 
consensus on the best intra-arterial local therapy; however, it represents a great 
rationale of care, based upon the premise that HCC is almost exclusively supplied 
by arteries. Embolisation, chemoembolisation and radioembolisation are some of 
the local treatments for advanced HCC and several embolics were developed for 
that purpose. Both TACE and TAE may shut-down the arterial blood flow, leading 
for tumour ischaemia and tumour cell death. Association of local chemotherapy 
to the embolic effect represents the rationale for TACE. For this purpose, new 
embolic particles, which may precisely elute drugs, were introduced (Drug Eluting 
Beads). For radioembolisation, micro-particles are injected into the feeding arteries 
as vehicles for delivering interstitial sources of radiation. When disease is widely 
spread into the liver, a whole hepatic liver distribution of antiblastic drug may be 
indicated. It may be obtained with intrarterial chemotherapy or with the newer 
technique, called percutaneous liver chemoperfusion. Because hepatic tumours 
are supplied by several feeders, complete tumour death may be obtained only if the 
entire vascular network is treated. If small feeding arteries are be missed, tumour 
will be not completely treated and it will relapse. For this reason, the knowledge of 
vascular abnormalities is mandatory for a better outcome.
Learning Objectives:
1.  To become familiar with the indications for intra-arterial treatment of HCC.
2.  To learn the techniques of intra-arterial treatment.
3.  To learn about results, complications and follow-up strategies.
Author Disclosure:
F. Orsi: Research/Grant Support; CELONOVA. Other; PROCTOR FOR 
DELCATH SYSTEM. 
Learning Objectives:
1.  To learn how to evaluate the function of the ischaemic myocardium.
2.  To identify methods of assessing the viability of the ischaemic myocardium.
3.  To get an overview of the therapeutic consequences depending on imaging 
findings.
Author Disclosure:
C. Loewe: Board Member; member of the steering committee B;S (Apixaban 
studies). Investigator; investigator for different multicenter trials sponsored by 
Bayer, Guerbet, BMS, GE HEalthcare. Speaker; speaker for Siemens, Bracco, 
GE Healthcare, Bayer, Guerbet, Covidien. 
A-184 16:40
C. The ischaemic heart after treatment: still alive? 
G. Bastarrika; Toronto, ON/CA (bastarrika@unav.es) 
Non-invasive cardiac imaging modalities have shown to possess diagnostic and 
prognostic value in patients with coronary artery disease. Moreover, non-invasive 
imaging-guided therapy has gained significant importance in the last decades. In 
particular, computed tomography (CT) and cardiac magnetic resonance (CMR) 
imaging have emerged as primary imaging modalities useful to evaluate the status 
of coronary vasculature and myocardium before and after coronary artery revascu-
larization. CT is particularly helpful to assess patency/stenosis of coronary artery 
bypass grafts or stents, to detect atherosclerosis progression in non-revascularized 
vessels and to plan new interventions. CMR is exceptionally effective in risk 
stratification after coronary revascularization, differentiating angina and non-cardiac 
chest pain, assessing periintervention myocardial damage and determining long 
term prognosis. Therefore, the assessment of the ischaemic heart after treatment 
may benefit from both, anatomical and functional imaging modalities. Appropri-
ate knowledge of the added clinical value of each imaging modality will enable 
to choose the more adequate diagnostic test for a given patient. This lecture will 
introduce and enhance knowledge about how to analyse cardiac images following 
stent implantation and bypass grafting, will determine the appropriateness of CT 
after coronary intervention and will introduce the value of MRI in the follow-up of 
patients undergoing coronary revascularization therapy. Importance of conventional 
as well as stress-based CMR protocols will be emphasized, within the context of 
available state of the art non-invasive cardiac imaging modalities.
Learning Objectives:
1.  To learn how to analyse cardiac images following bypass grafting.
2.  To understand the value of cardiac imaging after coronary interventions (PTA 
and stenting).
3.  To assess potential therapeutic consequences.
Author Disclosure:
G. Bastarrika: Speaker; Bayer, General Electric, Medrad, Siemens. 
A-185 17:00
Interactive case discussion 
C. Catalano; Rome/IT (Carlo.Catalano@uniroma1.it) 
During the presentation, cases on ischaemic heart disease will be shown in an 
interactive fashion. Cases will be selected in order to strenghten the concept that 
the speakers during the session have gone through. In particular, CT angiography 
cases of coronary arteries will be shown as well as examples on the ischaemic 
myocardium providing morphological and functional information. Eventually, 
cases of the ischaemic heart after treatment will also be shown, demonstrating 
the importance of cardiac imaging, especially in the clinical suspect of recurrency.
16:00 - 17:30 Room N/O 
Interventional Radiology 
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V. Válek; Brno/CZ (vlvalek@med.muni.cz) 
Poor prognosis of HCC has shown some improvement during the last years. 
Targeted therapy with radiofrequency ablation (RFA) and transcatheter arterial 
chemoembolisation (TACE) seems to have an influence on this development. 
RFA is recommended as a technique for the treatment of early stage (Child A or 
54
Postgraduate Educational Programme
S4 CB D E F GA
Learning Objectives:
1.  To understand the background to the publication of RP 159  along with 
its purpose and scope.
2.  To become familiar with the principles and prerequisites of clinical audit as 
outlined by RP 159.
3.  To become familiar with the relationship between clinical audit and regulatory 
controls.
4.  To gain an insight into potential national, regional and international issues 
associated with clinical audit.
Author Disclosure:
P. Wood: Advisory Board; European Commission project 2007-2008 Contract 
N TREN/07/NUCL/S07. 71512, Panel of Experts Member. CEO; Society of 
Radiographers in Finland. Consultant; Qulitor Ltd, clinical audits. 
A-191 16:30
B. Implementation in practice: a comparison of different models 
S. Geers-van Gemeren; Utrecht/NL (s.geers@nvmbr.nl) 
The Dutch Society of Medical Imaging and Radiotherapy (NVMBR) has implement-
ed clinical audit in 1999 for the fields radiology, nuclear medicine and radiotherapy. 
In the Netherlands, clinical audit is since 2010 obligatory for healthcare professions, 
regulated by law, to be able to practice. With clinical audit the quality of the provi-
sion of care by professionals is assessed by peers. In 1999, the NVMBR started 
with clinical audit. The NVMBR audit radiographers working in the Radiology and 
Nuclear Medicine departments every five years on request. For the radiotherapy, 
a multidisciplinary audit is developed since 2003. Pilots of multidisciplinary audits 
have been performed for radiology in 2004 and for nuclear medicine in 2010 and 
2012. The evaluation of the pilots shows a benefit for the department and for the 
professional groups. Implementation: in 2008, the NVMBR started with a web-
based tool ADAS (General Digital Audit System) to support the audit. The use of 
ADAS is evaluated amogst the members of the audit team and the departments. 
The development of professional standards is a prerequisite to start clinical audit. 
The use of ADAS in multidisciplinary audits is a requirement to be able to audit 
different professions and focus on the content and the quality of their contribution 
to patient care. Clinical audit is a good tool to improve the quality of patient care. 
Important are the professional standards, the culture of learning and willing to 
improve by the professionals. „Every defect is a treasure“. 
Learning Objectives:
1.  To understand the key components required to allow clinical audit to be imple-
mented in practice.
2.  To gain an insight into different implementation models.
3.  To be informed about the key considerations that must be made prior to 
implementing an audit model: organisation, auditors, process, financing, the 
roles of professional bodies, and outcomes.
A-192 17:00
C. A perspective on the impact and benefits of clinical audit 
S. O’Connor; Dublin/IE (s.oconnor@globaldiagnostics.ie) 
The purpose of this lecture is to demonstrate how systematic clinical audit can be 
embedded in a radiology department and to provide practical insight and advice 
on audit selection and implementation and how to achieve critical buy in from a 
multi-disciplinary team to ensure that clinical audit remains an integral and self-
sustaining component of a modern radiology service. The importance of appropriate 
resources and training will be discussed in tandem with review of current literature 
and guidelines available in this field. The findings, actions and outcomes will be 
evaluated to demonstrate the tangible and beneficial impact audits can have on 
patients, the team and the service delivery. Clinical Audit remains one of most 
important ways we have to ensure the quality of the service we provide. When 
implemented properly, it will result in an effective and efficient quality-assured and 
safe radiology service. The service must be delivered by a committed team of 
informed clinicians and will underpin an optimised patient journey.
Learning Objectives:
1.  To gain an insight into the use of clinical audit from the perspective of a clinical 
audit lead in an international diagnostic imaging service provider.
2.  To become familiar with the challenges that may be encountered when un-
dertaking clinical audit.
3.  To understand the significant impact that clinical audit can have from the 
perspective of the patient, the healthcare team and on service delivery.
A-189 16:51
C. Portal vein embolisation before surgery 
A. Denys, P. Bize; Lausanne/CH (Alban.Denys@chuv.ch) 
Portal vein embolisation (PVE) is performed before hepatectomy. Portal branches 
of segments that will ultimately be resected are embolized. This embolisation 
produces local per-portal inflammation and reroutes the portal flow towards seg-
ments that will be left in place by the surgeon inducing liver regeneration of these 
segments. Indications are mainly hepatectomies removing more than 70-80% of 
the functional liver in healthy liver of more than 50-60% when the liver has been 
harmed either by a chronic liver disease or cirrhosis or by chemotherapy or steatosis. 
The procedure is done percutaneously and different embolic agents can be used 
for PVE, such as embolic particles, coils and plugs. Results from experimental 
works suggest that PVE is more efficient when embolic agent occludes small 
portal branches and produces significant periportal inflammation. PVE indications 
as well as results are evaluated by CT volumetry of the liver either manually or 
automatized by dedicated algorithms.
Learning Objectives:
1.  To become familiar with imaging strategies and indications for embolisation.
2.  To understand embolisation methods.
3.  To learn about results, complications and follow-up strategies.
Author Disclosure:
A. Denys: Advisory Board; Bayer. Grant Recipient; Biocompatibles, Cook, 
Terumo. P. Bize: Advisory Board; Bayer. Grant Recipient; Biocompatibles, Cook, 
Terumo. 
Panel discussion:  
How to allow for more patients with HCC to be treated?  17:14
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A. Clinical audit: from the EURATOM treaty to EU guidelines: clinical 
audit RP 159 
P. Wood; Helsinki/FI (paivi.wood@suomenrontgenhoitajaliitto.fi) 
The EC directive 97/43/EURATOM introduced the concept of Clinical Audit for 
the assessment of radiological practices. The Member States were required to 
implement clinical audits in accordance with national procedures. This concept 
is of high importance for the improvement of the quality of imaging practices. 
In the past years, the implementation of clinical audits has been commenced in 
a number of varying “national procedures”. Need for guidance was obvious to 
achieve meaningful results. In 2007-2008, the EC conducted a project to prepare 
guidance on clinical audit. The purpose of the project was to provide clear and 
comprehensive information on existing procedures and criteria for clinical audits 
in radiological practices. The final European Guidelines were published in June 
2009. The EC guideline is to provide guidance on clinical auditing in order to 
improve implementation of Article 6.4 of Council Directive 97/43/ EURATOM. The 
guideline provides comprehensive information on existing procedures and criteria 
for clinical audit in radiological practices: diagnostic radiology, nuclear medicine 
and radiotherapy. Clinical audit is not research, quality system audits nor regulatory 
inspections and it is systematic and planned activity. Clinical audit is a systematic 
review of medical radiological procedures which seeks to improve the quality and 
the outcome of patient care through structured review. Clinical audit should be a 
multi-disciplinary, multi-professional activity. Follow general accepted rules and 
standards which are based on international, national or local legal regulations, 
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second focus will be to outline key features helpful for differential diagnosis because 
CT of the lung - similarly as radiography - frequently suffers from the fact that the 
pattern of lung reaction to inflammatory/infectious noxa is quite nonspecific. Taking 
these two goals into consideration, the following four pathologic situations will be 
discussed: pneumonia and complications, ARDS staging and signs of barotrauma, 
oedema and its differentialdiagnosis, and post-surgical conditions: normal versus 
pathologic findings.
Learning Objectives:
1.  To understand the spectrum of pathological lung conditions, which complicate 
intensive care treatment.
2.  To learn about the role of diagnostic imaging and its technical difficulties and 
requirements in the intensive care environment.
3.  To become familiar with the most important imaging signs and symptoms of 
tracheobronchial and lung conditions, influencing the treatment and survival 
of the intensive care patient.
A-196 16:41
Point-of-care versus diagnostic ultrasound in the intensive care unit 
E. Danse, P.-F. Laterre, L. Jacquet, A. Dragean, I. Nica, P. Trefois, L. Annet; 
Brussels/BE (etienne.danse@uclouvain.be) 
This topic will be focused on the role of sonography in the critical care. Point care 
sonography is mainly dedicated to procedural guidance (vessels access or fluid 
punction) or assessement of fluid in the pleural space or the abdominal cavity (for 
instance, FAST sonography in trauma patients). This “ultrasonic” stethoscope is 
more and more popular due to its miniaturisation at low cost. Diagnostic sonography 
has another medical scope based on the imaging knowledge of radiologists and on 
the capabilities of mid-range or high-level machines. The B mode and Color Doppler 
modalities are routinely used with additional contribution of contrast ultrasound when 
needed or available. In the intensive care unit, point care or diagnostic sonography 
are contributive for the diagnosis work-up of critical care patients, allowing an 
optimal use of CT and angiography or an urgent access to the operating room.
Learning Objectives:
1.  To understand the concept and role of point-of-care ultrasound and its technical 
and training requirements.
2.  To become familiar with the role and tasks of diagnostic ultrasound versus 
point-of-care ultrasound in the most common pathologic conditions in intensive 
care.
3.  To learn more about typical ultrasound findings and their significance in the 
diagnosis, differential diagnosis and therapy of intensive care patients.
A-197 16:59
Imaging in polytrauma 
U. Linsenmaier; Munich/DE (Ulrich.Linsenmaier@kliniken‑pasing‑perlach.de) 
Management of patients after polytrauma on IC units can be complex and de-
manding. Clinical diagnoses relay today on a thorough diagnostic workup which 
is mostly based on a standardised whole body CT (WBCT). ICU patients undergo 
follow-up MDCT to control findings (e.g.in non-operative treatment), new clinical 
CT indications arise, CT is often combined with bedside US and CR. Radiological 
Management of patients with polytrauma: imaging protocol for the initial workup: 
WBCT comprises nCCT, CMCT of thorax, neck and c-spine (arterial) and (pv) ab-
domen. CRs were mostly replaced, US is only used as FAST (focused abdominal 
solography in trauma). WBCT can be modified by CTA (@35-45s; for e.g. extremity 
injuries), late CT scans (@120s; e.g. for bleeding dynamics, pseudoaneurysms) 
and delayed CT urography (CTU @ 400-500s, for pelvic and GU injuries) and also 
retrograde CT cystography. CT scout views and clinical findings determine the 
extent. Follow-up imaging of ICU patients after polytrauma: comprise dedicated 
MDCT, US and CR, secondary imaging procedures are MR, MRA (indicated only 
in stable patients) and DSA (e.g. for interventional procedures). Findings from initial 
WBCT determine how to proceed in a “first things first” priority-oriented clinical 
algorithm. Special considerations apply in imaging MOF, shock, brain oedema and 
in paediatric and pregnant polytrauma. Radiological findings must be discussed in 
the clinical context. Treatment is priority oriented and carefully planned in the context 
of possible concomitant injuries, and the possible risk of multi-organ failure (MOF).
Learning Objectives:
1.  To appreciate the clinical significance of conditions characterised by multiple 
severe injuries and their systemic and multi-organ complications.
2.  To explain the special role of imaging, the diagnostic algorithm and the techni-
cal, organisational and training requirements for the diagnosis and follow-up 
of polytrauma patients.
3.  To consolidate knowledge of imaging signs and symptoms and their diagnostic 
value in patients with polytrauma.
16:00 - 17:30 Room Q 
Special Focus Session 
SF 7c 
Imaging in intensive care patients 
A-193 16:00
Chairman’s introduction 
A. Palkó; Szeged/HU (palkoand@gmail.com) 
Intensive care units are special places where everything happens very fast and 
most decisions taken are influencing not only the healing but also the survival 
of the patient; while the amount of available information supporting these deci-
sions is frequently rather limited. Results of imaging examinations are therefore 
of very high importance, however, the extraordinary circumstances both in terms 
of technical conditions and in state of the patients challenge the expertise of 
the radiology department. Radiologists cooperating with intensive care special-
ists must understand the unique constraints in this environment and be aware 
of the clinical significance of their reports. Imaging diagnostic algorithms and 
examination techniques are to be flexibly adapted to the clinical situation and a 
fast and close communication of and consultation about the imaging findings is 
a basic requirement. Speakers of this session will address these general topics 
through the most challenging specific areas of imaging the intensive care patients. 
Session Objectives:
1.  To understand the importance of imaging diagnostics in the unique and chal-
lenging clinical setting of the intensive care units.
2.  To learn about the technical and methodological considerations to be taken 
into account with this patient group.
3.  To learn more about the most important conditions and the imaging findings 
as well as the diagnostic imaging algorithms to be used in the intensive care 
environment.
Author Disclosure:
A. Palkó: Advisory Board; Euromedic Intl. Consultant; Covidien. 
A-194 16:05
Value of MRI for intensive care coma patients with unclear brain pathology 
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se) 
Evaluation of the degree of severity of injury, coma duration, and prediction of 
outcome are integral parts of the management of patients in coma at the intensive 
care unit. Advanced magnetic resonance imaging techniques with special focus 
on MR spectroscopy (MRS) and diffusion (DWI) but also of the cerebral vascular-
ity in form of different perfusion measurements have shown to be a valuable tool 
in the work-up or both patients with known as well as unknown cause for coma. 
The causes for coma are many including infections, metabolic, traumatic and can 
also be seen secondary to space occupying brain lesions. The present lecture will 
focus the value of different MR imaging techniques and sequences in the work-up 
of possible cause, monitor treatment and predict outcome in coma patients at the 
intensive care unit.
Learning Objectives:
1.  To understand the importance of magnetic resonance imaging in cases of 
unclear brain pathology causing severe dysfunction of the central nervous 
system.
2.  To understand the significance of imaging in the evaluation of brain function 
and potential outcome following anesthesia, injuries and hypoxia.
3.  To become familiar with the imaging signs and their predictive value and ac-
curacy regarding brain death, and future role of imaging in decisions concerning 
the termination of intensive treatment.
Author Disclosure:
P. C. Maly Sundgren: Board Member; ISMRM, ASNR. Consultant; ICON Medial 
Imaging. 
A-195 16:23
Computed tomography of pathologic lung conditions complicating 
intensive care treatment 
C.M. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com) 
Method of choice for imaging the lung of an intensive care patient is the bedside 
chest radiograph. CT is only done if complications are anticipated or radiographic 
findings are equivocal. One focus of the presentation is, therefore, to outline which 
diagnostic information is added by CT compared to the bedside radiograph. The 
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A-200 17:00
C. Evaluation of malfunction 
R. Uberoi; Oxford/UK (raman.uberoi@orh.nhs.uk) 
The incidence of end-stage renal disease is increasing, with limited availability of 
transplants, hemodialysis accesses have become the most commonly performed 
type of vascular surgical procedure.However, only 50% of all haemodialysis ac-
cesses remain patent at 3 years and interventional radiology plays a major role in 
maintaining function. Indications for intervention include failing haemodialysis graft 
or fistula, arm oedema, imaging findings indicative of a significant stentosis > 50% or 
presence of accessory veins. Clinical assessment alone will detect a large number 
of failing fistula's. If the venous pressures during haemodialysis exceed 120 mmHg, 
fistula flow falls to < 500 ml/min, graft flow decreases to < 650 ml/min, or access 
blood flow falls by more than 25%. There remains debate if prophylactive treatement 
of failing fisutlas results in better outocmes. Venous stenoses are characterised 
by extensive fibrosis and require ultra-high pressure balloon inflations or cutting 
balloon angioplasty for optimal treatment. Stenting provides no clear benefit over 
PTA alone and eliminates the option of using the stented vein for future surgical 
revision. Stenting is genenerally reserved for sub-otpimal results with no convincing 
evidence currently to support using covered stentgrafts over bare nitinol stents. 
When critical flow reduction and clotting ensue, the bulk of the thrombus is red 
thrombus, which is rich in fibrin and red cells and easily extracted with aspiration, 
rheolytic methods or pulse-spray thrombolysis, but a platelet-rich white clot at the 
arterial anastomosis may require mechanical removal with an angioplasty balloon 
or devices such as the Fogarty thrombectomy in 35% to 60%.
Learning Objectives:
1.  To understand the main indications and results of angioplasty.
2.  To learn about thrombectomy and aspiration.
3.  To become familiar with the indications for stenting.
Panel discussion: 
What training and special skills are radiologists expected to have 
in order to work with intensive care units? How should we manage 
the clinical and technical challenges posed by this very specific 
environment? 17:17 







A. Preoperative mapping 
L. Turmel-Rodrigues; Tours/FR (luc.turmel@wanadoo.fr) 
Nephrologists and surgeons are increasingly aware of the limitations of physical 
examination as a tool to assess arterial and venous anatomy prior to creating a 
vascular access. Greater emphasis is now being placed upon more objective 
methods. Arterial mapping is feasible almost exclusively by color duplex ultrasonog-
raphy. Imaging of the veins is indicated if there are inadequate findings on physical 
examination or whenever central vein stenosis is suspected. Iodinated contrast 
venography and later carbon dioxide venography were the modalities of choice 
before the advent of ultrasonographic mapping in the 1990s. CT angiography and 
magnetic resonance angiography play an equally shrinking role. Anatomic variability 
is a common feature of upper limb vasculature. The most common arterial variant 
is a high origin of the radial or ulnar artery at any level from the axillary artery to 
the elbow. Despite having more anatomical variation than arteries, the cephalic 
and basilic veins are the predominantly seen veins in the forearm and upper arm 
of normal subjects. At the elbow, the accessory cephalic, main cephalic, median 
cubital, and forearm basilic veins converge to form a venous network in the shape of 
capital “M”. Vessel size is usually underestimated since it is not always easy to tell 
from an image if a vein or artery is partially or completely spastic despite warming 
or use of vasodilators. There is a wide variation in practice as to what a surgeon 
does with a venous mapping report and the vascular access that is finally created.
Learning Objectives:
1.  To become familiar with the indications and techniques for pre-operative arterial 
venous mapping.
2.  To learn about the venous anatomy.
3.  To become familiar with the potential pitfalls of preoperative mapping.
A-199 16:30
B. Screening for problems 
D. Vorwerk; Ingolstadt/DE (dierk.vorwerk@klinikum‑ingolstadt.de) 
Dysfunction of dialysis fistulas and grafts is frequent and usually a stenotic process 
represents the underlying cause. While in grafts - in the absence of side branches - 
this will result in complete thrombosis after reaching a critical stenosis in conjunction 
with thrombophilic circumstances, in fistulas partial thrombosis is not rare leaving 
some parts of the fistula patent. There is few scientific work about the value of 
regular screening programs in dialysis fistulas and grafts and most did not find in 
an improved patency after starting surveillance programs by ultrasound. However, 
reintervention is not a good marker for the success of a surveillance program as it 
could be for the purpose of treatment of a stenotic leasion as well as for thrombosis. 
Definitively reintervention for a restenosis is usually simple, quick, effective and 
inexpensive while treating a thrombosed fistula or graft is time-consuming, expen-
sive and technically more challenging. Alternatively to ultrasound, measurement 
of recirculation is a less time-consuming method to detect dysfunction in addition 
to clinical exam and palpation.
Learning Objectives:
1.  To understand the spectrum of problems with dialysis fistula.
2.  To learn about screening protocols and the results of screening.
3.  To learn about the most common problems and how to detect them.
Author Disclosure:
D. Vorwerk: Consultant; Covidien, Cook, Bard,. Speaker; Cordis, Gore. 
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08:30 - 10:00 Room B 
Special Focus Session 
SF 8a 





With the rapid development of CT and MRI - angiography most diagnostic catheter 
angiographic studies have been replaced and conventional angiography has gained 
in the field of interventions. However, there are contraindications and limitations of 
these non-invasive techniques for diagnostic work-up. In this Special Focus Session 
“Is diagnostic catheter angiography still useful in neuroimaging?”, the audience 
will learn about the current indications of diagnostic catheter angio, its alternatives 
and the pro- and cons - both in three lectures and a panel discussion to follow. 
Session Objectives:
1.  To become familiar with the current debate on the need for diagnostic catheter 
angio.
2.  To learn about the pros and cons of diagnostic catheter angio.
3.  To learn about the pros and cons of alternative non-invasive angiography 
techniques.
A-204 08:35
What can we expect from vascular diagnostic procedures? 
R. Siemund; Lund/SE (roger.siemund@skane.se) 
Diagnostic vascular procedures are an important part in the primary work-up, 
therapy planning and follow-up of many disease of the central nervous system. 
Assessment of the supraaortic vessels is obviously mandatory in case of intrac-
ranial bleeding and acute or sub-acute stroke. Even in many cases with unclear 
neurological disease or symptoms vascular assessment is unavoidable at certain 
points during the diagnostic work-up in order to proof or to rule out, e.g. vasculitis 
or sinus thrombosis. For the referring clinicians and for the radiologist performing 
these vascular procedures, it is crucial to choose the most appropriate modality in 
each case. This presentation will focus on the different diagnostic needs in certain 
clinical situations. Strategies to chose the optimal modality based on a trade off 
between diagnostic yield, patient risk and economic costs will be discussed. 
Learning Objectives:
1.  To learn about the expectations from vascular diagnostic procedures in the 
diagnostic work-up.
2.  To become familiar with the expectations from vascular diagnostic procedures 
in therapy planning and therapeutic procedures.
3.  To learn about the expectations from vascular diagnostic procedures in the 
follow-up assessments.
A-205 08:58
Can non-invasive techniques as CTA and MRA replace catheter 
angio for diagnostic work-up? 
L. van den Hauwe, M. Voormolen, T. van der Zijden, R. Salgado, 
J.W. Van Goethem, P.M. Parizel; Antwerp/BE (lucvdhauwe@mac.com) 
Although catheter angiography remains the gold standard for cerebrovascular 
imaging, in recent years, it has been replaced to some extent by less-invasive 
techniques, such as CTA, MRA, and ultrasound. Some of these techniques allow 
for cerebrovascular imaging without exposure to ionising radiation, and/or without 
requiring an exogenous contrast agent that could cause nephrotoxicity, allergic 
reaction, or other adverse effects. Moreover, all of these techniques avoid the extra 
time, expense, and possibility of complications that are associated with arterial cath-
eterization. Ongoing developments in CT- and MR-based angiography continue to 
improve the effectiveness of these techniques, and to expand the clinical roles that 
they can fulfill. Nowadays, these noninvasive techniques not only provide images 
with high spatial resolution, but also offer time-resolved images, in which arterial 
and venous phases can be distinguished, and can provide selective visualisation 
of vessels supplied by a single supplying artery. This presentation will review the 
latest developments in CT- and MR-based cerebral angiography, and illustrate the 
use of these CT- and MR-techniques in the diagnosis of cerebral aneurysms and 
vascular malformations.
08:30 - 10:00 Room A 
Interactive Teaching Session 
E³ 820a 
Pitfalls in heart imaging 
A-201 08:30
A. CT 
G. Bastarrika; Toronto, ON/CA (bastarrika@unav.es) 
Cardiac CT is becoming the imaging modality of choice for an increasing number 
of clinical indications, not only to rule out coronary artery disease but also to 
evaluate cardiac morphology and function, and to determine patient outcome 
after coronary artery revascularization. However, as with any other imaging tools, 
appropriate interpretation of cardiac CT examinations is required in order to asset 
the clinical value of this newly established diagnostic imaging modality. This proc-
ess requires performance of thorough cardiac CT acquisition protocols, detailed 
knowledge of standard cardiac anatomic and physiologic terminology, as well as 
appropriate post-processing, reading, and reporting. In particular, radiologists 
need to recognize and be aware of the imaging findings that may confound and 
mislead to interpretation errors. This lecture will summarize practical aspects of 
post-processing, reading and reporting non-invasive cardiac CT examinations. The 
value and limitations of every available CT post-processing technique including 
two-dimensional multiplanar reformations, curved multiplanar reformats, maximum 
intensity projection (MIP), and volume-rendered images will be explained. Hints 
to improve reading results by recognizing technical causes for various artifacts in 
cardiac CT will be elucidated and reading approaches to diminish false positives, 
false negatives and inaccuracies when assessing coronary artery stenosis will 
be suggested. Finally, the essentials to achieve a comprehensive and structured 
cardiac CT report will be provided.
Learning Objectives:
1.  To learn about practical aspects of postprocessing, reading and reporting 
non-invasive cardiac CT examinations.
2.  To learn how to improve reading of results by recognising technical causes 
for various artifacts in cardiac CT.
3.  To become familiar with approaches to reducing false inaccuracies and mis-
interpretations when assessing coronary artery stenosis.
Author Disclosure:
G. Bastarrika: Speaker; Bayer, General Electric, Medrad, Siemens. 
A-202 09:15
B. MRI 
M. Francone; Rome/IT (marco.francone@uniroma1.it) 
Cardiac Magnetic Resonance (CMR) is a complex imaging technique due to the 
intrinsic anatomical and technical peculiarities of the exam. The first include the 
non-orthogonal cardiac orientation within the chest cavity requiring dedicated 
acquisition planes, but also the complex respiratory and cardiac motion to which 
heart is subject and the ubiquitous presence of fat tissue surrounding the cavi-
ties which can be overcome respectively using a combination of ECG-gated and 
breath hold sequences with additional utilisation of fat-suppression techniques. 
Potential additional anatomical pitfalls also include normal structures and variants 
like the Moderator: band, papillary muscles and the presence of prominent crista 
terminalis or myocardial trabeculations which recognition is mandatory and may 
mimic in some cases a pathological condition. Technical issues of CMR concerns 
the continuous intracavitary inflow of protons and the associated “slow-flow” artifacts 
(limiting visualisation of endomyocardial border in some cases), pitfalls related to 
ECG gating like inadequate synchronization or the T-Wave Swell phenomenon and 
finally a series of specific artifacts intrinsically related to the use of different pulse 
sequences that may interfere with image quality. An additional more complex issue 
to consider is also the widespread diffusion of high-field magnets which have further 
enhanced those aspects. Knowledge of the spectrum of those CMR peculiarities is 
mandatory in order to approach and provide a correct diagnosis according to the 
main clinical request. Present lecture with review most important anatomical and 
technical pitfalls of CMR examination offering, when possibile, practical solutions 
to overcome those limitations. 
Learning Objectives:
1.  To learn about common pitfalls in MRI evaluation of the heart.
2.  To become familiar with cardiac anatomical variants, potentially mimicking 
disease.
Author Disclosure:
M. Francone: Speaker; Bracco Medical Imaging. 
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changes in cholinergic neurotransmission/brain. Networks in cognitive impairment 
states of different dementia forms and Parkinson‘s disease, or changes of CBF early 
after ischemic stroke. To achieve this goal, a number of methodological challenges 
related to the unique technique design of combined PET-MR systems needs to be 
overcome, like realizing attenuation correction of the PET data, desirably without 
measured attenuation data. Taken together, combined brain PET-MR imaging is 
an important tool to support patient handling and research in neuropsychiatry and 
will help us to develop further towards individualized medicine. 
Learning Objectives:
1.  To learn about what we are able to do now.
2.  To understand the nuclear aspect of neuroimaging.
3.  To learn about the possibilities and limitations of neuroimaging.
Author Disclosure:
O. Sabri: Consultant; Bayer Healthcare. Grant Recipient; Bayer Healthcare. 
Investigator; Bayer Healthcare. Speaker; Bayer Healthcare. 
A-209 08:51
MR/PET in neuroimaging: radiology 
B.R. Rosen; Charlestown, MA/US (bruce@nmr.mgh.harvard.edu) 
PET and MRI are imaging modalities routinely used for clinical and research applica-
tions. PET is a quantitative technique that provides exceptionally sensitive assays 
of a wide range of biological processes. MRI provides high-resolution anatomical 
information with excellent soft tissue contrast, and the ability to measure a variety 
of physiological, metabolic and biochemical parameters. Given the complementary 
nature of each modality’s strengths and weaknesses, integrating PET and MRI 
should allow both investigators and clinicians the opportunity to gain in a single 
examination many of the positive attributes of both, and mitigate some of their 
limitations. More important, the wealth of information beyond morphology that 
MRI provide enables PET/MRI to go far beyond simple anatomical registration of 
PET molecular imaging, while the simultaneous acquisition of PET and MRI data 
opens up opportunities impossible to realize using sequentially acquired data. This 
manuscript paraphrases the Wagner Lecture delivered by B.R. at the 2011 Society 
of Nuclear Medicine Annual Meeting and summarizes the technical aspects of the 
novel technology PET/MRI in addition to emphasizing the areas where PET/MRI 
may make a significant impact. Although these areas include oncologic, neurologic, 
cardiac and psychiatric applications, PET/MRI has the potential to impact dramati-
cally the burgeoning field of molecular imaging. 
Learning Objectives:
1.  To demonstrate the value of this hybrid technique.
2.  To understand the radiological aspect of neuroimaging.
3.  To learn about the possibilities and limitations of neuroimaging.
Author Disclosure:
B. R. Rosen: Advisory Board; Janssen Scientific. Consultant; Siemens Medical 
Solutions. Other; Expert Witness for Wolf Greenfield Patent Lawyers. 
A-210 09:09
MR/PET in oncologic imaging: nuclear medicine 
O. Ratib; Geneva/CH (osman.ratib@hcuge.ch) 
We evaluated a new generation of whole-body hybrid PET-MR scanner to as-
sess its performance and added value in clinical application in oncology. A new 
whole-body hybrid PET/MR system (Philips Ingenuity TF) consisting of a GEMINI 
Time-of-Flight PET system and an Achieva 3 T X-series MRI system was tested 
in a clinical setting. The two scanners are separated by approximately 3 m, with a 
sliding bed allowing 180° rotation of the patient from one scanner to another with 
accurate registration between the two modalities. An initial evaluation included 62 
patients having two successive studies on PET-CT and PET-MR device. This initial 
phase was then followed by routine utilisation of the device in clinical applications, 
in particular, in head and neck cancers, in breast and prostate cancers as well as in 
paediatric cases. In the initial cohort of patients, PET images acquired in the PET/
MR with a delay of 85 ± 22 min (range 49-120 min) showed perfect correlation and 
identical diagnostic quality compared to the first PET acquired on PET/CT. In 42 
patients (68%), additional high-resolution MR sequences were acquired for clinical 
diagnosis showing excellent quality without any visually detectable artifacts. SUV 
measurements of tumour lesions obtained after correction with MR attenuation 
maps showed an excellent correlation with PET-CT (R2 = 0.89 and R2 = 0.95). Our 
preliminary data show that total body PET/MR is clinically applicable in oncologic 
patients yielding a comparable diagnostic performance as PET/CT with respect to 
lesion detection and localisation. 
Learning Objectives:
1.  To learn about what we are able to do now.
2.  To understand the nuclear aspect of oncologic imaging.
3.  To learn about the possibilities and limitations of oncologic imaging.
Learning Objectives:
1.  To become familiar with the diagnostic potential of CTA and MRA.
2.  To understand the current proved clinical indications where CTA and MRA can 
replace catheter angio.
3.  To learn about safety issues in non-invasive procedures.
A-206 09:21
Diagnostic catheter angiography is not dead: current indications and 
advantages over the non-invasive techniques 
T. Engelhorn; Erlangen/DE (tobias.engelhorn@uk‑erlangen.de) 
Despite computed tomography (CT) and magnetic resonance imaging (MRI), 
angiography including dynamic contrast-enhanced sequences, diagnostic catheter 
angiography is still considered the gold standard for imaging cerebral vasculature. 
Hereby, diagnostic catheter angiography is typically done in intracranial hemor-
rhages to exclude arteriovenous malformations (AVMs), dural extra-intracranial 
arteriovenous fistulas and aneurysms as cause of haemorrhage. AVMs as well as 
dural fistulas can be obscured by the surrounding blood in CT and MRI; aside, small 
(blister-like) aneurysms (< 2 mm) can be overlooked with CT and MRI angiography. 
In already diagnosed AVMs, fistulas and aneurysms, diagnostic catheter angiogra-
phy has to be performed to assess the exact architecture of the vascular malforma-
tion to decide absolutely certain if endovascular treatment is possible and what 
(special) material will be needed for neurointerventional treatment. Furthermore, 
diagnostic catheter angiography is still needed for follow-up imaging after endovas-
cular and surgical treatment of vascular malformations and intracranial stenosis. 
Nevertheless, despite the problem of metal artefacts intravenous high-resolution 
flat panel detector CT (DynaCT) seems to be almost comparable to diagnostic 
catheter angiography in follow-up imaging after neurointerventional procedures.
Learning Objectives:
1.  To learn about the current indications for diagnostic catheter angiography.
2.  To become familiar with complication rates of selective catheter angiography 
in high volume centers.
3.  To appreciate some technical innovations for diagnostic catheter angiography.
Panel discussion: 
The pros and cons of diagnostic catheter angiography in 
neuroimaging 09:44 
08:30 - 10:00 Room C 
New Horizons Session 
NH 8 




This New Horizons session aims to provide the latest insights into the hybrid 
imaging technique of MR/PET. Reflecting current research interests, this session 
focuses on MR/PET in neuroimaging and in oncologic imaging. These topics will 
be presented from two perspectives: that of nuclear medicine and that of radiol-
ogy. MR/PET uniquely combines functional and morphological diagnostic imaging 
in a single examination. With this new technology, imaging eliminates the known 
limitations of anatomical and molecular resolution. What we will also discuss in 
this session are the challenges we are faced with in showing that this new hybrid 
technology improves not only diagnostic accuracy but also treatment outcome. 
Session Objectives:
1.  To introduce the potential of this new imaging modality.
2.  To appreciate a new opportunity for cooperation between radiology and nuclear 
medicine.
A-208 08:33
MR/PET in neuroimaging: nuclear medicine 
O. Sabri; Leipzig/DE (osama.sabri@medizin.uni‑leipzig.de) 
With the recent introduction of simultaneous PET-MR imaging systems, it is possible 
for the first time to investigate functional and morphological brain changes or differ-
ent functional brain processes at the same time in the living human subject. This new 
opportunity has great potential to improve both clinical routine and research brain 
imaging. Examples of improved clinical routine imaging relate to dementia and brain 
tumour imaging. Research applications focus on the exciting opportunity to acquire 
PET and MR data simultaneously, focusing our interest to fast kinetic processes, like 
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Learning Objectives:
1.  To learn about the imaging modalities used for the assessment of cardiovas-
cular risk.
2.  To learn how to select the right test for the right patient.
3.  To become familiar with the newest innovations and newest guidelines in 
non-invasive cardiovascular risk assessment.
A-214 09:30
C. Interactive case discussion: how to deal with the results? 
A. van der Lugt; Rotterdam/NL (a.vanderlugt@erasmusmc.nl) 
In this session, several cases from patient care and preventive screening programs 
will be discussed. First, the application of the appropriate risk stratification strat-
egy based on clinical risk scores and imaging risk scores will be discussed. It will 
become that the strategy is tailored to specific patient populations. Second, the 
audience is asked to participate in the choice of the appropriate imaging technique, 
the interpretation of the results and the recommendation for advanced image 
workup or treatment. Finally, misuse of stratification tests in patients is discussed 
and explained. The audience will be encouraged to participate in the discussions 
via the electronic voting system.
Learning Objectives:
1.  To understand the strength of non-invasive risk stratification in properly selected 
patient populations.
2.  To consolidate knowledge of the selection of the appropriate imaging technique, 
image interpretation and image-based treatment recommendation.
3.  To learn about the risks of the inappropriate use of such risk stratification tests 
(Ca-scoring) in symptomatic patients.
08:30 - 10:00 Room D2 
Oncologic Imaging: Follow-up of Systemic and Local Therapies 
CC 819 





A. What can we expect from biomarkers 
B. Van Beers; Clichy/FR (bernard.van‑beers@bjn.aphp.fr) 
The purpose of this lecture is to become familiar with biomarkers and to consolidate 
knowledge of various biomarkers and their utility. Evidence-based assessment of 
anatomical and functional imaging biomarkers for tumour response. Biomarkers 
are quantitative parameters measured with imaging methods that can objectively 
assess disease status. Compared with biochemical and histological markers, im-
aging biomarkers have the advantage of being spatially and temporally resolved 
and are thus especially useful for assessing response to treatment. Anatomical 
imaging biomarkers based on tumour size (RECIST) are increasingly used but have 
limitations for assessing response to targeted treatments that induce biological 
changes much earlier than size changes in tumour burden. Therefore, reliance 
on tumour viability has increased. Viability criteria such as the mRECIST, EASL 
and Choi criteria are based on size measurements of viable, contrast-enhancing 
tumour regions or on tumour attenuation. The diagnostic efficacy and the repro-
ducibility of the different viability criteria should be further compared. In addition, 
there is a growing interest for validating functional imaging biomarkers such as 
perfusion and diffusion parameters obtained with ultrasound, CT and MR imaging. 
Although promising for early assessment of response to treatment, these newer 
functional biomarkers need extensive validation and standardization for their wide 
clinical use. The added value of the more complex functional biomarkers relative 
to the viability parameters should also be shown. Viability and functional imaging 
biomarkers are evolving and emerging parameters for the early assessment of 
response to treatment.
Learning Objectives:
1.  To become familiar with biomarkers.
2.  To consolidate knowledge of various biomarkers and their utility.
A-211 09:27
MR/PET in oncologic imaging: radiology 
H.-P. Schlemmer; Heidelberg/DE (h.schlemmer@dkfz.de) 
Sequential CT, MR and PET/CT is routine in daily oncology practice. In particular, 
PET/CT has emerged as an important method to detect, characterise, monitor and 
follow-up different tumour entities. Compared to CT, however, MRI provides superior 
soft tissue contrast and enables additionally to assess functional information, why 
MRI plus PET/CT would be desirable in many cases. But sequential imaging has 
several limitations: it is uncomfortabel for critically ill patients, costly and inefficient 
from a work-flow perspective. It results in spatial mismatch and misalignment cor-
rection is time consuming and still limited. Scientific and clinical considerations 
consequently argue for temporal and spatial coregistration of MR and PET data. 
Various MR techniques for imaging of perfusion, diffusion and metabolism could 
be precisely be related to PET-based measurements of perfusion, metabolism 
and cell receptor densities. Simultaneous PET/MR imaging can be advantages 
in different tumour, e.g. lung cancer, breast cancer, prostate cancer, lymphoma, 
seminal carcinoma concerning detection, staging as well as for therapy monitoring 
and follow-up. Coregistration of MR and PET data will also be useful for MRI-gated 
PET measurements of moving organs (in e.g. bronchial carcinoma) and can sup-
port biologically adapted Radiotherapy. It furthermore reduces the x-ray exposures, 
which is important particularly for young patients and patients who need multiple 
follow-up examinations. But crossfire of criticism is still justified, because the novel 
imaging technology may not enter routine before improvements of diagnostic ac-
curacy, influence on therapeutic management and economic reasonability have 
been carefully considered and evidenced by clinical studies. 
Learning Objectives:
1.  To demonstrate the value of this hybrid technique.
2.  To become familiar with the radiologic aspect of oncologic imaging.
3.  To learn about possibilities and limitations of oncologic imaging.
Author Disclosure:
H. -P. Schlemmer: Research/Grant Support; Siemens. 
Panel discussion: 
What benefits and risks should we expect in terms of basic research, 
clinical service, and economics? 09:45 
08:30 - 10:00 Room D1 
CLICK (Clinical Lessons for Imaging Core Knowledge): Never 
without Arteries 
CC 818 





A. Clinical considerations 
E. Minar; Vienna/AT (erich.minar@meduniwien.ac.at) 
″Abstract Not Submitted″ 
Learning Objectives:
1.  To learn about the frequency and importance of vascular diseases.
2.  To become familiar with clinical risk stratification strategies.
3.  To learn about the possibility of reducing cardiovascular risk.
A-213 09:00
B. Imaging techniques and typical findings 
H.J. Lamb; Leiden/NL (H.J.Lamb@lumc.nl) 
In this lecture, an overview will be given on available imaging techniques for car-
diovascular imaging. Focus will be on imaging modalities used for the assessment 
of cardiovascular risk, with special attention to obesity related imaging procedures. 
Imaging strategies are needed for selecting obese patients at risk for developing 
obesity related cardiovascular complications and progression to type 2 diabetes. 
In these selected patients, tailored, more agressive therapy should be initiated 
guided by imaging findings. 
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aturday
08:30 - 10:00 Room E1 
Emergency Radiology 
RC 817 
Polytrauma: redefining imaging issues for 
management priorities 
A-218 08:30
Chairman’s introduction: advanced imaging, logistics and 
management priorities in patients after polytrauma 
H. Alkadhi; Zurich/CH 
The management and logistics of the polytrauma patient remains challenging. 
This holds true for emergency physicians, orthopaedic surgeons, and for radiolo-
gists. In addition, workflow issues continues to evolve, with the current focus on 
the introduction of whole-body CT into the early resuscitation phase of severely 
injured patients as a standard and basic diagnostic imaging method. This sess-
sion is aimed at a thorough discussion on the requirements for advanced imaging 
in the early clinical situation, logistics and management priorities, and on quality 
control in emergency radiology. 
A-219 08:40
A. Vascular trauma 
G. Schueller; Bülach/CH (gerd.schueller@spitalbuelach.ch) 
In vascular trauma, it is essential to immediately recognize life-threatening condi-
tions and to initiate early treatment. New logistic concepts enable an accelerated 
diagnostic work-up, which is mainly driven by the early use of multidetector CT. The 
majority of patients succomb at the site of the injury according to severe injuries of 
the CNS, heart and great vessels. There is another peak of early deaths within the 
first 4 h after the injury, which, in the majority of cases, is due to visceral hemor-
rahge. On the other hand, this means that the vast majority of internal injuries can 
potentially be survived. From a radiologic point of view, this capability becomes 
feasible if standard of care is carried out by dedicated facilities in which trauma 
teams provide service in an 24 by 7 mode. The goal of this lecture is to describe 
the most relevant traumatic lesions to the aorta, the thorax, the abdomen as well 
as the pelvis. Both, classifications of major injuries will be emphasized, and several 
cases will be discussed, pointing out the crucal role of an interdisciplinary approach 
of surgeons, anesthesistsm and radiologists in the emergency setting. 
Learning Objectives:
1.  To become familiar with the use of dedicated MDCT protocols, classification 
of vascular injuries and treatment options.
2.  To become familiar with alternative imaging modalities such as US, DSA and 
MR.
3.  To learn about typical and atypical imaging findings.
A-220 09:00
B. Chest and abdomen 
M. Scaglione; Castel Volturno/IT (mscaglione@tiscali.it) 
Thoraco-abdominal injuries are a significant cause of death in the polytraumatized 
patients. Early recognition and communication of life-threatening thoraco-abdominal 
injuries is the major task the radiologists involved the emergency room. Although, 
most of these patients reach the hospital prior to die, lethality continues to remain 
high. Heart, thoracic great vessels, trachea, bronchus, pleura, lung, diaphragm, 
abdominal/retroperitoneal vascular and solid organ injuries are potential cause 
of death. Any appropriate surgical/interventional management approach must be 
carried out “around the clock”, before thoraco-abdominal injuries reach the level 
of clinical evidence. On the other way, non-operative management has actually 
become the standard of care for the most serious thoraco-abdominal injuries. 
These goals become feasible if a correct contrast-enhanced MDCT diagnosis, in 
a dedicated facility in which the trauma team works effectively 24 h a day, 7 days 
a week, is performed. Thus, in this lecture, the most serious thoraco-abdominal 
injuries will be illustrated, with special emphasis on vascular/ injuries as well as the 
value of post-processing techniques, protocols, pitfalls, tips and tricks. Furthermore, 
A-216 09:00
B. MRI biomarkers: from acquisition to post-processing 
O. Lucidarme, M. Wagner, C. Pellot Barakat, F. Frouin; Paris/FR 
(olivier.lucidarme@psl.ap‑hop‑paris.fr) 
MRI biomarkers must be able to show how tumours will respond to specific treat-
ment. They need to allow an assessment of the effectiveness of new treatment 
more rapidly than classical clinical end points. These biomarkers must be easy 
to obtain in order to facilitate a large spread of the technique. They have to be 
reproducible. The longest diameter of the tumour remains the easiest biomarker 
that can be obtained from any kind of morphologic acquisition with no need of post-
processing. Additional information about the tissular organization and cellularity 
can be now easily obtained using modern scanners through diffusion-weighted 
sequences. The ease with which those sequences are obtained masked for a while 
the necessity to perform a more complex post-processing than the one initially 
done to get reliable biomarkers. The MRI biomarkers of the microcirculation are 
numerous reflecting the O2 consumption, the blood volume, the blood flow, the 
vessel permeability, the extravascular volume. To get them, we need to do more 
sophisticated acquisitions and image processing that take into account the T1 of 
the tissue, the arterial input function, the respiratory motion, etc. Most of these 
new MRI biomarkers are now used in research and in phase I studies but remains 
not validated in more advanced clinical trial or in clinical practice. If we want to 
be able to use them widely and reliably we need to perfectly understand what are 
the consequences of the choices we make during the acquisition and the post-
processing of these biomarkers.
Learning Objectives:
1.  To become familiar with MRI biomarkers.
2.  To learn about tips and tricks for MRI biomarker evaluation.
A-217 09:30
C. Assessing the precision and accuracy of biomarker imaging: is it 
reproducible? 
C.B. Sirlin; San Diego, CA/US (csirlin@ucsd.edu) 
Validation of imaging biomarkers is the process of demonstrating that the bi-
omarkers are acceptable for their intended purpose. Two important metrics used 
in validation are accuracy and precision. Accuracy refers to the correctness of 
an imaging biomarker (e.g., hepatic proton density fat fraction estimated by MR 
imaging) in predicting an endpoint of interest. The endpoint of interest may be 
another imaging biomarker (e.g., hepatic proton density fat fraction measured by 
MR spectroscopy), a histology-based biomarker (e.g., steatosis grade estimated 
by histology), a disease process-based biomarker (e.g., gene expression assessed 
by an immuno-histochemical analysis), or a clinical outcome (e.g., future develop-
ment of cirrhosis assessed by a longitudinal outcome e study). Depending on the 
endpoint, biomarker accuracy often is evaluated by diagnostic performance/ROC 
analysis or regression analysis. Precision refers to the closeness of agreement 
(degree of scatter) between a series of biomarker estimates made on the same 
subject under prescribed conditions. The closer the agreement between repeated 
estimates, the more likely the estimates will be similar in the future, assuming no 
true change in the underlying property. For this reason, knowing the precision of 
a quantitative biomarker is critical for interpreting changes over time when the 
biomarker is estimated longitudinally in clinical care or clinical trials. Precision has 
technical and biological components. Technical precision may be considered at 
four levels: within-examination repeatability, between-examination repeatability, 
between-”laboratory” (e.g., manufacturer, platform, field strength, center) reproduc-
ibility, and robustness (invariance to typical changes in acquisition parameters). 
Biological precision may be affected by temporal variability and spatial variability. 
Learning Objectives:
1.  To understand imaging biomarker precision (repeatability and reproducibility) 
and accuracy and how it is evaluated.
2.  To understand how to interpret biomarker precision and accuracy in the context 
of the biomarker’s intended use.
Author Disclosure:
C. B. Sirlin: Advisory Board; GE, Bayer, Genzyme. Consultant; Bayer, 
Genzyme, Takeda, Profil, Isis, Vical, Merck, Synageva, Gilead, Siemens. 
Equipment Support Recipient; Siemens, GE. Research/Grant Support; NIH, 
Bayer, Bracco, GE, Siemens. Speaker; Bayer. 
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Learning Objectives:
1.  To understand when and why you should image dementia.
2.  To become familiar with the imaging findings of the most common primary 
degenerative and secondary vascular dementias.
3.  To understand how to recognise normal pressure hydrocephalus as an underly-
ing cause of subcortical dementia.
A-223 09:00
B. Movement disorders 
T.A. Yousry; London/UK (t.yousry@ucl.ac.uk) 
Disease or degeneration of the basal ganglia, cerebral cortex and sometimes the 
thalamus give rise to disorders of movements (MD) known as dyskinesias (Greek: 
difficult movement), which can be differentiated into hypokinetic and hyperkinetic 
syndromes. We will be concentrating on the hypokinetic syndromes, which include 
Idiopathic Parkinson’s disease (IPD), atypical PD (APD): multiple system atrophy 
(MSA), progressive supranuclear palsy (PSP) and cortico basal degeneration 
(CBD). These movement disorders (MD) are often difficult to diagnose and to treat. 
Up to now, the diagnosis is based on clinical criteria. However, despite the fact 
that imaging plays an increasing role in establishing and confirming the diagnosis 
of MD, many radiologists are not familiar with the role of the various imaging tech-
niques, in establishing the diagnosis, monitoring disease progression and furthering 
our understanding of the pathophysiology of MD. We will first review the role of 
“conventional” MRI in the workup of MD by presenting imaging signs that assist in 
the daily routine and that should be known by radiologists and neuroradiologists 
exposed to this disease entity. We will then review the contribution of specific 
imaging techniques such DTI, SWI and high field imaging as well as quantitative 
MR post-processing techniques in improving the diagnosis, providing biomarkers 
for the monitoring of the natural history and furthering our understanding of the 
pathophysiology of MD.
Learning Objectives:
1.  To learn the typical imaging findings, their anatomic substrate and the limita-
tions of conventional MRI.
2.  To understand the contribution of advanced imaging techniques such as 
DTI, SWI and high field imaging as well as quantitative MR post-processing 
techniques.
3.  To understand the role of MR in the diagnosis and differential diagnosis of 
movement disorders.
Author Disclosure:
T. A. Yousry: Advisory Board; Biogen Idec. Author; T Yousry. Board Member; 
European Radiology. Research/Grant Support; MS Society of Great Britain and 
Northern Ireland, PSP Association, MRC, Wellcome Trust, Stroke Association, 
British Heart Foundation, UCL/UCLH Biomedical Research Centre, Biogen Idec, 
GlaxoSmithKline, Novartis. Speaker; ESOR, King Abdullah Medical City. 
A-224 09:30
C. Metabolic disorders 
J.F. Schneider; Basle/CH (jacques.schneider@ukbb.ch) 
Metabolic disorders may present at any age. Their clinical symptoms are often 
scarce or non-specific. Brain MRI is often used in the setting of an acute illness 
but may be delayed in slowly progressive disease. Imaging appearance can be 
confusing as acute and chronic signal intensity alterations may overlap in many 
disorders. Furthermore, imaging appearance will vary during the course of the 
disease. Recognition of signal changes in specific structures is most helpful in the 
acute setting before chronic changes set in, which will blur characteristic patterns. 
A systematic approach based on the pattern of brain involvement is useful in the 
analysis of neurometabolic disorders, and has even been computerized. First, a 
decision whether grey or white matter involvement or both must be made based 
upon volume and signal alterations on T1-wi, T2-wi, FLAIR imaging and contrast 
enhancement. Second, alterations within either focal grey matter structures or 
specific white matter tracts must be recorded and estimation upon their timing, 
whether acute or chronic, must be made. Finally, this pattern recognition must be 
supplemented by microstructural data from diffusion-weighted images (DWI) and 
metabolic data from proton MR spectroscopy (MRS). Additional information from 
DWI is often restricted to the acute setting, because chronic diffusivity changes are 
mainly driven by unspecific myelin breakdown. On the other hand, MRS may not 
only identify abnormal levels of normal metabolites or demonstrate the presence 
of abnormal metabolites, but can also be used to monitor therapy. 
Learning Objectives:
1.  To become familiar with the imaging findings of the most important innate 
metabolic defects affecting CNS.
2.  To learn how to recognise patterns of gray and white matter involvement.
3.  To learn about specific discriminating imaging findings.
the importance of a rational and integrated imaging approach will be pointed out 
and, finally, the role of the radiologist in emergency room will be emphasized. 
Learning Objectives:
1.  To become familiar with the most important imaging findings and their impact 
on patient management.
2.  To understand common classification systems, trauma scoring systems and 
their impact on patient management.
3.  To learn about typical and atypical imaging findings.
A-221 09:20
C. Extremities 
U. Linsenmaier, L.L. Geyer; 
Munich/DE (Ulrich.Linsenmaier@kliniken‑pasing‑perlach.de)
Extremity injuries in patients after polytrauma can be complex and are initially often 
difficult to be fully diagnosed. Emergency radiology diagnosis is mostly based on 
a standardised whole body CT (WBCT), which can be extended and adapted to 
cover extremity injuries. Extremityinjuries comprise: fractures off (1) long bones, 
(2) articular joints, (3) complex fractures of hands and feet, (4) vascular, (5) soft 
tissue, (6) nerve and plexus injuries and (7) amputations. Imaging protocol: extrem-
ity MDCT is indicated in all major and complex bony fractures, carried out early or 
integrated with WBCT, CTA MIPs and MPRs enable a thorough workup.The role 
of US and CR is limited. Secondary imaging procedures comprise MR, MRA (in 
stable patients only) to evaluate instable articular injuries, injuries of tendons or 
major ligaments and nerve and plexus injuries) and DSA (for intervention). Clinical 
findings and findings from WBCT determine how to proceed, “first things first” in a 
priority oriented clinical algorithm. Treatment of extremity injuries must be priority 
oriented and carefully planned in the context of possible concurrent injuries, and 
a possible risk of multi-organ failure (MOF).
Learning Objectives:
1.  To become familiar with imaging strategies, the role of CR, CT and MR.
2.  To understand common classification systems and their impact on patient 
management.
3.  To learn about typical and atypical imaging findings.
Panel discussion: 
How to speed up your diagnoses? 09:40 
08:30 - 10:00 Room E2 
Foundation Course: Neuroimaging 
E³ 820b 





B. Gómez-Ansón; Barcelona/ES (bgomeza@santpau.cat) 
Cognitive decline and dementia consitute an increasingly important public health 
issue in Europe and worldwide. Our insight in several of these conditions has in-
creased. Thanks to knowledge gained in brain imaging. Also, imaging plays a crucial 
role in early, and differential diagnosis of dementia conditions. Recently, surrogate 
markers with imaging have been described in research literature, that can aid in 
treatment response and prognosis. Different techniques, such as CT, MRI, SPECT 
and PET with different tracers provide various types of information, and thus may 
have an added value to patient management. As progress is made, controversies 
arise about the most efficient use of imaging tools in clinical practice at different 
levels of health care, and especially in European countries with universal coverage. 
This lecture will deal with these various aspects. Recommendations and guidelines 
to investigate patients with dementia with imaging, and the added value of knowl-
edgeable radiologists will be discussed. Some of the imaging findings in the most 
common neurodegenerative dementias such as AD, and FTLD will be covered. In 
addition, due to recent advances in the field, the following contributions of imaging 
in knowledge about, and in clinical practice in dementia will be presented in more 
detail: 1) Reportable causes, such as prion disease and other rapidly progressive 
dementias; 2) Vascular involvement in dementias: vascular/mixed type dementia, 
and amyloid angiopathy; and 3) Ventricular dilatation and NPH.
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B. Non-mass like enhancement (NMLE): when to biopsy? 
C.K. Kuhl; Aachen/DE (ckuhl@ukaachen.de) 
Non-mass-like enhancement is a frequent finding in breast MRI. It relates to the 
fact that enhancement occurs in the normal-appearing fibroglandular tissue that 
surpasses that of the other parts of the parenchyma. There is no associated space 
occupying lesion. In pre-contrast non-fat-suppressed or fat-suppressed T1- and 
T2-weighted images, there is usually no observable correlation. The differential 
diagnosis of non-mass-like enhancement is between benign non-specific fibrocystic 
disease/adenosis, hormonal stimulation, and subclinical mastitis on one hand versus 
DCIS or (less likely) diffusely infiltrating (usually lobular) cancer on the other. Key 
components of differential diagnosis is configuration of the enhancement (does it 
follow the orientation of the milk duct or not?) and symmetry (symmetric or asym-
metric). Less important criteria are internal enhancement (internal architecture) 
and enhancement kinetics. It is important to realize that enhancement kinetics 
can only be used to corroborate the suspicion of DCIS - but they cannot be used 
to alleviate the indication to biopsy a finding which, based on configuration and 
asymmetry, is suspicious. Management depends on the different constellation of 
clinical, mammographic, and MRI findings. It usually includes short-term follow-up 
(6 months) and, if stable/persistent, MR guided vacuum biopsy.
Learning Objectives:
1.  To learn about the clinical significance of NMLE.
2.  To understand differential diagnosis for NMLE.
3.  To become familiar with a work-up algorithm of NMLE cases.
A-228 09:21
C. Monitoring response to neo-adjuvant chemotherapy 
T.H. Helbich; Vienna/AT (Thomas.Helbich@meduniwien.ac.at) 
Assessment of the change in tumour burden is an important feature of the clinical 
evaluation of cancer therapeutics. Tumour shrinkage and time to the development 
of disease progression are important end-points in cancer clinical trials. However, 
these end-points are useful only if they are based on widely accepted and read-
ily applied standard criteria. Criteria, known as RECIST, were published and are 
updated on a regular base. The revised RECIST includes a new imaging appendix 
and underlines the importance to move from anatomic unidimensional assessment 
to either volumetric anatomical assessment or to functional assessment with PET 
or MRI. The goal of the lecture is to discuss the value of the different MR imaging 
techniques (e.g. MR spectroscopy, diffusion-weighted imaging, angiogenesis map-
ping, PET-MRI) that evaluate response to treatment in breast cancer. Participants 
will learn about particular imaging challenges of assessing response to neo-adjuvant 
chemotherapy. In addition, they will learn to understand clinical aspects of neo-
adjuvant chemotherapy based on RECIST. 
Learning Objectives:
1.  To understand the clinical aspects of neo-adjuvant chemotherapy.
2.  To appreciate evidence-based protocols for imaging in this clinical setting.
3.  To learn about particular imaging challenges of assessing response to neo-
adjuvant chemotherapy.
Author Disclosure:
T. H. Helbich: Advisory Board; Phillips, Hologic. Grant Recipient; SIEMENS. 
Panel discussion:  
How can the specificity and sensitivity of breast MRI in these 
indeterminate clinical and imaging scenarios be maximised? 09:44 
08:30 - 10:00 Room F2 
Special Focus Session 
SF 8b 




S.A. Jackson; Plymouth/UK (simon.jackson1@nhs.net) 
During the past two decades, gastrointestinal imaging has undergone a number 
of exciting and rapid technological advances resulting in new areas of clinical 
application in the management of patients with GI and abdominal pathology. This 
evolution has included both improvements in speed and diagnostic accuracy of 
08:30 - 10:00 Room F1 
Breast 
RC 802 
Clinical challenges in breast MRI 
A-225 08:30
Chairman’s introduction 
F.J. Gilbert; Cambridge/UK (fjg28@cam.ac.uk) 
Breast MRI is now recognised as one of the most useful breast imaging techniques. 
In this session we adress the use of MRI as a screening tool in the high risk popula-
tion. The high sensitivity of dynamic contrast enhanced MRI together with the high 
negative predictive value make this a worthwhile test that should be implemented in 
clinical practice. Diffusion weighted imaging is now used diagnostically and could be 
considered in the screening situation. The advantage is no requirement for contrast 
and the rapidity and lower cost of the test. However further trials are needed to 
confirm this as a screening tool. Non mass like enhancement is an interpretation 
challenge in breast MRI. Often there is confusion between normal parenchymal 
enhancement and that of a more sinister pathology such as lobular cancer or DCIS. 
This presents difficulties for the radiologist. This talk gives guidance as to the cor-
rect interpretation of this feature and advises on further management. The use of 
MRI in the management of patients having neo-adjuvant vchemotherpy is widely 
accepted. Baseline examinations to assess the disease extent and subsequent 
examinations to establish size or volume changes together with a pre-operative 
examination to facilitate surgical planning are well accepted. The use of functional 
information that is available is less well established. Analysis of the DCE data 
can predict repsonse after one or two courses of treatment and the ADC values 
at baseline can be prognostic. Baseline choline measurements can also be of 
prognostic value with a low measure predicting a good response. 
Author Disclosure:
F. J. Gilbert: Equipment Support Recipient; GE. Grant Recipient; Philips. 
Speaker; Bracco. 
A-226 08:35
A. High risk patients: establishing clinical protocols 
J. Veltman; Almelo/NL (j.veltman@zgt.nl) 
Contrast-enhanced MRI has, especially in younger women with dense breasts, 
a superior sensitivity for detecting breast cancer. Young women usually do not 
need screening unless they have an increased risk for developing breast cancer. 
An increased risk can be based on a positive familial history or based on a proven 
gene-mutation. The BRCA1 and BRCA2 gene mutations are the most well known 
gene mutations related to an increased breast cancer risk. In this group, false 
negative rates up to 62% have been reported for mammography. Several papers 
have demonstrated the value of contrast-enhanced MRI in high risk screening for 
early detection and even demonstrated a more favourable lymph node status for 
these women. An upcoming MRI technique for detecting and classifying breast 
lesions is diffusion-weighted imaging (DWI). The main advantages of DWI are 
the short examination time and that no contrast is needed. In literature, DWI has 
demonstrated great diagnostic potential. Especially, high sensitivities have been 
reported (80%-97.8%). The specificity and spatial resolution are however still 
moderate. The high sensitivity values reported do give DWI potential to become 
a fast, non-contrast, and therefore relatively cheap, highly sensitive screening 
technique. At this point, contrast-enhanced MRI is the best available modality for 
the detection of breast cancer in women with an increased risk. The detection of 
smaller lesions, the patient anxiety, the often benign morphologic characteristics 
seen in cancers and the often aggressive nature of breast cancer in young women 
should lower the threshold for MRI-guided-biopsies significantly.
Learning Objectives:
1.  To become familiar with the literature on the role of breast MRI in screening 
of high risk patients.
2.  To understand current protocols in clinical practice.
3.  To appreciate the challenges of breast MRI imaging in this patient group.
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A-232 09:21
MR imaging of GI tract motility 
S.A. Taylor; London/UK (csytaylor@yahoo.co.uk) 
Rapid sequence MRI now allows capture of intestinal motility. In particular with 
sub-second image acquisition, it is possible to image bowel peristalsis and func-
tion. The technique can be applied anywhere from the mouth to the colon, but 
most work has focussed on gastric imaging and increasingly for the assessment of 
small bowel motility. MRI evaluation of gastric emptying has been validated against 
barostat measurements and scintigraphy, and is has entered clinical practice in the 
evaluation of gastric function both in disease and in response to pharmacokinetic 
stimulation. Repeat measurement of gastric volume is used to calculate emptying 
times while rapid sequences such as TRUEFISP facilities evaluation of peristaltic 
activity. Validating MRI assessment of small bowel motility is more complex-there 
is no simple standard if reference. Nevertheless, increasing data confirms the 
ability of MRI to detect abnormal small bowel motility, particularly in the context of 
Crohn’s disease, and following drug stimulation or inhibition. Software solutions 
are being developed which can quantify intestinal motility captured using MRI. This 
presentation will describe basic MRI protocols for assessing motility, introduce how 
software can be used to quantify activity, outline current areas of research and 
explore how the technique can be used in clinical practice.
Learning Objectives:
1.  To learn about the MRI protocols that can best assess bowel motility.
2.  To understand the various software approaches to quantifying bowel motility.
3.  To become familiar with how motility MRI can be used in clinical practice.
Panel discussion:  
When should we integrate these technological advances into our 
routine practice? 09:44 
08:30 - 10:00 Room G/H 
EFOMP Workshop 
New technology in diagnostic radiology: new frontiers in imaging 
of the lung
EF 1 






J.I. Bilbao1, P. Sharp2; 1Pamplona/ES, 2Aberdeen/UK (jibilbao@unav.es) 
A-234 08:40
Radiologist’s point of view: clinical and technical requirements for 
imaging of the lung 
H.-U. Kauczor; Heidelberg/DE (Hans‑Ulrich.Kauczor@med.uni‑heidelberg.de) 
Lung imaging has recently shown a series of groundbreaking technological de-
velopments. They especially involve CT, MRI, and PET, and are mainly related to 
high imaging speed; gating techniques; signal enhancement technologies including 
new contrast agents and mechanisms, as well as new probes and targets. Some 
years ago, MRI paved the way for comprehensive imaging of structure and func-
tion in lung disease. Such protocols targeted perfusion, ventilation, V/Q ratio; gas 
exchange, vascular permeability, blood flow, shunt; haemodynamics, heart function, 
lung volumes, respiratory motion and mechanics. Recent developments, such as 
„Interpolated volume imaging“ with high spatial resolution; contrast enhancement; 
single and multiphasic MR angiography; diffusion-weighted and diffusion tensor MRI 
sequences; multidirectional blood flow measurements; angiogenesis imaging and 
high-resolution ventilation imaging with hyperpolarized 129Xenon gas are the main 
drivers for broader translational and clinical implementation. In the meantime, CT 
has demonstrated a surprising development towards a complex quantitative imaging 
technology with fast progress in iterative image reconstruction, post-processing, 
registration algorithms as well as multi-energy CT, such as imaging of ventilation 
by inhaled Xenon gas. Beyond the modality-driven radiological view onto the future 
direction of pulmonary functional and molecular imaging, the objectives are shifting 
from morphology, e.g. size, volume, shape onto function, metabolism and molecular 
interactions as well as on multilevel analysis of tissue composition. Thus, future 
the cross-sectional imaging modalities but also the emergence of new functional 
and quantitative techniques. In particular, the role of both the non-ionising radiation 
modalities of ultrasound and MRI as well as developments in MDCT have led to 
significant improvements in the assessment of anatomy, organ function and disease 
activity as well as the emerging concept of personalised imaging. This session 
will review the place of these technological advances with cutting edge, in-depth 
lectures presented by international GI radiology experts assessing the current 
and future imaging applications in the management of patients with GI disease. 
Session Objectives:
1.  To review the significant recent advances in GI imaging.
2.  To understand the place of these advances in the clinical imaging of patients.
3.  To summarise the future directions of GI radiology in the 2 1st century.
A-230 08:35
CEUS of the bowel wall: when and how 
F. Maccioni; Rome/IT (francesca.maccioni@uniroma1.it) 
Contrast-enhanced ultrasound (CEUS) may play a relevant role in the evaluation of 
bowel wall microvascularity particularly in Crohn’s disease (CD), although strictly in-
dicated for characterisation of liver lesions only. CEUS of the bowel requires the use 
of harmonic technology and specific softwares. Post-processing includes analysis 
of TTP (time to peak), time-intensity curve and patterns of contrast-enhancement 
distribution within the bowel wall (inward, outward). Ultrasound contrast agents 
for intravenous use are made of a suspension of micro-bubbles (mean diameter 
3.0 -3.5 μm) passing through the pulmonary microcirculation. They are safe and 
do not require laboratory tests before their administration, not being nephrotoxic. 
Advantages in the evaluation of CD include the possibility to evaluate degree, 
characteristics and dynamics of contrast-enhancement of diseased intestinal 
segments without radiation exposure. Dynamics and patterns of enhancement 
have been correlated to CD activity with good sensitivity and specificty. CEUS as-
sessment of microvascular changes before and after pharmacological treatment 
may be valuble to monitor therapeutic effects. On the other hand, CEUS cannot 
provide information on the entire small and large bowel, because of its limited field 
of view. Only a few centimeters of diseased bowel, usually the terminal ileum, may 
be investigated, while CD frequently involves longer intestinal segments of small 
and large bowel. Therefore, the choice of the segment to analyze with CEUS is 
crucial. A limited evaluation may impair the final evaluation. CEUS of the bowel 
should be considered an advanced but focused diagnostic tool, to use after a 
comprehensive intestinal evaluation.
Learning Objectives:
1.  To review the relevant clinical indications for CEUS of the bowel.
2.  To learn how to optimally perform a CEUS examination of the bowel wall.
3.  To appreciate important findings in patients with IBD and learn how to evaluate 
inflammatory activity of the bowel wall.
A-231 08:58
Dual-energy (spectral) CT: GI applications 
P. Rogalla; Toronto, ON/CA (Patrik.Rogalla@uhn.on.ca) 
Dual-energy CT refers to the use of CT data representing two different energy 
spectra to display anatomy and pathology in addition to differentiating and clas-
sifying tissue composition. First applications are dating back to several decades 
ago, however, only recent technological advances in rapid data acquisition allowed 
for virtually simultaneous recording of two spectra: dual-source, rapid kV switch-
ing, dual energy helical or volume scanning, and dual-layer detector technology. 
Bowel peristalsis obviates the need for quasi simultaneous data recording to avoid 
misregistration. Nevertheless, clinical applications of dual-energy of the GI tract are 
sparse but exciting: mesenteric ischaemic disease, bleeding, Crohn’s disease, and 
CT colonography including digital cleansing and polyp detection using CAD. Beyond 
the fascinating technology, the challenging question however remains: is there an 
incremental value over single energy CT that translates into better patient care? 
Learning Objectives:
1.  To review the concept and technique of dual-energy CT.
2.  To understand the clinical application of dual-energy CT in GI imaging.
3.  To appreciate the additional benefits of the technique in routine clinico-
radiological practice.
Author Disclosure:
P. Rogalla: Research/Grant Support; Toshiba Medical Systems. 
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Patterns in chest radiology: are there subtype 
patterns of ground glass opacity (GGO)? 
A-237 08:30
Chairman’s introduction 
A. Oikonomou; Alexandroupolis/GR (aoikonom@med.duth.gr) 
Ground-glass opacity (GGO) is characterised on HRCT by the presence of a hazy 
increase in lung opacity that does not cause obscuration of underlying bronchial 
and vascular margins. Although a very common finding, it also constitutes a very 
non-specific term since it can be seen in a variety of different intraalveolar and 
interstitial processes with different histology including inflammatory, infectious and 
neoplastic diseases that have a common physiologic mechanism: partial displace-
ment of air. GGO may even be seen in normal processes such as poor ventilation 
in dependant lung areas and in expiration. Moreover, GGO can represent either 
an ongoing, active and potentially treatable disease or an irreversible process. In 
order to interprete correctly this highly non-specific but very significant finding, it 
is crucial to attempt to further classify the different large main entities in which this 
radiologic finding appears. Are there specific radiologic and HRCT findings that can 
help us differentiate GGO in autoimmune-inflammatory conditions from infectious 
and neoplastic processes? Are there associated findings other than GGO - such as 
nodules, reticulation or focal disease and distribution of findings that can narrow the 
differential diagnosis? Systematic evaluation of GGO and associated findings as 
well as integration with clinical information (acute, subacute or chronic symptoms) 
is essential in defining GGO subtypes in order to improve radiologic diagnosis. 
Session Objectives:
1.  To learn about the prevalence and low specificity of GGO.
2.  To appreciate the need for definition of GGO subtypes to improve radiological 
diagnoses.
A-238 08:35
A. Ground glass opacification: why do we see it and what does it mean? 
S.R. Desai; London/UK (sujal.desai@nhs.net) 
Radiologists who regularly review high-resolution CT (HRCT) should be aware of 
the range of patterns and, more importantly, their potential pathological meaning. 
A pattern of ground-glass opacification is one of the more common HRCT findings 
but, to the unwary, its interpretation can be problematic. An important underlying 
principle is that a ground-glass pattern may be caused by any process - physiologi-
cal or pathological - which partially displaces air. Physiological (i.e. non-disease 
related) ground-glass opacification is perhaps most commonly seen in subjects 
who, for whatever reason (e.g. breathlessness, obesity), are unable to maintain 
or achieve a satisfactory inspiratory effort during scanning. A generally increased 
lung density (in contrast to adults) is also a feature in infants and young children 
simply because there are fewer alveoli in the developing lung. Finally, it is worth 
noting that intravenous contrast administration (presumably because of a relative 
but temporary increase in capillary blood volume causing partial displacement of air) 
can unpredictably increase lung density. Disease processes which lead to partial 
filling of the air spaces, thickening of the interstitium, partial collapse of alveoli and/or 
an increased capillary blood volume will also manifest as a pattern of ground-glass 
opacification. In clinical practice, the recognised causes of ground-glass opacities 
on HRCT include pulmonary oedema (cardiogenic or otherwise), infections (e.g. 
pneumocystis jiroveci pneumonia) and some of the idiopathic interstitial pneumonias 
(e.g. non-specific interstitial pneumonia and respiratory bronchiolitis-associated 
interstitial lung disease). The presentation will review and revise the causes of 
physiological and disease-related ground-glass opacification on HRCT.
Learning Objectives:
1.  To appreciate the different physiological conditions which cause GGO pattern.
2.  To learn about the associations and reversibility of physiology-related GGO.
endpoints of pulmonary imaging might be: inflammation, homeostasis and energy 
balance, real-time visualisation of lung function: „Watch the lungs work“; imaging 
tumour biology and phenotype/genotype correlation. 
Learning Objectives:
1.  To comprehend the new approaches towards functional and molecular lung 
imaging.
2.  To understand their potential in comprehensive and quantitative lung imaging.
3.  To become familiar with new applications of structural functional and molecular 
imaging in lung disease.
Author Disclosure:
H. -U. Kauczor: Advisory Board; Siemens. Investigator; Boehringer Ingelheim. 
Speaker; Siemens, Boehringer, Bayer, Bracco. 
A-235 09:10
Respiratory motion correction in lung imaging 
J.A. Schnabel; Oxford/UK (julia.schnabel@eng.ox.ac.uk) 
Lung imaging poses challenging problems for diagnostic image interpretation and 
treatment planning due to motion corruption caused by respiratory motion and 
inconsistent breath holds. This is particularly true for multi-modality lung imaging, 
where complementary information provided by different scanning systems cannot 
be adequately fused without prior motion compensation. We present recent meth-
odological advances for respiratory motion correction in single- and multi-modality 
lung imaging. We have developed a range of non-linear registration methods, 
which are suitable for CT-CT lung registration, taking the complex sliding motion 
of the lungs into account. In addition, we have designed a modality-independent 
shape descriptor (MIND) suitable for MR-CT lung registration and reconstruction. 
Finally, we have made advances in registering diagnostic CT volumes to PET/
CT acquisitions, combining sliding motion with rigid/non-rigid motion modelling. 
We have applied our lung registration framework including 10 patients with em-
pyema, imaged using CT and MR; 10 patients with lung cancer scanned with CT 
over time; and 10 patients with lung cancer scanned with diagnostic CT and PET/
CT. Using clinically annotated landmark locations, we find a sub-voxel accuracy 
alignment and improved overlaps of the lungs after registration, compared to more 
conventional lung registration methods. Recent advances in non-linear registration 
of single- and multi-modality lung imaging have shown that respiratory motion can 
be compensated for, paving the way for more accurate clinical diagnosis and more 
effective treatment planning. 
Learning Objectives:
1.  To comprehend the problem of motion corruption and difference in breath 
holds in lung imaging.
2.  To become familiar with state-of-the-art motion correction methods in single- 
and multi-modality lung imaging.
3.  To understand the concept of modelling complex sliding motion of the lungs.
A-236 09:35
Role of tomosynthesis in lung imaging 
M. Båth; Gothenburg/SE (magnus.bath@vgregion.se) 
Tomosynthesis is an imaging technique that in recent years has become avail-
able for lung imaging. Using low-dose projections of the chest, acquired over a 
limited angular range, an arbitrary number of section images can be reconstructed, 
enabling the chest to be visualised in millimetre-thick slices at a very low effective 
dose. Compared to conventional chest radiography, the disturbance of overlapping 
anatomy (the main limiting factor for detection of pathology, e.g. pulmonary nodules 
in chest radiography) is considerably reduced in chest tomosynthesis. Early evalu-
ations have also shown that the detectability of pulmonary nodules is significantly 
higher in chest tomosynthesis than in conventional radiography. However, compared 
to computed tomography (CT) the limited angular range used in tomosynthesis 
results in a reduction in depth resolution, not allowing tomosynthesis to reach 
the same detection rate as can be obtained with CT. Especially, pathology in the 
subpleural region may be more difficult to interpret. Nevertheless, most lesions 
are visible in retrospect on chest tomosynthesis, suggesting that the technique 
may be suitable for follow-up. This presentation will summarise early evaluations 
and reported clinical experiences of the technique, as well as describe some of 
its strengths and limitations. 
Learning Objectives:
1.  To understand the technical principles of chest tomosynthesis.
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A. CTA and MRA of supra-aortic arteries 
J.H. Gillard; Cambridge/UK (jhg21@cam.ac.uk) 
There have been considerable advances in the imaging tools available for imaging 
the supra aortic vessels, specifically the carotid arteries. Developments ranging 
from rotational DSA (allowing for accurate delineation of vascular disease) to 
improvements in CTA and MRA (particularly Gadolinium-enhanced studies) have 
greatly improved our diagnostic armamentarium. In addition, there is increased 
understanding that atheromatous disease localised to the carotid bifurcation is 
only part of the problem with cerebrovascular disease. Increased coverage of 
the arch and intracranial circulation are becoming increasingly important requir-
ing greater spatial coverage. In the future, imaging of the wall components may 
become important. For the moment, however, management remains dependent 
on the accurate assessment of luminal stenosis. The greatest evidence suggests 
that contrast-enhanced MRA is the investigation of choice. However, CTA is ex-
tremely popular especially with clinicians, particularly as it allows algorithms for 
including or excluding calcification. There is a lesser evidence base, although the 
relentless progress of technology such as dual beam techniques makes it difficult 
to provide timely evidence. There are pros and cons for all methodologies, which 
will be addressed.
Learning Objectives:
1.  To learn about a structured reporting approach to angiographic studies of 
supra-aortic arteries.
2.  To understand the role of post-processing techniques and quantitative analysis 
of arterial stenosis.
3.  To be able to answer specific clinical questions about supra-aortic arterial 
occlusive diseases.
A-242 09:00
B. CTA and MRA of thoracic and abdominal aorta 
H.J. Michaely; Mannheim/DE (henrik.michaely@umm.de) 
This refresher course will review pertinent and state-of-the-art techniques for angi-
ographic imaging of the aorta with Magnetic Resonance Imaging and Computed 
Tomography Imaging. Clinical protocols and applications will be presented based 
on specific pathologies and key findings which should be included in every report 
will be highlighted. Where necessary radiologic-pathologic correlations and clas-
sifications are presented.
Learning Objectives:
1.  To learn about a structured reporting approach to aneurysmal and obstructive 
diseases.
2.  To learn the classifications of aneurysmatic aortic diseases.
3.  To understand the role of post-processing techniques in aortic diseases.
4.  To be able to answer specific clinical questions about aortic diseases.
Author Disclosure:
H. J. Michaely: Speaker; Siemens Healthcare Sector. 
A-243 09:30
C. CTA and MRA of peripheral arteries 
T. Leiner; Utrecht/NL (t.leiner@umcutrecht.nl) 
CTA and MRA are highly valuable imaging techniques in the diagnostic and inter-
ventional workup of patients with (suspected) peripheral arterial occlusive disease. 
In this part of the refresher course, the role of CTA and MRA in the diagnostic and 
interventional pathway of patients with suspected peripheral arterial occlusive 
disease will be discussed, also relative to the role of more widely available tech-
niques such as duplex ultrasonography. An important focus of the presentation 
will be how to report relevant findings in a structured and coherent fashion to the 
referring clinician. The role of source image review and advanced postprocessing 
techniques to detect and to visualize clinically relevant features to optimally facilitate 
interventional radiological and surgical treatment will be discussed in detail. In this 
A-239 08:58
B. Inflammatory and infectious GGO 
K. Marten-Engelke; Göttingen/DE (kmarten@med.uni‑goettingen.de) 
Ground-glass opacity (GGO) is defined as increased attenuation of the lung paren-
chyma without obscuration of the pulmonary vascular markings on CT images. GGO 
may be the result of a variety of interstitial and alveolar infectious and non-infectious 
inflammatory diseases. As an imaging finding alone, GGO does usually not allow 
a specific diagnosis. GGO in inflammatory disorders often will be present in the 
company of other interstitial or alveolar findings. However, the number of diseases 
that cause diffuse-isolated GGO or GGO as the predominant finding is relatively 
small and can be prioritised with clinical information. The most common cause of 
diffuse-isolated GGO in immunocompromised hosts are a variety of diffuse, oppor-
tunistic pneumonias, e.g. pneumocystis jiroveci pneumonia (PCP), cytomegalovirus 
pneumonia (CMV) or herpes simplex pneumonia (HSV), that constitute the first 
differential. Chronic onset disorders in immunocompetent patients include cellular 
non-specific interstitial pneumonia (NSIP), subacute hypersensitivity pneumonitis 
(HP), organising pneumonia, air-space sarcoid and drug-induced lung disease. 
In these disorders, ancillary findings such as an associated reticular pattern with 
traction bronchiectasis/bronchiolectasis (NSIP), mediastinal lymphadenopathy 
(sarcoidosis), superimposed nodularity or cysts may help to refine the diagnosis. 
In patients with collagen vascular disorders, e.g. scleroderma, GGO secondary to 
pulmonary involvement needs to be differentiated from drug-induced lung disease. 
This refresher course will put GGO in the context of outpatients versus inpatients, 
the acuity of clinical symptoms, e.g. fever, cough and dyspnoea, signs of massive 
systemic inflammation, and the clinical situation such as inhalational history, pneu-
motoxic drug administration, immunocompromisation, or bone marrow-suppression.
Learning Objectives:
1.  To learn more about the inflammatory conditions which cause GGO.
2.  To appreciate the histopathological correlates of inflammatory and infectious 
GGO.
3.  To become familiar with GGO in autoimmune and infectious lung disease.
A-240 09:21
C. GGO in dysplasia and neoplasia 
G.R. Ferretti, S. Lantuejoul; Grenoble/FR (GFerretti@chu‑grenoble.fr) 
In this course, we will review the dysplastic and neoplastic conditions that are 
associated with persistent GGO in the lung parenchyma. We will separate these 
conditions into those that are responsible for localised diseases such as single 
nodular GGO and those responsible for more extended diseases. Nodular GGO 
can be separated into pure or mixed or part-solid nodules. Pathology-radiology 
correlations showed that Nodular GGO are related to atypical adenomatous hyper-
plasia (AAH), adenocarcinoma (ADC) in situ (AIS), minimally invasive ADC (MIA), 
and invasive ADC according with the new IASLC/ATS/ERS lung adenocarcinoma 
classification. Differential diagnosis include exceptional metastases of angiosar-
coma and melanoma as well as infection, inflammation and localised fibrosis. Dif-
fuse GGO related to neoplastic conditions is rare and may be due to lepidic ADC 
(former advanced ADC with BAC component), diffuse large B-cell non-Hodgkin’s 
Lymphoma, Intravascular lymphomatosis (IVL), mucosa-associated lymphoid tissue 
(MALT) lymphoma. These neoplastic diseases should be differentiated from infec-
tious and inflammatory causes of diffuse GGO. We will review the value of different 
morphological CT criteria in order to differentiate benign from malignant localised 
GGO such as the size, the morphology (round, oval, flat), presence of mixed versus 
pure GGO, and the multiplicity of nodular shadows. Discussion will also include the 
changes that may occur within the nodule as well as the mean doubling time. The 
role of PET CT and trans-thoracic biopsy will be discuss. Finally, we will present 
the current recommendations regarding the management of nodular GGO.
Learning Objectives:
1.  To learn more about the dysplastic and neoplastic conditions causing GGO.
2.  To appreciate the histopathological correlates of dysplastic and neoplastic 
GGO.
3.  To understand how to estimate malignancy on the basis of GGO pattern.
Panel discussion: 
How should we report and manage ground glass opacity? 09:44 
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B. EVAR techniques and results 
F. Fanelli; Rome/IT (fabrizio.fanelli@uniroma1.it) 
Abdominal aortic aneurysm (AAA) is a relatively common disease among the 
elderly population. AAA, more than 5 cm in diameter, is generally prone to rupture 
with a mortality rate up to 63%. Stent-grafts’ expected characteristics are related 
to low profile, adequate flexibility, kink resistance, longitudinal strength, easy and 
precise deployment, reliable fixation system, low permeability and modularity for 
customization of limb length. Endoleak is the most frequent complication of EVAR. 
Type I and III require immediate treatment for the continuous pressure present 
within the sac. Type II is necessary when the sac increases. Aortic stent-grafts can 
be successfully positioned in more than 90 % to 95 % of cases. A cause of failure 
may be the inability to insert the device through a severely diseased or tortuous 
iliac artery. Device misplacement or migration are rare but dangerous and require 
surgical conversion. EUROSTAR reports operative complications can be grouped 
into three categories: failure to complete the procedure (2.5 %); device or procedure 
related complications (10 %); arterial complications (3%). The incidence rate of 
systemic complications within the first 30 days is 18 %. Mortality within 30 days 
after operation is 2.6 %. The recent introduction of fenestrated and branched aortic 
endografts has greatly broadened the management options of patients with aortic 
aneurysms. Consequently, the use of such devices is becoming widespread and 
thanks to technology clinical outcomes are proving quite satisfactory.
Learning Objectives:
1.  To understand indications and contraindications for EVAR.
2.  To know more about advantages of different types of stent-graft.
3.  To become familiar with percutaneous vascular access.
4.  To learn about the latest trials.
Author Disclosure:
F. Fanelli: Consultant; Medtronic, Ev3 - Covidien, WL Gore. Research/Grant 
Support; Cook. Speaker; Cook, Medtronic, WL Gore. 
A-247 09:21
C. Imaging follow-up and treatment of complications 
R. Morgan; London/UK (robert.morgan@stgeorges.nhs.uk) 
The first part of the lecture will discuss the optimal imaging protocol for follow-up 
after endovascular aneurysm repair. The merits of CT versus ultrasound versus 
MRI will be discussed. In the second part, the material will focus on the different 
types of complications after EVAR and their management. This will include the 
management of type 1a and 1b endoleaks, the embolisation of type 2 endoleaks 
by both the transarterial and the direct sac puncture routes, iliac limb problems, 
endograft migration and component separation.
Learning Objectives:
1.  To learn about available imaging methods for follow-up.
2.  To become familiar with complications and failure of EVAR.
3.  To understand how to treat endoleaks.
Author Disclosure:
R. Morgan: Advisory Board; Angiodynamics. Consultant; William Cook, Europe, 
Covidien. 
Panel discussion:  
What are the best imaging methods for follow-up? 09:44 
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A. Modern views on value of coronary calcium scoring for risk assessment 
A. Stadler; Vienna/AT (alfred.stadler@meduniwien.ac.at) 
The assessment of the amount of arterial calcification with computed tomography 
is a standard method in the risk stratification of coronary heart disease. Coronary 
calcium detection by CT has been shown to identify atherosclerotic plaque and to 
quantitatively assess coronary calcium. Many studies have demonstrated the as-
presentation, the relative merits and shortcomings of both techniques in specific 
patient populations will also be discussed.
Learning Objectives:
1.  To learn about a structured reporting approach to peripheral arterial obstructive 
diseases.
2.  To understand the importance of quantitative analysis of peripheral arterial 
obstructions and how to report these analyses.
3.  To be able to answer specific clinical questions about peripheral arterial dis-
eases.
Author Disclosure:
T. Leiner: Grant Recipient; The Netherlands Organisation for Health Research 
and Development. Research/Grant Support; My department receives research 
support from Philips Healthcare, Bracco, Bayer Healthcare. Speaker; Philips 
Healthcare, Bracco, Bayer Healthcare, GE Healthcare, Lantheus Medical. 
08:30 - 10:00 Room N/O 
Interventional Radiology 
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H. Rousseau, J. Auriol, C. Lions, F. Mokrane; Toulouse/FR 
(rousseau.h@chu‑toulouse.fr) 
Endovascular aneurysm repair (EVAR) is a well-established technique for the 
treatment of abdominal aortic aneurysms (AAA). Meta-analysis have demonstrated 
that it can reduce perioperative mortality, complications and hospitalization but 
patient selection, technical expertise, surveillance and complication detection and 
management are crucial to determine long-term performance of EVAR devices. 
Actually, profound knowledge of state-of-the-art imaging techniques and strong 
diagnostic and interventional imaging skills play a fundamental role. Whether it 
is patient assessment, the choice of the appropriate technique and follow-up, the 
outcome of interventional procedures will always be closely related to the efficiency 
of pre, peri and post-procedural imaging. There will be a discussion on imaging after 
EVAR, focusing on imaging techniques like CT, MRA and CEUS, just to name a few. 
Author Disclosure:
H. Rousseau: Consultant; GORE, MEDTRONIC, BOLTON.
A-245 08:35
A. Pre-therapeutic radiological evaluation 
J. Raupach, O. Renc, P. Hoffmann, J. Zizka; Hradec Kralove/CZ 
(janraupach@seznam.cz) 
Endovascular abdominal aortic aneurysm repair (EVAR) was introduced over 20 
years ago to primarily treat old and sick patients. Due to technical improvements 
and satisfactory clinical results of this technology, the number of patients treated with 
stent-grafts is steadily increasing. There is also tendency to use this therapy for rup-
tured abdominal aortic aneurysms. Pre-operative assessment of aortic morphology 
regarding suitability for stent-graft implantation is, therefore, an important challenge 
for every radiologist now. Main limitation of EVAR is unfavourable anatomy of landing 
zones and access vessels. Gold standard for EVAR planning is contrast-enhanced 
CTA. Alternative modality for patients with contraindications for CT, such as renal 
impairment, is unenhanced MR with steady-state free precession sequence. A 
number of 2D or 3D reconstructions are generated to provide information about 
the aneurysm morphology. Dedicated vessel analysis and planning software can 
be applied. Usually, axial images and thin MPR reconstructions are sufficient in 
emergent cases. Proper stent selection is a domain of operator and is still matter 
of his/her experience. The planning procedure can be subdivided into 4 different 
sections: infrarenal neck, aneurysmal sac, aortic bifurcation and access vessels. 
There are several critical and rules which must be obeyed during the evaluation 
process and general radiologists should be aware of. The presentation will review 
main inclusion and exclusion criteria for EVAR. 
Learning Objectives:
1.  To learn about the best pretreatment imaging modality.
2.  To understand planning and sizing of appropriate stent-graft.
3.  To become familiar with critical criteria and vessel morphology.
1
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2.  To understand the accuracy of myocardial perfusion in identifying ischaemia 
and its role in risk assessment.
3.  To learn the prognostic value of viability imaging in ichaemic heart disease.
08:30 - 10:00 Room Q 
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A. Craniocervical junction abnormalities 
B. Ozgen Mocan; Ankara/TR (burce@hacettepe.edu.tr) 
Craniocervical junction (CCJ) is defined as the region extending from the basioc-
ciput to the second cervical interspace. This region anatomically consists of the 
occiput, the first and second cervical vertebrae, surrounds the cervicomedullary 
junction and the lower cranial nerves. Evaluation of this region requires a basic 
knowledge of the anatomical landmarks and the normal osseous relationships. 
The radiologists must also be familiar with the CCJ craniometry that uses several 
lines, angles and measurements, such as Chaberlain’s line, McGregor’s line and 
Welcher’s basal angle. The CCJ pathology may result in clinical symptoms when 
there is compression of adjacent neurovascular structures or abnormal cerebrospi-
nal fluid dynamics and the symptoms may range from pain, vertigo to cranial nerve 
palsies. The discussion of CCJ pathologies often involves the terms platybasia, 
basilar invagination and basilar impression; terms that are often subject to confusion 
and misnaming. The disorders of this region include congenital malformations (as 
a component of a syndrome such as achondroplasia, Down syndrome or as an 
isolated developmental anomaly) as well as acquired conditions including inflam-
matory, infectious and neoplastic processes.
Learning Objectives:
1.  To learn about normal cervical junction development and anatomy.
2.  To understand congenital cervical junction anomalies.
3.  To appreciate acquired cervical junction pathology.
A-252 09:00
B. Inflammation, infection and tumours: the role of imaging 
M.I. Argyropoulou; Ioannina/GR (margyrop@cc.uoi.gr) 
Intramedullary and intradural-extramedullary tumours are less common than in-
tracranial tumours. Spinal cord enlargement and heterogeneous appearance with 
solid and cystic components represent the main characteristics of intramedullary 
tumours. Low-grade astrocytomas (pilocytic) are the most common followed by 
gangliogliomas. Extensive involvement of the spinal cord is common. Holocord in-
volvement and calcifications are most frequently seen in gangliogliomas. Paediatric 
intramedullary ependymomas are almost never seen outside the context of NF2. 
Metastatic disease due to CSF seeding of intracranial tumours (Medulloblastomas) 
represent the most common intradural-extramedullary tumours. Multiple intradural 
neurinomas and meningiomas are found in NF2. Inflammatory demyelinating dis-
orders may affect the cord and the spinal nerve roots in childhood. Guillain--Barre 
syndrome is an autoimmune acute demyelinating poly-radiculoneuropathy charac-
terised by either diffuse or ventral nerve root enhancement. Spinal cord lesions in 
multiple sclerosis (MS) are mainly located dorsolaterally, extend over less than two 
vertebral segments in length and affect less than half of the cross-sectional area 
of the cord. Spinal cord lesions in Acute disseminated encephalomyelitis (ADEM) 
extend over more than three vertebral segments in length and occupy more than 
two-thirds of the cross-sectional area of the cord. Differences in brain and spinal 
cord imaging findings are useful in the differential diagnosis between MS and ADEM. 
Spinal cord involvement similar to that found in ADEM may be found in idiopathic 
acute transverse myelitis (ATM) and in neuromyelits optica (NMO). Lack of brain 
involvement in ATM and the presence of the NMO specific IgG autoantibody are 
useful in the differential diagnosis with ADEM.
Learning Objectives:
1.  To learn about the etiologies and the imaging findings of infectious, para-
infectious and autoimmune disorders.
2.  To appreciate the role of spinal MRI in the differential diagnosis of multiple 
sclerosis vs its mimics.
3.  To become familiar with the imaging findings of primary and metastatic tumours.
4.  To learn about the indications of whole spine MRI with presence of brain 
tumours.
sociation between the degree of coronary calcium, the burden of atherosclerosis, 
and the risk for cardiovascular events associated with coronary calcium. The CAC 
scorning can provide individual risk assessment and can reclassify the low and 
particularly intermediate Framingham risk cohort into lower- and higher-risk strata. 
Absence of CAC is associated with a very low risk of future cardiovascular events, 
with modest incremental value of other diagnostic tests in this very low-risk group. 
The role of CAC in the work up of symptomatic patients is under discussion and 
there is evidence that the absence of CAC has a high negative predictive value 
for ruling out acute coronary syndrome. Although the CAC measurement is highly 
standardised, some technical aspects have to be considered, all possibilities of 
dose reductions have to be utilised. This presentation will show the technical and 
epidemiological fundamentals of CAC scoring and discuss the clinical applications 
of the method. 
Learning Objectives:
1.  To understand what kind of information calcium scoring can deliver and the 
appropriate indications.
2.  To become familiar with its role in an asymptomatic and in a symptomatic 
population.
3.  To learn about the current data and guidelines supporting its use for assess-
ment of cardiac risk.
A-249 09:00
B. Coronary CTA: from detection of stenosis to prognosis 
N.R. Mollet1, F. Cademartiri2; 1Turnhout/BE, 2Rotterdam/NL 
(nramollet@gmail.com) 
CT coronary angiography permits comprehensive assessment of coronary artery 
disease including detection of both significant stenosis and non-significant plaques, 
and their location and extent within the coronary tree. Plaques can be further divided 
into calcified, non-calcified or mixed plaques. Such comprehensive assessment 
of coronary artery disease may further improve risk stratification compared to 
assessment of the calcified plaque burden only. The vast majority of current pub-
lications investigating the prognostic value of CT coronary angiography included 
symptomatic patients. These studies have shown that CT coronary angiography 
has an independent prognostic value compared to traditional risk factors. Moreover, 
CT coronary angiography significantly improved currently used risk stratification 
models, e.g. the Framingham risk score alone or combined with calcium scoring. 
To date, data on the prognostic value of CT coronary angiography in asymptomatic 
individuals is scarce, mainly because of the relatively high radiation exposure 
using older 16- or 64-slice CT equipment. However, radiation exposure can be 
significantly reduced to values approaching these of traditional calcium scoring 
using more up-to-date CT scanner technology. The results of currently ongoing 
follow-up studies investigating the prognostic value of CT coronary angiography 
in high-risk, asymptomatic patients are needed to further establish its precise role 
in clinical decision making.
Learning Objectives:
1.  To understand the accuracy of CTA in the diagnosis of coronary disease.
2.  To become familiar with the strengths and limitations of the various quantifica-
tion techniques.
3.  To appreciate the prognostic value of CTA in coronary disease.
A-250 09:30
C. Myocardial perfusion and viability for risk scoring 
A. de Roos; Leiden/NL (A.de_Roos@lumc.nl) 
The combined evaluation of coronary anatomy, myocardial perfusion at rest/
stress as well as viability imaging using late gadolinium enhancement provides a 
comprehensive evaluation of ischaemic and non-ischaemic heart disease. Recent 
advances in myocardial perfusion imaging include demonstration of superior per-
formance over SPECT imaging, whole heart perfusion imaging and developments 
from visual to true quantitative perfusion analysis. Integrated coronary/perfusion/vi-
ability evaluation has great diagnostic as well as prognostic performance. Perfusion 
analysis provides highly relevant information on the haemodynamic significance 
of a coronary artery stenosis in correspondance to the invasive assessment frac-
tional flow reserve measurement. Myocardial perfusion may help to select optimal 
therapy in coronary artery disease. Dysfunctional, hibernating myocardium can be 
characterised by the combined assessment of perfusion (perfusion-contractility 
(mis)match), late gadolinium enhancement of scar transmurality and recovery of 
wall motion under low dose dobutamine stimulation. MRI evaluation of perfusion, 
scar, area at risk, wall motion at rest and under stress provides optimal data for 
improved risk stratification in various clinical scenarios.
Learning Objectives:
1.  To become familiar with the current status of CT and MRI for evaluation of 
myocardial perfusion and viability.
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ESR meets South Africa 
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C. Sperryn; Cape Town/ZA (csperryn@iafrica.com) 
In South Africa, HIV infection is a high risk factor for stroke in young patients. 
Prof Victor Mngomezulu will present HIV-related Cerebrovascular Disease: The 
South African experience. A systematic review of published literature from three 
major South African academic centres in the last 12 years. The concept of the 
Rich focus as the cause of tuberculous meningitis is controversial. Using original 
images from Arnold Rich’s work, as well as that of the South African physician JN 
Coetzee’s thesis on tuberculous meningitis, Dr Pieter Janse van Rensburg will 
illustrate why there is doubt as to the role of the Rich focus as the cause of basal 
cisternal tuberculous meningitis and propose a more likely pathogenetic mechanism 
based on radiological-pathological correlations using MR imaging. The incidence 
of tuberculosis (TB) is increasing in both developing and developed world, and 
is complicated by the emergence of multi-drug resistant disease and co-infection 
with HIV. Dr Tracy Kilborn will cover the varied presentations of TB in the spine 
and discuss the MRI features. South Africa has the highest global HIV prevalence, 
estimated at 5.6 million people, including 377,000 children. Prof Richard Pitcher de-
scribes the 5-year findings of a Cape Town-based US-UCT collaborative paediatric 
pulmonology HIV-research group focussing on severe CXR abnormalities in HIV 
infected children. The two interludes will be presented by Prof Zarina Lockhat. The 
first will cover radiology training in South Africa. The final interlude will be a celebra-
tion of SOUTH AFRICA: the country, its people, its diversity, and its attractions. 
Session Objectives:
1.  To learn about cerebrovascular disease in HIV infected patients in South Africa.
2.  To understand the pathogenesis of TB meningitis and its implications for treat-
ment.
3.  To become familiar with the MR imaging of spinal TB in children and possible 
differential diagnoses.
4.  To consolidate knowledge of chest radiograph reporting in HIV-infected chil-
dren.
5.  To appreciate South Africa, the country, its diversity and how its radiologists 
are trained.
A-257 10:35
HIV-related cerebrovascular disease: the South African experience 
V. Mngomezulu; Johannesburg/ZA (victor.mngomezulu@wits.ac.za) 
The purpose of this lecture is to describe the South African experience in HIV-
related cerebrovascular disease. A systematic review of published literature from 
the three major South African academic centres in the last 12 years was conducted 
in order to catalogue their combined experience and to highlight unique features 
of these conditions in the setting of a developing country with a relatively high 
seroprevalence. A comparison was made with experiences in developed countries. 
In South Africa, HIV infection is a high risk factor for stroke in young patients less 
than 46 years. These patients do not exhibit the usual risk factors for stroke found 
in non-infected patients. Most (> 90%) present with ischaemic stroke and (< 5%) 
with intracranial haemorrhage. In the majority of cases (> 80%), a primary aetiol-
ogy is usually found and in 20% HIV vasculopathy, presenting with characteristic 
clinical and imaging features is thought to be the cause. 2/3 of infarcts are large 
vessel cortical and 1/3 small vessel sub-cortical infarcts. Intracranial haemorrhage 
is often a consequence of HIV-related dilated aneurysmal arteriopathy. Dissection 
is a possible complication of this arteriopathy and is thought to be a more likely 
cause of SAH than saccular aneurysm formation and rupture. In 40-50% patients, 
stroke is the first manifestation of HIV infection. Intravenous drug abuse and 
atherosclerotic strokes are not prominent features. HIV-related cerebrovascular 
disease in South Africa mirrors that found in most parts of the world. There are 
however some features that appear to be unique in this setting.
A-253 09:30
C. Imaging spinal trauma in childhood 
M. Maas; Amsterdam/NL (m.maas@amc.nl) 
The presentation will focus on acute trauma in the cervical spine and more chronic, 
sports-related overuse kind of trauma in the lumbar spine of pediatric patients. The 
clearance of the paediatric cervical spine on admission on the Emergency Room re-
mains a challenge for both clinicians as well as attending radiologists. The literature 
on the use of The National Emergency X-Radiography Utilisation Study (NEXUS) 
criteria in children is discussed. Also, the use of MDCT in the paediatric population 
is critically debated. Focus is set on age-related trauma mechanism. In clearing 
C-spine, conventional Radiography remains mainstay. Guidelines for interpretation 
of these views will be given and examples of its use are presented. In addition, the 
imaging findings when using MDCT will be enhanced. A brief discussion on use of 
MRI in the (sub) acute setting, in the light of evidence-based criteria will be sup-
plied. In high-performing athletes, overuse trauma of the spine, mainly the lumbar 
spine is well known. The urge for competing at the highest level leads to intensive 
training programs in young children and adolescents. The growing lumbar spine is 
an area of well-known overuse-related injuries. Within the range of stress-induced 
bone marrow edema like patterns of abnormality, the devastating end stage is a 
stress fracture, of the pars intervertebralis. The potential role of imaging, both in 
detecting as well as in potential prognosis will be discussed. Imaging strategy both 
in the acute as well as in the overuse type of injury will finalize the presentation.
Learning Objectives:
1.  To understand how best to investigate suspected spinal trauma in a child.
2.  To appreciate the imaging findings.
3.  To consolidate knowledge about the differences between paediatric and adult 
spinal trauma.
10:30 - 12:00 Room A 
Interactive Teaching Session 
E³ 920a 
Tips and tricks in chest imaging 
A-254 10:30
A. Plain radiography 
J. Cáceres; Barcelona/ES (josecac@gmail.com) 
There are certain signs in the chest radiograph, which help in the identification and 
differential diagnosis of selected processes. Their appearance is characteristic 
enough to be identified. Some of them correspond to normal variants, which should 
not be confused with pathologic processes. In this presentation, we will describe 
several signs in chest imaging that, in our experience, have proven helpful to us 
in the diagnosis of chest pathology.
Learning Objectives:
1.  To become familiar with useful signs in the diagnosis of chest disorders in the 
chest radiograph.
2.  To learn about common pitfalls in plain radiography of the chest.




J. Vilar; Valencia/ES (vilarsamper@gmail.com) 
Interpretation of chest images is fraught with errors. Confusing images may occur in 
chest CT and conventional radiography. Understanding the cause of the error and 
using some “ tricks” the radiologist may overcome these situations. Three aspects 
that may be of useful are: Gravity, Space and Time. Gravity may help the radiologist 
by using simple manoeuvres such as prone or lateral decubitus. Space relates to 
the location of the lesion. Upper or lower lobe locations are associated with certain 
pathologies. Time lapse is a major factor that may influence our diagnosis. Previous 
studies are essential. Fast growth or reduction of a lesion usually is associated with 
non-neoplastic disorders. Follow-up in acutely ill patients may be of great value and 
well as in lesions in oncologic patients. The lecture will present cases of variable 
difficulty where using these simple “tricks” the diagnostic problem can be solved.
Learning Objectives:
1.  To become familiar with useful signs in the diagnosis of chest disorders in CT.
2.  To learn about common pitfalls in CT of the chest.
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A-260 11:10
Interlude: South Africa: the country, its people, its diversity and its 
attractions 
Z. Lockhat; Pretoria/ZA (Zarina.Lockhat@up.ac.za) 
South Africa (SA) is an extraordinary country, with so many mixed cultures, extreme 
diversity and a deep rooted history, that is constantly undergoing change not as 
an event but rather as a process. Herewith, I have tried to present a lighthearted 
celebration of South Africa, the country, its people, its diversity and its attractions. 
The Great Outdoors- SA has an abundance of everything nature can bestow, 
mountains, forests, endless beaches and world heritage sites. With a population 
of 55 million people, diverse, yet integrated, it is a nation that is growing and heal-
ing, and the pride of our nation include people who have had a profound effect on 
the national and international psyche. South Africa, like many other countries, has 
its fair share of troubles and tribulations; however, its people have a tenacity and 
resilience whose stories shine brightly despite all the dark headlines we are sadly 
famous for. Leave ordinary behind, visit South Africa, and explore and experience 
the land of the Big Five, the longest wine route in the world, diamonds, gold, whale 
watching, shark diving, languorous hikes and climbs, the Comrades or the Two 
Oceans Marathon, the Cape Argus cycling tour.
A-261 11:15
Spinal tuberculosis in children 
T. Kilborn; Cape Town/ZA (tracykilborn@gmail.com) 
Children represent a high-risk group for acquiring tuberculosis (TB). Although TB 
involving the spine occurs in less than 1% of paediatric patients with TB, it remains 
a significant cause of morbidity usually as a result of its insidious onset and indolent 
course that results in delayed presentation. Radiography has disadvantages, the 
atlanto-occipital and cervicothoracic junctions and posterior elements are difficult 
to visualise. CT carries a high-radiation burden but is useful prior to surgical 
reconstruction. MRI is the optimal imaging modality. Spondylodiscitis is the most 
frequent manifestation of spinal TB. Hallmarks are the involvement of multiple ver-
tebral bodies (usually > 3) most commonly thoracic. The resultant kyphotic gibbus 
is more often responsible for cord compromise than the inflammatory mass. Lack 
of proteolytic enzymes results in partial or complete disc preservation, commonly 
with anterior subligamentous, paravertebral or extradural spread, all specific for 
TB. The addition of a coronal T2 of the mediastinum to show lymphadenopathy 
and parenchymal disease is useful in supporting the diagnosis, as skin testing is 
frequently negative. Radiculomyelitis is seen on post-contrast MRI in up to 80% 
of cases of meningitis as a result of inferior extension but can also be seen in 
spondylodiscitis. Intramedullary tuberculomas and tuberculous abscesses are 
rare, more commonly associated with meningitis than as an isolated finding, their 
T2 signal correlates with the degree of caseous necrosis; the pattern of contrast 
enhancement and MRS assist in diagnosis. Accurate, timely radiological diagnosis 
is crucial in spinal TB to guide management and achieve good clinical outcomes.
Learning Objectives:
1.  To learn about the spectrum of tuberculous infection of the spine in children 
namely; intramedullary spinal tuberculomas, tuberculous spondylitis and rarely 
tuberculous epidural abscess.
2.  To appreciate the incidence of tuberculous arachnoiditis and tuberculomas 
in patients presenting with tuberculous meningitis and its implications for 
management.
3.  To become familiar with MR imaging of spinal TB and possible differential 
diagnoses.
4.  To discuss the role of ultrasound and CT in the imaging algorithm.
5.  To understand the importance of accurate and timely radiological diagnosis 
for guiding management.
A-262 11:30
Chronic chest radiographic changes in a cohort of HIV-infected 
South African children 
R. Pitcher, C. Lombard, M. Cotton, S. Beningfield, H. Zar; Cape Town/ZA 
(pitcher@sun.ac.za) 
Sub-Saharan Africa (SSA) remains the region most affected by HIV. South Africa 
has the highest global prevalence, estimated at 5.6 million people, including 
377,000 children. However, there has been progress in addressing the SSA HIV 
pandemic. Twenty-two countries, including SA, documented a declining HIV inci-
dence from 2001 to 2009; approximately 105,000 South African children are now 
on ART, compared to 12,000 in 2005. Respiratory illness is the leading cause of 
morbidity and mortality in HIV-infected children and includes both acute and chronic 
conditions. The high burden of respiratory illness is reflected in a high prevalence 
Learning Objectives:
1.  To learn about the clinical and imaging spectrum of cerebrovascular disease 
in HIV infected patients in South Africa.
2.  To appreciate the role of other co-factors in the pathogenesis of HIV related 
cerebrovascular disease.
3.  To become familiar with the challenges and technical strategies in the medical 
and interventional management of these conditions.
A-258 10:50
Interlude: Radiology training in South Africa 
Z. Lockhat; Pretoria/ZA (Zarina.Lockhat@up.ac.za) 
Academic Radiology in South Africa is dynamic, evolving and exciting. Various 
facets and institutions are involved in academic training, teaching and continuing 
medical education. These include the Radiological Society of South Africa (RSSA), 
The College of Medicine of South Africa (CMSA), the nine academic universities, 
and the international liaisons that the RSSA has nurtured and developed over many 
years. The College of Medicine hosts biannual national examinations in Diagnostic 
Radiology and Imaging, and this is supported by the academic institutional cur-
riculum, which may extend over a period of four or five years. Training and exami-
nations in Radiology is constantly being reviewed and refined with consultations 
between the RSSA and CMSA, and attention being given to local and international 
standards. Training and teaching is conducted in many forms, with supervision by 
Consultant Radiologists and includes didactic lectures, presentations at multidis-
ciplinary interdepartmental meetings, journal review, group and individual tutorials 
and workshops. Practical training is hands-on with supervision by Consultants in 
all aspects of Radiology including general radiology and special investigations, 
mammography and biopsy, ultrasound, CT and PET/CT, MRI and angiography and 
intervention. Registrars rotate through these subspecialty areas during their train-
ing. Candidates have access to academic libraries, a multitude of e-resources, and 
digital imaging. The Radiological Society of South Africa plays a fundamental role 
in continuing medical education and specialty training in South Africa. The RSSA 
has hosted numerous international speakers at congresses, workshops, webinars, 
visiting lecture programs. There is ongoing support for private and public sector 
radiologists and specialists in training in terms of radiological literature, awards 
and financial support towards fellowships and postgraduate training. Amongst the 
challenges facing South African Radiology, are the vast spectrum of pathology that 
is seen in imaging not only due to Tuberculosis and AIDS, but diseases peculiar to 
the African continent; and perhaps more importantly, the retention of highly skilled 
and talented Radiologists.
A-259 10:55
New concepts in the pathogenesis of cerebral TB 
P. Janse van Rensburg, R. Hewlett; Stellenbosch/ZA 
(neurotb2013‑ecr@yahoo.com) 
From its inception, the concept of the Rich focus as the ordinary cause for tu-
berculous meningitis has been controversial. Unfortunately, the concept persists 
unequivocally in certain in parts of academic literature. Using some of the original 
images from Arnold Rich‘s work, as well as that of the South African physician JN 
Coetzee‘s thesis on tuberculous meningitis, we illustrate why there is significant 
doubt as to the role of the Rich focus as the cause of basal cisternal tuberculous 
meningitis. A more likely pathogenetic mechanism based on the original work done 
by them, as well as on radiological-pathological correlation using MRI, is direct 
infection of the choroid plexi. The MRI correlate of the Rich focus is proposed to be 
the combination of granulomata and meningeal enhancement following the course 
of a convexity sulcus amongst others. Although the Rich focus may co-exist with 
basal cisternal tuberculous meningitis, these eruptive granulomata have no role 
in the pathogenesis of the inflammatory reaction localised to the basal cisterns.
Learning Objectives:
1.  To learn more about the morphological spectrum of tuberculous meningoen-
cephalitis as shown on contrast MRI.
2.  To understand the pathogenesis of TBM and its implications for disease 
progression and treatment.
3.  To appreciate the importance of imaging-pathologic correlation.
4.  To become familiar with imaging of TBM.
5.  To consolidate knowledge of neurotuberculosis.
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B. Tumours of the spinal cord 
J. Van Goethem, C. Venstermans, F. De Belder, L. van den Hauwe, P. Parizel; 
Antwerp/BE (johan.vangoethem@ua.ac.be) 
Tumours of the spinal cord are rare but may cause significant and longstanding 
morbidity. Detecting spinal cord tumours on imaging and differentiating them 
from other pathology is the most important task for the neuroradiologist. Second, 
determining the relationship of the tumour with the spinal cord and the extent of 
the tumour along with non-tumoural spinal cord changes such as oedema or sy-
ringomyelia is essential in therapy planning and monitoring. Finally, attempting to 
diagnose the type of tumour according to imaging criteria may be difficult in some 
cases but is less critical in patient management.
Learning Objectives:
1.  To become familiar with the imaging findings of primary and metastatic tumours 
of the spinal cord.
2.  To be able to recognise metastatic disease in the extradural, epidural, subdural 
and paraspinal compartments.
3.  To learn how best to use imaging and create the appropriate protocol.
A-265 11:30
C. Phacomatosis 
M.A. Papathanasiou; Athens/GR (matpapath@hotmail.com) 
The phakomatoses, also referred to as neurocutaneus syndromes, are congenital 
malformations affecting mainly structures of ectodermal origin, i.e., the nervous 
system, the skin, the retina, the globe and its contents. Visceral organs are also 
involved, but to a lesser extent. The classical diseases included in this group are 
neurofibromatosis, type I (NF1-Von Recklinghausen disease) and type II (NF2-
bilateral vestibular schwannomas), tuberous sclerosis (Bourveville’s disease), 
retinocerebellar angiomatosis (Von Hippel-Lindau disease) and encephalotrigeminal 
angiomatosis (Sturge-Weber syndrome). Although these conditions are separate, 
each the result of a change in a distinct gene, they share a tendency towards 
development of hamartomatous lesions and tumours of the nervous system, 
associated with other multisystem features. In addition, even though the genes 
involved are different, they all act through a tumour suppressor mechanism. The 
imaging findings of these disorders will be reviewed and appropriate imaging 
protocols will be presented for each of the conditions. The role of neuroradiology 
will be discussed in confirming the diagnosis, follow-up of patients and screening 
of asymptomatic relatives.
Learning Objectives:
1.  To learn how and when you should image.
2.  To consolidate knowledge about conventional neuroimaging findings of the 
more common phacomatoses.
3.  To be informed of the possible applications of advanced neuroimaging tech-
niques.
10:30 - 12:00 Room G/H 
EFOMP Workshop 
New technology in diagnostic radiology: new frontiers in imaging 
of the lung
EF 2 





Pulmonary nodule detection using CAD 
A. Retico; Pisa/IT (alessandra.retico@pi.infn.it) 
Computer-aided detection (CAD) systems can be usefully implemented to assist 
the radiologists in the detection of pulmonary nodules in screening for lung cancer 
with low-dose computed tomography (CT). The main necessary steps to build a 
CAD system are presented: the lung segmentation algorithm, the selection of the 
nodule candidates, the feature extraction and the classification procedure to reduce 
the number of false positive findings. The use of CAD systems for the detection of 
pulmonary nodules at low-dose CT screening for lung cancer may have a strong 
impact on the positivity of screening results and follow-up recommendations; thus, 
a high sensitivity and a limited false-positive rate are the fundamental goals to be 
of chest x-ray (CXR) abnormality. The CXR remains the most common imaging 
modality in the evaluation of respiratory illness in HIV-infected children in low and 
middle income countries. A better understanding of the clinical and immunological 
correlates of severe CXR abnormalities is, therefore, important for those practicing 
in Sub-Saharan Africa. This presentation describes the 5-year findings of a Cape 
Town based collaborative paediatric HIV-research group and focuses on severe 
CXR abnormalities in 330 HIV-infected children with limited access to antiretroviral 
therapy (ARV). CXR reporting methodology will be described. The prevalence of 
severe radiographic abnormality and the main chest radiographic patterns will be 
documented. The clinical and immunological correlates of severe CXR abnormality 
as well as the factors implicated in persistence, will be defined. The impact of ARV’s 
on the natural history of severe CXR abnormality will be reported. Recommenda-
tions will be made with respect to appropriate interventions to prevent severe CXR 
abnormalities in this context. 
Learning Objectives:
1.  To learn about the level of chronic chest radiographic changes encountered 
in HIV-infected children who do not have access to HAART.
2.  To better understand the clinical and immunological correlates of chest radio-
graphic changes in HAART-naïve HIV-infected children.
3.  To appreciate
a. the burden of paediatric pulmonary disease on resource-limited healthcare 
environment with a high prevalence of paediatric HIV-infection.
b. the impact of HAART on chest radiographic changes in HIV-infected children.
c. the importance of the early initiation of HAART in HIV-infected children.
d. the challenges to healthcare delivery in a resource-limited healthcare 
environment.
4.  To become familiar with standardised chest radiographic reporting techniques 
utilised for research in paediatric pulmonary radiology.
5.  To consolidate knowledge of paediatric chest radiograph reporting, with par-
ticular emphasis on:
i. The impact of technical factors
ii. The importance of standardised terminology
iii. Paediatric-specific normal variants
iv. Useful chest radiographic signs
Panel discussion:  
HIV and TB: What impact do they have on health care workers? 11:45 
10:30 - 12:00 Room E2 
Foundation Course: Neuroimaging 
E³ 920b 




A. Brain tumours 
M.M. Thurnher; Vienna/AT (majda.thurnher@meduniwien.ac.at) 
Brain tumour imaging objectives include: a) the diagnosis of brain tumour and the 
ability to distinguish it from non-tumoural lesions, b) assessment of histological 
grade of the tumour, c) delineation of the tumour borders and exact extention, d) 
differentiation between tumour and peritumoural oedema, and e) the evaluation of 
possible recurrence and therapy-induced phenomena. In the past years, several 
advanced MR techniques have been developed that provide new insights into 
pathophysiology of brain tumours. In general, the more aggressive a neoplasm, the 
more abnormal the vasculature with greater vascular density, tortuosity, permeability 
and higher tumour blood volume. Perfusion MRI methods have been developed 
to provide non-invasive and robust surrogate markers of tumour angiogenesis 
and capillary permeability. Furthermore, MRI provides information on microstruc-
tural (diffusion-weighted imaging), physiologic, and metabolic (MR spectroscopy) 
changes of tumour tissues. In this lecture, the most common diagnostic problems 
in evaluation of brain tumours and a standardised MRI protocol for brain tumour 
characterisation will be discussed.
Learning Objectives:
1.  To learn about the imaging findings and the limitations of conventional MRI in 
the evaluation of brain tumours.
2.  To become familiar with new MRI techniques available for advanced brain 
tumour imaging.
3.  To learn about the potential of ‘functional imaging’ (fMRI, PET, SPECT) in 
tumour characterisation, treatment decisions, and follow-up.
5
Postgraduate Educational Programme
S6 CB D E F GA
A-269 11:35
Lung imaging: developments in role of MR 
J.M. Wild; Sheffield/UK (j.m.wild@sheffield.ac.uk) 
MRI of the lungs has evolved radically in the last ten years to the point that it is now 
becoming used routinely in clinical practice. This talk will focus on the technical chal-
lenges and solutions for imaging lung structure and function with MRI methods using 
both the endogeneous protons in the lungs and inhaled magnetic contrast agents. 
The low proton density in the lungs (~ 0.1 g/cm3) and the magnetic inhomogoneity 
between tissue and air (susceptibility difference ~ 8 ppm) make structural proton 
MRI of the lung micro-structure challenging, particularly at higher B0 fields. Short 
echo time pulse sequences, parallel imaging and respiratory gating can all help 
improve proton anatomical MRI. Signal from the major pulmonary vessels can be 
enhanced using paramagnetic contrast agents and T1 weighted ultrafast pulse 
sequences for volume coverage providing 3D pulmonary angiograms. Pulse se-
quence methods for pulmonary angiography and time resolved pulmonary perfusion 
mapping will be covered. The role of under sampled and view shared sequences 
with parallel imaging will be discussed within the constraints of tradeoffs between 
spatial and temporal resolution. Functional lung imaging methods will be covered 
with particular focus on the role of inhaled gaseous contrast agents ranging from 
pulmonary blood pool enhancement by oxygen inhalation to state of the art methods 
for imaging lung function with hyperpolarised 3He and 129Xe MRI. Again the focus 
will be on technical challenges with a “how to do it” theme. Clinical images will be 
used as a means of highlighting the applications of the respective methodologies. 
Learning Objectives:
1.  To comprehend the basic MR physics of imaging protons and hyperpolarised 
gases in the lungs.
2.  To understand the techniques that are in use in clinical lung and pulmonary 
vascular MRI.
3.  To become familiar with established and future clinical applications of MRI in 
lung and pulmonary vascular disease.
Author Disclosure:
J. M. Wild: Advisory Board; Novartis. Author; NA. Board Member; NA. CEO; 
NA. Consultant; NA. Employee; University of Sheffield. Equipment Support 
Recipient; GE Healthcare. Grant Recipient; Novartis, GSK, Bayer, Pfizer. 
Research/Grant Support; EU FP7, EPSRC. 
10:30 - 12:00 Room L/M 
Standards and Audit Session  





Radiologists’ performance: assessment using peer review 
G. Boland; Wellesley, MA/US (gboland@partners.org) 
Peer review is a necessary and essential quality standard, but is adherence to a 
routine robust program is variable across imaging practices. Peer review should 
focus not just on perception error but on reporting content, language and mode of 
communication, as well as adherence to best practices, national guidelines and 
variability of radiologist recommendations, ideally within a clinically time-sensitive 
framework. There is lack of consensus on how to achieve these goals including the 
percentage, frequency and types of cases peer reviewed, whether by individuals 
or consensus, by subspecialty or generalist radiologist, by rank or educational 
level (trainee versus practicing specialist), real time versus remote peer review 
(weeks or months after the original imaging procedure), use of electronic tools 
and/or integration, communication of variation or error to radiologists, referring 
physicians and/or patients, medico-legal issues, remuneration policies and disci-
plinary procedures. This lecture will address the current and future status of peer 
review, evaluating the issues highlighted above and will propose workable peer 
review tools and procedures that are intended to maximize quality and minimize 
unnecessary overhead. 
Learning Objectives:
1.  To comprehend the importance of peer review to education, clinical care, 
research, best practices and cost.
2.  To understand how to implement an effective peer review program.
3.  To become familiar with the differing peer review tools including electronic 
decision support.
Author Disclosure:
G. Boland: Board Member; Radiology Consulting Group. 
achieved by the CAD developers. As different CAD systems may be characterised 
by different strengths and weaknesses, a procedure to combine them can enhance 
the detection performance. The method to combine CAD systems, the CAD usage 
modalities, and the way to estimate the impact of CAD systems on the observer 
performance are discussed. 
Learning Objectives:
1.  To comprehend the basic steps to design a CAD system for lung nodule 
detection in CT scans.
2.  To be aware of the possible usage of CAD as second reader in the clinical 
practice.
3.  To understand how the impact of CAD on the reader sensitivity is evaluated.
A-267 10:50
Optimisation in lung imaging of children 
C. Owens; London/UK (owensc@gosh.nhs.uk) 
This presentation will try to address the issues surrounding the use of CT in children 
and to outline the concept of how CT can be designed and customised for children, 
so as to be ‘fit for purpose.’ That is to answer specific clinical questions accurately 
and precisely, yet be delivered at the lowest possible radiation dose to the patient. 
The session will attempt to outline the role which CT plays and the relative strengths 
and weaknesses within cardiothoracic (body) CT using specific examples. 
Learning Objectives:
1.  To understand the importance of a dynamic team approach to optimisation of 
local CT techniques in all hospitals.
2.  To appreciate the iterative nature and concept of sharing protocols across 
sites.
3.  To become familiar with the techniques, tips and tricks to perform ‘as low as 
reasonably achievable’ CT imaging that is ‘fit for purpose’.
4.  To consolidate knowledge of low dose acquisition of CT images and post 
processing techniques to optimise images using images to illustrate.
A-268 11:10
Lung imaging: developments in role of PET 
M.-E. Meyer, P. Bailly, J. Daouk; Amiens/FR 
(Meyer.Marc‑Etienne@chu‑amiens.fr) 
Respiratory motion management: Lung PET acquisitions typically last several 
minutes, leading to a spread in the activity projection. In reconstructed images, this 
spreading results in poor evaluation of the lesion intensity and overestimation of the 
lesion size. Respiratory-gated PET/CT acquisition is one solution to this problem. 
Several processing methods are based on amplitude- or frequency-based analyses 
of the respiratory signal and reconstruction of a few gates, each of which contains 
negligible residual motion. However, none of these methods are fully satisfactory, 
due to inappropriate attenuation correction (although the latter can be improved 
by breath-hold or 4D CT acquisitions). Moreover, positional blurring related to the 
underlying, inter-cycle variability in respiratory amplitude may still exist, especially 
with frequency-based methods. To overcome this issue, advanced techniques 
relying on proper event selection (respiratory motion compensation or full motion 
correction) have been suggested. Adaptive treatment and advanced follow-up: Even 
though clinical PET imaging of the lung is mainly performed for diagnostic purpose, 
it also has other uses. Various methods for gross tumour volume definition have 
been developed for radiotherapy planning. Furthermore, gated PET/CT acquisi-
tions may help to optimise the definition of processing margins and minimize the 
dose delivered to non-malignant tissues. Moreover, the lesion’s functional volume 
measured with 18F-FDG PET during radiochemotherapy is likely to have significant 
prognostic value. Lastly, other radiopharmaceutical agents are being developed 
for the optimization of radiotherapy planning, notably by assessing hypoxic cell 
targeting (e.g. 18F-FMISO). 
Learning Objectives:
1.  To learn about respiratory motion management in PET acquisitions.
2.  To understand techniques of respiratory motion compensation or full motion 
correction to prevent inappropriate attenuation correction and errors in quan-
tification.
3.  To consolidate knowledge of adaptive treatment and advanced follow-up: 
optimisation of radiotherapy planning.
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Interventional oncology: the era of molecular targeted therapy 
J.-F. Geschwind; Baltimore, MD/US (jfg@jhmi.edu) 
Cancer is a disease characterised by healthy cells undergoing genetic mutations 
that result in the uncontrolled growth of a tumour, which in turn causes a grave 
disruption of homeostasis and eventually leads to death. Current treatments in-
cluding surgery, chemotherapy, radiotherapy and immunotherapy have not proved 
effective enough to cause a significant reduction of cancer-related mortality in the 
last decade. The WHO projected the number of global cancer deaths to increase 
45% from 2007 to 2030 (7.9 to 11.5 million deaths). Cancer is also characterised by 
several hallmarks or phenotypes, which can be difficult to target. One of the most 
important phenotypes is the up-regulation of the major energy-producing pathway, 
glycolysis, which plays a crucial role in the uninterrupted growth of tumours and is 
an indispensible “metabolic event” critical for the sustained growth and invasion 
of tumours. This phenotype has been used clinically for diagnostic purposes but 
never exploited as a possible therapeutic approach. A new class of drugs has been 
designed to selectively target such a pathway causing tumour cell death. Although 
cancer is considered a “systemic” disease, it can be treated loco-regionally. The 
progress in imaging technology has led to a revolution in image-guided therapies 
for cancer. It has become possible to zoom in on the tumour and deliver toxic 
doses of chemicals or radiation, which would not be feasible systemically. With 
better drugs, more effective drug delivery systems and sophisticated imaging, 
we now have more potent tools to design weapons with increased precision and 
lethality against cancer.
Learning Objectives:
1.  To learn about basic principles of cancer biology.
2.  To understand the importance of tumour metabolism and recognise its role in 
cancer growth.
3.  To appreciate the growing impact of image-guided therapies for cancer.
Author Disclosure:
J. -F. Geschwind: CEO; PreScience Labs, LLC. Consultant; Biocompatibles/
BTG, Bayer HealthCare, Guerbet, Nordion, Merit, Abbott and Jennerex. Grant 
Recipient; Biocompatibles/BTG, Bayer HealthCare, Philips Medical, Nordion. 
Other; Founder, PreScience Labs, LLC. 
12:30 - 13:30 Room N/O 
The Beauty of Basic Knowledge: Head and Neck 
MC 24C 
Main pipelines of the neck: pharynx and larynx 
A-274 12:30
Main pipelines of the neck: pharynx and larynx 
M. Becker; Geneva/CH (minerva.becker@hcuge.ch) 
The purpose of this lecture is to familiarize the radiologist with current imaging 
protocols for the evaluation of common pathologic conditions of the larynx and 
pharynx, to describe the key anatomic structures relevant to tumour spread and 
to discuss the clinical implications of CT and MRI in the pre-therapeutic work-up 
of squamous cell carcinoma of this region. A systematic review will include key 
radiologic features and characteristic patterns of submucosal spread in squamous 
cell carcinoma of the larynx and pharynx, as well as implications of cross-sectional 
imaging for staging and treatment. The lecture will also review the characteristic 
aspect of rare tumours of the region and of common and less-common inflammatory 
or traumatic conditions. Typical radiologic findings in neoplastic and non-neoplastic 
conditions will be discussed with an emphasis on potential pitfalls and on how to 
A-271 11:00
Radiologists’ individual performance: use of standardised test images 
A.G. Gale; Loughborough/UK (a.g.gale@lboro.ac.uk) 
How well an individual radiologist performs is complex. Such performance can 
be understood in two ways: how well does someone identify an abnormality cor-
rectly and how well do they agree with colleagues on the radiological outcome. 
Various measures of performance can be utilised such as; sensitivity, specificity, 
ROC scores, abnormality detection and radiological feature classifications. Test 
sets of carefully selected exemplar images are useful in assessing these skills. 
Such sets are particularly important in screening scenarios where in real life the 
abnormality incidence is very low and so it can be difficult to gauge an individual’s 
skill level. However, care must be taken in interpreting the results of test sets as 
the individual knows it is a test, the sets are usually weighted with abnormal and 
possibly rare cases - all factors which affect any performance measures. Illustra-
tions will be presented from the use of the PERFORMS national self-assessment 
scheme in the UK which is used in breast screening. Individuals examine sets of 
recent challenging screening cases and receive immediate detailed feedback as 
well as subsequent feedback where their performance is anonymously compared 
to colleagues. The scheme identifies individuals who are under-performing, the 
underlying reasons for their performance can be determined and improvement 
strategies proposed for them to follow. The PERFORMS scheme is available in-
ternationally as well as being rolled out across other radiological domains. Overall 
it is argued that screening performance test sets, are a very useful educational 
exercise as well as an external quality assurance tool. 
Learning Objectives:
1.  To understand the use of standardised test sets.
2.  To comprehend the advantages and limitations of using test sets to measure 
the radiological performance.
Author Disclosure:
A. G. Gale: Research/Grant Support; NHS Breast Screening Programme. 
A-272 11:30
Radiologists’ performance: referrers’ view 
J.M.L. Bosmans; Gent/BE (janbosmans@telenet.be) 
Since 1988, several authors have surveyed the views and expectations of refer-
ring clinicians regarding the radiology report. Their findings are strikingly similar, 
taking into account that these have been obtained over a quarter of a century, and 
in several countries in North America and Europe. In general, referring clinicians 
are rather pleased with the radiology report. Their greatest concern is that the 
radiologist may not properly address the clinical question. However, they are quite 
aware that the radiologist, to think and act as a clinician, needs adequate clinical 
information and a clearly formulated clinical question. They value clarity, brevity, 
clinical correlation and timely delivery of the report. Depending on their specialism, 
referrers appreciate the report to a different degree. General practitioners rely more 
on the report than on hospital specialists and they especially value the radiologist’s 
advice on planning of future investigations. A clear majority of the referrers would 
favor a shift from free text reporting to structured reporting, as well as the use of 
a comprehensive radiological lexicon. Although radiologists share many of the 
views and expectations of referrers, concretizing these preferences will necessitate 
fundamental organisational and educational changes. Together with the conviction 
that things are at their best the way they are, the main obstacle is fear of productiv-
ity loss. As we already know very well what referring clinicians want, there is little 
need for further descriptive research. Instead, we should concentrate on guidelines, 
education, and technical solutions for the productivity problem. 
Learning Objectives:
1.  To become familiar with the views and expectatations of referring clinicians 
concerning communication with the radiologist and more specifically regarding 
the radiology report.
2.  To understand the different needs of particular subgroups of referrers.
3.  To become familiar with the views and expectations of referrers regarding 
structured reporting and its potential effect on productivity and training.
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from Spain, represented by their National Society AETR (Asociación Española de 
Técnicos en Radiología), that represents near 10,000 Radiographers in the fields 
of Diagnostic imaging, nuclear medicine and radiotherapy, working in a very high-
standard Health System, with almost 800 hospitals, providing care to 46 millions 
inhabitants. At this first historical EFRS meets session, the invited speakers will give 
us a perspective of Spanish Radiographers’ role in advanced areas of practice. In 
the last decade, AETR has essentially being focused in promoting Radiographer 
Education in Spain and therefore an overview about this topic will also be addressed. 
This “EFRS meets Spain” session intends to be a space of a proactive debate 
and exchange of knowledge as a trigger for the development of the profession. 
Session Objectives:
1.  To understand Spanish radiographers’ education and professional status and 
its comparison with other European countries.
2.  To learn about the role of radiographer within the framework of the Spanish 
health system.
3.  To learn about areas of professional development for radiographers in Spain.
A-285 14:05
The Spanish radiographer’s role in advanced MRI research 
E. Alfayate Sáez; Madrid/ES (ealfayate@fundacioncien.es) 
A Radiographer, as part of a MRI research team, is more than just a professional 
obtaining patient´s images for either the investigational studies or clinical trials. 
Being part of the team means participating and understanding the project as a 
whole. It means one must know the study‘s objectives, collaborate in the protocol 
design and optimization, and inform the patient about the exam and steps to follow 
in order to maximize his cooperation. Personal data protection and individual privacy 
must be guaranteed through all the process; a written informed consent should 
be signed by the patient as well. Taking care of all these particular aspects is very 
important for a successful completion of each study/trial. Due to rapid technologi-
cal advances, and the necessity to deal permanently with state-of-the-art scientific 
areas, Continuous Professional Development (CPD) for a Radiographer working 
in a research team is critical. The radiographer is part of a multidisciplinary team, 
where each professional performs a very specialized task, combining efforts is 
crucial in order to produce a work of excellence that can be shared with the scientific 
community. Thanks to the continuous investment in new technology, we have the 
opportunity, in our site, to conduct research in diverse areas, such as cardiology, 
traumatology, gynaecology, obstetrics and neurology. Through this presentation 
we will share some of the research we are working on, as well as the importance 
of the Radiographer role in a research centre. 
Learning Objectives:
1.  To understand the role of radiographer in a MRI research centre.
2.  To understand the daily activity in a MRI research center and the continuous 
professional development related to it.
3.  To learn about the potential areas of research development in MRI.
A-286 14:23
The radiographer’s specialisation in ultrasound: two decades of 
experience in a public hospital 
M.P. Peña Fernández; Getafe/ES (mpalomapena@yahoo.es) 
About 20 years ago, a Radiology Department from a hospital belonging to the 
community of Madrid, from the Spanish National Health System, started to train 
Radiographers to perform ultrasound procedures. Currently, there are 10 radiogra-
phers perfoming ultrasound in our Hospital. To perform ultrasound exams with high-
quality standards, a good training and a professional commitment with Continuous 
Professional Development (CPD). According to our experience, a training period of 
7 months (35 h per week) was considered adequate as a minimal requirement for 
a Radiographer to perform high-standard ultrasound exams. Radiologists‘ support 
and participation in the learning process was extremely important for the success 
of the integration of Radiographers in Ultrasound. Study protocols and image 
quality parameters were established in order to facilitate the delegation process 
from Radiologists. Radiographers give oral and/or written comments about imaging 
findings, to facilitate the clinical report made by the Radiologist. The integration of 
Radiographers in performing ultrasound exams resulted in a considerable improve-
ment on the Department productivity and patient workflow.
Learning Objectives:
1.  To understand the role of the radiographer in ultrasound.
2.  To learn about inter-professional relations in ultrasound.
3.  To appreciate the advantages of a radiographer in ultrasound for radiology 
department outcomes and for the quality of patient care.
avoid them. Emphasis will be put on what the clinician needs to know and how to 
report the findings in a systematic way.
Learning Objectives:
1.  To become familiar with the anatomy of the pharynx and larynx.
2.  To learn how to choose and tailor imaging techniques according to clinical 
presentation.
3.  To appreciate the most common pathologies affecting these structures.
4.  To be able to provide a useful differential diagnosis of pharyngeal and laryngeal 
lesions.
12:30 - 13:30 Room P 





V.N. Cassar-Pullicino; Oswestry/UK (Victor.Pullicino@rjah.nhs.uk) 
There are a host of inflammatory and infections insults that can manifest focally 
or diffusely within the musculoskeletal system. The appearances of the underly-
ing pathological processes in both the soft tissues and skeleton cover a very wide 
imaging spectrum. The appearances vary depending on the timing and degree of 
inflammatory insult and the host response in the involved tissues. The approach 
of this lecture will cover the imaging manifestations using all modalities covering 
radiography, ultrasound, CT, scintigraphy and magnetic resonance imaging. The 
basic knowledge that is required will be displayed in 4 major musculoskeletal cat-
egories covering disorders involving the Soft Tissues, Joints, Bones and Entheses. 
The imaging manifestations will also be linked with the evolution of the pathologi-
cal processes covering acute, sub-acute and chronic stages of the inflammatory/
infections disorders. By the end of the session, the audience will have a clear 
understanding of how to make best use of the imaging modalities in the correct 
diagnosis of a wide variety of inflammatory and infections conditions that can affect 
the musculoskeletal system.
Learning Objectives:
1.  To understand the pathophysiology of inflammatory conditions of the muscu-
loskeletal system.
2.  To learn about the basic imaging criteria for the diagnosis of arthritis, osteo-
myelitis, and spondylitis.
3.  To become familiar with the differential diagnosis of the most common inflam-
matory diseases.
14:00 - 15:30 Room B 
EFRS meets Spain 
EM 5 







G. Paulo1, C. Ruiz Blanco2; 1Coimbra/PT, 2Madrid/ES 
(graciano@estescoimbra.pt) 
Radiographers’ involvement in ECR has already a tradition and a history of success, 
revealed not only by the increase of participants but also for the quality development 
of the scientific content of Radiographers’ sessions. The consolidation of the rela-
tionship between ESR/ECR and the young EFRS (European Federation of Radiog-
rapher Societies, founded in 2008 and representing Radiographers’ Societies from 
33 European Countries and 35 Higher Education Institutions - HENRE) gave us the 
opportunity to have, for this first time in ECR history an “EFRS MEETS” session. For 
this session, the country of ECR 2013 President, Prof. José Ignacio Bilbao, was cho-
sen and therefore we have the privilege and the honour to receive Radiographers’ 
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Spain, in relation with the rest of Europe, through the different comparative studies 
of Radiographers that have been done by the Ministry of Health and Consumer 
Affairs, as well as the different Associations and Syndicates of the states, European 
and International that represent our community. So, which is our present educative 
framework in respect to our European workmates? 
Learning Objectives:
1.  To understand the Spanish radiography education model.
2.  To learn about the limitations of Spanish education on free movement on 
professionals in Europe.
3.  To learn about solutions for education-model development regarding profes-
sional harmonisation.
Panel discussion:  
Could a transnational and multi-professional combined statement 
contribute to professional development? 15:22 
16:00 - 17:30 Room A 





C.S. Balleyguier; Villejuif/FR (balleyguier@igr.fr) 
Breast Cancer detection relies almost exclusively on the radiologist. Mammography 
is the basic tool for screening. Sonography and MRI are complementary techniques. 
Sensitivity of mammography is very high (close to 90%) in case of fatty breast. 
However, accuracy declines in case of dense breast. The most challenging cancers 
are infiltrative lobular carcinoma and cancers presenting only with architectural 
distortion. Mammography is by far the best examination for the detection and 
characterisation of microcalcifications. Sonography is not a screening tool, but 
is a useful complement to questionable mammograms. MRI is very powerful and 
might become the primary screening tool in selected populations like high-risk 
women, but should not replace mammography in all cases due to the risk of false 
positive findings. A combined report of both MRI and mammogram is desirable. The 
radiologist should be familiar with the most common traps: lesions seen on only 
one view, cancer seen only as a mild asymmetry of breast density, identification 
of neoplastic calcification in the middle of uneven microcalcifications and mildly 
enhancing images in MRI or lesions masked by a severe background enhancement. 
The radiologist should be fully aware of BIRADS terminology and should be able 
to propose the correct indications for biopsy, as well as the preferred guidance.
Learning Objectives:
1.  To understand the respective role of each imaging technique in the diagnosis 
of breast cancer.
2.  To learn about common pitfalls in the diagnosis of breast cancer.
A-297 16:45
B. Follow-up 
G. Forrai; Budapest/HU (forrai.gabor@t‑online.hu) 
The role of radiologist is to provide detailed pre-operative assessment and post-
therapy follow-up included detection and differential diagnosis of recurrence and 
post-therapy sequelae. Diagnostic tools are combination of clinical examination, 
mammography, sonography, MRI, PET/CT and guided biopsy. Additional diagnostic 
help is obtained by comparison with prior films. The quality of the post-operative 
imaging depends also on preoperative assessment. All the congenital and benign 
conditions must be known before surgery in order to avoid post-operative interpre-
tation problems. Pathology results and preoperative films as well as prior surgical 
and/or needle biopsy results must be present. Post-therapy conditions are some-
times challenging because post-therapy changes may mimic recurrent disease. 
Breast cancer is a heterogeneous disease, therefore, the spectrum of morphology 
and progression dynamics may be very different. Follow-up is chosen when the 
post-therapy changes are stable or show typical benign morphology features. 
Progressing or indeterminate lesions have to be biopsied if all imaging modalities 
fail to provide an equivocal diagnosis. Monitoring neoadjuvant chemotherapy by 
prediction of response is a new step toward individualized therapy of breast cancer.
Learning Objectives:
1.  To understand the common features of recurrent breast cancer.
2.  To learn how to establish imaging follow-up protocols or breast cancer.
A-287 14:41
Interlude: Radiology and Spanish art 
C. Ruiz Blanco; Madrid/ES (presidencia@aetr.net) 
This interlude in digital video format, wants to show another application of x-rays 
used in Art. This relation of the x-rays and art goes back to France, during the 
First World War, where the first x-ray art image was made, using an x-ray table. 
In 1931, the Siemens-Reiniger-Feifa build the first x-ray unit especially designed 
for the study of paintings. This technique has evolved using the technological 
developments advances of the radiological field, such as film digitalization, digital 
x-ray systems, CT, and even more sophisticated techniques. The use of Radiol-
ogy in art created the possibility to analyse, study, observe and identify, through a 
“non-invasive” technique, several kinds of damages from different sources, giving 
important orientations for restoring strategies. The use of x-rays is also used in 
the conservation and restoration of archaeological artifacts, giving orientation for 
cleaning and conservation and also information about the method of the origin and 
creation of archaeological objects. The given information also contributes to obtain 
information about the evolution of civilizations as well as artistic changes through 
centuries. There are several other applications for Radiology in art. Through this 
video, a visit to several Spanish museums will give us an overview about this 
interesting topic.
A-288 14:46
The radiographer as the interface between patient and technology in 
promoting safety in radiation protection 
J.A. Soria Jerez; Madrid/ES (juansoria.madrid@gmail.com) 
Since Roentgen discovered x-rays, two facts are scientifically irrefutable: they 
are a irreplaceable tool for clinical diagnosis and therapy and despite this major 
advantage they are not harmless. During the exposure to ionising radiation, several 
interactions with matter happen that can cause deleterious effects to patients and 
staff, if high-standard radiation protection measures are not used. Radiographers, 
acting in the interface between patient and technology in medical imaging, are the 
ultimate gatekeepers of patient and staff radiological protection, keeping always 
in mind the necessity to deliver acceptable diagnostic images according to ALARA 
principal. Being the last contact point with the patient before the exam is performed 
its mandatory that the Radiographer verifies several important check points related 
to patient information, patient physical condition and the clinical information given 
by the referrer in order to guarantee the best approach for the exam performance, 
namely if it is justified. A specific explanation about the exam to be performed 
must be given, with a language adequate for patient understanding, not only to 
obtain the necessary informed consent but also to get the maximum cooperation 
possible. Taking into account the diversity of parameters used when performing 
the radiological procedure, they should be carefully adapted to each individual 
patient and to the outcome expected according to the clinical information. In this 
presentation, an overview through the key elements for the radiological procedure 
will be made concluding that an optimal knowledge about them will allow to obtain 
the best diagnostic image with the lowest exposure possible.
Learning Objectives:
1.  To learn how to enhance patient safety in radiation protection.
2.  To learn about radiographers’ role in optimising procedures.
3.  To understand the continuous professional development requirements needed 
to maintain high standards in patient safety.
A-289 15:04
Educational status of radiographers in Spain: comparison with the EU 
M.R. Soto García; Barcelona/ES (martasotogarcia@gmail.com) 
As Radiographers, in Spain we develop our professional activity in a techno-
scientific area that is in constant evolution and specialization. The characteristics 
and the importance of these activities are linked to the continuous advances of the 
techniques taken in the Diagnose for the Image centres. This reality requires a deep 
change in the formative curricular content in our profession. Our profession must 
evolve towards university training. It is very important to the process of the medi-
cal image, that the developments in technology are accompanied by well-trained 
professionals, trained in the different modalities and possibilities of acquisition of 
images, and with adequate knowledge of use, protection concepts and attention 
to patients, that only a grade career can give. Without this base, the quality of 
medicine in this country is seriously limited. Because of that, we should not let 
Radiographers be condemned to undertake their duties in Spain, in comparison 
with the EU spirit in the right of free circulation of citizens, because the bureaucratic 
and real difficulties that take to have a lower qualification to the rest of countries 
around us are insurmountable. For this reason, I will present the actual situation in 
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earlier. Furthermore, several studies revealed that a complete remission of my-
eloma confirmed by MRI or PET-CT goes along with a better prognosis compared 
to a complete response based only on serological parameters. Therefore, current 
studies address the capabilities of the novel imaging techniques to assess minimal 
residual disease to identify possible sources of relapse. 
Learning Objectives:
1.  To understand the pathophysiologic mechanisms of multiple myeloma.
2.  To be able to compare the significance of imaging and serological markers for 
response evaluation in myeloma.
3.  To assess the significance of the depth of response to systemic treatment.
A-301 16:51
Evaluation of response in lymphoma with PET/CT 
S.F. Barrington; London/UK (sally.barrington@kcl.ac.uk) 
Changes in glucose metabolism with 18 F Fluorodeoxyglucose (FDG) Positron 
Emission Tomography and CT (PET-CT) give an early indication of response to 
lymphoma treatment, prior to changes in tumour size. ‘Interim’ PET-CT (iPET) after 
1-3 cycles of chemotherapy is more accurate than CT alone and outperforms the 
international prognostic score (IPS) in advanced Hodgkin Lymphoma (HL) and the 
IP index (IPI) in aggressive non-Hodgkin Lymphoma (NHL). The importance of iPET 
lies in its potential application for response-adapted therapy, with current phase 
III trials in progress to establish: 1. if abbreviated chemotherapy ± radiotherapy is 
sufficient to cure patients with good 'metabolic' response in HL. 2. If escalation of 
chemotherapy and/or early transplantation can improve survival in patients with 
poor 'metabolic' response in advanced HL and aggressive NHL. iPET assesses 
the degree of chemosensitivity rather than the completeness of overall response. 
A method of interpretation which reflects the continuous nature of data obtained 
using iPET with the ability to alter the threshold used to define a 'positive' versus 
negative result, according to the clinical or research question led the development 
of a five-point scoring system (5PS). The 5PS was adopted at the first international 
conference in iPET held in Deauville. The 'Deauville Criteria' (DC) grade response 
by comparing any residual uptake with uptake in normal mediastinum and liver. The 
DC have been validated in an international study in HL and have good interobserver 
agreement in a multicentre trial setting. DC are gaining widespread acceptance 
for clinical and trial use.
Learning Objectives:
1.  To understand the role of interim PET/CT in the evaluation of metabolic re-
sponse to lymphoma.
2.  To become aware of proposed reporting criteria developed for assessment of 
interim PET/CT.
3.  To get an overview of current clinical trials exploring the role of response 
adapted therapy according to PET/CT.
Panel discussion:  
Is it time for biomarker response criteria in haematological 
malignancies? 17:14 
16:00 - 17:30 Room C 
Urogenital Imaging 
CC 1121 




A. Imaging patients with renal colic 
G. Heinz-Peer; St. Pölten/AT (gertraud.heinz@stpoelten.lknoe.at) 
Helical CT is now accepted as the imaging technique of choice for evaluating 
patients with acute flank pain in whom renal or ureteral calculi are suspected. It is 
superior to excretory urography and there is no need for intravenous contrast media 
injection for this study. Diagnostic confidence is often improved and the likelihood of 
stone passage can be predicted. Non-urologic causes of abdominal pain can often 
be diagnosed. Recently, dual-energy CT scanners have been utilised to detect and 
to characterise urinary tract calculi. It has been shown that uric acid stones can be 
differentiated from non-uric acid stones with high specificity. Disadvantages of CT 
include that it is generally more expensive compared to conventional techniques 
and that it may be less accurate in guiding treatment, since the degree of obstruction 
16:00 - 17:30 Room B 
State of the Art Symposium 
SA 11 




E. de Kerviler; Paris/FR (eric.de‑kerviler@sls.aphp.fr) 
Response to treatment in haematological malignancies has long been assessed 
by the evolution of serological markers in multiple myeloma or bidimensional 
measurements of target lesions in lymphoma. However, these response criteria 
failed to identify patients with minimal residual disease or with inactive residual 
masses. Functional imaging such as PET, diffusion or perfusion studies have already 
proven to be effective or are very promising ones. This aim of this multidisciplinary 
session with a Nuclear Medicine physician, a Haematologist and a Radiologist, is 
to present the State of the Art in the management of patients with haematological 
malignancies and to show the techniques that may become tomorrow’s standards. 
Session Objectives:
1.  To become reacquainted with the standard criteria for therapeutic response 
in myeloma and lymphoma.
2.  To demonstrate the role of CT, MRI and PET in the assessment of therapeutic 
response.
3.  To show that functional imaging is now essential for patient evaluation at 
baseline and follow-up.
4.  To consider future imaging biomarkers in the assessment of response.
A-299 16:05
Opportunities and limitations of PET, CT and MRI answering the 
haematologist’s questions 
T.C. Kwee; Utrecht/NL (thomaskwee@gmail.com) 
Imaging plays an important role in the evaluation of lymphoma; relevant targets for 
imaging include 1. tumour characterisation and detection of Richter‘s transformation, 
2. staging, 3. response assessment and 4. restaging. Although several of these 
targets can be reached to some extent, considerable challenges remain. In this 
lecture, the imaging characteristics of lymphoma at ultrasound, CT, MRI, and PET 
with 18F-FDG will be briefly reviewed. Subsequently, the utility and limitations of 
structural imaging with CT and MRI, and the additional value of 18F-FDG PET will 
be demonstrated. Finally, the following emerging imaging concepts and techniques 
will be discussed: tumour biology assessment with 18F-FDG PET, immuno-PET with 
89Zr-rituximab and diffusion-weighted MRI. 
Learning Objectives:
1.  To learn the various imaging features of lymphoma.
2.  To learn the advantages and limitations of CT, PET, and MRI in the evaluation 
of lymphoma.
3.  To understand the importance of and opportunities provided by (new) functional 
imaging methods for staging and follow-up of lymphoma.
A-300 16:28
Evaluation of response in multiple myeloma 
J. Hillengass; Heidelberg/DE (jens.hillengass@med.uni‑heidelberg.de) 
Multiple myeloma is a haematologic malignancy characterised by the infiltration 
and proliferation of monoclonal plasma cells mainly in the bone marrow. Previously, 
treatment-response was assessed mainly by measurement of the concentration 
of monoclonal protein in serum and light chains in urine. The introduction of 
cross-sectional imaging such as MRI, CT and PET-CT to extend or even replace 
conventional radiological survey in the imaging work up of patients with monoclonal 
plasma cell diseases led to new insights in the pathophysiology of the disease but 
also showed that imaging findings improve response assessment. Especially, MRI 
has extended the knowledge concerning growth patterns of myeloma cells in bone 
marrow. It was found that patients with this disease can present with either a diffuse 
infiltration, a focal pattern or a combination of both. Furthermore, some patients 
even do not show any signs of infiltration at all. Although conventional response 
criteria correlate with imaging-based assessment of the remission of the disease, 
it has been demonstrated that, e.g., PET-CT is able to detect response to therapy 
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D. Interactive case discussion 
N.C. Cowan; Birmingham/UK (nccowan.uro@gmail.com) 
16:00 - 17:30 Room D1 







A. Clinical considerations 
P.M. Parizel, P. Cras, T. Menovsky, T. Van der Zijden, M. Voormolen; Antwerp/BE 
(paul.parizel@ua.ac.be) 
Stroke is the most common non-traumatic neurological emergency, and the lead-
ing cause of serious, long-term disability. Worldwide, each year, an estimated 15 
million people suffer a stroke. Accurate data on stroke incidence across Europe 
are lacking, but according to WHO estimates, the number of stroke events is likely 
to increase to more than 1.5 million per year in 2025. On average, higher rates of 
stroke occur in eastern, and lower rates in Southern European countries. Stroke 
risk factors and predisposing diseases can be broadly categorized as “controllable” 
or “uncontrollable”. Controllable risk factors are subdivided into medical (hyperten-
sion, atrial fibrillation, hypercholesterolemia, diabetes, atherosclerosis) and lifestyle 
(smoking and tobacco use, alcohol use, obesity, physical inactivity). Uncontrollable 
risk factors include age, gender, race, famility history, previous stroke or TIA, fibro-
muscular dysplasia, patent foramen ovale. In acute stroke patients, non-invasive 
multiparametric neuroimaging plays a pivotal role in patient selection, treatment 
decision-making, and and guiding therapeutic interventions. Identification of the 
ischaemic penumbra, using MRI and/or CT, has entered routine clinical practice. 
In acute stroke patients, the challenge for radiologists is to provide a fast and ac-
curate diagnosis, and using the tools that are available, to assess the infarct core/
ischaemic penumbra, to guide the decision-making, and to perform interventional 
treatment of stroke patients, in order to reduce the size of the infarction and to 
protect the surrounding brain at risk. Ultimately, thanks to advanced neuroimaging 
techniques, we have the potential to elucidate mechanisms of recovery and develop 
imaging biomarkers for predicting recovery and monitoring treatment responses.
Learning Objectives:
1.  To become familiar with the frequency and causes of stroke.
2.  To learn about the most important risk factors and predisposing diseases.
3.  To learn about the importance of imaging for treatment decision-making and 
planning.
A-307 16:30
B. Imaging techniques and typical findings 
J. Vymazal; Prague/CZ (Josef.Vymazal@homolka.cz) 
Cerebrovascular disease represents a major source of global mortality and morbid-
ity. Imaging examinations play a critical role in the management of stroke patients, 
from establishing the initial diagnosis to determining and guiding further treatment. 
Haemorrhagic stroke, or intracerebral haemorrhage, represents 10-15 % of stroke 
cases and approximately 85 % of strokes are ischaemic. The specificity of clinical 
tests is unacceptably low, therefore imaging is the initial step in the management 
of a stroke patient. Non-contrast CT confirms the presence of haemorrhage, it 
does not exclude ischaemia and/or stroke mimics such as encephalitis, multiple 
sclerosis, hypertensive encephalopathy, etc. Perfusion CT confirms the presence 
of ischaemia immediately. Its radiation burden is not negligible. MRI with SWI 
confirms the presence of haemorrhage and DWI reveals ischaemia minutes after 
stroke. Perfusion MRI with DWI is able to detect the ischaemic penumbra. PWI and 
DWI with MRI always cover the whole brain. Modern state-of-the-art CT scanners 
cover almost the whole brain with PWI; older scanners a limited slab only. The 
presence of penumbra is important for further management decisions but it is not 
unambiguous. MRI is also better in imaging the posterior fossa and better detects 
small infarcts. There is no radiation burden with MRI. However, MRI is slower, it 
is less clear. The overall radiation dose to patients is greater than that of observed 
when excretory urography was the imaging study of choice. Ultrasonography (ei-
ther by itself or in conjunction with conventional radiography) is utilised to image 
renal colic patients as an alternative to CT at some institutions. The color Doppler 
twinkling artifact increases sensitivity in detecting small urinary tract stones that 
lack posterior acoustic shadowing. Magnetic resonance urography has been used 
by some as another alternative to CT. The management of urinary stone disease 
depends on the clinical presentation, stone location, stone size, and possibly on 
stone “hardness”. 
Learning Objectives:
1.  To learn about imaging approaches to patients with renal colic.
2.  To become familiar with the strengths and limitations of various imaging 
techniques.
3.  To learn about the management of patients with renal colic.
A-303 16:20
B. Percutaneous treatment of renal stones 
S. Moussa; Edinburgh/UK (smoussa@sky.com) 
Urinary tract calculi: common condition, 15% of men and 6% of women in devel-
oped countries will have one stone, 50% will recur, majority are idiopathic 80%. 
Treatment modalities include Extracorporeal Shock Wave Lithotripsy (ESWL), 
Flexible Ureteroscopy and Lasertripsy, Percutaneous Nephrolithotomy (PCNL), 
Litholapaxy, Open surgery! Stone size (burden), stone position, radiolucency, 
obstruction, anatomy, body (spinabifida, spinal deformity/fusion), renal (horseshoe, 
ectopic), calyceal (duplex, diverticular). are the factors affecting the management 
of urinary tract calculi. The management of stone disease has evolved in recent 
years since the advent of ESWL as well as with advances in interventional radio-
logical techniques allowing for safer percutaneous access to the upper urinary 
tract. There has been an increase in the use of CT in the evaluation of patients 
with stone disease, particularly complex stones where 3D reconstraction has been 
shown to be of great value as well as CT-guided renal access. The technique of 
percutaneous nephrolithotomy will be described together with factor affecting the 
choice of approach, number of puncture and patient position. Examples of some 
complex cases will be discussed. For best practice in stone management, the fol-
lowing points must be considered: accurate imaging and preoperative evaluation 
of the patient, if possible use of 3D-CT for planning, close discussion between 
radiologist and endourologists, team effort including anaesthesia and all theatre 
staff, and recognition and early management of complications.
Learning Objectives:
1.  To appreciate the importance of imaging, stone selection and planning for 
percutaneous nephron-lithotomy (PCNL).
2.  To become familiar with the technical aspects and different approaches to 
PCNL.
3.  To appreciate the importance of recognising and avoiding complications.
A-304 16:40
C. Intervention in ureteral obstruction and ureteral trauma 
A. Magnusson; Uppsala/SE (anders.magnusson@radiol.uu.se) 
There are a variety of causes of obstruction of the upper urinary tract out of which 
ureteral stones, gynaecologic malignancies and prostatic cancer are the most 
common. Treatment depends upon the level of obstruction, and whether it is an 
acute or chronic obstruction. Acute as well as chronic obstruction is usually initially 
treated by the insertion of a nephrostomy tube. However, chronic upper urinary 
tract obstruction is often later treated by the insertion of a ureteric stent using ei-
ther an ante- or retrograde approach. Most nephrostomy tubes are inserted using 
ultrasound guidance combined with fluoroscopy but in some cases, it is neces-
sary to use CT guidance. The majority of nephrostomy insertions can wait until 
daytime with one important exception, patients with obstruction and suspicion of 
infection of the upper urinary tract. These patients require immediate relief as it is 
a life-threatening condition! Nephrostomy relief was one of the first interventional 
procedures, but the technology has evolved so that today it is simple and safe. 
Trauma to the ureter is rare, and are most likely to occur iatrogenically. Patients 
with ureteral trauma and urine leakage requires relief with a nephrostomy tube. 
Often these tube insertions are more complicated because it generally is no hy-
dronephrosis due to urine leakage.
Learning Objectives:
1.  To learn how to manage a patient with ureteral obstruction.
2.  To understand when and how to treat a patient with ureteral trauma.
3.  To learn more about how to perform a nephrostomy.
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functions will be underlined. Clues to clinical/radiological differential diagnoses of 
most common conditions and radiological features at the anterior cranial fossa 
will be highlighted.
Learning Objectives:
1.  To learn the imaging techniques of the anterior skull base with an emphasis 
on the olfactory apparatus.
2.  To become familiar with the imaging findings.
3.  To understand how to differentiate between lesions in the anterior skull base.
A-310 16:30
B. Middle cranial fossa pathologies 
A. Borges; Lisbon/PT (borgalexandra@gmail.com) 
The central skull base (CSB) is a complex anatomic area pierced by a variety of 
foramina and canals which provide crossroads for disease spread between the 
extracranial head and neck and the middle cranial fossa. Of utmost importance are 
the cavernous sinuses located intracranially on each side of the sphenoid body and 
the pterygopalatine fossa in the extracranial compartment,squeezed between the 
posterior wall of the maxillary sinus and the base of the pterygoid plates.Besides 
intrinsic pathology originating from the bone structures composing the central skull 
base and systemic disease, the CSB can also be involved by intracranial lesions 
and those originating from different compartments of the suprahyoid neck. Imaging 
bares a tremendous impact on the diagnosis and patient’s management as this 
area is essentially occult to clinical examination. CT and MRI have a complimentary 
role in the evaluation of CSB lesions providing a roadmap of bone and soft tissue 
involvement, respectively. Often, tailored imaging technique is mandatory to answer 
specific clinical questions. Here, we present a radiology friendly approach to central 
skull base pathology based on the site of origin, pattern of growth and imaging 
characteristics of different lesions, highlighting the most important features in the 
differential diagnosis and in treatment planning.
Learning Objectives:
1.  To become familiar with imaging strategies for the middle cranial fossa.
2.  To know more about imaging findings of common lesions.
3.  To learn how to differentiate between the lesions in middle cranial fossa.
A-311 17:00
C. Posterior cranial fossa pathologies 
H. Tanghe; Rotterdam/NL (tanghe@planet.nl) 
The jugular foramen is an opening in the skull base. The radiologic evaluation 
requires high quality imaging with CT and MR. Angiography is reserved for preop-
erative embolisation. It is important to recognize the “pseudo lesions”. The most 
common tumour of the jugular foramen is the paraganglioma. The second is the 
schwannoma of the lower cranial nerve causes, the jugular foramen meningioma 
is the third most common. The differential diagnosis shall be discussed. The cer-
ebellopontine angle (CPA) and the internal auditory canal (IAC): The IAC is a bony 
conduit for several nerve’s and a vessel: the neuro-vascular bundle. The CPA is 
a cistern of the peripheral cerebral spinal fluid, and several anatomical structures 
goes through this cistern, it is also the place of some frequent disease processes. 
Most of the lesions in the CPA are benign tumours with in order of frequency: 
vestibular schwannoma and meningioma. The third most common lesion is a 
benign cystic lesion: the epidermoid cyst. In the IAC you can encounter the same 
benign tumoural lesion as in the CPA, but also inflammatory lesions, viral lesions 
and malign lesions. Why is it important in your imaging protocol of the IAC and 
CPA region to use gadolinium? The differential diagnosis of the different lesions 
shall be discussed.
Learning Objectives:
1.  To learn the imaging techniques in the posterior cranial fossa.
2.  To become familiar with the imaging findings of common posterior cranial fossa 
pathologies.
3.  To understand how to differentiate between the lesions in the posterior cranial 
fossa.
has limited availability and it is often not suitable for restless patients and those 
with some metallic implants.
Learning Objectives:
1.  To learn about state-of-the art imaging in cases of suspected stroke.
2.  To discuss potential pros and cons of using MR and CT.
3.  To become familiar with most recent innovations in stroke imaging.
A-308 17:00
C. Interactive case discussion: what is next after diffusion and perfusion? 
A. Dörfler; Erlangen/DE (arnd.doerfler@uk‑erlangen.de) 
The management of acute ischemic stroke is rapidly developing. Clinical data sug-
gest that interventional stroke treatment may provide superior clinical outcomes 
when compared with intravenous thrombolytic therapy only. However, organized 
and comprehensive stroke care is currently delivered in only a few cerebrovascular 
centers providing an efficient system for rapid diagnosis and especially dedicated 
interventional stroke treatment. Delivery of expert and timely neuroendovascular 
interventions to a large number of acute stroke patients is challenging. Especially 
advanced neuroimaging capabilities have shown to be crucial for patient selection 
for subsequent aggressive therapies. Hereby the combination of various imaging 
techniques may help to differentiate patients who may profit from intravenous or 
interventional therapy in an even extended time window from those who do not. 
Regarding our own experience, „multimodal MR imaging“ and a mismatch between 
findings on diffusion and perfusion MR images may be pragmatically used to predict 
the presence of a penumbra and provide substantially greater information about 
brain ischemic pathophysiology and overall a more sensitive diagnosis for acute 
stroke, especially in patients with an uncertain time window of symptom onset and 
vertebrobasilar ischemia. The current presentation focuses on our imaging work-
flow and algorithm of patient selection. A focus is put on interactive clinical cases, 
subsequent interventional stroke treatment and on some organisational aspects 
necessary for providing a comprehensive neurointerventional stroke service. 
Learning Objectives:
1.  To become familiar with typical cases demonstrating the crucial role of imaging 
modalities in the diagnosis and treatment decision-making in ischaemic stroke.
2.  To consolidate knowledge of the selection of the appropriate imaging technique, 
image interpretation and image based treatment recommendation.
3.  To learn about the importance of imaging for treatment decisions and planning.
16:00 - 17:30 Room D2 
Head and Neck 
RC 1108 





A. Anterior cranial fossa with special emphasis on olfactory 
apparatus lesions 
T.P.J. Duprez; Brussels/BE (thierry.duprez@uclouvain.be) 
Medical imaging has nowadays integrated the diagnostic armamentarium of anos-
mic patients regarding not only qualitative assessment of the olfactory tract but 
also quantitative evaluation of olfactory bulb volumes which are known to closely 
correlate to the olfactory function. Many clinical studies in various pathological 
conditions have evidenced the value of such measurements in the work-up of 
olfactory dysfunction for both aetiologic and prognostic purposes. Imaging work-up 
also plays a role in the medico-legal evaluation of post-traumatic anosmia together 
with electrophysiological and clinical olfactory testings. Technical improvements in 
fibre tracking (FT) using diffusion-tensor imaging (DTI) and appropriate designs of 
olfactory stimulation at BOLD-based functional MRI (fMRI) are expected to allow 
insights into the neurophysiological processes and circuitry of olfaction in a very 
near future. Imaging work-up of the anosmic patients will be the corner stone of 
this lecture. The relevance of the different imaging techniques will be detailed. 
Beyond the work-up of anosmia, a comprehensive overview of the most common 
lesions of the olfactory tract seen in clinical practice will be given. Additional review 
of lesions observed at the anterior cranial fossa near the olfactory tract will be done 
which comprehensively includes all commonly observed developmental, traumatic, 
inflammatory and neoplastic conditions that are not arising from the olfactory tract. 
Their potential impact on the olfactory function or on other sensory/neurological 
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to be aware of the imaging appearance to avoid misdiagnosis and inappropriate 
treatment, and to be familiar on new functional MRI sequences (DWI-DCE) to 
improve the diagnostic work-up. Soft-tissue tumours/tumour-like lesions about the 
knee include a wide variety of entities, ranging from cysts or anatomical variants 
to aggressive high-grade sarcomas. Special vigilance in evaluation is warranted 
when a soft-tissue mass is not in the typical position or does not have other 
characteristic features of a cyst, when the size of the mass or the accompanying 
symptoms seem out of proportion to the injury or underlying degenerative process, 
and when symptoms persist beyond what is expected. It is essential to be familiar 
with the imaging characteristic appearance of these lesions to allow a confident 
diagnosis as most of these lesions are benign. A complete review of the spectrum 
of soft tissue lesions will be performed: sarcomas, lipoma, haematoma, haeman-
gioma, chondroma, synovitis, bursae-cysts like lesions intra and para-articular, 
haematoma, ossifications, aneurysms, adventitial disease or anatomical variants 
such as accessory gastrocnemius muscle. Not only the most common lesions will 
be discussed but also less common but important lesions with characteristic US 
and/or MRI appearance. 
Learning Objectives:
1.  To know more about the spectrum of intra and para-articular soft tissue tumours, 
and soft tissue tumour-like lesions.
2.  To become familiar with US and MRI findings of specific soft tissue lesions.
Panel discussion:  
What are the remaining clinical questions that imaging currently 
cannot answer and how can we answer them in the future? 17:14 
16:00 - 17:30 Room E2 






Cholangiocarcinoma comprises carcinomas arising from the biliary duct system and 
can be divided into intra- and extrahepatic cholangiocarcinomas. Depending on the 
tumour localisation and extent, local and systemic therapy differs. Especially surgical 
therapy, which is the cornerstone of treatment in many patients, is demanding and 
complex. Radiology plays a key role in the primary diagnosis of this disease, therapy 
decision making, preparation for surgery, and image-guided locoregional therapy. 
An interdisciplinary experienced team is needed for the selection and performance 
of the appropriate diagnostic and therapeutic sequence in an individual patient. The 
diagnostic and interventional radiologist in this team has to know about surgical 
and clinical relevance of imaging findings and needs profound understanding of the 
potential of the different therapy options. This session gives an insight into experi-
ences from the past and future concepts in the cholangiocarcinoma management 
provided by an expert team of clinicians from surgery, oncology, and radiology. 
Session Objectives:
1.  To learn about state-of-the-art diagnosis of cholangiocarcinoma.
2.  To understand the value of surgical and systemic strategies in therapy.
3.  To appreciate image-guided interventional treatment.
A-317 16:05
Surgery of hilar and extrahepatic cholangiocarcinoma 
P. Neuhaus; Berlin/DE (peter.neuhaus@charite.de) 
The characteristic growth pattern of hilar cholangiocarcinoma with periductal 
infiltration makes curative tumour resection with appropriate safety margins dif-
ficult. Therefore, a radical surgical strategy is required and extrahepatic bile duct 
resection alone is considered as palliative procedure, and recurrence is inevitabley. 
Extended hepatectomies have evolved as curative treatment standard - adequate 
liver function provided. If permitted by tumour extension and liver volumes, a right-
sided hepatectomy is preferable, because of its higher radicality compared to left 
hemihepatectomies. Due to the biliary anatomy, a R0 resection is more likely in right 
hemihepatectomies, since the left hepatic duct has a longer extrahepatic course, 
which facilitates an adaequate safety margin. In addition, a second critical step, the 
dissection of the right hepatic artery running dorsally close to the tumour region, 
can be avoided. Major drawback of right trisectionectomies is a low-remnant liver 
volume, leading to an elevated perioperative risk. Therefore, optimal conditioning 






F.M.H.M. Vanhoenacker; Antwerp/BE (filip.vanhoenacker@telenet.be) 
MRI of the knee joint is one of the most requested examinations in most MR depart-
ments. Most MRI exams are performed for evaluation of internal derangement of 
the joint due to trauma or (degenerative) cartilage lesions. Inflammatory disorders 
and infectious processes about the knee may cause significant morbidity and 
therefore early detection is of utmost importance. Soft tissue tumours (STT) and 
pseudotumours around the knee joint comprise a heterogeneous group of benign 
and malignant lesions. This integrated RC on the knee will provide an up-to-date 
overview of the role of imaging in the diagnosis and planning of treatment strategy 
of knee trauma, inflammation and soft tissue lesions. Current controversies and 
remaining clinical questions include the role of high-field MR imaging, imaging 
evaluation of clinical instability patterns, evaluation of disease activity of inflamma-
tory disorders and response to Disease Modifying Anti-Rheumatic Drugs treatment 
and the role of functional imaging in the evaluation of STT.
A-313 16:05
A. Patterns of injury 
P. Van Dyck; Antwerp/BE (pieter.van.dyck@uza.be) 
Traditional classification systems for knee joint instability include straight, rotational 
and combined types of knee instability. The basic consideration in this classifica-
tion is the status of the posterior cruciate ligament after injury. Correct diagnosis 
of knee instability is not a simple matter. Much controversy remains as to which 
ligaments are being tested during the standard clinical knee laxity tests. This 
sometimes leaves the clinician, even the most experienced ones, confused as to 
what the laxity tests really show. In addition, the arthroscope cannot fully assess 
the unstable knee. Thus, the addition of the information provided by magnetic 
resonance (MR) imaging can be extremely helpful in order to establish prognosis 
and plan for definitive treatment. Therefore, a thorough knowledge and recognition 
of the different knee ligament instability patterns by radiologists is essential to ac-
curately report the findings on MR and to heighten awareness for specific injuries 
to improve their detection.
Learning Objectives:
1.  To know more about the imaging appearances of soft tissue and osteoarticular 
injury.
2.  To become familiar with the patterns of bone and soft tissue injury in the knee.
A-314 16:28
B. Inflammatory disease 
A. Cotten; Lille/FR (anne.cotten@chru‑lille.fr) 
Inflammatory disorders of the knee are mainly related to infectious or rheumatic 
diseases, but other disorders can be associated with a similar clinical, biological or 
radiological presentation, including degenerative and crystal-induced diseases, and 
tumours. The bone, the joint and/or the soft tissue can be affected. The aims of this 
lecture are to present the main radiological features of the different inflammatory 
disorders encountered at the knee, the usefulness of each imaging modality and 
the more frequent misdiagnoses when such a condition is suspected.
Learning Objectives:
1.  To know more about the imaging appearances of soft tissue and osteoarticular 
inflammation.
2.  To become familiar with imaging findings of specific inflammatory conditions.
A-315 16:51
C. Soft tissue tumours/tumour-like lesions 
J.C. Vilanova; Girona/ES (kvilanova@comg.cat) 
Because MRI of the knee is the most frequent examination, so does the frequency 
of encountering incidental soft tissue tumour/tumour-like lesions in and about the 
knee. Although, sometimes imaging techniques are requested due to symptoms 
related to a soft tissue lesion around the knee. It is important for the radiologist 
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A-320 16:50
Radiology - diagnostics and image guided therapies in intrahepatic 
cholangiocarcinomas 
B. Gebauer; Berlin/DE (bernhard.gebauer@charite.de) 
Approximately 5-10 % of all cholangiocarcinomas (CC) are intrahepatic cholangi-
ocarcinomas (ICC). Because of the lack of symptoms ICCs are usually later diag-
nosed, compared to extrahepatic CCs. ICCs are subclassified in a mass-forming, 
a periductal infiltrating and an intraductal ICC. Mass forming ICC is characterised 
by usually large hypovascular, intrahepatic mass in CT or MRI. Periductal infiltrat-
ing and intraductal ICCs usually present with a cholestasis distal to the tumour. 
Tumourthrombosis of intrahepatic portal vein branches is often associated with 
ICCs. Therapy of first choice is surgical resection, however only 10-30% are surgical 
candidates. Local tumour ablation using thermal (e.g. RFA, MWA) or radiogenic 
(e.g. CT-brachytherapy) are alternatives in non-surgical patients with localised 
disease. For RFA a maximum of 5 cm with a maximum of 5 lesions is commonly 
accepted as the upper limit. ICCs are often centrally in the liver with limitations to 
thermal ablation (e.g. heat sink effect). Radiogenic ablation (e.g. CT-guided brachy-
therapy) is suitable to overcome size and location limitations of thermal ablation. 
In unresectable, disseminated ICC whole liver treatment strategies (e.g. hepatic 
arterial infusion (HAI) or radioembolisation) could be an alternative to systemic 
chemotherapy. Liverarterial ports could be implanted by interventional radiologist 
(IR) using either the femoral or the subclavian artery as access site. Transarterial 
chemoembolisation (TACE) with doxorubicin and cisplatin as therapeutic agents is 
often performed in ICCs with median survival rates of 9-28 months. Radioemboli-
sation with admission of Y-90 loaded particles via the liver artery into the tumour 
demonstrated a median survival of 9.3-22 months.
Learning Objectives:
1.  To learn about image guided therapy decisions.
2.  To learn about local ablation in non-surgical candidates (RFA, CT-brachyther-
apy).
3.  To learn about intra-arterial port implantation.
4.  To learn about transarterial radioembolisation.
Author Disclosure:
B. Gebauer: Other; Sponsorship for studies or traveling expenses or proctoring: 
Perceptive Inf. /Parexel, C. R. BARD, SIR-Tex Medical, AGA Amplatzer/St. Jude 
Medical, Cook, Angiodynamics/RITA, Bayer-Schering. 
Case presentation (part 1): hilar cholangiocarcinoma 17:05 
Case presentation (part 2): CCC multimodal treatment 17:17 
16:00 - 17:30 Room F1 
Special Focus Session 
SF 11 
Adults with congenital heart disease (GUCH) 
A-321 16:00
Chairman’s introduction: Why should a radiologist gather 
information on GUCH patients? 
M. Gutberlet; Leipzig/DE (matthias.gutberlet@herzzentrum‑leipzig.de) 
The numbers of newborns with congenital heart disease (CHD) is not rising but the 
number of infants with congenital heart disease who achieve adulthood is constantly 
increasing due to improved medical treatment especially in cardiac surgery and 
pediatric cardiology. The imaging modality of choice during infancy in patients with 
congenital heart disease is echocardiography. But in older patients, especially after 
cardiac surgery, it becomes very often more and more difficult to achieve an ad-
equate acoustic window to assess important anatomical structures. In particular the 
visualisation of the right ventricle, which is involved in many CHD, becomes difficult. 
Therefore, all cross-sectional imaging modalities, especially magnetic resonance 
imaging but also computed tomography, and also the radiologist comes into play. 
Session Objectives:
1.  To learn about the increasing number of GUCH patients.
2.  To appreciate the importance of lifelong imaging follow-ups.
3.  To become familiar with the need for specialised GUCH centres.
Author Disclosure:
M. Gutberlet: Research/Grant Support; BmBF (German Federal Ministry of 
Education and Research), Competence Network of Congenital Heart Defects. 
Speaker; Bayer, Bracco, Siemens, Philips, GE. 
of the liver is mandatory. This includes decompression of cholestasis via ERc or 
PTC, portal embolisation of the right lobe and treatment of cholangitis. However, 
in about 30%, severe atrophy of the left lobe due to long-standing cholestasis or 
occlusion of the left portal branch interdicts an extended right hemihepatectomy. 
For tumours below the cystic duct junction, surgery consist of partial pancreato-
duodenectomy. In case of additional hilar involvement, combined hepatectomy and 
pancreatic resection might be considered in selected cases. Depending on tumour 
characteristics and surgical methods 5-year survival rates of 20-50 % have been 
reported after curative major liver resection.
Learning Objectives:
1.  To become familiar with prognosis depending on the evolution of surgical 
approach.
2.  To become familiar with surgical decision making: left/right liver resection, hilar 
resection, pancreatic head resection.
3.  To become familiar with technique of extended right hemihepatectomy.
4.  To become familiar with liver function, volume.
5.  To become familiar with biliary decompression left/right, internal/external.
A-318 16:20
Radiology - diagnostics and portal vein embolisation in hilar and 
extrahepatic cholangiocarcinoma 
T. Denecke; Berlin/DE (timm.denecke@charite.de) 
In hilar and extrahepatic cholangiocarcinoma, en-bloc resection of the tumour 
is prognostically advantageous. This requires accurate diagnosis of the tumour 
before the resection. Some pitfalls may occur due to benign lesions mimicking 
cholangiocarcinoma with stricture of the biliary duct; the sequence of diagnostic 
imaging (including MRI with MRCP, CT, and ERC/PTC), examination protocol, and 
brush cytology help to avoid these. Furthermore, the prediction of the actual tumour 
extent has to be accurate. This necessitates not only accurate imaging but also 
a standardised terminology and classification system to enable non-ambiguous 
communication between the surgeon, gastroenterologist, and radiologist. This 
regards the tumour extent concerning bile ducts, portal vein, and hepatic arteries. 
Besides the local tumour extent, also the liver configuration and volume of the future 
liver remnant determine the possibility of surgery and the surgical technique. If too 
small, hyperplasia of the left-sided liver remnant in preparation of extended right 
liver resection can be achieved by right portal vein embolisation. Distinct volumetric 
and functional analysis of the embolized liver is performed also after embolisation 
to avoid hepatic insufficiency after the resection.
Learning Objectives:
1.  To learn about diagnosis/differential diagnosis.
2.  To learn about surgical planning through imaging: bile ducts, vascular system, 
hyperplasia induction, liver function testing.
A-319 16:35
Medical treatment of cholangiocarcinomas 
H. Riess; Berlin/DE (hanno.riess@charite.de) 
The purpose of medical treatment in patients with biliary tract cancers is to improve 
survival and quality of life. In the postoperative setting, adjuvant chemotherapy has 
been investigated alone or in combination with radiotherapy, however its role is 
still undefined, but it should be considered. Most patients present with unresect-
able or relapsed cancer. To ensure biliary drainage and to prevent cholangitis 
and biliary abscess formation is an essential prerequisite prior to the application 
of cytotoxic drugs. A few prospective randomised controlled trials demonstrated 
a survival benefit of chemotherapy as compared with best supportive care alone 
and improvement of quality of life has been confirmed. The combination regimen 
of gemcitabine combined with cisplatin (or oxaliplatin) has been recognised as 
standard therapy. Beyond these, other cytotoxic drugs have to be considered 
experimental. The same is true for molecular-targeted therapies due to the fact 
that to date only a few agents have been tested in this disease. Due to the fact 
that biliary tract cancers may remain limited to the liver for a long period of time 
hepatic arterial infusions therapy has been used with success but its role is still 
undefined. This and various issues remain to investigated in the setting of large 
cooperative clinical trials. 
Learning Objectives:
1.  To become familiar with chemotherapy of extrahepatic cholangiocarcinoma.
2.  To become familiar with treatment concepts for intrahepatic cholangiocarci-
nomas.
3.  To become familiar with systemic vs. intra-arterial chemotherapy.
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or flow quantification e.g. through baffles or in dysfunctional valves after surgical 
repair, 3. excellent soft tissue contrast enabling tissue characterisation. Both, MR 
and CT are powerful tools for imaging grown-up congenital heart disease. Thus, 
imaging should be tailored to the specific needs of the patient, desired information 
and available expertise and equipment.
Learning Objectives:
1.  To learn about the pros and cons of different imaging modalities for GUCH 
patients.
2.  To become familiar with imaging of the most common entities in GUCH.
3.  To consolidate knowledge of imaging protocols after surgical correction of 
CHD.
Panel discussion:  
Can we now get all the information we need to treat GUCH patients, 
non-invasively? 17:20 
16:00 - 17:30 Room F2 






Medical imaging has always been personalized as it provides individual assess-
ment of the location and extent of an abnormality, and in the future, it will prove 
fundamental to almost all aspects of personalized medicine. Stratification based 
on imaging biomarkers can help identify individuals for preventive intervention and 
can improve disease staging. In vivo visualisation of loco-regional physiological, 
biochemical, and biological processes using molecular imaging can detect diseases 
in pre-symptomatic phases or facilitate individualized drug delivery. Furthermore, 
imaging is essential to patient-tailored therapy planning, therapy monitoring, and 
follow-up of disease progression, as well as targeting non-/minimally-invasive 
treatments, especially with the rise of theranostics. For personalized medicine to 
reach its highest potential, medical imaging must be an integral part. Radiologists 
need to be prepared for this new paradigm as it will mean changes in training, in 
research, and in clinical practice. Following an in-depth explanation of the role of 
predictive, prognostic and personalized medicine for modern health-care, given by 
the Secretary General of EPMA, renowned experts in the different fields of personal-
ized medical imaging will give an insight into the recent developments in this new 
area of our profession. The presentation will be followed by a panel discussion. 
Session Objectives:
1.  To understand the concept of personalised radiology.
2.  To get an overview of the role of imaging in personalised medicine.
3.  To learn about the concept of personalised medicine and personalised health-
care.
A-326 16:06
Personalised medicine: hope or hype? 
O. Golubnitschaja; Bonn/DE (Olga.Golubnitschaja@ukb.uni‑bonn.de) 
1. Current healthcare: what is behind the issue? For many acute and chronic disor-
ders, the current healthcare outcomes are considered as being inadequate. In fact, 
severe chronic pathologies such as cardiovascular disorders, diabetes and cancer 
are treated after onset of the disease. Pessimistic prognosis considers pandemic 
scenario for type 2 diabetes mellitus, neurodegenerative disorders and some types 
of cancer over the next 10-20 years followed by economic disaster of healthcare 
systems in a global scale. 2. Advanced healthcare tailored to the person: What 
is beyond the issue? Advanced healthcare promotes the paradigm change from 
delayed interventional to predictive medicine tailored to the person, from reactive 
to preventive medicine and from disease to wellness. The innovative Predictive, 
Preventive and Personalised Medicine (PPPM) is emerging as the focal point of 
efforts in healthcare aimed at curbing the prevalence of both communicable and 
non-communicable diseases such as diabetes, cardiovascular diseases, chronic 
respiratory diseases, cancer and dental pathologies. Cost-effective management of 
diseases and critical role of PPPM in modernisation of healthcare is acknowledged 
as priorities by global and regional organizations and health-related institutions (UN, 
EU, NIH, etc). 3. Why integrative medical approach by PPPM as the medicine of 
the future? PPPM is the new integrative concept in healthcare. Expected outcomes 
are conducive to more effective population screening, prevention early in childhood, 
A-322 16:05
A list of typical surgical procedures: the top ten in GUCH 
M. Hübler, D. Hitendu, M. Schweiger, M. Greutmann; Zurich/CH 
(michael.huebler@kispi.uzh.ch) 
Advances in the treatment of congenital heart disease (CHD) in pediatric cardiac 
care have resulted in an increasing number of grown up congenital heart (GUCH) 
patients. More than 90% of those diagnosed with CHD will now survive into adult-
hood thus increasing the prevalence of CHD in adults to about 0.4% of the general 
population. In the near future the number of GUCH patients will be exceeding 
those pediatric patients with CHD. Unfortunately quite a considerable number of 
GUCH patients will have anatomic and physiologic abnormalities. At least 10% 
of them suffer even from severe lesions with an urgent need for medical and/or 
interventional and/or surgical therapies. Echocardiography plays a key role as a 
diagnostic tool but specially in complex post-operative anatomies cross-sectional 
imaging techniques were indispensible. Almost two third of surgeries in GUCH 
patients were first surgical procedures. One third of them being single or multiple 
reoperations. Percentage of frequent surgeries in GUCH patients: Aortic valve /
LVOT procedures: 25%; Tetralogy of Fallot repair/pulmonary valve replacement: 
16%; Atrial septal defect surgery: 15%; Aortic arch/coarctation operations: 13%; 
Ventricular septal defect surgery: 10%; AV-valve repair: 8%; Univentricular heart/
Fontan procedures: 6%; Transposition complex: 3%; Ebstein-repair: 2%; Heart 
transplantation/Mechanical circuclatory support: 2%. Median age of the patients 
was 36.5 years (range limits 18.0 - 72.2 years). Perioperative mortality was higher 
after palliative surgery than after corrective surgery and was highest among pa-
tients withuniventricular heart (20%) and transposition of the great arteries 12 (%). 
Learning Objectives:
1.  To become familiar with the most common surgical procedures in congenital 
heart disease (CHD).
2.  To know more about the typical postoperative problems in GUCH patients.
3.  To learn about how imaging can help the cardiac surgeon.
A-323 16:30
‘Adults are not just big children’: differences between children and adults 
A.M. Taylor; London/UK (a.taylor76@ucl.ac.uk) 
Though the assessment of congenital heart disease shares many similarities 
across all ages, there remain specific issues for those with adult, or gown-up, 
congenital heart disease. These include: the importance of cross-sectional imaging 
(MRI & CT) due to the difficulty of echocardiography in many patients (poor echo 
windows, complex vascular anatomy) in this patient group, the presence of histori-
cal operative procedures and anatomies (e.g. patients with Senning and Mustard 
procedures) that are now vary rarely seen in the paediatric population, and, as the 
adult population with congenital heart disease ages, the ever increasing burden of 
atherosclerosis and other common disease of ageing. This presentation will outline 
the role of cross-sectional (MRI & CT) for assessing patients with adult congenital 
heart disease, with focus on pre-procedural planning and post-procedural following. 
Learning Objectives:
1.  To understand the age dependency in the selection of imaging modalities.
2.  To learn about radiation exposure issues in GUCH patients.
3.  To understand what the difference between imaging of children and adults.
Author Disclosure:
A. M. Taylor: Advisory Board; Medtronic. Employee; UCL Institute of 
Cardiovascular Science. Grant Recipient; Siemens, Medtronic, UK NIHR, 
UK DH. Research/Grant Support; Siemens – Research agreement. Speaker; 
Siemens – ESC Munich. 
A-324 16:55
Which modality, for which patient? MRI or CT, that’s the question 
J. Bremerich; Basle/CH (jbremerich@uhbs.ch) 
Both, MR and CT provide relevant information on cardiac morphology and func-
tion for management of CHD. Arguments in favour of CT are 1. short acquisition 
time which is particularly relevant in patients with limited capability to cooperate; 
2. high sensitivity and specificity for calcification in pericardial/valvular disease or 
after surgical repair; 3. submillimeter spatial resolution enabling precise measure-
ments for procedure planning or assessment of small structures such as atrial 
baffle stenosis after atrial switch procedure; 4. short bore with the patients head 
located outside the scanner, which is particularly helpful in claustrophobia; 5. 3D 
datasets enabling postprocessing in any desired plane and slice thickness; 6. no 
restrictions related to electric implants. Arguments for MR on the other hand are 
1. no radiation required which is particularly relevant for repeated imaging in this 
young patient group, 2. capability of imaging cardiac function with the goldstandard 
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A-329 16:54
Role of imaging in personalised therapy monitoring 
A.R. Padhani; Northwood/UK (anwar.padhani@stricklandscanner.org.uk) 
Many imaging biomarkers have emerged which individually or collectively provide 
unique information on tumour behaviour including response to treatment. There 
are several requirements that must be met before imaging biomarker (s) can be 
considered as being able to direct a person’s management. First, the biomarker 
should have a known biologic basis with a recognised method for quantification 
and to be adequately validated. With regard to the latter, it is important that the 
biomarker reports on/measures biologically meaningful cellular/tissue process such 
as reporting on cell death, on angiogenesis, proliferation and metabolic shutdown 
NOT simply conveying information on receptor occupancy or down regulation of 
pathways that may or may not be important. Data acquisition procedures should 
have been optimised and the test’s performance should have been established. 
The level of change in the imaging biomarker that can be considered as real should 
be known (that is, the measurement error). Reproducibility needs to have been 
determined by appropriately powered test-retest studies. Imaging biomarkers can 
only be useful if they can detect biologically meaningful effects directly related to 
treatments (that is, magnitude of biological effects detected must be greater than 
the reproducibility/measurement error) at appropriate time points to be able to 
effect patient management. Finally, it must be know how much therapy-induced 
change is meaningful in terms of patient benefit in terms of hard clinical endpoints 
such as surgical resectability, organ preservation, progression free and overall 
survival, etc. These aspects will be considered in detail using practical examples.
Learning Objectives:
1.  To become familiar with the general role of imaging in treatment monitoring 
and drug development.
2.  To understand the requirements of imaging biomarker development for treat-
ment monitoring in personalised medicine.
3.  To understand how to develop the evidence base so that imaging biomarkers 
can be used for personalised therapeutic approaches.
Author Disclosure:
A. R. Padhani: Advisory Board; Siemens HeathCare. Speaker; Siemens 
HeathCare. 
Panel discussion:  
Is imaging providing an added value to the ‘omics’ of personalised 
medicine? 17:10 
16:00 - 17:30 Room G/H 
Neuro 
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A. Diffusion-weighted imaging (DWI) and diffusion tensor imaging (DTI) 
M. Law; Los Angeles, CA/US (meng.law@usc.edu) 
We have made significant progress in the application of advanced MRI techniques, 
such as DWI and DTI. DWI has certainly been useful in differentiating acute 
ischaemic stroke from other pathologies that could mimic stroke, such as demy-
elinating lesions, tumours and inflammatory disease. DTI has gained popularity 
in visualisation of the white matter tracts for pre-surgical planning. We will review 
how DTI can be used in this setting. We will also review what the challenges and 
pitfalls are for using DTI, fiber tractography (FT) and fractional anisotropy (FA) 
maps for pre-surgical planning. These include the need for standardization of 
acquisition techniques (direction, stopping criteria), processing, visualisation and 
quantitation of DTI metrics. We will also review what errors have been reported 
with using FT and FA maps when compared with intra-operative electrophysiologic 
mapping. DWI, functional diffusion maps and DTI have also been used in the pre 
and post-therapeutic brain. We will review potential applications in characterisa-
tion of pseudoprogression, pseudoresponse and radiation necrosis. In addition, 
how diffusion can potentially help in predicting a favourable therapeutic response 
to chemo-radiation. Finally, as there are some challenges and limitations, we will 
review some of the controversies about DTI, FT and whether in fact these tools 
are ready, reliable or really needed in clinical practice. Perhaps review what needs 
to be done to make these tools essential and easy to use in everyday practice.
identification of persons at-risk, stratification of patients for optimal therapy planning, 
prediction and reduction of adverse drug-drug or drug-disease interactions relying 
on emerging technologies: medical imaging, pharmacogenetics, pathology-specific 
molecular patters, disease modelling, individual patient profiles, etc.
Learning Objectives:
1.  To understand the definition of personalised medicine.
2.  To learn about some of the successful examples of personalised healthcare.
3.  To understand the present limitations in adapting personalised medicine.
A-327 16:22
Imaging for disease prediction 
M. Vernooij; Rotterdam/NL (m.vernooij@erasmusmc.nl) 
Epidemiology being a group-level discipline, it seems a long way off from per-
sonalized or individual-level medicine. But nothing could be less true. Regarding 
personalized medicine as stratified medicine, it is exactly this stratification that 
is enabled by results from epidemiological group-level studies. Increasingly, it is 
being realized that population studies will play a key role in achieving the medical 
paradigm shift from “cure” to “prevention”. The large-scale application and analysis 
of medical images in controlled population cohorts is known as Population Imaging. 
It centers on the non- or minimally invasive assessment of structural and functional 
changes that may reflect specific pathology. The new imaging techniques that are 
currently applied in population studies are likely to be the beginning of an ava-
lanche in epidemiologic studies of many diseases. Population Imaging enables 
epidemiologists to study disease at an earlier stage than when a clinical diagnosis 
can be made, allows for objective assessment of the disease or trait, and makes 
repeated assessment possible. Of essential importance is that recent developments 
in image data acquisition and analysis make it feasible to use these techniques 
at a large scale. Yet, this poses increasingly high demands on data management 
and storage infrastructures that are both costly and technically demanding. Other 
potential drawbacks include that population imaging is subject to important ethical 
considerations - for example, regarding incidental abnormalities - and is critically 
looked at regarding valorization of results. This presentation will discuss Population 
Imaging and its role in improving models for disease prediction and prevention.
Learning Objectives:
1.  To learn about population imaging.
2.  To become familiar with the role of imaging in disease prediction.
3.  To understand the need for validated imaging biomarkers.
A-328 16:38
Molecular imaging: a solution for personalised diagnosis and treatment? 
F.M.A. Kiessling; Aachen/DE (fkiessling@ukaachen.de) 
With increasing knowledge in molecular mechanisms of diseases, the number of 
therapeutics that specifically block disease-related pathways rise. However, due 
to the heterogeneity of tumours, not all patients will benefit from these specific 
therapies. Therefore, advanced in vitro and in vivo diagnosis is required to pre-
select patients to therapy, to monitor therapy response and to optimise doses 
and combinations of therapeutics. Molecular imaging can be used to characterise 
pathologies by their particular molecular profile. By this, pre-selection of patients, 
therapy optimisation and monitoring and sensitive therapy response assessment 
become feasible. Another important aspect of personalised diagnosis is the en-
hanced permeability and retention (EPR) effect. Many drugs will only be effective 
if they sufficiently extravasate in the target tissue to reach the tumour cells. In this 
respect, theranostic agents (drugs with imaging markers) can help to investigate 
whether EPR is high enough to justify its use. Even more, there are agents that 
slowly release drugs from carriers (e.g. liposomes, hydrogels or polymers). In this 
case, not only EPR is interesting to be monitored but also the release kinetics and 
the effectiveness of the drugs at the target tissue. In this context, release of drugs 
can be triggered and controlled by imaging, as it was shown for microbubbles 
carrying drugs or genes.
Learning Objectives:
1.  To become familiar with the role of molecular imaging for disease localisation 
and characterisation, patient selection to therapy and therapy monitoring.
2.  To learn about individualised image-guided drug delivery systems.
3.  To understand the concept of theranostics: the combination of targeted imaging 
and targeted therapy.
Author Disclosure:
F. M. A. Kiessling: Board Member; ESR Research Board, Concil ESMI. 
Founder; invivoContrast GmbH. Grant Recipient; DFG, BMBF, EU, GIF. 
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A. Mycobacterial infections 
C. Beigelman; Lausanne/CH 
Primary TB typically presents with consolidation in the middle and lower lobes, 
and necrotic lymphadenopathy. Fibrosis, tuberculomas and calcified nodes may 
result as sequelae. Cavitation and tree-in-bud appearance involving the apical 
and posterior segments of the upper lobes and the superior segments of the lower 
lobes are the hallmarks of reactivation TB, typically seen in immunocompetent 
patients. In immunocompromised patients, primary TB findings are more commonly 
observed, as miliary or disseminated disease or atypical manifestations in case 
of severe immunosuppression. Pleural effusion and tracheobronchial involvement 
may be observed. The “classical” appearance of Non-TB mycobacteria (NTM), less 
common and more indolent than TB, typically affects males more than 50 years old 
with pre-existing pulmonary disease or underlying immunologic disorder. Despite 
a great overlap in the radiologic appearances of both infections, the presence 
of cavities on sites other than than the upper lobes should suggest a NTM infec-
tion. The “nonclassical” form related to MAC infection that predominantly affects 
elderly women with no pre-existing pulmonary disease mainly consists in mild 
bronchiectasis and centrilobular nodules predominantly located in the lingula and 
middle lobe. A high rate of lymphadenopathy and disseminated disease are seen 
in immunocompromised patients. The radiologist has to ensure the diagnosis of 
active TB and mention scarring before starting specific treatments to suggest NTM 
infections, immune reconstitution inflammatory syndrome with paradoxal worsening 
in HAART treated HIV-infected patients as multi-drug resistant TB, to appreciate 
extent of disease and follow-up, to diagnose the complications and to propose MRI 
or PET scans in some situations. 
Learning Objectives:
1.  To appreciate the imaging features of primary and post-primary infections in 
TB.
2.  To learn about the similarities and differences between TB and non-TB my-
cobacterial infections.
3.  To understand the radiologist’s role in diagnosis.
A-334 16:30
B. Infectious disease in immuno-compromised patients 
C.-P. Heussel; Heidelberg/DE 
The appropriate investigation technique, frequently targeted differential diagnosis 
and the special needs of immunocompromized patients are the needs to be un-
derstood by the referring physician as well as by the radiologist. Thus, an intensive 
interdisciplinary co-operation on a patient basis, as well as on a department basis 
is essential. Early detection of a focus is the major goal in febrile neutropenic 
patients. As pneumonia is the most common focus, chest imaging is a special 
radiological task. The sensitivity of chest x-ray, especially in supine position, is 
known to be less. Therefore, the very sensitive thin-section multislice-CT became 
gold standard in neutropenic hosts and might be cost-effective in comparison to 
antibiotic treatment. The infiltrate needs to be localised, so that this information can 
be used as guidance for invasive procedures for further microbiological work-up. 
Furthermore, the radiological characterisation of infiltrates gives a first and rapid 
hint to differentiate between different sorts of infectious (e.g. typical bacterial, 
atypical bacterial, fungal) and non-infectious aetiologies. Follow-up investigations 
need careful interpretation according to disease, recovery, and concomitant treat-
ment. Due to a high incidence of fungal infiltrates, interpretation of the follow-up 
of an infiltrate must use further parameters besides to the lesion size. Besides the 
Learning Objectives:
1.  To appreciate DWI in the characterisation of focal brain lesions.
2.  To understand how to differentiate between tumoural and non-tumoural disease 
using DWI.
3.  To consolidate knowledge on how to combine DWI with other advanced MRI 
tools.
4.  To find out if DTI is really useful in the clinical setting or merely a mathematical 
algorithm of the tensor.
Author Disclosure:
M. Law: Advisory Board; Bayer Healthcare. Consultant; Fuji Inc, iCAD inc. Grant 
Recipient; Bayer Healthcare. Shareholder; Prism Clinical Imaging. Speaker; 
Toshiba America Medical. 
A-331 16:30
B. Perfusion imaging 
Y. Özsunar; Aydin/TR (yeldaozsunar@gmail.com) 
Conventional contrast-enhanced CT and/or MR imaging are the current standard 
techniques for the diagnosis and treatment evaluation of brain neoplasms. However, 
this method is quite limited in its ability to depict the angiogenesis which is a hall-
mark of tumour growth and metastases. To characterise the angiogenesis of brain 
tumours, Perfusion Weighted Imaging (PWI) and Nuclear Medicine Tecniques, such 
as PET and SPECT are used. PWI is an evolving technique proven to be especially 
valuable and practical for the evaluation of central nervous system neoplasia. Both 
exogenous and endogenous tracer methods can be used as in ASL and Dynamic 
Susceptibility Weighted Perfusion Imaging, respectively. Perfusion imaging refers 
to several recently developed techniques that are used to non-invasively measure 
cerebral perfusion via assessment of various haemodynamic measurements, 
such as cerebral blood volume, cerebral blood flow, and mean transit time. These 
techniques have great potential in becoming important clinical tools in the evalu-
ation of pre and post-treated brain tumours. PWI is used to differentiate tumoural 
versus non-tumoural brain masses and primary versus secondary brain tumours. 
The technique helps to grade primary tumours, guide biopsy and surgery, and 
differentiate recurrent tumour from radiation necrosis.
Learning Objectives:
1.  To appreciate the value of perfusion imaging.
2.  To understand why perfusion imaging is needed.
3.  To become familiar with principles, applications, and pitfalls of various perfu-
sion imaging techniques.
4.  To consolidate knowledge of perfusion imaging of various brain masses that 
can be encountered in daily practice.
A-332 17:00
C. Follow-up after treatment 
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se) 
Glioblastoma is the most common primary brain tumour. Due to the ineffective 
therapy, the prognosis of gliomblastoma is poor and has driven the research to find 
new therapeutic agencies. However, despite advanced neuroimaging techniques, it 
remains difficult to predict and to monitor tumour response in individual patients. For 
example, anti-angiogenic therapy may present with decreased contrast enhance-
ment of the tumour and reduced surrounding edema, so called “pseudoresponse” 
since the decreased enhancement can be secondary to an antipermeability effect 
rather than the result of reduction in tumour size. The opposite is seen in the treat-
ment with termozolomide and radiation where an increase in area of enhancement 
is seen that resolves over time - so called pseudoprogression. Both these conditions 
are well demonstrated on conventional MR imaging as well as on advanced MRI 
like diffusion and perfusion imaging. However, they still may cause confusion and 
wrongly results in change of therapy as well as in the interpretation of results of 
Phase I and Phase II clinical trials. To partially address this issue, the MacDonald 
criteria have recently been revised. The present lecture will focus on present 
knowledge and research on the use of advanced imaging to support response or 
progression during ongoing therapy.
Learning Objectives:
1.  To understand the present traditional model for the follow-up and monitoring 
of brain tumour treatment.
2.  To become familiar with different imaging biomarkers for early assessment of 
brain tumour treatment response.
3.  To consolidate presently available knowledge and ideas on brain tumour imag-
ing follow-up for future brain tumour treatment and monitoring of response.
Author Disclosure:
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This distinction between MSCT and CBCT is useful, as there are decisive differ-
ences in application, performance, and in image reconstruction. These differences 
will be reviewed in the presentation, with a particular focus on why image quality 
in MSCT is so much better than in CBCT.
Learning Objectives:
1.  To understand the principles of volumetric image formation with flat detectors.
2.  To understand the difference between CBCT and MSCT.
3.  To learn about reconstruction techniques and image processing.
4.  To become acquainted with the important image quality parameters.
A-337 16:30
B. Medical applications of CB imaging 
M. Grass; Hamburg/DE (Michael.Grass@Philips.com) 
Tomographic x-ray imaging using flat detectors is used today on a variety of dif-
ferent imaging systems. The most important area is cone beam imaging using 
interventional C-arm systems. For these systems, the increasing complexity of 
minimal invasive procedures requires the availability of high-resolution 3D image 
information for intervention planning, guidance and outcome control. Interventional 
volume imaging was first applied in neuroradiology using rotational angiography 
acquisitions. Today, it is used in a wide variety of procedures in interventional radiol-
ogy, cardiology and oncology based on angiographic and soft tissue protocols. One 
of the inherent advantages of this approach is the direct registration of the volume 
images into the interventional procedure for image guidance. Other application 
areas using different scanning systems are on-board imaging in radiation therapy 
or integration of flat detector tomography and SPECT. The course teaches the 
generation of 3D volume information from flat detector systems and its utilisation 
in clinical applications. Image acquisition protocols are introduced and scan modes 
and system design parameters are explained. Application specific calibration and 
processing steps are introduced to show how cone beam imaging is tailored for 
specific clinical applications. Image quality characteristics and their relevance 
for the different clinical applications are discussed. Examples are presented for 
angiographic and soft tissue volumetric imaging. Medical applications utilising 
the reconstructed volume images for diagnosis, intervention planning, guidance 
or outcome control are discussed. Image-guided interventions are presented for 
needle and catheter procedures. Examples for medical applications in radiation 
therapy and nuclear medicine are introduced.
Learning Objectives:
1.  To become acquainted with the applications of CB imaging.
2.  To learn about systems design and parameters.
3.  To understand image quality characteristics.
4.  To learn how to use cone beam images in image guided interventions.
Author Disclosure:
M. Grass: Employee; Philips Research. 
A-338 17:00
C. 3D dentomaxillofacial imaging 
K. Horner; Manchester/UK (keith.horner@manchester.ac.uk) 
In the last decade, three-dimensional dentomaxillofacial imaging through cone-
beam CT (CBCT) technology has become widely available. While uptake amongst 
dentists in Europe is quite low, it is increasing. Dental CBCT (Digital Volumetric 
Tomography; DVT) equipment is compact and often affordable. The driver for 
dental CBCT was implant dentistry, but its use has spread into other areas, includ-
ing paediatric applications. Radiation doses are variable. Some systems offer a 
fixed, large, field of view and others fixed exposure factors, obstructing attempts 
at optimization. Typically, doses are at least an order of magnitude greater than for 
“conventional” imaging. Image quality is also variable, which means that certain 
types of equipment may be unsuitable for some clinical applications. A key aspect of 
using CBCT relates to justification. Imaging in three dimensions may be perceived 
by dentists as inevitably superior, a view which is often implicitly encouraged by 
those selling equipment. The research on diagnostic efficacy is limited and often 
fails to consider differences between laboratory research and the clinical situation. 
In 2012, The European Commission published “Radiation Protection 172: Evidence-
based Guidelines on Cone Beam CT for Dental and Maxillofacial Radiology”. This 
provides a comprehensive set of recommendations, including referral criteria, a 
quality assurance programme and optimization strategies. Priorities for future 
research are relating exposures to the necessary image quality requirements for 
specific clinical applications, along with research on the impact on clinical outcomes 
of CBCT-based treatments. It is clear that much work remains before the place of 
CBCT in dentistry can be established. 
lungs, also other organs systems suc as brain, liver and para nasal sinuses need 
attention and are to be imaged with the appropriate technique. 
Learning Objectives:
1.  To appreciate the various types of immuno-deficiencies and their related 
infections.
2.  To become familiar with the role of the radiologist in immuno-compromised 
patients.
3.  To learn how to follow pulmonary infections in immuno-compromised patients.
Author Disclosure:
C. Heussel: Grant Recipient; Novartis, Pfizer. Shareholder; GSK, Stada. 
Speaker; Schering-Plough, Pfizer, Basilea, Boehringer Ingelheim, Novartis, 
Roche, Astellas, Gilead, MSD, Lilly, Bracco, MEDA Pharma, Intermune, Chiesi, 
Siemens, Covidien, Pierre Fabre. 
A-335 17:00
C. Emerging infections 
T. Franquet; Barcelona/ES (tfranquet@santpau.cat) 
Despite advances in diagnosis and treatment, new pulmonary infections have been 
diagnosed. Streptococcus pneumoniae remains the main etiological agent in out-
patients with community-acquired pneumonia (CAP). Elderly patients or those with 
toxic habits, and various comorbidities favour the development of severe CAP. In 
addition, the development of nucleic acid amplification techniques has emphasized 
the role of concomitant bacterial and viral pneumonia in the outcome of CAP in 
elderly patients. Healthcare-associated pneumonia has been recently defined as a 
different infectious condition by the American Thoracic Society/Infectious Diseases 
Society of America (ATS/IDSA). The main concern of this new disease is the risk of 
having an infection due to multidrug-resistant pathogens. With the advent of HAART 
and increased long-term survival of HIV-positive patients, the range of pulmonary 
manifestations has also evolved. In patients with haematological malignancies or 
after HSC transplant, Aspergillus is a common infection. Actually, Aspergillus spp. 
isolation from LRT samples in COPD may indicate an increased diagnosis pos-
sibility of IPA. New emerging viruses such as Human metapneumovirus (hMPV), 
SARS-associated coronavirus, and Avian influenza caused by the H5N1 virus 
have been diagnosed. In 2009, an outbreak of a novel swine-origin influenza A 
(H1N1) virus was reported. The clinical diagnosis of new pulmonary infections 
as well as the presence of concomitant bacterial and viral infections has been 
significantly enhanced by improved laboratory methods. A systematic approach 
to the radiological evaluation of lung infections is essential and includes not only 
chest imaging pattern recognition, but also integration of available demographic, 
clinical and laboratory information. 
Learning Objectives:
1.  To learn more about emerging infections.
2.  To become familiar with radiological patterns and conditions which suggest 
viral infections.
3.  To learn how to improve diagnostic accuracy.
16:00 - 17:30 Room L/M 







A. Fundamentals of cone-beam imaging 
M. Kachelrieß; Heidelberg/DE (marc.kachelriess@dkfz.de) 
Traditionally, x-ray CT scanners were equipped with a single or a few detector 
rows only, image reconstruction was assuming parallel slices, which was a good 
approximation for these fan-beam systems. About a decade ago, the number of 
slices increased to 16 or more and the parallel slice approximation was no longer 
valid. The cone-beam nature of these multi-slice CT (MSCT) scanners had to be 
taken into account by specific cone-beam reconstruction algorithms. While these 
MSCT systems -- today they are simultaneously acquiring up to 320 slices - are 
cone-beam CT systems in a general sense, the notion of cone-beam CT (CBCT) 
is also associated with a specific kind of cone-beam CT, namely those equipped 
with flat detectors, i.e. the non-diagnostic or non-clinical CT systems. MSCT, in 
contrast, is a cone-beam CT system for diagnostic use, i.e. a clinical CT system. 
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B. Interventions after liver transplantation 
P.P. Goffette; Brussels/BE (pierre.goffette@uclouvain.be) 
Bile tract complications occur in 10-35% of liver transplants. The incidence is high-
est in the first few months after LT. Type of surgical anastomosis, cold and warm 
ischaemic liver injury and pre-existing biliary diseases are all the factors influenc-
ing the frequency, type and severity of complications which includes strictures, 
leakage, stones formation and bilomas. Systematic PTC at 6 months after LT is 
recommended to disclose biliary complications at early stage. Main indications 
for percutaneous approach include: 1. early anastomotic strictures unaccessible 
to endoscopy, 2. late non-anastomotic strictures due to arterial occlusion, recur-
rent sclerosing cholangitis, CMV infection, 3. access for subsequent procedures 
such as lithotripsy, intrahepatic stones, sludge or biliary cast removal and 4. 
biliary leaks. The conventional approach to biliary strictures included: 1. repeated 
prolonged high-pressure balloon bilioplasty (3X) at 3 weeks interval. 2. long-term 
drainage with large bore drains, 3. chronic catheters left in place in patients with 
recurrent or diffuse strictures. Long-term patency of bilioplasty is reported from 50 
to 60% at 5 years (80% 6 months patency). Cutting balloons and metallic stents 
may be useful to treat refractory strictures in non surgical candidates. Retrievable 
covered stents for resistant stenosis is associated with an 50% restenosis rate at 
12 months. The management of biliary leaks (5-15%) includes drainages of both 
injured biliary duct and biloma. Temporary insertion of covered stent may be neces-
sary to manage hilar or anastomotic leaks. Selective embolisation of intrahepatic 
leaks or segmental portal vein embolisation is an alternative to surgery to manage 
refractory non-anastomotic leaks.
Learning Objectives:
1.  To know about the appropriate imaging algorithm for the detection of biliary 
complications after liver transplantation.
2.  To become familiar with the techniques of interventional treatment of biliary 
complications after liver transplantion.
3.  To understand the results and complications in comparison with surgical 
management.
A-342 16:51
C. In tandem with endoscopy 
D.F. Martin; Manchester/UK (derrick.martin@uhsm.nhs.uk) 
Most biliary intervention are performed endoscopically but endoscopy may fail and 
the trans-hepatic placement of a catheter into the duodenum assists endoscopic 
access. Previously, the primary management of malignant bile duct obstruction 
was with the endoscopic placement of 10 F plastic stents. When ERCP failed, 
PTC using a 7 F catheter allowed the placement of an endoscopic 10 F stent but 
kept complications low because of the avoidance of a 10 F trans-hepatic track. 
Now, with the advent of 6 Fr trans-hepatic delivery systems for 10 mm diameter 
metal stents, this combined procedure has fallen into disuse. However, endoscopic 
access for the management of stones can fail, most commonly because of a peri-
ampullary diverticulum. In this situation, a trans-hepatic approach allows wire-guided 
sphincterotomy leading to successful endoscopic management and the avoidance 
of open bile duct surgery. This presentation will describe the technical aspects of 
this approach together with illustrative case examples. The technique has a very 
high success rate with complications of haemorrhage, bile leak and cholangitis 
in approximately 10% of patients. Polya-gastrectomy is declining in its incidence 
and experienced Endoscopists who can deal with these patients are becoming 
uncommon. A trans-hepatic approach may allow a guide wire to be passed along 
the afferent loop for endoscopic access. There is a small but growing experience of 
EUS-guided biliary drainage for the management of biliary obstruction. Gastroenter-
ologists favour this approach because it appears to generate fewer complications 
than a trans-hepatic approach and is certainly less uncomfortable for the patient. 
These newer techniques will be illustrated and discussed.
Learning Objectives:
1.  To be aware of the indications for tandem use of percutaneous and endoscopic 
approach.
2.  To learn the tips and tricks of tandem technique.
3.  To learn about the results and complications of tandem treatment.
Panel discussion:  
Are there new possibilities in the area of biliary interventions? 17:14 
Learning Objectives:
1.  To become acquainted with CBCT systems for dentomaxillofacial imaging.
2.  To learn about image quality characteristics and patient dose compared to 
other techniques.
3.  To learn how to access CB images and influence the clinical outcome.
16:00 - 17:30 Room N/O 
Interventional Radiology 
RC 1109 
Update on biliary interventions 
A-339 16:00
Chairman’s introduction 
M. Krokidis1, A.A. Hatzidakis2; 1Cambridge/UK, 2Iraklion/GR 
(mkrokidis@hotmail.com) 
There are some basic IR techniques everybody needs to know before starting to 
treat biliary diseases. Τhese are Percutaneous Transhepatic Cholangiography 
(PTC) and Percutaneous Transhepatic Biliary Drainage (PTBD). These basic proce-
dures are essential first for opacification and then for getting access into the biliary 
tree. After accessing the biliary system, decisions must be made about the need 
for further interventional procedures. Presence of benign or malignant strictures, 
stones or other kind of disease are leading us to the necessary actions, such as 
dilatation, stenting or lithotripsy. Dilatation of stenosed parts of the biliary system is 
performed after negotiation of the stricture or occlusion with help of high-pressure 
angioplasty balloons of variant sizes. Balloons of 8-14 mm width can be used alone 
or two parallel to each other. Stenting is rarely needed in benign biliary disease 
and usually in cases where multiple dilatations are not responding. Percutaneous 
lithotripsy with or without cholangioscopic assistance is a wide-used technique for 
clearance of biliary stones or fragments. Extraction balloons or baskets and special 
lithotripsy devices are commonly used for impacted or large calculi.
Session Objective:
1.  To review the various interventional techniques for the treatment of complex 
biliary diseases.
A-340 16:05
A. Fistula and benign stenosis 
M. Bezzi; Rome/IT (mario.bezzi@uniroma1.it) 
Benign biliary strictures (BBS) can be seen with a wide array of non-neoplastic 
causes. In westerncountries, iatrogenic stricture accounts for up to 80% of all 
BBS, with cholecystectomy and orthotopic liver transplantation being the most 
common causes. Post-surgical BBS often present with biliary fistulas. Various 
imaging modalities are used in diagnosing fistulas and BBS, the most commonly 
used being ERCP and MRCP. MRCP has the advantage of non-invasive imaging, 
allows evaluation of the biliary system beyond a tight stricture with assessment of 
hepatic parenchyma and other intra-abdominal organs. The cause, number, and 
distribution of BBS decide the type of management. Other factors to be considered 
are the degree of inflammation/fibrosis, the presence of ongoing infection or sep-
sis, and the experience of the surgeon and interventional radiologist/endoscopist 
at the institution. Balloon dilatation or balloon dilatation with long-term external/
internal drainage are generally accepted as the treatment of choice for benign 
biliary strictures. The percutaneous treatment of these strictures by dilatation has 
a success rate from 60 to 90 %. The primary insertion of a bare metallic stent is not 
currently indicated, while, covered metal stents can be placed in selected patients 
if they can be safely retrieved. Successful outcomes regarding the management of 
BBS requires careful planning by a multidisciplinary team with regard to thorough 
diagnostic studies, and appropriate operative approach. Whatever appropriate 
treatment is selected, the need for careful long-term follow-up must be strongly 
emphasized, as no therapy is totally free of recurrence.
Learning Objectives:
1.  To know about the etiology of fistulas and benign stenoses.
2.  To become familiar with the various imaging modalities and findings in benign 
fistulas and stenoses.
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3.  To appreciate how image quality is defined in MRS, to highlight the parameters 
which affect image quality in MRS and how these can be modified by the 
radiographer.
4.  To become familiar with examples of common MRS artefacts and how these 
can be corrected by the radiographer.
A-345 17:00
C. Challenges and opportunities in paediatric MR 
V. Syrgiamiotis; Athens/GR (syrgiamiotisvasilis@gmail.com) 
Magnetic Resonance Imaging paediatric examination requires a particular set of 
skills and expertise in order to successfully obtain diagnostic images with minimal 
distress to the patients and their family. Many developments have already been 
processed, but there is too much space uninvestigated. The four main challenges in 
imaging children are: anatomical, physiological, behavioural, developmental issues 
which will be overviewed. Techniques and opportunities, which may overcome daily 
difficulties, will also be presented. Paediatric MR Imaging can be considered as a 
series of subspecialties. Each field requires its own specialized skills, knowledge 
and equipment to be performed. 3 T imaging develops rapidly, but even in 1 and 
in 1, 5 T, there are common challenges and opportunities - techniques that apply 
to imaging paediatric patients and number of them will be presented. The lack 
of ionising radiation, simultaneously with the high level of imaging details, has 
made MRI the examination of choice. There is no “one size fits all” regarding to 
the children imaging. Awareness of the challenges and pediatric techniques are 
the key for the success.
Learning Objectives:
1.  To learn about the basic anatomical/physiological differences within the pae-
diatric population, contrasting it with the general adult population.
2.  To understand the MRI scan parameter modifications required to accommodate 
these differences and their trade-offs.
3.  To become familiar with examples of improved, optimised imaging protocols 
against standard, preset, commercially available adult imaging protocols.
4.  To consolidate knowledge on the optimal use of equipment to achieve a suc-
cessful and clinically useful paediatric MRI exam.
16:00 - 17:30 Room P 
Radiographers 
RC 1114 





A. New trends in MR safety 
P. Bauer; Vienna/AT (petra.bauer@akhwien.at) 
With the introduction of high-field and ultra-high-field MR scanners operating at 3 
T and recently at 7 T and with the development of stronger gradient systems MR 
safety issues become more and more critical. The specific absorption rate (SAR) 
produced by the radiofrequency (RF) field of the transmitting coils increases with 
the square of the field strength that means that the SAR at 3 T is four times higher 
compared to 1.5 T. This may lead to thermal injuries. The stronger gradient mag-
netic fields may result in peripheral nerve stimulation which produces paresthesias 
and pain. With the stronger static magnetic field the attraction forces significantly 
increase therefore a strict access control to the magnet room is mandatory. Pos-
sible access control will be discussed. Another topic in MR safety is the increasing 
number of patients with different kinds of implants which may pose a problem when 
an MR examination is planned. Therefore, careful screening of such patients in 
necessary to detect implant an possible harmful metallic material in the body an 
when detected or known the compatibility of these implants have to be checked 
to provide a safe MR examination of these patients. Possible ways to define MR 
safety of implants will be discussed. The White paper on MRI safety, last updated in 
June 2007, is the most important scientific paper concerning MRI safety. It can be 
used as basic concept for building up an own safety concept in your own institute.
Learning Objectives:
1.  To become familiar with the standard MRI safety measures (metal check and 
SAR limits).
2.  To understand the new challenges for MRI safety given the technological 
advances in high-field magnets, faster gradients coils, hybrid MR imaging and 
new contrast agents.
3.  To learn about updated MRI safety guidelines with reference to recent literature, 
white papers and accredited MRI safety websites.
4.  To appreciate the MRI safety implications for pregnant women, neonates and 
the general paediatric population.
A-344 16:30
B. MR spectroscopy: the role of radiographers in data optimisation 
J. McNulty; Dublin/IE (jonathan.mcnulty@ucd.ie) 
Magnetic resonance spectroscopy (MRS) is an advanced quantitative imaging 
technique discovered by Bloch and Purcell in 1946 which preceded clinical magnetic 
resonance imaging (MRI). MRS uses the gradient system to selectively excite small 
volumes of tissue but rather than producing an image, it uses the free induction 
decay (FID) of specific nuclei to produce a spectrum which contains key informa-
tion about the chemical/metabolic composition of the volume of interest. MRS 
has been used clinically for a wide range of disease processes to aid diagnosis, 
to monitor response to treatment or disease progression and is widely used in 
research. Clinical applications include lesion characterisation in oncology imag-
ing along with the imaging of neurological and psychiatric disorders. High-quality 
MRS data have been shown in some cases to reduce the need for further invasive 
diagnostic procedures such as biopsy. Radiographers have a key role to play in 
the acquisition of high-quality spectra in order to ensure the acquired data can be 
used for quantitative purposes and is free of any significant artefacts. Appropriate 
quality assurance, detailed consideration of sequence parameters, appropriate 
voxel position in single voxel MRS, the correct application of spatial saturation 
bands and chemical suppression techniques, shimming, eddy current, motion 
and susceptibility minimisation will all directly impact on the quality of the spectra 
and thus radiographers undertaking MRS for clinical or research purposes should 
be aware of such challenges and the steps that may be taken to ensure quality.
Learning Objectives:
1.  To learn about the basic principles of MR spectroscopy contrasting them to 
the basic principles of MR imaging.
2.  To understand the benefits of using MRS in clinical practice.
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60 min for proximal small bowel (1000 ml) and 2 h for distal small bowel or colonic 
anastomosis (1000 ml). Rectal contrast should be instilled via a bag using gravity - 
200-300 ml is usually sufficient for distal colonic or rectal anastomoses and no delay 
necessary. In patients with catastrophic post-operative complication is suspected 
(such as haemorrhage or perforation) IV contrast alone may be used. In a minority 
of patients with severe renal impairment risk of renal toxicity from IV contrast must 
be balanced against detection of signs that indicate bowel ischaemia or improve 
delineation of anatomy in oedematous patients. Specific complications or patterns 
of complication are recognised in individual operations. However, additional factors 
complicate interpretation including use of haemostatic compounds (misinterpreted 
as abscess) or mesh placement (limiting access for interventional procedures). 
Retained swabs left in error must be notified to the surgeons.
Learning Objectives:
1.  To become familiar with an optimised MDCT protocol for the detection of post-
operative complications.
2.  To learn the normal post-operative appearance of common surgical material 
including mesh, packing and sutures.
3.  To understand the expected findings of peritoneal air, fluid and bowel dilatation 
in the immediate post operative course.
4.  To learn the most common causes of clinical deterioration in the post-operative 
state and their imaging findings.
A-349 09:00
B. MDCT in a patient with small bowel ischaemia 
S. Romano; Naples/IT (stefromano@libero.it) 
Intestinal ischaemia and infarction are important causes of acute abdominal dis-
ease which appropriate diagnosis has to be as more as accurate being of crucial 
importance for the surgical or medical managament of the affected patients. At 
the basis of an efficient report lays the deep knowledge of the patho-physiologic 
mechanism leading to arterial, venous or low-flow state vascular injury of the intes-
tines. When the mechanism is clearly understood, from a radiological point of view, 
it is essential to know how to optimise the MDCT technique in case of suspected 
intestinal ischaemia and what are main findings and intestinal features of the injured 
intestine. A further step is represented from the differentiation of various stages of 
disease from early potential transient ischemia to late infarction. However, it is also 
strongly important to become familiar with the reperfusion damage of the intestine, 
frequently observed but as still as a challenge for an effective diagnosis. The ac-
curacy of the various radiological signs of bowel ischaemia should be considered 
and discussed, whereas presentation of several clinical cases with the description 
of their respective reports and final diagnosis still represents the “key” to improve 
an effective diagnosis of intestinal ischemia in daily radiological practise. 
Learning Objectives:
1.  To understand the patho-physiologic mechanism leading to arterial, venous 
or low-flow state vascular injury.
2.  To learn how to differentiate different stages of disease from early potentially 
transient ischaemia to late infarction.
3.  To become familiar with reperfusion damage of the intestine.
4.  To understand the accuracy of the various radiological signs of bowel isch-
aemia.
A-350 09:30
C. MDCT in a patient with small bowel obstruction 
P. Taourel; Montpellier/FR (p‑taourel@chu‑montpellier.fr) 
The questions regarding the CT diagnosis of bowel obstructions are as follows: 
is there an obstruction? What is the level and the cause? Are there findings of 
closed loop obstruction and of strangulation? What is the treatment recommended: 
surgery or follow-up, laparoscopy or laporotomy? To answer these questions, the 
CT semiology is based on findings validated in the literature that will be described 
in this lecture, by underlining the potential pitfalls in interpretating a CT exam in 
bowel obstruction. The technical modalities of the CT will be detailed: thickness of 
the slices, role of acquisition without contrast and reformatting.
Learning Objectives:
1.  To understand a simple classification for the causes of bowel obstruction.
2.  To become familiar with CT protocols.
3.  To learn a structured approach to the reporting of CT.
4.  To understand the accuracy of the various radiological signs of bowel obstruc-
tion.
08:30 - 10:00 Room A 
Interactive Teaching Session 
E³ 1220 
Pitfalls in brain imaging 
A-346 08:30
A. CT 
L. van den Hauwe1, S. Pugliese2, J.W. Van Goethem1, C. Venstermans1, 
F. De Belder1, T. van der Zijden1, M. Voormolen1, P.M. Parizel1; 1Antwerp/BE, 
2Rome/IT (lucvdhauwe@mac.com) 
The majority of emergency CT studies reported by junior radiologists or general ra-
diologists out-of-hours comprise brain scans. Brain CT studies are often performed 
to detect acute life-threatening abnormalities, such as stroke, intraparenchymal or 
subarachnoid haemorrhage, cerebral edema, etc. Misrecognition of these - often 
subtle - but life-threatening abnormalities can lead to inappropriate patient man-
agement and worsen patient outcome. Errors in interpretation can generally be 
categorized as either perceptual or cognitive in nature. Perceptual errors are those 
in which the radiologist does not see the abnormality, resulting in a false-negative 
interpretation (e.g. basilar artery thrombosis, deep cerebral venous thrombosis, 
PRES,…). Cognitive errors, on the other hand, are those in which an abnormality 
is identified but the meaning or significance of the abnormality is not recognised. 
Cognitive errors can result in false-positive interpretation if, for example, a normal 
anatomic variant is mistaken for a pathologic condition. While the more common 
normal variants and artifacts often do not present a problem for experienced clini-
cians and neuroradiologists, less-experienced individuals should beware of these 
diagnostic hazards. In order to reduce false-negative and false-positive reporting, 
a check list of the review areas (blind spots) to be verified on any brain CT scan 
will be offered and most frequent normal variants will be discussed.
Learning Objectives:
1.  To learn about common pitfalls in CT evaluation of the brain.




In this interactive teaching session, the audience will learn about normal anatomic 
variations as well as common diagnostic pitfalls in neuro-MR imaging commonly 
encountered in clinical practice. The lecture will cover variants commonly seen on 
brain and head and neck MRI as well as common vascular variations seen on MR 
angiography. Further, the use and limitations of the newer diagnostic techniques, 
such as diffusion-weighted MRI, perfusion-weighted MRI, magnetic resonance 
spectroscopy will be discussed.
Learning Objectives:
1.  To learn about common pitfalls in MRI evaluation of the brain.
2.  To become familiar with anatomical variants, potentially mimicking disease.
08:30 - 10:00 Room B 
GI Tract 
RC 1201 




A. MDCT in the post-operative abdomen 
D.J.M. Tolan; Leeds/UK (djmtolan@doctors.org.uk) 
MDCT offers rapid assessment of the post-operative abdomen in a very complex 
patient group - an open dialogue with the surgical team allows precise knowledge 
of procedure performed, any resection performed and anastomoses created 
(including if bowel has been defunctioned with stoma) and the current clinical 
status (especially, if there is concern for sepsis or haemorrhage) or any concern 
for obstruction or ileus. Positive oral contrast can assess anastomotic integrity, 
either orally/via nasoenteral tube or rectally via foley catheter. The authors uses 
8% non*ionic iodinated contrast with 30-min delay for oesophagogastric (500 ml), 
Postgraduate Educational Programme




C. Malignant tumours 
R.H. Oyen, F. Claus, D. Hompes, L. De Wever; Leuven/BE 
(Raymond.Oyen@uzleuven.be) 
The retroperitoneum can host a variety of malignancies, primary or metastatic. They 
can cause a diagnostic and therapeutic challenges because of rarity, substantial 
size, and close relationship with vital structures. Sarcomas comprise a third of 
retroperitoneal tumours, liposaroma and leiomyosarcoma predominating. Other 
include lymphomas and metastases (germ cell tumours, carcinomas, melano-
mas). CT is the modality of choice to determine the origin, size, relationship to 
adjacent structures and to evaluate metastases. Low-grade liposarcomas harbour 
a predominantly fatty component; high-grade lesions show solid attenuation with 
contrast enhancement. Biopsy is not required with clear radiological diagnosis. 
When the appearance is not typical of a liposarcoma, other diagnosis must be 
considered. Lymphoma is not uncommon, displacing or encasing main vessels. 
Some reluctance remains on FNAC or needle biopsy of retroperitoneal lesions. 
In selected patients with non-diagnostic imaging, biopsy is safe, rapid, reliable, 
accurate and inexpensive (1) to identify lesions that may not require resection, (2) 
when the appearance suggests a mass where neoadjuvant treatment may be ap-
propriate (gastrointestinal stromal tumour, Ewing’s sarcoma) and (3) to determine 
further therapeutic strategies if a tumour is deemed unresectable or with distant 
metastases. Although parts of the gastrointestinal and/or urinary tracts are often 
largely displaced, invasion and related symptoms are unusual. However, complete 
surgical resection is the only potential curative treatment option and clearance of 
macroscopic disease often requires en bloc resection of the contiguous organs (i.e. 
colon, kidney, pancreas and spleen). Local recurrence occurs in a large proportion 
and remains the major cause of death.
Learning Objectives:
1.  To learn about the spectrum of malignant retroperitoneal neoplasms.
2.  To understand the role of preoperative cytology/histology by needle aspiration/
biopsy.
3.  To learn about the predictors for survival after resection of retroperitoneal 
sarcoma.
A-354 09:30
D. Interactive case discussion 
U.G. Mueller-Lisse; Munich/DE 
The retroperitoneum includes the adrenal glands, the different organs of the urinary 
tract and the male and female reproductive system, the large blood vessels of 
the body, and different structures of the lymphatic system, the peripheral nervous 
system, and the lower gastro-intestinal tract. During embryologic development, the 
retroperitoneum separates from both the peritoneal cavity and the lung cavities, 
while it remains connected with the mediastinum. Different fascial planes subdivide 
the retroperitoneum and separate it from other spaces in the body. Congenital 
anomaly or acquired disease may alter those separations and, subsequently, bring 
about secondary diesease or disorder. The interactive case discussion will highlight 
clinically relevant aspects of retroperitoneal anatomy, normal variants, and disease 
in selected examples that illustrate each of the sub-topics of the categorical course.
08:30 - 10:00 Room D1 
CLICK (Clinical Lessons for Imaging Core Knowledge): Never 
without Arteries 
CC 1218 




A. Clinical considerations 
R. Iezzi; Rome/IT (roberto.iezzi@rm.unicatt.it) 
Acute Aortic Syndrome (AAS) describes the acute presentation of patients with 
characteristic “aortic pain” caused by one of several life-threatening thoracic aortic 
pathologies. These include aortic dissection, intramural haematoma, penetrating 
atherosclerotic ulcer, aneurismal leak and traumatic transaction. All disorders giving 
rise to AAS can be distinguished in terms of their aetiology and radiological appear-
ance. There is, however, considerable overlap with the possibility of progression 
from one pathological process to another. The need to consider and highlight acute 
08:30 - 10:00 Room C 
Urogenital Imaging 
CC 1221 




A. Retroperitoneal anatomy: an embryology based approach 
F.M. Danza; Rome/IT (fmdanza@gmail.com) 
The classical radiological anatomy of the retroperitoneum (RP) divided into 3 com-
partments (perirenal, anterior and posterior pararenal spaces). in some instances, 
it does not fit with the diffusion and appearence of fluid collections or masses, sug-
gesting the need of some anatomical corrections.The embryologic development of 
the abdomen, with rotations and adesions of primitive gut and mesia, is the key to 
understand the real radiological anatomy of retroperitoneum and entire abdomen in 
adults. This new vision, based on embryo, recognizes acquired and true retroperi-
toneal compartments and distinguishes the sopramesocolic from undermesocolic 
ones. In such a way becomes evident that RP compartments are more than 3, 
have asymmetric and different topographic distribution in abdomen and pelvis and 
develop different intercommunication with the peritoneal portion of the abdomen. 
The diagnostic importance of fascial planes, better defined as “peritoneal fascial 
adesions”, is crucial in determining and recognizing the patterns of diffusion of 
diseases and their radiological counterpart. The real comunications between RP 
lodges and peritoneal reflections is better understood, leading to identification of 
five doors of intercomunication, that are crossroads for the spread of diseases. In 
such a way RP and peritoneum are to be considered as a unique anatomic complex 
and the so called “subperitoneal space” is the “common denominator” leading to 
a modern view of the radiological anatomy for a correct reading of patological 
pictures. The consciousness of these anatomical landmarks and the application 
of these new concepts during diagnostic radiological work are a formidable aid in 
interpreting pathological patterns.
Learning Objectives:
1.  To understand the development of the retroperitoneum during the embryo 
development, introducing the concept of a unique subperitoneal space.
2.  To understand the importance of fascial planes in determining the pattern of 
diffusion of diseases.
3.  To apply these new concepts signs during routine diagnostic work.
A-352 08:50
B. Anatomical variants and benign diseases 
S. Merran; Paris/FR 
This lecture will deal with the imaging findings observed in patients with benign 
retroperitoneal lesions, including variants of vascular anatomy and of renal position 
and morphology. Such anomalies are often encountered during imaging studies, 
and must be recognised before surgery and/or interventional manoeuvers to 
avoid iatrogenic damage. The role of radiology in the diagnosis of patients with 
retroperitoneal fibrosis will be discussed, with special attention to findings during 
follow-up and about criteria which can help to differentiate such condition from 
retroperitoneal lymphoma. There will be presentation of findings in patients with 
retroperitoneal abscess, together with discussion of techniques to guide efficiently 
and safely percutaneous drainage. A large variety of space occupying lesions can 
be encountered within the retroperitoneum, both benign and malignant. Diagnostic 
clues to recognise the benign ones will be presented, with discussion on how to 
reach a differential diagnosis among them. 
Learning Objectives:
1.  To learn about the most important variants of retroperitoneal vessels and about 
renal anomalies.
2.  To understand the role of radiology in patients with retroperitoneal fibrosis and 
infections.
3.  To become familiar with benign retroperitoneal tumours and learn about the 
clues for differential diagnosis.
3
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involvement of arterial branches should be evaluated. In coronary artery disease, 
affected arteries, obstruction and degree of stenosis, areas of infarction and signs 
of pulmonary congestion are important.
Learning Objectives:
1.  To become familiar with typical cases illustrating the role of imaging modalities 
in the diagnosis and differential diagnosis of acute chest pain.
2.  To consolidate knowledge of the selection of the appropriate imaging technique, 
image interpretation and image based treatment recommendation.
3.  To understand the most important information urgently needed for treatment 
decisions and planning.
Author Disclosure:
T. R. C. Johnson: Research/Grant Support; Bayer, Siemens. Speaker; 
Siemens. 
08:30 - 10:00 Room D2 
Oncologic Imaging: Follow-up of Systemic and Local Therapies 
CC 1219 




A. Systemic therapies 
V. Vilgrain, M. Ronot, M. Zappa, S. Faivre, E. Raymond; Clichy/FR 
(valerie.vilgrain@bjn.aphp.fr) 
Sorafenib, a tyrosine kinase inhibitor, has shown clinical efficacy in patients with 
hepatocellular carcinoma (HCC) and is the standard of care for patients with 
advanced-stage HCC. Nowadays, many targeted therapies are evaluated in HCC 
either as sole treatment or in combination with other treatments such as tumour 
ablation, chemo-embolisation, and surgical resection. Therefore, there is a need 
to assess efficacy of targeted therapy in HCC. RECIST is the reference method 
to evaluate treatment efficacy in solid tumours but does not seem appropriate in 
evaluating targeted therapy as objective responses were seen in very few cases 
in patients treated with sorafenib or sunitinib. New criteria have been proposed 
to evaluate treatment efficacy of non-surgical treatments in patients with HCC. 
The most common ones are the Choi criteria, the EASL criteria, and the modi-
fied RECIST criteria. All these criteria mainly focus on internal tumour changes 
such as appearance of necrosis or disappearance of tumour hypervascularity. 
Many examples will be shown during the lecture. Another approach is based on 
functional imaging and especially perfusion-related imaging. Contrast-enhanced 
ultrasound, CT perfusion and dynamic contrast-enhanced MR imaging have the 
capability to assess perfusion changes in patients under treatment. Advantages 
and disadvantages of these modalities will be discussed. Last, other functional 
tools that are not routinely used will be presented.
Learning Objectives:
1.  To learn about difficulties in HCC assessment with local therapy.
2.  To become familiar with various evaluation criteria of HCC.
A-359 09:00
B. Endovascular therapies 
R. Salem; Chicago, IL/US (r‑salem@northwestern.edu) 
The mainstay treatment for HCC include ablation and embolisation. Chemoemboli-
sation, the gold standard treatment for intermediate disease, results in response 
rates ranging from 35-45%. New treatment modalities including drug-eluting beads 
and radioembolisation appear to improve on this, with responses up to 50% by 
size and 75% by necrosis criteria. This presentation will focus on the methodolo-
gies for response assessment and the specific challenges faced by radiologists 
when interpreting response following embolotherapy. Response criteria including 
WHO, RECIST, EASL and mRECIST, as they relate to endovascular therapies, 
will be discussed in detail. 
Learning Objectives:
1.  To appreciate the value of different imaging techniques for assessment of 
intra-arterial therapies of HCC.
2.  To become familiar with post-treatment imaging after intra-arterial therapies 
according to type of therapy.
Author Disclosure:
R. Salem: Advisory Board; Sirtex, Nordion. Consultant; Nordion, Sirtex. 
thoracic pathology as an AAS is clear. In an ageing morbid population and with 
modern imaging techniques, it is becoming a more commonly encountered clinical 
phenomenon. Furthermore, thoracic aortic pathology can be a difficult diagnosis to 
make. Clinical findings are often absent, the chest radiograph may be normal, and 
symptoms may be confused with acute myocardial infarction. An AAS, therefore, 
encourages prompt recognition of symptoms heralding an unstable phase in these 
disease processes indicating imminent aortic rupture. This will hopefully expedite 
recognition and avoid diagnostic delays. Current diagnostic techniques center 
around the use of computed tomography (CT), transesophageal echocardiography 
(TEE), magnetic resonance imaging (MRI), and aortography. These four techniques 
provide variable informations, in order to obtain a correct diagnosis, an assessment 
of the localisation and extension of disease, and an accurate planning of treatment. 
It is mandatory to underline that aortic pathology is often unsuitable for conservative 
medical treatment and many patients are also poor surgical candidates. As a result 
minimally invasive endovascular aortic repair is now increasingly being undertaken.
Learning Objectives:
1.  To become familiar with clinical diagnostic algorithms in cases of non-cardiac 
acute chest pain.
2.  To learn about the constituents of acute aortic syndrome.
3.  To become familiar with prognosis, treatment and outcome and learn about 
the influence of imaging on treatment decisions in acute chest pain.
A-356 09:00
B. Imaging techniques and typical findings 
F. Wolf; Vienna/AT (florian.wolf@meduniwien.ac.at) 
Acute chest pain is a very common admission diagnosis of patients entering an 
emergency department. The sufficient triage of these patients is crucial in order to 
start the right treatment and to minimize unnecessary hospital stays. Computed 
tomography is a very important tool in the differential diagnosis of acute chest pain. 
Aortic pathologies are one of the clinical most relevant differential diagnoses of 
acute non-cardiac chest pain. There are 5 variants of aortic dissections: classical 
dissection, atherosclerotic penetrating ulcer (PAU) ± intramural haematoma, intimal 
tear without intramural haematoma, intramural haematoma (without intimal tear) 
and traumatic/iatrogenic dissection. CT plays a major role in the detection and dif-
ferential diagnosis of these 5 variants as well as in the decision how to treat these 
patients. Choosing the right imaging protocol is crucial in order to find the right 
diagnosis. ECG-triggering is a key factor that has positive influence on the image 
quality especially in the region of the aortic root. Using a so-called "triple-rule-out" 
protocol is critical due to different reasons and might offer sufficient image quality 
only with scanners of the newest generation. This presentation will show stable 
imaging protocols for aortic pathologies in patients with acute chest pain. Moreo-
ver, it will discuss the usefulness of the "triple-rule-out protocol". The 5 variants of 
thoracic aortic dissection will be presented combined with clinical cases.
Learning Objectives:
1.  To learn about state-of-the-art CT angiographic imaging in acute chest pain 
(after ruling out MI).
2.  To become familiar with the techniques and advantages of ECG gating in CT 
angiographies of acute chest pain.
3.  To discuss the potential role of additional MR angiography.
A-357 09:30
C. Interactive case discussion: what is really important? 
T.R.C. Johnson; Munich/DE (thorsten.johnson@med.uni‑muenchen.de) 
In chest pain evaluation, a close collaboration with clinicians is essential. An initial 
workup should include a brief history, clinical exam, ECG and laboratory markers 
including tropin and d-dimer. TSH and creatinine are not mandatory in acute cases. 
Chest x-ray is the modality of choice in subacute pain if the clinical presentation 
is suggestive of, for example, pulmonary edema, pneumothorax, pneumonia, 
rib fractures or metastases. If clinical history and presentation are suspicious of 
myocardial infarction or there are ECG findings or a positive troponin, the patient 
should be referred to cardiology to allow immediate catheterization. In cases of 
acute, unclear chest pain, CT is the modality of choice. Long bolus techniques can 
be used to cover pulmonary and aortic system, and high-pitch modes with ECG-
triggering are preferable to assess coronary arteries, depending on the available 
CT technology. In case of acute pulmonary edema with typical presentation, the 
administration of contrast media can worsen the situation and should be avoided. 
Depending on the diagnosis, there are different important diagnostic criteria. In 
pulmonary embolism, number and level of affected arteries, degree of obstruction, 
and right heart strain should be assessed. In case of aortic dissection, involvement 
of coronary ostia, entry and re-entry, and organ supply or ischaemia are important 
criteria. In case of aortic ulcer or aneurysm, signs of rupture or haematoma and 
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unday
not surprising that especially amongst elite gymnasts low-back pain is a very com-
mon phenomenon. It is not always easy to recognize this. They usually accept a 
certain amount of pain as being normal and consider it more or less normal. There 
are, however, some potentially devastating diseases and conditions that can be 
the underlying cause and it is very important to recognize these, so that proper 
treatment can be applied.
Learning Objectives:
1.  To become familiar with the types of chronic injuries seen in the gymnast’s 
spine.
2.  To understand the strengths and weaknesses of different imaging modalities 
for imaging these injuries.
A-363 09:30
C. Upper limb overuse injuries in golfers 
P.J. O’Connor; Leeds/UK (philip.o’connor@leedsth.nhs.uk) 
Golf is particularly well suited to the development of upper limb overuse injury. 
Repetitive actions combined with relatively high forces damage soft tissues, joints 
and bone. This is particularly the case in professional golfers where the swing 
forces are more clearly reproduced with higher repetition rates compared to ama-
teurs. This lecture details the common upper limb overuse injuries focussing on 
the elbow, wrist and shoulder.
Learning Objectives:
1.  To understand the types and mechanisms of overuse injuries seen in the upper 
limb in golfers.
2.  To understand the advantages and disadvantages of different imaging modali-
ties.
3.  To become familiar with the imaging findings seen in overuse injuries of the 
upper limb.
08:30 - 10:00 Room E2 
Neuro 
RC 1211 
Stroke: is the prognosis getting any better? 
A-364 08:30
Chairman’s introduction 
J.-P. Pruvo; Lille/FR (jean‑pierre.pruvo@chru‑lille.fr) 
Stroke remains a major health burden, the first cause of disability in young adults, 
the second cause of dementia and the third cause of death in Europe and the 
US. Brain imaging must be performed very early after symptom onset in order to 
confirm the diagnosis, to evaluate the infarct size, to assess the salvageable brain 
tissue and to detect the site of occlusion. The role of each imaging technique, CT or 
MR, remains widely debated by the scientific community. This specific topic will be 
developed by PM Parizel during the first lecture. In case of ischaemic stroke which 
represent more than 80% of cases, several therapeutic options may be chosen ac-
cording to the delay between symptom onset and patient admission. This includes 
IV thrombolysis, mechanical thrombectomy or, after the initial phase, craniectomy in 
case of malignant stroke. In the near future, the use of brain hypothermia during the 
first 6 h after stroke onset and before brain imaging could potentially reduce brain 
damage related to ischaemia in large population of patients. This will be discussed 
in the second lecture by VM Pereira. For the secondary prevention of ischaemic 
stroke, P Vivela will talk about the exact role of extracranial or intracranial stenting 
which is another topic widely debated since the recent multicenter studies which 
did not prove the real benefit of these techniques to prevent a recurrent stroke. 
A-365 08:35
A. Initial imaging work-up: CT or MR? 
P.M. Parizel, T. Van der Zijden, F. De Belder, C. Venstermans, 
L. van den Hauwe, R. Salgado, J. Van Goethem, M. Voormolen; Antwerp/BE 
(paul.parizel@ua.ac.be) 
Neuroimaging plays a crucial role in the diagnosis, management, and outcome 
prediction of patients with acute stroke. Patient history and clinical neurologic 
examination neither reliably identify the involved vascular territory, nor the etiol-
ogy, extent or type of stroke. With the arrival of promising new therapies aimed 
at re-establishing blood flow, reducing the size of the infarction and protecting 
the surrounding brain at risk (penumbra), the traditional role of neuroimaging has 
changed. Thanks to multiparametric CT and MRI techniques, our understanding of 
A-360 09:30
C. Ablative therapies 
C. Ayuso; Barcelona/ES (cayuso@clinic.ub.es) 
The evaluation of treatment efficacy is a key issue with prognostic and patient 
survival implications. It is crucial to have objective and reproducible criteria for 
specific groups of patients. The goal of ablative therapies of HCC is to induce 
tumoural tissue destruction. Complete response (CR) after initial chemical and 
thermal percutaneous ablation, defined as the absence of contrast enhancement 
of the treated tumour at CEUS, dynamic CT or MR, has been reported to correlate 
to long-term survival. Nevertheless, the clinical effectiveness of imaging techniques 
to assess initial treatment success differs according to tumour size. The success 
rate of RF has been demonstrated superior to PEI in HCCs > 2 cm, and it depends 
on the ability to ablate all viable tumour tissue including an adequate tumour-free 
margin all around the lesion of 0.5 to 1 cm. Thus, the effectiveness of RF directly 
depends on the tumour location and size. RF is considered an effective treatment 
in lesions ² 3 cm and its effectiveness is progressively reduced along tumour size 
and it is not effective in lesions > 5 cm. CEUS beyond one month may confirm CR 
or detect residual tumour, deserving a final ablation procedure. CT and MR are 
more effective in the follow-up to confirm the CR and to detect local recurrence, 
or additional HCC lesions in the liver parenchima. The presence of transient hy-
peraemic inflammatory changes in the periphery of the treated area is a common 
finding that should be considered to avoid overestimation of the recurrence rate.
Learning Objectives:
1.  To learn about the value of different imaging techniques for the assessment 
of ablative therapies of HCC.
2.  To become familiar with post-treatment imaging after ablative therapies ac-
cording to type of therapy.
08:30 - 10:00 Room E1 
Musculoskeletal 
RC 1210 




A. Overuse injuries in the footballer’s ankle 
S.J. Eustace; Dublin/IE (eustacesj@gmail.com) 
This talk will briefly review normal ankle MRI anatomy and biomechanics. It will 
then make brief reference to common MR imaging protocols and finally review 
imaging appearances of common injuries encountered in footballers, including 
both technical and diagnostic pitfalls.The relative advantages and disadvantages 
of MRI versus other imaging techniques including ultrasound in both diagnosis and 
prediction of return to sport will be reviewed.
Learning Objectives:
1.  To learn the spectrum of overuse injuries sustained by footballers at the ankle 
joint.
2.  To understand the mechanisms by which these injuries occur.
3.  To become familiar with the imaging findings seen in overuse injuries at the 
ankle.
A-362 09:00
B. Overuse injuries in the gymnast’s spine 
M.C. De Jonge; Amsterdam/NL (MdJonge@zuwehofpoort.nl) 
Gymnastics participation has increased in the last years. It is predominantly a 
sport in which very young children and adolescents participate. It is also an activity 
that is characterised by one of the highest injury rates. Whereas in the adult, the 
skeleton is usually much stronger than the supporting soft tissues (e.g. muscles 
and ligaments) and this is not the case in children and adolescents. They are, 
therefore, at special risk to sustain injuries to the skeletal structures. It is also the 
large number of training hours and intensity of the training that is very demanding. 
Apart from the acute injuries they are particularly vulnerable to injuries caused by 
this overuse. Not only the appendicular skeleton is at risk due to the use of the 
upper extremity as a weightbearing structure but also the axial skeleton is under 
constant strain. The repetitive high-force flexion and (hyper)extension movements 
together with rotation and compressive loading of the spine puts the thoracic and 
more commonly the lumbar spine under a lot of stress and force. It is, therefore, 
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atherosclerotic and non-atherosclerotic diseases, make a critical appraisal of the 
literature, discuss the current indications for endovascular treatment and give a 
glimpse into the future challenges for stenting.
Learning Objectives:
1.  To understand the natural history of extracranial and intracranial carotid and 
vertebral artery atherosclerotic and non-atherosclerotic diseases.
2.  To become familiar with the endovascular treatment indications of extracranial 
and intracranial arterial disorders.
3.  To understand the endovascular treatment strategies aimed at stroke preven-
tion.
4.  To recognise the present and future challenges for PTA and stenting of extra-
cranial and intracranial arteries.
Panel discussion:  
What is the future of stroke prevention and treatment? 09:44 
08:30 - 10:00 Room F1 
Special Focus Session 
SF 12 




A. van der Lugt; Rotterdam/NL (a.vanderlugt@erasmusmc.nl) 
Biomarkers are increasingly important in clinical practise and research as 
they reflect normal and pathological biological processes. Imaging biomarkers 
have the advantage of being non-invasive, spatially located, and temporally 
resolved. Quantification is of utmost relevance for imaging biomarkers to fully 
exploit the morphological and/or functional information in the images. Accurate 
quantification in medical imaging relies on standardised data acquisition and 
data analysis. Although tremendous progress has to be made in the coming 
years, some imaging biomarkers have already reached the clinical and research 
domain. The ESR has released a white paper on imaging biomarkers (Insights 
into Imaging 2010; 1:42-45), prepared by the ESR Working Group on Imag-
ing Biomarkers. That document aims to contribute to further exploitation of the 
enormous wealth of biomarker information available in imaging. In this session, 
the concept of imaging biomarkers is explained and applied to the field of car-
diac radiology. It will make clear what the prerequisites are for qualification as 
imaging biomarker and which imaging biomarkers are currently being developed. 
Session Objectives:
1.  To appreciate the increasing role of imaging biomarkers in radiological research 
and clinical practice.
2.  To understand the importance of quantification and standardisation of imaging 
biomarkers.




J.-P. Vallée; Geneva/CH (jean‑paul.vallee@hcuge.ch) 
A biomarker is “a characteristic that is objectively measured and evaluated as an 
indicator of normal biological processes, pathogenic processes, or pharmacological 
responses to a therapeutic intervention”. There is a tremendous interest of both in-
dustry and the scientific community to develop and validate new biomarkers as they 
can be used for risk and disease assessment as well as being efficient surrogates 
of clinical endpoints to decrease study sizes. Biomarkers are derived from either 
biospecimens or imaging. Imaging biomarkers are mainly represented on parametric 
maps, where the intensity of each pixel corresponds to an anatomical, functional 
or molecular parameter measured from the images. As a unique feature, imaging 
biomarkers are able to analyze the whole organ rather than just a sample. However, 
the measurement process of imaging biomarkers that rely on some kind of signal 
emitted from the human body is usually more complex and less standardised than 
the measurement of biomarkers obtained from biospecimens. The qualification of 
imaging biomarkers is therefore of utmost importance. This includes the acceptance 
of standardised and reproducible procedures for both the image acquisition and 
processing, a correlation with pathology, as well as with other validated biomarkers, 
the pathophysiology of stroke, in terms of cerebral blood flow and cell metabolism, 
has greatly improved. Identification of the ischaemic penumbra with MRI and/or 
CT has entered routine clinical practice. A patient suspected of having suffered an 
acute stroke should be cleared for thrombolytic therapy, by excluding intracranial 
hemorrhage and non-stroke causes of the patient‘s symptoms. The critical 3 to 6 
h time window for thrombolytic therapy necessitates rapid and accurate diagnosis. 
The fundamental goals of neuroimaging in the patient with acute stroke are therefore 
to rule out intracranial hemorrhage, e.g. by CT or MRI, to show ischaemic brain 
tissue, e.g. by DW-MRI, to show tissue blood flow and identify the penumbra, 
e.g. by perfusion CT or MRI, and to assess vessel patency, e.g. by performing 
CTA or MRA. The purpose of this presentation is to present a comprehensive 
imaging protocol for patients with suspected stroke, to discuss advantages and 
disadvantages of CT and MR in the initial work-up of acute stroke patients, and to 
illustrate imaging patterns.
Learning Objectives:
1.  To become familiar with a comprehensive imaging protocol in patients with 
suspected stroke.
2.  To know the advantages and disadvantages of CT and MR in the initial work-up 
of stroke patients.
3.  To recognise the different imaging patterns in stroke.
A-366 08:58
B. Stroke: is there really any therapy? 
V. Mendes Pereira, K.-O. Lovblad; Geneva/CH (vitormpbr@hotmail.com) 
Stroke is a life-threatening condition that affects significant amount of active patients 
accounting for a large number of disabilities or deaths. The treatment of acute stroke 
treatment started in 1990s with the use of rtPA intravenously. The NINDS study 
demonstrated the efficacy this approach in a cohort of patients up to 3 h. The results 
demonstrated a clinical improvement (mRS 0-1) of 36% on the treated group. The 
IV therapy demonstrated better results for patient arriving early at the hospital and 
for distal located occlusions. Proximal occlusions and posterior fosse lesions had 
still a very bad clinical prognosis. Intra-arterial (IA) therapy was then proposed to 
be an alternative for those proximal occlusions by promoting lyses of clot in situ. 
The PROACT II was the study that demonstrated a significant improvement (mRS 
0-2: 40%) of the IA treatment compared to placebo up to 6 h after the beginning of 
the symptoms for M1 located lesions. Mechanical thrombectomy was proposed to 
enlarge the therapeutic window and to be used in cases with contra-indications to 
the use of thrombolytics. The first studies reported recanalization rates higher than 
previous studies with a variable effect on patient’s outcome: 25% for an aspiration 
system (penumbra device) to 36% for the Merci device. More recently, retrievable 
intracranial stents started to be used in stroke and have demonstrating a remark-
able efficiency on recanalization and on clinical improvement.
Learning Objectives:
1.  To learn the natural evolution of untreated stroke.
2.  To understand the advantages and disadvantages of the different therapeutic 
options in stroke patients.
3.  To recognise imaging patterns that may determine therapy in stroke patients.
A-367 09:21
C. Stenting: does it prevent stroke? 
P. Vilela; Almada/PT (ferrovilela@sapo.pt) 
Angioplasty and stenting has been increasingly used to treat extra/intracranial 
stenosis aiming to prevent future strokes. Extracranial atherosclerotic stenosis trials 
were focused in comparing the results of stenting and surgey, especially for carotid 
artery. Most of these trials have shown higher rate of periprocedural complications, 
especially stroke, with carotid artery stenting (CAS). However, the CREST trial 
results have showed a similar 30-day overall complication rate and equivalents 
rates of future strokes and restenosis. For the intracranial atherosclerotic stenosis, 
the SAMMPRIS trial has demonstrated that aggressive medical treatment was 
safer and had better long-term results compared with endovascular treatment. 
The benefits and risks of each treatment may differ between patients. It has been 
demonstrated that older patients have worse outcomes with CAS than with CAE. 
Moreover, arterial stenosis may cause a stroke by different mechanisms, such as 
haemodynamic failure, direct occlusion of perforating arteries or thrombosis at the 
site of the atheromatous plaque, and distal thromboembolism. It is reasonable to 
accept that angioplasty and stenting may not have the same protective effect in 
these different situations. Patient selection based on the subgroup analysis taken 
from the published and future trials, in the plaque vulnerability or in the cerebrov-
ascular reserve status may depict which patients will benefit most from each type 
of treatment modality. The author will review natural history of extra and intracranial 
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Imaging biomarkers of myocardial ischaemia 
L. Natale; Rome/IT (lnatale@rm.unicatt.it) 
Quantification of myocardial perfusion is tipically obtained by nuclear medicine; 
both MRI and CT are relatively new techniques in this field, and the major limitation 
for their application as imaging biomarkers is represented by lack of standardiza-
tion and a not so high reproducibility for MRI, while for CT the experience is still 
limited. Furthermore, there is a lack of clinical trials and data on patiets outcome. 
Nevertheless, new dual bolus techniques for perfusion MRI seems to be promis-
ing as well as new applications of CT, as fractional flow reserve measurements 
demonstrated by the Discover Flow study. However, semiquantitative approaches, 
such as upslope of time/intensity or time/density curves, have been vaidated and 
can represent a valid surrogate of myocardial blood flow quantification. From their 
normalisation, the perfusion reserve index can be obtained, and this has been 
standardised in some studies. Atherosclerosis biomarkers with CT have been 
represented for a long time only by Coronary Calcium Score. Standardization of 
Agatston Score has been achieved with EBCT and now also with MDCT, while 
less data are available for volume and mass indexes. New possible biomarkers of 
plaque composition, such as density measurements of plaques, need further studies 
for standardization and reproducibility, both for acquisition and post-processing. 
Concerning quantitative assessment of dobutamine stress MRI, there are still no 
significant published data. In clinical practice only qualitative assessment is used, 
with a very poor reproducibility reported in many papers.
Learning Objectives:
To become familiar with the quantitative imaging biomarkers of:
1)  myocardial perfusion (MRI/CT),
2)  cardiac contraction after high dose dobutamine challenge (MRI)
3)  coronary atherosclerosis (CT)
Panel discussion:  
How should we implement quantitative biomarkers in clinical 
practice? 09:45 
08:30 - 10:00 Room F2 
Breast 
RC 1202 
Multi-modality breast imaging 
A-373 08:30
Chairman’s introduction 
M. Lesaru; Bucharest/RO (mlesaru@hotmail.com) 
Multi-modality breast imaging appears as a natural result of the radiologist‘s im-
plication in the multidisciplinary clinical team. The classical role in the diagnosis 
of breast malignancies is improved by multimodality lymph node imaging by this 
helping to better determine targets for biopsy in preoperative staging.The onco-
plastic reconstructive techniques became another challenge for breast-imaging 
specialists, especially when local recurrence is suspected. For a correct follow-up 
of these patients, the need of „imported“ information from other specialties is obvi-
ous and this should be coupled with a correct imaging protocol. In our days, the 
role of the radiologist expands from diagnosis to therapy using innovative image 
guided procedures, aspect which is also true for the breast. In this integrated RC, 
experts will present a clinical update of these new techniques and there will be an 
opportunity to discuss about how the evolution of such techniques is changing the 
nature of the modern multi-disciplinary team meeting.
A-374 08:35
A. Conventional, functional and interventional lymph node assessment 
P.D. Britton; Cambridge/UK (peter.britton@addenbrookes.nhs.uk) 
Patients with newly diagnosed breast cancer require their axillary lymph node status 
to be histologically established. Standard practice is to perform this surgically with 
sentinel lymph node biopsy (SLNB). Those patients whose nodes are free of disease 
require no further treatment. However patients with metastatic deposits usually 
undergo a second operation to remove all their remaining nodes [axillary lymph 
node dissection (ALND)]. If such patients can have their lymph node metastases 
diagnosed pre-operatively, they will be spared an (unnecessary) preliminary SLNB 
operation. Consequently all patients eligible for SLNB now undergo pre-operative 
and a demonstration of an impact on patient outcome or estimation of the size of 
the effect in clinical trials or experimental studies. In an standardization effort, the 
structured reporting of imaging biomarkers is likely to expand and affect the clini-
cal practice of radiologists. Imaging biomarkers, therefore, provide a tremendous 
opportunity for Radiology to move toward an integrative discipline.
Learning Objectives:
1.  To understand the concept of imaging biomarkers.
2.  To learn about the different types of biomarkers (anatomical/functional/mo-
lecular).
3.  To understand the different applications of imaging biomarkers (detection, 
prediction, response).
4.  To learn about the standardisation and validation of imaging biomarkers.
A-370 08:45
Imaging biomarkers for myocardial function 
J. Bogaert; Leuven/BE (Jan.Bogaert@uz.kuleuven.ac.be) 
As the heart generates the driving force to propagate the blood through the vascular 
system, assessment of its performance (“cardiac function”) is crucial since many 
diseases have an impact on the performance of the heart. Though the patient’s 
complaints and clinical examination provide valuable information regarding the 
functional status of the heart, quantitative measures of cardiac function (‘imaging 
biomarkers’) have been established in the last decades, and are nowadays rou-
tinely used in daily clinical practice. The ease of these measures is that age- and 
gender-adjusted normalised values can be used as reference to determine whether 
a patient’s cardiac function is still within normal limits, and thus allow to assess 
severity of dysfunction and to categorize patients. Moreover, functional parameters 
such as ejection fraction (EF) have shown to yield prognostic value and are therefore 
often used as surrogate for hard end points such as cardiac death in many stud-
ies. Though ejection fraction, expressing the relative amount of blood ejected by 
a ventricle during each cardiac contraction. is definitely the functional parameter 
with whom we are most familiar with, it is important to emphasize that cardiac 
function assessment cannot be reduced or simplified to one single parameter, and 
that several other parameters need to be considered. It has become clear over 
the last decades that unraveling and assessment of cardiac function is extremely 
complicated. This presentation will deal how MRI and CT can be used to quantify 
the most important imaging biomarkers on cardiac function.
Learning Objectives:
To become familiar with the quantitative imaging biomarkers of:
1)  cardiac mass (MRI/CT)
2)  ventricular volume (MRI/CT)
3)  ventricular function (MRI/CT)
A-371 09:05
Imaging biomarkers of myocardial viability 
P. Croisille; Saint‑Etienne/FR (pierrecroisille@me.com) 
Direct imaging of myocardial necrosis and/or fibrosis is now possible with the use 
of delayed-enhancement MRI (DE-MRI) that show abnormalities in the distribution 
of gadolinium chelates and demonstrates nonviable tissue as “hyper enhanced” of 
bright regions. It is related to various mechanisms including delayed wash-in and 
wash-out kinetics of non-viable tissue that contains replacement fibrosis and differ-
ent volumes of distribution of gadolinium in viable and nonviable regions. Accurate 
quantification of areas of scar and viable tissue is now of outmost importance in 
predicting mortality, as the benefits of revascularization rise steeply when this area 
reaches a critical size. When combined with low-dose dobutamine challenge that 
can be assess either using cine-MRI or quantitative strain imaging with motion 
encoding techniques such as MR-tagging, CMR provides a unique tool that can not 
only assess the amount of irreversibly damaged myocardium but also its mechanical 
impact and further help to predict the potential benefits of revascularization. After 
acute myocardial infarction, oedema is believe to be an important biomarker that 
can be uniquely assess using CMR. More than an estimate of the area at risk, T2 
imaging provides an overall marker of both ischaemic and reperfusion injuries that 
may be used to monitor reperfusion strategies.
Learning Objectives:
To become familiar with the quantitative imaging biomarkers of:
1)  infarct size using delayed enhancement (MRI/CT)
2)  areas at risk in myocardial infarction using T2w MRI
3)  cardiac contractility using cine or tag MRI after low dose dobutamine challenge
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Learning Objectives:
1.  To understand indications for therapeutic interventions in malignant and benign 
lesions.
2.  To learn about current image guided therapeutic techniques in malignant and 
benign lesions.
3.  To appreciate possible future developments of therapeutic interventions.
Panel discussion: 
How is the evolution of multi-modality breast imaging changing the 
nature of the multi-disciplinary meeting (MDM)? 09:44 
08:30 - 10:00 Room G/H 
Genitourinary 
RC 1207 




A. Female pelvis MRI 
A.G. Rockall; London/UK (a.rockall@imperial.ac.uk) 
In this refresher course lecture, a systematic approach for reporting MRI in the 
female pelvis will be presented. Reports will be tailored to the clinical details and 
the information required by the clinician for further patient management. Critical 
findings that need to be included in the report will be reviewed. Items to be included 
on a ‘check-list’ will be also presented. Examples will include cases of cervical and 
endometrial cancer and complex adnexal masses. Proforma reporting styles for 
cervical and endometrial cancer will be presented and discussed. 
Learning Objectives:
1.  To learn a structured reporting approach to MR imaging.
2.  To learn a structured reporting approach to uterine and cervical cancer staging.
3.  To learn a structured reporting approach to adnexal masses.
A-378 09:00
B. Prostate MRI 
J.J. Fütterer; Nijmegen/NL (j.futterer@rad.umcn.nl) 
In this presentation, a standardised reporting system for multiparametric prostate 
MRI examinations will be presented (PI-RADS). Furthermore, the imaging assess-
ment of prostate cancer, with emphasis on information useful for surgical and focal 
treatment planning, will be discussed. Emphasis will be placed on functional MR 
imaging techniques in conjunction with clinical staging nomograms and tumour 
localisation. The major teaching points of this exhibit are knowledge of the role of 
multi-parametric MR imaging in the detection, localisation, and characterisation 
of prostate cancer. Knowledge of standardised reports will enable us to overcome 
current limitations in communication with the referring physicians.
Learning Objectives:
1.  To learn a structured reporting approach to MR imaging.
2.  To learn the most essential points and details to be reported in prostate cancer 
patients.
3.  To understand the major weaknesses of a prostate MR report.
Author Disclosure:
J. J. Fütterer: Consultant; Galil Medical, Inivivo. 
A-379 09:30
C. CT urography 
N.C. Cowan; Birmingham/UK (nccowan.uro@gmail.com) 
The principal reason for the existence of CT urography is for diagnosing upper 
urinary tract urothelial cancer (UUC), which most often presents with haematuria. 
Studies providing a breakdown of the prevalence of disease in patients presenting 
with haematuria show UUC to be a rare but important cause of disease. Examples 
of the typical and atypical UUC and bladder cancers will be demonstrated so the 
radiologist will become familiar with the spectrum of radiological signs in order to 
make the diagnosis. A structured method for reporting CT urography will be demon-
strated using a template and examples worked through. Aspects of CT urography 
technique especially those influencing image acquisition and processing will be 
explored and technical tips relating to protocol design given to optimise reporting. 
ultrasound of the axilla and needle biopsy of any morphologically abnormal node. 
This enables 40% of patients with lymph node metastases to be diagnosed pre-
operatively and these patients are saved an unnecessary SLNB operation. The 
author will describe examination technique and the appearances of normal and 
abnormal lymph nodes. Biopsy criteria and the auditing of results will also be 
discussed. Current ultrasound and biopsy techniques are imperfect and 60% of 
patients with lymph node metastases are still diagnosed surgically. Reduction of 
this false negative rate will require both improved targeting and improved sampling 
of the sentinel node. The author will discuss how this might best be achieved by 
breast radiologists in the future.
Learning Objectives:
1.  To learn about normal lymph node morphology.
2.  To understand criteria suggestive of morphological abnormality.
3.  To become familiar with factors affecting overall sensitivity of pre-operative 
lymph node assessment.
A-375 08:58
B. Multi-modality assessment of the breast following oncoplastic surgery 
M. Torres-Tabanera, S. Perez-Rodrigo; Madrid/ES 
(mtorrestabanera@gmail.com) 
Oncoplastic breast procedures were introduced to fill the gap between compre-
hensive oncologic surgical treatment of breast cancer, and the achievement of 
cosmetic results that fulfill patient expectations in both, body imaging and psycho-
logical wellbeing. Due to its complexity and relevance for the patient, the decision 
of performing these procedures must be made as part of the multidisciplinary 
approach of breast cancer treatment. As a consequence, the role of breast radi-
ologists has expanded beyond the anatomic region of the breast and the usual 
imaging techniques. A basic knowledge of oncoplastic techniques is mandatory 
in order to understand the spectrum of findings from a multi-modality approach. 
Implants and/or autologous reconstruction techniques (based on pedicle, free or 
perforator flaps, as well as lipofilling techniques) are widely applied. The role of the 
radiologist in the multidisciplinary team is twofold: assessment during the planning 
stage, and imaging evaluation at follow-up. The assessment during the planning 
stage includes the determination of the local extent of the disease, that make it 
possible the choice of the appropriate surgical technique, and the imaging study of 
the donor site in those cases where autologous reconstruction is elected. Imaging 
evaluation at follow-up comprises the recognition of changes and potential pitfalls 
after reconstruction, the identification of short/mid/long-term reconstruction compli-
cations, and the detection of recurrent/second carcinomas. Controversial aspects 
will be reviewed, as the probability of recurrence after oncoplastic surgery, the need 
to establish multimodality follow-up protocols and the interrelations between the 
autologous tissues and the mastectomy bed or remaining breast.
Learning Objectives:
1.  To learn about the range of oncoplastic breast procedures in current clinical 
practice.
2.  To become familiar with imaging features resulting from oncoplastic surgery.
3.  To appreciate the potential pitfalls encountered while imaging such cases.
A-376 09:21
C. Image guided therapy in breast lesions: indications and techniques 
G. Manenti, G. Simonetti; Rome/IT (guggi@tiscali.it) 
Breast conservation therapy has become the treatment standard for early-stage 
breast cancer. There is increasing demand for minimally invasive and non-surgical 
treatment methods for patients with small breast cancer. With the improvements 
in imaging techniques that have allowed the earlier detection of smaller breast 
cancers and the desire for improvements in cosmetic outcome, a number of 
minimally invasive techniques for the treatment of early-stage breast cancers are 
being investigated. The challenge is that these therapies can be used as a routine 
adjunct in the treatment of selected breast cancers. Percutaneous tumour excision, 
radiofrequency ablation (RFA), interstitial laser ablation, focused ultrasound abla-
tion (FUS) and cryotherapy provide interesting alternatives to open breast surgery. 
These techniques may offer complete tumour ablation with less psychological mor-
bidity, better cosmetic results and reduced inpatient care compared with traditional 
surgery. The challenge will lie in the ability to identify multifocal disease and in situ 
carcinoma as well as to ensure complete and effective eradication of the breast 
cancer. Additional research is needed to determine the efficacy of these techniques 
when they are used as the sole therapy and to determine the long-term local recur-
rence rates and survival. In this course, we give an overview of minimally invasive
approaches for the therapeutic management of benign breast lumps and early-stage 
breast cancer, related to indications and techniques.
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1.  To learn about the T staging of lung cancer.
2.  To become familiar with the current state of the different imaging technique to 
assess the T stage.
3.  To appreciate limitations and pitfalls.
A-382 08:58
B. Lymph node staging 
W.F.M. De Wever; Leuven/BE (walter.dewever@uzleuven.be) 
Accurate lung cancer staging is essential. Mediastinal lymph node metastases 
determine patient outcome. Non-invasive radiological mediastinal staging investiga-
tions (CT, PET, PET/CT) have their limitations and yield false negative and positive 
results, so tissue sampling is needed. This must be done in a more invasive way 
(mediastinoscopy, mediastinotomy, endobronchial ultrasound-guided transbronchial 
needle aspiration (EBUS-TBNA), endo-oesophageal ultrasound-guided fine needle 
aspiration (EUS-FNA). EBUS-TBNA is a minimally invasive mediastinal staging 
tool. It allows the bronchoscopist to visualize airway structures and surrounding 
processes. The main indications for EBUS-TBNA are 1. staging the mediastinum 
in suspected non-small cell lung cancer, 2. diagnosis of lung cancer when there is 
no endoluminal tumour but mediastinal or hilar adenopathy, 3. diagnosis of unex-
plained mediastinal lymphadenopathy and 4. tissue banking samples for research 
studies. EBUS-TBNA samples the same lymph node stations as mediastinoscopy 
but also stations 10-11. Based on data from systematic reviews and meta-analysis, 
results for sensitivity, specificity and negative predictive value with EBUS-TBNA 
for mediastinal staging are 88-93%, 98-100% and 60-86%, respectively. At this 
moment, mediastinoscopy should still be done to confirm negative EBUS-TBNA 
results and when the pre-test clinical probability of lung cancer is high. EBUS-TBNA 
is well tolerated. Pneumomediastinum, pneumothorax, haemomediastinum and 
infectious complications can occur very rarely. A post-procedure chest radiograph 
is not usually needed.
Learning Objectives:
1.  To learn about N staging in lung cancer.
2.  To learn the current state of endobronchial ultrasound for intrathoracic inter-
vention.
3.  To become familiar with limitations and pitfalls.
A-383 09:21
C. Distant metastasis and whole body imaging 
G. Antoch; Düsseldorf/DE (antoch@med.uni‑duesseldorf.de) 
Staging lung cancer patients includes whole-body assessment to exclude distant 
metastases. Detection of distant metastatic spread has an impact on patient 
management. Currently, a variety of different guidelines and staging algorithms 
are available from different countries and different societies. The most important of 
these guidelines will be summarized to give the audience an overview concerning 
current recommendations. In addition, state-of-the-art imaging with whole-body 
PET/CT and MRI have been available for some time. These imaging modalities 
offer tumour staging including T-stage, N-stage, and M-stage in a single session. 
Taking into account both, time and budget, „one-stop shopping“ may be considered 
desirable when staging lung cancer patients. But do whole-body MRI and PET/CT 
really offer staging in a single session at comparable accuracy? This talk addresses 
current recommendations for staging of distant metastases in lung cancer patients 
and discusses the accuracies of whole-body imaging modalities in this indication.
Learning Objectives:
1.  To appreciate the role of PET/CT and whole-body MRI.
2.  To learn about the sensitivity and specificity.
3.  To become familiar with the role of imaging in early response evaluation and 
in follow-up.
Author Disclosure:
G. Antoch: Speaker; Bayer Healthcare, Nordion, Siemens. 
Panel discussion: 
Facts and controversies in lung cancer staging 09:44 
In adults, CT urography is now the preferred initial examination for patients with 
haematuria at high risk for UUC. A practical method for risk stratification will be dis-
cussed. For patients with haematuria, early and accurate diagnosis helps optimise 
prognosis but conventional investigative pathways are complicated and lengthy, 
utilising multiple imaging tests and many diagnostic algorithms exist without rigorous 
evaluation. CT urography offers a single imaging test of high-diagnostic accuracy 
with the potential to replace multiple alternative imaging tests in the diagnostic 
pathway, improve patient experience, improve diagnostic performance and accel-
erate diagnosis. A system for imaging haematuria involving use of CT urography, 
unenhanced CT of the kidneys, ureters and bladder, urinary tract ultrasound and 
cystoscopy will be proposed.
Learning Objectives:
1.  To learn how to read and report CT urography.
2.  To understand how to optimise CT urography for haematuria and urothelial 
cancer.
3.  To report specimen cases and self-assess your own performance.
08:30 - 10:00 Room I/K 
Chest 
RC 1204 
Lung cancer staging in 2013 
A-380 08:30
Chairman’s introduction: the latest TNM classification 
J. Biederer; Heidelberg/DE (Juergen.Biederer@med.uni‑heidelberg.de) 
Based on comprehensive evaluation of clinical outcomes, the latest 7th TNM clas-
sification of lung cancer has brought significant changes compared to the former 
editions. For the first time, non-small cell and small cell lung cancer are covered 
by one system. Local tumour size (M-staging) is now categorized in 5 steps with 
diameters of 2, 3, 5 and 7 cm. The classification of lymph node involvement (N-
staging) has been refined, now integrating findings from PET, if available. Staging 
of distant metastases differentiates between metastases inside the contralateral 
lung (M1a) and lesions inside other organs (M1b). Lung metastases on the same 
side of the chest are now called T3 (within the same lobe) or T4 (within other 
lobes). The recommended imaging technology for lung cancer staging comprises 
CT (T, N, M), PET (N-staging) and MRI (M-staging). The diagnostic scope of all 
modalities individually, in combination or as hybrid technology for T/N/M-staging 
will be presented and discussed against the background of the current guidelines. 
The role of other important methods (endobronchial ultrasound) and thoracic 
interventions will be addressed.
Author Disclosure:
J. Biederer: Speaker; Siemens. 
A-381 08:35
A. Local tumour staging 
L. Bonomo; Rome/IT (lbonomo@rm.unicatt.it) 
Main changes in the 7th edition TNM classification are reflected in the T-staging. 
These changes are largely related to the re-classification of the size and location 
of the primary tumour and satellite nodules. In particular, the new staging system 
distinguishes five size-based categories (with cut-off points at 2, 3, 5 and 7 cm), 
despite the two size groups of the former classification (divided by a 3 cm cut-off 
point). Therefore, inside the old T1 and T2 groups, the new classification distin-
guishes T1a, T1b, T2a and T2b, according to a significantly different survival rate 
among the subgroups. For the same reason, additional ipsilateral nodules are 
now classified as T3 if located in the same lobe as that of the primary tumour and 
T4 if located in a different lobe. Multidetector computed tomography (MDCT) is 
the standard imaging technique for assessing the T-staging of patients with lung 
cancer. Due to the increased image quality compared to the conventional CT, 
MDCT scanners can depict with greater confidence an invasion in surrounding 
tissues (pleura, mediastinum and chest wall or a transfissural tumour growth) and 
can detect more and smaller lesions. To investigate T-staging other non-invasive 
imaging techniques, including FDG-PET scanning and MRI, are now available. 
However, they offer only a little extra benefit in the T-staging of lung cancer, owing 
to the limited ability of PET for precise anatomic location and size measurement 
and to the significant challenges of MRI in the study of the lungs, mainly due to 
inhomogeneity of magnetic field and cardio-respiratory motion artifacts.
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A-386 08:58
B. Risk in MRI 
R.R. Peeters; Leuven/BE (ronald.peeters@uzleuven.be) 
With the advent of higher field MRI scanners in clinical practice and the construc-
tion of ‘MRI compatible’ implanted devices, the list of the do’s and don’ts while 
performing an MRI examination on patients changes constantly. In this presentation, 
basic safety guidelines and rules will be explained regarding static magnetic field 
effects, time varying magnetic field effects, radiofrequency effects and acoustic 
noise effects, both with regard to the patient as well as the personnel using the 
equipment. Due to the advances in medical technology, the list of possible ‘safe’ 
and ‘unsafe’ items changes almost daily. Therefore, it is very important to have all 
the information about the patient’s condition and implants prior to the MRI procedure 
in order to asses possible contraindications in advance. While until a couple of 
years ago cardiac pacemakers and neurostimulators were contraindicated in the 
MRI environment, the advent of ‘MRI compatible’ pacemakers and other implanted 
devices introduces challenges in patient safety management. In fact, these devices 
are only safe in certain configurations and also in a lot of cases specific MRI scan 
sequences and RF antennas are only allowed. Following the postponed European 
EMF directive, the protection of staff working with EM fields also became a topic of 
debate. What are the possible risks for staff working with MRI magnets and how 
can one implement practical rules for the safe use of the MRI equipment.
Learning Objectives:
1.  To learn about the risks for patients from MRI procedures.
2.  To be informed about the contraindications for MRI scan.
3.  To learn about risks for staff in an MRI department.
A-387 09:21
C. Communication of risk to patients and public 
G. Gamhewage; Geneva/CH (gamhewageg@who.int) 
Communicating risk to key stakeholders is core work in both public health and 
clinical medicine. While most professionals understand instinctively and culturally, 
how risk should be communicated. But few use a systematic tool to determine 
the best strategy for risk communications. The first critical step in communicating 
risk is to clarify the change we want to see in our target audiences as a result 
of our communications. Step two looks in depth at the different audiences and 
looks at their position on the issue being communicated against the energy they 
will invest in either agreeing or disagreeing with the change you want to see. The 
third step deals with choosing a risk communications strategy for the target group. 
One practical model builds on Peter Sandman’s framework for communicating 
risk. The model, which has been tested extensively and adapted by the World 
Health Organization, places emphasis on the perception, beliefs and emotional 
reaction of the target audience. Perception is influenced by many factors includ-
ing controllability of the hazard, impact on children, novelty and magnitude, and 
cultural beliefs. The emotional response of the target audience is then analyzed 
against the extent of the hazard as determined by technical experts. Based on this 
analysis, one of four risk communications strategies can be used to communicate 
risk: education and surveillance; precautionary advocacy; crisis communication; 
or outrage management. As changes occur in the perception or the magnitude of 
the risk over time, and changing circumstances, the analysis is repeated and the 
best current strategy applied.
Learning Objectives:
1.  To become familiar with communicating risk according to the imaging modality.
2.  To become familiar with important rules in communication.
3.  To understand the relationship between threat/hazard and perception of parents 
regarding imaging for their child.
4.  To learn how to select an appropriate risk communications strategy suited to 
parents and children.
Author Disclosure:
G. Gamhewage: Advisory Board; Sarvodaya Shramadana Samithiya, Sri 
Lanka. Author; authorship of any material I have produced in the last 12 years 
is the property of my employer. Board Member; Formerly Vice-Chair of the 
Co-existence Initiate based in the USA. Employee; World Health organization. 
Founder; Amazing Teens Project, Switzerland. Grant Recipient; through 
employer only. Speaker; too many to list, all within public health or community 
development. 
Panel discussion:  
How to communicate risk to patients and the public? 09:44 
08:30 - 10:00 Room L/M 
Physics in Radiology 
RC 1213 
Risk assessment and risk communication 
A-384 08:30
Chairmen’s introduction 
M.M. Rehani1, P. Vock2; 1Vienna/AT, 2Berne/CH (madan.rehani@gmail.com) 
Risk free society is utopian. Every action in life entails some risk. What mat-
ters is the balance between risk and benefit. Wherever benefit to the person 
overweighs risks, it is easy to accept. Situations become critical when the risk 
is unknown, is unsubstantiated but still probable sometime in future, is well 
known at higher level but cannot be demonstrated at the levels at which action 
is taken or is disputed in the scientific community. Some of these features match 
with radiation risk. Besides scientific aspects of extent of risk, there are issues 
of perception of risk. Medical radiation risk reminds many professionals of the 
risks observed after the Hiroshima and Nagasaki incident. Moreover, many get 
deterred by an extremely small amount of radiation emitted by radioisotopes 
whereas thousands of times higher x-radiation in radiology practice does not 
cause any flutter. Rational understanding of risk, its estimation, perception and 
communication is needed. Current knowledge of radiation risks provides clear 
ground for safe practice of radiology and effective communication of risks to 
patients, public and referring doctors. It is the duty of the radiology, medical phys-
ics and radiological technology professional to communicate risks appropriately 
so as to avoid misinformation. In this session, the first two speakers will analyse 
the risks of imaging using ionising radiation and MRI, and the third speaker will 
introduce the delicate task of communication that we will then discuss in the panel. 
Session Objectives:
1.  To learn about risk, risk estimation, risk perception and communication.
2.  To become familiar with radiation risk: past and present.
3.  To appreciate why we need to inform patients and the public about the risks 
and how.
4.  To understand what referring doctors should know about risk.
A-385 08:35
A. Radiation risks for patients and staff 
E. Vaño; Madrid/ES (elivano@terra.es) 
The International Commission on Radiological Protection (ICRP) made a revision of 
the risk factors for stochastic effects in 2007. No substantial changes in the global 
factors of cancer risk occurred in comparison with the previous ones from 1990. But 
relevant changes were proposed for some organs as breast and lung. ICRP insisted 
on the important differences on the higher risk factors for children compared to 
adults and on the caution to apply the quantity effective dose in medical exposures. 
For deterministic effects (tissue reactions), the most relevant changes (proposed in 
2001) are the new threshold doses for radiation opacities (cataracts) in the lens of 
the eyes and for circulatory disease to the heart or brain. These changes, especially 
the one on the lens opacities, should have a relevant impact on the radiation safety 
aspects of professionals involved in fluoroscopy-guided interventional procedures. 
The ICRP released a statement in April 2011, alerting the medical community on 
these changes and recommending a change in the dose limit for the lens of the eye 
for occupationally exposed persons. The immediate consequence was a change 
in the International and European Basic Safety Standards to adopt this new limit. 
Concerning radiation induced cataracts, it appears that the rate of dose delivery 
does not modify the incidence. Radiation cataracts develop in a characteristic 
sequential and progressive fashion. The rate at which these changes develop, is 
strongly dose-dependent with an age-modulating component. The latent period for 
radiation cataracts seems to be inversely related to dose.
Learning Objectives:
1.  To get the latest information on stochastic risks in radiology.
2.  To understand the risks for children compared to adults.
3.  To get the latest information on tissue reaction to medical procedures.
4.  To learn about radiation cataract and its dose dependence.
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B. Can we prevent post-partum haemorrhage in high-risk patients? 
J.-P. Pelage; Caen/FR (pelage‑jp@chu‑caen.fr) 
Post-partum hemorrhage remains a major cause of maternal mortality and mor-
bidity worldwide. Prevention of post-partum haemorrhage should be promoted to 
reduce the incidence and the severity of this complication. Identification of high-risk 
patient such as women with abnormal placentation is necessary. Placenta accreta 
is mainly related to the increased use of cesarean section. This condition is often 
diagnosed after failed attempts to manually remove the placenta. However, placenta 
accreta can be suspected before delivery with the use of ultrasound and Doppler. 
Confirmation of the diagnosis should be obtained with pelvic MRI. Placenta percreta 
is defined as the trophoblastic invasion of the whole myometrium and serosa of 
the uterus. This invasion may also involve adjacent structures such as the blad-
der or the digestive tract. Placenta percreta carries a high risk of complications 
and its management may ultimately require hysterectomy and partial resection of 
adjacent organs. Placental abnormalities present a formidable clinical challenge 
and interventional radiologists play a major role. Among the various options, two 
types of procedures have been popularized in tertiary care centers. Placenta ac-
crete should be left in place and prophylactic embolisation of the uterine arteries 
can be performed. In patients with placenta percreta, prophylactic placement of 
angiography balloons or compliant occlusion balloons in the common or internal 
iliac arteries can be discussed. These balloons should be inflated at the time of 
delivery only in case of haemorrhage. Additional embolisation of the uterine arteries 
may be needed. Some authors recommend non-resorbable microspheres instead 
of gelatin sponge to obtain better devascularization.
Learning Objectives:
1.  To learn how to identify a high-risk patient.
2.  To become familiar with preventive measures and medication.
3.  To know more about techniques for invasive prevention.
4.  To learn about the results obtained through preventive techniques.
Author Disclosure:
J. -P. Pelage: Advisory Board; Keocyt. Consultant; Cook, Terumo, Merit Medical. 
Research/Grant Support; Cook, Terumo, Merit Medical. 
A-391 09:21
C. Treatment of post-partum haemorrhage 
M. Szczerbo-Trojanowska; Lublin/PL (ewamak@MRI.am.lublin.pl) 
Post-partum haemorrhage (PPH) is a life-threatening complication of approximately 
1%  of deliveries. Is defined as blood loss of more than 500 ml during a vaginal 
delivery, more than 1000 ml with a caesarean delivery or a reduction of haematocrit 
level by at least 10%  between admission and the post-partum period. Bleeding 
which appears during the first 24  h following delivery is recognised as a primary 
PPH. Delayed or secondary bleeding may occur after the first 24  h up until the 
sixth week following delivery. Active bleeding can be detected most frequently from 
vaginal, pudendal or uterine arteries with an approximate flow rate of 0.5-1 ml/min. 
Uterine atony or diminished myometrial contractility account for 80%  of PPHs. 
Embolisation of the pelvic arteries represents an attractive alternative procedure 
for management
of post-partum bleeding. In unstable patients with massive bleeding embolisation 
can be performed from the anterior division of the internal iliac artery. Selectivity 
of catheterisation and subsequent embolisation depends on the haemodynamical 
and clinical status of the patient. Several embolic materials can be used: pledgets 
of absorbable gelatin sponge, microspheres, fibred steel coils or fibred platinum 
microcoils. Success rates for embolisation have been reported to exceed 90%. 
Secondary embolisation is required in 9-14%  of cases and is usually satisfactory. 
Complications of are rare and do not exceed 6-7%  of cases. The most common 
are pelvic infections and non-target embolisations. The postembolisation syndrome, 
including pain and fever, typically resolves in 2-3 days. Return of normal menses 
is observed 3-4 months after embolisation. 
Learning Objectives:
1.  To learn about clinical evaluation of post-partum haemorrhage.
2.  To become familiar with relevant anatomy.
3.  To understand catheterisation and embolisation techniques.
4.  To become familiar with results of embolisation
 
Panel discussion:  
How to reduce the radiation doses of these methods? 09:44 
08:30 - 10:00 Room N/O 
Interventional Radiology 
RC 1209 




A.-M. Belli; London/UK (Anna.Belli@stgeorges.nhs.uk) 
Interventional Radiology (IR) is increasingly being applied in the management of 
obstetric and gynaecological haemorrhage. National reviews of maternal deaths 
from post-partum haemorrhage have recognised that maternal deaths may be 
prevented by IR and that all obstetric units should have protocols and arrangements 
in place to ensure appropriate and timely referral to IR. The important role that IR’s 
play in the management of fibroids has also highlighted how these techniques can 
be applied to other gynaecological conditions which may result in haemorrhage. 
This session will start by describing which gynaecological disorders may result in 
haemorrhage, and the technical aspects of treatment followed by the published 
evidence for embolisation. The session will then focus on obstetric haemorrhage, 
with an emphasis on prophylaxis and how women deemed at high risk from 
haemorrhage might be managed safely. The techniques used for prophylaxis of 
haemorrhage will be described in detail and the published data presented. The 
final presentation will concentrate on the technical aspects of embolisation when 
haemorrhage has occurred to ensure the best results by knowing the relevant 
anatomy and appropriate technique of embolisation. The publshed evidence of 
the results of embolisation in PPH will be presented. These presentations will be 
followed by a panel discussion on how IR’s can reduce the radiation dose whilst 
simultaneously ensuring successful outcomes for their therapies, an important 
issue in a young and fertile group of women. 
A-389 08:35
A. Etiology and treatment of gynaecological benign and malignant 
causes of massive bleeding 
A. Keeling; Dublin/IE (aoifekeeling@hotmail.com) 
Following this presentation, one should be familiar with causes of massive bleeding 
due to gynaecological disorders, diagnostic imaging of gynaecological bleeding, 
clinical indications for embolisation, technique employed for embolisation, po-
tential procedure-related complications and management and existing literature 
and embolisation results. Uterine fibroids and post-partum haemorrhage are the 
most common causes of vaginal bleeding treated with uterine artery embolisation 
(UAE). However, a myriad of other benign and malignant aetiologies for massive 
vaginal bleeding are less commonly discussed. As vaginal bleeding can be life-
threatening, it is paramount that Interventional Radiologists are familiar with its 
diagnosis, aetiology and the pivotal role of UAE. Traditionally, surgery, usually 
hysterectomy, was performed. The minimally invasive technique of transcatheter 
embolisation has become a viable alternative due to speed of haemostasis and its 
uterus preserving, thus fertility preserving nature. Technology advancement with 
advent of microcatheters and choice of embolic material, along with refinement of 
procedure skill have enabled the widespread practice of embolisation. Pelvic arterial 
anatomy, including possible arterial communications will be revised. Aetiology of 
non-obstetric massive vaginal haemorrhage, along with typical clinical presenting 
features are outlined. Imaging appearances of the aetiologies are presented. 
Selection of patients, procedure technique, pitfalls and procedure complications 
are discussed. Importance of clinical involvement of Interventional Radiologists 
in patient follow-up is emphasized. Massive gynaecological haemorrhage is life-
threatening and Interventional Radiologists are well positioned to successfully treat 
this with transcatheter arterial embolisation. Overview of aetiology, radiological 
appearances, embolisation technique and literature is provided.
Learning Objectives:
1.  To know more about causes of massive bleeding due to gynaecological dis-
orders.
2.  To learn about diagnostic imaging and therapeutic embolisation.
3.  To review published results obtained through embolisation.
1
Postgraduate Educational Programme
S9 CB D E F GA
2.  To understand the categories of patients for which specifically tailored protocols 
must always be employed.
3.  To appreciate the potential impact of patient specific protocols on image quality 
and patient dose through the use of sample cases.
4.  To discover a simple framework which could assist radiographers in introducing 
patient specific examination protocols to their departments.
08:30 - 10:00 Room Q 
Paediatric 
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D. Roebuck; London/UK (derek.roebuck@gosh.nhs.uk) 
Cancer is a major cause of death and disability in children. Radiologists have an 
important part to play in the paediatric oncology multidisciplinary team. Our potential 
roles include screening (in children at high risk of developing a tumour), initial diag-
nosis and staging, biopsy, treatment, supportive care (for example central venous 
and/or enteric access procedures), detection and characterisation of complications 
of treatment, surveillance for recurrence and palliative care. Despite the relative 
rarity of each type of paediatric cancer, radiologists have tried hard to develop imag-
ing protocols, working in collaboration with colleagues in oncology. The approach 
is more standardised in some tumour types than others. This session will help the 
practicing paediatric radiologist develop methods for reporting imaging studies in 
children with tumours of the liver, adrenals, kidneys, and central nervous system. 
A-395 08:35
A. Renal and adrenal tumours in children 
A.M.J.B. Smets; Amsterdam/NL (a.m.smets@amc.uva.nl) 
Primitive malignant renal tumours comprise 6% of all childhood cancers. Wilms’ 
tumour (WT) is the most frequent type accounting for more than 90%. Imaging 
alone cannot differentiate between these tumours with certainty but it plays an 
important role in screening, diagnostic workup, assessment of therapy response, 
preoperative evaluation and follow-up. The outcome of WT after therapy is excel-
lent with an overall survival around 90%. This allows for a risk-based stratification 
maintaining excellent outcome in children with low-risk tumours while improving 
quality of life and decreasing toxicity and costs. The imaging issues for WT from 
the European perspective will be discussed as well as the characteristics of other 
paediatric malignant renal tumours. Primary adrenal malignant tumours can be 
categorized according to their origin. Adrenocortical neoplasms are rare in chil-
dren. A size greater than 5-10 cm suggests malignancy as well as signs of local 
invasion or distant metastasis. The most frequent malignant medullary tumour is 
neuroblastoma. It accounts for 7-10% of all childhood cancers and has a survival 
rate between 5 and 80% depending on age at diagnosis, tumour spread, genetic 
markers, etc. It is related to borderline malignant ganglioneuroblastoma and be-
nign ganglioneuroma. Imaging cannot distinguish between these tumours but it is 
essential in the diagnostic workup and during follow-up. Currently, 2 systems are 
used to stage neuroblastoma: The International Staging System (INSS) is based on 
surgery; the International Neuroblastoma Risk Group (INRG) has developed image-
defined risk factors (IDRF) used for staging. Both staging systems will be discussed. 
Learning Objectives:
1.  To appreciate the role of US, CT, MRI and scintigraphy.
2.  To become familiar with the imaging findings and the main differential diagno-
ses.
3.  To learn about the imaging strategies for diagnosis and staging.
A-396 08:58
B. Paediatric liver malignancies 
D. Roebuck; London/UK (derek.roebuck@gosh.nhs.uk) 
The main aims of imaging are confirmation of the hepatic origin of the tumour, 
diagnosis and staging. Differential diagnosis is facilitated by combining imaging 
findings with clinical parameters, such as serum alpha-fetoprotein (AFP). Children 
with malignant liver tumours often require three modalities (US, chest CT and 
MRI) for optimal imaging. Vascular tumours of infancy (congenital and infantile 
haemangiomas) and mesenchymal hamartoma should be diagnosed on imaging 
08:30 - 10:00 Room P 
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A. Innovations in dose optimisation 
S. Foley; Dublin/IE (shane.foley@ucd.ie) 
Computed Tomography (CT) use has grown dramatically in recent years especially 
with the advent of multidetector technologies. Although providing non-invasive 
high-quality cross-sectional images of the body, concerns exist given the relatively 
large radiation doses involved and the rising number of referrals. In keeping with 
the ALARA principle, efforts continue apace to optimise radiation doses throughout 
radiology but within CT in particular, to minimise risks to both patients and popula-
tions, while maximising the diagnostic yield. This refresher course considers CT 
dose optimisation techniques and especially recent innovations within the modality. 
First, it looks at the knowledge base pertaining to radiation dose within CT, the 
influencing factors, and how these are routinely combined within clinical practice. 
Recent developments in scanner design and software have greatly assisted CT 
users in optimising radiation doses and allowed the consistent individualisation of 
doses. The principles of these technologies, such as automatic exposure control, 
cardiac gating and innovative reconstruction algorithms will be introduced and 
discussed. A variety of non-scanner based approaches to optimisation will also be 
examined, such as the use of superficial shielding, heart rate control medication 
and patient positioning as well as some useful tips from the literature that can help 
users optimise doses within their own CT departments. Finally, as numerous CT 
manufacturers aim to provide routine sub-millisievert scanning, possibilities for 
future optimisation methods will be presented
Learning Objectives:
1.  To consolidate knowledge in the area.
2.  To become familiar with recent developments based on scanner design features 
and to be aware of the evidence base that supports these developments.
3.  To become familiar with recent developments based on non-scanner based 
approaches such as shielding and to be aware of the evidence base that 
supports these approaches.
4.  To learn more about the potential for future developments in the area.
A-393 09:15
B. Developing patient specific examination protocols 
H. Precht; Odense/DK (hepr@ucl.dk) 
The CT technology has developed rapidly during the last years and facilitates 
multiple technical settings, such as dose, collimation, pitch and more advanced 
possibilities as Iterative Reconstructions, Dual Energy and contrast protocol. All 
these technical opportunities can be used to optimise the CT examination focusing 
on image quality and/or dose. Optimization strategies addressing patient groups 
and/or anatomic protocols to start optimising image quality involves consideration 
of patient‘s age, radiation sensitive area, suspected pathology or volume of a given 
anatomy according to ICRP. On this basis, the level of information about the patient 
and purpose of the examination is essential. Hereby requested image quality will 
differ regarding the specific patient and case. Image quality involves both objective 
and subjective parameters and will always be based on individual preferences. 
To optimise image quality, close cooperation between radiologists, radiographers 
with technical capabilities and physicists is required. This interaction can serve as 
leverage for the possibility to make the CT examination present the expected pathol-
ogy more precise at the lowest possible radiation dose and use the full potential 
of the CT scanner. Sample clinical cases representing optimization focusing on 
the individual patient will be presented to support reflection on radiation dose and 
image quality. An ongoing research project implementing technical optimization in 
Cardiac CT aiming on the newly developed technical factors including a subproject 
of post-mortem cardiac CT compared to histopathology will be presented as an 
example to how these techniques could have a future applicability in the Medical 
Imaging departments. 
Learning Objectives:
1.  To understand the importance of employing patient specific examination pro-
tocols in computed tomography by exploring the benefits of such protocols.
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08:30 - 10:00 Room Z 
Professional Challenges Session 
PC 12 
Legal matters related to multimodality techniques 
A-398 08:30
Chairman’s introduction 
K. Åhlström Riklund; Umea/SE 
Mutimodality imaging is rapid increasing and with this combined imaging 
radiology and nuclear medicine meet in a new way. The hybrid techniques 
give new combined information of both structural and molecular or biochemical 
type of the patient. The two principally different types of information should 
not compete but complement each other. It is however a challenge to use 
the combined information in the best way and not least the legal issues of for 
instance training and allowance are sensitive issues needing to be discussed. 
There are several ways to take care of hybrid imaging. PET/CT and SPECT/
CT are so far the most common used hybrid imaging techniques but also PET/
MR is recently introduced. In the beginning the CT was used only for attenuation 
correction and some anatomical guidance. Todays PET/CT-scanners are 
equipped with high performance CT and the challenge to use them in a proper 
diagnostic way has to be solved. There are educational issues both for radiology 
and nuclear medicine. The development of hybrid imaging influences guidelines 
and a restricted update will be presented. The radiation safety is also an issue 
and the different modalities engaged in hybrid imaging have different demands 
for buildings, personnel and patients. All these demands have to be taken into 
consideration and educational activities have to be done. A wide range of legal 
issues are involved in imaging and some of them are different for CT and PET. 
This symposium will give an introduction to the situation but the discussion must 
continue. 
Session Objectives:
1.  To learn about legal matters in multimodality imaging in different parts of 
Europe, in radiology and nuclear medicine.
2.  To understand the challenges in hybrid imaging, with respect to both radiology 
and nuclear medicine.
3.  To consolidate knowledge of the situation in different parts of Europe.
Author Disclosure:
K. Åhlström Riklund: Research/Grant Support; Research contract at my 
department, for 3T from General Electric and Philips and for PET/CT from 
General Electric. Speaker; invited speaker at single educational occasions for 
General Electric (no fees).
A-399 08:35
Radiological legal matters in eastern Europe 
M. Studniarek; Gdansk/PL 
Comparison of organisation in departments equipped with hybrid imaging units 
were performed on the basis of questionnaires sent to National Societies of 15 
countries. Installation of PET/CT, PET/MRI and SPECT/CT in the departments of 
nuclear medicine provides the possibility to produce, prepare and inject adequate 
activities of any radiopharmaceuticals. We did not find any such installation out-
side the Nuclear Medicine Unit. 4-5-year specialisations of radiology and nuclear 
medicine are separated and independent in majority of national education systems. 
NM specialisation provides more clinical settings and frequently only few months 
(3-6) in radiology unit. Organisation of reporting system is different, but the main 
rule is acceptation of National Health Organisation and Funds. There are some 
conditions of insurance companies for payment: at PET/CT scanner there have 
to be employed both NM specialist and radiologist. Responsibility for the report is 
also shared. But if CT part is only for attenuation correction the report is frequently 
prepared by NM specialist alone. Specialist fully reporting (with diagnostic CT and 
MRI) in most of countries needs supplementary education, but usually a nuclear 
medicine specialist needs longer training in radiology. Anywhere symmetric condi-
tions exist, basing on personal experience (more than 600 PET/CT procedures 
elaborated under supervision). In PET/MRI diagnostic potential of MRI needs better 
experience. In this new modality neither experience based solutions nor separated 
procedures are elaborated yet. Guidelines for hybrid procedures are prepared by 
grounds if possible, and biopsy is rarely required. The major malignant primary 
tumours are hepatoblastoma, hepatocellular carcinoma, rhabdoid tumour, undif-
ferentiated (embryonal) carcinoma, and hepatocellular carcinoma variants (tran-
sitional liver cell tumour and fibrolamellar carcinoma). Malignant vascular tumours 
(epithelioid haemangioendothelioma and angiosarcoma) are rare. The distinction 
between multifocal primary liver tumours and metastases from an extrahepatic 
primary tumour (or multifocal infantile haemangioma) can almost always be made 
on a combination of imaging and clinical features. There are two major staging 
systems in current use. The Children’s Oncology Group (COG) use a surgical 
staging system, in which the main role of radiology is the detection of extrahepatic 
spread and preoperative surgical planning. The other major trials group, SIOPEL, 
uses the PRETEXT system, in which the role of imaging is much more important 
because surgery is delayed and chemotherapy is stratified according to clinical 
and radiological risk factors. Because COG now also collect PRETEXT data, there 
is an intercontinental consensus that the ideal radiology report should include a 
description of each of its parameters. 
Learning Objectives:
1.  To understand the role of US, CT and MRI.
2.  To become familiar with the imaging findings and the main differential diagno-
ses.
3.  To learn the imaging strategies for diagnosis and in staging.
A-397 09:21
C. Oncologic imaging in the paediatric brain 
G. Hahn; Dresden/DE (gabriele.hahn@uniklinikum‑dresden.de) 
Brain tumours of children account for 15% to 20% of all primary brain tumours. 
Posterior fossa tumours and supratentorial tumours occur in nearly equal frequency. 
However, supratentorial tumours are more common in the first two to three years of 
life, whereas infratentorial tumours predominate from ages 4 to 10. The symptoms 
of children with brain tumours depend upon the age at the time of presentation and 
the location. MR is today the study of choice for diagnosis of intracranial neoplasms 
because the multiplanar imaging capability is extremely useful in determining the 
exact extent of the tumour and its relationship to surrounding normal structures. 
For MR evaluation, the standard sequences are T2-, T1-, FLAIR-sequences in 
axial, saggital and coronal planes. Neuronavigation sequences are important for 
planning tumour surgery. The most common posterior fossa tumours of childhood 
are medulloblastomas, astrocytomas and ependymomas. Brainstem tumours 
should be separated into four separate major categories with different diagnostic 
pathway, prognosis and therapy. Supratentorial tumours involve the parenchyma 
of the brain or grow intra- or suprasellar, intraventricular and in the pineal region. 
Tumours arising from the calvarium are rare in childhood.
Learning Objectives:
1.  To understand the role of CT, MRI and MRS.
2.  To become familiar with the imaging findings and the main differential diagno-
ses.
3.  To learn about the imaging findings of post-chemo/radiation therapy conditions 
and complications.
Panel discussion:  
How far should the radiologist go in suggesting tumour recurrence 
or post-treatment complications? 09:44 
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Author Disclosure:
K. Åhlström Riklund: Research/Grant Support; Research contract at my 
department, for 3T from General Electric and Philips and for PET/CT from 
General Electric. Speaker; invited speaker at single educational occasions for 
General Electric (no fees). 
A-402 09:29
International, regional, national and local framework requirements
A. Perkins; Nottingham/UK 
The installation of clinical PET-CT, SPECT-CT and PET-MR scanners has placed 
additional demands on organisations and staff with respect to safety and training. 
Adequate training of the clinical and radiographer/technologist (practitioner) work-
force in dual modalities is still not in place in many countries. Throughout the world 
medical exposures continue to constitute the major source of radiation exposure 
to the population, hence it is essential to minimize such activity whilst ensuring 
appropriate medical benefit. Radiological protection frameworks originate from the 
ICRP, however the final requirements at national and local level vary depending on 
the different regulatory systems in place. Even with regulatory structures in place, 
there is much scope for improvement at local level. In the US the “Image Gently” 
campaign was an example of medical communities striving to reduce radiation 
doses, especially in paediatric patients. In order to ensure requirements it is es-
sential to have appropriate scientific support. In the EU the European Directive 
97/43/Euratom (1997) on the health protection of individuals against the dangers of 
medical exposures, introduced the term “Medical Physics Expert”. Directive 97/43 
defines the Medical Physics Expert as an expert in radiation physics or radiation 
technology applied to exposure, whose training and competence is recognised by 
the competent authorities. These individuals are required to have expertise in all 
modalites relating to the safety of patients, staff and the general public. The object 
of this presentation is: to provide information about the origin of the radiation protec-
tion framework; to describe the framework for radiation protection at international, 
regional and national levels; to explain the responsibilities of different parties and 
staff groups within the working environment. Examples of suitable educational and 
professional resources will be provided. 
Learning Objectives:
1.  To learn about the origin of the radiation protection framework.
2.  To appreciate the framework for radiation protection at international, regional 
and national levels.
3.  To understand the responsibilities of different parties within the working envi-
ronment.
Author Disclosure:
A. Perkins: Author; Multiple. Board Member; Gamma Technologies Ltd. UK. 
CEO; Gamma Technologies Ltd. UK. Consultant; Quotient Bioresrech, UK. 
Employee; University of Nottingham. Founder; Gamma Technologies, UK. Grant 
Recipient; Multiple. Investigator; Multiple. Research/Grant Support; Multiple. 
Speaker; Multiple.
Panel discussion:  
A discussion with questions from the audience about the differences 
across Europe 09:47 
10:30 - 12:00 Room B 
ESR meets Chile 
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Introduction: Radiology in Chile: reality and challenges 
P. Soffia, M.A. Pinochet; Santiago/CL (psoffia@alemana.cl) 
Chile is a long and narrow strip of land between the Andes and the Pacific Ocean. 
Due to its length, it has a wide variety of climates, from the dryest desert in the world, 
located in the northern part of the country, to the ice-covered Patagonia in the south. 
national societies including indications of European societies, except of SPECT/
CT procedure. In Poland only SPECT is paid. 
Learning Objectives:
1.  To learn about legal matters in multimodality imaging in eastern Europe.
2.  To understand the specific role and diagnostic applications of PET/CT imag-
ing as a result of national guidelines in eastern Europe, with the example of 
Poland.
3.  To consolidate knowledge of the limits of the application of diagnostic CT in 
PET/CT units in radiology and nuclear medicine procedures listed (officially 
identified) in Poland.
A-400 08:53
Legal matters in nuclear medicine 
G.K. von Schulthess; Zurich/CH (gustav.vonschulthess@usz.ch)
Multimodality imaging using PET faces two main obstacles in Switzerland. First, a 
combined tariff had to be devised after the government no longer accepted billing 
as PET and CT separately. After long negotiations a new flat tariff has been ac-
cepted which is subdivided into technical, NM and radiological reading fees and 
cost for PET-tracers. It is assumed that eventually a similar tariff can be used for 
PET/MR and for SPECT/CT. One additional optional tariff applies for either CM-
CT, dual isotope or dual time point imaging with PET, and is billable only once. 
Second, the major legal issues arises from the introduction of new tracers. FDG 
is largely reimbursed for oncological procedures, but not for other indications, nor 
are other tracers reimbursed. Swissmedic approval (Swiss FDA approval) exists 
for FDG, Fluoride and F-Choline, but the latter two are not reimbursed as the 
government thinks that there is not enough evidence for the cost-effectiveness of 
their use. Currently the largest nuisance concerns tracers such as F-ethyltyrosine, 
Ga-Dotatate and F-DOPA, as similar very costly procedures with inferior PET- or 
SPECT tracers (e. g. FDG in brain tumors) are fully reimbursed. This results in the 
dilemma for the physician to either apply an inferior method and get reimbursed or 
an excellent method without reimbursement.
Learning Objectives:
1.  To understand issues facing tracer development and clinical use of tracers.
2.  To understand the process of getting new tracers approved for clinical use.
3.  To understand the process of getting reimbursement for integrated imaging 
procedures.
Author Disclosure:
G. K. von Schulthess: Consultant; Icon Medical Imaging plc. Equipment 
Support Recipient; GE. Grant Recipient; GE, Bayer. Research/Grant Support; 
GE. Speaker; GE. 
A-401	 09:11
Legal matters in Scandinavia 
K. Åhlström Riklund; Umea/SE 
Recently, the medical specialties in Sweden have undergone comprehensive 
changes. Radiology was the base for all radiology specialties, with a possibility to 
obtain additional specialty license in pediatric radiology, or neuroradiology. In 2006, 
a new specialty was introduced. All three radiology specialties together with basic 
training in nuclear medicine and clinical physiology were merged into a common 
specialty. After achieving this specialty in imaging it was possible to proceed with 
modular training in clinical physiology, neuroradiology or nuclear medicine to qualify 
for additional licenses. Recently, a new national review of the specialties decided to 
revert to the old system where the training in radiology and clinical physiology are 
separated and with a possibility to ad on training to achieve additional licenses in 
neuroradiology or nuclear medicine. It is not possible to get a license only in nuclear 
medicine. The updating of national guidelines is an ongoing work and increasing 
recommendation of PET/CT in several diagnoses can be seen. A few examples will 
be presented. To operate a cyclotron and PET/CT facility requires several permits 
from national authorities. For the cyclotron a permit from the Radiation and Nuclear 
Safety authority is demanded. To produce PET tracers permits from the National 
Medical Products Agency is needed. All tracers have to be produced in accordance 
with good manufacturing practice and a marketing approval is required for each 
tracer. For FDG, which is marketed in Sweden a manufacturing authorization is 
also required. The process to receive these permits is time consuming.
Learning Objectives:
1.  To learn about the educational situation in multimodality imaging in northern 
Europe.
2.  To learn about national guidelines for multimodality imaging in northern Europe.
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cultural traditions. Chile is a magic land with contrasting cultural manifestations and 
geographical landmarks, a unique country to live, visit and enjoy. 
A-406 11:00
Neuroimaging in epilepsy: in search of invisible lesions 
M. Galvez; Santiago/CL (mgalvezm@gmail.com) 
Evaluation of patients with refractory epilepsy includes review of clinical manifes-
tations, electroencephalography and brain MRI findings. Brain images attempt to 
localize and characterise the epileptogenic lesion that can correspond to cortical 
dysplasia, mesial temporal sclerosis, brain tumour or vascular lesion. Nevertheless, 
it is possible to identify a structural lesion in patients with focal epilepsy in only 
approximately 85% of the cases, even when utilising imaging protocols optimised 
for epilepsy. The group of patients with refractory parcial seizures and a normal 
conventional MRI has a worse post-operative prognosis. This is the reason why 
it is necessary to have alternative imaging techniques to better visualize these 
brain lesions. Brain segmentation and cortical dysplasia: Cerebral cortex and white 
matter brain segmentation obtained from post-processing analysis of the images 
can determine subtle areas of alteration of the cortical - subcortical differentiation, 
which is a characteristic finding for cortical dysplasias. MRI brain volumetry and 
mesial temporal sclerosis: volumetric quantification of different brain structures has 
significantly improved the sensibility and specificity of the diagnosis of hippocampal 
atrophy. This is a useful tool specifically to identify subtle unilateral alterations 
and atrophy or for identifying mild bilateral hippocampal atrophy which are dif-
ficult to identify by expert visual evaluation. Functional MRI (fMRI) resting state 
and brain connectivity: epilepsy corresponds to electrical alterations of neuronal 
brain circuits that can be visible today with fMRI using resting state technique, 
which in initial reports shows alterations of brain connectivity in these patients. 
Learning Objective:
1.  To learn about solutions to improve visualisation of epileptogenic lesions not 
visible on conventional MRI.
A-407 11:20
Interlude: Chile, land of wine and poets 
G. Soto Giordani; Santiago/CL (gloria.soto@gmail.com) 
Chile is a land of poets and wine, a land where wines are a matter not just of 
taste but also of economic performance - it’s the world’s fifth largest exporter of 
wine - a land and where poets, like Neruda and Gabriela Mistral, are not just in-
spirational, but Nobel laureates. Nicanor Parra, the Chilean self-named anti-poet, 
introduces Chilean wine to the world by saying: “Wine is everything, it’s the sea, 
the twenty-league boots, the magic carpet, the sun, the seven-tongued parrot”. At 
the same time he asks, “Is there anything more noble than a bottle of wine and a 
good conversation between two twin souls?” Neruda’s devotion to Chilean wine, 
considered a national treasure, is magnificently related in his poem Ode to Wine: 
“I like on the table, when we’re speaking, the light of a bottle of intelligent wine. 
Drink it, and remember in every drop of gold, in every topaz glass, in every purple 
ladle, that autumn labored to fill the vessel with wine; and in the ritual of his office, 
let the simple man remember to think of the soil and of his duty, to propagate the 
canticle of the wine”. Poetry and wine are part of Chilean identity, they form part 
of the profound soul of the country. 
A-408 11:25
MDCT patterns in mesenteric ischaemia: usefulness in predicting 
clinical outcome 
A. Huete; Santiago/CL (hueteahg@hotmail.com) 
Mesenteric ischaemia has high morbidity and mortality. Intestinal necrosis is a major 
determinant of poor outcome. Patterns of bowel abnormality on MDCT predicting 
necrosis and patient death are evaluated in patients with superior mesenteric artery 
embolism (SME). Bi-phasic MDCT angiography was obtained in 31 patients with 
SME. Consensus evaluation by 2 readers depicted 5 patterns of abnormal bowel 
wall: absent enhancement on both phases (wAV), absent enhancement only on 
arterial phase (wA), “target” appearance (wT), homogeneous thickening (wH) 
and hyper-enhancement (wE). Correlation was made with surgical findings and 
medical charts. Intestinal resection was used as marker of bowel necrosis and 
mortality was based on in-hospital death. 13/31 patients had intestinal necrosis 
(42%). Mortality was 29% (9/31). 22 patients had an abnormal bowel wall, 13/22 
with necrosis. aAV was seen in 11 patients, 10 with necrosis (p < 0.01). No other 
pattern correlated significantly with intestinal necrosis. wAV demonstrated 77% 
sensitivity (0.46-0.94 95%CI), 94% specificity (0.71-1.00), 91% PPV (0.57-1.00), 
85% NPV (0.61-0.96), +LR 13.85 (2.01-95.19) and -LR 0.24 (0.09-0.66) as imaging 
marker predicting bowel necrosis. Normal bowel was seen in 9 cases, none with 
Approximately 17 million people live in Chile, mainly distributed in the central region 
where a Mediterranean climate predominates. From a total of 25,000 physicians, 
only 600 are radiologists. Radiology was one of the first medical specialities in the 
history of Chilean medicine. In 1896, only 3 months after Roentgen’s discovery of 
x-rays, Professors Zegers and Salazar took the first radiograph in Latin America, at 
the University of Chile. The Chilean Society of Radiology was founded in 1941 and 
has approximately 400 members. Eight radiology residency programs are offered to 
medical graduates, 6 of them in Santiago, the main city. Chile has a mixed health 
system, 75% of the population belong to the public system and 25 % to the private 
system. Most public hospitals have Radiology Departments with CR, state of the art 
US and multi-slice CT. Only 6 public hospitals have 1.5 T MR systems, in contrast, 
more than 70 MR scanners are available in private centers. About half of the main 
public hospitals have RIS-PACS systems, and several teleradiology services have 
beeing stablished. The main challenges faced by Chilean radiology are related to the 
shortage of radiologists, implementation of teleradiology systems and turf battles. 
Session Objectives:
1.  To learn about some interesting recent and ongoing Chilean radiological 
research projects in the field of diagnostic imaging.
2.  To get a glimpse of unique radiological and non-radiological topics in Chile.
A-404 10:35
TI-RADS: a US classification of thyroid nodules related to cancer risk 
E. Horvath; Santiago/CL (eleonora.horvath@gmail.com) 
There is a high prevalence of thyroid nodules on ultrasonographic (US) examina-
tions. However, most of them are benign and may be subjected to excess FNAB. We 
propose a new, useful classification called TIRADS that is based on the concepts 
of the Breast Imaging Reporting and Data System of the American College of 
Radiology. Our TIRADS classification is based upon ten characteristic US patterns 
that allow us to approach the likelihood of malignancy regardless of nodule size. 
This classification was developed based on a prospective series of 1097 nodules 
studied by FNAB, allowing us to classify these patterns into one of five categories: 
TIRADS 1 = normal thyroid; TIRADS 2 = benign findings (0% malignancy); TIRADS 
3 = probably benign findings (< 5% malignancy probability); TIRADS 4 = suspicious 
findings (5 to 80% malignancy probability) and TIRADS 5 = highly suspicious find-
ings (> 80% probability of malignancy). In a similar fashion to the BIRADS system, 
TIRADS 4 or 5 nodules require a diagnostic procedure such as FNAB, while those 
classified as TIRADS 2 or 3 are subject to follow-up.TIRADS classification is a 
powerful tool to classify thyroid nodules regarding their likelihood of malignancy, 
allowing to correctly select those that require punction given their suspicious 
US pattern, and sort out those low-risk nodules to be followed-up. This reduces 
patient-related stress, and provides a better administration of resources involved. 
It also provides a standarized report, allowing a fluid communication with clinicians. 
Learning Objectives:
1.  To learn about an ultrasonographic-based pattern classification that enables a 
cancer risk approach to an accurate selection of thyroid nodules that require 
fine needle aspiration biopsy (FNAB).
2.  To understand the description of the 10 US pattern for thyroid nodule clas-
sification.
3.  To correctly classify the pattern into the TIRADS categories.
4.  To learn how to determine those patterns most closely related with malignancy.
A-405 10:55
Interlude: Chile, land of geographical and cultural contrasts 
G. Soto Giordani; Santiago/CL (gloria.soto@gmail.com) 
Chile is one of the slimmest countries in the world, 4,265 km long and just 356 km 
wide at its widest point. It has the driest desert in the world along with enormous 
glaciers, fjords, beaches, lakes, forests, volcanoes, as well as spouting geysers. 
Imposing natural barriers mark the nation’s boundaries, isolating the country from 
the rest of South America. The Atacama Desert separates the country from Peru, 
the Andes Mountains create a frontier with Bolivia and Argentina, and the chilly 
waters of the Drake Sea point to Chile’s proximity with Antarctica in the south. The 
immensity of the Pacific Ocean to the west completes the country’s geographic 
isolation. The diversity of climate along its length and the differences in ethnic 
background result in a variety of cultural expressions, each with its own traditions 
of music, dance, and mythological tales. In the north, Aymara Indians have been 
able to preserve many aspects of their Andean culture. Central Chile, a fertile land 
well known for its fine vineyards, has strong European influence. In the south, the 
Mapuche Indians are a cultural group who strongly contributed to the formation of 
Chilean culture. On the other hand, 3680 km off the coast of Chile, the remote Easter 
Island is inhabited by native islanders who keep alive many of their Polynesian 
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Learning Objectives:
1.  To become familiar with common and rare benign adnexal lesions.
2.  To appreciate the added value of CT and MRI in the differential diagnosis of 
benign adnexal masses.
3.  To learn about an algorithm for evaluating incidental adnexal masses with 
imaging.
A-411 11:10
C. Imaging the infertile couple 
J. McHugo; Birmingham/UK 
Investigating the subfertile couple: Infertility is a common problem said to effect 
between 9 and 20% of couples; defined as an inability to conceive following 2 years 
of unprotected intercourse. Modern technologies now allow the majority of couples 
to achieve a successful pregnancy. Imaging plays a major part in the investiga-
tion particularly of the female allowing an individualised cost effect approach to 
therapy in this situation. This lecture will allow the participant to understand the 
common causes of infertility, understand the role of imaging in the investigation 
of the infertile couple, be able to update their knowledge of imaging techniques 
in the assessment of tubal patency and integrate an imaging strategy to provide 
a cost effective service. 
Learning Objectives:
1.  To understand the incidence and causes of infertility in female and male 
patients.
2.  To learn about cost-effective strategies for imaging in cases of female and 
male infertility.
3.  To understand the rationale for best outcomes.
A-412 11:30
D. Interactive case discussion 
E. Sala; New York, NY/US (salae@mskcc.org) 
10:30 - 12:00 Room Q 







Emergency radiology management in patients with polytrauma 
U. Linsenmaier, L.L. Geyer, S. Wirth; 
Munich/DE (Ulrich.Linsenmaier@kliniken‑pasing‑perlach.de) 
Polytrauma results in patients suffering from multiple injuries and is the leading 
cause of death below the age of 45. Adequate handling of these complex patients 
and their injuries is a major challenge for any trauma hospital and deserves an 
interdisciplinary approach in which emergency radiology plays a key role. Even 
for advanced trauma centers running designated emergency radiology units, it is 
a challenge to integrate advanced radiology services in an interdisciplinary team 
treating patients with multiple injuries. Besides diagnostic imaging, the manage-
ment of the patient in an interdisciplinary environment is crucial. This lecture will 
focus on 1st management and logistics, 2nd what must be diagnosed and what can 
be diagnosed with advanced state of the art radiological imaging. The lecture will 
comprehensively cover: the use of conventional radiography, ultrasound, MDCT; 
logistics and management of the patient; MDCT in the primary patient survey, the 
ATLS concept; advanced scanning protocols for MDCT; volume image reading 
VIR and handling large datasets; metastable and unstable patients undergoing CT; 
MDCT during or after CRP Imaging protocol for the initial workup. WBCT comprises 
nCCT, CMCT of thorax, neck and c-spine (arterial) and (pv) abdomen. CRs were 
mostly replaced, US is only used as FAST (focused abdominal solography in 
trauma). WBCT can be modified by CTA (@35-45s; for e.g. extremity injuries), late 
CT scans (@120s; e.g. for bleeding dynamic, pseudoaneurysms) and delayed CT 
urography (CTU @400-500s, for pelvic and GU injuries) and also retrograde CT 
cystography. CT scout views and clinical findings determine the extent.
intestinal necrosis (p:0.004). wAV also showed a strong correlation with mortality 
as 8/9 patients with wAV died (89%) and 3/14 (14%) survived the embolic event 
(p < 0.001). Absent mural enhancement of bowel wall in arterial and venous phase 
depicted on MDCT angiography correlates strongly with the presence of bowel 
necrosis and mortality in SME.
Learning Objectives:
1.  To learn to identify the most frequent patterns of ischaemic bowel wall damage 
in patients with arterial mesenteric ischaemia using MDCT angiography.
2.  To correlate patterns of bowel wall ischaemia on MDCT with clinical outcome.
3.  To identify secondary, non-specific findings of bowel ischaemia on MDCT that 
signal a potential adverse clinical course.
Panel discussion:  
Creating networks between Latin American and European radiology: 
a unique opportunity for collaborative research projects 11:45 
10:30 - 12:00 Room C 
Urogenital Imaging 
CC 1321 




A. Imaging congenital anomalies of the female genital system 
K. Kinkel; Chêne‑Bougeries/CH (karen.kinkel‑trugli@wanadoo.fr) 
Diagnostic circumstances of congenital anomalies of the female reproductive sys-
tem correspond to repeated pregnancy loss or dysmenorrhoea due to obstruction 
at the onset of menstruation during childhood. A septated or unicornuate uterus 
may benefit from subsequent surgery, whereas no surgical solution exist so far for 
bicornuate or didelphus uterus. The 3D capabilities of ultrasound allow differentiation 
of septated versus bicornuate uterus but remains challenging for associated uterine 
pathologies. To confirm uterine aplasia, the thickness and length of a uterine septa 
and any functionality of a remnant uterine horn unenhanced MRI is indicated. The 
protocol includes native sagital T2, oblique axial and coronal T2 and T1-weighted 
sequences with and without fat suppression to identify associated endometriosis 
or ovarian poly cystic disease. Hysterosalpingography helps to verify tubal patency 
and communication between cavities. Associated renal tract anomalies are seen 
in 30% and can be classified with either ultrasound or MRI.
Learning Objectives:
1.  To understand Mullerian duct anomalies through embryology and its classifica-
tion.
2.  To learn about the indications of MRI or 3D US according to clinical and 
sonographic findings.
3.  To understand imaging technique and report requirements and the impact of 
imaging results on treatment options.
A-410 10:50
B. Benign ovarian masses 
R. Forstner; Salzburg/AT (r.forstner@salk.at) 
The goal of imaging adnexal masses is to identify patients with definitely benign le-
sions from those that require further evaluation for ovarian cancer. Sonography has 
been established as first-line imaging modality allowing characterisation in 80-90% 
of adnexal lesions. Complementary MRI is a powerful diagnostic tool and renders 
specific diagnosis of a spectrum of benign lesions, e.g. of dermoids, haemorrhagic 
cysts, endometriomas, hydrosalpinx, and of inflammatory masses. Compared to 
CT, it is particularly superior in assessment of haemorrhagic and solid adnexal 
lesions. In the latter, diffusion-weighted MRI aids in the differentiation of benign 
from malignant masses, e.g. of solid metastases. Challenges in imaging adnexal 
masses include rare benign mimicks of ovarian cancer, e.g. cystadenofibroma, 
rare types of dermoids and sometimes ovarian torsion. Important discrimina-
tors for management of a patient presenting with an adnexal mass include age, 
menopausal status, imaging findings (size, complexity of lesion, vascularization), 
change in follow- up, clinical information including symptoms, laboratory data and 
CA-125. An algorithm how to evaluate adnexal masses including incidental adnexal 
lesions will be provided.
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in observing isolated neurons and discussing their connections. Research at this 
time was an individual activity. Soon, however, knowledge widened and became 
multidisciplinary, demanding working in groups. Research groups constituted the 
new minimal structure. Only groups were able to develop multidisciplinary projects 
with enough quality to survive. However, as in biology, the functional explanation 
of excellence shows that only international networks can explain a successful 
development. As the brain is structured in a network of connections, research is 
also organized today as a network of groups with a common interest, varying in 
time. The connectome, considered as the complete set of nerve cells and their 
connections, will change over time as new connections form and old ones die. 
This plastic networking allows groups and individuals to participate in worldwide 
high quality research. Similar to neural centres and connections, only research 
networks with a well-defined structure, formed by successful groups of qualified 
scholar researchers advance science. This lecture will focus on the concept of 
science and research, and how communication, grouping and socialisation do influ-
ence both. As young researchers are the basis of science, they should know and 
follow the path and rules of scholars such as Ramón y Cajal and Humboldt. Some 
interesting facts and controversies about science, research, advices, personalities 
and countries will be presented.
Learning Objectives:
1.  To learn about Santiago Ramón y Cajal, a Spanish histologist, neuroscientist, 
and Nobel laureate.
2.  To appreciate the change from individual research to multidisciplinary working 
groups.
3.  To understand the concept of science and research, and how communication, 
grouping and socialisation do influence both.
12:30 - 13:30 Room P 





F.M.H.M. Vanhoenacker; Antwerp/BE (filip.vanhoenacker@telenet.be) 
Analysis of clinical features (age, location, concomitant diseases) is a prerequisite 
for characterisation of bone tumours. For imaging characterisation, plain films are 
the mainstay, as they accurately depict matrix, cortical permeation or disruption, 
and periosteal reaction. MRI has an additional role as most tumours have low SI on 
T1-WI and high SI on T2-WI. In certain cases, however, a combination of distinctive 
findings (SI, enhancement patterns) allows for an accurate diagnosis or narrows 
the differential diagnosis. Intratumoural fluid-fluid levels are often seen in ABC, but 
also in fibrous dysplasia, chondroblastoma, (telangiectatic) osteosarcoma, and GCT. 
Ring-and-arc enhancement is seen in chondroid tumours. Intraosseous lipomas, 
haemangioma and nontumoural lesions (Paget’s disease, irradiation) are of high 
SI on T1-WI. GCT and dense bone islands are of low SI on T1-WI and T2-WI. 
Flow voids may be seen in metastasis of renal cell carcinoma. Characterisation 
and grading of Soft Tissue Tumours (STT) based on imaging remains even more 
limited and histology is usually required for a definitive diagnosis. Ultrasound is 
mostly nonspecific but may be used for superficially located cystic STT. On MRI, 
analysis of multiple parameters (shape, presence of signal voids, fluid-fluid levels, 
SI, intratumoural necrosis, multiplicity, pattern/degree of enhancement) yields the 
best results. The highest confidence is reached in benign lesions, such as lipomas, 
vascular lesions, benign neural tumours, periarticular cysts, hematomas, PVNS, 
GCTTS, and abscesses. The major role of MRI consists -however- of local tumour 
staging and monitoring of treatment. Whole body MRI and PET-(CT) may evaluate 
distant tumour spread. 
Learning Objectives:
1.  To understand the basic principles of diagnosing bone and soft tissue tumours.
2.  To become familiar with the most important entities and their typical imaging 
presentations.
3.  To learn about the specific advantages and weaknesses of the different imaging 
modalities.
Learning Objectives:
1.  To understand the complex up to date radiological management of patients 
with polytrauma/multiple trauma.
2.  To become familiar with basic concepts, MDCT protocols and major findings 
in patients with polytrauma/multiple trauma.
A-414 11:00
Imaging of non-traumatic intracranial haemorrhage 
Z. Merhemic; Sarajevo/BA (merhemic.zulejha@gmail.com) 
Non-traumatic intracranial haemorrhage can be classified according to its lo-
calisation as subarachnoid haemorrhage (SAH), intracerebral haematoma (ICH), 
intraventricular haemorrhage (IVH), and subdural haematoma (SDH). In 80-90% 
of cases, the cause of non-traumatic haemorrhage is an aneurysm rupture. In 
young individuals, the most common cause is bleeding in vascular malformation, 
and in eldery patients high blood pressure or haemorrhagic transformation of a 
cerebral infarct will be more commonly seen. Less frequentlly, coagulopathy, or 
intratumoural bleeding will be the underlying pathology. The accurate identification 
and characterisation of an intracranial haemorrhage has important and immediate 
implications for further diagnostic workup, clinical management, and patient out-
come. In emergency situation, the diagnosis of intracranial hemorrhage is usually 
obtained by NECT scan. CT angiography (CTA) will usually follow demonstrating 
aneurysm or vascular malformation. MRI has proved to be more accurate in identify-
ing the underlying aetiology of non-traumatic haemorrhage. Selective intra-arterial 
subtraction angiography (DSA) will be necessary in some cases.
Learning Objectives:
1.  To review different underlying pathologies of non-traumatic intracranial haemor-
rhage.
2.  To learn how to use CT/CTA, MRI/MRA, and DSA in patients with non-traumatic 
intracranial haemorrhage.
3.  To discuss the value of T2* (GRE/SWI) in evaluation of causes of intracranial 
haemorrhage.
A-415 11:30
Case-based learning in radiology 
P. Pokieser; Vienna/AT (peter.pokieser@meduniwien.ac.at) 
To learn directly from routine cases by observation of professional work is by far the 
most established and time-tested learning method. “Case-based learning (CBL)” 
is a widely used term of modern medical education for learning techniques includ-
ing “real world settings” to facilitate collaborative, interactive and student-centred 
exploration of different clinical situations. Case-based learning strategies can give 
the opportunity to see theory in practice. In diagnostic radiology, the case materi-
als are easy to use for case-based eLearning. This advantage has led to many 
institutional, national and international teaching activities, supporting case-based 
learning in many ways. Materials like case collections can be helpful to design 
CBL courses. CBL courses often include blended learning scenarios, where the 
direct contact of participants is enriched by collaborative online learning between 
meetings. This lecture will provide an overview about CBL followed by dedicated 
examples of successful CBL. 
Learning Objectives:
1.  To learn about the basics of case based learning.
2.  To understand the pedagogic potentials of “real world settings”.
3.  To become familiar with case based ESR learning facilities.
12:15 - 12:45 Room A 
Plenary Session 
HL 3 




Research and science: from individuals to societies - the Ramón y 
Cajal background 
L. Martí-Bonmatí; Valencia/ES (marti_lui@gva.es) 
Santiago Ramón y Cajal (1852-1934) was a Spanish histologist, neuroscientist, 
and Nobel laureate. His pioneering investigations on brain microscopic structure 
made him the father of modern neuroscience. He was a solitary researcher involved 
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3.  To improve the skills required for accurate interpretation of plain film and CT 
imaging of the chest.
14:00 - 15:30 Room B 
New Horizons Session 
NH 14 
Imaging of the mind 
A-420 14:00
Chairman’s introduction: New insights into the state of 
consciousness through neuroimaging 
S. Sunaert; Leuven/BE (Stefan.Sunaert@uz.kuleuven.ac.be) 
The past 15 years have seen a major change in the scientific understanding 
of comas, with the main advances being made using EEG, positron emission 
tomography and MRI. Experts are now able to prove that some patients who 
seem comatose are in fact conscious, but their ability to communicate with the 
outside world has been damaged, for instance following a traumatic or anoxic 
event. This session addresses how locked-in syndrome patients are able to com-
municate through MRI, showing that they still feel, hear and understand what is 
going on around them, a development which could dramatically improve their fate. 
Session Objectives:
1.  To become familiar with recent advances in functional brain imaging, and how 
these lead to ‘the imaging of consciousness’ and ‘reading the mind’.
2.  To understand how imaging contributes to the study of the functional con-
nectivity and network topology of the human brain.
3.  To understand how these new techniques and insight lead to (pre-) clinical 
applications.
A-421 14:05
Brain wiring: resting state fMRI 
F. Barkhof; Amsterdam/NL (f.barkhof@vumc.nl) 
Functional MRI employs the contrast between oxygenated and deoxygenated blood 
to create the so-called “BOLD” contrast using T2*-sensitive sequences like EPI. 
Classically, functional MRI is used to determine the effect of task using a variety of 
motor and cognitive paradigms, for example, to map hand and language function 
in preoperative work-up. However, in the absence of an overt task, continuous 
low-frequency oscillations in the BOLD signal occur, very much like in EEG. These 
resting-state fMRI changes show temporo-spatial coherence and can be analysed 
using a variety of methods, including seed-based correlation analysis and inde-
pendent component analysis (ICA) or graph analysis. Resting-state fMRI studies 
in normal subjects consistently show around 10 networks, including the so-called 
default-mode network (DMN), but also primary visual and auditory networks, and 
more complex salience, working memory and executive networks. These major 
networks are extremely consistent across subjects and can be determined from fMRI 
runs as short as 5-10 min while lying still in the scanner. In a variety of diseases, 
alterations in resting-state networks have been reported, often leading to lower 
DMN activity (e.g. in Alzheimer’s disease, coma and advanced multiple sclerosis), 
but increased activity can also be found early in the disease course. Graph analysis 
techniques are developing quickly and reveal complex alterations in hierarchical 
connectivity across the brain, with for example rewiring from posterior to a more 
anterior dominance in Alzheimer’s disease.
Learning Objectives:
1.  To understand the basics of resting-state fMRI.
2.  To become familiar with the organisation of intrinsic connections as detected 
with resting state fMRI in the human brain.
3.  To consolidate the current knowledge of brain networks in aging and dementia, 
and pharmacology research.
A-422 14:28
fMRI in disorders of consciousness: diagnostic and legal challenges 
C. Di Perri, S. Laureys; Liège/BE (caroldiperri@hotmail.com) 
When patients in “vegetative state” (recently coined unresponsive wakefulness 
syndrome) show minimal signs of consciousness but are unable to reliably com-
municate the term minimally conscious state (MCS) is used. MCS was recently 
subcategorized in MCS+ (i.e., presence of command following) and MCS- (i.e., 
presence of non-reflex movements). Patients who show non-behavioral evidence 
of consciousness or communication only measurable via ancillary testing (e.g., 
functional MRI,) can be considered to be in a functional locked-in syndrome. Taken 
12:30 - 13:30 Room Q 
The Beauty of Basic Knowledge: Head and Neck 
MC 24D 
The suprahyoid neck: anatomy and diagnostic 
algorithm of the neck mass 
A-418 12:30
The suprahyoid neck: anatomy and diagnostic algorithm of the neck mass 
A. Trojanowska; Lublin/PL (agnieszka30@yahoo.com) 
Three layers of the deep cervical fascia define the suprahyoid neck compartments, 
which include prevertebral, retropharyngeal, carotid, masticator, parapharyngeal 
and pharyngeal mucosal space. Knowledge of the structures inherent to these 
spaces will provide the radiologist with an accurate basis for differential diagnosis, 
since allocation of a tumour to a certain compartment limits the number of diagnos-
tic possibilities. Expanding lesions usually distort or displace adjacent structures 
and fascia in predictable fashion, which is crucial in defining the site of origin. 
Both MRI and CT are frequently used in the imaging of suprahyoid neck lesions. 
The introduction of functional imaging has also given some benefits. Primary and 
secondary, benign and malignant processes occupying major suprahyoid neck 
spaces will be discussed, with regard to crucial findings necessary for appropriate 
treatment selection and treatment planning. Since correct diagnosis requires close 
collaboration with ENT surgeons, clinical findings will also be discussed, together 
with practical information needed for surgery.
Learning Objectives:
1.  To become familiar with the compartmental anatomy of the suprahyoid neck.
2.  To understand the central role of the parapharyngeal space in the localisation 
of suprahyoid neck masses.
3.  To be able to localise and provide a useful differential diagnosis of a SHN 
mass.
4.  To learn the best imaging approach to the suprahyoid neck.
14:00 - 15:30 Room A 
Interactive Teaching Session 
E³ 1420 
Common and uncommon errors in plain film and 
CT imaging of the chest: how to improve your 
performance 
A-419 14:00
Common and uncommon errors in plain film and CT imaging of the 
chest: how to improve your performance 
D. Tack1, N. Howarth2; 1Baudour/BE, 2Chêne‑Bougeries/CH 
(denis.tack@skynet.be) 
Missed lung lesions are one of the most frequent causes of malpractice issues. 
Chest radiography plays an important role in the detection and management of 
patients with lung cancer, chronic airways disease, pneumonia and interstitial lung 
disease. Among all diagnostic tests, chest radiography is essential for confirming 
or excluding the diagnosis of most chest diseases. However, numerous lesions 
of a wide variety of disease processes affecting the thorax may be missed on a 
chest radiograph. The chest radiograph will also help narrow a differential diag-
nosis, help to direct additional diagnostic measures, and serve during follow-up. 
The diagnostic usefulness of the radiograph will be maximized by the integration 
of the radiological findings with the clinical features of the individual patient. CT 
has a tremendous spatial resolution that helps detecting lesions in the chest, and 
has proven to be more sensitive and specific than chest radiographs. However, 
missing lesions or misinterpreting lesions in CT of the chest is not uncommon. In 
this session, we will provide interactive cases of chest examinations (radiographs 
and CT) in which lesions have been missed and or misinterpreted, with a special 
focus on how correlation with MDCT of missed lung lesions can help improve 
interpretation of the plain chest radiographs. 
Learning Objectives:
1.  To learn about the common reasons for errors in interpretation of plain film 
and CT imaging.
2.  To understand how a side-by-side comparison of chest x-rays and MDCT of 
missed lesions can help reduce the busy radiologist’s error rate.
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impact on quality of life. This is of special importance because more than 25% 
of patients eligible for radical treatment are in the age range of 40  to 65  years.
Conventional anatomical T2-weighted MRI is the mainstay in prostate cancer 
imaging. On T2-weighted images, normal prostate tissue displays an intermediate 
to high-signal intensity while the transition-zone has lower signal intensity than the 
peripheral zone. Currently, several MR imaging techniques are being explored. 
These include 1H-MR spectroscopic imaging, dynamic contrast-enhanced MR 
imaging, and diffusion-weighted imaging. Multiple studies have explored optimal 
parameter settings for the diagnostic MR-protocol, which allows accurate tumour 
localisation. Although reported accuracies of the different separate and combined 
MP-MRI techniques vary for diverse clinical prostate cancer indications, MP-MRI 
has shown promising results and may be of additional value in prostate cancer 
localisation and local staging. To increase MR imaging accuracy for the different 
clinical prostate cancer indications, one or more functional MR imaging techniques 
should be combined with T2-weighted MR imaging in a MP-MRI of the prostate. 
The optimal strength of MP-MRI is yielded by combining the information of the 
various techniques.
Learning Objectives:
1.  To understand multiparametric MR imaging techniques.
2.  To learn how to interpret prostate MRIs.
3.  To understand the potential of new MRI developments.
Author Disclosure:
J. J. Fütterer: Consultant; Galil Medical, Invivo. 
A-425 14:20
B. Scrotal tumours 
P.S. Sidhu; London/UK (paulsidhu@btinternet.com) 
Ultrasound remains the imaging modality of choice for the assessment of any form 
of scrotal pathology. The resolution capabilities of the technique and the superficial 
nature of the scrotal contents allow ultrasound examination to deliver optimal imag-
ing. Testicular tumours maybe imaged and characterised with ease, without need 
for further imaging techniques. The addition of colour Doppler ultrasound allows 
for the interrogation of the vascularity of any lesion seen, and the addition of newer 
techniques such as contrast-enhanced ultrasound and tissue elastography has 
beneficial effects to aid interpretation and diagnosis. Nearly all focal abnormalities 
of the testis in the adult patient are malignant lesions, with primary germ cell tu-
mours a frequent abnormality in the younger patient, and lymphoma or a secondary 
malignancy common in the older patient. However, benign abnormalities such as 
a focal infarction, haematoma or an epidermoid cyst may mimic malignancy. It is 
important to be able differentiate benign from malignant causes, with testis sparing 
the ultimate goal. Non-germ cell tumours present a specific conundrum, with the 
newer imaging techniques likely to be of benefit in distinguishing these tumours 
from germ cell tumours. Extra-testicular tumours are nearly always benign and 
include lipoma and adenomatoid lesions. Inflammatory disease may also simulate a 
tumour and presents an unexpected pitfall. A carful scrotal ultrasound examination, 
using all the available ultrasound techniques should allow the examiner to make a 
confident assessment of any scrotal tumour, and allow for the correct management 
without need for further imaging. 
Learning Objectives:
1.  To understand the pathological types of primary and secondary tumours of 
the testis.
2.  To appreciate the US features of the various histological types of testicular 
tumours.
3.  To appreciate the role of newer US imaging techniques, and the role of further 
imaging.
Author Disclosure:
P. S. Sidhu: Author; Multiple peer reviewed papers on testicular abnormalities. 
Speaker; Bracco, Hitachi and Siemens. 
A-426 14:40
C. The penis 
M. Bertolotto; Trieste/IT (bertolot@univ.trieste.it) 
Ultrasonography (US) is the first-line imaging modality in patients with penile 
disease. Using high-end equipment, after pharmacologically induced erection 
penile anatomy is well defined and virtually all clinically significant penile vessels 
can be evaluated in normal and in impotent men. The superior soft-tissue contrast 
resolution afforded by MR imaging provides an opportunity to advanced imaging 
evaluation of the penis in selected cases. In the clinical practice, erectile dysfunc-
tion is the most frequent penile abnormality which is investigated with Doppler 
US. The clinical role of this evaluation, however, reduced after the introduction of 
together, our studies show that awareness is an emergent property of the collective 
behavior of frontoparietal top-down connectivity. Within this network, external (sen-
sory) awareness depends on lateral prefrontal/parietal cortices while internal (self) 
awareness correlates with precuneal/mesiofrontal midline activity. Of clinical impor-
tance, this permits to improve the diagnosis, which remains very challenging at the 
bedside. Current technology now also permits to show command-specific changes 
in fMRI signals providing motor-independent evidence of conscious thoughts and 
in some cases even of communication. We will conclude by discussing related 
ethical and legal issues and the challenge of measuring and improving quality of 
life in these challenging patients with disorders of consciousness. 
Learning Objectives:
1.  To understand the role of structural MRI, DTI and spectroscopy in severe brain 
injury.
2.  To become familiar with the role of resting state and activation fMRI in diagnosis 
and prognosis after coma.
3.  To understand which fMRI paradigms are “consciousness tests” in coma and 
related condition.
A-423 14:51
fMRI of cognitive functions: discriminating normal aging, minimal 
cognitive impairment and Alzheimer’s disease 
A. Falini; Milan/IT (falini.andrea@hsr.it) 
The earliest pathologic abnormalities associated with Alzheimer’s disease (AD) 
develop in the brain decades before the onset of the first memory symptoms. 
Such alterations include misfolded proteins aggregating into extracellular amyloid 
plaques and intracellular neurofibrillary tangles, followed by inflammatory dam-
age, oxidation, excitotoxicity, and cell death in the central nervous system. The 
prospect of experimental treatment to slow or prevent disease progression has 
prompted an increased interest in the identification of individuals with AD early in the 
course of the disease. The primary end points in current trials for AD are dictated 
by cognitive outcomes; owing to their reduced variability compared with clinical 
measures surrogate biological and imaging outcomes are of great interest. Recent 
years have witnessed impressive advances in the use of MR imaging with varying 
success either to contribute to establish a diagnosis of AD and to monitor disease 
progression, as well as to test the efficacy of disease-modifying agents. New MR 
techniques such as Diffusion Tensor Imaging (DTI) and functional imaging (fMRI) 
are likely able to fill voids and improve our ability to discover early the pathologic 
process associated with dementia. Detecting such preclinical changes could imply 
a major role for neuroimaging in risk stratification and early disease prevention. 
Some of the brain changes occurring in dementia can also be seen in middle-aged 
and elderly individuals who are cognitively intact, and are considered part of the 
normal aging process. The possibility to distinguish normal from abnormal aging 
is another fundamental issue in which neuroimaging may play a role.
Learning Objectives:
1.  To consolidate knowledge of dementia and Alzheimer’s disease clinically.
2.  To become familiar with common imaging features of dementia and Alzheimer’s 
disease.
3.  To appreciate the results from fMRI and DTI and other advanced neuroimaging 
techniques used in research of dementia and Alzheimer’s disease.
Panel discussion:  
New insights into the state of consciousness through neuroimaging. 
Where are we and where should we go? 15:14 
14:00 - 15:30 Room C 
Urogenital Imaging 
CC 1421 




A. Imaging of prostate cancer: an update 
J.J. Fütterer; Nijmegen/NL (j.futterer@rad.umcn.nl) 
Prostate cancer is a major health issue in ageing men. No treatment is required 
in less-aggressive prostate cancer but there is consensus that radical treatment 
is needed in aggressive prostate cancer. Radical treatment has to start while the 
tumour is still confined to the gland and has not spread beyond. Potential side ef-
fects of radical treatment, such as impotence and incontinence, have a substantial 
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has a high chance of missing ischaemia, active bleeding or focal abnormalities 
while MR is logistically more challenging, more time consuming and artefact-prone. 
Invasive angiography is a technique that is best suited for evaluating the smaller 
vessels and for combination with endovascular treatment. CT is best performed 
using biphasic techniques that include a late arterial phase that also serves as 
CT angiography (CTA) and a portal phase that is used to look at bowel perfusion. 
Both phases can be combined in a split bolus technique, which saves one scan 
and is thus suitable for saving radiation dose in younger individuals. The course 
will discuss the most appropriate protocols and will explain under which conditions 
catheter angiography will remain necessary. Typical findings of vascular causes of 
acute abdomen will be discussed. Direct signs on CTA include stenosis, occlusion, 
vasospasm, aneurysms and extravasation. Indirect signs such as reduced bowel 
perfusion, bowel necrosis, post-ischaemic hyperperfusion, and collateral perfusion 
will be illustrated. The typical findings of NOMI and other rarer vascular cause of 
acute abdomen will be demonstrated. By integrating clinical setting and imaging 
findings a final diagnosis can be made in the vast majority of cases. 
Learning Objectives:
1.  To learn about the importance of selecting the appropriate imaging technique 
in cases of acute abdomen to detect vascular causes.
2.  To become familiar with the typical imaging appearance of the different vascular 
causes of acute abdomen and their most important differential diagnosis.
3.  To become familiar with potential pitfalls and problems of identifying vascular 
causes of acute abdomen.
Author Disclosure:
M. Prokop: Research/Grant Support; Toshiba Medical Systems. Speaker; 
Bracco, Bayer, Toshiba. 
A-430 15:00
C. Interactive case discussion: how to proceed? 
A. Palkó; Szeged/HU (palkoand@gmail.com) 
The goal of this problem-oriented, case-based presentation is to involve the audi-
ence in an interactive communication aimed at clarifying and clearly understanding 
the role and clinical significance of imaging and image-guided intervention in the 
diagnosis and treatment of abdominal vascular emergencies. We will discuss 
and solve not only typical but also unusual cases in order to introduce the proper 
diagnostic algorithm providing the fastest possible treatment to the patient in these 
most frequently very severe, potentially lethal conditions; in which time elapsing 
between onset of symptoms and correct diagnosis is critical from the point of view 
of successful therapy and chance of survival.
Learning Objectives:
1.  To become familiar with typical cases, illustrating the role of imaging modalities 
in the diagnosis and differential diagnosis of acute abdomen.
2.  To consolidate knowledge of the selection of the appropriate imaging technique, 
image interpretation and image based treatment recommendation.
3.  To understand the most important information urgently needed for treatment 
decisions and planning.
Author Disclosure:
A. Palkó: Advisory Board; Euromedic Intl. Consultant; Covidien. 
14:00 - 15:30 Room D2 
Oncologic Imaging: Follow-up of Systemic and Local Therapies 
CC 1419 




A. The zone of cell death and collateral phenomena on cross-
sectional imaging: from histopathology to the standardisation of terms 
A. Denys, P. Bize; Lausanne/CH (Alban.Denys@chuv.ch) 
The field of image-guided ablation has expended recently with new ablation tech-
niques like micro-wave, irreversible electroporation, cryoablation. Nevertheless, 
after each treatment, whatever the technique used, we will leave in place in the 
treated organ, a scar instead of the tumour. Follow-up of these treated areas are 
done by radiologists using CT of MR or contrast enhanced ultrasound. Standardi-
zation of terms has been done in 2003 by an international committee presided 
by Dr Goldberg. This allows reporting criteria identical from one center and from 
oral medications for impotence. Differentiation among different forms of erectile 
dysfunction is mainly based on evaluation of Doppler waveform changes in the 
cavernosal arteries. Peyronie’s disease is the most frequent cause of penile indura-
tion. Imaging is often required to evaluate the extension of the plaques, involvement 
of the penile septum, and relationship between the plaques and penile vasculature. 
In patients with penile traumas, imaging allows accurate evaluation of albugineal 
tears, extra-albugineal and cavernosal hematomas, vascular lesions producing 
high-flow priapism and other pathological changes. Compared to US, MR imag-
ing has some advantages in identification of small albugineal tears, and is more 
accurate in identification of urethral or spongiosal involvement. Other situations 
in which penile imaging can be required are circumscribed or diffuse cavernosal 
fibrosis, tumours, priapism, severe inflammation, and evaluation of postsurgical 
complications. Most of these conditions are first investigated with US; MR is the 
imaging modality of choice for tumour staging. 
Learning Objectives:
1.  To learn about the most relevant penile diseases that can be diagnosed by 
imaging.
2.  To know the diagnostic roles of US, MRI and other imaging techniques.
3.  To understand how imaging influences treatment and follow-up.
A-427 15:00
D. Interactive case discussion 
J.O. Barentsz; Nijmegen/NL (J.Barentsz@rad.umcn.nl) 
14:00 - 15:30 Room D1 
CLICK (Clinical Lessons for Imaging Core Knowledge): Never 
without Arteries 
CC 1418 
Angina, non-occlusive mesenteric ischaemia (NOMI) 




A. Clinical considerations 
P. Rogalla; Toronto, ON/CA (Patrik.Rogalla@uhn.on.ca) 
Mesenteric ischaemia is a medical condition in which inflammation and injury of 
the small intestine result from inadequate blood supply. Causes of the reduced 
blood flow can include changes in the systemic circulation (e.g. low blood pressure) 
or local factors such as constriction of blood vessels or a blood clot. Mesenteric 
ischaemia leads to mediator release, inflammation, and ultimately infarction. Ab-
dominal pain is out of proportion to physical findings. Early diagnosis is difficult, but 
early conventional angiography and exploratory laparotomy are believed to have 
the highest sensitivity, however, angiography represents a fairly invasive imaging 
technique and surgical intervention has its own limitation, in particular if clinical 
suspicion is vague or repeatedly expressed. Mortality of the disease is dramatically 
high, ranging between 32% and 77%. In fact, the prognosis depends on prompt 
diagnosis (less than 12-24 h and before gangrene) and early surgical intervention. 
Multislice CT with its ultra-fast acquisition modes, isotropic image resolution and 
multiplanar reconstruction capabilities, its widespread availability and ubiquitous 
applicability may be regarded as the imaging modality of choice in patients with 
suspected mesenteric ischaemic disease. 
Learning Objectives:
1.  To learn about the frequency and importance of the vascular causes of an 
acute abdomen.
2.  To learn about the differential diagnosis as well as the different vascular causes 
of acute abdomen.
3.  To learn about prognosis, treatment and outcome of acute abdomen caused 
by vascular diseases.
Author Disclosure:
P. Rogalla: Research/Grant Support; Toshiba Medical Systems. 
A-429 14:30
B. Imaging techniques and typical findings 
M. Prokop; Nijmegen/NL (M.Prokop@rad.umcn.nl) 
Vascular causes of acute abdomen are best examined using computed tomography. 
Ultrasound and MR are able to visualize some of the relevant findings but ultrasound 
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A. Soft tissue mass: US/MR 
C. van Rijswijk; Leiden/NL (C.S.P.van_rijswijk@lumc.nl) 
Ultrasonography (US) is a readily available non-invasive technique that can be used 
for the detection of a soft tissue mass. It gives a first impression of the size, location 
in relation to the fascia and consistency of soft tissue lesions. An important ability 
of US is the potential to differentiate between cystic and solid lesions; however, 
specificity in further characterising a soft tissue mass is low. MR is the next imag-
ing modality to perform for the evaluation of soft tissue lesions. MR is accurate in 
determining size, confinement to or extension beyond the anatomic compartment 
of origin and the relationship to the neurovascular bundle and adjacent bone and 
joints. Although histopathological examination remains the gold standard, differen-
tiation between malignant and benign soft tissue masses, indication of the grade of 
malignancy and prediction of the histological diagnosis are challenging goals of MR 
imaging. As such, characterisation of soft tissue masses starts with interpretation of 
signal characteristics on T1- and T2-weighted sequences. Combinations of signal 
intensities reveal the different tumour components (e.g. fat, water, and blood), and 
thus provide indirect information about the nature of soft tissue masses. Additional 
imaging parameters combined with clinical parameters, such as age, gender, etc. 
should be evaluated for defining a differential diagnosis, such as multiplicity, loca-
tion, origin (e.g. subcutaneous, intramuscular), size, shape, margins, peritumoural 
oedema, bone involvement and rate of growth.
Learning Objectives:
1.  To become familiar with the strengths/weaknesses of US/MRI in assessing 
soft tissue tumours.
2.  To understand the US/MRI specific findings that aid diagnosis.
3.  To learn a structured approach to reporting.
A-435 14:30
B. MR of vertebral body collapse 
R. Lalam; Oswestry/UK (radhesh.lalam@rjah.nhs.uk) 
It is not uncommon for a reporting radiologist to come across vertebral body col-
lapse in day-to-day practice. A number of imaging options are available to the 
radiologist to assess the nature of the vertebral body collapse. Vertebral body col-
lapses are broadly divided into benign and malignant depending on the aetiology. 
Benign collapses are most often due to metabolic diseases such as osteoporosis 
and trauma. It is vital to be able to differentiate these two categories of vertebral 
involvement to initiate appropriate therapy. Radiographs have a low sensitivity and 
specificity in differentiating these categories of vertebral body collapse. MRI, on the 
other hand, is excellent at differentiating between benign and malignant lesions on 
standard imaging sequences. A number of features including retropulsion, T1 signal 
characteristics, clefts, soft tissue abnormalities, posterior element involvement and 
contrast enhancement help in this differentiation. Advanced imaging protocols 
including diffusion and in/out of phase imaging are rarely needed. In some clinical 
circumstances where the differentiation is not possible despite all these measures, 
CT scan, follow-up imaging and/or a biopsy may be necessary. 
Learning Objectives:
1.  To be able to differentiate benign from malignant causes.
2.  To learn about the changes of the vertebral body with time, disease progres-
sion and therapy.
3.  To learn a structured reporting approach.
A-436 15:00
C. MR of the unstable shoulder 
M. Zanetti; Zurich/CH (marco.zanetti@hirslanden.ch) 
Static instabilities are defined by the absence of classic symptoms of instability and 
are associated with rotator cuff or degenerative joint disease. Dynamic instabili-
ties are subdivided in two main categories. The first category is characterised by 
a history of trauma resulting in unidirectional anteroinferior instability, commonly 
associated with a fibrous or osseous Bankart lesion that requires surgical repair 
one country to another. Furthermore, it allows a more homogeneous literature 
and evaluation of success. Nevertheless, techniques are not all the same and the 
cellular and tissue damage in the tumour and around it in the healthy parenchyma 
are not identical and does not have the same evolution over time.
Learning Objectives:
1.  To understand histopathologic changes after various ablation techniques.
2.  To become familiar with post-ablation imaging based on histo-pathologic cor-
relation of ablation zones in various organs.
3.  To learn about the adequate terms for reporting and publishing on post-ablation 
imaging.
A-432 14:30
B. PET/CT for the evaluation of ablative therapy: Who? Where? 
When? Does it help? 
D. Deandreis; Villejuif/FR (Desiree.DEANDREIS@igr.fr) 
Tumour ablative therapy is frequently used in clinical practice because of its safety 
and good tolerability. One issue is the lack of reliable imaging modality to assess 
efficacy. The purpose is to define the impact of FDG-PET/CT in this field. The fol-
lowing items will be discussed: the typical post-therapeutic aspect on PET/CT, the 
best PET criteria to define recurrence, the best candidate for PET/CT follow-up 
and the best timing point to assess response. Published data until now show that 
FDG-PET/CT is a useful tool in ablated liver tumours follow-up, detecting residual 
disease easily and earlier than conventional imaging. Only limited reports evaluat-
ing the usefulness of FDG-PET/CT in lung lesions are available but the results 
are promising, showing a high negative predictive value of the technique during 
the follow-up. Few data are available on bone lesions. In general, diffuse, periph-
eral, homogeneous FDG uptake in the treated lesion is related with inflammatory 
processes; on the other hand, heterogeneous and focal uptake is more frequently 
related to disease relapse. SUVmax (Standardised Uptake Value) is higher in case 
of persistent tumoural disease than in completely ablated lesions, but in some cases 
it is not a reliable indicator. Finally, the good timing after treatment still remains to 
be defined but FDG-PET/CT should be performed at least 3-6 months after treat-
ment to avoid dubious or inconclusive findings due to inflammatory reaction that 
frequently occurred during the first months.
Learning Objectives:
1.  To understand who are the best candidates for a PET/CT follow-up of ablation 
therapies.
2.  To learn about what is the optimal timing of PET/CT in the follow-up of ablative 
therapies.
A-433 15:00
C. Everyday practice: MR and CT for evaluating response to thermal 
ablation 
C. Dromain, C. Caramella, L. Vilcot, S. Bidault, F. Bidault, F. Deschamps; 
Villejuif/FR (dromain@igr.fr) 
The aim of thermal ablation treatment is to generate an area of thermocoagula-
tion whose diameter is larger or at least equivalent to that of the tumour. This 
necrotic scar usually shrinks with time, but most often very slowly. Therefore, 
criteria of response based on size measurement cannot be applied. The pattern 
of thermal ablation area is similar whatever the thermo-ablation technique used. 
On CT imaging thermal ablation area are well circumscribed and oval shaped. 
An extending ground-glass opacification, a cavitation or bubble lucendies can be 
observed after thermal ablation of lung tumours. The criterion commonly used to 
assess the efficacy is the absence of enhancement in the thermal ablation necrosis 
which corresponds to tissue devoid of viable tumour. On MR imaging the thermo-
ablation areas is typically hyperintense on unenhanced T1, due to the presence 
of proteinaceous material, and hypointense on T2, explained by the dehydrating 
effect of thermal damage. Residual tumour is typically round shaped and located at 
the periphery of necrotic area or in contact with large vessels. MR imaging allows 
earlier detection of residual liver tumour than CT imaging. Indeed, unenhanced 
MR images offer an excellent contrast between residual tumour with low signal 
on T1 and high signal on T2 and between thermal ablation necrotic area with high 
signal on T1 and low signal on T2.
Learning Objectives:
1.  To become familiar with the imaging aspects of successful ablation.
2.  To learn about the main pitfalls of post-ablation imaging.
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Learning Objectives:
1.  To become familiar with current criteria.
2.  To learn about imaging features which are highly specific for nodal disease.
3.  To understand the diagnostic performance of cross-sectional imaging.
Author Disclosure:
W. Schima: Advisory Board; GE Healthcare. Speaker; Siemens. 
A-439 14:28
B. DWI MR: what does it contribute? 
H.C. Thoeny; Berne/CH (harriet.thoeny@insel.ch) 
Up to date, lymph node staging is based on size and shape criteria only, however, 
micrometastases can also be present in normal sized lymph nodes and nodes can 
be enlarged due to inflammatory changes. New contrast agents in MRI such as 
ultrasmall particles of iron oxide (USPIO) have substantially improved the diagnostic 
accuracy of lymph node staging compared to conventional MRI. Unfortunately, 
USPIO are not commercially available, and therefore, new approaches to differ-
entiate benign from malignant lymph nodes are required. Diffusion-weighted MRI 
(DWI) is a non-invasive method that provides tissue microstructural information, 
and several studies mainly in the pelvis have shown promising results for lymph 
node detection and differentiation between benign and malignant nodes. These 
studies reported sensitivities of 79-87% and specificities of 74-93% using the un-
derlying apparent diffusion coefficient (ADC) value; lower ADCs were reported in 
malignant nodes as compared to benign ones. In these studies, lymph nodes with 
short axis diameter greater than 5 mm were included. It should be noted that there 
is an overlap between ADC values of benign and malignant nodes; no significant 
difference in ADC was found in some studies. Further investigations on the use of 
ADC in lymph node diagnosis including histopathological validation are needed 
to reduce the high rate of false positive nodes. The combination of USPIO with 
DWI might facilitate and improve lymph node staging in the future, provided, that 
USPIOs will become available for clinical use.
Learning Objectives:
1.  To understand the principles of DWI of nodes.
2.  To recognise the imaging appearance of nodes on DWI MRI.
3.  To become familiar with studies evaluating the diagnostic performance of DWI 
MRI.
A-440 14:51
C. Nuclear medicine: PET and other nuclear medicine techniques 
P.L. Choyke; Bethesda, MD/US (pchoyke@nih.gov) 
Radionuclide methods have become increasingly important in the assessment of 
nodal disease. Broadly speaking, radionuclide methods can be characterised as 
those involving sentinel node detection and those that image nodes throughout 
the body. Sentinel node imaging is an established method of detecting nodes 
draining tumours (e.g. breast, melanoma). FDG PET has recently become in-
creasingly important in nodal staging of cancers, particularly lung cancer, thyroid 
cancer and lymphoma. Increased uptake in lymph nodes is highly predictive of 
nodal involvement and portends a worse prognosis. The ability to localize nodes 
on the CT portion of the study makes biopsy relatively straightforward. However, 
FDG PET is not infallible. For instance, false positive activity is seen in diseases, 
such as sarcoid and false negatives can occur in tumours such as prostate cancer 
and renal cancer. Thus, there has been interest in the development of new PET 
agents. For instance, FLT PET has been useful for distinguishing inflammation from 
tumour within nodes and various agents such as F-Choline and F-ACBC have been 
used to identify nodal metastases in prostate cancer. Additional agents have been 
proposed, however, FDG remains an excellent first imaging test for lymph node 
staging and this is highly complemented by the use of FLT PET.
Learning Objectives:
1.  To learn which tumours are typically FDG-avid.
2.  To understand the factors that contribute to the diagnostic performance of 
FDG-PET.
3.  To become familiar with other nuclear imaging techniques for lymph node 
imaging.
Author Disclosure:
P. L. Choyke: Other; Research Agreements: GE, Siemens, Philips. 
Panel discussion:  
When and how could imaging make diagnostic biopsy unnecessary? 15:14 
(TUBS). The second category is known as atraumatic multidirectional bilateral re-
habilitation inferior capsular shift (AMBRI). This pattern of multidirectional instability 
is believed to be the result of atraumatic ligamentous and capsular laxity. Treatment 
is rehabilitation initially, followed by inferior capsular shift if indicated. The anterior 
instability is characterised by avulsion of the labroligamentous complex from the 
anteroinferior aspect of the glenoid, which, with complete disruption of the scapular 
periosteum, is termed a fibrous Bankart lesion. The presence of an associated 
adjacent glenoid rim fracture is referred to as an osseous Bankart lesion. Osseous 
Bankart lesions can easily be missed on MR images; therefore, CT arthrography is 
preferred by some authorities. In post-traumatic posterior dislocation, tears occurring 
in the posterior labrum are referred to as a reverse Bankart lesion and impaction of 
the anterosuperior humeral head are called reverse Hill-Sachs defect. Recurrent 
(atraumatic) posterior shoulder instability has to be distinguished from acute and 
chronic (locked) posterior dislocation. Recurrent (atraumatic) posterior instability 
is not related to trauma, but rather to laxity of supporting capsular and muscular 
structures and/or to the shape of the bony glenoid or the labrum.
Learning Objectives:
1.  To learn about the specific imaging findings of instability.
2.  To become familiar with the different types of shoulder instability.
3.  To learn a structured approach to reporting.
14:00 - 15:30 Room E2 
Oncologic Imaging 
RC 1416 
The essentials of lymph node imaging of solid 
tumours: what the radiologist needs to know 
A-437 14:00
Chairman’s introduction 
R.G.H. Beets-Tan; Maastricht/NL (r.beets.tan@mumc.nl) 
Positive lymph node status is an important predictor for a poor prognosis. Accu-
rate nodal staging often influences the choice of treatment and outcome of these 
patients. However, detection of nodal infiltration by non-invasive imaging has been 
challenging and to date FNA or biopsy has remained important to dictate treatment. 
Nowadays, the combination of morphological and functional or metabolic information 
with modern imaging technology offers us new perspectives. In this session, we 
will learn about the present status of lymph node imaging using new generation 
CT, MRI or PET and become familiar with the strength and weaknesses of each.
A-438 14:05
A. The current criteria for nodal involvement on CT/MRI 
W. Schima; Vienna/AT (Wolfgang.Schima@khgh.at) 
In a variety of diseases, such as metastatic disease, lymphoma and inflamma-
tion, lymph node enlargement can be seen. Thus, lymph node characterisation is 
important to differentiate between benign and malignant disease. It is based on 
size (short axis diameter) and morphologic criteria, such as shape, homogeneity, 
and contrast enhancement. For abdominal nodes, location-specific size criteria 
apply (upper limit of normal: lower paraaortic 11 mm, upper paraaortic 9 mm, 
gastrohepatic ligament 8 mm, portocaval space 10 mm, retrocrural space 6 mm; 
pelvic nodes 10 mm). However, in clinical practice, often a universal size threshold 
of 10 mm is used in abdominal imaging. In chest CT, an upper limit of normal of 
10 mm is universally applied. However, size criteria alone are unreliable: CT for 
lung cancer staging has a pooled sensitvity of 51% (i.e., false negative diagnoses 
of metastatic deposits in normal-sized nodes), and a specificity of 86% (i.e., false 
positive diagnoses due to enlarged reactive nodes). With MRI, the same size 
criteria apply. However, additionally features such as central necrosis (T2w fatsat 
or gadolinium-enhanced images) are suggestive of metastasis (or suppurative 
infection). Lymph node-specific USPIO MR agents can depict tumour deposits in 
subcentimeter pelvic nodes. Unfortunately, they did not reach market approval. DWI 
is helpful in identifying in lymph nodes as they exhibit high SI with higher b-values. 
However, diffusion pattern of benign and malignant nodes overlap, so that ADC 
values do not aid in characterisation. Despite the use of modern MDCT and MRI 
techniques, lymph node characterisation needs further improvement. 
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Percutaneous nephrostomy (PCN) and ureteral stenting 
F. Orsi; Milan/IT (franco.orsi@ieo.it) 
Percutaneous minimally invasive interventions in the urinary tract needs a renal 
access by means of percutaneous nephrostomy. Indications for percutaneous 
nephrostomy include urinary diversion for hydronephrosis, treatment of nephrolithi-
asis, ureteral intervention (stent placement) and ureteroscopy. The most common 
extension of percutaneous nephrostomy is placement of an ureteral stent for 
treating the obstructions. Transient haematuria is very common after percutaneous 
nephrostomy, but severe bleeding requiring transfusion or intervention is rare. Com-
plications can be minimized by using the ultrasound guidance for the percutaneous 
renal approach, meanwhile the rest of the procedure should be guided by fluoro 
imaging. Technique for percutaneous nephrostomy and anterograde ureteral stent 
placement will be presented.
Learning Objectives:
1.  To become familiar with the indication for percutaneous nephrostomy in patients 
with malignant urinary obstruction.
2.  To learn about the technique, clinical results and complications of PCN and 
antegrade ureteral stenting.
Author Disclosure:




M. Krokidis1, A.A. Hatzidakis2; 1Cambridge/UK, 2Iraklion/GR 
(mkrokidis@hotmail.com) 
Palliative Percutaneous Transhepatic Biliary Drainage (PTBD) is a therapeutic 
procedure leading to drainage of the obstructed bile duct system. If endoscopy is not 
possible and if patient is inoperable, then the percutaneous treatment is indicated. 
Drainage of the bile ducts is performed with a small plastic multiple hole pigtail 
catheter. Self-locking catheters are preferred in order to minimize the dislocation 
risk. The percutaneous catheter is pushed through the malignant stricture, so that 
bile is draining through the catheter towards the bowel loops. Technical success 
rate of percutaneous biliary drainage can reach nearly 100% in experienced hands, 
while the major complications rate is usually lower than 5%. Clinical efficacy is 
usually lower, but still over 90%. The drainage procedure can be extended with 
the placement of a permanent metallic stent, which keeps the stenosed biliary 
duct patent, without need for a catheter. Metallic biliary stents have been proved 
as the best palliative treatment of non-resectable malignant obstructive jaundice, 
allowing longer patency rates than plastic endoprostheses. The technique is safe, 
with low-complication rate and procedure-related mortality between 0.8 and 3.4%. 
Still controversial remains in the timing between initial drainage and metallic stent 
placement, as well as the question of balloon dilatation before stent insertion. There 
is evidence that if the initial transhepatic drainage is completed without causing any 
severe complications, especially bleeding in form of haemobilia, primary metallic 
stenting can follow as a single-step procedure. 
Learning Objectives:
1.  To become familiar with the indications for drainage in malignant biliary ob-
struction.
2.  To learn about the technique, clinical results and complications of percutaneous 
cholangiography and biliary stenting.
Panel discussion:  
How invasive can palliation be? When to say no to palliative 
treatment? 15:15 
14:00 - 15:30 Room F1 
Special Focus Session 
SF 14a 
Palliative interventional techniques in cancer 
A-441 14:00
Chairman’s introduction 
K.A. Hausegger; Klagenfurt/AT (klaus.hausegger@lkh‑klu.at) 
This session will focus on palliative cancer treatment. Four different topics (treatment 
of lytic bone lesions, treatment of malignant pleural effusions, treatment of maligang uri-
nary obstruction and treatment of malignant biliary strictures) will be discussed. In ad-
dition to that we also plan to discuss the ethical aspect of palliative treatment strategies. 
Session Objectives:
1.  To learn about different palliative techniques in cancer.
2.  To understand when to indicate different palliative techniques.
3.  To become familiar with the limitations of palliative techniques.
4.  To learn when palliation does not help the patient.
A-442 14:03
Cementoplasty of lytic bone metastasis 
A. Gangi, J. Garnon, G. Tsoumakidou, I. Enescu; Strasbourg/FR 
(gangi@rad6.u‑strasbg.fr) 
Osteolytic destruction of the vertebral body by metastasis from breast, renal, lung 
and bladder cancers, multiple myeloma and lymphomas are a source of debilitating 
pain and disability. Due to the multifocal nature of these lesions, surgical treatment in 
the form of vertebrectomy and strut grafting is rarely undertaken. Radiation therapy 
does not provide consolidation, is not always effective in relieving pain and its effects 
are generally delayed by 1-2 weeks after commencement of therapy. Percutaneous 
vertebroplasty with injection of cement allows for consolidation and restoration of 
vertebral body strength resulting in effective pain relief and stabilisation of the spine. 
The procedure is palliative and does not address tumour progression and ablation. 
Hence, it should be used as a complement to other treatment modalities for cancer. 
Only painful metastasis and lesions affecting the stability of the spine should be 
treated. In patients with destruction of the vertebral body with paravertebral tumour 
extension, vetebroplasty can be combined with thermal ablation (RFA, Cryoabla-
tion) for reduction of tumour mass and consolidation of the vertebral body. Further, 
the procedure can be performed at multiple levels thus addressing the multifocal 
nature of the disease process. However, it must be stressed that vertebroplasty is 
specially indicated for management of local pain from metastastic disease and not 
for diffuse back pain with multiregional involvement of the spine. Cementoplasty is 
used in other location of tumours with compression fracture. The best examples 
are: acetabular lytic tumours, femoral or tibial condyle pathological fractures. 
Learning Objective:
1.  To learn about the indications, techniques, clinical results and complications 
of cementoplasty.
A-443 14:21
Pleural drainage, pleurodesis 
F. Gleeson; Oxford/UK (fergus.gleeson@orh.nhs.uk) 
A significant number of patients present with and/or are symptomatic from pleural 
effusions. It is important for radiologists to be familiar with the means of assessing 
effusion size and aetiology, and the methods available for their drainage, including 
pleurodesis. There are recognised complications from pleural drainage, and knowl-
edge of the pleural anatomy and cause of these complications may help reduce 
their incidence. Following pleural drainage and pleurodesis, follow-up scanning 
may be necessary, and knowledge of post-intervention appearances may help 
determine treatment success and disease relapse. This presentation will discuss 
the aetiologies of effusions, their imaging appearances and the techniques used 
for drainage and pleurodesis.
Learning Objectives:
1.  To become familiar with the indication for drainage of malignant pleural effu-
sion.
2.  To learn about the indications, technique and clinical results of pleurodesis.
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characteristics of a fibroadenoma can be followed in virtually every patient, but not 
in high risk patients. A biopsy is then mandatory. In general, breast MRI findings 
are reported using the BIRADS breast MRI lexicon. This lexicon provides a list of 
terms that can be used for the description of breast lesions. When familiar with 
the terms, a certain set of descriptors will lead to a more or less specific lesion 
classification, although this is still not easily reproduced between different readers 
as interreader variability is rather high. In any case, it is essential to keep in mind 
for what purpose the MRI is made. It does no good to assess a 3 cm nodule in the 
breast as probably malignant, if it is biopsy proven cancer. Moreover, tumour size 
for a surgeon is different than for a medical oncologist.
Learning Objectives:
1.  To understand how to integrate conventional (mammography and US) findings 
in a breast MRI report.
2.  To learn how to include morphological and kinetic information and why this 
needs to be done thoroughly.
3.  To become familiar with the necessary skills to compose a report on a breast 
cancer patient (staging, follow-up, relapse, etc).
Author Disclosure:
R. M. Mann: Speaker; Bayer Healthcare. 
14:00 - 15:30 Room G/H 
Special Focus Session 
SF 14b 
Comprehensive CT cardiothoracic imaging: a new 
challenge for radiologists 
A-449 14:00
Chairman’s introduction 
L. Bonomo; Rome/IT (lbonomo@rm.unicatt.it) 
Over the past few years, the use of CT in cardiovascular imaging has dramatically 
increased, since technological developments have made it suitable for the two- 
and tthree-dimensional visualisation of the heart, and of large and small vessels, 
e.g. coronary arteries. Further development in terms of temporal resolution and 
anatomical coverage has allowed the simultaneous study of systemic arterial 
circulation and pulmonary circulation on the same scan, with gradual reduction 
of exposure dose. There are several outcomes of this technological revolution. 
Morpho-functional information obtained for the entire chest in a single scanning 
makes it possible to simultaneously assess the heart and the lungs. Investigating 
interactions between these two systems, linked through embryological, anatomi-
cal, mechanical, physiological, physiopathological, and therapeutic relations, is 
among the challenges of imaging today. In this Special Focus Session, three 
presentations will be given: the first presentation will discuss strategies that en-
able minimising the radiation exposure imparted by dedicated ECG-synchronised 
image acquisition protocols of the entire thorax, but still allow comprehensive 
diagnostic evaluation of all aspects of heart-lung axis disorders; the second pres-
entation will demonstrate that different clinical indications requiring a chest CT 
imaging may have underlying coronary or cardiac causes that are not clinically 
evident, while patients scheduled for thoracic surgery may present unexpected 
heart or coronary artery findings detectable at pre-operative CT; the third will give 
examples of chest CT using a variety of protocols, ranging from a non-contrast 
screening study to a highly sophisticated contrast-enhanced CT perfusion study. 
Session Objectives:
1.  To understand the importance of looking at the heart on a CT scan of the chest.
2.  To learn how to optimise integrated cardiothoracic imaging with CT.
3.  To become familiar with the key imaging findings and learn how to report.
A-450 14:05
How to optimise integrated cardiothoracic imaging with CT 
U.J. Schoepf; Charleston, SC/US (schoepf@musc.edu) 
The advent of advanced, latest generation CT systems enables rapid image acquisi-
tion of the entire chest with ECG synchronisation. This ability has substantially ex-
panded our ability to non-invasively study the heart-lung axis and diseases thereof. 
Historically, the relatively high radiation exposure associated with retrospectively 
ECG-gated techniques on older generation CT systems had limited the more wide-
spread application of this approach, especially in younger patients. This presentation 
will discuss strategies that enable minimising the radiation exposure imparted by 
dedicated ECG-synchronised image acquisition protocols of the entire thorax, but 
14:00 - 15:30 Room F2 
Breast 
RC 1402 





E. Azavedo; Stockholm/SE (edward.azavedo@ki.se) 
The purpose is to plan a structured report of a Mammography Examination so that 
the reader gets a clear message to make a clinical decision for management of 
the case. Examples will be presented of different types of findings of which some 
will be actionable and others will not warrant any action from a clinician. Relevant 
findings will be reported in detail in order to get the message across to the reader. 
Questions from the referring clinician must be answered with the help of the ob-
tained images. Findings that are seen but do not warrant any actions may not be 
reported in detail and in some cases not reported at all or reported together within 
a group of non-actionable findings. In cases of lesions that will warrant surgery, it 
is necessary to describe the extent of the disease to plan adequate type of surgery. 
Examples will be shown so that the audience can reflect on the important aspects 
to be noted and reported. Examples of rather concise reports that answer the refer-
ring clinician’s questions and substantial information on actionable imaging findings 
must be reported with a clear message possibly without risks for misinterpretation.
Learning Objectives:
1.  To become familiar with the basic parts of a structured report.
2.  To understand which information a clinician needs in a report of a breast cancer 
patient.
3.  To learn how to compose a report on a patient with a BI-RADS 3 lesion.
A-447 14:30
B. Breast US 
J. Camps Herrero; Valencia/ES (juliacamps@ono.com) 
Breast ultrasound is one of the main imaging modalities in breast radiology, it 
allows us to characterise lesions and also guide interventional procedures. The 
BI-RADS categorisation of ultrasonographic findings facilitates the diagnostic 
approach and also helps the radiologist to use a common language, understood 
not only by the rest of the radiological community, but also by other breast cancer 
professionals. Ultrasound can be a diagnostic procedure in its own, but is mainly 
a modality that characterises the findings of other modalities (mammography and 
MRI) and, as such, correlation between all these techniques is the mainstay of 
everyday clinical practice. This act of correlating and integrating the information 
of all modalities is what makes a breast radiologist a key actor in the diagnosis, 
staging and follow-up of breast cancer and other benign or high risk entities. The 
final product of this integration will be the radiological report, the means by which 
we convey all the information we have gathered through all the procedures to our 
clinical colleagues. This report shall also follow some composition rules in order 
to be clear and concise.
Learning Objectives:
1.  To become familiar with BI-RADS categories of breast US.
2.  To learn how to integrate clinical information and radiological findings.
3.  To learn how to compose a US report in a breast cancer patient.
Author Disclosure:
J. Camps Herrero: Advisory Board; Bayer. 
A-448 15:00
C. Breast MRI 
R.M. Mann; Nijmegen/NL (r.mann@rad.umcn.nl) 
Breast MRI is a dynamic examination that evaluates contrast extravasation within 
breast tissue. The technique has a high sensitivity (> 95%) for breast cancer. It 
requires both high-spatial resolution and reasonable temporal resolution as the 
combination of morphological and dynamic assessment of lesions yields the highest 
specificity. Because breast MRI is not a first line technique, mammography and 
ultrasound are generally available. Findings from these examinations can thus 
be used in the interpretation of breast MRI examinations and vice versa. It is also 
essential to be aware of the medical history of the woman scanned as this may 
affect the interpretation. For example, a probably benign breast nodule with all 
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E. J. R. van Beek: Advisory Board; Siemens Lung MRI. CEO; Quantitative 
Clinical Trials Imaging Services, Inc. Speaker; Toshiba Medical Systems, Vital 
Images. 
Panel discussion:  
Is a single CT scan technique and protocol feasible for all the 
cardiothoracic problems? 14:14 
14:00 - 15:30 Room I/K 
Genitourinary 
RC 1407 




The speakers in this course will update the audience on contrast media safety. The 
first speaker is covering new concepts of non-renal reactions to contrast media. 
Acute reactions within 1 h following contrast administration and late reactions after 
1 h up to 7 days following contrast administration typically occur more often after 
administration of iodinated contrast media. Acute reactions are treated according to 
their symptoms while most late skin reactions are mild or moderate and self-limiting. 
Data will be presented that patch and delayed reading intradermal tests may help 
guide patients. The second speaker will address NSF. The presentation will review 
clinical features, risk factors and prevention of NSF. Patients with GFR less than 
30 ml/min/1.73 m2 have increased risk of developing NSF. Low stability gadolinium 
contrast media show the strongest association with NSF. Following existing guide-
lines on use of gadolinium contrast agents minimizes the risk of NSF. Potential 
long-term harm from gadolinium accumulation in the body is discussed. The last 
speakers will cover contrast medium-induced nephropathy with more recently pub-
lished guidelines related to that issue. The presentation will include the definition of 
CIN, the choice of contrast medium, and prophylactic measures. A recent change in 
ESUR guidelines will be explained. The risk of CIN is considered significantly lower 
following i.v. CM administration and patients referred for enhanced CT are genuinely 
at risk if they have an eGFR < 45 ml/min/1.73 m2. Both, volume expansion with isot-
onic saline or sodium bicarbonate may be used for preventing CIN in at risk patients. 
Session Objectives:
1.  To discuss the safety steps to be taken before contrast administering.
2.  To present the newest safety guidelines.
A-454 14:05
A. Acute non-renal reactions to contrast media: new concepts 
O. Clément; Paris/FR (olivier.clement@inserm.fr) 
Acute immediate hypersensitivity reactions occur within the hour following the 
administration of contrast media. They can be seen with either Iodinated and 
Gadolinium-based contrast agents. Over the last ten years, new concepts have been 
emerged in the way to understand, manage and explore hypersensitivity reactions. 
The clinical appearance is best classified by the Ring and Messmer scoring, from 
Grade 1 (cutaneous and subcutaneous signs) to Grade 4 (cardiovascular arrest). 
The mecanisms involve either true IgE-mediated hypersensitivity or non-allergic 
hypersensitivity. The differential diagnosis in favour of allergy is made on a triade: 
clinical signs (the more severe, the more chances to be allergic); elevated Try-
pase levels in the plasma (indicating mastocyte triggering); and positive skin tests 
performed one month after the reaction. These new concepts induce important 
consequences on the way to manage hypersensitivity reactions: be prepared to 
treat adequately the patient, be prepared to draw blood after the reaction to dose 
tryptase levels, send the patient to a dedicated allergologist, forget about the 
preventive role of premedication against severe reactions.
Learning Objectives:
1.  To understand what are allergic and non-allergic hypersensitivity reactions.
2.  To learn the clinical symptoms according to the Ring and Messmer classifica-
tion.
3.  To understand the importance of tryptase sampling and skin testing in the 
follow-up.
Author Disclosure:
O. Clément: Board Member; French Society of Radiology. 
still enable comprehensive diagnostic evaluation of all aspects of heart-lung axis 
disorders. These include general measures such as individual adjustment of the 
x-ray tube voltage by manual or automated means, automated anatomical tube 
current modulation, and image reconstruction using iterative algorithms. Strategies 
specific to ECG-synchronized acquisitions consist in ECG-dependent tube current 
modulation, use of prospectively ECG-triggered techniques, and ultra-high pitch 
image acquisition, where clinically appropriate. Lastly, suitable approaches for 
image post-processing and display will be discussed that aim at maximising the 
diagnostic benefit for the comprehensive CT assessment of the heart-lung axis. 
Learning Objectives:
1.  To learn how to select CT protocols that enable assessment of the heart-lung 
axis with the lowest possible radiation dose.
2.  To become familiar with the ECG-synchronisation protocols for cardio-thoracic 
CT image acquisitions.
3.  To understand strategies for image post-processing and displaying for evaluat-
ing diseases affecting the heart-lung axis.
Author Disclosure:
U. J. Schoepf: Consultant; Bayer, Bracco, GE, Medrad, Siemens. Grant 
Recipient; Bayer, Bracco, GE, Medrad, Siemens. Investigator; Bayer, Bracco, 
GE. Research/Grant Support; Bayer, Bracco, GE, Medrad, Siemens. Speaker; 
Bayer, Bracco, GE, Medrad, Siemens. 
A-451 14:28
Coronary artery imaging from a chest CT examination: when and how 
R. Marano; Rome/IT (riccardo.marano@rm.unicatt.it) 
The continuous technological evolution of multi-detector CT scanner characterised 
by larger detector array with increased anatomical coverage per rotation, faster 
rotation and table speed, and shorter acquisition time have made reliable to perform 
chest imaging with reduced cardiac motion artifacts, improving the assessment 
of heart and contiguous structures in the course of routine thorax CT. Further, the 
larger anatomic coverage of detectors and the availability of scan protocols with 
lower radiation dose have also made reliable to apply ECG-synchronization to chest 
CT study, and therefore to couple cardiac/coronary imaging with chest imaging. 
Different clinical queries requiring a chest CT imaging may underlie cardiac or coro-
nary source that is not clinically evident; similarly, patients scheduled for thoracic 
surgery, staging or studied in emergency setting may present unexpected heart 
or coronary artery findings that can be detected in the course of pre-operative CT 
or may change the treatment and prognosis. Therefore, the capability to perform 
the assessment of both the heart and chest by a single diagnostic tool is becom-
ing progressively significant because the evaluation of the heart often can provide 
clinically relevant information in the course of routine or emergency chest CT that 
is not otherwise easily available.
Learning Objectives:
1.  To become familiar with the main clinical indications that could require assess-
ment of the heart and coronary arteries in the course of chest CT.
2.  To learn how to recognise the normal and abnormal appearance of heart and 
coronary arteries commonly observed on chest CT.
3.  To learn about the acquisition protocol to couple chest CT with ECG-gated 
cardiac CT.
A-452 14:51
Cardiopulmonary functional imaging from a chest CT examination: 
when and how 
E.J.R. van Beek; Edinburgh/UK (edwin‑vanbeek@ed.ac.uk) 
The use of CT for chest diseases has rapidly expanded and now covers both 
pulmonary and cardiac diseases. However, it is also increasingly realised that 
these two organ systems have a direct impact on one another, and therefore we 
need to address the fact that pathology in one system may well lead to changes 
in the other. This presentation will give examples of chest CT using a variety of 
protocols, ranging from a non-contrast screening study to a highly sophisticated 
contrast-enhanced CT perfusion study. It will give examples of findings in one 
system and its impact on the other. Furthermore, it will demonstrate the capability 
to gain information from standard CT examinations related to pulmonary function, 
cardiac function and how these may be used.
Learning Objectives:
1.  To understand the feasibility of CT based cardiopulmonary functional imaging.
2.  To be able to grasp clinical scenarios where cardiopulmonary functional CT 
imaging may be helpful.
3.  To be able to set the use of CT within a larger framework of imaging modalities.
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A. Clinical SPECT/CT and PET/CT 
T. Beyer; Zurich/CH (thomas.beyer@cmi‑experts.com) 
Over 16 years ago, Hasegawa (UCSF) and colleagues presented a prototype 
SPECT/CT-system comprising a clinical SPECT-camera in tandem with a clinical 
single-slice CT. The combined SPECT/CT was used to perform a small number of 
clinical studies, such as for quantitative estimation of radiation-dosimetry in brain 
cancer, whereby the CT data were used also to generate the SPECT attenuation-
correction-factors (ACF). Since then, SPECT/CT has benefited a great deal from 
the advances in CT-technology and several commercial combination designs are 
available today. The clinical adoption of SPECT/CT in oncology and cardiology has 
been rapid. The proposal to combine PET with CT was made in the early 1990s by 
Townsend, Nutt et al. In addition to intrinsic image alignment, the anticipated benefit 
of PET/CT was to use the CT-images to derive the PET-ACF‘s. The first clinical 
prototype-PET/CT became operational in 1998 at the University of Pittsburgh. Since 
then, PET/CT-technology has grown rapidly by incorporating new concepts of PET 
and multi-slice CT. Today almost all PET systems are sold with a CT attached with 
an installed base of over 5,000 PET/CT-systems worldwide. The improvement in 
accuracy of PET/CT compared with PET or CT for re-/staging averages 10-15% 
across all cancers. Acquisition protocol standardization and cross-specialty training 
are two of the most important pre-requisites for adopting dual-modality imaging as 
part of state-of-the-art patient management. 
Learning Objectives:
1.  To review the origins of SPECT/CT and PET/CT imaging systems.
2.  To understand the basic principles and general clinical applications.
3.  To speculate on trends in dual-modality PET- and SPECT-based imaging 
technology.
Author Disclosure:
T. Beyer: Employee; cmi-experts GmbH. Founder; cmi-experts GmbH. 
A-458 14:30
B. Clinical MR/PET 
G. Antoch; Düsseldorf/DE (antoch@med.uni‑duesseldorf.de) 
MR/PET imaging has recently been introduced into clinical routine. Apart from 
addressing technical challenges, such as MR-based PET attenuation correction, 
potential indications for MR/PET are currently defined. These indications include 
oncology, neurology and cardiology. Considering oncologic indications, MR/PET 
is - most probably - not going to replace PET/CT as the workhorse but will rather 
serve as an imaging modality for specific indications. As an example, the combina-
tion of high soft-tissue contrast from MRI coupled with functional data from PET is 
beneficial in imaging of soft-tissue tumours where local tumour assessment can 
be combined with whole-body tumour staging in a single session. Indications such 
as breast tumours or prostate cancer potentially benefit from the combined MR/
PET approach and studies evaluating these questions are underway. In neurology 
and cardiology, functional data from both imaging modalities, MR and PET, may 
complement one another and this is currently investigated for different indications. 
This talk will address current indications of MR/PET imaging in the clinic based on 
the available literature and own experience.
Learning Objectives:
1.  To become acquainted with the origins and evolution of MR/PET.
2.  To be informed of the current applications.
Author Disclosure:
G. Antoch: Speaker; Bayer Healthcare, Nordion, Siemens. 
A-459 15:00
C. Preclinical hybrid imaging 
N. Belcari; Pisa/IT (belcari@df.unipi.it) 
During the past decade, we have observed a growing interest in in-vivo imaging 
techniques for small animals. On the shadow of the successful application of dual-
A-455 14:28
B. Nephrogenic systemic fibrosis: from pathophysiology to 
recommendations 
H.S. Thomsen; Herlev/DK (henrik.thomsen@regionh.dk) 
Gadolinium (Gd) belongs to the lanthanides in the periodic table, which all affect 
collagen. The ability to hold Gd varies from chelate to chelate, non-ionic linear 
chelates being the weakest binders. Transmetalation (exchange of Gd with another 
ion, e.g. zinc) leads to NSF, a horrifying very late adverse reaction to some Gd-
CM. Since 2007, the various Gd-CM have been classified into 3 groups: high risk 
(of NSF), intermediate risk and low risk. The authorities have introduced several 
restrictions on the use of high risk agents which be followed by every physician 
in EU. The agents are contraindicated in 1) patients with severely reduced renal 
function including dialysis, 2) acute renal insufficiency, 3) neonates and 4) pregnant 
women. They may only be used with caution in patients with moderately reduced 
renal function and children less than 1 year old. There must be at least 7 days 
between 2 injections in those patients. Renal function must always be determined 
by laboratory methods before use of high risk agents. Women should stop lacta-
tion for 24 h. These agents should never be given in higher doses than 0.1 mmol/
kg per examination in any patient. For the intermediate and low-risk agents, the 
restrictions are significantly less; they should only be used with caution in patients 
with severely reduced renal function including dialysis. If a physician does not follow 
these rules, he or she will have legal problems as they have - by the authorities - 
been introduced into the summary of product characteristics.
Learning Objectives:
1.  To understand the underlying pathophysiology.
2.  To learn about the clinical implications of the recent recommendations/guide-
lines.
3.  To become familiar with legal issues.
A-456 14:51
C. Contrast medium-induced nephropathy and new guidelines 
F. Stacul; Trieste/IT (fulvio.stacul@aots.sanita.fvg.it) 
The Contrast Media Safety Committee of the European Society of Urogenital Ra-
diology has updated its 1999 guidelines on contrast medium-induced nephropathy 
(CIN). Topics reviewed included the definition of CIN, the choice of contrast medium, 
and the prophylactic measures used to reduce the incidence of CIN. The definition 
of CIN is a complex topic and understanding of it continues to evolve. The CMSC 
considered appropriate to keep the definition agreed in 1999. However, nephrolo-
gists recently agreed on a new definition. In the previous guideline, a number of 
risk factors were listed (raised S-creatinine levels, particularly secondary to diabetic 
nephropathy, dehydration, congestive heart failure, age over 70 years, concurrent 
administration of nephrotoxic drugs). The significance of these risk factors has 
been confirmed and new risk factors were added. The CMSC agreed that the risk 
of CIN is significantly lower following intravenous CM administration and concluded 
that patients referred for enhanced CT are genuinely at risk if they have an eGFR 
< 45 ml/min/1.73m2. The previous CMSC guideline suggested the use of low or 
iso-osmolar CM in patients with risk factors for CIN and the CMSC considered that 
this previous guideline should not be changed. The CMSC considered that there is 
enough evidence to recommend that either volume expansion with isotonic saline 
or sodium bicarbonate may be used for preventing CIN in at risk patients, while the 
efficacy of NAC and other drugs in reducing the incidence of CIN remains unproven. 
Learning Objectives:
1.  To become familiar with newest guidelines on contrast induced nephropathy 
(CIN).
2.  To understand the future clinical implications of the new guidelines.
Author Disclosure:
F. Stacul: Advisory Board; GE Healthcare. Speaker; Bracco, GE Healthcare. 
Panel discussion:  
What is the most appropriate radiological approach to patients with 
falling eGFR and when should contrast media be administered and 
when should it not? 15:14 
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weighting (and contrast enhancement administration), fat sat and DWI sequences 
can be used to increase the confidence in differentiating the normal laryngeal soft 
tissues from neoplasms. MR time-resolution is, surely, its main limit. Ultrasound, 
though limited by the ossified cartilages walls, may integrate cross-sectional im-
aging and clear doubts about tumour extra-laryngeal spread or provide a guide 
to FNAC. When reporting, the radiologist should be aware of the checklist of the 
key points to address, and should also know how to navigate inside the volume 
of interest. Clinical findings, anatomic landmarks and tissue-decomposition are 
critical elements in image interpretation.
Learning Objectives:
1.  To become familiar with the typical findings of T1-T4 laryngeal cancer.
2.  To learn about the patterns of local nodal involvement.
3.  To understand possible imaging pitfalls in staging.
A-462 14:28
B. Evaluation after surgery and non-surgical treatment: expected findings 
S. Bisdas; Tübingen/DE (sotirios.bisdas@med.uni‑tuebingen.de) 
When compared to primary tumour assessment, the effectiveness of cross-
sectional imaging is rather limited in the follow-up of laryngeal cancer treated by 
chemoradiation or surgery. Endoscopic examination is relatively easy and yields 
a satisfactory accuracy in detecting recurrent disease. Essential requirements 
for the proper interpretation of the post-treated larynx include knowledge of the 
initial tumour appearance, the applied surgical technique and/or the (neo)adjuvant 
chemoradiation therapy. The altered anatomy, the absence of symmetric landmarks 
and the additional changes in the normal tissue are expected findings, which should 
not be misinterpreted as residual or recurrent tumour. At the glottic level, the post-
therapeutic changes are limited, but the paraglottic spaces may show increased 
density. Symmetric thickness of the walls of the laryngeal ventricles, the aryepiglot-
tic folds and increased attenuation of the subcutaneous fat with thickening of the 
neck muscles are most pronounced during the first months after completion of the 
radiotherapy. On the other hand, variable asymmetric scar tissue with shortening 
of the larynx and alteration of the contrast-enhancement pattern are seen after 
conservative surgery. On contrary, total laryngectomy results in a smooth appear-
ance of the neopharynx with symmetric thickness (partly collapsed) and variable 
enhancement. Possible flap reconstructions present as fat planes running along 
the neopharynx. Finally, transoral laser excision results in low soft tissue loss with 
a limited range of changes. Among them, the frequently observed plaque-like 
lesions without contrast enhancement may be usually attributed to scar tissue.
Learning Objectives:
1.  To appreciate the expected imaging findings after surgery of laryngeal cancer.
2.  To become familiar with imaging findings after non surgical treatment.
3.  To know about the possible imaging pitfalls.
A-463 14:51
C. Cancer recurrence: how to address clinical dilemmas 
B. Verbist; Leiden/NL (b.m.verbist@lumc.nl) 
As treatment choices for laryngeal cancer emphasize functional laryngeal preserva-
tion if possible, not only accurate staging by imaging for optimal treatment planning 
is of utmost importance, but also strategies for early identification of recurrences are 
necessary. Possible treatment options for laryngeal cancer are open or endoscopic 
surgery, radiotherapy, including intensity modulated radiation therapy (IMRT) or 
image-guided radiotherapy (IGRT) and eventually added induction or concomitant 
chemotherapy. Treatment changes will influence the detection of recurrent disease. 
Curative treatment of recurrent laryngeal cancer will require either conservation 
laryngeal surgery or total laryngectomy. In this lecture, the diagnostic as well as 
the therapeutic challenges of local recurrence of laryngeal cancer and/or regional 
nodal metastases will be discussed. The value and pitfalls of different imaging 
techniques will be addressed and possible treatment options will be reviewed.
Learning Objectives:
1.  To understand the limitations of clinical examination.
2.  To appreciate the value of different imaging techniques in the detection of 
recurrence.
3.  To become familiar with the imaging findings of recurrent laryngeal cancer.
Panel discussion:  
Diagnostic algorithms for diagnosis and follow-up of laryngeal 
cancer 15:14 
modality imaging in the clinical environment, such as combined PET-Computed 
Tomography (CT) or SPETC/CT, the hybrid imaging modalities have been recently 
transferred to small animal scanners. Nowadays, the possibility of easy integration 
of nuclear imaging techniques with other modality such as PET/SPECT/CT or PET/
MR or has become a mandatory requirement in the design of small animal imaging 
systems. The combination of different imaging modalities in the same scanner offers 
the possibility to perform experiments more effectively than with a single modality 
only. This is especially true when two modality scans are performed sequentially 
or simultaneously and without moving the animal. Present technologies for the 
construction of hybrid systems for small animals will be presented together with 
examples of commercially available hybrid scanners. Looking at the next future, 
small animal PET/MR seems to be one of the most appealing perfect choice for 
hybrid imaging, combining the exquisite sensitivity of PET with the morphological/
functional/spectroscopic high-resolution imaging of MR. The present major limitation 
on the development of simultaneous PET/MR scanners is the non-insensitivity of 
PMTs to magnetic fields. A reliable solution could be the development of magnetic 
field insensitive position-sensitive photodetectors. A brief overview of the present 
status of development of the detector technology for PET/MRI will be also presented. 
Learning Objectives:
1.  To learn about hybrid imaging tools in animal imaging/pre-clinical research.
2.  To understand possible clinical applications.
14:00 - 15:30 Room N/O 
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A-460 14:00
Chairman’s introduction 
J.E. Kabala; Bristol/UK (Julian.Kabala@UHBristol.nhs.uk) 
Around 89% of laryngeal cancer cases are estimated to be related to the com-
bined effects of alcohol and smoking. The prevalence of these two risk factors 
strongly influences the incidence of laryngeal cancer. This is highest in Central 
and Eastern Europe, around 8 per 100,000 population compared to around 5 
per 100,000 in Western Europe. The disease is more common in males than 
females throughout Europe, with the highest ratio where the incidence is highest 
(around 25 males to 1 female in Lithuania and Portugal) and lowest ratio where 
the incidence is lowest (around 6 males to 1 female in the UK, France and The 
Netherlands). The mucosal surface of the tumour is staged by direct inspection. 
MRI or CT is utilised to assess deep extension of the tumour (e.g. cartilage inva-
sion) and inaccessible sites (e.g. subglottic region). Small localised superficial 
tumours may be successfully treated with radiotherapy or surgery (including laser 
excision) alone. Advanced tumours require consideration of radical surgery and 
radiotherapy. Chemotherapy may modestly improve recurrence-free survival rates 
at the cost of increased toxicity. Salvage surgery and/or radiotherapy may have 
some success in the event of recurrence following single modality treatment but 
usually has a poor outcome if the initial treatment has been combined surgery 
and radiotherapy. Chemotherapy may deliver a remission of variable duration 
in some patients. Functional imaging (fMRI, positron emission tomography) 
has not yet become routinely established; but may ultimately provide some as-
sistance particularly in the challenging imaging situation following intervention. 
Session Objectives:
1.  To discuss the epidemiology.
2.  To learn about the available diagnostic imaging modalities.
3.  To become familiar with the available treatment options.
A-461 14:05
A. Staging of laryngeal cancer: pearls and pitfalls 
R. Maroldi; Brescia/IT (maroldi@med.unibs.it) 
Larynx can be analysed by imaging techniques that have some specific strengths 
but also some limits. MSCT is very fast; it acquires a volume from which the proper 
view of the structures of interest can be extrapolated. MSCT provides detailed 
information on mineralised cartilages and fat spaces inside the larynx. The main 
variant in the examination technique is the time-delay after contrast agent admin-
istration (i.e. arterial vs. advanced venous phase). Subtle changes in soft tissues 
are difficult to detect on MSCT. MR, whose ability in separating tissue and detecting 
even mild oedematous changes or fibrosis, overcomes this limitation. More variants 
in the exploration of soft tissue-composition are possible with MR. Besides T2, T1 
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B. The importance of evidence-based practice for the future of 
advanced practice in radiography 
A. England; Liverpool/UK (aengland@liverpool.ac.uk) 
Advanced radiographic practice has dominated discussions within the radiographic 
profession for over a decade. Within the UK, advanced practitioner roles are now 
well established and continue to develop. With the number of advanced practitioners 
steadily growing, there are increasing demands on training and education. With 
advancements in practice questions have arisen regarding the need for evidence 
to prove competency, effectiveness and from which to base recommendations 
for future practice. In the first half of the millenium, there were a series of reports 
providing comparative data on the accuracy of radiographers undertaking advanced 
practice, e.g. barium enema investigations or plain radiographic reporting. Such 
studies generally provided a comparison again the current standard, a report or 
examination by a radiologist. Such comparisons can carry limitations as they were 
rarely multicentre in design and the true status of the patient was often unknown. 
Training schemes were also highly heterogenous, they may have been in-house, 
via short courses or as part of validated post-graduate degree programme. It was 
often difficult to apply published research findings locally and gain unequivocal 
support from our radiology and clinical colleagues. Questions have also arisen as 
to what role research evidence of past radiographic performance plays in driving 
future developments. This may be by expanding into new areas or the more wide-
spread role out of existing practices nationally or internationally. This paper aims 
to discuss these issues and the likely contribution of evidence-based practice in 
carving out the future of radiographic advanced practice.
Learning Objectives:
1.  To become familiar with examples of evidence-based practice in the area of 
advanced practice and role development in radiography.
2.  To understand the importance of such an evidence-based approach when 
considering the introduction of advanced roles in a clinical setting.
3.  To gain an insight into the education and training requirements for advanced 
practice and role development.
Author Disclosure:
A. England: Employee; University of Liverpool. Research/Grant Support; 
National Institute for Health Research. 
A-467 14:51
C. The view from the European level 
G. Paulo; Coimbra/PT (graciano@estescoimbra.pt) 
Technological evolution and new scientific developments have driven health care 
sector towards an unprecedented increase of its organizational complexity. One of 
the major contributors for that increase was, without doubt, the influence of medical 
imaging technology development. This change of paradigm is obviously a key driver 
for a (r)evolution in the daily practice of radiographers, because the radiographer is 
the ultimate interface between patient and technology and the gatekeeper regarding 
radiation protection. This demands for a permanent focus on patient care and safety, 
based on high-professional standards. To develop a profession, it is mandatory to 
develop the field of knowledge related to it. Evidence-based radiography practice 
is one of the best ways to achieve this desideratum, because it integrates the best 
research evidence with clinical knowledge and expertise, addressing the patient 
in a holistic way. It is necessary to build bridges between radiographer education 
institutions and clinical environments, combining efforts and promoting collaboration 
between radiographers from the academic and the clinical field. Radiographer role 
development and advanced practice is mandatory to develop more cost-efficient 
and cost-effective health systems. This is one of the most important pillars in the 
EU, once these systems are considered to be a central component of the Union’s 
high levels of social protection and contribute to social cohesion and social. Radi-
ographer advanced practice will definitely contribute to increase medical imaging 
department’s workflow, decrease patient waiting time, allowing earlier diagnosis, 
decrease length of hospital stay and therefore decreasing health expenditure, 
contributing to economical growth.
Learning Objectives:
1.  To understand the influence of evidence-based practice on the future of the 
radiography profession in Europe.
2.  To become familiar with the advantage of advanced practice and role develop-
ment in radiography in health systems.
3.  To understand the benefits of advanced practice and role development in 
radiography for the patients.
Panel discussion:  
How to use the EFRS guidance document on role development 15:14 
14:00 - 15:30 Room P 
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S. Mathers1, D. Tscholakoff2; 1Aberdeen/UK, 2Vienna/AT (s.mathers@rgu.ac.uk) 
The tasks and duties performed by radiographers in a modern imaging department 
are constantly evolving. The main drivers have been i) the relentless develop-
ment of technology in both the diagnostic and therapy fields and ii) the change 
in radiographer education leading to a graduate profession. The latter has lead 
to radiographers in some countries such as Netherlands and United Kingdom 
to develop their roles to carry out tasks which were previously performed by 
radiologists for example performing ultrasound and musculo-skeletal reporting. 
One outcome of this process is all imaging staff, including radiographers and 
radiologists, work together as a team to provide a first class and timely service 
for patients. Increasingly this change of practice is attracting interest from imag-
ing professionals across Europe. During this session, the history of radiographer 
role development will be reported and current work practices explained. The need 
for ongoing research and audit to support this change will be debated and the 
necessity for robust education and governance to underpin this process will be 
described. In conclusion, benefits of radiographer’s performing these roles will be 
described from a European perspective, and the contribution of radiographers to 
a modern health care service will be outlined. This will be supported by the Eu-
ropean Federation of Radiographer Societies (EFRS) document which has been 
developed to explain role development areas which are possible and the education 
required to carry out these roles. This session will conclude with a panel discus-
sion with opportunities for delegates to ask questions of our expert presenters. 
Session Objectives:
1.  To appreciate the potential importance of advancing and developing the role 
of radiographers for the profession and for healthcare.
2.  To become familiar with the level of activity across international societies in 
fostering this.
3.  To understand the importance of such role developments meeting real clinical 
needs.
A-465 14:05
A. The current status: a clinical perspective 
C. McLaren; London/UK (clare.mclaren@gosh.nhs.uk) 
Career progression in radiography has historically been through management with 
experienced radiographers leaving behind their clinical role. This loss of senior 
radiographer skills leaves a gap that can often be difficult to fill. We started to ad-
dress this issue in the interventional radiology (IR) service at Great Ormond Street 
Hospital in 2001. Our aim was to change the career structure for radiographers in 
IR, make the job more appealing, improve staff retention, and to develop skills that 
radiographers have, but don’t always get the chance to use. The role of clinical 
specialist radiographer in IR has developed alongside that of nurses. The areas of 
role extension were chosen to suit a radiographer’s skills and knowledge of fluor-
oscopy and imaging parameters. Initially, these included airway and oesophageal 
intervention and angiography. For this role to work well, you need a dedicated 
radiographer. New skills are required, for example, gaining patient consent for 
procedures and presenting imaging findings at multi-disciplinary team meetings. 
All aspects of IR are included in this role, including pre- and post-operative ward 
visits and reporting. This role was fully supported by the IR consultants and most 
senior consultants in the hospital, but did meet with initial opposition from some 
staff. We have implemented dedicated operating lists for procedures undertaken 
by the clinical specialist radiographer and thereby streamlined the patient pathway.
Learning Objectives:
1.  To become familiar with the current status from the perspective of a radiogra-
pher in an advanced practice in a paediatric interventional role.
2.  To understand the key factors that facilitate this advanced role, as well as the 
challenges faced during implementation.
3.  To become familiar with the impact that this advanced role has had on patient 
care, interprofessional relationships and service delivery, in one institution.
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1.  To understand the role of radiographs, US, CT and MRI.
2.  To become familiar with the most common conditions that cause acute chest 
pain and/or distress in children.
3.  To appreciate the different differential diagnoses, depending on the age of the 
patient.
4.  To understand the consequences of delaying in their diagnosis and treatment.
A-470 15:00
C. The role of the interventional radiologist in paediatric trauma 
J.B. Karani; London/UK (johnbkarani@hotmail.com) 
Outcome data from trauma series have demonstrated improved patient survival by 
the prompt diagnosis of the range of injuries and the recognition of life-threatening 
sequels, principally that of active arterial haemorrhage. Widely used trauma scoring 
systems are applicable in the paediatric population although often the mechanisms 
and combination of injuries may differ from those encountered in adults. A CT 
diagnosis of active haemorrhage demands early operative or non-operative inter-
vention with embolisation or use of alternative endovascular techniques including 
delivery of vascular stents. This principle is applicable to blunt or penetrating liver, 
splenic, renal or pelvic trauma. It is also applicable in some cases to severe me-
diastinal vascular and limb trauma. Important caveats are firstly the use of CT in 
an overall trauma service and avoidance of any inappropriate irradiation. Second, 
in paediatric interventional practice due regard needs to be given to delivery of 
implantable devices that may have adverse sequels in later life. Nevertheless the 
demand for immediacy in intervention may outweigh any such consideration.This 
presentation will summarise the importance of CT technique and intervention in 
both the early and the delayed sequels of trauma with an emphasis on abdominal 
and thoracic trauma.
Learning Objectives:
1.  To understand the role of CT, CTA and conventional angiography in the diag-
nosis of traumatic vascular complications.
2.  To understand the importance of vascular and non-vascular intervention fol-
lowing trauma in children.
14:00 - 15:30 Room Z 
Special Focus Session 
SF 14c 
Advances in forensic radiology 
A-471 14:00
Chairman’s introduction 
G. Guglielmi; Foggia/IT (g.guglielmi@unifg.it) 
Post-mortem Computed Tomography has been recognised as a powerful technique 
to assist forensic pathologists in their post-mortem investigation. In particular, 
CT has proven to be useful in the recognition of bone structure, the detection of 
embolisms and the diagnostic of gross abnormalities of soft tissues. On the other 
hand, CT scan without injection of contrast agent cannot provide information 
about abnormalities of the vascular bed of the viscera and lesions of the vascular 
system. In order to investigate post-mortem vascular system, a standardised CT-
angiography is necessary. It consists in the acquisition of one native scan and 
three angiographic phases during the perfusion of the body established with a 
mixture of paraffin oil and a specific oily contrast agent injected through the can-
nulation of the femoral artery and vein by means of a device reproducing perfusion 
conditions in analogy to living patients. Based on post-mortem MDCT studies, a 
new approach has been developed called virtual anthropology. In some cases 
of unidentified bodies, positive identification of the deceased can be obtained 
by adopting comparative or reconstructive criteria. These approaches permit as-
sessment and determination of some important anthropological parameters: racial 
phenotype, age at death, sex and stature. More recently, MRI has been used to 
augment forensic investigation with an outlook into post-mortem studies applied on 
musculoskeletal, cardiovascular and angiographic fields and in forensic imaging of 
the living, such as cases of child abuse, survived strangulation and age estimation. 
Session Objectives:
1.  To become familiar with the role of imaging in forensic pathology.
2.  To learn how the use of a contrast medium may help the native scan to recog-
nise vascular lesions.
3.  To learn about the possibilities of MDCT in anthropological identification.







A. The acute non-traumatic neurological patient: CT or MRI? 
E. Vázquez; Barcelona/ES (evazquez@vhebron.net) 
Neurological deficits in children are an urgent condition that depends significantly 
on imaging for a prompt accurate diagnosis because significant overlap is present in 
clinical history, presentation and neurological examination. There are five major clini-
cal categories of non-traumatic neuroemergencies: focal neurological deficit, head-
ache, increasing confusion, visual progressive deficit and progressive myelopathy. 
Different imaging modalities, such as ultrasound (neonates and infants), computed 
tomography (CT) or magnetic resonance imaging (MRI) are utilised dependent on 
age of the patient and neurologic symptoms. The purpose of the present lecture is 
to discuss the causes and imaging appearance of acute neurological conditions in 
childhood, broadly categorised into stroke and stroke-mimics (infection, inflammatoy 
demyelination, metabolic disorder, cerebral neoplasms or drug poisoning). A review 
of the main indications to perform a neuroimaging procedure in these children will 
be undertaken as well as a differential diagnosis based on representative cases 
selected from the daily routine in a paediatric tertiary hospital. Practical algorithms 
with the preferential use of either CT or MRI will be developed for each section. 
CT continues to be the first imaging modality in these patients with acute clinical 
presentations in many centers because it does not require sedation, even there 
is an accompanying radiation. MR imaging is nowadays better for imaging these 
children owing to the saved radiation, the more complete provided information and 
the useful advanced techniques that can be used, such as diffusion imaging (DI), 
spectroscopy, arterial spin labelling (ASL) or susceptibility-weighted imaging (SWI).
Learning Objectives:
1.  To learn about the currently limited role of CT in the non-traumatic acute set-
ting.
2.  To become familiar with radioprotection strategies and protocols adapted to 
children.
3.  To consolidate the role of MRI as the modality of choice for acute non-traumatic 
neurologically ill children, with an emphasis on newer techniques.
4.  To become familiar with imaging findings and the main differential diagnosis 
of acute neurological conditions in children.
A-469 14:30
B. Imaging of acute chest pain and/or distress in children 
C.E. de Lange; Oslo/NO (clange@ous‑hf.no) 
Acute chest pain in children is a common complaint in the emergency department, 
but patients rarely present with significant distress or life-threatening symptoms 
requiring immediate care or resuscitation. The most frequently reported cause is 
benign musculoskeletal pain followed by respiratory and gastrointestinal causes, 
while cardiac causes are less frequent. A thorough clinical history and careful 
physical examination will determine in most cases, the patients in need of further 
investigation to establish a diagnosis. In this regard, radiology plays an important 
role, especially in the emergency setting in patients with more serious associated 
symptoms like acute breathing difficulties, swallowing problems, fever or sepsis. 
When choosing the appropriate technique for investigation, the consequences of 
radiation exposure in children must be considered. Plain radiography and fluoros-
copy still remains the most important and frequently used tool to gain information 
on various acute chest/pulmonary problems. Ultrasonography is the first choice 
for diagnosis/ treatment of pleural effusions. Multidetector computed tomography 
and magnetic resonance imaging are mainly used for investigating pulmonary /
mediastinal masses and congenital abnormalities of the great vessels and the 
lungs. This lecture will discuss the choice of imaging technique and urgency of 
radiological management depending on the symptoms and age of the patient. 
The imaging characteristics of the different causes of acute chest pain and/or 
distress in children will be reviewed, represented by the more common conditions 
involving the chest wall, respiratory tract, oesophagus and the heart, as well as 
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es: the use of criteria and characteristics specific to MSCT, or the transposition of 
techniques used on dry bones in physical anthropology. It permits assessment and 
determination of some important anthropological parameters: racial phenotype, 
age at death, sex, stature. MSCT has many advantages over dry bone analysis: 
one of its major assets in forensic anthropology is the elimination of lengthy bone 
preparation, which may sometimes cause anatomical damage, especially when 
bone is already fragile (high useful when bones are very burned or charred). MSCT 
presents numerous inherent advantages over plain x-rays, in particular the ability 
to provide three-dimensional information. Post-processing allows segmentation of 
an individual bone, which can be highly useful for its analysis. 
Learning Objectives:
1.  To learn about the different paleo-pathological diagnoses and anthropological 
identification of bone lesions with MSCT.
2.  To learn about the possibilities of MSCT for comparative identification.
3.  To understand reconstructive identification and the main techniques useful for 
age-at-death assessment and sex determination.
A-475 14:59
Forensic MR imaging 
T.D. Ruder; Zurich/CH (thomas.ruder@irm.uzh.ch) 
Over the last decade, forensic imaging underwent enormous expansion and in many 
institutes across the world, pre-autopsy post-mortem CT or MR is now standard 
practice. Currently, CT is more widely used than MR in forensic imaging due to 
examination time constraints, limited access to MR scanners, and the complexity 
of MR technology. Nevertheless, MR imaging can be of great utility in forensic 
investigations. This lecture provides a summary of forensic applications of MR 
imaging. This includes an introduction to normal post-mortem findings on MR, such 
as posterior fluid sedimentation and temperature-dependent alterations of image 
contrast; a discussion of post-mortem musculoskeletal MR imaging in trauma cases, 
an outline of the current state-of-the-art in post-mortem cardiac MR with special 
emphasis on myocardial infarction; an overview of post-mortem MR angiography; 
and finally a synopsis of current applications and research efforts in forensic MR 
in living subjects, such as child abuse, survived strangulation and age estimation. 
Learning Objectives:
1.  To learn about typical post-mortem alterations in MR imaging.
2.  To become familiar with application of MR imaging in the post-mortem setting.
3.  To understand the added value of post-mortem cardiac MR in cases of cardiac 
death.
Panel discussion:  
Which imaging technique for which forensic scenario? 15:17 
16:00 - 17:30 Room A 





E. Castañer; Sabadell/ES (ecastaner@tauli.cat) 
Based on representative cases, we will review the main causes of thoracic non-
traumatic vascular emergencies (acute aortic syndrome, pulmonary thromboem-
bolism and haemoptysis); MDCT angiography has become the first-line imaging 
test for the diagnosis of this entities. As acute aortic disease is the most common 
fatal condition in patients with chest pain, prompt recognition and treatment is 
of paramount importance, we will review the spectrum of acute aortic pathology 
focusing on the distinctive findings of each entity (classic dissection, intramural 
haematoma, and penetrating aortic ulcer) and upgrading the clues for their diagno-
sis. Acute pulmonary embolism (PE) remains a common clinical challenge. MDCT 
pulmonary angiography has become the first line imaging study in the diagnosis 
of PE because of its speed, accuracy, low-interobserver variability, and ability to 
provide alternative diagnoses. We will review the role of MDCT in the evaluation of 
acute thrombotic PE: findings of acute PE (including how to evaluate the severity of 
an episode of PE at CT pulmonary angiography), some potential pitfalls as well as 
some of the controversies in imaging young and pregnant patients. Massive hae-
moptysis is a life-threatening condition that is associated with a high mortality rate. 
Haemoptysis usually involves bleeding from the bronchial arteries or, less frequently, 
from non-bronchial systemic arteries. Haemoptysis of pulmonary arterial origin is 
A-472 14:05
Imaging in forensic medicine 
M. Thali; Zurich/CH (michael.thali@irm.uzh.ch) 
Over 15 years ago, the Virtopsy Project with its systematic integration of various 
technologies and modalities, such as photogrammetric 3D surface scanning, 
computer tomography and magnetic resonance scanning as well as in the area 
of clinical and post-mortem forensic medicine as well as post-mortem biopsy and 
angiography was perceived by professional circles as being revolutionary. After a 
decade, these technologies have been integrated as an evolutionary process devel-
opment in daily forensic practice. The almost completed documentation procedure 
in the post-mortem area has also influenced future image-based documentation 
and analysis processes in clinical forensic medicine.
Learning Objectives:
1.  To learn why imaging methods are becoming essential modalities in forensic 
medicine.
2.  To become familiar with the modalities that can be used in forensic imaging.
3.  To learn what the future developments in forensic radiology and imaging will 
be.
A-473 14:23
Advances in post-mortem CT angiography 
S. Grabherr; Lausanne/CH (Silke.Grabherr@chuv.ch) 
Performing a postmortem, MDCT-scan has become routine in some forensic insti-
tutes, especially in Switzerland. In order to investigate the vascular system, different 
techniques of post-mortem CT-angiography have been tested. Multi-phase post-
mortem CT-angiography (MPMCTA) is a recently developed standardised technique 
which allows investigating the vascular system of human bodies similarly than in 
clinical CT-angiography. It consists in the performance of one native CT-scan and 
three angiographic phases (arterial, venous and dynamic phase). Data acquisition 
is performed after and during the perfusion of the body with a mixture of paraffin oil 
and the oily contrast agent Angiofil via a special perfusion device called Virtangio. 
Different studies have already proofed that the use of this method increases the 
sensitivity of the radiological exam significantly, especially concerning the detec-
tion of lesions of the vascular system and soft tissue. Depending on the findings, 
the sensitivity of the post-mortem CT-angiography is even higher than the one of 
conventional autopsy. Therefore, the performance of pre-autopsy MPMCTA has 
already become a new gold standard, especially in cases in which the source of 
a haemorrhage should be detected or a modified vascular anatomy is the result 
of a surgical intervention. However, there are still some diagnoses that have to be 
confirmed by conventional autopsy. In order to investigate the limits and advantages 
of post-mortem CT-angiography, an international working group has been created 
in 2012. The aim of this group is also to create recommendations for the indication 
of the exam and for the interpretation of the images.
Learning Objectives:
1.  To consolidate knowledge of the advantages and limits of post-mortem CT 
angiography.
2.  To understand the method of multi-phase post-mortem CT angiography and 
the indication for its performance.
3.  To become familiar with the objectives and latest achievements of the Technical 
Working Group of Post-mortem Angiography Methods (TWGPAM).
Author Disclosure:
S. Grabherr: Research/Grant Support.
A-474 14:41
Virtual anthropology and forensic identification using MDCT 
F. Dedouit; Toulouse/FR (fabded2@hotmail.com) 
The applications of Multi Slice Computed Tomography (MSCT) in anthropology, 
paleoanthropology, bioarcheology and paleopathology are grouped under the term 
paleoradiology. In recent years, a new approach has been developed called virtual 
anthropology, based on post-mortem MSCT studies. In some cases of unidentified 
bodies, both investigations can be carried out simultaneously through a single 
MSCT acquisition. The first analysis identifies causes of death, possible pre-existing 
disease processes and non-lethal abnormalities, while the second detects criteria 
potentially useful for positive identification of the deceased, based on comparative 
and reconstructive identification criteria. The comparative reconstruction is based 
on detection of surgical material, variants of normal radiological appearances, and 
pre-existing abnormalities whether congenital or acquired (permitting a complete 
paleopathological study), and ante-mortem MSCT images can be compared with 
post-mortem images. Reconstructive identification is based on two main approach-
0
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A. State-of-the-art techniques in 2013 
T. Mang; Vienna/AT (thomas.mang@meduniwien.ac.at) 
Computed tomographic colonography (CTC) is a reliable technique for the detec-
tion and classification of neoplastic and non-neoplastic lesions of the colon. It is 
based on a thin-section CT dataset of the cleansed and gas-distended colon, 
acquired in the prone and supine positions. Tagging of faecal residuals with orally 
administered contrast media is generally recommended. For screening CTC, low-
dose CT scanning protocols without IV contrast should be used. For diagnostic 
CTC, the use of IV contrast media and standard dose protocols for one scanning 
position is recommended for the evaluation of extra-colonic organs, particularly in 
patients with known colorectal cancer. Although CTC is considered to have a high 
safety profile, there could be a very small risk for complications such as perfora-
tions, bleeding, or cardiac events associated with the procedure. The risk can be 
minimized by adhering to recommended technical standards. Two-dimensional 
and three-dimensional views are used, in combination, for image interpretation. 
Colonic findings are characterised by their morphology, by their attenuation charac-
teristics and by their mobility. Knowledge of the CTC imaging features of common 
colonic lesions and artifacts is necessary to characterise findings and to avoid 
pitfalls. Computer-aided detection (CAD) algorithms automatically highlight polyp 
“candidates,” based on morphologic criteria. Used as a second reader, CAD has 
been shown to reduce the number of perceptual errors by pointing out possible 
abnormalities that might otherwise have been missed. CAD should be applied by 
radiologists only after they have been sufficiently trained in unassisted evaluation 
of CTC and the use of CAD.
Learning Objectives:
1.  To become familiar with an optimised technique and how it can be optimised 
for specific patient groups.
2.  To briefly describe basic interpretation and the role of CAD.
3.  To understand the most common interpretative pitfalls and potential complica-
tions, and how they can be avoided.
A-480 16:28
B. How to set up a service 
P. Lefere; Roeselare/BE (radiologie@skynet.be) 
Implementation of CT colonography (CTC) is a complicated and delicate proc-
ess, requiring consideration of several aspects. First, there is a need of intensive 
training, covering both the technical approach of CTC and the different aspects of 
interpretation. CTC workshops (ESGAR) are being organised since many years 
throughout Europe. They play a crucial role in the basic learning process by dealing 
with the several technical aspects and challenges of interpretation. They also allow 
for a personal contact with the international CTC-faculty. More recently, advanced 
workshops for experienced CTC-radiologists are being organised allowing for 
refinement of existing knowledge. As part of the learning process, independent 
double reading is a valuable option in the start up to avoid false-negative and 
false-positive findings, to refine the lessons learned during the workshops and 
to deal with difficult cases. Efficient CTC-implementation also relies upon the 
smooth performance of an experienced and well-organised CTC-team, consisting 
of administrative workers, radiographers and radiologists. The goal is to offer a 
patient-friendly and efficient diagnostic work up to both the patient and the clinician 
in a cost-effective way. Rigorous adoption of indications and contra-indications of 
CTC is a very important part of this process. Different approaches are necessary 
according to the patient or suspected pathology. At the end, the barium enema 
should be considered obsolete and totally replaced by an efficient combination of 
CTC and other imaging options, such as ultrasound, regular abdominal CT, and MR 
imaging. This lecture will present the options for CTC implementation in flow charts.
Learning Objectives:
1.  To appreciate the need for training prior to CTC and understand the role of 
training courses and double reporting.
2.  To become familiar with ways of maximising service efficiency, including cost 
effectiveness, and how best to replace the barium enema.
3.  To appreciate the differences in approach from setting up a service for older 
symptomatic patients to setting up colorectal cancer screening.
4.  To learn a basic audit framework.
Author Disclosure:
P. Lefere: Board Member; Co-founder of Virtual Colonoscopy Teaching Centre. 
Other; Collaboration for education in CTC with Bracco, Vital Images (Toshiba) 
and iCAD. 
rare, estimated at less of 10% of haemoptysis cases. MDCT angiography permits 
noninvasive, rapid, and accurate assessment of the cause and consequences of 
haemorrhage into the airways and helps guide subseqüent management.
Learning Objectives:
1.  To become familiar with the main causes of thoracic vascular emergencies.
2.  To understand the role of MDCT angiography in thoracic emergencies.
3.  To learn about the radiological signs in vascular thoracic emergencies and its 
impact on the management of these patients.
A-477 16:45
B. Pulmonary 
C.M. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com) 
Acute respiratory failure can have multiple underlying causes including infection, 
fluid overload, immunological diseases or exacerbation of pre-existing lung disease. 
Since the clinical symptoms are nonspecific, imaging plays an important role. The 
first imaging method is mostly the chest radiograph, easy to access and to obtain, 
but non-diagnostic in many cases. (HR)CT offers more possibilities to define the 
differential diagnosis. Option of this interactive workshop will be to get familiar 
with the spectrum of diseases that can cause acute respiratory failure and learn 
about key findings in radiography as well as CT to reduce the differential diagno-
sis. The interaction between preexisting lung disease, clinical information (e.g., 
chemotherapy, rheumatoid arthritis, COPD) and imaging findings will be discussed 
by clinical case studies. Emphasis will be put on the patient on “intensive care”. 
Options but also limitations of imaging findings will be illustrated. 
Learning Objectives:
1.  To learn about the role of imaging in severe attacks of obstructive lung disease.
2.  To become familiar with direct and indirect signs of pleural disease causing 
respiratory failure with special emphasis on the intensive care patient.
3.  To learn about imaging features that are helpful for the differential diagnosis 
of pulmonary consolidations causing respiratory failure.
4.  To understand the interaction of comorbidity, age and extent of pulmonary 
disease resulting in severe respiratory failure and the role of imaging in it.
16:00 - 17:30 Room B 
GI Tract 
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A. Laghi; Rome/IT (andrea.laghi@uniroma1.it) 
CT Colonography (CTC) is a well-established modality for colonic imaging, already 
implemented in several diagnostic-imaging departments worldwide. In order to be 
competitive and to fulfill clinical requirements, radiologists should provide an high-
quality service. State-of-the-art techniques should be used to maximize diagnostic 
performances, to improve patient comfort and to minimize potential risks. The 2012 
ESGAR Consensus will be presented and discussed in order to provide the attend-
ees with the newest information on CTC techniques, including bowel preparation, 
fluid/faecal tagging, colonic distention, scanning protocols and reading approaches. 
A second important issue is the organization of the service. Radiologists interested 
in CTC should be aware of how to start a service. This means to be informed about 
marketing strategies to general public and other physicians (i.e. gastroenterolo-
gists, primary care physicians, etc). as well as about the additional tools needed to 
successfully run and to improve a CTC service. Concepts of quality control in CTC 
will be introduced and known data about quality issues in CTC will be presented. 
The main objective at this time is the definition of possible metrics for assessing 
quality in CTC: some parameters will be derived from those experimented and 
currently used for conventional colonoscopy, but some others, completely different 
and specifically tailored for CTC should be created ex-novo. Finally, it is important 
to establish good relationships with gastroenterologists, since most of the goals 
are common. CTC and colonoscopy are, in fact, complimentary techniques and 
the joint use of both the techniques will result in a clear benefit for our patients. 
Author Disclosure:
A. Laghi: Speaker; Bracco, General Electric Healthcare, Im3d. 
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3.  To become familiar with an imaging algorithm for diagnostic approaches, and 
different strategies.
A-483 16:20
B. Paediatric adrenal tumours 
P.-H. Vivier; Rouen/FR (pierre‑hugues.vivier@chu‑rouen.fr) 
Adrenal lesions may occur as a result of neoplasms, haemorrhage, infection, or 
cysts. Adrenal masses in children may present with an asymptomatic adrenal mass 
lesion, an endocrinopathy, a hypertensive or metabolic crisis or a paraneoplastic 
syndrome. Neuroblastoma is the most common extracranial solid neoplasm in 
children, accounting for 10% of all paediatric neoplasms, and 15% of all childhood 
mortality from neoplasms. The median age at diagnosis is about 16 months, and 
95% of cases are diagnosed by 7 years of age. It may be seen also antenatally 
or in the newborn period. About half of the patients have metastatic disease at 
diagnosis. Ultrasound is usually the first imaging examination performed. Extension 
assessment requires 123I-mIBG-scintigraphy, chest x-ray and abdominal CT or MRI. 
Fluorodeoxyglucose positron-emission tomography is useful in neuroblastomas 
which fail to or weakly accumulate mIBG. Proper terms allow correct staging 
according to the 2011 Consensus Report from the International Neuroblastoma 
Risk Group. Two stages of localised disease are differentiated on whether image-
defined risk factors (IDRFs) are or are not present. IDRFs are features detected 
with imaging at the time of diagnosis. Less aggressive medullary tumours include 
ganglioneuroblastoma, ganglioneuroma and pheochromocytoma. Neoplasms 
that arise from the adrenal cortex are rare in children and include adrenocortical 
carcinoma and adenoma.
Learning Objectives:
1.  To become familiar with the different adrenal tumours in paediatrics.
2.  To learn how imaging can help in differentiating neuroblastoma from Wilm’s 
tumour.
3.  To understand the value of adequate examinations for the initial workup of 
adrenal tumours.
A-484 16:40
C. Prenatal detection of GU diseases 
F.E. Avni; Lille/FR (favni@skynet.be) 
During this course, the participants will learn how to evaluate the fetal GU tract in 
utero; the criteria used in order to diagnose GU malformation will be detailed and 
illustrated. The in utero management of uropathies will be explained. Also, the 
importance of MR imaging as a complementary examination will be discussed. The 
role of imaging in counselling parents will be explained. Furthermore, the postnatal 
work-up will be addressed and the potential role of each imaging examination 
will be evaluated leading to a standardised approach. Finally, the rationale of this 
management will be discussed in the light of up to date scientific data.
Learning Objectives:
1.  To learn how to assess the diagnostic criteria of foetal uropathies.
2.  To learn how to apply a standardised post-natal approach.
3.  To understand the rationale behind a standardised approach.
A-485 17:00
D. Interactive case discussion 
M. Claudon; Vandoeuvre‑lès‑Nancy/FR (m.claudon@chu‑nancy.fr) 
16:00 - 17:30 Room D1 
CLICK (Clinical Lessons for Imaging Core Knowledge): Never 
without Arteries 
CC 1518 
When every step counts: imaging and management 




A. Clinical considerations 
M. Schillinger; Vienna/AT (m.schillinger@imed19.at) 
Indications for interventional treatment of peripheral artery disease mainly depend 
on clinical considerations. Precise knowledge on patients’ clinical background, 
A-481 16:51
C. Interaction with gastroenterologists: friends or enemies? 
A. Graser1, C. Hassan2; 1Munich/DE, 2Rome/IT 
(Anno.Graser@med.uni‑muenchen.de) 
CT colonography is ready to be used on a larger scale. The examination is well 
accepted by patients and provides accurate depiction of the large bowel. It has a 
high sensitivity in the detection of relevant polyps and may help to pre-select pa-
tients who need to undergo subsequent colonoscopy for resection of such findings. 
However, conflicts of interest may exist between radiology and gastroenterology as 
they now “compete” for the same patients. This presentation will discuss political 
issues involved in one modality being used by different subspecialties. It will also 
focus on ways to create fruitful cooperations, communicate findings, recommend 
further tests and follow-ups, and unite the forces of both disciplines in order to 
benefit our patients. Indications to CT colonography and colonoscopy will also be 
discussed. Participants in the session will learn about when and how to best use 
CTC, and when to refer patients to colonoscopy.
Learning Objectives:
1.  To understand what the gastroenterologists wants to know when referring their 
patients for CTC in both symptomatic and screening patients.
2.  To learn how to formulate local polyp reporting guidelines and how best to 
integrate the service with the needs of patients.
3.  To propose the most effective method for integrating endoscopic and CTC 
services, minimising competition and maximising cooperation.
Author Disclosure:
A. Graser: Advisory Board; Pfizer Pharma. Consultant; Siemens AG Healthcare. 
Grant Recipient; Bayer Healthcare. Speaker; Siemens AG Healthcare, Bracco 
AG. 
Panel discussion:  
How to create an efficient CTC team? 17:14 







A. Imaging strategies for children: urinary tract infection and vesico-
ureteral reflux 
M. Riccabona; Graz/AT (michael.riccabona@medunigraz.at) 
UTI is a common query in paediatric uroradiology. As treatment strategies based 
on new insights into pathophysiology have changed, the role of imaging had to be 
revised. The imaging algorithm, techniques and some examples of common find-
ings in childhood UTI will be presented in the light of this new concept and imaging 
potential; particularly age-related aspects and different strategies (“bottom-up” vs. 
“top-down” approach) are discussed. Infants and children with UTI are commonly 
primarily assessed by ultrasound (US). A dedicated detailed US study in a well-
hydrated patient including post-void assessment often answers all queries neces-
sary for managing, particularly if Power Doppler and contrast-enhanced voiding 
urosonography for assessment of vesico-ureteric reflux (VUR) are applied. Urinary 
tract malformations, signs for upper tract involvement, complications and even 
(indirect signs for) VUR can be reliably assessed in most cases. Only for evalu-
ation of scaring (and equivocal US findings) DMSA scintigraphy and increasingly 
MRI - also for assessment of sonographically insufficiently addressable complica-
tions - are used. Voiding cystourethrography (VCUG) remains the gold standard 
for VUR assessment, particularly if a functional modified technique is applied and 
ce-VUS is not available. However, as VCUG is invasive with considerable radiation 
burden, thorough justification and patient selection is mandatory. CT (and IVU) 
are used only exceptionally, most commonly for the work-up of UTI complicated 
by or associated with childhood urolithiasis, or for complications and differential 
diagnosis if MRI is not available. 
Learning Objectives:
1.  To learn about the information provided by ultrasonography, MRI and nuclear 
medicine examinations.
2.  To become familiar with the technique and indications for micturating cysto-
urethrogram and contrast-enhanced voiding urosonography.
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1.  To become familiar with typical cases illustrating the role of different imaging 
modalities in the diagnosis and differential diagnosis of PAOD.
2.  To consolidate knowledge of the selection of the appropriate imaging technique, 
image interpretation and image based treatment recommendation.
3.  To understand the needs and principles in modern multidisciplinary manage-
ment of PAOD.
16:00 - 17:30 Room D2 
Oncologic Imaging: Follow-up of Systemic and Local Therapies 
CC 1519 




A. Follow-up imaging of thermal ablative therapies for lung tumours 
A.R. Gillams; London/UK (alliesorting@gmail.com) 
Routine imaging follow-up uses pre- and post-contrast enhanced CT with compari-
son to previous imaging. Factors assessed include size, shape, density, cavitation 
and enhancement. The normal ablation zone initially increases in density and may 
increase a little in size but after 3 months consistently reduces in size. An increase in 
the size of the ablation zone, a change in the shape of the ablation zone indicating 
an increase in one area, or the development of nodular enhancement, > 10 HU, 
indicates local tumour progression. Early diagnosis provides the best opportunity 
for re-treatment and long-term tumour control. A baseline CT study is required 
within the first 4-6 weeks post ablation. Thereafter, routine interval scanning is at 
2-4 month intervals depending on the aggressiveness of the cancer, e.g. primary 
lung, melanoma and most sarcoma metastases require two monthly assessment. 
Colorectal metastases are assessed three monthly, more indolent tumours may 
be scanned 4 monthly. Delayed complications include pneumothorax, effusion and 
infection. CT features of infection are enlargement of the ablation zone which may 
fill with fluid containing pockets of gas, the development of smooth rim enhancement 
and oedema in the surrounding parenchyma. Infected cavitating ablation zones, like 
other chronic infective cavitating lesions, may recruit a systemic collateral circula-
tion and this can result in large volume haemoptysis. Some authors recommend 
PET-CT but this modality is poor at detecting small volume disease and carries a 
heavy financial and radiation burden. It does have an advantage in assessing the 
significance of borderline hilar and mediastinal lymphadenopathy.
Learning Objectives:
1.  To consolidate knowledge of imaging aspect of successful ablation.
2.  To become familiar with the main pitfalls of post-ablation imaging.
3.  To learn about the imaging aspects of most common complications.
Author Disclosure:
A. R. Gillams: Speaker; CoVidien. 
A-490 16:30
B. Follow-up imaging of percutaneous local treatment of bone tumours 
F. Deschamps, G. Farouil, T. de Baere; Villejuif/FR (Frederic.Deschamps@igr.fr) 
Thermal ablation techniques (radiofrequency and cryotherapy) are increasingly 
used to treat bone metastases. No post-procedure imaging is required for palliative 
intent because the success can be clinically assessed. However, post-procedure 
imaging is crucial if a local tumour control is expected or if a local complication is 
suspected. CT is routinely used. It allows depicting any fracture on the treatment 
site but the ablation zone as well as any residual tumour is usually poorly seen. 
Size increase and/or contrast enhancement within the ablation zone at CT is 
considered as incomplete treatment but is often lately discovered. On the other 
hand, MRI accurately determines the extent of the ablation zone and is probably 
the best imaging technique to depict any residual tumour as well as any damage 
to the surrounding tissue. Indeed, it has been demonstrated that the correlation 
between the diameter of coagulation necrosis and lesion size at MRI is strong. 
Nevertheless, there are some limitations with MRI: the post-procedure imaging find-
ings are often unknown and there is a poor reproducibility in MRI protocols between 
the different hospitals and radiologists. In order to avoid a huge heterogeneity for 
the follow-up, standardised protocol must be used not only for post-procedure 
imaging but also for the pre-op MRI. Moreover, fluorine-18-fluorodeoxyglucose 
positron emission tomography (FDG-PET) is another tool for early diagnosis of 
incomplete treatment that consists in a peripheral increased focus uptake activity. 
therefore, is crucial. The following issues have to be considered: a. clinical stage 
of peripheral artery disease. This mainly includes the differentiation between 
patients with intermittent claudication and critical limb ischaemia. Interventional 
revascularization is an option for patients with intermittent claudication, it is a must 
for patients with critical limb ischaemia. b. Knowledge on patients comorbidities 
are essential in estimating the potential risk of any interventional procedures, this 
includes cardio-pulmonary comorbidities, renal disease, thyroid disorders and 
disorders of coagulation. c. Patients concomitant medication has to be considered 
to decide whether peri- and post-procedure standard medication can be used. In 
conclusion, clinical considerations have to be carefully evaluated prior to all inter-
ventional vascular procedures in patients with peripheral artery disease. 
Learning Objectives:
1.  To become familiar with clinical diagnosis and classification of peripheral 
arterial occlusive disease.
2.  To learn about the most important clinical differential diagnosis.
3.  To learn about the importance of imaging for treatment decision-making and 
planning.
A-487 16:30
B. Imaging techniques and typical findings 
T. Leiner; Utrecht/NL (t.leiner@umcutrecht.nl) 
Both CTA and MRA are highly valuable non-invasive imaging techniques in the 
clinical management of patients with peripheral arterial occlusive disease. This part 
of the refresher course will focus on the role of CTA and MRA in the diagnostic 
and interventional pathway of patients with suspected peripheral arterial occlusive 
disease, i.e. indications for imaging. The presentation will discuss relevant technical 
developments in CT and MR technology that facilitate routine high-quality imaging 
studies. In addition, the most commonly used imaging protocols will be discussed 
as well as the relative merits and shortcomings of CTA and MRA in specific patient 
populations. Furthermore, typical findings and relevant literature and guidelines 
as well as clinical recommendations will be reviewed with regard to evidence of 
clinical utility of both techniques.
Learning Objectives:
1.  To learn about state-of-the art MR angiographic imaging of the peripheral 
arteries (including modern non-enhanced techniques).
2.  To learn about state-of-the art CT angiographic imaging of the peripheral 
arteries (including modern dose-saving techniques).
3.  To become familiar with the appropriate selection of the right patient for the 
right imaging test.
Author Disclosure:
T. Leiner: Grant Recipient; The Netherlands Organisation for Health Research 
and Development. Research/Grant Support; My department receives research 
support from Philips Healthcare, Bracco, Bayer Healthcare. Speaker; Philips 
Healthcare, Bracco, Bayer Healthcare, GE Healthcare, Lantheus Medical. 
A-488 17:00
C. Interactive case discussion: how to deal with the results? Typical 
cases, pitfalls, and what is next? 
L.P. Lawler; Dublin/IE (llawler@mater.ie) 
Suitably skilled diagnostic and interventional radiologists, with an interest in car-
diovascular disease, are a major healthcare asset with a potential large contribu-
tion to make to the public health challenge of PAOD. Contemporary high-quality 
invasive and non-invasive 2D and 3D angiographic studies are user-friendly for 
display, distribution and interpretation. However, radiologists must seek to provide 
a ‘value-added’ that is above and beyond simple descriptors of the images pro-
duced. Open and endovascular algorithms for PAOD are relatively straightforward 
and uniform but the imaging studies should seek to align themselves with local 
practice actively guide the patient selection and therapeutic approach. Similarly, 
the radiologist needs to be versed in the post-surgical appearances and the report 
narrative should reflect the local vernacular of practice. When available through 
EPR and PACS comprehensive reports seek to reconcile ABIs, Doppler, CTA, MRA 
and DSA studies in a succinct conclusion that guides management and problem 
solving. Furthermore, we need to be insightful to the comparative advantages and 
limitations of each modality to avoid pitfalls in interpretation. In this presentation, I 
shall seek to illustrate and discuss a multimodality and multidisciplinary approach. 
There will be case discussion including all modalities, optimal imaging protocols 
and 3D processing. A range of therapeutic interventions and post-operative ap-
pearances will be addressed including features of complications. I hope to com-
municate an approach which acknowledges the central role of radiologists in the 
modern care pathway of PAOD.
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2.  To learn about current developments with a clinical focus on who should 
undergo what and when, what kind of CT exam to use in order to triage 
emergency patients to the appropriate therapy options.
A-493 16:15
A. Imaging of the most frequent emergencies of the upper abdomen 
C.J. Zech; Basle/CH (CZech@uhbs.ch) 
The causes of frequent non-traumatic emergencies in the upper abdomen include 
oncological and inflammatory diseases or diseases related to cholestasis. Although 
US often is the first line modality to examine patients with acute abdominal diseases, 
the findings for treatment decisions are in many cases assessed by dedicated 
MDCT protocols. A monophasic venous enhanced-CT usually provides a robust 
and broad overview and enables the evaluation of many diseases. Nevertheless, in 
some clinical instances, the addition of arterial phase images is warranted. This is 
mainly the case when acute bleeding or occlusion/pathologies related to the arterial 
vessels like mesenteric occlusion is suspected. Additional plain CT images can be 
helpful in when patients had previous surgery or in cases biliary stone disease is 
suspected. MRI usually plays only a minor role in imaging of abdominal emergen-
cies, with the clear exception of MRCP to evaluate the biliary system to decide 
about the indication of a therapeutic ERCP. Since MRCP protocols can be set up 
and acquired quickly and usually allow the very adequate evaluation of the biliary 
and pancreatic ductal system, it should be offered also for emergency patients. 
Interventional radiology can offer usually effective treatment options for patients 
with emergencies of the upper abdomen.
Learning Objectives:
1.  To become familiar with dedicated MDCT protocols.
2.  To learn about other types of imaging such as US and MR.
3.  To learn about typical and atypical imaging findings.
A-494 16:35
B. Imaging of the most frequent emergencies of the gastrointestinal tract 
M. Zins, I. Boulay-Coletta; Paris/FR (mzins@hpsj.fr) 
Acute abdominal pain due to gastrointestinal (GI) tract pathology is one of the most 
frequent causes of patient presentation to the emergency room. Rapid and accurate 
diagnosis is crucial for applying appropriate treatment. US and CT have emerged 
as the most accurate non-invasive imaging tools for emergent evaluation of acute 
abdominal pain. This lecture will detail the typical and atypical imaging features 
and the respective indications of US and CT in the most frequent emergencies of 
the GI tract including appendicitis, diverticulitis, small and large bowel obstruction, 
bowel ischaemia and infection.
Learning Objectives:
1.  To become familiar with dedicated MDCT protocols.
2.  To learn about other types of imaging such as US and MR.
3.  To learn about typical and atypical imaging findings.
A-495 16:55
C. Imaging of the most frequent emergencies of the genitourinary tract 
L.E. Derchi; Genoa/IT (derchi@unige.it) 
This presentation will deal with three of the most common and important acute 
problems of the GU system: testicular and ovarian torsion and the renal colic. US is 
the technique of choice in patients with acute scrotum and is able to identify torsion 
in up to 86% - 94% of cases. Tips and tricks to improve diagnostic accuracy and 
recognize possible false negatives will be presented. Difficulties can be encountered 
also in identifying ovarian torsion, and the role of US, CT and MRI in this field will 
be addressed, stressing the need for accurate correlation of clinical and radiological 
findings to reach the correct diagnosis. MDCT is the gold standard examination 
in patients with suspected renal colics, being able to recognize presence, loca-
tion and size of the obstructing stone (s) in virtually all cases, or to identify other 
pathologic conditions which are responsible for the patient’s symptoms. However, 
stone disease is frequent, recurrent and often affects patients of relatively young 
age; then, radiation exposure concerns have to be taken into account. Protocols 
using US as the first approach can solve up to 75% of cases, reserving MDCT 
only for those which are undetermined after US. The US examination techniques 
to be used in these situations will be addressed.
Learning Objectives:
1.  To become familiar with dedicated MDCT protocols.
2.  To learn about other types of imaging such as US and MR.
3.  To learn about typical and atypical imaging findings.
Panel discussion:  
How to speed up your diagnoses? 17:15 
It is a reproducible imaging technique that also allows depicting other metastases 
location or disease progression.
Learning Objectives:
1.  To learn about the post-ablation aspects, according to the ablation technique 
used.
2.  To consolidate knowledge of the imaging aspects of successful ablation on 
various types of follow-up imaging, including CT and MRI.
A-491 17:00
C. Follow-up imaging of thermal ablative therapies for kidney tumours 
D.J. Breen; Southampton/UK (David.Breen@uhs.nhs.uk) 
The imaging follow-up of renal tumour ablation is critical as this represents defini-
tive treatment of primary, curable carcinoma. Functional imaging such as FDG-
PET plays no role due to the poor FDG-avidity of a large proportion of clear cell 
carcinomas. Diligent post-contract CT or MR assessment remains the mainstay 
of follow-up remembering that papillary/chromophobe carcinomas are notori-
ously hypovascular. Careful subtraction MR imaging or dual energy CT are useful 
techniques for highlighting the usually crescentic marginal or peripheral nodular 
disease that indicates a subtotal treatment. Late arterial phase imaging with brisk 
contrast injection technique (at >= 5 m/s) is the best method to detect any such 
residual disease. Given improved image guidance and treatment dosimetry with 
techniques such as cryoablation subtotal treatment rates should now be well below 
5% in experienced centres, if not negligible. Studies have suggested that there is a 
small but persistent late local recurrence rate of ~5% with current RFA technique. 
Such recurrences usually declare themselves as enhancing marginal nodules at 
the edge of the otherwise involuting ablation zone. These recurrences have been 
reported at anything from 1 to 4 years post treatment. Comparitively cryoablation 
series report trivial rates of late local recurrence, effectively in equipoise with sur-
gical resection. Where the tumour mass is non-enhancing, gradually involuting, 
demonstrates a peri-tumoural 'halo' artefact in the adjacent fat and a subjacent, 
adequate wedge of cortical infarction recurrences are barely ever detected. These 
features are now establishing themselves as makers of complete and effective 
renal tumour ablation.
Learning Objectives:
1.  To learn about the post-ablation aspects, according to ablation technique used.
2.  To become familiar with the imaging aspect of successful ablation.
3.  To appreciate the imaging aspect of most common complications.
Author Disclosure:
D. J. Breen: Consultant; Microsulis Medical Ltd. , Galil Medical Ltd. 
16:00 - 17:30 Room E1 
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ER: comprehensive imaging of non-traumatic 
abdominal emergencies 
A-492 16:00
Chairman’s introduction: logistics and management of critical 
patients with abdominal complaints 
S. Wirth, M.F. Reiser; Munich/DE (swirth@med.uni‑muenchen.de) 
Emergency Radiology is a very rapidly growing field of modern radiology and 
of major importance in patient care. In particular, the number of CT examina-
tions has still been continuously rising during the last decade because CT is 
fast, easily available, provides high-resolution cross sectional images and is 
thus playing a key role for patients with emergent abdominal complaints. How-
ever, every modality plays its own important role even when indications may 
change with today‘s possibilities. An excellent co-operation with referring 
physicians remains indispensible. Thus, radiologists need to have a concise 
understanding of specific pathologies and have to get used to being involved 
more deeply into choosing the appropriate imaging way. On one hand, the pro-
cedures have to be standardised to a maximum but the trend towards personal-
ized medicine may be helpful to overcome some of the remaining limitations. 
Session Objectives:
1.To learn about requirements for abdominal imaging for an emergency radiol-
ogy department.
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S11B C D E F GA
S
unday
crucial knowledge to interpret these MRI’s adequately. Using anatomical landmarks, 
AI is divided as 1) anterior impingement, with a subdivision in anteromedial and 
anterolateral impingement and 2) posterior impingement, also divided in posterior 
and posteromedial impingement. The specific clinical and radiological features are 
shown. Although plain film is mainstay in daily practice AI is not easily detected. 
Guidelines on improving use of plain film are provided. Also value of easy to perform 
additional plain films with low costs are explained. Since MR is thought essential 
in workup of chronic ankle pain, guidelines for standardised interpretation and 
reporting are provided. Together with demonstrating the typical imaging features, 
the reading radiologist is comfortable to be able to provide the surgeon with the 
necessary answers. In our daily practice, MRI holds several orthopaedic limita-
tions, which are discussed. MDCT of both ankles, in neutral and maximal plantar 
flexion are thought of important additional value. Typical MDCT features of various 
AI subtypes are displayed. When radiologists are able to closely interact with the 
clinical colleagues, optimal care in chronic ankle pain can be provided.
Learning Objectives:
1.  To understand impingement mechanisms of the ankle.
2.  To become familiar with anterior and posterior ankle impingement.
3.  To learn about the typical imaging findings.




Femoroacetabular impingement (FAI) results from abnormal contact between the 
femoral neck and the acetabular rim. The two basic mechanisms of FAI are cam 
and pincer impingement. Cam impingement is by far more common, is caused by 
osseous abnormalities of the femoral head-neck junction and leads to damage of 
the anterosuperior labrum and articular cartilage. Pincer impingement is character-
ised by acetabular overcoverage or abnormal retroversion of the acetabulum and 
provokes a typical pattern of injuries of the anterosuperior labrum and the poster-
oinferior joint surface. Both conditions are thought to initiate premature osteoarthritis 
and thus have gained increasing attention over the last decade. Plain radiography 
and MR imaging represent important tools for the diagnosis and preoperative plan-
ning of patients with FAI with a view to depiction and quantification of predisposing 
osseous abnormalities and definition of the extent of joint damage. It is however 
important to keep in mind, that the diagnosis always has to be based on clinical 
findings and cannot be established solely on the basis of imaging findings. This 
course will focus on imaging features, which support the diagnosis of cam and 
pincer type FAI, the strenght and weaknesses of different imaging modalities, and 
the potential impact of radiological findings on clinical decisions.
Learning Objectives:
1.  To understand impingement mechanisms of the hip.
2.  To become familiar with cam and pincer type femoroacetabular impingement 
(FAI).
3.  To learn about the typical imaging findings.
4.  To appreciate the strength and weaknesses of different imaging modalities.
Panel discussion:  
Form or function: is impingement a clinical or imaging diagnosis? 17:14 
16:00 - 17:30 Room F1 
Special Focus Session 
SF 15a 
Traumatic brain injury 
A-500 16:00
Chairman’s introduction 
A. Rovira-Cañellas; Barcelona/ES (alex.rovira@idi‑cat.org) 
Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. 
Every year, about 1.5 million people die and several million receive emergency 
treatment for this cause. In clinical practice, the severity of TBI is generally classified 
as severe, moderate, or mild according to the level of consciousness measured with 
the Glasgow Coma Scale (GCS). Nonetheless, the increasing use of early sedation, 
intubation, and ventilation in more severely injured patients has decreased the value 
of the GCS for classification purposes. Alternatively, and particularly in these more 
severe patients, TBI can be classified according to morphological criteria based on 
CT or MRI studies. Although MRI may be more sensitive for detecting small white 
matter lesions in later phases following TBI, CT remains the examination technique 
16:00 - 17:30 Room E2 
State of the Art Symposium 
SA 15 




The Latin word “impingere” means to thrust, to strike or to dash against some-
thing. Impingement in the musculoskeletal system has received considerable 
attention as an important mechanism for causing damage to joints and tendons. 
Impingement refers to a dynamic, abnormal contact between two anatomic 
structures. Because of the dynamic component, the diagnosis of an impinge-
ment based on imaging alone may not be possible. Some predisposing factors 
like a cam deformity at the proximal femur, leading to femoroacetabular im-
pingement are well known. However, in other conditions, such as subacromial 
impingement at the shoulder joint, imaging findings may be much less evident. 
Session Objectives:
1.  To learn about the role of imaging for the diagnosis of impingement syndromes.
2.  To understand what the clinician needs to know from the radiologist.
3.  To learn the diagnostic value of different imaging modalities to answer the 
clinical questions.
Author Disclosure:




P. Robinson; Leeds/UK (Philip.Robinson@leedsth.nhs.uk) 
The anatomy, biomechanics and function of the shoulder girdle means that this 
area is extremely vulnerable to developing impingement syndromes both from 
athletic use and normal degenerative processes. The shoulder girdle anatomy 
will be reviewed in the context of the proposed theories concerning causes or 
associated causes of internal and external impingement syndromes. Imaging as-
sessment will focus on ultrasound and MRI demonstration of the normal anatomy 
and relevant variations in normal. In external impingement syndormes, the relation-
ship of the rotator cuff, overlying bursae and coracohumeral arch is the centre for 
both primary (morphological abnormality of the arch or rotator cuff) and secondary 
(micro or macro glenohumeral instability) causes. Imaging abnormalities of the 
arch, rotator cuff and bursae will be presented for both ultrasound and MRI and 
their relevance to clinical findings and subsequent management of impingement 
will be discussed. In internal impingement, a brief overview of the theories for 
posterosuperior and anterosuperior impingement will be presented. Anterosuperior 
impingement is not as well recognised as other impingement syndromes but the 
mechanism and imaging findings will be presented. Despite the differing theories 
for posterosuperior impingement, there are a common group of imaging features 
that occur. These imaging findings will be illustrated but because the areas affected 
include the glenoid labrum, capsule and undersurface of the rotator cuff the imaging 
focus will be on MRI (including arthrography) rather than ultrasound which cannot 
accurately assess this region. 
Learning Objectives:
1.  To understand impingement mechanisms of the shoulder.
2.  To become familiar with external and internal shoulder impingement.
3.  To learn about the typical imaging findings.
4.  To appreciate the strength and weaknesses of different imaging modalities.
A-498 16:28
Ankle 
M. Maas; Amsterdam/NL (m.maas@amc.nl) 
Ankle impingement (AI) is an important cause of chronic ankle pain. AI is a painful 
mechanical limitation of full-ankle movement, secondary to osseous and/or soft-
tissue pathology. Radiologists are frequently encountered with requests for MRI of 
the ankle, an investigation that needs to answer important preoperative questions. 
The presence of multiple ligaments, tendons and joint extensions make interpre-
tation of MRI challenging. Anatomy of this small joint is considered difficult, yet 
5
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spectroscopy and functional MRI have been shown to hold great promises in this 
indication, since they enable quantification of neuronal suffering, injury of the white 
matter or physical and functional disconnection of critical brain areas. Lesions of 
the mesencephalon, thalamus, corpus callosum and diffuse destruction of the white 
matter secondary to increased intracranial pressure often lead to an unfavorable 
evolution. A method for reliable prognostication of outcome in severe TBI could 
be developed by integrating clinical and neuroimaging information. This aim will 
require a large multicenter study using a harmonized imaging protocol and com-
mon clinical data elements.
Learning Objectives:
1.  To understand the value of diffusion tensor imaging and MR spectroscopy in 
severe cases.
2.  To understand the role of these techniques in early- and late-phase diagnosis 
and treatment follow-up.
3.  To learn about the lesion patterns associated with favourable and unfavourable 
outcomes.
Author Disclosure:
D. Galanaud: Consultant; Olea Medical, La Ciotat, France. 
A-504 16:59
Cerebrovascular trauma: diagnosis and therapy 
T. Krings; Toronto, ON/CA (timo.krings@uhn.ca) 
Vascular injury of the head and neck region is a rare and often life-threatening 
complication of head or neck trauma and is due to two major pathomechanisms: 
penetrating or blunt trauma. Both the arterial and the venous site of the CNS 
vasculature can be involved, the latter one being often overlooked. Concerning 
arterial lesions, depending on how many layers of the arterial vessel are affected 
and on the spatial relationship to adjacent structures, dissections, false aneurysms 
or arteriovenous fistulae may develop. On the venous side, dural tears, compressive 
effects on pial veins and a deranged clotting system may lead to delayed venous 
thrombosis. In this lecture clinical and imaging findings, as well as diagnostic and 
treatment strategies in these lesions are described. 
Learning Objectives:
1.  To learn about the classification of the different types of cerebrovascular trauma.
2.  To become familiar with vascular emergencies requiring urgent treatment.
3.  To become familiar with treatment strategies in cerebrovascular trauma.
Panel discussion:  
Role of neuroimaging in traumatic brain injury in 2013 17:17 
16:00 - 17:30 Room F2 
Special Focus Session 
SF 15b 
Digital breast tomosynthesis 
A-505 16:00
Chairman’s introduction 
G. Gennaro; Padua/IT (gisella.gennaro@ioveneto.it) 
In the past two decades, important progresses have been obtained by manufac-
turers in development of digital breast tomosynthesis (DBT), a 3D breast imaging 
technique which aims to overcome inherent limitations of mammography associ-
ated with normal breast tissue superimposition. Several retrospective studies 
have demonstrated DBT potentials in reducing both false negatives and false 
positives compared to standard mammography. Nowadays, commercial DBT 
systems are facing on the market, with different technical solutions in terms of both 
physical parameters which control DBT acquisition, and reconstruction algorithms. 
Moreover, several clinical questions are still open about the actual applications 
of tomosynthesis in clinical practice. Different scenarios have been considered, 
either proposing DBT to replace mammography, or to be used as an adjunct to 
mammography, together with other diagnostic tools, like mammography extra-views 
or ultrasound. One concern about the real use of DBT regards its impact on the 
clinical workflow, caused by the strong increase in the amount of DBT images to 
be reviewed compared to the current standard of care in breast imaging; one pos-
sible solution comes from computer-aided detection (CAD), which could support 
lesion detection, as well as speed up radiologists’ reviewing time. This session aims 
to cover the tomosynthesis subject, including all the aspects mentioned above. 
Session Objectives:
1.  To understand the physical parameters and reconstruction methods which 
determine digital breast tomosynthesis (DBT) image quality.
of choice in the acute phase. However, both CT and conventional MRI fall short in 
accurate prediction of outcome, because of their inability to depict the full extension 
of brain injury and because they offer qualitative rather than quantitative information. 
In the last few years, advanced MR techniques such as diffusion tensor imaging 
(DTI) and proton MR spectroscopy (MRS) have been used to provide quantitative 
assessment of the extent of brain damage and have been proposed as markers 
of axonal injury and to predict long-term outcome. Outcome prediction is important 
because it has an impact on the choice of specific treatment methods, on deciding 
whether or not to withdraw treatment, and on counseling patients and relatives. 
Session Objectives:
1.  To understand the role of neuroradiology in the initial assessment.
2.  To appreciate the role of conventional and non-conventional imaging tech-
niques in the diagnosis and monitoring of primary and secondary traumatic 
lesions of the brain.
3.  To learn about the prognostic value of neuroimaging.
4.  To become familiar with the various types of cerebrovascular traumas and 
their treatment options.
Author Disclosure:
A. Rovira-Cañellas: Advisory Board; NeuroTec, Bayer AG. Board Member; 
Neuroradiology, Am J Neuroradiol. Consultant; Novartis. Research/Grant 
Support; Bayer AG. Speaker; Bayer AG, Novartis, Sanofi-Aventis. 
A-501 16:05
Acute brain trauma: CT vs MRI 
M. Muto; Naples/IT (mutomar2@gmail.com) 
Traumatic brain injury is a common condition related to multiple mechanism of action 
of the traumatic vector axis that can cause mild clinical abnormality up to dramatic 
and urgent situation that needs to be treated surgically in emergency. Multiple clas-
sification has been published to correlate clinical findings, with risk factors trying to 
define with category of patients needs to be image. Loss of consciousness is an 
important clinical criteria to decide about CT evaluation or not. Focal contusion, 
lacero-contusion, epidural-subdural haematoma, post-traumatic subarachnoid 
hemorrhage, subtentorial and infrafalx haematoma, skull fractures are all conditions 
easily visible with CT and the semeiotic of this finding is well established also with 
MR. Clinical evaluation of those patients is also sometimes problematic related to 
the fact that we are dealing with unstable polytrauma patients. The real diagnostic 
problem are patients with coma state and minimal CT abnormality in which a diffuse 
axonal injury must be suspected and confirm by MR examination showing typical 
abnormal signal intensity at the level of the cortical-subcortical junction or at the 
level of the brainstem. The evolution and the follow-up of those patients can be 
performed either by CT or MR in relation to type of injury. MR perfusion can also give 
more information about the recovery of normal vascular supply in trauma patients.
Learning Objectives:
1.  To understand the role of neuroradiology in the management of brain trauma 
patients.
2.  To learn about the correlation between neuroradiological features and clinical 
findings.
3.  To understand the importance of imaging follow-up.
A-502 16:23
New imaging techniques in the detection and quantification of brain 
damage 
S. Sunaert; Leuven/BE (Stefan.Sunaert@uz.kuleuven.ac.be) 
This talk will cover the use of new magnetic resonance imaging techniques in the 
detection and quantification of brain damage. Susceptibility weighted imaging has 
become standard in the detection of microbleeds and diffuse axonal injury. More 
subtle changes in brain function and connectivity can be studied by the combination 
of fMRI, resting state fMRI and diffusion tensor imaging. These can be used at the 
stage of diagnosis, but also have a role in the prediction of outcome and follow-up 
of brain plastic changes after injury. 
Learning Objectives:
1.  To consolidate knowledge of new advanced imaging techniques.
2.  To learn about quantifying brain damage using these techniques.
3.  To understand the challenges of performing MR examinations in these patients.
A-503 16:41
Advanced imaging of brain trauma: outcome prediction 
D. Galanaud; Paris/FR (galanaud@gmail.com) 
Determining the prognosis of a patient with severe traumatic brain injury (TBI) 
at the acute phase remains challenging. MRI is now considered the method of 
choice to address this issue. Sequences such as diffusion tensor imaging, MR 
Postgraduate Educational Programme
S11B C D E F GA
S
unday
view) and the increased workload and possibly fatigue to the radiologists. CAD has 
been shown to reduce radiologists‘ false negatives in screening mammography. It 
can be expected that CAD may be useful for DBT interpretation. DBT in clinical use 
is still at an early stage. Although the impact of CAD on DBT interpretation has not 
been reported, some important issues associated with CAD use can be expected 
based on the experiences in screening mammography. In this talk, the potential 
usefulness of CAD in DBT and the issues as observed from the reported prospective 
studies of CAD use in the clinic will be discussed, including the potential impact of 
off-label use (i.e., CAD systems approved as second reader used as concurrent or 
first reader), user training, and quality assurance of CAD performance. Because of 
the increased reading time for DBT, there will be an even stronger tendency that 
radiologists may want to use CAD as a concurrent or even first reader to improve 
workflow. To have a CAD system for such intended use, much more stringent 
requirements for the standalone performance of the CAD system and properly 
designed studies to evaluate its impact as a concurrent or first reader should be 
required before the CAD system can be approved for clinical use with DBT.
Learning Objectives:
1.  To learn about the challenges of DBT interpretation in clinical practice.
2.  To understand the potential impact of computer-aided detection on DBT.
3.  To learn about CAD as a second reader to improve DBT sensitivity.
4.  To appreciate CAD as a concurrent reader to improve DBT workflow.
Panel discussion:  
Digital breast tomosynthesis: replacing or just supporting standard 
mammography? 17:14 
16:00 - 17:30 Room G/H 
Neuro 
RC 1511 




A. Anatomy of the limbic system 
T.A. Yousry; London/UK (t.yousry@ucl.ac.uk) 
The anatomy of the limbic lobe and system can be seen as being composed of 
2 main structures: the limbic and the intralimbic gyri. 1. The limbic gyrus is com-
posed of the subcallosoal gyrus anteriorly, followed in an arc by the cingulated 
gyrus, isthmus and finally the parahippocampal gyrus. The latter is composed 
of 2 parts: i) a posterior narrow segment, the superior surface of which is called 
subiculum, and ii) a more voluminous anterior segment, also known as the piriform 
lobe. The latter consist of the anterior part of the uncus and the entorhinal area. 
2. The intralimbic gyrus arches within the limbic gyrus. It is divided into 3 parts: i) 
anterior (prehippocampal rudiment); ii) superior (indisium griseum); and iii) inferior 
(hippocampus). The latter consist of 2 lamina rolled inside each other: the cornu 
ammonis and the dentate gyrus, with the cornu ammonis consisting of 4 neuronal 
fields (CA1-4). We will review the MRI characteristics of these structures and their 
relationships with each other, using 1.5 T, 3 T and 9.4 T high field imaging. At the 
end of this lecture, you will know the major subdivisions of the limbic lobe/system 
a will be able to identify them on MRI.
Learning Objectives:
1.  To learn the components of the limbic system.
2.  To understand the structure of the hippocampus proper.
3.  To become familiar with the imaging characteristics at 1.5 T, 3 T, and 9.4T.
Author Disclosure:
T. A. Yousry: Advisory Board; Biogen Idec. Author; T Yousry. Board Member; 
European Eadiology. Research/Grant Support; MS Society of Great Britain 
and Northern Ireland, MRC, Wellcome Trust, Stroke Association, British 
Heart Foundation, UCL/UCLH Biomedical Research Centre, Biogen Idec, 
GlaxoSmithKline, Novartis. Speaker; ESOR, King Abdullah Medical City. 
A-510 16:30
B. Temporal lobe epilepsy 
I.N. Pronin; Moscow/RU (pronin@nsi.ru) 
Neuroimaging is essential in the work-up of patients with temporal lobe epilepsy 
(TLE) because in majority of the cases, the structural lesions causally related to 
the epilepsy are small and the success of the surgery is directly dependent on the 
2.  To learn about DBT clinical performance and potential clinical applications.
3.  To understand if CAD could be successfully applied compensate for the time 
required to review DBT images.
A-506 16:05
Optimisation of image acquisition and reconstruction in DBT 
M.J. Yaffe, J.G. Mainprize; Toronto, ON/CA (Martin.Yaffe@sri.utoronto.ca) 
Digital breast tomosynthesis (DBT) is an extension of digital mammography (DM) 
and is typically built on a DM platform. To accomplish tomosynthesis image acquisi-
tion, the x-ray tube moves over a range of angles about a pivot point located above 
the digital detector to obtain a series of low-dose digital projection radiographs. 
The detector may be stationary or (in the isocentric design) also rotate about the 
pivot point. The x-ray tube may temporarily halt as each projection is acquired or 
may move continuously during acquisition. From the set of projection images, an 
algorithm reconstructs a quasi three-dimensional representation of the x-ray at-
tenuation properties of the breast tissues. As in CT, the reconstruction algorithm 
may be based on an iterative approach or employ Fourier methods or filtered back 
projection. Constraints may be applied to speed or simplify the reconstruction. The 
reconstructed images are often viewed as a “movie-loop” where adjacent x-y planes 
(parallel to the x-ray detector) are displayed sequentially. Because a complete 
range of angular data is not obtained, the dataset is highly undersampled, giving 
rise to artefacts. Typically in DBT, the spatial resolution in the x-y plane is quite 
high while it is coarser in the z (x-ray tube to detector) direction. The quality of 
the reconstructed image and the dose to the breast are dependent on the angular 
range and number of projections, the dose used per projection and the perform-
ance of the x-ray detector and electronics. In this presentation an approach to 
optimization will be discussed. 
Learning Objectives:
1.  To understand DBT principles.
2.  To learn about DBT acquisition and optimisation.
3.  To understand DBT reconstruction algorithms.
4.  To become familiar with radiation dose from DBT.
Author Disclosure:
M. J. Yaffe: Equipment Support Recipient; GE Healthcare. J. G. Mainprize: 
Equipment Support Recipient; GE Healthcare. 
A-507 16:28
Current role of DBT in diagnostic imaging 
S. Zackrisson, K. Lång, A. Tingberg, P. Timberg, D. Förnvik, M. Dustler, 
I. Andersson; Malmö/SE (sophia.zackrisson@med.lu.se) 
The sensitivity of mammography for the detection of breast cancer is less than 
optimal. One of the main reasons is that a 3D structure (the breast) is projected 
on to a 2D plane (radiographic image) meaning that the normal breast tissue 
can conceal a tumour especially if the breast tissue is “dense”. Digital breast 
tomosynthesis, DBT, is a three-dimensional radiographic technique which may 
reduce the impact of overlapping tissues in breast cancer detection. The aims 
of this presentation are: 1. to describe the potential impact of DBT on sensitivity 
and specificity of breast cancer detection. 2. To illustrate limitations of DBT and its 
impact on image interpretation time and effort. 3. To discuss if DBT is applicable to 
screening. A review of the current literature and studies on diagnostic and screen-
ing DBT will be presented. DBT is a promising tool in breast imaging. However, 
further evidence from the ongoing trials is needed to establish its place in breast 
cancer diagnosis and screening.
Learning Objectives:
1.  To understand the potential impact of DBT on sensitivity and specificity of 
breast cancer detection.
2.  To appreciate limitations of DBT and its impact on image interpretation time 
and effort.
3.  To understand if DBT is applicable to screening.
Author Disclosure:
S. Zackrisson: Research/Grant Support; Swedish Cancer Foundation, Swedish 
Research Council. 
A-508 16:51
Clinical aspects of computer aided detection and diagnosis in DBT 
H.-P. Chan; Ann Arbor, MI/US (chanhp@umich.edu) 
Digital breast tomosynthesis (DBT) can potentially increase the sensitivity and 
reduce recall rate in breast cancer screening. However, the chance of oversight 
may not be negligible because of the very large search space (~50-80 slices per 
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A-513 16:05
A. Coronary CTA in patients with severe arrhythmias and high heart rate 
C. Loewe; Vienna/AT (christian.loewe@meduniwien.ac.at) 
Beside all advances in scanner technology, heart rate remains a critical issue for 
coronary CTA and motion artifacts due to cardiac function represent still the most 
frequent reason for limited diagnostic image quality in cardiac CTA. Thus, heart rate 
control by medical treatment is standard of care for cardiac CTA. The target heart 
rate is defined depending on the scanner system used and ranged below between 
60 and 70 bpm. However, there are patients and conditions, where a heart rate 
control is not possible or not successful, whereas a relevant proportion of CTA’s 
are performed in patients with heart rates higher than the target frequency including 
children, emergency patients, patients suffering from severe COPD and/or heart 
transplant recipients. Scanning at higher heart rates has severe implications for 
scan protocol selection and on dose saving strategies. During this presentation, 
possibilities for heart rate control beyond beta blockers should be discussed and 
examination strategies for patients with high heart rates will be presented. Different 
to high heart rates and even more critical with regard to image quality is arrhythmia. 
Due to the complexity of cardiac synchronization, a CT suite is not the place for 
cardiac resynchronization, whereas the indication to CTA has to be reevaluated 
depending on referring diagnosis and severity of arrhythmia. Since there are patients 
undergoing CTA because of arrhythmia including patients prior to ablation treatment, 
strategies for examination and image reconstruction in case of arrhythmic patients 
have to be established and will be presented during this presentation.
Learning Objectives:
1.  To understand the criteria for optimal patient selection and preparation to 
achieve best results.
2.  To learn about acquisition techniques in patients with arrhythmias and tachy-
cardia.
3.  To become familiar with the post-processing techniques available for optimising 
images quality following the scan.
Author Disclosure:
C. Loewe: Board Member; steering committee member B;S (Apixaban studies). 
Investigator; investigator in different multicenter trials sponsored by BMS, 
Guerbet, GE Healthcare, Bayer. Speaker; speaker for Siemens, Bracco, GE 
Healthcare, Bayer, Guerbet, Covidien. 
A-514 16:28
B. Severe coronary calcinosis and stents: tips and tricks in image 
acquisition and interpretation 
F. Pugliese1, A. Rossi2; 1London/UK, 2Trieste/IT (francesca.pugliese@libero.it) 
Cardiac computed tomography (CT) has become a widely available diagnostic tool 
used in a range of heart conditions. The commonest application of this technique 
is the evaluation for coronary artery patency (coronary CT angiography) in patients 
with chest pain. When coronary arteries are heavily calcified, or post-coronary 
angioplasty with stent implantation, diagnostic problems can occur. In these 
circumstances, the evaluation of the coronary arteries on CT is hampered by the 
occurrence of high-density artefacts caused by calcifications and stent struts. These 
artefacts may preclude the appropriate assessment of the coronary lumen. The 
presence of motion artefacts in the dataset, or image noise in very large patients 
may exacerbate the problem. In this scenario, accurate patient selection and 
preparation remain key to ensure that the diagnostic yield of the cardiac CT study 
is good. Optimisation of scan parameters (kV, mAs), contrast injection protocol and 
use of appropriate post-processing techniques (e.g. dedicated convolution filters) 
play an important role in daily clinical practice. Recent technical developments 
include dual-energy scan techniques and gemstone spectral detector systems that 
acquire simultaneously high and low kilovoltage datasets. This is done to achieve 
tissue differentiation. In principle, by using monochromatic image reconstruction 
the effect of high-density artefacts may be decreased. Using a similar principle 
high-density structures can be subtracted from the image. The introduction of 
iterative reconstruction algorithms may play a role because these algorithms are 
theoretically more accurate in the modeling of physical noise and tissue geometries. 
Learning Objectives:
1.  To understand the challenge of calcification and stents when performing 
coronary CTA.
2.  To become familiar with technical features that maximise image quality in this 
patient group.
3.  To be aware of the accuracy of coronary CTA in stented or calcified vessels 
with the optimum imaging techniques.
accuracy of these lesions’ identification. For this reason, there has been ongoing 
interest in utilising new advanced imaging techniques to improve the ability to 
identify, diagnose, characterise and delineate the epilepsy cause. Structural high-
resolution MRI commonly reveals the structural basis of partial seizures. In a case 
with TLE, there are different disorders such as hippocampal sclerosis, long-term 
epilepsy-associated tumours, focal cortical dysplasias, vascular malformations, 
encephalitis, gyral scarring and so on. Functional imaging, however, can demon-
strate the pathophysiological processes that occur in epilepsy. MRS allows the 
“in vivo” assessment of brain metabolism on the basis of investigation of various 
cerebral metabolites involved in a variety of neuronal processes that occur in TLE. 
DWI and DTI are sensitive tools to identify microstructural changes and integrity in 
the white brain matter. fMRI offers the possibility to assess the physiologic proc-
esses of neuronal activity to be measured in terms of local brain volume, flow, and 
oxygen saturation. The traditional radiotracer methods such as SPECT and PET 
have been used in attempt of noninvasive assessment of cerebral blood flow and 
energy metabolism caused by neuronal activity. MEG increases the MRI sensitivity 
in detection of subtle or invisible epileptogenic foci on structural MRI. 
Learning Objectives:
1.  To become familiar with MR-characteristics of neoplastic and non-neoplastic 
causes of temporal lobe epilepsy.
2.  To learn about optimised imaging protocol.
3.  To appreciate the potential impact of modern MR-imaging techniques to 
improve visualisation of structural brain changes.
A-511 17:00
C. fMRI in epilepsy 
N. Bargalló; Barcelona/ES (bargallo@clinic.ub.es) 
Functional MRI (fMRI) is a non-invasive tool that is capable to detect the subtle 
homodynamic changes produced in regional brain activation. The main fMRI 
clinical application until now is localisation and evaluation of brain eloquent areas 
in surgical planning of brain pathology. fMRI application in epilepsy patients are 
language lateralization, memory function assessment and localisation of ictal and 
interictal BOLD changes. There are several factors that can influence the results 
of a fMRI experiment such as the scan noise for the rest condition, the simplicity 
of the task performance, the monitoring of the experiment during the exam, how to 
achieve a real baseline condition and the most important, to use the most specific 
paradigm that would activate the selected brain areas. In practical approach, one 
must be aware that sometime fMRI studies are applied in paediatric or impaired 
cognitive epilepsy population when deciding the language or memory paradigm, 
and is recommended to use multiple and feasibility tasks to assure the results. 
fMRI for language lateralization is currently used in the clinical practice and pro-
vides comparable results to the intracarotid amobarbital test (IAT). In fMRI studies 
for memory function assessment, results show changes in epileptic patients, but 
further studies are required to validate this technique to an individual level. A new 
application is ictal or interictal fMRI with EEG recorded that provide more detailed 
information about simultaneously electrographic and homodynamic changes in 
the seizure process, with encouraging results for epileptogenic area localisation 
and propagation patterns. 
Learning Objectives:
1.  To become familiar with the application and limitations of fMRI.
2.  To appreciate technical aspects and interpretation of fMRI for language locali-
sation and memory testing.
3.  To consolidate of advanced fMRI applications.
16:00 - 17:30 Room I/K 
Cardiac 
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Cardiac CT and MRI in difficult patients: what to do? 
A-512 16:00
Chairman’s introduction 
M. Hamilton; Bristol/UK (Mark.Hamilton@UHBristol.nhs.uk) 
What is a difficult patient? It is perhaps easier to state that an easy patient is a 70 kg 
middle-aged healthy adult. Why? Slim, can breath hold, calm, has a slow steady 
sinus rhythm with no sinus arrhythmia. Almost everyone else can be a problem. 
Anxiety, obesity, breathlessness, arrhythmia, small size, high heart rates can all 
cause problems and may require the examination to be modified accordingly. This 
session will assist you to get the best out of your patients and scanner. 
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1.  To become familiar with technical dose parameters in CT.
2.  To understand how to assess patient dose.
3.  To be informed about the role of diagnostic reference levels in CT.
A-517 16:30
B. New frontiers in CT: functional and spectral imaging 
N. Pelc; Stanford, CA/US (pelc@stanford.edu) 
Recent advances have generated renewed interest in dual energy CT and CT-
perfusion imaging. This presentation will discuss the basic principles, and the 
strengths and limitations of the techniques and implementations of multi-energy 
methods for material characterisation, and of CT methods for imaging tissue per-
fusion. Conventional CT measures the linear attenuation coefficient at one energy 
and cannot uniquely identify tissue. Multi-energy imaging measures attenuation 
at different energies to more fully characterise materials. An important limitation 
is that in the diagnostic energy range, the attenuation is dominated by only two 
interactions (Compton and photoelectric). While there can be residual ambiguity, 
spectral CT still provides important information. Measurements at two spectra 
can be achieved using multiple kVp and/or filtration or with detectors with energy 
discrimination. These various approaches to obtain energy dependent measure-
ments have different dose efficiency and different sensitivity to subject motion. The 
simplest method to process the multi-energy data reconstructs CT images from each 
spectrum and performs the multi-energy analysis on the reconstructed images. A 
somewhat preferred method performs energy dependent processing on the raw 
projections prior to reconstruction. Hybrid methods are now available. To measure 
perfusion with CT, images are acquired dynamically following the injection of a 
contrast agent and physiological models are used to convert the measured contrast 
agent concentration to perfusion estimates. Both dual energy and perfusion CT 
acquire multiple images, and so issues of radiation dose are relevant. Acquisition 
protocols can be optimised to mitigate these concerns.
Learning Objectives:
1.  To learn about new developments in functional and spectral CT imaging.
2.  To learn about impact on patient dose.
Author Disclosure:
N. Pelc: Advisory Board; Samplify, Inc. Board Member; RTR, Inc. Research/
Grant Support; GE Healthcare. Shareholder; GE. 
A-518 17:00
C. New image reconstruction techniques 
J. Sijbers; Antwerp/BE (jan.sijbers@ua.ac.be) 
The purpose of this presentation is to provide insight into novel reconstruction 
techniques in computed tomography and to discuss their impact on dose. Next 
to very fast, analytic reconstruction methods, iterative algebraic reconstruction 
methods are emerging, which are computationally much more demanding, but far 
more flexible and promising. These methods often exploit prior knowledge to either 
increase image quality or reduce dose. A short overview of standard and emerging 
techniques will be given. Compared to analytic reconstruction methods, iterative 
reconstruction algorithms have the potential to reduce patient dose. Moreover, 
these methods are suited for multiple acquisition geometries. Thanks to the avail-
ability of parallel processing hardware and efficient computational tools, iterative 
reconstruction methods are becoming increasingly popular. Future developments 
are promising for dose reduction as well as quality improvement of CT images. 
Learning Objectives:
1.  To understand the principles of iterative reconstruction techniques in CT.
2.  To learn about novel algorithms.
3.  To learn about the impact on patient dose.
A-515 16:51
C. Cardiac MRI: possible problems and how to avoid them 
E. Mershina; Moscow/RU (elena_mershina@mail.ru) 
Lack of movement artifacts is one of major prerequisites for getting good image 
quality in cardiac MR. Data acquisition should be synchronized with patient’s ECG 
or pulse. Special attention should be paid to good quality of ECG recordings and 
recognition of artifacts related to influence of permanent and alternating magnetic 
fields during examination. It is more difficult to perform cardiac MRI in patients 
with atrial fibrillation or frequent extrasystoli then in ones with sinus rhythm. In 
patients with arrhythmia prospective ECG synchronization should be used instead 
or retrospective one or special antiarrhythmic protocols may be designed. Breath-
ing artifacts usually are not a problem for cardiac MRI because most sequences 
are acquired during a single breath-hold. Using SSFP and parallel imaging allows 
to obtain a complete set of cine MR images through the whole heart in 1-8 short 
breath-hold periods. Possible way to perform successful examinations in difficult 
patients, especially the ones with heart failure, is a technique of real-time cardiac 
MR. To meet the challenges and the benefits of cardiac MRI one must balance 
the constraints of signal-to-noise ratio, contrast-to-noise ratio, spatial and tempo-
ral resolution, scan time and image quality. Radiologist performing cardiac MRI 
should be aware of specific flow artifacts which are more prominent in case of 3 T 
systems. They should not be misinterpreted as inracardiac masses or abnormal 
flow jets. Late-enhancement studies with Gd are very dependent on correct selec-
tion of TI time. Modern MR scanners allow getting good cardiac images even in 
very difficult cases.
Learning Objectives:
1.  To learn the importance of patient selection and preparation in achieving high 
quality scans.
2.  To understand the practical techniques available for performing a successful 
scan in difficult patients such as those with arrhythmia or poor breath-holding 
ability.
3.  To learn how imaging parameters can be changed for optimal results.
Panel discussion:  
When to scan and when not to? How can we make the best of what 
we have? 17:14 
16:00 - 17:30 Room L/M 
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A. Patient dose assessment in CT 
P.C. Shrimpton; Didcot/UK (paul.shrimpton@hpa.org.uk) 
CT remains a particular focus for efforts in radiological protection owing to its steadily 
increasing clinical application and the relatively high patient doses. Dosimetry is 
an essential element within good CT practice in order to allow the assessment of 
typical radiation risks in support of the justification of procedures, and the routine 
monitoring and comparison of typical doses in pursuit of the optimisation of patient 
protection. The practical basis for dosimetry in contemporary CT remains the 
(updated) CT dose index (CTDI100), measured in either free air or the standard 
CT dosimetry phantoms. These latter measurements underpin the dose indicators 
commonly displayed by the CT scanner: volume-weighted CT dose index (CTDIvol) 
and dose-length product (DLP). Whereas these quantities are not patient doses, 
they nevertheless provide useful characterisation of each CT exposure in order 
to allow comparison of practice and facilitate improvements in patient protection. 
Typical levels of CTDIvol and DLP at each CT centre, periodically determined as 
the mean values observed for representative samples for each patient group and 
type of examination (and associated clinical indication), should be adopted as local 
diagnostic reference levels (DRLs). These should be subject to periodic review 
and compared with both corresponding national DRLs and also practice at other 
CT centres in pursuit of optimised patient protection. When required, estimates of 
typical organ and effective doses to reference patients from standard CT examina-
tions can be made on the basis of appropriate dose coefficients normalised to the 
dose indicators (CTDIair, CTDIvol or DLP). 
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A-521 17:00
C. CT and MRI of the neck: how to address key clinical questions 
D. Farina; Brescia/IT (nappaje@yahoo.it) 
Accurate assessment of neck pathology requires a systematic approach which 
starts from the application of appropriate scanning strategies. MRI of the neck 
can be challenging, due to intrinsic difficulties posed by the anatomy of this region. 
Scans may be severely degraded by motion artefacts because neck immobility 
is simultaneously affected by breathing, swallowing, coughing. Magnetic field in-
homogeneities, particularly marked at the junction between supra- and infrahyoid 
neck may result in very poor fat suppression and gross anatomic distortion on 
DWI. Spatial and, even more, contrast resolution are somehow weakened by the 
distance between the neck coil and its target. All these drawbacks can be efficiently 
controlled selecting alternative coils, sequences, acquisition parameters if the 
operator is sufficiently flexible to tailor the protocol to the patient. CT is overall less 
demanding, however, appropriate management of acquisition phases (particularly 
plain and arterial phase) may optimise the information provided by the technique. 
Knowledge of the anatomy of the neck is pivotal to image interpretation: the 
space-based classification offers a shortcut to diagnosis because once the space 
of origin of the lesion is established, the list of differentials invariably narrows. The 
discrimination between solid, cystic or fatty content (relatively easy on both MRI 
and CT) offers further clues to the diagnosis. Furthermore, the identification of the 
space of origin of the lesion allows to predict its pattern of growth and its relation-
ships with vessels and nerves. All these information is what the clinician needs to 
know to plan further diagnostic steps and therapy. 
Learning Objectives:
1.  To understand key clinical questions.
2.  To learn how to do a structured reading of the CT and MRI scans of the head 
and neck.
3.  To become familiar with reporting in order to address the needs of the clinician.
16:00 - 17:30 Room P 
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A. Recent developments 
S. Rep; Ljubljana/SI (sebastijan.rep@guest.arnes.si) 
Positron emission tomography (PET) and single photon emission computed 
tomography (SPECT) systems are used to image accumulation and distribution 
of radiopharmaceuticals to provide physiological information for diagnostic and 
therapeutic purposes. However, these images often lack sufficient anatomical 
detail, a fact that has triggered the development of a new technology termed hybrid 
imaging. Hybrid imaging is a term to describe the combination of x-ray computed 
tomography (CT) systems and magnetic resonance imaging (MR) with nuclear 
medicine imaging devices (PET and SPECT systems) in order to provide the tech-
nology for acquiring images of anatomy and function in a registered format during 
a single imaging session with the patient positioned on a common imaging table. 
There are two primary advantages to this technology. First, the x-ray transmission 
images acquired with CT can be used to perform attenuation correction of the PET 
and SPECT emission data. In addition, the MR and CT anatomical images can be 
fused with the PET and SPECT functional images to provide precise anatomical 
localisation of radiopharmaceuticals. Technology and problems common to SPECT/
CT and PET/CT are respiratory motion, quantification, radiation dose considera-
tions, CT-based attenuation correction, contrast CT or metallic parts and motion 
between or during studies. Advances in SPECT and PET include the introduction 
of a new PET and SPECT scintillators and processing software. In general, the 
combination of PET or SPECT with CT or MRI may lead to new insights in research 
and novel clinical applications. 
Learning Objectives:
1.  To become familiar with the basic principles of hybrid imaging.
2.  To learn about the newest techniques in hybrid imaging.
3.  To understand the potential technical implications of the use of hybrid imaging.
16:00 - 17:30 Room N/O 
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A. Sinonasal CT scans: technique and evaluation 
H.B. Eggesbø; Oslo/NO (h.b.eggesbo@medisin.uio.no) 
Computed tomography (CT) is the primary modality in paranasal sinus imaging. 
In “screening sinus CT” radiation dose can be as low as 20 mAs. However, opti-
mal imaging of rhinosinusitis, fungal sinusitis, and tumour needs radiation dose 
> 50 mAs. Additional imaging techniques that are mandatory are: 1. axial volume 
uptake in order to keep dental filling artefacts to the axial plane. Coronal volume 
uptake cause dental filling artefacts into the maxillary sinuses and can obscure 
odontogenic cause to maxillary sinusitis. 2. Image reformation in several planes 
axial/coronal/sagittal/oblique is valuable to delineate pathology. 3. Bone algorithm 
is standard, but additional soft tissue algorithm can detect small calcifications in 
a fungus ball (mycetoma), high attenuation of pus-filled sinuses and inspissated 
mucus in allergic fungal sinusitis, and fatty tissue obliteration outside the sinuses 
in invasive fungal sinusitis. 4. Slice thickness should be no more than 3 mm, while 
0.625 mm is optimal for evaluating bone erosion or odontogenic cause to sinusitis. 
Approach to a systematical interpretation: 1. Development of the 4-paired sinuses. 
2. Pneumatisation variants that may interfere with mucociliary transport: concha 
bullosa, agger cells, infraorbital cells, and large ethmoid bulla. Sphenoethmoidal 
cells and anterior clinoid process pneumatisation may contain the optic nerve. 3. 
Anatomical variants: nasal septum deviation, accessory maxillary sinus ostium 
(often misinterpreted as surgical procedure), low ethmoid roof/deep olfactory 
fossa that can cause cranial perforation during surgery. 4. Last and important, to 
discriminate sporadic findings from conditions that need follow-up as inflammatory 
patterns of chronic rhinosinusitis, fungal sinusitis and tumours.
Learning Objectives:
1.  To learn how to perform a state-of-the-art CT examination of the sinuses.
2.  To understand how to evaluate and what to report on CT examinations of the 
sinuses.
A-520 16:30
B. Temporal bone: CT and MRI 
M.M. Lemmerling; Gent/BE 
CT examination of the temporal bone: temporal bone CT scans should be performed 
in a reproducable way. Axial reconstructions are made in the plane of the lateral 
semicircular canal, and coronal reconstructions exactly perpendicular to this plane. 
Thin-sliced images are postprocessed using high-resolution algorithms. MR exami-
nation of the temporal bone: the challenge is to perform a complete examination. 
The standard version of such an exam starts with axial T2-weighted images of the 
brain and posterior fossa, and axial T1- and heavily T2-weighted images covering 
the temporal bone. After intravenous injection of gadolinium axial and coronal T1-
weighted images are performed. Temporal bone report on CT and MRI. Structured 
reporting is the result of structured viewing. In the evaluation of the middle ear on 
CT examinations, it is best to follow the sound wave on the axial images (from 
tympanic membrane over malleus, incus and stapes to oval window) than inspect 
the fissula antefenestram region and the oval window. The inner ear is evaluated 
from cranially to caudally (semicircular canals, vestibule and vestibular aqueduct, 
cochlea and cochlear aqueduct). The facial canal, carotid canal and jugular fossa are 
finally evaluated. On the coronal images, one should at least inspect the intactness 
of tegmen tympani and the bony cover of the lateral semicircular canal. On MRI, 
after viewing the brain images, one best first tries to detect abnormal enhancing 
inner ear structures on the gadolinium-enhanced T1-weighted images, and than 
explains them using the heavily T2-weighted images.
Learning Objectives:
1.  To learn how to perform a state-of-the art CT and MRI examination of the 
temporal bone.
2.  To learn how to create a complete temporal bone report.
0
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A. Scoliosis: what the radiologist needs to know 
J.-F. Chateil, S. Missonnier; Bordeaux/FR 
(jean‑francois.chateil@chu‑bordeaux.fr) 
Disorders of the spinal posture are common in children and adolescents. Scoliosis 
may be primitive, structural, particularly during adolescence; during this period, 
careful follow-up is mandatory, because worsening is frequent. Scoliosis can also 
be secondary, and imaging is important to find a cause and adapt management. 
Among the aetiologies, radiologist must recognize spine malformations, dysplastic 
and neuromuscular scoliosis. In addition, scoliosis may also be secondary to a 
primitive lesion, tumour-related or not, whether the initial disease could be within 
the spinal canal, spinal or paravertebral. The initial clinical examination is essential, 
and must be completed first with AP and lateral full spine x-rays, if possible with a 
low dose device (flat panel, slot-scanning system), keeping in mind that follow-up 
with repetitive exposures may be necessary. Reproducible measures of different 
curvatures help to assess the overall static spine and the importance of scoliosis with 
Cobb angle. The assessment of axial rotation can be obtained through 3D simula-
tions. Morphologic evaluation of the spine is mandatory: if a secondary scoliosis 
is suspected, the research to aetiology needs to perform CT or MRI, depending 
on the clinical signs. Similarly, these explorations are useful in the preoperative 
assessment when surgical treatment is necessary. 
Learning Objectives:
1.  To learn about the aetiology of scoliosis.
2.  To become familiar with imaging findings, measurements and follow-up.
3.  To understand how to report imaging findings.
A-526 16:30
B. Benign bone tumours and pseudotumours in children: the pitfalls 
K.J. Johnson; Birmingham/UK (karl.johnson@bch.nhs.uk) 
While assessing any bone lesion in a child, the first consideration is in determin-
ing whether it is pathological or a normal variant. For those pathological lesions, 
it is then very important to determine those that are aggressive/malignant and 
those that are benign. This presentation will highlight those features that classify 
a bone tumour as being benign. In addition, the spectrum of imaging abnormalities 
which may mimic tumour (so-called pseudo-tumours) will also be discussed. The 
importance of good quality radiographs as the initial modality of choice will be il-
lustrated and reference to the need and value of other modalities as required in the 
diagnostic pathway will be covered. The presentation will emphasise the different 
radiological findings which would be expected depending on the age of the child. 
The importance of recognising post-traumatic changes and pathological fractures 
which occur as a consequence of an underlying bony lesion will be considered. 
The aim is to provide an illustrative review of an approach to a skeletal lesion, 
recognising normal variants, identifying typical benign lesions and understanding 
their relationship with trauma and infection.
Learning Objectives:
1.  To recognise the most common benign bone tumours and pseudotumours.
2.  To understand the differences between benign bone and pseudo tumours and 
malignancies in children.
3.  To understand imaging modalities that could help in the differential diagnosis 
of benign bone tumours and pseudo tumours in children.
A-527 17:00
C. Congenital bone dysplasias 
A.C. Offiah; Sheffield/UK (amaka.offiah@nhs.net) 
By the end of the session, delegates will understand the radiological investigations 
that should be performed when a dysplasia is suspected. The latest classifica-
tion system will be reviewed and the requirements of the radiology report will be 
highlighted. Delegates will be led through the process of interpreting the imaging, 
A-523 16:30
B. Clinical applications 
T. Lindner; Ternitz/AT (63629@fhwn.ac.at) 
Hybrid imaging is not anymore a specialty for research purposes only. It is more and 
more coming into clinical routine and in the last few years, multimodality devices 
have started replacing single modality imaging devices in the clinical workflow. The 
first part of the presentation will be a short overview of the devices and technologies 
used for hybrid imaging in human medicine. Starting from a short introduction of 
SPECT-CT, the main part will be the PET-CT and a little introduction to the topic of 
MR-PET. The main topics covered here are the main indications in clinical routine, 
like oncology (primary tumours and metastasis), metabolic disorders, cardiac 
pathologies, etc. The second part presented are the major benefits and drawbacks 
of hybrid-imaging devices. The topics covered are the overall costs, the logistics, 
the availability of the devices, a short overview of the radiation dose to which the 
patient is exposed in the different devices and the diagnostic outcome. In this part 
also, a comparison to single modality devices is given, including two single acquisi-
tions on two devices for retrospective hybrid imaging (Image Fusion). The last part 
presented are clinical case studies. Here, the major part is also a comparison of 
single modalities to hybrid imaging. In this part, the presented benefits and draw-
backs will be shown on examples of real clinical patients in the daily workflow. In 
the end, a conclusion is given and also a future outlook of methods coming into 
clinical routine in the next few years.
Learning Objectives:
1.  To become familiar with the major clinical applications of hybrid imaging.
2.  To understand its benefits and drawbacks compared with a single modality.
3.  To become familiar with some case studies.
A-524 17:00
C. Trends in radiography education 
P. Hogg; Manchester/UK (P.Hogg@salford.ac.uk) 
Educational challenges continue to be difficult to address and with an emphasis on 
hybrid imaging and radiographer/nuclear medicine technologist (NMR/T) roles, this 
presentation will explore some of these issues. Practice varies significantly between 
and within European countries. Legal and cultural challenges can be difficult to 
overcome and our ambition here should lie with enhancing the patient experience 
whilst maximizing physical and human resource. Legal restrictions in some countries 
do not allow NMTS to make x-ray exposures and clearly a change in law would be 
necessary to redress this. Roles need to - to reflect the nature of hybrid imaging. For 
instance, after SPECT acquisition, a decision may need to be taken to justify CT. 
Emphasizing the importance of patient experience, such decisions should be taken 
appropriately by suitably trained NMR/Ts / radiographers acting in an advanced 
capacity. Alongside, NMR/Ts making x-ray exposures, justifying CT imaging after 
SPECT would require people to think differently and accept change and how it 
may impact into their professional group. Extending from a focus on imaging, the 
hybrid department would need to centrally embrace the end user more than ever 
before. An example is illustrated for oncology, where the nuclear medicine and 
oncology teams would need to work more closely. This will require multi-professional 
working in which the NMR/T should play an important role in patient diagnosis and 
management. Returning to curriculum design, it is worth noting that the skills and 
knowledge required for effective team working will need instilling. 
Learning Objectives:
1.  To understand the impact on education.
2.  To learn how these new requirements can be met by changes in the curriculum 
of educational institutions in Europe.
3.  To understand what further changes in European laws, research infrastructure, 
and collaboration might be required to strengthen and protect the introduction 
of hybrid imaging in clinical practice.
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by use of examples of the most common conditions from several of the broad 
groups of dysplasias.
Learning Objectives:
1.  To understand the role of the radiologist in diagnosing congenital bone dys-
plasias.
2.  To understand how to classify bone dysplasias.
3.  To become familiar with reporting radiological studies related to bone dyspla-
sias.
Author Disclosure:
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A-531 08:35
Abdomen 
S.G.F. Robben; Maastricht/NL (s.robben@mumc.nl) 
The most efficient way to learn is to make many mistakes and to be corrected 
shortly thereafter. Preferably without serious damage to the patient. Eventually, 
the summation of these mistakes is called “experience”. The retention rate of this 
way of learning exceeds the retention rate of lectures (like this) many times. Until 
now, this method has only been incorporated in medical curricula in virtual environ-
ments (for obvious reasons). 
Learning Objectives:
1.  To become familiar with the most important differential diagnoses.
2.  To learn about imaging strategies for children.




B. Bernardi, T. Verdolotti; Rome/IT (bruno.bernardi@opbg.net) 
Three main categories of error are responsible for the majority of “missed” or 
misinterpreted observation on diagnostic radiology: system-related (latent or 
technical, error), radiologist-related (active error in recognition, interpretation and/
or judgment due to lack of knowledge in specific fields or to many other factors), or 
a combination of both. In this lecture are presented active errors leading to missed 
diagnosis, the most feared event for pediatric neuroradiologists but also a great 
opportunity for learning. Learning from errors requires a critical appraisal of our 
radiological practice and the implementation of a change aimed at improving our 
performance, also through multidisciplinary meeting, particularly useful in paedi-
atric neuroradiology In the first months of life, MRI evaluation of the brain requires 
specific knowledge about its normal development and optimised sequences for age 
and strength of the MR system; an insufficient satisfaction of such conditions may 
result in failing to detect a lesion, in incorrect interpretation of a normal structure 
as a pathological finding or vice versa. In other cases, the abnormal finding is 
recognised but its interpretation is incorrect. This is sometimes due to an incorrect 
transmission of the clinical history or to the report of an earlier examination that can 
be misleading. The increasing complexity of MRI of the CNS with ever increasing 
expectations, the rarity of some neurological diseases and the spread of diseases 
previously unusual in our Country, through migration and tourism, may be other 
sources of diagnostic errors. 
Learning Objectives:
1.  To understand the significance of MR findings in a developing brain.
2.  To learn how to avoid misinterpretations of easily detectable MR abnormalities.
3.  To become familiar with the differential diagnosis of uncommon diseases.
A-533 09:21
Musculoskeletal 
K. Rosendahl; Bergen/NO (karen.rosendahl@helse‑bergen.no) 
The role of skeletal imaging is to detect, and possibly quantify, any bone involve-
ment to secure a correct diagnosis, to search for complications to treatment and 
to guide further management. Growing bone is challenging, as bone structure, 
shape and size changes continuously until skeletal maturity. The numerous normal 
variants of growth which may mimic pathology have been accurately described 
radiographically, but little is known on the appearances on magnetic resonance 
imaging (MRI). Thus, radiography remains an important method with a high spe-
cificity for a number of diseases through “pattern recognition”. Its low sensitivity for 
cartilage, bone marrow and soft tissue involvement, however, has opened the way 
for additional techniques, such as ultrasound, MRI, computed tomography (CT) and 
nuclear imaging. Mistakes do occur along the whole chain of events involved in 
imaging; from choosing the most appropriate modality and image protocol, to image 
processing, analysis and communication of the results. During this lecture, we will 
focus on controversies regarding US screening programmes for developmental 
dysplasia of the hip, discuss some of the limitations of ultrasound in the assessment 
of soft tissue lesions, and of MRI in the assessment of juvenile idiopathic arthritis. 
Learning Objectives:
1.  To become familiar with the various controversies regarding US screening 
programmes for developmental dysplasia of the hip.
2.  To understand the value of ultrasonography in the study of the musculoskeletal 
system.
3.  To learn how and when to use MRI for investigations and differential diagnosis.
08:30 - 10:00 Room A 
Interactive Teaching Session 
E³ 1620 
Acute abdominal inflammatory disorders 
A-528 08:30
A. Colitis and enterocolitis 
D.J.M. Tolan; Leeds/UK (djmtolan@doctors.org.uk) 
The imaging related to colitis and enterocolitis relies on detection of thickening and 
abnormal enhancement or blood flow to the large or small bowel. The main imaging 
modalities in day to day use are ultrasound, CT and MRI. However, these augment 
endoscopic assessment which is the primary diagnostic evaluation of choice for 
biopsy and histological confirmation. Imaging allows non-invasive global assess-
ment of the bowel and a search for complications, particularly outside the lumen 
(such as perforation, abscess or fistula). The patient clinical status and disease 
distribution influence the likely differential diagnosis as much as the imaging signs. 
This includes the length of symptoms and immune status as much as the degree of 
wall thickening, pattern of enhancement and location of the abnormality. Particular 
imaging signs include pneumatosis, a variety of enhancement patterns and extra 
intestinal features such as ascites. Specific conditions that will be covered include 
inflammatory bowel disease (Crohn’s disease vs ulcerative colitis), the immune 
competent patient (gastroenteritis and pseudomembranous colitis) immunocom-
promised patient (neutropoenic enterocolitis and CMV colitis) as well as ischaemia.
Learning Objectives:
1.  To know how to choose the appropriate imaging modality.
2.  To become familiar with the patterns of distribution and appearance in imaging.
3.  To learn how to differentiate ischaemia from inflammation.
A-529 09:15
B. Liver and bile ducts 
C.D. Becker; Geneva/CH (Christoph.Becker@hcuge.ch) 
Obstruction of the extra- or intra-hepatic bile ducts may occur in stone disease and 
a variety of other benign or malignant pathologic conditions and may be complicated 
by acute cholangitis and pyogenic liver abscess. We review the role of the different 
radiologic techniques that are used in the context of obstructive jaundice and its 
complications and discuss the advantages and shortcomings of each modality with 
regard to the clinical situation and treatment.
Learning Objectives:
1.  To know the advantages of each imaging technique.
2.  To become familiar with the findings in infrequent infections.
3.  To learn how to study obstructive jaundice.
08:30 - 10:00 Room B 
Special Focus Session 
SF 16a 
My most beautiful mistakes in paediatric radiology 
A-530 08:30
Chairman’s introduction 
P. Tomà; Rome/IT (paolo.toma@opbg.net) 
The only way that we can avoid making the same mistakes again is to learn from 
them. The prevalence of errors in medical diagnosis has received increasing 
attention. Learning from mistakes is important to maintain and improve the qual-
ity of care and patient safety. The invited experts will focus on a single area of 
paediatric radiology. An expert is a person who has made all the mistakes that 
can be made in a very narrow field. The interpretation of imaging in children is 
challenging and requires knowledge of the normal appearance of the maturing 
anatomic structures that change with age. Special attention needs to be given to 
radiation protection in paediatric radiology: the speakers will examine all aspects. 
Session Objectives:
1.  To become familiar with growth and development of newborns to teens.
2.  To become familiar with the main pitfalls in paediatric radiology.
4
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C. GU complications in patients with spinal cord damage 
S. Agarwal; Wrexham/UK (sanaga28@hotmail.com) 
Spinal cord damage is a complex and devastating condition arising from trauma, 
tumours, ischaemia, infection and congenital causes. The management and 
follow-up of these patients pose several challenges unique to this particular 
group. Urinary tract complications are one of the commonest causes of morbidity 
and mortality in these patients, the incidence of which has significantly reduced in 
recent decades but remains as one of the important systems to follow-up and man-
age. Primary problem relates to bladder dysfunction (neurogenic bladder), which 
in turn causes upper urinary tract complications such as reflux, hydronephrosis, 
infection and stone formation, eventually leading to renal failure if left unmonitored 
and untreated. Pathophysiology of neurogenic bladder is complex and the clinical 
findings depend on the level and the extent of cord damage, however, some basic 
understanding is paramount for management of these patients. Ultrasound scan 
and plain radiographs have been the main modalities for regular follow-up of upper 
urinary tract in these patients. Imaging difficulties due to obesity, constipation, im-
mobility, deformities and prosthesis are common occurrence. The development of 
radionuclide, CT and MR imaging with continuous progress in the scanning and dose 
radiation techniques have enabled us to commonly use them during management 
of the complications. Routine use of these techniques for follow-up and monitoring 
can be limited by availability, logistics and radiation involved.
Learning Objectives:
1.  To understand the pathophysiology of urinary tract problems in patients with 
spinal cord damage.
2.  To become familiar with the urinary tract complications associated with this 
group of patients.
3.  To understand the role of different modalities and common problems during 
imaging.
A-537 09:30
D. Interactive case discussion 
S.K. Morcos; Sheffield/UK (morcsk2@aol.com) 
08:30 - 10:00 Room D1 
CLICK (Clinical Lessons for Imaging Core Knowledge): Never 
without Arteries 
CC 1618 
The fast and the furious: vascular trauma resulting 




A. Clinical considerations 
H. Hoppe; Berne/CH (hanno.hoppe@gmail.com) 
The majority of blunt thoracic aortic injuries (BTAI) results from deceleration trauma. 
Thereof, 70% are caused by motor vehicle crashes and 13% by motorcycle acci-
dents. Accordingly, the incidence of BTAI is high in fatal traffic injuries and increases 
with age. It is rare in the paediatric population. The most common site of BTAI is 
the medial aspect of the lumen distal to the origin of left subclavian artery where 
injury is found in about 93% of hospital admissions and in about 80% of autopsy 
studies. This is due to a high pressure combined with rotational forces exerting 
stress at the aortic isthmus. The most common type of injury is false aneurysm 
(58%), followed by dissection (25%) and intimal tear (20%). Most patients with BTAI 
die at the scene. For patients reaching the hospital, timely imaging is essential for 
definitive management since risk for rupture of contained aortic injury is highest 
within the first 24 hours. Regarding treatment of BTAI, there is a paradigm shift 
from open repair to endovascular repair. In selected patients with minor grade aortic 
injuries, nonoperative management has been applied. Modern treatment options 
have resulted in improvement of survival. 
Learning Objectives:
1.  To learn about the frequency and importance of arterial involvement in decel-
eration trauma.
2.  To know more about the differential diagnosis as well as the different localisa-
tions of arterial lesions.
3.  To learn about prognosis, treatment and outcome after arterial involvement.
Panel discussion:  
How have you changed or improved yourself after recognising your 
mistakes? 09:44 
08:30 - 10:00 Room C 
Urogenital Imaging 
CC 1621 




A. Imaging of renal trauma 
V. Logager; Copenhagen/DK (VILOE@heh.regionh.dk) 
Approximately, 10% of all trauma admissions have kidney injuries. According to 
the American Association of Surgeons in Trauma (AAST), blunt traumas can be 
graded in a 5-point Renal Injury Scale. (Moore EE, Shackford SR, Pacher HL et.al. 
Organ Injury Scaling: Spleen, Liver and Kidney. J. Trauma 1989;29:1664-1666). On 
the basis of the patient‘s clinical findings an imaging algorithm is set. In general, 
patients that are normotensive with microscopic haematuria have less than 0.2% 
risk of serious kidney damage and imaging is unnecessary, whereas patients with 
either: A) gross haematuria or B) microscopic haematuria and blood pressure less 
than 90 mmHg or occasionally C) microscopic haematuria and positive result of 
diagnostic peritoneal lavage will require imaging. Contrast-enhanced CT is the way 
to go. Imaging should be in 3 phases (cortico medullary, delayed 3-5 min and late 
phase (more than 10 min). Image reading should be a multiplanar approach. Most of 
the findings do not require surgical intervention, the rest does. On the basis of case 
presentations, findings will be analysed, discussed and correlated to the patient‘s 
clinical status and treatment possibilities, including where and which signs to look 
for. Which modality could be used to solve the diagnostic problem when the clinical 
picture does not fit with the radiological picture. Always expect the unexpected.
Learning Objectives:
1.  To learn how to recognise and describe the different types of traumatic renal 
injuries.
2.  To learn how to correlate these image findings with clinical severity.
3.  To understand treatment possibilities.
A-535 08:50
B. Postoperative anatomy and complications after GU interventions 
H.C. Thoeny; Berne/CH (harriet.thoeny@insel.ch) 
Radical prostatectomy, cystectomy with various forms of urinary diversion, and hys-
terectomy including pelvic lymph node dissection as well as (partial) nephrectomy 
are the most frequent surgical procedures performed in patients with urogenital 
malignancies. Familiarity with normal postoperative imaging features and potential 
complications are important to avoid misinterpretation to ensure appropriate post-
operative management. Although complications are relatively rare in experienced 
centers, it is important to be aware of early (< 1 month) and late (> 1 month after 
surgery) post-operative complications for the respective intervention including 
anastomotic leaks, fluid collections (urinoma, lymphocele, abscess, haematoma), 
alterations in bowel motility, vascular complications, fistulas, sepsis, wound infec-
tion, urinary infection, ureteral strictures, calculi, etc. in order to initiate appropri-
ate treatment. Furthermore, these patients have to undergo regular radiological 
follow-up to detect recurrence as early as possible. It is important to be aware of 
the typical location of recurrence and to know the appropriate imaging methods 
and techniques to make needed to make correct and timely diagnosis. In patients 
with bladder and renal cancer as well as gynaecological malignancies, CT is the 
method of choice to detect recurrence. In patients with prostate cancer suspicious 
for local recurrence, MR imaging is superior to CT, however CT is the method of 
choice when lymph node, organ or bone metastases are suspected.
Learning Objectives:
1.  To become familiar with expected imaging findings after (partial) nephrectomy, 
ileal bladder substitute and radical prostatectomy.
2.  To understand common complications after surgery.
3.  To learn where and how to detect tumour recurrence.
Postgraduate Educational Programme
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Learning Objectives:
1.  To learn about HIFU in breast tumours.
2.  To become familiar with the post-HIFU aspects of various types of imaging.
A-542 09:00
B. Pre- and post- imaging appearance of breast lesion excision 
system (BLES) lesions 
S.D. Allen; Sutton/UK (steven.allen@rmh.nhs.uk) 
The breast lesion excision system (BLES) has evolved as a breast radiological 
technology over the last decade and is now in widespread use in Europe and 
across the world. It was designed as a large biopsy device but more recently due 
to its unique capability to obtain a single large breast tissue specimen in only a few 
seconds by utilising a radiofrequency cutting and cauterising wave, it has increas-
ingly been explored in the therapeutic setting. It is easy to use under ultrasound or 
mammographic guidance with procedures taking a similar length of time to that of 
a vacuum biopsy, and with patient preparation and anaesthetic essentially identi-
cal. The technical aspects of performing these procedures will be detailed as well 
as its use specifically to perform excisional biopsies. This is limited by patient and 
lesional factors, all of which will be discussed in more detail. Following a BLES, 
the post procedure appearances need to be considered in order that follow-up 
imaging can be interpreted accurately. Risks and complications of this procedure 
are outlined as well as a discussion made of the latest papers in this field that may 
suggest future applications and developments.
Learning Objectives:
1.  To understand the mechanism of the BLES technique.
2.  To become familiar with the post-BLES aspects of various types of imaging.
A-543 09:30
C. Common features and pitfalls in imaging the treated breast 
J. Camps Herrero; Valencia/ES (juliacamps@ono.com) 
During the past years, it has been shown that there is not a single disease entity 
called “breast cancer”. There are different subtipes that entail diverse recurrence 
risks, this is is the first issue to take into account, and patients will be stratified 
accordingly before any follow-up is planned. Imaging findings in a patient treated 
for breast cancer will depend on the type of treatment: breast conserving therapy 
(BCT), mastectomy (and all the reconstructive techniques) radioteraphy and 
minimally invasive techniques. In order to differentiate between fat necrosis and 
other common post-treatment changes from relapse, it is important to know the 
timeline when all these changes take place and also schedule the follow-up imag-
ing procedures accordingly. Another important issue to take into account are the 
limitations and indications of the different modalities (mammography, ultrasound 
and MRI). Although ultrasound and mammography have traditionally been used 
in the follow-up of these patients, MRI is beeing used more and more often due 
to its superior multiplanar capabilities and the functional information not supplied 
by the other techniques.
Learning Objectives:
1.  To learn about the post-surgical and post-radiation therapies aspects of the 
breast and their timing.
2.  To learn about how to diagnose a recurrence in the treated breast and its 
differential diagnoses.
3.  To become familiar with the imaging findings of post-ablation (RFA) of breast.
Author Disclosure:
J. Camps Herrero: Advisory Board; Bayer. 
08:30 - 10:00 Room E1 
GI Tract 
RC 1601a 
Diagnosis and staging of esophageal cancer 
A-544 08:30
Chairman’s introduction 
Z. Tarján; Budapest/HU (ztarjan@gmail.com) 
Oesophageal cancer is more frequent in western countries. Squamous cell car-
cinoma occurs in the upper and middle third, adenocarcinoma is typical in the 
distal third and EG junction. The diagnosis is based on endoscopy with biopsy. 
A-539 09:00
B. Imaging techniques and typical findings 
H. Alkadhi; Zurich/CH 
Arterial injury may occur after blunt or penetrating trauma. The clinical outcome 
of patients with traumatic vascular injury depends on a rapid diagnosis and repair 
of injury. But despite recent advances in the prehospital care, CT technology 
and therapy, trauma to the arteries (and particularly to the aorta) continues to be 
associated with a considerable morbidity and mortality. Imaging of the arteries in 
the emergency setting remains a challenging imaging practice, requiring broad 
knowledge of the attending radiologist.
Learning Objectives:
1.  To learn about the importance of selecting the appropriate imaging technique 
to allow for the detection of arterial involvement in trauma patients.
2.  To become familiar with the typical image appearance of arterial involvement 
in trauma patients.
3.  To learn about the most important findings and diagnoses for treatment plan-
ning.
A-540 09:30
C. Interactive case discussion 
R. Morgan; London/UK (robert.morgan@stgeorges.nhs.uk) 
This session will discuss the main types of vascular trauma arising from motor 
vehicle accidents. The imaging strategies for the trauma patient will be presented. 
Main focus points of the session will include the diagnosis and management of 
aortic trauma by endografts, and the role of embolisation for the management of 
visceral orfan trauma. 
Learning Objectives:
1.  To become familiar with typical cases illustrating the role of appropriate imaging 
modalities in the assessment of patients after deceleration trauma.
2.  To consolidate knowledge of the selection of the appropriate imaging technique, 
image interpretation and image based treatment recommendation.
3.  To understand the most important information urgently needed for treatment 
decisions and planning.
Author Disclosure:
R. Morgan: Advisory Board; Angiodynamics. Consultant; Cook. 
08:30 - 10:00 Room D2 
Oncologic Imaging: Follow-up of Systemic and Local Therapies 
CC 1619 




A. MRI-guided HIFU therapies in the breast 
M. Sklair-Levy; Tel Aviv/IL (mirisklair@gmail.com) 
Magnetic resonance high-intensity focused ultrasound is an innovative, non-invasive 
tumour ablation technique. MRI and focused ultrasound are combined allowing real-
time anatomic guidance and temperature mapping during treatment. MRI-guided 
FUS treatment is performed under local anesthesia with analgesic and sedative 
agents to reduce pain, unnecessary motion, and claustrophobia. Imaging:T2-W 
images to define the tumour. T1-weighted with-contrast to verify efficacy after MRg-
FUS. MRI-guided FUS ablation of breast cancer to date, most protocols have been 
treat-and-resect protocols, FUS ablation followed by surgery. Results of studies is 
variable with histopathologic analysis demonstrating complete tumour necrosis in 
20% to 100% of patients treated. There are only a few FUS ablation studies where 
treated tumour tissue was left in situ after ablation, without a following surgery. All 
patients tolerated the MRI-guided FUS procedure well, and only minor complica-
tion, a skin burn, was reported. Several issues need to be further investigated for 
successful cancer treatment with MR-guided focused Ultrasound, including patient 
selection criteria, definition of treatment margins and optimal transducer technology. 
In summary, FUS ablation has the potential to become an important modality for 
non-invasive image-guided treatment of localised breast cancer. Multiple phase I 
studies have proven MRI-guided and US-guided FUS ablation of breast cancer to 
be technically feasible and safe. 
Postgraduate Educational Programme
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a good modality for predicting the efficacy of neoadjuvant chemotherapy/chemora-
diotherapy for advanced oesophageal cancer. The two most important prognostic 
indicators for OC are depth of tumour penetration and the number of malignant 
lymph node metastases. The 5-year survival rate for patients with tumours remain-
ing in the oesophageal wall and without nodal involvement is approximately 40%.
Learning Objectives:
1.  To learn about optimised EUS, MDCT and PET-CT techniques for esophageal 
cancer staging.
2.  To critically review those imaging findings impacting on patient management 
with regard to palliation, radiation therapy and surgery.
3.  To understand the potential of imaging prognostic markers.
A-547 09:21
C. Treatment response 
B. Mahon; Birmingham/UK 
The last decade has seen a change in the therapy of patients with oesophageal 
cancer. For many years, the standard therapy for locally advanced lesions has 
been surgical resection. However, overall survival for patients with locally advanced 
tumours after resection remains poor, with a five-year survival rate between 10% 
and 20%. Most patients still present with an advanced tumour stage; therefore, 
multimodal therapy regimens have been introduced, some using neo-adjuvant 
chemotherapy or chemo-radiotherapy followed by radical resection, whereas others 
use adjuvant protocol. Imaging therefore can potentially play an important role in 
assessing for tumour response. Being able to measure this response to treatment 
can determine subsequent treatment. Conventional staging tools such as CT are 
often undertaken to predict responses to neo-adjuvant therapy, however how 
useful is this? The higher resolution technique of endoscopic ultrasound is often 
undertaken as a primary staging tool, however can it provide any useful information 
after neo-adjuvant treatment? Positron emission tomography have shown promising 
results in the early selection of responders and non-responders during the course 
of neo-adjuvant therapy, allowing physicians to alter the treatment plan accordingly, 
however remains a relatively expensive investigation. This is explored together with 
practical examples of each modality along with potential pitfalls. 
Learning Objectives:
1.  To learn the normal post-surgical and post-radiation therapy imaging findings 
and criteria and to differentiate between these and local recurrence.
2.  To become familiar with anatomical and functional imaging criteria to assess 
treatment response.
3.  To learn the rationale for follow-up of patients after definitive or neo-adjuvant 
chemoradiotherapy.
Panel discussion:  
Cross-sectional techniques: developing an integrated imaging 
algorithm in oesophageal cancer 09:44 
08:30 - 10:00 Room E2 
Oncologic Imaging 
RC 1616 
Complications of cancer treatment and the 




One of the complications after curative treatment of cancer patients that affect 
patients’ prognosis is a local or distant recurrence. In the absence of a distant 
recurrence, the patient with a local recurrence still has a chance for cure if it is 
detected in an early curable state. Here is where imaging plays a crucial role. 
Treatment effects from surgery, chemo- or radiotherapy, however, provide a dif-
ficult ground for imaging evaluation. Late toxicity effects such as inflammation and 
fibrosis confound imaging appearances of a recurrence and expose the radiologists 
to a diagnostic dilemma. This session will address the different imaging findings of 
treatment sequelae in head and neck, liver, pancreas and rectal cancer patients 
and will give an understanding of how various imaging methods can differentiate 
between treatment-related effects and active tumour regrowth.
Author Disclosure:
M. Laniado: Consultant; Janssen Pharmaceutica N. V. 
However, barium studies are frequently used as a first line exam for patients with 
oesophageal complaints for assessing both morphology and motility. Only surgical 
resection including all associated nodes at a very early stage has been shown to 
improve survival rates. Dilatation and stent placement, endoscopic laser ablation 
and external-beam radiation therapy alone or together with chemotherapy are 
typically used as palliation to relieve dysphagia and decrease tumour burden. The 
main purpose of the staging is to select patients suitable for surgical resection or 
select early mucosal cancers suitable for endoscopic treatment. There is unique 
lymphatic anatomy of the oesophagus, as lymphatic vessels in the lamina propria 
make it possible to have lymph node metastases from superficial T1 tumours. The 
number of the positive nodes correlates with survival. There is often direct drain-
age of the submucosal lymphatic plexus into the thoracic duct facilitating systemic 
metastases. Tumours invading the pleura, peritoneum, pericardium and diaphragm 
are resectable, while aorta, carotid arteries, azygos vein, trachea, left main broncus 
and vertebral body invasion and distant metastatic disease precludes curative 
surgical resection. Involved celiac lymph nodes are considered distant metastases 
for squamous cell carcinoma, but N1 disease for esophageal adenocarcinoma. 
Size, viability, stage and resectability may change after therapy, therefore needs 
accurate assessment by radiology for further therapeutic decisions.
A-545 08:35
A. Diagnosis 
M. Krokidis; Cambridge/UK (mkrokidis@hotmail.com) 
Oesophageal cancer is the sixth leading cause of death from cancer worldwide. 
More than 90% of oesophageal cancers are either squamous-cell carcinomas or 
adenocarcinomas. Approximately, three quarters of all adenocarcinomas are found 
in the distal oesophagus, whereas squamous cell carcinomas are more evenly 
distributed between the middle and lower third. The cervical oesophagus is an 
uncommon site of disease. The pathogenesis of oesophageal cancer remains 
unclear. At the time of the diagnosis of oesophageal cancer, more than 50% of 
patients have either unresectable tumours or visible metastases on imaging. The 
most common symptom of presentation is dysphagia which is present in > 70% of 
the cases; odynophagia may also be present in a smaller percentage of patients. 
The patients are usually presented also with significant weight loss which appears 
to be also an important prognostic factor of the outcome of the disease. Diagnosis 
is based on the findings of a contrast swallow- which is usually the first exam to be 
performed; oesophageal cancer may present as polypoid, infiltrative, varicoid, or 
ulcerative lesions. Endoscopy usually confirms the findings of the swallow study, 
revealing the presence of a mass and offering the possibility of taking biopsy sam-
ples. Endoscopic ultrasound is the imaging method that is used for local staging 
and CT and PET-CT are used to determine the presence of metastatic disease. 
In case of presence of enlarged lymphnodes, fine needle aspiration or even open 
biopsy may be performed.
Learning Objectives:
1.  To become familiar with the pros and cons of each of the main diagnostic imag-
ing modalities available when assessing a patient with suspected esophageal 
cancer.
2.  To learn the basic imaging findings of esophageal cancer through each modality 
with emphasis on local disease.




V. Válek; Brno/CZ (vlvalek@med.muni.cz) 
Imaging technology including EUS, PET, MDCT and MRI is suggested for the 
staging of esophageal cancer. “T” characteristics are assessed with EUS, overall 
accuracy is 72% - 90%, the accuracy decreases after neoadjuvant therapy. MDCT 
can define the local extent of tumour. Aortic invasion is suggested when tumour 
contacts over 90% of the circumference of the vessel (accuracy 59% - 82%). MRI 
provides little advantage over CT, CT and MR cannot distinguish between T1 
and T2. EUS with fine-needle biopsy provides the best modality for assessing LN 
(sensitivity, 85%; specificity, 97. Accuracy for N staging showed no significant dif-
ference (66% for EUS, 68% for PET, and 63% for CT). Most common locations for 
metastatic “M” disease from oesophageal adenocarcinoma involve the liver, lung, 
and bone. For the evaluation of distant metastases, PET has a higher sensitivity 
than CT. An operable tumour has been defined as of radiological stage T1-3, N0 or 
1, M0, with a primary length of ²5 cm. In "T" staging, EUS could play an important 
role in the choice of candidates for endoscopic and surgical treatment. However, it 
remains unclear how to best select patients for a non-operative approach. PET is 
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post-treatment anatomy as well as the typical patterns of distribution both of post-
treatment and recurrent disease is essential. In the initial stage, an important role 
of imaging is to target areas for biopsy confirmation of locally recurrent disease. CT, 
MRI as well as PET/CT hybrid imaging with 18 F-fluorodeoxyglucose as a tracer all 
individually have their important role in the work-up. If anterior resection has been 
performed, endorectal ultrasonography is an additional option for evaluation of the 
anastomosis in these patients. For treatment planning of recurrent rectal cancer, 
diagnostic imaging is presented by the radiologist in a multidisciplinary conference 
to make sure that the information brought by the images is used to select the best 
possible treatment for the patient. In this presentation, the role of different imaging 
techniques for diagnosis of locally recurrent rectal cancer and challenges based on 
differentiation of recurrent disease from post treatment changes will be discussed.
Learning Objectives:
1.  To understand the role of CT, PET and MRI in the surveillance of patients after 
rectal cancer surgery.
2.  To become familiar with the imaging changes of the irradiated and resected 
tumour bed.
3.  To understand the diagnostic algorithm for early detection of a local recurrence 
in the treated tumour bed.
Panel discussion:  
How to differentiate between treatment sequelae and active disease  09:44 
08:30 - 10:00 Room F1 
Abdominal Viscera/GI Tract 
RC 1601b 
Abdominal MRI: standard and advanced protocols 




A. Fistula in ano 
A. Gupta; London/UK (arungupta1@nhs.net) 
MRI is a fundamental part of perianal fistula evaluation in any patient in whom 
surgical or biological therapy is being considered. This lecture will explain what 
role MRI plays in the management and how MRI should be performed optimally. 
Hardware requirements, the choice of sequences to use, interpretation of the MRI 
scan and the significance of the findings will be discussed. The future directions 
of MRI scanning will also be reviewed.
Learning Objectives:
1.  To learn optimised MRI state-of-the-art protocols to image patients with fistula 
in ano.
2.  To understand of the role of imaging in fistula classification and staging, im-
pact on therapeutic decision-making, assessment of activity and in treatment 
monitoring.
3.  To describe how to provide an optimal MRI fistula report.
A-553 09:00
B. Pelvic floor disease 
M. Bazot, L. Jarboui, I. Thomassin-Naggara, F. Haab, E. Darai; Paris/FR 
(marc.bazot@tnn.aphp.fr) 
Pelvic floor disease (PFD), including pelvic organ prolapse (POP), urinary inconti-
nence, defaecatory dysfunction, and pelvic floor relaxation is a common condition. 
Physical examination is the first step to determine the presence of PFD but has 
limitations. MR imaging performed in decubitus position after rectal opacification 
by sonographic gel is an excellent imaging modality for evaluation of PFD. Static 
MRI using sagittal, axial, and coronal T2-weighted MRI sequences provides de-
tailed informations of pelvic organs and pelvic floor anatomy. Dynamic MRI using 
rapid T2/T1 MRI sequences in midsagittal plane are performed at rest, squeezing, 
straining, and defecation, and must be repeated two or three times. Images are 
reviewed with cine for evaluation of anterior (cystocele), middle (uterine, vaginal, 
or apex prolapse), posterior (rectocele), and peritoneal prolapses (peritoneocele, 
enterocele, sigmoidocele). Competition between these different compartments is 
common. The use of reference lines (pubococcygeal, H and M lines) is helpful for 
image evaluation. MRI has excellent clinical correlation and can be associated with 
other modalities (ultrasonography, electrophysiologic examinations) depending 
A-549 08:35
A. Head and neck cancer 
L. Oleaga Zufiría; Barcelona/ES (lauraoleaga@gmail.com) 
Identification of recurrent tumour in the post-therapy setting is often challenging. It is 
essential to have a baseline study for monitoring changes and evaluating possible 
recurrences. After surgery, there is distortion of the anatomy, the fat planes are lost, 
functional lymphadenectomy may be associated with muscle resection, resection 
of the jugular vein or grafting, therefore, it is essential to know this data to properly 
analyze the images. The immediate postoperative baseline study after surgery 
should be performed between 4 and 6 weeks after surgery. When radiotherapy 
is performed, there is loss of fat planes, significant edema in the mucosa and in 
subcutaneous tissue. The recommended baseline study should be obtained at 3 
months after a completion of radiation therapy. The imaging methods used for the 
staging and follow-up of head and neck tumours varies between centres. CT is the 
most commonly used imaging technique, however, at some institutions MRI or PET 
are used to detect tumour recurrence after therapy, either surgery or chemo/radia-
tion. Distinction between post-treatment changes and recurrent or residual tumour 
might be difficult to assess on imaging. A soft tissue mass present in the baseline 
study that decreases in size, should be considered treatment-related changes. If the 
mass increases in size, it is suggestive of persistent or recurrent tumour. A new onset 
mass in the follow-up study should be considered as recurrence. Late complications 
due to chemo/radiation include soft-tissue necrosis, osteochondronecrosis, carotid 
atherosclerosis, myelopathy, nerve paralysis secondary to fibrosis and sarcomas.
Learning Objectives:
1.  To learn about the possible range of late toxicity effects after surgery and 
chemoradiotherapy of the neck.
2.  To become familiar with the imaging findings after surgery and chemoradio-
therapy.
3.  To understand which imaging method to use to differentiate between treatment 
sequelae and remaining tumour.
A-550 08:58
B. Liver and pancreatic cancer 
C. Catalano; Rome/IT (Carlo.Catalano@uniroma1.it) 
In the recent past, there have been significant improvements in the treatment of 
cancer, including liver and pancreatic tumours. Surgery provides excellent results 
in liver and pancreatic cancer, although early and late complications must always 
be taken into account. Percutaneous treatments have several advantages over 
surgery, above all the minimal invasiveness; nevertheless, there might be com-
plications, although less common as compared to surgery. In the assessment of 
early complications, namely abscess formation and bleeding, US and especially 
contrast enhanced CT provide the best results. All patients undergoing surgery or 
percutaneous treatments should undergo strict follow-up with imaging modalities. 
In both liver and pancreatic cancer, recurrency must be considered, especially if 
the tumour at the time of treatment is at an advanced stage; for this purpose, the 
radiologist should exactly know the type of procedure the patient was submitted 
in order to avoid misinterpretation determined by surgical material or granuloma-
tous components. In all cases, it is crucial, for the assessment of recurrencies, 
comparative studies that allow to detect even minimal modification. In this respect, 
functional studies play an important role: PET-CT already has a well defined role, 
while diffusion weighted and perfusion MR is gaining importance. In all cases, the 
combination of different imaging modalities and correct clinical information help in 
the diagnosis, allowing early detection of complications and recurrencies.
Learning Objectives:
1.  To become familiar with the imaging of complications following pancreatic 
surgery and liver chemotherapy and/or radiotherapy.
2.  To understand how these changes can conceal or mimic active disease.
3.  To learn how to distinguish post-treatment changes from residual or recurrent 
disease.
A-551 09:21
C. Rectal cancer 
L.C.O. Blomqvist; Stockholm/SE (lennart.k.blomqvist@ki.se) 
Treatment of rectal cancer is multi-modality based and continuously improved. De-
spite reduction of recurrence rates, local recurrence of still occurs in about 5-10 % 
of patients. Complications of rectal cancer treatment, such as anastomotic leakage 
occur in about 10 % of patients. Neoadjuvant treatment with chemo- and/or radio-
therapy also induces changes in the pelvic tissues that challenge the diagnosis of 
locally recurrent disease. To make correct diagnosis, knowledge about the normal 
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A. Postoperative spine 
L. van den Hauwe, J.W. Van Goethem, C. Venstermans, F. De Belder, 
P.M. Parizel; Antwerp/BE (lucvdhauwe@mac.com) 
The increase in the number of surgical spinal procedures is reflected by the 
increase in post-operative imaging studies (conventional x-rays, CT, and MRI). 
Imaging assessment of the spine after surgery is complex and depends on several 
factors, including the age and anatomy of the patient, indication for and type of 
surgery performed, biomaterials used, time elapsed since the surgical procedure, 
and - most importantly - the duration and the nature of the post-surgical syndrome. 
Adequate understanding of the various surgical techniques (both instrumented 
and non-instrumented), coupled with an appropriate awareness of the possible 
complications - acute and late - is vital when interpreting post-operative studies. 
Normal post-operative findings as well as imaging findings in acute complications 
(haematoma, spondylodiscitis) and the failed back surgery syndrome (recurrent 
disc herniation vs epidural fibrosis) will be discussed.
Learning Objectives:
1.  To become familiar with the appropriate imaging technique in the postoperative 
spine.
2.  To learn how to differentiate between normal and abnormal postoperative 
findings.
3.  To recognise the most common postoperative complications.
A-557 08:58
B. Indications for vertebroplasty 
A. Gangi, J. Garnon, G. Tsoumakidou, I. Enescu; Strasbourg/FR 
(gangi@rad6.u‑strasbg.fr) 
Percutaneous vertebroplasty is a therapeutic, image-guided procedure that involves 
injection of radio-opaque cement (methyl methacrylate) into a painful, collapsed 
vertebral body to consolidate it, in an effort to relieve pain and provide stability. 
Cementoplasty can be considered for five specific indications: 1. osteoporotic frac-
tures: vertebroplasty has become the standard of care for osteoporotic fractures; 2. 
painful bone tumours: osteolytic destruction of the vertebral body by metastases are 
a source of debilitating pain and disability; 3. aggressive vertebral hemangiomas: 
in patients with haemangiomas localised to the bone only, vertebroplasty for direct 
vascular embolisation with stabilization can be performed. However, haemangi-
omas, with epidural and/or paravertebral involvement, sclerotherapy (ethibloc or 
alcohol) is preformed first, followed two weeks later by vertebroplasty; 4. painful 
vertebral fractures associated with osteonecrosis (Kummel’s disease); 5. traumatic 
vertebral fractures in young patients associated to an augmentation technique 
(Stentoplasty). In combination with bone surgery and others: conditions in which 
anterior stabilization of the vertebral body is required prior to or after posterior 
surgical stabilization or epidural decompression. The absolute contraindications 
to the performance of vertebroplasty are uncorrectable coagulopathy, presence of 
vertebral osteomyelitis, discitis or infection of the overlying skin, systemic infection, 
and presence of free posterior wall fragment with or without retropulsion associated 
with spinal canal stenosis and/or neurological symptoms, asymptomatic vertebral 
compression fractures and prophylaxis for osteoporosis. Following spinal trauma, 
vertebral burst fractures with disco-ligamentous disruption require surgical stabiliza-
tion and are not indicated for vertebroplasty alone.
Learning Objectives:
1.  To consolidate knowledge of the actual indications for vertebral augmentation.
2.  To understand the contraindications and limitations.
3.  To become familiar with the algorithm of patient selection.
4.  To understand the best timing for vertebral augmentation.
A-558 09:21
C. Percutaneous treatment of spinal diseases 
M. Muto; Naples/IT (mutomar2@gmail.com) 
Spine pain is a very common problem in western country. It is very important to find 
a correct clinical and diagnostic approach to understand the source of the pain. 
X-ray, CT and MR can give a wide spectrum of finding helping clinicians to choose 
the best mini-invasive treatment. Beside vertebral body fractures, herniated disk, 
spinal canal stenosis and degenerative facet joint disease are the major cause 
of spine pain. Multiple percutaneous disk treatment are available and the choice 
of the device is made in relation of the type of herniated disk and clinical finding. 
The presence of cono-cauda syndrome, hyperalgic sciatica and progressive foot 
droop represent an urgent indication to surgery. Percuatneous disk treatment can 
be apply also to cervical disk disease. Radiofrequency facet joint ablation, perig-
on clinical setting. MRI is essential when choosing conservative versus surgical 
treatment (multicompartment POP, pelvic floor relaxation, incidental pathologic 
conditions).
Learning Objectives:
1.  To learn the clinical indications and the optimised dynamic MR imaging protocol 
for investigating pelvic floor disease in patients.
2.  To understand common and uncommon findings related to the posterior, 
middle and anterior compartments and how they impact on subsequent patient 
management.
3.  To understand how to introduce MRI into a pelvic floor therapy and how to 
best integrate with conventional techniques.
A-554 09:30
C. Suspected biliary tumour 
C. Matos; Brussels/BE (cmatos@ulb.ac.be) 
Magnetic Resonance (MR) imaging has been accepted as a major non-invasive 
diagnostic modality for investigating the bile ducts. MR imaging with MR cholan-
giopancreatography (MRCP) may be used as a replacement for diagnostic endo-
scopic retrograde cholangiopancreatography (ERCP) and has gained acceptance 
by gastroenterologists, surgeons and general practicionners because of its high 
success rate and because of the ability to project a virtual cholangiogram image 
display. Comprehensive MR imaging of biliary tumours should a) show the size 
and location of a primary lesion and assess the longitudinal and radial extent of 
bile duct involvement, b) enable the characterisation of biliary stenosis, c) show 
involvement of the hepatic artery and lobar branches and of portal vein and lobar 
branches for the purpose of surgical planning, d) depict the presence and extent 
of liver invasion and lobar atrophy and hypertrophy and e) enable the detection 
of regional lymph nodes and metastases. To achieve this, MR imaging should be 
performed at high field strength, using multichannel, phased-array coils, paral-
lel imaging technology and ideally before any biliary drainage procedure. This 
lecture will emphasize the importance of a comprehensive protocol that includes 
T2-weighted imaging and MRCP, gadolinium-enhanced T1-weighted imaging, and 
diffusion-weighted imaging. Imaging characteristics that may indicate a specific 
diagnosis of biliary tumour will be described.
Learning Objectives:
1.  To learn the basic MRI technique for patients with suspected biliary tumour.
2.  To understand advanced imaging protocols for both structural and functional 
imaging of the bile ducts, and when these are indicated.
3.  To understand the MR imaging findings which best differentiate benign from 
malignant disease, and how to produce an optimised report.
08:30 - 10:00 Room G/H 
Neuro 
RC 1611 
Spine: update on postoperative imaging and 
minimally invasive procedures 
A-555 08:30
Chairman’s introduction 
J. Van Goethem; Antwerp/BE (johan.vangoethem@ua.ac.be) 
Spinal surgery has evolved significantly over the past decades. From simple dis-
cectomies and laminectomies over herniectomies and posterior fusions we now 
have a plethora of open, classic surgical procedures, fusion procedures, artificial 
discs and posterior elements devices. More importantly minimally invasive proce-
dures, started with vertebroplasties but nowadays also including more complex 
procedures and even transcutaneous fusion surgery is available. Scientific studies 
that support the use of some of these procedures are still scarce and sometimes 
only anecdotal information is available. Imaging in these patients is sometimes 
complex and depends not only on the patients’ complaints but also on the type of 
procedure and time lapse since the intervention.
Author Disclosure:
J. Van Goethem: Consultant; Zimmer Spine. 
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A-561 08:58
B. PE in oncologic patients 
B. Ghaye; Brussels/BE (benoit.ghaye@uclouvain.be) 
Oncologic patients have a 4 to 6 times increased risk of venous thromboembolism 
(VTE) compared to the general population. The risk is further increased in patient 
undergoing new antitumoural treatments. VTE decreases the overall survival by 
three times in this population, making it important to be detected by the radiolo-
gists. Most of those VTE episodes are clinically suspected by the clinician and are 
incidentally found on follow-up oncologic thoracic CT. Unfortunately, radiologists 
fail to report 30 to 75% of pulmonary embolism (PE) in clinical routine. New CT 
software or technical refinements should help the radiologists to detect PE on 
oncologic thoracic CT. Radiologists have also to look for other types of pulmonary 
embolism in cancer patients, including tumoural and exogeneous materiel (i.e. 
cement, catheter, radioactive seeds) embolism.
Learning Objectives:
1.  To learn about the increased risk of venous thromboembolism.
2.  To understand the means of recognising peripheral PE, including CAD and 
new software tools.
3.  To learn how to deal with clinically unsuspected PE, both for reporting and 
treatment.
A-562 09:21
C. PE during pregnancy and puerperium 
M.-P. Revel; Paris/FR (marie‑pierre.revel@htd.aphp.fr) 
The risk of venous thromboembolism (VTE) is especially increased during the 
third trimester antepartum and the first 6 weeks post-partum. VTE remains the 
first cause of maternal death in developed countries. There is no validated clinical 
probability scoring system for VTE in
pregnancy and puerperium and a negative D-dimer test is insufficient to rule out 
VTE. Thus, all patients require further diagnostic tests, accounting for the low preva-
lence of VTE in most reported series. Fetal radiation dose is considered negligible 
with both ventilation perfusion (V/Q) scan and computed tomography pulmonary 
angiography (CTPA). The latter provides high maternal breast radiation dose, but 
allows alternative diagnosis, such as post-partum pneumomediastinum, a cause 
of chest pain after vaginal delivery. CT may also help detecting mild pulmonary 
oedema, in dyspneic patients developing peripartum cardiomyopathy. Compres-
sion ultrasound of the legs and magnetic resonance imaging are alternative tests 
avoiding radiation exposure, but require further investigation when negative. 
Compression ultrasound is the first-line test in women with symptomatic leg. In the 
remaining patients, V/Q scan is recommended if chest x-ray is normal, in patients 
free of pulmonary disease and is diagnostic in 80%  of cases. CT angiography is 
performed if chest x-ray is abnormal or V/Q scan is not diagnostic. CT parameters 
require adjustment to avoid excessive breast radiation exposure during CTPA. 
To optimise pulmonary arteries opacification, CTPA should not be performed at 
deep inspiration, to avoid increasing inferior vena caval flow and the return of non-
opacified blood to the right atrium. 
Learning Objectives:
1.  To learn more about the increased risk of venous thromboembolism.
2.  To appreciate the pros and cons of US, CT, MR and scintigraphy.
3.  To learn about specific diagnostic algorithms.
Panel discussion:  
Pulmonary embolism work-up in 2013 09:44 
08:30 - 10:00 Room L/M 
Special Focus Session 
SF 16c 
Making homogeneous the reading in HCC 
A-563 08:30
Chairman’s introduction 
C. Bartolozzi; Pisa/IT (carlo.bartolozzi@med.unipi.it) 
Management and prognosis of HCC patients is strongly dependent on early 
diagnosis, definition of tumour extension and on an efficient communication with 
referring clinicians. Thus, radiologists need to be aware of the implications of 
their own interpretation and reporting of imaging findings. International guidelines 
angliar and interarticular steroid injection can also be performed helping patients 
with spine pain to reduce drugs dependence. The position of interspinous spacer 
can be apply in patients with low back pain, degenerative disk disease and spinal 
canal stenosis associated also to spino-plasty giving a redistribution of axial load 
on the lumbar spine elements.
Learning Objectives:
1.  To understand the clinical indications for percutaneous treatment of spinal 
diseases.
2.  To know what diagnostic modality to suggest.
3.  To become familiar with the different percutaneous techniques available.
Panel discussion:  
Minimally invasive spinal procedures: the radiologist’s future role? 09:44 
08:30 - 10:00 Room I/K 
Chest 
RC 1604 




M. Rémy-Jardin; Lille/FR (martine.remy@chru‑lille.fr) 
Owing to substantial advances in CT technology during the past decade, the routine 
analysis of pulmonary arteries down to the subsegmental level is now possible and 
CT is considered the reference standard for the imaging diagnosis of pulmonary 
embolism. This imaging modality has also seen its impact extended to the prognostic 
approach of acute pulmonary embolism and is widely available throughout Europe. 
Despite high rates of awareness and adoption of management guidelines in the 
radiological community, radiologists have variable degrees of conformance with 
these recommendations, reflecting the variable degrees of conformance also seen 
among clinicians and the variable categories of patients in whom this diagnosis 
is suspected or incidentally recognised. Full implementation of guidelines has the 
potential to reduce the number of CT examinations, and thus to decrease not only 
radiation exposure and health care costs. The purpose of this refresher course is 
to emphasize the benefits and limitations of guidelines as actually implemented in 
routine clinical practice throughout Europe. 
A-560 08:35
A. Pioped 1-2-3: what have we learned so far? 
C. Engelke; Göttingen/DE (c.engelke@med.uni‑goettingen.de) 
The goal of this refresher course is to summarize the published data from the three 
large National Heart, Lung and Blood Institute-sponsored prospective multicenter 
studies on the diagnosis of acute pulmonary venous thromboembolism (VTE) - the 
„Prospective Investigations of Pulmonary Embolism Diagnosis“ (PIOPED I to III): 1. 
the „Prospective Investigation of Pulmonary Embolism Diagnosis“ (PIOPED I) study 
on the diagnostic accuracy of scintigraphy, 2.  the „Pulmonary Embolism Diagnosis 
(PIOPED) II trial on the diagnostic accuracy of multi-detector row pulmonary CT 
angiography (PCTA) and 3.  the „Prospective Investigation of Pulmonary Embolism 
Diagnosis III“ trial on the diagnostic accuracy of gadolinium-enhanced magnetic 
resonance angiography (Gd-MRA) as diagnostic tolls in patients with suspected 
acute VTE. While the results of the PIOPED I study supported the first-line use 
of V/Q lung scanning in the diagnostic evaluation of patients with suspected VTE 
before CTA could be developed to become a widely available reliable diagnostic 
tool the results of each study with its conceptual details are now set into current 
perspective and the evolution of PCTA to become the imaging reference standard in 
the diagnosis of acute VTE is outlined. Furthermore, the current status of Gd-MRA 
of pulmonary arteries and peripheral veins is outlined. The course
will discuss the recommendations of all PIOPED studies and open the discussion 
for current clinical applications of all three modalities in this patient group.
Learning Objectives:
1.  To appreciate the results of Pioped 1-2-3 in the light of technological refine-
ments in 2013.
2.  To become familiar with the pros and cons of CT versus MR.
3.  To understand the residual potential indications of scintigraphy.
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can offer additional features like hyperintensity in high b-value DWI images and 
T2w images or missing hepatobiliary uptake to help for the differential diagnosis. 
Other entities which can pose difficulties are small pseudolesions, which are usually 
depicted as hypervascular areas or small hemangioma. In cirrhotic liver, the most 
common cause for pseudolesions are small ap-shunts. Beside the late vascular 
images and hepato-biliary phase images, morphology and shape of this entity is 
often characteristic. Hepatic haemangioma is a rarely seen lesion in cirrhotic livers. 
A certain proportion of large HCCs also present with atypical vascular features. In 
these cases, image-guided biopsy is needed to establish the diagnosis.
Learning Objectives:
1.  To learn about common tricks and traps in interpreting atypical findings in HCC 
surveillance.
2.  To learn about the key elements for homogeneous reading and reporting in 
‘atypical’ HCC.
3.  To understand the key role that specific findings reported by radiologists have 
in determining patient management.
Author Disclosure:
C. J. Zech: Advisory Board; Bayer. Speaker; Bayer, Bracco, Siemens. 
A-566 09:11
How to evaluate tumour response to therapies 
J. Ricke; Magdeburg/DE (Jens.Ricke@med.ovgu.de) 
Assessing tumour response in HCC is extremely challenging. First, previous studies 
such as the SHARP trial have demonstrated that systemic treatment with targeted 
molecules such as Sorafenib (the only approved drug as of today) cannot be 
evaluated based on established morphologic size criteria such as RECIST or WHO 
alone. In SHARP and other studies, response criteria based on tumour size did not 
correlate with overall survival. Thus, response criteria adding tumour perfusion as a 
variable such as EASL or, not supported by appropriate evidence today, mRECIST 
need to be considered. In addition, all criteria at hand today have been developed 
for systemic approaches, in theory targeting all lesions simulatenously. In HCC, 
locoregional treatments are well accepted specifically in the intermediate tumour 
stages. These techniques are staged approaches that may often be repeated over 
time. Thus, tumour growth at a given time point may not necessarily correlate with 
prognosis since the lesion in question may not even have been targeted yet by 
the therapy. In this lecture, response criteria established for HCC will be reviewed 
and their appropriateness for clinical use or as study endpoints will be discussed.
Learning Objectives:
1.  To understand imaging findings after HCC locoregional and systemic treat-
ments.
2.  To learn about the current guidelines for defining HCC response to treatment.
3.  To learn about the key elements of homogeneous reading and reporting after 
HCC treatment.
A-567 09:29
Information technology: the practical impact on the management of 
HCC patients 
I. Bargellini; Pisa/IT (irenebargellini@hotmail.com) 
The need for more quantifiable and standardised data is advocated in oncologic 
imaging, for clinical practice and research purposes. The Liver Imaging Reporting 
and Data System (LI-RADS®), adopted by the ACR in March 2011, represents a 
step forward in the standardization of liver findings, in the attempt 1) to reduce vari-
ability in lesion interpretation and omissions of relevant information, 2) to improve 
communication with clinicians, patient management and outcome monitoring, and 
3) to enable performance auditing and quality assurance. With the adoption of 
standardised categories, liver CAD (computer-aided diagnosis) may become an 
intriguing reality. CAD enables automated cataloguing of lesions, each lesion be-
ing displayed with size, kinetics, ADC, and segmental localisation, thus facilitating 
comparison of serial exams. Cataloguing also provides a solid basis for potential 
research database. In later years, new software have been developed providing 
simple, automated workflows for routine oncology reading. These user-friendly 
platforms facilitate comparisons among different imaging modalities over time and 
provide auto-measurements for reproducible tumour response evaluation accord-
ing to different criteria (RECIST, WHO, tumour volume, SUV quantification). They 
enable to collect and share results in a structured manner, automatically storing 
measurements captured during reading and providing an overview of the findings 
for easy exporting or dictation. Management of HCC patients requires a continuous 
integration between imaging findings and clinical data. Development of specifically 
designed interactive database is required to gather all the clinical, radiological and 
have been developed to provide confident non-invasive diagnosis of HCC in the 
setting of liver cirrhosis, according to typical imaging findings. However, atypical 
enhancement patterns may be frequently encountered in HCC nodules, and 
their understanding, interpretation and reporting may be challenging, requir-
ing the need for adjunctive information, such as diffusion characteristics and 
hepatobiliary function of the nodules. On the other hand, strict and continuous 
follow-up is essential in HCC patients, and treatment outcome represents a strong 
prognostic indicator. However, understanding of tumour response to treatment 
requires knowledge of the different findings after percutaneous, transarterial and/
or systemic therapies. The development of specific cataloguing systems for focal 
liver lesions, the improvement and standardization of imaging criteria to assess 
tumour response to therapy and the creation of specific software and platforms 
for oncologic follow-up may facilitate the radiologist’s daily workflow, yet improving 
homogeneity and consistency in image interpretation. The session will provide 
an up-to-date overview of typical and atypical findings in liver imaging and di-
agnostic criteria to assess tumour response and will focus on the importance of 
standardization for efficient reporting and communication with referring clinicians. 
Session Objectives:
1.  To become familiar with common and uncommon findings in HCC and with 
updated guidelines in HCC diagnosis and follow-up.
2.  To understand how interpretation and reporting in HCC influence patient 
management.
3.  To learn about recent developments in computer-aided reporting.
A-564 08:35
HCC diagnosis: how to report ‘typical’ findings 
C. Ayuso; Barcelona/ES (cayuso@clinic.ub.es) 
Diagnosis of early stage HCC is a key point with prognostic and patient survival 
implications, thus it is crucial to have standardised reports for clinical and research 
purposes, being aware that specificity is the goal in the diagnosis of HCC. Any 
categorization as “possible” or “probable” HCC will require pathologic confirmation 
to avoid wrong treatment indications. Any new hepatic nodule ³ 1 cm detected by 
screening US, whether hypo or hyperechoic, in a population at risk of HCC is sus-
picious to be an HCC and deserves a cross-sectional dynamic study. CEUS can 
recognize the "wash-in wash-out" HCC profile, but it may overlap with the vascular 
profile of intrahepatic cholangiocarcinoma. Thus, AASLD recommends to examine 
these lesions under dynamic MR or MDCT to get a confident HCC diagnosis. Most 
of HCCs > 2 cm show arterial enhancement followed by wash-out in the portal/
delayed phase that makes possible to detect the lesion as hypointense/hypodense 
compared to the surrounding liver. The term "wash-out" would be desirable to be 
stated only when extracellular contrast medium is used for MR to avoid confusion 
in the application of non-invasive criteria when hepatobiliary contrast agents are 
used and lesions are hypointense on the delayed venous and/or hepatobiliary 
phases. Fatty metamorphosis and pseudocapsule have low sensitive without any 
additional diagnostic improvement over dynamic studies. DWI has shown high 
sensitivity but any strong data on specificity is yet available. Differentiation of very 
early distinctly and indistinctly nodular HCC types is by now not feasible by means 
of imaging techniques.
Learning Objectives:
1.  To learn about AASLD/EASL imaging criteria for non-invasive diagnosis of 
hepatocellular carcinoma.
2.  To understand the need for standardised interpretation and reporting in HCC 
surveillance.
3.  To learn the current terminology in HCC reporting.
A-565 08:53
How to interpret and report ‘atypical’ findings 
C.J. Zech; Basle/CH (CZech@uhbs.ch) 
In imaging, the depiction of arterial hypervascularisation and venous wash-out is 
the hallmarks of non-invasive HCC diagnosis. However, the findings in patients 
with liver cirrhosis or longstanding chronic hepatitis B or C often include unclear 
or atypical findings. The aim of imaging is to sensitively and specifically make the 
diagnosis of typical HCC nodules on the one hand, and provide the differential 
diagnosis of unclear and atypical cases on the other hand. Very often untypical 
nodular findings represent early forms of carcinogenesis - from uncomplicated 
regenerative nodules to early HCCs. The edge between benign and malignant 
is hard to determine - however, it seems that high-grade dysplastic nodules are 
usually regarded as pre-malignant lesions. On the other hand, it is known that also 
small overt HCC (< 2 cm) often also does not show typical vascular features. MRI 
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of the head and neck. In addition, the radiologist should be aware of ‚key‘ find-
ings with direct impact on treatment choice. This approach will be demonstrated 
using clinical examples from daily practice, focusing on oropharynx/oral cavity 
and larynx/hypopharynx. Since so many specialists are involved in care of these 
patients, structured radiological reporting is strongly recommended. Based on the 
imaging finding, it is (usually) possible to conclude the report with a ‚radiological‘ 
TN (M)-stage which serves as proposal towards the head and neck tumour board.
Learning Objectives:
1.  To learn how to make a choice between CT and MRI.
2.  To understand which imaging findings should be assessed to obtain a radio-
logical TN-stage.
3.  To become familiar with structured radiological reporting of head and neck 
tumours.
A-570 09:00
Detection of tumour recurrence in head and neck cancer: challenges 
and pitfalls 
M. Becker; Geneva/CH (minerva.becker@hcuge.ch) 
The purpose of this lecture is to provide a simplified, systematic approach on 
how to detect tumour recurrence on MRI, PET/CT and PET/MRI examinations of 
patients treated for head and neck squamous cell carcinoma. First, the radiologist 
will be familiarized with the relevant imaging findings of post-therapeutic expected 
tissue alterations with a special focus on their temporal relationship. Then a brief 
discussion of common complications affecting the soft tissues, vasculature and 
bony structures will follow. A systematic review will include key radiologic features of 
osteoradionecrosis, soft-tissue necrosis, neck fibrosis and scar tissue mimicking tu-
mour recurrence. Typical radiologic findings of tumour recurrence will be discussed 
with an emphasis on the early detection of lesions, their appearance on different 
imaging modalities and the added value of multimodality fusion or hybrid imaging 
techniques. The potential pitfalls of post-therapeutic image interpretation and how 
to avoid them will be equally addressed. Major emphasis will be put on what the 
clinician needs to know and on how to report the findings in a comprehensive way.
Learning Objectives:
1.  To appreciate the spectrum of expected tissue alterations after therapy and 
their temporal relationship.
2.  To understand the imaging aspects of common complications after therapy.
3.  To become familiar with key imaging features of tumour recurrence.
4.  To learn the potential pitfalls in post-therapeutic image interpretation and how 
to avoid them.
A-571 09:20
Locoregional treatment failure in head and neck cancer: causes and 
clinical implications 
R. Maroldi, P. Nicolai; Brescia/IT (maroldi@med.unibs.it) 
It is estimated that 50-60% of patients with locally advanced squamous cell carci-
noma (SCC) of the head and neck receiving a multimodal treatment will develop 
locoregional and/or distant relapse within 2 years. Therefore, surveillance and 
treatment planning in this cluster of patients is a demanding activity for a head 
and neck multidisciplinary team. Although there are some subtle differences in 
the pattern of recurrence in relation to the primary site and the type of treatment 
(surgical vs. non-surgical), relapse of the disease more frequently involves the 
primary site than the neck, although both sites can be affected at the same time. 
The reasons for treatment failure at the primary site in surgically treated patients 
can be the presence of inadequate surgical margins, perineural spread, or vascular 
embolisation. Regional failures can occur in a previously dissected neck or in an 
untreated field. There is general consensus in the literature that surgery is the 
treatment offering the best rescue chance in recurrent SCC of the head and neck. 
This possibility is higher in laryngeal cancer than in the oral cavity, oropharyngeal, 
and hypopharyngeal localisations. In early lesions of the larynx, conservative 
surgical techniques can be considered an oncologically sound alternative to total 
laryngectomy. Salvage surgery is instead feasible in 20%-40% of patients with 
recurrent SCC of the oral cavity, oropharynx, and hypopharynx. Irrespective of the 
primary treatment, patients require a compulsory follow-up which should combine 
clinical examination, including endoscopy with narrow-band imaging, and imaging 
techniques, with the intent to early diagnose recurrences.
Learning Objectives:
1.  To understand the most frequent causes of local and regional post-treatment 
relapses.
2.  To become familiar with the indications and options for salvage surgery and 
non-surgical procedures.
surgical data for each single patient, thus facilitating communication among clini-
cians, decision making and outcome analysis.
Learning Objectives:
1.  To understand the need for new systems to improve standardization of reading 
and reporting.
2.  To learn about now tools and software for managing oncologic patients.
3.  To understand the added value of computer technology in the management 
of HCC patients.
Panel discussion:  
Case-based discussion: a practical demonstration of how 
interpretation and reporting affect patient management 09:47 
08:30 - 10:00 Room N/O 
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V. Vandecaveye; Leuven/BE (vincent.vandecaveye@uz.kuleuven.ac.be) 
Organ sparing surgery and radiation treatment such as intensity modulated radio-
therapy (IMRT) - often combined with chemotherapy - have enhanced the need 
for advanced imaging in the head and neck in the pre- and post-treatment head 
and neck; including CT, (functional) MRI, PET/CT and PET/MRI. The radiologist 
plays an indispensable role as a consultant to the clinician for appropriate staging 
of the deep tumour extension in the pretreatment setting and characterisation and 
staging of indeterminate (sub)mucosal and nodal lesions in the post-treatment 
setting.The vast progression in anatomical, functional and hybrid diagnostic mo-
dalities raises many questions and potential problems for daily clinical practice: 
which imaging technique is most suitable, also taking into account cost-benefit? 
How should the report be structured in order to reach the demands of the clinician? 
Moreover, increasing knowledge is required from the radiologist regarding treatment, 
patterns of tumour spread and treatment failure and the appearance of tumour 
recurrence versus expected - and often treatment induced - tissue changes that 
may mimic tumoural recurrence. As such, key points to provide accurate and cost-
efficient oncologic imaging in the pre- and post-treatment head and neck include 
knowledge of the several treatment types and their indications and most frequent 
causes and patterns of treatment failure, knowledge of imaging features that dif-
ferentiate malignant from benign lesions, knowledge of proper implementation of 
imaging techniques according to the indication and the ability to deliver a compre-
hensible and structured report enabling both diagnosis and treatment planning. 
Session Objectives:
1.  To learn how to choose the optimal imaging modality for head and neck cancer 
staging and detection of tumour recurrence.
2.  To understand which elements are key to writing a structured radiological 
report in diagnosis and staging.
3.  To become familiar with the imaging features of tumour relapse versus com-
plications in the post-treatment neck.
4.  To understand the clinical role of imaging in post-treatment patient manage-
ment.
A-569 08:35
Building blocks for locoregional staging of head and neck tumours 
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl) 
In the head and neck, squamous cell carcinoma is by far the most prevalent histol-
ogy. As in any cancer, correct pretherapeutic TNM-staging is an important factor in 
treatment planning of head and neck neoplasms. This is a multidisciplinary effort. 
While the otolaryngologist uses endoscopy to evaluate the mucosal surface, it is 
the radiologist‘s role to describe the deep extent of lesions. CT or MRI has become 
essential for pre-therapeutic staging of these tumours. In this era of cost concern, 
it seems to be a good principle to do one cross-sectional study that accurately 
answers the clinical questions. The relative value of CT and MRI in this aspect 
will be discussed. The role of PET CT (MR) in primary staging is evolving. To be 
an effective consultant, the radiologist‘s report should contain information needed 
by the treating physician (surgeon and/or radiation oncologist). Therefore, it is 
helpful if the radiologist is aware of tumour spread patterns in the various subsites 
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C. Cardiac MRI in ischaemic heart disease 
J. Bremerich; Basle/CH (jbremerich@uhbs.ch) 
Cardiac MRI is a powerful tool for assessment and management of ischaemic 
heart disease. It provides a lot of relevant data and thus requires structured and 
standardised reporting. In ischaemic heart disease, cardiac MRI provides data on 
1. cardiac structure such as thrombus, aneurysm or pericardial effusion, 2. car-
diac function such as left and right ventricular ejection fraction, 3. flow in valvular 
dysfunction and 4. enables tissue characterisation to define presence and extent 
of infarction as well as to identify differential diagnoses, e.g. myocarditis or Takot-
subo cardiomyopathy. Standardised reporting should be categorised into cardiac 
structure, function, tissue characterisation (usually referred to as late gadolinium 
enhancement) and extracardiac findings. Tables with normal values for female 
and male patients are helpful. In many institutions, the report is signed by both, 
a radiologist and a cardiologist which underlines the shared responsibility and 
enhances acceptance from referring physicians. Cardiac MR is a powerful tool for 
assessment of ischaemic heart disease. Structured reporting including tables with 
normal values is helpful to present the enormous quantity of data in a clear fashion. 
Signatures from both, radiologist and cardiologist are helpful to demonstrate shared 
responsibility and complementary expertise.
Learning Objectives:
1.  To know when to do cardiac MRI in ischaemic heart disease.
2.  To become familiar with protocols of cardiac MRI and image processing.
3.  To learn about a structured reporting approach to cardiac MRI.
08:30 - 10:00 Room Q 
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The question that this refresher course is aimed to answer is the following: will 
novel IT tools really improve quality and efficiency in daily radiological practice? 
In fact, since the early installations of PACS, IT tools have been primarily consid-
ered as productivity tools rather than enabling technologies for fostering quality 
in medical care. The three distinguished lecturers in this course will address the 
following topics: improving quality and efficiency of computerised order entry 
through decision support, improving quality and efficiency of reporting by structure 
and templates, improving quality and efficiency of dose management through 
exchange between modalities and registries. They will cover all aspects of the 
radiological workflow: from the selection of the diagnostic procedure, to the opti-
mization of the acquisition parameters, to the efficient reporting of diagnostic and 
non-diagnostic data (such as radiation dose). They will demonstrate how newly 
adapted IT tools may provide assistance throughout the radiological workflow, with 
potentially enormous gains in terms of safety for the patient and quality assurance. 
Session Objectives:
1.  To highlight the need for IT tools to ensure quality control.
2.  To understand how to collect data concerning radiation dose.
3.  To learn about the integration of contrast media injectors into PACS.
A-576 08:35
A. Improving quality and efficiency of computerised order entry 
through decision support 
P. Mildenberger; Mainz/DE (peter.mildenberger@unimedizin‑mainz.de) 
Communication of orders is a logical and relevant extension to integrated infor-
mation systems in healthcare. The electronic communication of orders and the 
entry (OE) into RIS improves the workflows. But quality improvements require 
additional efforts to link order-entry-solutions with health knowledge for ordering 
the appropriate imaging procedure. These Clinical Decision Support (CDS) tools 
should be based on generally accepted and implemented criteria, e.g. evidence-
based medicine. It is known that the acceptance of such systems, if successful 
and efficient implementation are given, is very good. IT concepts for CDS are well 
known, standards for classifications are available, but semantic interoperability is 
still an developing area. Actually, clinical information systems provide different levels 
of integration of OE and CDS. Further developments could be an implementation 
3.  To understand the role of imaging in decision-making concerning local and 
regional recurrences.
Panel discussion:  
Advanced imaging in clinical practice: how does it help the patient? 09:50 
08:30 - 10:00 Room P 
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A. Chest x-ray in cardiac disease 
M.B. Rubens; London/UK (m.rubens@rbht.nhs.uk) 
The chest x-ray is a fundamental investigation in the management and follow-up of 
all patients with known or suspected heart disease. As in all areas of clinical practise, 
an organised approach to the patient is paramount and the following sequential 
approach is proposed: 1. Extra-cardiac analysis. This requires assessment of the 
quality of the radiograph, assessment of situs, scrutiny of the bones and soft tissues 
for features of previous interventions, syndromes and systemic diseases, inspec-
tion of the upper abdomen and assessment of the aortic and azygous arches. 2. 
Physiological analysis. This concerns analysis of the pulmonary vasculature. The 
possible vascular patterns are normal, increased (these are pulmonary venous 
hypertension, pulmonary arterial hypertension, plethora and systemic supply to the 
lungs), decreased and uneven. Each of these patterns has a precise physiological 
meaning. 3. Anatomic analysis. This concerns the cardiovascular silhouette. The 
CXR may suggest specific chamber enlargement; this should be interpreted in the 
context of the pulmonary vascular pattern. The shape and size of the aortic arch 
and central pulmonary arteries and any abnormal calcification may also be diag-
nostically useful. Finally, the cardio-thoracic ratio may provide important prognostic 
information, as may sequential changes in heart size. 
Learning Objectives:
1.  To be aware of the indications for performing a chest x-ray in patients with 
cardiac disease.
2.  To become familiar with the most important and relevant findings for the 
diagnosis of cardiac disease.
3.  To learn about a structured approach to reading chest x-ray in cardiac patients.
A-573 09:00
B. Coronary CTA 
F. Wolf; Vienna/AT (florian.wolf@meduniwien.ac.at) 
Cardiac CT is a relatively young discipline in the era of computed tomography espe-
cially due to the fast and still on going technical developments. Using standardised 
protocols performed by well-trained technicians and reported by well-trained and 
experienced radiologists, cardiac CT quickly can become a routine examination. 
Beside the coronaries cardiac function with wall motion, myocardial perfusion, 
valvular disease and pericardial pathologies can be imaged with cardiac CT. 
Depending on the indication, the optimal imaging protocol has to be chosen. A 
cardiac CT exam is planned with or without coronary calcium scoring. Retrospective 
ECG gating or prospective ECG triggering is selected to image the heart during 
the whole cardiac cycle or only in a predefined phase of the cardiac cycle. The 
contrast media protocol depends on the body weight of the patient as well as the 
imaging protocol and indication. Reading and reporting of cardiac CT exams should 
be done in a standardised way - this ensures not to miss any important pathology 
and facilitates the fast orientation of the clinicians within the report. Moreover, im-
portant non-cardiac findings should also be included in the report. This presentation 
will show in a step-by step approach how to perform a perfect cardiac CT exam 
tailored to the individual patient and how to read and report the important cardiac 
and non-cardiac findings in a standardised way. The presentation will be finished 
with some clinical cases and the respective reports.
Learning Objectives:
1.  To appreciate the scope of information needed by a referring physician from 
a coronary CTA examination.
2.  To become familiar with protocols of cardiac CT and image processing.
3.  To learn a structured approach to reading cardiac CT examinations.
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Introducing the EFSUMB: the world’s largest ultrasound society 
N. Gritzmann; Vienna/AT (norbert.gritzmann@gmail.com) 
The acronym EFSUMB is explained. The membership is presented. The committees 
and the educational portal are discussed. The individual benefit being an EFSUMB 
member is presented. The potential fields of collabration of the societies are ad-
dresssed. The European Course Book and the Euroson schools are presented. 
The guidelines regarding CEUS are addressed.
Learning Objectives:
1.  To learn about the work and responsibility of the different committees.
2.  To understand the membership basis and objectives of the EFSUMB.
3.  To learn about the benefits for ultrasound societies and individual members.
4.  To learn about the educational tools of the EFSUMB.
A-580 08:48
ESR/EFSUMB collaboration: a newly established platform for joint 
development of ultrasound in radiology and clinical specialties 
L.E. Derchi; Genoa/IT (derchi@unige.it) 
The European Society of Radiology has established a working group on ultrasound 
with the aim of promoting advances in ultrasonography within the radiological com-
munity. Liaising with other societies in this field is one of the goals of the working 
group: the first move in this direction has been to meet with the European Federation 
of Societies in Ultrasound in Medicine and Biology in order to know each others, 
to identify common problems and to work together. It has been decided to meet 
on an annual basis and to held joint sessions at meetings of the two societies. 
The title of this session: “Advances in diagnostic ultrasound: better results through 
cooperation” demonstrates that sharing experiences gained from different points of 
view is felt by both parties as the best way to enhance knowledge and to ameliorate 
our practices in order to offer the best service to our patients.
Learning Objectives:
1.  To learn about the goals of the ESR Working Group on Ultrasound.
2.  To understand the cooperative agreement between the ESR and EFSUMB.
3.  To learn about the initial results of the cooperation between the two societies.
A-581 09:06
Image fusion and intervention 
T. Lorentzen; Herlev/DK (tlo@dadlnet.dk) 
Image fusion can be carried out between all image modalities provided they are 
geometrically consistent. Fusion ultrasound (FUS) is the application of image fu-
sion, where dynamic ultrasound (US) images are presented simultaneously with 
corresponding images obtained from a previously acquired CT, CT/PET or MRI 
volume. The first step on a FUS procedure is to load a dataset (CT, CT/PET or MRI) 
into the US-system by means of an USB-memory stick, a CD-ROM, a hard drive, or 
via the network cable and a DICOM query/retrieve connection to PACS. A magnetic 
field is created around the patient by a magnetic transmitter and position sensors 
mounted on the US-transducer enable definition of the actual three-dimensional 
transducer position. Definition of three points defines a plane, by which alignment 
(registration) can be established between an US-image and the corresponding slice 
from the uploaded dataset of the previously acquired CT-exam. The US-exam is 
carried out as usual and images are shown in real-time (master) side-by-side and 
simultaneously with the corresponding dynamic virtual CT-image (slave). Small liver 
metastases for US-guided biopsy or US-guided ablation ablation might in some 
cases be difficult to find with conventional US, and in this situation FUS can often 
provide a helpful guide to the correct lesion area. Finally, in some cases, a biopsy 
might be avoided either due to agreement between a suspicious tumour finding on 
CT and subsequent fusion with contrast enhanced US that confirms the tumour or 
because the subsequent fusion provides a benign explanation to the CT finding.
of interoperability profiles and the representation of CDS knowledge in web-based 
services of non-commercial organisations.
Learning Objectives:
1.  To understand the relationship of decision support tools and evidence-based 
medicine.
2.  To learn how decision support tools can be implemented for requesting radio-
logical studies.
3.  To appreciate potential effects of decision support tools on workflow efficiency.
Author Disclosure:
P. Mildenberger: Founder; GeSITmbH. Speaker; Bracco. 
A-577 08:58
B. Improving quality and efficiency of reporting by structure and templates 
N. Dugar; Doncaster/UK (Neelam.Dugar@gmail.com) 
What does radiology report quality and structure/template mean from a patient’s 
and a clinical perspective will be discussed. How radiologists can use technology 
and informatics to optimise and to improve report quality and reporting efficiency. 
We are aware that electronic transfer of reports to the requester is hugely important 
for timely management of patients. Vendor neutral standards for transfer of radiol-
ogy reports in a multivendor environment will be discussed. Role of documents 
standards like CDA, pdf and also current messaging standards like HL7v2, to 
support transfer of reports between multi-vendor systems will be touched upon. 
Report templates both from electronic document standard perspective and clinical 
perspective will be discussed.
Learning Objectives:
1.  To learn about clinical requirements for structured reports.
2.  To become familiar with the IT requirements for report templates.
3.  To appreciate the potential to generate data for evidence-based radiology.
A-578 09:21
C. Improving quality and efficiency of dose management through 
exchange between modalities and registries 
E. Vaño; Madrid/ES (elivano@terra.es) 
The European directive on Medical Exposures requires the assessment and 
evaluation of patient doses, especially in procedures involving high doses to the 
patient. In the current draft of the new directive of Basic Safety Standards, some 
requirements on patient dosimetry in diagnostic and interventional radiology have 
been reinforced: x-ray systems should provide dosimetric information with the 
capability to be transferred to the examination report (for all CT and interventional 
systems). Diagnostic reference levels (DRLs) shall be reviewed regularly. These 
requirements will push the industry and the users to develop better strategies to 
evaluate patient doses, to transfer these values to the patient reports (contributing 
to the patient dose tracking system) but also to do available software to process 
these dosimetric data and to do some automatic analysis. This analysis should 
include: a) periodic calibration factors for patient dose quantities, b) automatic 
detection of high dose values (especially relevant for interventional procedures), c) 
statistical analysis to update DRLs and to do comparisons with the existing ones, 
and d) suggest corrective actions to fulfill the quality assurance programs and the 
clinical audit requirements. DICOM radiation dose structured reports are represent-
ing a significant advantage but more efforts will be necessary for the automatic 
process of the relevant data contained in the report, to verify that the radiological 
risk is acceptable and to suggest, if appropriate, corrective actions to improve the 
clinical practice. Without these last steps, patient dosimetry efforts and European 
regulations for radiation safety could only have a moderate impact.
Learning Objectives:
1.  To learn about current European regulation requirements and standards on 
patient dosimetry.
2.  To become familiar with the dose reporting evolution and dose structured 
reporting.
3.  To appreciate the potential for dose analysis and reporting as well as future 
registries.
Panel discussion:  
Will novel IT tools really improve quality and efficiency in daily 
radiological practice? 09:44 
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A. Axial skeleton 
E. Llopis; Valencia/ES (ellopis@hospital‑ribera.com) 
The purpose of this interactive course on axial skeleton is to overview spine 
emergency lesions in order to improve prognosis on acutely compromised cord. 
First, how to select the best protocol depending on clinical scenarios. Second, to 
analyse key signs for each anatomic location: intradural-intramedullary, intradural-
extramedullary and extramedullary lesions and third to become familiar with 
MRI specific findings for spinal infection, tumour cord compression, trauma and 
postsurgical complications. 
Learning Objectives:
1.  To understand the principal indications for emergency spinal imaging.
2.  To be able to analyse the pros and cons of each imaging modality in spinal 
trauma: how, why, when?
3.  To become familiar with key MRI findings in spinal infection, tumour cord 
compression and other non-traumatic spine disorders.
4.  To become familiar with the main emergency complications following spinal 
surgery.
A-585 11:15
B. Peripheral skeleton 
V.N. Cassar-Pullicino; Oswestry/UK (Victor.Pullicino@rjah.nhs.uk) 
In this interactive session focussing on peripheral musculoskeletal lesions pre-
senting to the Accident and Emergency Department, we will review the strengths 
and weaknesses of the imaging modalities applied to chosen bone, joint and soft 
tissue lesions. The imaging-based approach will strengthen the understanding of 
the different pathological entities which vary from trauma to infection in both the 
paediatric and adult age groups.
Learning Objectives:
1.  To learn when and how to use the different imaging modalities in acute skeletal 
lesions.
2.  To learn about the US and MRI findings in infection.
3.  To understand the value of MDCT in acute MSK lesions.
10:30 - 12:00 Room B 
Interactive Teaching Session 
E³ 1720a 
Pitfalls in pelvic imaging 
A-586 10:30
A. Pitfalls in MRI of the pelvis 
E. Sala; New York, NY/US (salae@mskcc.org) 
There are several MRI pitfalls that should be recognised when imaging the female 
and male pelvis. MRI appearances of uterus and ovaries are dependent on the 
phase of menstrual cycle/use of exogenous hormone therapy. Normal post-surgical 
and post-radiation appearances of the pelvis can sometime mimic tumour recur-
rence. It is important to become familiar with these appearances in order to avoid 
potential pitfalls. One very common pitfall is differentiation of transient myometrial 
contraction from adenomyosis. Interrogation of all imaging planes over the dura-
tion of the entire MRI examination can be useful to distinguish between the two, 
although myometrial contractions can last up to 45 min. Choice of correct imaging 
plane is crucial for precise classification of uterine anomalies (coronal oblique) and 
accurate evaluation of parametrial invasion (axial oblique) in patients with cervical 
cancer. Both dynamic contrast-enhanced MRI and diffusion weighted MRI improve 
the accuracy of MRI in evaluation of the malignant pelvic conditions. However, 
certain pitfalls related to each technique should be recognised in order to avoid 
misinterpretation. It is crucial to be familiar with the anatomy of the uterovesical 
(UV) ligament as it is often the site of pelvic lymphoma (such as bladder or cervix 
lymphoma). However, some benign conditions such as endometriosis can involve 
Learning Objectives:
1.  To understand the technical aspects of image fusion with ultrasound (US) and 
other imaging modalities (most frequently CT or MRI).
2.  To learn how to align two sets of data, obtained through different axial imaging 
techniques, with one another and perform live US scanning, where the fused 
image follows the live US.
3.  To understand how a lesion, even when invisible, can be targeted for US-
guided, using CT and MRI image fusion.
A-582 09:24
The EFSUMB non-liver CEUS guidelines 
F. Piscaglia, S. Marinelli, E. Terzi; Bologna/IT (fabio.piscaglia@unibo.it) 
Given the many new organs studied by CEUS, EFSUMB decided to publish in 
2012 the update of its clinical recommendations on CEUS separately for hepatic 
and non-hepatic applications. These are based on comprehensive literature sur-
veys and/or on expert committee reports and/or on the views of a panel of experts 
authors, providing a recommendation level (RL) for each indication based on the 
Levels of Evidence provided by the Centre for Evidence-Based Medicine, Oxford 
(UK). Worth to remind that most of daily routine non-hepatic applications continue 
to be off-label and patients should be informed and must consent to the investiga-
tion. In general, microbubble contrast agents are very safe with an extremely low 
incidence of side effects. Herein, the most important non-hepatic applications of 
CEUS from guidelines are listed. One very important issue is the use of CEUS in 
paediatrics. In this setting, CEUS has several advantages, a) lack of any radiation 
exposure, b) excellent safety, c) easy repeatability to monitor potentially evolving 
situations, d) user friendly approach, allowing parents to stand aside and in contact 
with their examinee children and e) no need for sedation or general anesthesia to 
obtain a relaxed lying patient. The main applications are the characterisation of 
pancreatic masses, distinguishing between solid and cystic, the assessment of local 
complications of Chron disease, the identification of renal parenchymal ischaemia 
or infarction, the assessment of blunt minor abdominal trauma to ascertain the ab-
sence of parenchyma injuries, the identification of endoleaks in treated abdominal 
aortic aneurysms and several others. 
Learning Objectives:
1.  To learn about new guidelines and clinical recommendations on the use of 
contrast enhanced ultrasound in non-liver applications, which were released 
by the EFSUMB in 2012.
2.  To learn about the process of producing the document.
3.  To learn, based on the evidence, which organs are suitable for CEUS in daily 
practice, and which are only suitable for research using CEUS.
Author Disclosure:
F. Piscaglia: Advisory Board; Bayer. Board Member; Bayer. Consultant; Bracco. 
Speaker; Bayer, Siemens.
A-583 09:42
The EFSUMB/WFUMB liver-CEUS guidelines 
M. Claudon; Vandoeuvre‑les‑Nancy/FR (m.claudon@chu‑nancy.fr) 
The present document describes the third iteration of recommendations for the 
use hepatic of contrast-enhanced ultrasound (CEUS) and contrast-specific imaging 
techniques which were introduced ten years ago in Europe and Canada. Time has 
moved on, and the need for worldwide guidelines on the use of contrast-enhanced 
ultrasound (CEUS) in the liver has become apparent. WFUMB (World Federation 
for Ultrasound in Medicine and Biology) and EFSUMB (European Federation of 
Societies for Ultrasound in Medicine and Biology) initiated further discussions in 
2010, in conjunction with the AFSUMB (Asian Federation of Societies for Ultrasound 
in Medicine and Biology), AIUM (American Institute of Ultrasound in Medicine), 
ASUM (Australasian Society for Ultrasound in Medicine), FLAUS (Federation 
of Latin American Societies for Ultrasound) and ICUS (International Contrast 
Ultrasound Society) to bring the 2008 liver guidelines up-to-date, recognizing the 
fact that contrast agents are now licensed in many parts of the world, including 
Australasia, Brazil, Canada, China, Europe, India, Japan and Korea. The content of 
these international liver guidelines includes general considerations on CEUS, char-
acterisation of focal liver lesions (FLL) in non-cirrhotic and cirrhotic liver, portal vein 
thrombosis, FLL biopsy guided by CEUS, detection of FLL by both transabdominal 
and intraoperative approaches, monitoring of abative tratement, liver transplanta-
tion, contrast quantification and monitoring of systemic treatment of malignancies.
Learning Objectives:
1.  To learn about the current practice of contrast enhanced ultrasound (CEUS) 
worldwide.
2.  To learn how the CEUS international guidelines were established.
3.  To learn about the main indications for CEUS in cases of liver disease.
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is an increasing disease in the elder population, primary hyperparathyreoidism is 
the most common systemic metabolic bone disease following osteoporosis with 
an incidence of 21-25 cases/100.000 population/year, and Paget`s disease has a 
prevalence of 10% in the population elder than 80 years. Therefore it is challenging 
for the radiologist to be familiar with these diseases.To understand the radiologic 
changes of metabolic bone diseases it is necessary to have knowledge about 
their pathophysiology and pathologic anatomy. In most cases of osteomalacia, 
hyperparathyreoidism, renal osteodystrophy and Paget`s disease the diagnosis 
can be made with conventional radiography and scintigraphic bone scan. The use 
of advanced radiologic techniques (CT,MRI,PET) is limited, because there are 
hitherto only few experiences and a lack of specific patterns, in contrast to x-rays 
with an overwhelming fundus of more or less specific findings. 
Learning Objectives:
1.  To understand the basic pathophysiology of metabolic and endocrine bone 
diseases.
2.  To become familiar with the most typical imaging findings of metabolic and 
endocrine diseases.
3.  To appreciate specific imaging patterns and to discuss the value of different 
imaging techniques.
16:00 - 17:30 Room C 
GI Tract 
RC 1901 
Cross-sectional imaging of colitis 
A-590 16:00
Chairman’s introduction 
S.A. Taylor; London/UK (csytaylor@yahoo.co.uk) 
Cross-sectional imaging is playing an increasing role in the diagnosis, staging 
and follow-up of colitis. Often the radiologist diagnoses colitis on cross-sectional 
imaging, and the clinician requires the most likely diagnosis. Alternatively, imaging 
is used to assess the severity of a known colitis and monitor treatment response. 
This session will describe state of the art protocols for assessing the inflamed colon 
using CT, MRI and USS. The common aetiologies of colitis will then be discussed 
and tips and tricks as to how to limit the differential diagnosis presented. Finally, the 
role of cross-sectional imaging in the management of inflammatory bowel disease 
(IBD) will be described with emphasis on disease activity. An integrated approach 
to imaging patients with colonic IBD will be presented.
A-591 16:05
A. What protocol to use? 
S. Schmidt; Lausanne/CH (sabine.schmidt@chuv.ch) 
The role of cross-sectional imaging in the diagnosis of colitis is increasing following 
recent technologic advances. Prior colonic cleansing is usually not required, unlike 
in CTC. However, careful attention to examination technique is essential, since 
collapsed colon may suggest colonic wall thickening, thus mimicking colitis. When 
using CT or MRI, adequate luminal distension is required, while this optional in US 
where direct compression of the bowel aids diagnosis. Recommended imaging 
protocols will be discussed. CT remains the work horse for imaging suspected colitis, 
especially in emergency settings. It is widely available and facilitates rapid data 
acquisition with excellent spatial resolution aiding image interpretation. Intravenous 
contrast-medium administration can reveal the typical target sign of colitis, which 
can easily be differentiated from other wall patterns, such as diffuse enhancement, 
seen in cancer. MRI does not expose patients to radiation and provides excellent 
tissue contrast facilitating the detailed analysis of the inflamed colonic wall. Both 
conventional and diffusion-weighted sequences provide functional non-invasive 
assessment of the severity of colitis and monitoring of treatment responses, es-
sential in Crohn patients. Colonic US is safe, well tolerated and, in general, freely 
available, although it requires specific operator expertise. It simultaneously provides 
morphological and functional information. Absent peristalsis and wall thickening 
in acute colitis usually reduce intraluminal air, thus facilitating colonic assessment 
compared to healthy subjects. Akin to CT and MRI, the three colonic wall layers 
are differentiated and pericolonic findings can be assessed. However, US can be 
limited by patient‘s body habit and the radiologist‘s practical experience. 
Learning Objectives:
1.  To become familiar with the role of colonic distension prior to imaging of 
suspected or known colitis.
2.  To understand typical CT, MRI and US protocols.
3.  To highlight the pros and cons of CT, MRI and US.
the UV-fold and invade both bladder and uterine wall. Certain MRI features can 
be helpful in making the correct diagnosis. 
Learning Objectives:
1.  To become familiar with normal variations in MRI appearances of female pelvis 
resulting from physiologic conditions (e.g. different phases of menstrual cycle) 
and treatments (including exogenous hormone therapy, surgery and radiation) 
potentially mimicking disease.
2.  To discuss the role of correct MR imaging plane in avoiding potential mis-
classification of uterine anomalies and parametrial invasion in patients with 
cervical cancer.
3.  To recognise certain pitfalls related to dynamic contrast-enhanced MRI and 
diffusion weighted MRI.
A-587 11:15
B. Pitfalls in pelvic ultrasound 
K. Kinkel; Chêne‑Bougeries/CH (karen.kinkel‑trugli@wanadoo.fr) 
Pitfalls of sonographic findings in the pelvis can be related to technical issues, 
interpretation errors or due to the patient’s specific condition or pathology. Com-
mon problems consist of insufficient bladder filling, misinterpretation of posterior 
enhancement or shadowing according to the anatomical structure and pathology 
of a size that goes beyond the field of view of the probe. Organ specific problems 
will be illustrated in interactive questions particularly for the uterus and the ovaries.
Learning Objectives:
1.  To become familiar with anatomical variants, potentially mimicking disease.
2.  To learn about common pitfalls in pelvic ultrasound.
12:30 - 13:30 Room N/O 
The Beauty of Basic Knowledge: Head and Neck 
MC 24E 
Temporal bone: so beautiful, yet so complicated 
A-588 12:30
Temporal bone: so beautiful, yet so complicated 
B. De Foer; Wilrijk‑Antwerp/BE (bert.defoer@gza.be) 
The complex temporal bone anatomy will be reviewed, as specifically visualized 
on the two most important imaging techniques for temporal bone imaging, CT and 
MRI. The use of adapted imaging techniques for various clinical conditions, indica-
tions and questions will be discussed and illustrated. The issue of CBCT versus 
MDCT in temporal bone imaging will be discussed and different MRI protocols 
adapted to various clinical conditions, indications and questions will be highlighted. 
The most important pathological issues in the external ear, middle ear and inner 
will be demonstrated including congenital, tumoural, infectious and inflammatory 
pathologies. In the middle ear, special attention will be paid to chronic middle ear 
infection, cholesteatoma and otodystrophies. In the inner ear, special attention will 
be paid to the broad scala of pathology of the vestibulocochlear nerve.
Learning Objectives:
1.  To become familiar with temporal bone anatomy.
2.  To learn how to choose and tailor imaging techniques according to clinical 
presentation.
3.  To appreciate the most common pathologies affecting the three main compart-
ments of the temporal bone.
12:30 - 13:30 Room P 






Systemic metabolic bone diseases in the narrower sense include osteoporosis, 
osteomalacia, hyperparathyreoidism and renal osteodystrophy. But also Paget`s 
disease is traditionally counted among the metabolic diseases, although it has 
inflammatory roots. In this course osteoporosis will not be discussed. Osteomalacia 
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16:00 - 17:30 Room D2 
Contrast Media 
RC 1906 





P. Leander; Malmö/SE (peter.leander@med.lu.se) 
There are different reasons for optimising contrast media (CM) use in computed 
tomography (CT). The first and maybe most obvious is to obtain a highly diagnos-
tic procedure and we are all familiar with terms as, e.g. arterial and portovenous 
phase. Different CM phases in CT is to high extent based upon an understanding 
of the pharmacokinetics of iodinated CM. As small water-soluble non-protein bound 
molecules these CM are distributed by the blood circulation and throughout the 
extracellular space. With modern CT-systems there are often more CM phases 
employed in protocols for gaining even more information, e.g. tumour vascularity, 
pancreatic parenchymal enhancement and mucosal delineation. In early CT, mostly 
of technical reasons, protocols seldom took advantage of using lower voltage than 
120 kV. As iodine is not ideal for the photon spectrum obtained from such high 
energy, nowadays lower kV is more often included in protocols. Another important 
reason for optimisation of CM use is the risk of CM-induced nephropathy (CIN) and 
how this could be balanced but still obtaining diagnostic information. By taking all 
above into consideration, the lecture will give an overview about the patient, CM, 
scanning factors and CM enhancement. The lecture will give few protocols, if any, 
ready to bring home, but instead understanding with “longer half-live” how CM 
protocols are setup on the basis of factors as CM distribution, iodine attenuation, 
risk of adverse events, and more. By this approach, one can become familiar and 
understand any CM protocol for CT.
Learning Objectives:
1.  To understand the pharmacokinetics of iodinated contrast media.
2.  To learn about patient, contrast medium and scanning factors associated with 
contrast enhancement and scan timing.
3.  To become familiar with protocols for optimised contrast enhancement.
A-595 16:30
B. MRI 
G.M. Bongartz; Basle/CH (gbongartz@uhbs.ch) 
Contrast media for Magnetic Resonance Imaging are mainly based on Gadolinium 
(Gd) or other metallic compounds like Iron (Fe) or Manganese (Mn). All of these 
do not actively alter the magnetic signal upon intravascular application but rather 
enhance relaxivity of neighbouring molecules. The impact of all contrast media 
for MRI on the signal intensity is strong and thus the overall amount of contrast 
media given is much less compared with iodinated contrast media. Gd is by far 
most frequent in clinical use. Due to its toxicity it must be fixed in stable chelates. 
Recently, Nephrogenic Systemic Fibrosis (NSF) as an unexpected side-effect of 
Gd-compounds in renally impaired patients has been detected and led to certain 
Gd-specific restrictions or contraindications for medical use. As a key consequence, 
restrictive use of Gd compounds in renally impaired patients is mandatory, which 
meanwhile let the disease more or less disappear. Special preparations of Gd 
compounds enable tissue-specific application (like hepatocyte-specific contrast). 
Following the injection of this contrast media, both documentation of the vascular 
perfusion as well as of cellular activity is possible. Similarly, Fe compounds may 
be applied to characterise the reticulo endothelial system. Mechanisms for contrast 
and examples for typical application will be given.
Learning Objectives:
1.  To understand the differences between iodinated contrast agents and gado-
linium chelates and their impact on contrast medium administration.
2.  To learn about injection and scanning protocols for optimised vascular and 
parenchymal enhancement.
3.  To review the influence of tissue-specific contrast media on the injection and 
scanning protocols.
Author Disclosure:
G. M. Bongartz: Research/Grant Support; Bayer Healthcare Switzerland. 
A-592 16:28
B. Differentiating between the causes of colitis 
B. Gallix; Montpellier/FR (b‑gallix@chu‑montpellier.fr) 
The final diagnosis of the type of colitis is based on clinical and laboratory data and 
colonoscopic and biopsy findings. However, information provided by endoscopy 
is limited to the mucosal surface. Cross-sectional imaging techniques, such as 
ultrasound, computed tomography, and magnetic resonance, are widely used to 
assess patients with non-specific abdominal pain and are gaining acceptance for 
the assessment of patients with suspected acute or chronic colitis. Cross-sectional 
studies are useful alternative tools not only in the assessment of bowel wall ab-
normalities, but also for the assessment of extraluminal alterations. Differentiating 
between the causes of colitis is based on the location of involvement, extent and 
appearance of colonic wall thickening, extraluminal changes, and type of com-
plications encountered. When chronic inflammatory colitis suspected, imaging 
help to distinguish ulcerative colitis from Crohn colitis. Infectious types of colitis 
share the features of wall thickening, pericolonic stranding, and various degrees 
of ascites according to the severity of the disease. Pseudomembranous colitis 
demonstrates marked wall thickening and, occasionally, skip areas but is associ-
ated with broad-spectrum antibiotic treatment or chemotherapy. Neutropenic colitis 
is characterised by right-sided colonic and ileal involvement, whereas ischaemic 
colitis is characterised by vascular distribution pattern and history. Diverticulitis is 
a focal asymmetric process with fascial thickening and inflamed diverticula. The 
diagnosis of ischaemic colitis is suspected when the distribution of the colon wall 
involvement follow the vascular. The ischaemic changes are commonly segmental 
especially on left colon in elderly patients.
Learning Objectives:
1.  To learn the most common cause of colitis through cross sectional imaging in 
both immune competent and immune compromised patients.
2.  To become familiar with differentiating infectious, inflammatory, ischaemic and 
autoimmune conditions based on cross sectional imaging criteria.
3.  To understand the limitations of cross sectional imaging in differentiating 
between its causes.
A-593 16:51
C. The role of cross-sectional imaging in colonic inflammatory bowel 
disease 
J. Rimola; Barcelona/ES (jrimola@clinic.ub.es) 
Endoscopy is currently considered the reference standard for the evaluation of co-
lonic disease activity in patients with inflammatory bowel disease (IBD). However, it 
only allows evaluation of the mucosal surface and is not always complete. It cannot, 
therefore, help to estimate the depth of involvement of transmural inflammation and 
extraluminal complications, both characteristics of IBD. An evolving role of cross-
sectional imaging for the evaluation of patients with IBD is increasingly recognised, 
especially in the setting of Crohn’s disease (CD) since the cross-sectional imaging 
has demonstrated to have a high diagnostic accuracy not only for assessing the 
presence and extension of luminal disease but also for evaluating the CD-related 
acute or chronic complications. Available evidence suggests that ultrasound, 
computed tomography and magnetic resonance have similar and high diagnostic 
accuracy for the detection of disease activity, location, severity, and complica-
tions, particularly for penetrating and stricturing lesions which are characteristic 
of CD. Thus, the choice of the technique for assessing CD may be influenced by 
local availability or expertise. In case of ulcerative colitis, cross-sectional imaging, 
although less evaluated, may also be helpful in certain circumstances. There is 
evidence indicating that cross-sectional imaging is a problem-solving tool as alter-
native to endoscopy whenever tissue sampling is not required, that can provide a 
valuable guidance for performing medical and surgical treatment with maximized 
efficacy and safety. Overall, findings from crosss-sectional imaging accurately 
reflect disease activity and provide reliable information for decision-making and 
patient care optimization. 
Learning Objectives:
1.  To learn the optimised examination protocols for ulcerative colitis and colonic 
Crohn’s disease in the acute, subacute and chronic disease setting.
2.  To describe criteria for the assessment of disease activity through CT, MRI 
and ultrasound.
3.  To outline an integrated approach to the use of cross sectional imaging in 
colonic inflammatory bowel disease.
Author Disclosure:
J. Rimola: Advisory Board; Genentech. Research/Grant Support; Abbott. 
Panel discussion:  
The role of cross-sectional imaging in the diagnosis and follow-up of 
colitis 17:14 
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Learning Objectives:
1.  To become familiar with the techniques used in standard MR.
2.  To learn about the strengths/weaknesses of standard MR along with diagnostic 
problems related to anatomical variation.
A-599 16:28
B. CT arthrography 
C.W.A. Pfirrmann; Zurich/CH 
With modern multidetector CT scanners, CT arthrography with multiplanar recon-
struction in high resolution is possible. CT arthrography is performed with intra-
articular injection of non-diluted iodinated contrast material. CT arthrography of 
virtually any joint from head to toe is possible. There are several indications and 
advantages for CT arthrography. Imaging time with CT arthrography is much faster 
than MR. This is especially advantageous for anxious patients. Also for patients with 
claustrophobia, CT is often a better option. CT arthrography has the advantage of 
high contrast between cartilage and contrast material. Therefore, CT arthrography 
may be superior in defining cartilage defects. In the postoperative patient, artefacts 
from metal may be present in or near the joint. With CT arthrography, these arte-
facts are often less pronounced, compared to MR imaging. Assessment of bony 
structures may be easier with CT arthrography compared to MR arthrography. 
Small osseous fragments, such as glenoid rim fractures may be difficult to see with 
MR arthrography, with CT these fragment or calcifications may be easily seen. CT 
arthrography is a valuable alternative in patients that have a contraindication for 
MR imaging. For example, the diagnosis of a meniscal tear is possible in the same 
way using CT arthrography as with MR imaging. In the shoulder, CT arthrography 
is well suitable for the assessment of labral lesions, cartilage damage and rotator 
cuff tendons using the same diagnostic criteria as with MR arthrography.
Learning Objectives:
1.  To become familiar with the techniques used in CT arthrography.
2.  To learn about the strengths/weaknesses of CT arthrography.
Author Disclosure:
C. W. A. Pfirrmann: Advisory Board; Advisory Board Orthopaedic Diagnostics, 
Siemens. 
A-600 16:51
C. MR arthrography 
J. Kramer; Linz/AT (kramer@ctmri.at) 
MR arthrography (MRA) is a relatively simple procedure, requires no anesthesia, 
and is essentially devoid of complications. With some experience, it is easy to per-
form and is a strong aid in patients when conventional MR exams dont provide the 
needed information for sufficient therapy. MRA, by virtue of its ability to demonstrate 
accurately intra-articular structures and especially pathologic alterations of these 
structures (e.g. labral lesions - shoulder, hip; partial articular-sided cuff tears), adds 
an important component to the radiologist’s armamentarium. Although not appropri-
ate for all patients, MRA plays an important role in the evaluation of patients with 
suspected intra-articular pathology who have equivocal clinical and conventional 
MR imaging findings. However, even nowadays, clinical use of MRA is limited due 
to several reasons: the conversion of a non-invasive procedure into an invasive, 
albeit minimally invasive, procedure; increased cost and time required to perform 
MRA compared with conventional MR imaging; and the need to obtain patient’s 
consent for performing a MRA exam since the use of intra-articular gadolinium 
compounds has not yet been approved generally. By the way, the experience to 
perform MRA’s has to be part of radiologoists training program.
Learning Objectives:
1.  To become familiar with the techniques used in MR arthrography.
2.  To learn about the strengths/weaknesses of MR arthrography.
Panel discussion:  
Which imaging technique for which clinical scenario? 17:14 
A-596 17:00
C. PET/CT 
X. Montet; Geneva/CH (xavier.montet@hcuge.ch) 
Optimisation of iodinated contrast media administration during PET-CT acquisi-
tion. When a CT scan of a combined PET/CT is performed as a full diagnostic CT, 
including iodinated contrast media administration, the diagnostic quality of the 
examinatioin is improved. Nevertheless, the possibility that contrast-enhanced CT 
used for attenuation correction may introduce errors in the standardised uptake 
value (SUV) will be discussed during this lecture. Different optimised contrast-
enhanced CT protocols will then be discussed.
Learning Objectives:
1.  To become familiar with the role of contrast-enhanced CT in PET/CT.
2.  To understand the influence of CT contrast-enhancement on attenuation cor-
rection of PET images.
3.  To learn about the importance of adequately timing the injection of CT and 
PET agents for optimal PET/CT.






A.H. Karantanas; Iraklion/GR (akarantanas@gmail.com) 
Intraarticular imaging is a difficult task because of the small size of the anatomic 
structures and the curved shape of the articular surfaces. Technological advances 
during the past two decades have improved our ability of imaging the joints. The 
most important of them include high-field MRI scanners and MDCT technology. 
Common joint disorders afflicting wide age groups include degeneration, inflamma-
tion and trauma. Early depiction of disease allows accurate treatment planning in 
trauma, early suppression of inflammation in rheumatologic disorders, and monitor-
ing of degeneration in osteoarthritis. Depiction of early signs of disease activity or 
recurrence improves the efficiency of newer treatments. The importance of updated 
imaging is highlighted by the fact that new surgical techniques are applied in the 
cartilage and meniscus. Modern imaging allows clear depiction of the involved joint 
structure: synovium, articular cartilage, labrum and subchondral bone. The high 
spatial and contrast resolution provided currently with MRI and CT highlights find-
ings which are clinically irrelevant. Radiologists should be familiar with the technical 
prerequisites for achieving a high-quality examination, as well as the pitfalls and 
variants that might simulate disease. Thorough knowledge of the above will allow 
the application of the proper imaging technique in each individual clinical scenario.
A-598 16:05
A. Standard MR techniques 
C. Faletti; Turin/IT (falettic@atlink.it) 
In the evaluation of the muscoloscheletric apparatus and in particular that of os-
teoarticular pathology, it is essential that the magnetic resonance examination be 
modulated on the basis of clinical requirements. That is the most suitable plane and 
sequence to evidence the underlying mechanisms/alterations at the source of the 
symptomatology has been chosen. Basically, the structures that are to be evidenced 
are represented by fibrous-connective tissue, cartilage, synovial tissue and bone 
and the modifications that may be caused on these by the varying pathologies must 
be taken into consideration. The morphology of the structure is best defined with 
the use of spin-echo sequences, in particular that of T1/PD-T2 weighted images. 
The sequences that exploit the suppression of fat, or fat-water separation, do seem 
to be the most suitable for a panoramic and comprehensive evaluation of the joint 
under study, as the various components may be observed in such a way so as to 
make a complete and satisfactory primary diagnostic codification on the underlying 
problem. Depending on the individual requirements, specific sequences may be 
added, such as those that give more detailed information/evaluation of cartilage 
damage, or a better view of flogistic synovial processes, with, for example, the 
enhancement of a paramagnetic contrast medium. Diagnostics may be hampered 
by the use of lower magnetic fields, such as permanent magnets. Also in this case, 
the solution is a modulation of the various characteristics of the different sequences 
and the intrinsic possibilities of the equipment available.
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111In-DTPA-octreotide has a substantial value in detection, diagnosis and staging 
of NET and more particular in gastroenteropancreatic NETs. Newer SSR-binding 
radiopharmaceuticals have been developed for PET, mainly with gallium-68 as ra-
diolabel, with higher affinity and more advantageous pharmacokinetics. When used 
with high-resolution and rapid-throughput multimodal whole body imaging of modern 
PET/CT cameras these tracers provide the current state of the art SSR imaging. 
We will also discuss the clinical value of metabolic tracers, such as [18F]-FDG for 
glucose metabolism imaging, [18F]-DOPA and [11C]-HTP ([11C]5-hydroxytryptophan) 
for amino acid metabolism imaging. The clinical merits and indications of these 
tracers will be explained. The continuously evolving quest to develop tracer for 
other receptor systems expressed on NETs will be illustrated, e.g. bombesin, VIP, 
CCK and glucagon-like peptide receptor ligands. Finally, the role of imaging as 
selection for metabolic and peptide receptor radionuclide therapy will be discussed.
Learning Objectives:
1.  To learn about the cellular properties of GEP-NET used in molecular imaging.
2.  To become familiar with the different modalities and new tracers being used.
3.  To learn about the performance of the different methods available.
A-604 16:51
C. Anatomical imaging: transabdominal US, endoscopic US, MDCT 
and MRI. What is the most appropriate imaging approach? 
V. Vilgrain, M.-P. Vullierme, P. Ruszniewski, A. Sauvanet; Clichy/FR 
(valerie.vilgrain@bjn.aphp.fr) 
Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are a heterogeneous 
group of neoplasms that arise from cells of the diffuse neuroendocrine system and 
may present with a wide spectrum of clinical presentations. Their prognosis is mainly 
related to their biology, proliferation and differentiation. The main goals of imaging 
are the diagnosis and the staging of these tumours. Diagnostic challenge is very 
different in functional tumours where clinical presentation and laboratory parameters 
are of utmost importance and in non-functional tumours where imaging may show 
characteristic features such as hypervascularization and calcifications. Staging is 
also essential as locoregional involvement and distant metastases (such as liver 
metastases) may change the therapeutic approach and are major prognostic fac-
tors. Multimodal work-up including morphological imaging modalities with CT, MR 
imaging, and endoscopic ultrasound being the most useful and functional imaging 
is needed. The latter includes somatostatin receptor scintigraphy, FDG PET and 
more recent functional tools such as PET using 68Ga and 18 F-DOPA. Imaging may 
also play a role in assessing prognosis in combination with tumour differentiation 
and tumour proliferation obtained from pathologic examination. Last, imaging is 
useful in evaluating tumour response after treatment. Although surgery remains 
the only potentially curative therapy for patients with primary GEP-NETs, other 
available treatments include chemotherapy, interferon, somatostatin analogues, 
and targeted therapies. Imaging criteria rely not only on changes in tumour size 
but also on internal tumour changes.
Learning Objectives:
1.  To learn how to recognise the specific imaging features of GEP-NET.
2.  To learn about the strengths and weaknesses of the different imaging modali-
ties.
3.  To understand the optimal use of the different imaging modalities in relation 
to tumour localisation and staging.
Panel discussion:  
The future of hybrid imaging 17:14 
16:00 - 17:30 Room F1 
Special Focus Session 
SF 19 
Tablet-computers in radiology: friend or foe? 
A-605 16:00
Chairman’s introduction 
E. Neri; Pisa/IT (emanuele.neri@med.unipi.it) 
Tablets in radiology represent a novelty. Since the introduction of the tablets in the 
market, the radiological field has been probably the first medical discipline to dis-
cover the many advantages of these devices. In fact, many applications for image 
management have been made available on the apps stores (Apple and Android), 
and let radiologists and non-radiologists to handle DICOM images on the Tablet, 
a part of the patient’s record. However, the emerging applications are driving the 
process from the simple DICOM image viewing to the full integration of the Tablet 
16:00 - 17:30 Room E2 
Oncologic Imaging 
RC 1916 
Gastro-entero-pancreatic neuro-endocrine tumours 
(GEP-NET): a multidisciplinary update 
A-601 16:00
Chairman’s introduction 
C. Matos; Brussels/BE (cmatos@ulb.ac.be) 
Since a large number of neuroendocrine cells may undergo malignant transforma-
tion, gastroenteropancreatic neuroendocrine tumours (GEP-NET) are a heterogene-
ous group of cancers that differ in their biology and clinical presentation. Diagnosis 
of these tumours has been improved by advances in pathology and classification, 
and by tumour imaging with the combined use of structural imaging techniques and 
functional imaging techniques. Multimodality imaging is increasingly recognised 
not only in detecting and staging disease but also in characterising biological 
patterns of lesions that may be relevant to the selection and delivery of therapy. 
In this refresher course, the complex nature of GEP-NET and the intrinsic uses 
and limitations of each diagnostic imaging modality will be underlined. Insights to 
hybrid structural and molecular imaging techniques will be provided and discussed.
A-602 16:05
A. Tumour biology, pathogenesis and classification 
B. Wiedenmann; Berlin/DE (bertram.wiedenmann@charite.de) 
Neuroendocrine tumour cells are characterised by the coexpression of neuronal 
and epithelial proteins and cellular organelles such as synaptic vesicles containing 
synaptophysin of neurons and intermediate filaments/cytokeratins of the epithelial 
cells. Based on presence of secretory vesicles and the continous, uncontrolled 
vesicular release of biogenic amines, neuropeptides and hormones, patients suffer 
in half of the cases of socalled functional symptoms and syndromes. Examples are 
the carcinoid syndrome (excessive release of serotonine) or the Zollinger-Ellison 
syndrome (excessive release of gastrin). Activation or inhibition of certain G-protein 
coupled receptors (e.g. somatostatin receptors) or channel proteins (R-type calcium 
channels) can lead to the control of the hypersecretion or socalled functionality 
of the affected patients. Medical interference with signal transduction pathways 
involving tyrosine kinase receptors as such mTor and channel proteins can lead 
to an inhibition of cellular and tumour growth. These observations have led to the 
establishment of new therapies, especially for pancreatic NETs using especially 
mTor and tyrosine kinase inhibitors. Whereas the tumourigenesis is unknown in the 
case of sporadic NETs, hereditary NETs appear to develop via a menin mutation 
through the intermediate stage of hyplasia before they develop the full metastatic 
potential. Based on the above given tumour biological and histopatholical find-
ings, a rather robust classification for NETs has been developed by the European 
Neuroendocrine Tumour Society (ENETS) using a TNM-classification together 
with a grading-system. Furthermore, the formerly used terms such as APUDOMa, 
Neurocrestoma, Carcinoid., etc have been largely replaced by the meanwhile 
generally accepted term neuroendocrine tumour.
Learning Objectives:
1.  To learn about basic aspects of GEP-NET biology, pathogenesis and clas-
sification.
2.  To understand the epidemiology and current treatment options.
3.  To become familiar with rational clinical management.
Author Disclosure:
B. Wiedenmann: Advisory Board; Novartis, Pfizer, IPSEN. Consultant; Lexicon 
Pharmaceuticals. Investigator; Novartis, IPSEN. Speaker; Novartis, Pfizer, 
IPSEN. 
A-603 16:28
B. The current role of nuclear medicine techniques 
C.M. Deroose; Leuven/BE (christophe.deroose@uzleuven.be) 
This presentation will focus on the pivotal role of nuclear medicine in the diagnosis 
and treatment of neuroendocrine tumours (NETs). The metabolic and molecular 
imaging capabilities of both positron emission tomography (PET) and single 
photon emission tomography (SPECT) have made a great impact in the clinical 
management patients with these tumours. One of the post-prominent posterchilds 
of molecular imaging in oncology is scintigraphy of the somatostatin receptor (SSR). 
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second solution can continue to function after disconnecting from the network. It is 
undeniable that portable devices will become a major component of our technical 
environment and will significantly change workflow and clinical practice. Current 
solutions may not be adequate yet for routine diagnostic tasks but they provide 
convenient mobile solutions for on-call and remote consultations. 
Learning Objectives:
1.  To understand the DICOM readers available for tablet-computers.
2.  To become familiar with the different approaches to DICOM reading (local vs 
remote) and the PACS/tablets integration.
3.  To appreciate the pros and cons of DICOM image-reading with tablet-com-
puters in regards to image quality and displays.
A-609 16:59
Mobile teleradiology with tablet-computers: a critical appraisal 
E.R. Ranschaert; ‚s‑Hertogenbosch/NL (ranschaert@telenet.be) 
Over the past few years several applications and viewers have been developed 
for smartphones and tablet computers with the purpose of using them for remote 
reviewing and interpretation of radiology images. With tablet computers such as 
the iPad, DICOM images can be viewed from any location within or outside the 
hospital. Other key clinical applications include reviewing images with patients at 
their bedside, teleconsulting with and distribution of images to colleagues. The 
usefulness and accuracy of mobile devices is however still limited by hard- and 
software. Their use for reviewing patient information also introduces new questions 
about issues, such as security, confidentiality, integrity, availability and account-
ability. These issues and potential solutions will be discussed in more detail during 
this presentation. 
Learning Objectives:
1.  To learn about mobile teleradiology within and outside the hospital.
2.  To become familiar with the potential risks of mobile teleradiology (data security, 
confidentiality, etc).
Panel discussion:  
Are we ready and confident enough to use tablet-computers in 
clinical practice? How and when? 17:17 







A. Physics and practical aspects of high-quality hand-held and 
automated breast US 
M.H. Fuchsjäger; Graz/AT (michael.fuchsjaeger@medunigraz.at) 
Ultrasound (US) is the adjunct method of choice to mammography in breast imaging. 
Over the past two decades, US technology has undergone profound advancements 
and refinements. US has therefore become an assessment tool with a defined field 
of indications as well as a unique set of diagnostic descriptors for breast lesion 
differentiation. The ACRIN 6666 study has demonstrated the special benefit of US 
in patients at risk with dense breast tissue. The BI-RADS lexicon for Ultrasound, 
in its second edition, expanded the role of breast US. Further enhancement of 
image quality as well as the recent advent of automated breast US has even 
fueled scientific discussions of a potential role of US for breast cancer screening. 
Automated breast US, which is based on computed generation of a 3D imaging 
data set obtained from many parallel 2D images, offers a different approach with 
a variety of benefits. Images are obtained by the sonographer in standardised 
fashion, whole breast data sets can be reviewed at any time after the examination, 
reducing operator dependence, and image fusion with, i.e. MRI is easily possible. 
The basic physical background, the significance as well as important aspects of 
practical use of hand-held and automated breast US will be explained and illustrated 
by respective imaging examples. Emphasis will be laid on strengths and potential 
weaknesses of both US technologies with regard to breast imaging.
Learning Objectives:
1.  To understand the physics of hand-held and whole breast US.
2.  To become familiar with the practical technique of hand-held and whole breast 
US.
3.  To appreciate the clinical applications of hand-held and whole breast US 
including automated screening.
with the PACS, allowing the handling of a full patient’s record and presumably the 
possibility to report. In view of this rapid technological development again radiology 
fall in the middle of storm and is asked to find solution to problem: are the Tablets 
suitable to read and report DICOM images? And which kind of images (CT, MRI, 
x-ray, etc).? How can we manage the portability of patient’s data (security issues, 
data loss, etc).? Which will be the impact on teleradiology? All these issues will 
be addressed by the panel of experts that will speak in the special focus session. 
Session Objectives:
1.  To give an overview of current tablet-computer technology and its practical 
use in radiology.
2.  To discuss the pros and cons of using tablet-computers.
3.  To analyse specific and critical areas of utilisation (DICOM images reading 
and teleradiology).
A-606 16:05
Tablet-computers: a technical overview 
J. Fernandez-Bayó; Sabadell/ES (jFernandezB@tauli.cat) 
Since their introduction in 2001, tablet PCs have evolved extensively. They have 
become very popular, filling the gap between laptop computers and smart mobile 
phones. We will review technical aspects like the processors, storage space and 
memory, size and weight, connectivity and networking, software, autonomy, and 
battery life in different devices. Special focus will be on the displays and different 
possible uses in radiology.
Learning Objectives:
1.  To learn about PC evolution: from desktops, to laptops and tablets.
2.  To appreciate the portability of a tablet-computer.
3.  To become familiar with the hardware features with a specific focus on displays 
and networks.
A-607 16:23
Radiological features of the tablet-computer 
P. Sacco1, L. Faggioni2; 1Siena/IT, 2Pisa/IT (lfaggioni@sirm.org) 
Tablet devices are more and more becoming a part of everyday life, with portability, 
versatility, connectivity, and user-friendliness being their main advantages. Hospital 
informatisation and filmless radiology have led to an efficient standardisation of 
digital images generated by the various imaging modalities, which has further 
catalysed the diffusion of mobile devices in health enterprises. The high screen 
resolution, high wireless connection speed and large processing power of current 
tablets allow displaying medical images with a sufficient quality for image review 
and analysis in clinical practice. Retrieving examinations from the PACS, accessing 
radiology information systems, reporting, taking notes and memos, and sending 
messages are only some of the many possible uses of tablets. Today radiologists 
can choose from a lot of apps and web services available on tablets, such as 
learning resources (e.g. textbooks, journal articles, atlases, databases, lessons 
and podcasts), tools for remote connectivity (e.g. file sharing, audio- and videocon-
ferencing, instant messaging), apps and tools designed to create presentations, 
process images, and review cases. For these reasons tablets can often provide a 
convenient, fast and versatile alternative to laptops. Examples of applications of 
tablets in radiology will be presented and discussed.
Learning Objectives:
1.  To appreciate the radiological features available on a tablet-computer.
2.  To become familiar with radiological atlases, databases, social networks.
3.  To learn how the tablet-computer can help at a congress and prepare presenta-
tions.
A-608 16:41
Reading DICOM images on the tablet 
O. Ratib; Geneva/CH (osman.ratib@hcuge.ch) 
The purpose is to review the different techniques allowing review and evaluation 
of DICOM images on hand-held tablets and mobile devices. Mobile devices such 
as smart phones and touchscreen tablets have taken the market by storm and are 
becoming major players in medical informatics providing convenient solution for 
physicians on the move. The resolution and processing power of these devices allow 
nowadays displaying medical images with sufficient resolution for image review and 
analysis in clinical practice. There are however different types of software solutions 
that can be implemented for such tasks. Two major different design are: (1) online 
web-based applications where the device serves as a “thin-client” to display images 
rendered and manipulated on a remote computer and (2) local applications that 
reside on the mobile device and can run independently after images have been 
downloaded on the device. The first solution requires the user to be constantly 
connected to the network to be able to display and manipulate images, while the 
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vasculopathies (atherosclerotic and hypertensive small vessel disease, CADASIL, 
Fabry’s disease, Susac’s syndrome), multiple sclerosis and variants, primary and 
systemic vasculitis, sarcoidosis, adult forms of leukoencephalopathies, trauma and 
radio chemotherapy, and acquired metabolic conditions (hepatic encephalopathy, 
alcoholism), among others. While it is recognised that a combination of findings 
from clinical history, physical examination, and laboratory tests is commonly 
required to correctly establish a firm and clear aetiological diagnosis of T2-HI, a 
detailed analysis of different MRI features should also be considered essential: e.g. 
lesions shape, size, and distribution; contrast-uptake; and associated structural 
lesions (microbleeds, infarcts, spinal cord, brainstem and cerebellar involvement, 
large-vessel disease). In addition to these conventional MRI-based features, non-
conventional MR techniques (diffusion, MR spectroscopy, and perfusion) may also 
provide in some cases useful diagnostic information. Knowledge of these features 
will assist the diagnostic work-up of patients presenting with T2-HI and should be 
considered a first step to take full advantage of the potential of MRI, and in doing 
so should result in a reduced chance of misdiagnoses and facilitate the correct 
diagnosis of sometimes treatable disorders. 
Learning Objectives:
1.  To learn about recognition patterns that might be helpful in suggesting the 
most likely etiology of brain multifocal T2 lesions.
2.  To understand the role of spinal cord imaging in the differential diagnosis.
3.  To appreciate a neuroradiologic diagnostic strategy for multiple white matter 
lesions of unknown origin.
Author Disclosure:
A. Rovira-Cañellas: Advisory Board; NeuroTEC, Bayer-Schering Pharma. 
Board Member; American Journal of Neuroradiology, Neuroradiology. Research/
Grant Support; Bayer-Schering Pharma. Speaker; Bayer-Schering Pharma, 
Sanofi-Aventis, Biogen Idec, Novartis. 
A-614 16:30
B. New developments in the diagnosis of multiple sclerosis 
F. Barkhof; Amsterdam/NL (f.barkhof@vumc.nl) 
Although the diagnosis of multiple sclerosis (MS) can be made on clinical grounds 
alone, MRI is frequently used to demonstrate dissemination in time (DIT) or 
space (DIS) in patients presenting with a clinically isolated syndrome (CIS) sug-
gestive of MS or to provide prognostic information early in the disease course. In 
the 2010 updated criteria, DIS can be demonstrated by the presence of one or 
more asymptomatic T2 lesions in minimally 2 of 4 crucial anatomical locations: 
juxtacortical, periventricular, infratentorial or in the spinal cord. Compared to the 
2005 revision of the McDonald criteria, a second reference MRI after 30 days is 
no longer required for demonstration of DIT; new T2 and/or gadolinium-enhancing 
lesions on follow-up MRI compared to the baseline scan, but irrespective of the 
timing of this baseline scan, are sufficient for DIT. In fact, simultaneous presence 
of asymptomatic gadolinium-enhancing and non-enhancing lesions at any time is 
sufficient for demonstration of DIT, even at presentation. MS can thus be diagnosed 
according to the 2010 revisions of the McDonald criteria based on a single scan 
in patients with a typical CIS.
Learning Objectives:
1.  To understand the 2010 revision of the McDonald criteria for MS.
2.  To become aware of MRI red-flags in the diagnostic process.
3.  To become familiar with new developments in pulse-sequences and field-
strength.
4.  To understand how to use spinal cord imaging in a diagnostic setting.
A-615 17:00
C. Imaging of MS treatment-related complications 
M.M. Thurnher; Vienna/AT (majda.thurnher@meduniwien.ac.at) 
The findings of recently published studies on MTR and diffusion in white matter in 
MS and other white matter diseases further strengthen the key position of magnetic 
resonance imaging (MRI) not only in diagnostic work-up of all forms of suspected 
demyelinating diseases, but also in post-treatment monitoring. Until 2005, progres-
sive multifocal leukoencephalopathy (PML) was exclusively reported in patients 
with AIDS or in immunosuppressed patients with malignant diseases. In 2004, 
the α-antegrin inhibitor Natalizumab (Tysabri®) was introduced for the treatment 
of relapsing-remitting MS. Soon after that, cases of PML have been described in 
multiple sclerosis (MS) patients treated with natalizumab. Current studies suggested 
that 1 in 1,000 persons would develop PML after approximately 18 months of treat-
ment. Furthermore, PML was also reported in a patient with Chron‘s disease treated 
with natalizumab. Immune reconstitution inflammatory syndrome (IRIS) has been 
also reported in natalizumab-associated PML. IRIS is a syndrome that emerges 
when the immune system recovers after an immune deficiency state. Typical for 
A-611 16:30
B. Complicated cysts and complex-cystic lesions: differentiation and 
management 
G. Rizzatto1, C.F. Weismann2; 1Gorizia/IT, 2Salzburg/AT 
(christian.weismann@inode.at) 
At ultrasound (US) cysts are categorized as simple, complicated or complex. 
A complicated cyst contains low-level internal echoes or intracystic debris that 
shifts with changes in patient position. In some cases, the content is thicker and 
simulates a hypoechoic solid mass. The term complicated only describes the US 
appearance and does not indicate that pus or blood is responsible for the internal 
echoes. Complicated cysts do not contain solid mural nodules. Only in some 
cases of inflammation, there may be a thickened wall, generally uniform. History 
and clinical examination may be very helpful. Color flow mapping (CFM) may add 
further information and elastography can solve the problem showing the typical 
aspect of fluid containing masses. A solid component places the cystic lesion into 
the category of complex breast cysts. Complex patterns include irregular thickened 
walls, intracystic masses, thickened septa and discrete solid component. Masses 
may be predominantly solid with only small cystic foci. Complex cystic masses 
have a substantial chance of malignancy, up to 30 percent. Again history may be 
useful as long as CFM. But there is a general agreement that aspiration and/or core 
biopsies are mandatory. Multiple samples must be acquired in different locations. 
If pathology report is discordant with US findings patients can be further evaluated 
with magnetic resonance or US follow-up. 
Learning Objectives:
1.  To learn about the US appearance of complicated cysts and complex-cystic 
lesions.
2.  To consolidate knowledge on differential diagnosis for these respective lesions.
3.  To understand the diagnostic algorithm for a work-up of these lesions.
A-612 17:00
C. The use of ultrasound in the evaluation of the nipple-areolar complex 
R. Salvador; Barcelona/ES (rafasalvador@telefonica.net) 
Nipple and areola can be well examined by any clinician. Ultrasonography can 
add new findings mostly related to the main ducts merging at the retroareolar 
region. A thorough description of the anatomical aspects of the region, and its 
pathologicaal benign and maalignant conditions will be described. Duct ectasia, 
infection, ductal papillomas, hyperplasia, and DCIS, as well as Paget disease of 
the nipple and some other skin pathologies can arise in this area of the breast. A 
description of the US techniques to review the region, including the use of Doppler 
US, Elastography, 3D ultrasound so called Automated Breast Ultrasound Scan 
(ABVS) and other techniques that have been used not only to diagnose, but to 
treat some diseases. US ductography and pecutaneous sampling or excision of 
papillomas will also be done. 
Learning Objectives:
1.  To understand the normal anatomy of the nipple-areolar complex.
2.  To become familiar with conditions commonly affecting the nipple-areolar 
complex.
3.  To appreciate the value of US for diagnosis and management of these condi-
tions.
Author Disclosure:
R. Salvador: Advisory Board; Member of the Medical Advsory Board of Philips 
Healthcare. 
16:00 - 17:30 Room G/H 
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A. Differential diagnosis of multiple T2-HI white matter lesions 
A. Rovira-Cañellas; Barcelona/ES (alex.rovira@idi‑cat.org) 
Focal white matter T2 hyperintense lesions (T2-HI) are commonly observed MRI 
abnormalities not only in the elderly, but also in middle age and young patients. In 
addition to physiological ageing brain changes, a large list of different disorders 
should be considered in patients presenting with T2-HI such as hypoxic-ischaemic 
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congenital bronchial abnormality. In cystic fibrosis, bronchiectasis is one of the 
key features of lung involvement. Bronchiectasis can present with a variety of 
non-specific clinical symptoms, including hemoptysis, cough, and hypoxia. Bron-
chiectasis is defined as localised or diffuse irreversible dilatation of the cartilage-
containing airways or bronchi. The imaging gold standard for bronchiectasis is 
thin-section CT. Morphologic criteria on thin-section CT scans include bronchial 
dilatation with respect to the accompanying pulmonary artery (signet ring sign), 
lack of tapering of bronchi, and identification of bronchi within 1 cm of the pleural 
surface. Bronchiectasis may be classified as cylindric, varicose, or cystic, depending 
on the appearance of the affected bronchi. It is often accompanied by bronchial 
wall thickening, mucoid impaction, and small-airways abnormalities. Besides CT, 
nowadays MRI of the lung is able to image the relevant morphological features of 
bronchiectasis. In addition, functional changes due to bronchiectasis can be studied. 
Learning Objectives:
1.  To learn more about the imaging findings in bronchiectasis, especially at MRI.
2.  To appreciate the role of imaging in primary diagnosis, surveillance and therapy 
monitoring.
3.  To become familiar with the role of imaging in surgical planning.
16:00 - 17:30 Room N/O 
Head and Neck 
RC 1908 
Temporal bone: imaging the most common 




A. Conductive hearing loss: what’s behind it? 
A. Trojanowska; Lublin/PL (agnieszka30@yahoo.com) 
New computed tomography techniques and new magnetic resonance sequences 
have led to an important improvement in temporal bone imaging. Computed to-
mography is the method of choice for imaging of conductive hearing loss, which 
can be caused by several factors, including developmental anomalies, middle ear 
inflammation, tumours, and temporal bone fractures. However, in some cases, 
magnetic resonance imaging can add important information. High-resolution 
computed tomography plays a critical role in the evaluation and management of 
conductive hearing loss. It is possible to demonstrate osteolysis, osteosclerosis and 
demineralization changes in otic capsule and ossicular chain. CT and MR may also 
visualize tumour, post-inflammatory changes in tympanic cavity and temporal bone 
trauma. MR is especially helpful when evaluating the presence of cholesteatoma 
in the middle ear and mastoid. Because of the ability of CT to demonstrate the 
detailed anatomy of temporal bone, thorough diagnosis of congenital malformations 
and anatomical variants is possible.
Learning Objectives:
1.  To review the most common causes of conductive hearing loss.
2.  To become familiar with the imaging findings in patients with conductive hearing 
loss.
3.  To differentiate the most frequent causes of conductive hearing loss.
A-620 16:30
B. Sensorineural hearing loss: a challenge for radiologists 
J. Casselman1, B. De Foer2; 1Bruges/BE, 2Antwerp/BE 
(jan.casselman@azbrugge.be) 
MR is the modality of choice in patients with sensorineural hearing loss (SNHL) 
and the complete auditory pathway from the cochlea to the auditory cortex must be 
studied in these patients. The labyrinth, internal auditory canal (IAC) and cerebel-
lopontine angle (CPA) are best studied using submillimetric heavily T2W images, 
showing the intralabyrinthine fluid and nerves. But submillimetric Gd-enhanced T1W 
images or 3D-Flair images remain more sensitive. The auditory pathway in the brain-
stem is best studied with a multi-echo sequence (m-FFE/medic/merge) or T2W TSE 
sequence and the auditory cortex is best studied on T2W TSE images. The most 
frequent pathology in the labyrinth is: labyrinthitis, intralabyrinthine schwannoma, 
congenital malformation, post-traumatic lesions. Unenhanced (trauma, hemorrhagic 
labyrinthitis) and Gd-enhanced T1W images are needed in these patients and both 
submillimetric T2W images and CT images are needed in the pre-operative work-up 
of cochlear implant candidates. Cochleovestibular schwannomas, meningiomas, 
epidermoid tumours and facial nerve neuritis are the most frequent lesions detected 
in the IAC and CPA. Contrast-enhancement is crucial in these patients although 
the IRIS phenomenon, as the patent deteriorates clinically, the PML lesions on MR 
enlarge and increased gadolinium enhancement can be seen within days to weeks. 
In this lecture, imaging characteristics and typical patterns of therapy-associated 
PML in MS and IRIS will be discussed. 
Learning Objectives:
1.  To become familiar with therapy options in multiple sclerosis (MS).
2.  To understand therapy induced complications.
3.  To understand the pathophysiology of immune reconstitution inflammatory 
syndrome (IRIS).
4.  To become familiar with imaging findings in IRIS.
16:00 - 17:30 Room I/K 
Chest 
RC 1904 
Phenotypes in obstructive airway disease: how 




A. Asthma and associated conditions 
P.-Y. Brillet; Bobigny/FR 
Asthma is a chronic inflammatory disorder of the airways responsible for recurrent 
episodes or airflow limitation. It is associated with airway hyperresponsiveness 
and remodelling. The role of CT is limited to patients with severe disease or for 
differential diagnosis. CT is important for the diagnosis of associated conditions 
(mainly, allergic bronchopulmonary aspergillosis and Churg Strauss syndrome). 
Special attention should be paid to acquisition protocols in young patients. Usual 
findings include bronchial (thickening of bronchial wall, decrease of lumen and distal 
bronchiectasis) and bronchiolar (mucoid impactions, air trapping) abnormalities. 
The role of imaging for characterisation of phenotypes will be discussed.
Learning Objectives:
1.  To learn more about the imaging findings in asthma and associated conditions, 
especially with low-dose and expiratory CT.
2.  To appreciate the potential to grade the severity of the disease from CT.
3.  To learn how to report findings indicative of asthma and associated conditions.
Author Disclosure:
P. -Y. Brillet: Speaker; Novartis. 
A-617 16:30
B. Chronic obstructive pulmonary disease (COPD) 
N. Sverzellati; Parma/IT (nicolasve@tiscali.it) 
Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mor-
bidity and mortality worldwide. It is a heterogeneous disease affecting the airways, 
the parenchyma as well as the vasculature with different severity during the course 
of the disease. Computed tomography (CT) with aid of dynamic expiratory scanning 
has become the standard modality to visualize and objectively quantitate emphy-
sema and airways disease. Differentiating between an emphysema-predominant 
and an airway-predominant phenotype via CT may clearly impact follow-up strategy 
and therapeutic decision making in clinical practice. It is also important to realize 
that a low-dose CT examination allows now a complete phenotypical definition of 
COPD. In addition, recent evidences suggest that both CT and magnetic reso-
nance imaging (MRI) may provide useful measures of the presence and severity 
of pulmonary vascular disease for clinical correlation. 
Learning Objectives:
1.  To learn more about the imaging findings in COPD, including low dose and 
expiratory CT.
2.  To become familiar with the concept of CT phenotyping: airway obstruction 
vs. alveolar destruction.
3.  To appreciate the radiological findings of remodelling of airways and pulmonary 
vasculature.
A-618 17:00
C. Cystic fibrosis and other bronchiectatic diseases 
M.U. Puderbach; Heidelberg/DE (m.puderbach@dkfz.de) 
Several different diseases go along with the development of bronchiectasis. 
Bronchiectasis may result from chronic infection, proximal airway obstruction, or 
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hyperechoic muscular fascia, while perforating veins traverse muscular fascia and 
connect deep with superficial veins. B-mode depicts anatomic detail (relevant to 
venous wall, valves, diameter, intraluminal content, course, tributaries). Retrograde 
flow (reflux) which is the diagnostic hallmark of CVI, is detectable by Color Dop-
pler; however, reflux is more reliably and quantitatively assessed by Pulsed-Wave 
Doppler. Reflux-provoking maneuvers include Valsalva (for proximal deep veins 
and saphenofemoral junction), Parana maneuver and distal manual compression 
with rapid release. Automatic inflation/deflation devices ensure more standardised 
and reproducible compression, but are not routinely used. Reflux lasting more 
than 0.5 seconds in superficial and perforating veins (and more than 1.0 second 
in deep veins) is indicative of insufficiency. In addition to its role for the diagnosis, 
for venous mapping and for postoperative evaluation, US is an integral part of the 
modern interventional treatments of CVI. In this context, US is indispensable for 
patient selection, intraprocedural guidance and follow-up. 
Learning Objectives:
1.  To become familiar with normal venous anatomy the indications for imaging 
and the US techniques.
2.  To learn about the typical and atypical appearances of venous pathology.
3.  To understand the potential pitfalls and limitations of US.
A-624 16:28
B. Rare venous diseases of the lower extremities 
M. Greiner1, P. Lemasle1, A. Bisdorff-Bresson2; 1Neuilly sur Seine/FR, 2Paris/FR 
(milka.greiner1@free.fr) 
Rare venous diseases of the lower extremities are challenging to diagnose due to 
their numerous and heterogeneous presentations and their lack of knowledge. They 
can be parted in: 1) local and simple venous malformations which can be truncular 
such as persistance of marginal, sciatic, lateral embryonic veins, venous aneurysms 
or extra truncular. The later are low-flow venous malformations and carry a high risk 
of recurrence when stimulated by trauma, hormonal changes or non-appropriate 
treatment. 2) Complex vascular malformations in which complete understanding 
of the malformation is needed before venous treatment. They are rare disorders 
of vascular development, present at birth but not always early diagnosed. They 
are often more complex than they appear. They include glomuvenous malforma-
tions, Klippel-Trénaunay Syndrome and other combined malformations without 
arterio-venous shunt. The differential diagnosis with regional or diffuse high-flow 
malformations with arterio-venous shunt such as Parkes-Weber Syndrome is not 
always easy and traditional eponyms have become obsolete. This topic highlights 
the differences in clinical appearance which allow the diagnosis in most of the cases, 
the place of the imaging study which confirms the diagnosis and which is important 
because in all these anomalies imaging instead of biopsy is now the standard for 
diagnostic confirmation and the main decision makings. Rare venous diseases of 
the lower limbs have to be known in order to establish appropriate treatment and 
follow-up and to avoid disastrous therapeutic consequences.
Learning Objectives:
1.  To become familiar with anatomic variants.
2.  To learn about anatomy with specific congenital disorders, such as persistent 
sciatic vein Klippel Trenaunay-Weber syndrome.
3.  To become familiar with differential diagnosis and pitfalls in the diagnosis of 
the above conditions.
A-625 16:51
C. CT venography and MR venography 
G. O’Sullivan, D.G. Lohan; Galway/IE (gerard.osullivan2@hse.ie) 
Both CT and MR venography are assuming greater significance in assessing 
particularly central venous structures prior to endovenous intervention. Obviously, 
they are both more expensive and less widely available than ultrasound and should 
not be used on every patient. Therefore, which patients should undergo CTV or 
MRV? In our institution, it is only symptomatic patients with limb swelling, ulcera-
tion, or significant post-thrombotic syndrome sequelae who merit either of these 
techniques. A detailed discussion of CT and MR-imaging parameters, contrast 
media injection protocols and flow dependent and independent techniques will 
be undertaken. A variery of pitfalls and artefacts can cause misinterpretation and 
these will be discussed with examples.
Learning Objectives:
1.  To learn about its indications and pros and cons compared to US.
2.  To become familiar with imaging parameters, contrast media protocols and 
flow dependent and flow independent techniques.
3.  To become familiar with pitfalls and artefacts that affect correct evaluation of 
imaging findings after endovascular treatments.
T2W-images are needed to confirm the presence of all nerve branches in the 
IAC and to distinguish epidermoid cysts from arachoid cysts. Multiple sclerosis, 
infarction, tumour and trauma are the lesions which are most often found along 
the central auditory pathway (brainstem/cortex). Contrast administration and DWI 
images are needed in the acute setting. In mixed hearing loss (sensorineural and 
conductive), otosclerosis must be excluded on CT. The above-mentioned imaging 
techniques and pathology will be illustrated and discussed.
Learning Objectives:
1.  To learn which imaging techniques should be used.
2.  To become familiar with the different causes of sensorineural hearing loss.
3.  To recognise and differentiate the imaging findings in the most frequent causes 
of sensorineural hearing loss.
A-621 17:00
C. Tinnitus and vertigo: diagnostic algorithm 
R.B. de Bondt; Zwolle/NL (rbjdebondt@gmail.com) 
Tinnitus: a buzzing or ringing in the ear, may be pulsatile or non-pulsatile, subjec-
tive or objective. Evaluation of patients with tinnitus requires a detailed history to 
determine if the patient also has hearing loss, vertigo, or headaches; a complete 
medical examination including a neurologic and ENT examination with audiologic 
evaluation. Accurate distinction of these entities and strategies determines the most 
appropriate imaging study. Vertigo: dizziness, is classified central or peripheral 
and might originate from different pathology of which the location is very difficult 
to differentiate on clinical examination. Therefore, a systemic radiological work up 
is mandatory based on the clinical setting. Imaging strategies - which modality 
when to use - and imaging protocols will be discussed. Most common pathology 
responsible for tinnitus or vertigo will be displayed.
Learning Objectives:
1.  To learn the most common causes.
2.  To understand imaging strategies.
3.  To become familiar with typical imaging findings.
16:00 - 17:30 Room P 
Vascular 
RC 1915 
Lower extremity venous insufficiency 
A-622 16:00
Chairman’s introduction 
D.J. West; Stoke‑on‑Trent/UK (davidwest@veincentre.com) 
Venous disease is very common and potentially lethal. In the United States, a first 
VTE happens in approximately 1 in every 1000 persons each year. This rises to 
500 per 1000 at the age of 80. Leg ulcers resulting from superficial and/or deep 
venous insufficiency occur in approximately 1% of population at some time in 
their lives usually over 65 years. Varicose veins adversely affect the quality of life 
of approaching 50% of the population. Rare venous disorders are challenging 
to diagnose and treat. Despite all this, venous disease is the cinderella among 
vascular diseases and too little attention is paid to its accurate management and 
appropriate treatment. Consequently, there are inumerable unnecessary deaths 
from VTE and untold distress from chronic ulceration which is still managed primarily 
by bandaging. Interventional radiologists are well trained and equipped to make a 
major impact in the management of most venous disease. It is a challenging and 
rewarding area and well suited to an introduction to “real” clinical care.
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A-623 16:05
A. Venous anatomy and ultrasound 
H. Moschouris; Piraeus/GR (hipmosch@in.gr) 
Chronic venous insufficiency (CVI) is a common vascular disease with significant 
clinical impact. Physical examination is not always adequate for the diagnosis 
and for the assessment of the extent of CVI; therefore, imaging investigation (with 
ultrasonography-US, as the primary modality) is very often required. US exami-
nation is performed with legs in a dependent position. Veins are interrogated in 
a segmental manner from groin to foot, with a linear, high frequency transducer. 
Lower limb veins can be divided in three systems, which can be readily appreci-
ated by US: superficial and deep veins lie respectively, above and beneath the 
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be needed to reach the right diagnosis. Unnecessary overuse of these imaging 
modalities, and the subsequent family anxiety that ensues from this overuse, should 
be avoided with careful analysis of the x-ray and clinical findings. 
Learning Objectives:
1.  To learn about normal variants in the neonatal and paediatric musculoskeletal 
system.
2.  To familiarise oneself with the imaging appearances of common normal vari-
ants.
3.  To understand how to differentiate between normal variants and disease.
4.  To learn how to integrate age, location and clinical history with the radiological 
features before establishing a diagnosis.
Panel discussion:  
Which imaging modality is best for planning endovascular 
management? 17:14 
16:00 - 17:30 Room Q 
Paediatric 
RC 1912 
Normal variants in paediatric imaging: not to be 





A. Rossi; Genoa/IT (andrearossi@ospedale‑gaslini.ge.it) 
The paediatric central nervous system is a complex structure undergoing rapid 
development. As such, there is a rapid, continuous modification of what is “normal” 
in relation with age and the stage of development. Knowledge of the normal patterns 
of brain development in the clinically relevant ages from 0 to 18 years is necessary 
to interpret neuroimaging findings correctly. Knowledge of embryology and normal 
variants is also greatly helpful. MR imaging equipment and parameters need to 
be adjusted and optimisation for paediatric studies. Pitfalls often occur from the 
misunderstanding of normal conditions, that are perceived as abnormal based on 
a comparison with the appearance of the normal brain in adults. This includes, for 
instance, the evaluation of the brain in the first 2-3 years of life during the course 
of the process of myelination. A summary of the most frequent conditions that may 
lead to misinterpretation of findings will be provided here. 
Learning Objectives:
1.  To learn about normal variants in the neonatal and child’s brain.
2.  To understand the typical imaging characteristics of normal variants that should 
suffice for correct interpretation.
3.  To become familiar with the differentiation between normal variants and dis-
ease.
A-627 16:30
B. Chest and abdomen 
S.G.F. Robben; Maastricht/NL (s.robben@mumc.nl) 
Many radiologists are reluctant to examine children because: a) they cry, b) do not 
listen, c) struggle, d) urinate, vomit and loose their stools all over the place, e) have 
annoying parents and f) demonstrate an enormous amount of normal variations. 
This is the rationale of the existence of paediatric radiologists. This refresher course 
intends to clarify item f). Unfortunately items a-e cannot be changed. 
Learning Objectives:
1.  To learn about normal variants in the neonatal and paediatric chest and abdo-
men.
2.  To familiarise oneself with the imaging appearances of common normal vari-
ants.
3.  To understand how to differentiate between normal variants and disease.
A-628 17:00
C. Musculoskeletal 
F. Saez; Bilbao/ES (fersaez@seram.org) 
The skeleton of a child is a developing system with a variety of changing normal 
appearances. Imaging studies, especially plain films, are requested for many 
clinical reasons, and the radiologist is in the position to determine if an image is 
a normal finding or we are dealing with a lesion. The way physis and epiphysis 
grow, ossify, and fuse constitutes a great source of physiologically bizarre appear-
ances, which the radiologist must be familiar with. This talk will concentrate on the 
plain film diagnosis of some of the most common musculoskeletal variants. Other 
imaging modalities will also be shown when appropriate for the case. Irregularities, 
asymmetries, partial fusions, hypo- or hyper-dense bone areas, accessory bones, 
prominent normal structures, external artifacts, and potential fracture lines are the 
most often encountered pseudolesions. A defective radiological technique may also 
be potentially misleading. Patient age, location of the supposed “abnormality” and 
lack of significant local symptoms are key factors. Usually plain films, correlated with 
regional clinical findings, are the only imaging method that is required. However, in 
certain doubtful situations, ultrasound, CT, MRI, Bone Scan, or even biopsy, may 
